 # of RX ,description,AMITRIPTYLINE,BUPROPION,CITALOPRAM,DESVENLAFAXINE,DOXEPIN,DULOXETINE,ESCITALOPRAM,FLUOXETINE,MIRTAZAPINE,NORTRIPTYLINE,OTHER,PAROXETINE,ROPINIROLE,SERTRALINE,TRAZODONE,VENLAFAXINE
  16 ,Age: 13-19 | Gender: Female,0.01200800534,0.06676386305,0.2838842322,0.2824716267,0.1089552239,0.2120123203,0.1374918843,0.2625168077,0.1077731881,0.04090909091,0.1876975494,0.2529902138,0.1328125,0.298520142,0.04183639767,0.2990056818
  2 ,"Age: 13-19 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",,,,,,,,0.3619047619,,,,,,0.3838862559,,
  2 ,Age: 13-19 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831),,0.03571428571,,,,,,,,,,,,0.4198895028,,
  2 ,Age: 13-19 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260),,,,,,,0.1255230126,,,,,,,0.3865336658,,
  2 ,"Age: 13-19 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",,,0.2983870968,,,,,,,,,,,0.3703703704,,
  1 ,Age: 13-19 | Gender: Female | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659),,,,,,,,0.3287197232,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.3888888889,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1333333333,,
  3 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.06944444444,0.1388888889,,,,,,0.1893491124,,
  3 ,Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,0.02416918429,,,,,0.1317829457,,,,,,,0.3620689655,,
  1 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.09322033898,,
  3 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.07643312102,0.1764705882,,,,,,0.1834862385,,
  5 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1617161716,,,,0.08505747126,0.1279863481,,,0.1226415094,,,0.1392961877,,
  2 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.119047619,,,,,,0.1391304348,,
  1 ,Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,,,,,,,,0.1960784314,,
  3 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.07446808511,0.1590106007,,,,,,0.1637168142,,
  1 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.1590909091,,,,,,,,
  3 ,Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02479338843,,,,,,0.1282051282,,,,,,0.186746988,,
  3 ,"Age: 13-19 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.0589569161,0.201754386,,,,,,0.1658536585,,
  1 ,Age: 13-19 | Gender: Female | ALBUTEROL,,,0.3858267717,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ALBUTEROL SULFATE,,,,,,,0.1530054645,,,,,,,,,
  9 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL,0.01582591494,0.06422018349,0.2702702703,,,0.1677419355,0.1086956522,0.234939759,,,0.2056410256,,,0.2765957447,,0.4403669725
  1 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL,,,,,,,,,,,0.1383928571,,,,,
  2 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE,,,0.3816793893,,,,,,,,0.223880597,,,,,
  2 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE,,,,,,,0.2105263158,,,,0.1478873239,,,,,
  3 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL,0.01388888889,,,,,,,0.3700440529,,,0.2008196721,,,,,
  1 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840),0.01315789474,,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,0.006802721088,,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.007407407407,,,,,,,,,,,,,,,
  4 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss,,,,,,,0.09433962264,0.3461538462,,,0.27734375,,,0.3881578947,,
  1 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.00542888165,,,,,,,,,,,,,,,
  3 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL,0.02112676056,,,,,,,,,,0.2051282051,,,0.3639240506,,
  1 ,Age: 13-19 | Gender: Female | AMITRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.170984456,,,,,
  5 ,"Age: 13-19 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.04724409449,,,,,0.1193016489,0.3107344633,,,,0.2756756757,,0.5092592593,,
  2 ,"Age: 13-19 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,0.1454545455,0.3168316832,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,,,,,,0.24375,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1055276382,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.05882352941,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.08762886598,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.0701754386,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1176470588,,,,,,,,,
  6 ,Age: 13-19 | Gender: Female | ARIPIPRAZOLE,,,0.1981981982,,,0.08666666667,0.05586592179,0.1635220126,,,,,,0.1224489796,,0.1513157895
  1 ,Age: 13-19 | Gender: Female | ARIPIPRAZOLE | ESCITALOPRAM OXALATE,,,,,,,,,,,0.09174311927,,,,,
  2 ,Age: 13-19 | Gender: Female | ARIPIPRAZOLE | FLUOXETINE HCL,,,,,,,,0.2045454545,,,0.1120689655,,,,,
  1 ,Age: 13-19 | Gender: Female | ARIPIPRAZOLE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.1153846154,,
  2 ,Age: 13-19 | Gender: Female | ARIPIPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.09589041096,,,0.1724137931,,
  1 ,Age: 13-19 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401),,0.03846153846,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.03846153846,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL,,0.04195804196,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | Last AD: Same & No Remiss,,0.01657458564,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04790419162,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.04365904366,,,,,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | AZITHROMYCIN,,,,,,,0.1968085106,,,,,,,0.3937823834,,
  10 ,Age: 13-19 | Gender: Female | BUPROPION HCL,,0.04494581631,0.2174688057,,,0.1415929204,0.121927237,0.2466555184,,,0.2142857143,0.2234042553,,0.2630434783,0.03351955307,0.25
  3 ,Age: 13-19 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,0.05445544554,0.327510917,,,,,,,,0.234375,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,,,,,,,,,0.16,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | DULOXETINE HCL,,,,,,,,,,,0.1455696203,,,,,
  5 ,Age: 13-19 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE,,0.02341137124,,,,,0.1930232558,0.248,,,0.1844660194,,,0.2676056338,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,,,,,0.1652173913,,,,,
  2 ,Age: 13-19 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.0206185567,,,,,0.2878787879,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.1443850267,,,,,
  5 ,Age: 13-19 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL,,0.06363636364,,,,,0.1139240506,0.2506224066,,,0.2163225172,,,0.2117647059,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04519774011,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1441441441,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1962616822,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2242990654,,,,,
  3 ,Age: 13-19 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | SERTRALINE HCL,,,,,,,,0.2746478873,,,0.1743119266,,,0.3361344538,,
  3 ,Age: 13-19 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,0.04605263158,,,,,,0.1804511278,,,0.158490566,,,,,
  2 ,Age: 13-19 | Gender: Female | BUPROPION HCL | LAMOTRIGINE,,,,,,,,0.1666666667,,,0.09243697479,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.09558823529,,,,,
  4 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss,,,,,,,0.1554054054,,,,0.2283464567,,,0.4272727273,0.04545454545,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02312138728,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.02898550725,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss,,0.02482269504,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.01485148515,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,0.01694915254,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5378787879,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5267857143,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.5403726708,,,,,
  2 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3450134771,,,,,,,,,0.4070660522,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.3076923077,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3341968912,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | MIRTAZAPINE,,,,,,,,,,,0.1927083333,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5339805825,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.1857923497,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1704781705,,,,,
  3 ,Age: 13-19 | Gender: Female | BUPROPION HCL | PAROXETINE HCL,,0.05128205128,,,,,,,,,0.2407407407,0.2722513089,,,,
  3 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.07604562738,,,,,,,,,0.05208333333,,,,,0.1525423729
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1653543307,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.07627118644,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1393442623,,,,,
  1 ,"Age: 13-19 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.25,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.06779661017,,,,,
  1 ,Age: 13-19 | Gender: Female | BUPROPION HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.08771929825,,,,,
  6 ,Age: 13-19 | Gender: Female | BUPROPION HCL | SERTRALINE HCL,,0.03237410072,0.1982758621,,,,0.1229050279,0.2298387097,,,0.2297297297,,,0.3023474178,,
  2 ,Age: 13-19 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,0.06086956522,,,,,,,,,0.1417624521,,,,,
  3 ,Age: 13-19 | Gender: Female | BUPROPION HCL | TRAZODONE HCL,,0.04943502825,,,,,,,,,0.1760738374,,,,0.0157480315,
  3 ,Age: 13-19 | Gender: Female | BUPROPION HCL | VENLAFAXINE HCL,,0.06481481481,,,,,,,,,0.1700288184,,,,,0.3072916667
  1 ,Age: 13-19 | Gender: Female | CEFDINIR,,,,,,,0.1641791045,,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | CETIRIZINE HCL,,,0.3725490196,,,,0.08256880734,,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,0.09090909091,,,,,,,0.3511450382,,
  11 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE,0.02586206897,0.04754601227,0.3401572467,,,0.198757764,0.1392857143,0.2339075249,,,0.1703406814,0.2025723473,,0.2726574501,0.005208333333,0.4397590361
  2 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,,,,,,0.25,,,,0.1601941748,,,,,
  5 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,0.06956521739,0.2990936556,,,,,0.3112244898,,,0.1546052632,,,0.2516556291,,
  1 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1570247934,,,,,
  4 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2941176471,,,,0.06741573034,0.22,,,,,,0.256097561,,
  1 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.05504587156,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,0.2679425837,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2313432836,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2843137255,,,,,,,,,,,,,
  4 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2672413793,,,,,0.1923076923,,,0.06611570248,,,0.2713178295,,
  1 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1227436823,,,,,,,,,,,,,
  6 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.02830188679,,,,,0.1567567568,0.3413173653,,,0.2009345794,,,0.3577586207,0,
  2 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,,,,,,0.247706422,,,,0.369047619,,,,,
  1 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.2548108825,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2209302326,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2647058824,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.5742092457,,,,,,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.575,,,,,,,,0.472,,,,,
  3 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2926829268,,,,,,,,0.1036585366,,,0.1203703704,,
  1 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2242990654,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.06703910615,,,,,
  4 ,"Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.4344827586,,,,,0.1557377049,,,0.09142857143,,,0.1455696203,,
  1 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,0.5815602837,,,,,,,,,,,,,
  6 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,0.03921568627,0.312039312,,,,0.2115384615,0.2173913043,,,0.1397379913,,,0.3164179104,,
  3 ,Age: 13-19 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,0.2385057471,,,,,,,,0.1883333333,,,,0.016,
  3 ,Age: 13-19 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016),,,0.2890625,,,,,0.3023255814,,,,,,0.2962962963,,
  2 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,,,,,,0.214953271,,,,,,0.2246376812,,
  10 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.02312138728,0.02717391304,0.3349056604,,,,0.1330589849,0.31678487,,,0.1604278075,0.304,,0.4180138568,0.04568527919,0.4194630872
  1 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.513986014,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.3315789474,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.504587156,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840)",0.005128205128,,,,,,,,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.06086956522,0.1604938272,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.07284768212,,,,,,0.09803921569,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.3190954774,,,,,,0.4013157895,,
  1 ,"Age: 13-19 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.5271317829,,
  1 ,Age: 13-19 | Gender: Female | DESOGESTREL-ETHINYL ESTRADIOL,,,,,,,,,,,,,,0.4444444444,,
  2 ,Age: 13-19 | Gender: Female | DESVENLAFAXINE SUCCINATE,,,,0.2973760933,,,,,,,0.1700680272,,,,,
  3 ,Age: 13-19 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE,,,,,,,0.09036144578,0.2869565217,,,,,,0.4303482587,,
  1 ,Age: 13-19 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,,,,,,,0.4722222222,,
  1 ,Age: 13-19 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | SERTRALINE HCL,,,,,,,,,,,,,,0.5169491525,,
  1 ,Age: 13-19 | Gender: Female | DIZZINESS AND GIDDINESS (dxo:ICD9:7804),,,,,,,,0.2816901408,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | DOXEPIN HCL,,,,,0.1555555556,,,,,,0.1883116883,,,,,
  3 ,Age: 13-19 | Gender: Female | DULOXETINE HCL,,,,,,0.2396053559,0.1639344262,,,,0.1465076661,,,,,
  1 ,Age: 13-19 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.1428571429,,,,,
  1 ,Age: 13-19 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL,,,,,,,,,,,0.149122807,,,,,
  1 ,Age: 13-19 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.06481481481,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.1237458194,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.3865546218,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.2151394422,,,,,0.1448598131,,,,,
  12 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE,0.01162790698,0.03526448363,0.4004237288,,,0.3245614035,0.1820750908,0.2246056782,0.07185628743,,0.139314845,0.2397959184,,0.2517613903,0.03892215569,0.4423076923
  5 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,0.04347826087,,,,,0.1585160202,0.2937293729,,,0.1348511384,,,0.2114695341,,
  2 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,0.1538461538,0.2566371681,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,0.1240310078,,,,0.1466666667,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,,,,0.05769230769,,,,,
  4 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2293577982,,,,0.1347708895,0.1384615385,,,,,,0.203125,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.05454545455,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.1214285714,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.09401709402,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.09865470852,,,,,,,,,
  3 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1111111111,,,,0.06474820144,,,0.1944444444,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,0.1139240506,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,,,,,0.06626506024,,,,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.05940594059,,,,,
  7 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.03001876173,0.4761904762,,,,,0.3344947735,,,0.1133603239,,,0.3737113402,0.04975124378,0.4695121951
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.2857142857,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2016806723,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.08296943231,,,,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03333333333,,,,,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.2397660819,,,,,,,,0.007462686567,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,,,,,0.4936708861,,,,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1015089163,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.1283783784,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.06796116505,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.09302325581,,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,0.1446540881,,,,,,,0.2173913043,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.4697336562,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.5034482759,,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.3817330211,,,,0.4105263158,,,,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,,,,,0.1709401709,,,,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1184210526,,,,,
  3 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1587301587,,,0.05381165919,,,0.1428571429,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.02290076336,,,,,
  2 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.165,,,,,,0.1772151899,,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.08465608466,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.08612440191,,,,,
  4 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1984126984,0.1877022654,,,0.1228070175,,,0.1623188406,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.1009174312,,,,,
  1 ,"Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1111111111,,,,,
  5 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL,,0.02816901408,,,,,0.1390728477,0.2112211221,,,0.1330561331,,,0.3081861958,,
  3 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,0.1310344828,,,,0.0981595092,,,0.2321428571,,
  3 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.170212766,,,,0.1423401689,,,,0.01435406699,
  1 ,Age: 13-19 | Gender: Female | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,,,,,0.1607142857,,,,,
  3 ,Age: 13-19 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE,,,0.3428571429,,,,0.1344537815,,,,,,,0.4372469636,,
  1 ,Age: 13-19 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1338582677,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,,,,0.1982758621,,
  3 ,"Age: 13-19 | Gender: Female | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1369047619,,,,,0.1869158879,,,,,,0.1333333333,,
  1 ,"Age: 13-19 | Gender: Female | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,0.125,,
  1 ,"Age: 13-19 | Gender: Female | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1791044776,,
  13 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL,0.02730375427,0.05855599773,0.2367549669,,,0.1914414414,0.1150372988,0.3042067234,0.09872611465,0.03738317757,0.1542443064,0.2270363951,,0.2490504612,0.02272727273,0.3684210526
  3 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,0.2169491525,,,0.05511811024,,,0.15,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.1804511278,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,0.1474654378,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.15,,,,,,,,
  5 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2101910828,,,,0.07508532423,0.3181818182,,,,,,0.2022058824,,0.2016806723
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.07389162562,,,,,,,,,
  3 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.0737704918,,,,0.09302325581,,,0.1964285714,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.2059620596,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1578947368,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.1278195489,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2085308057,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.171314741,,,,,,0.09836065574,,
  3 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.1769230769,,,0.06504065041,,,0.07843137255,,
  4 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.188034188,,,,,0.25,,,0.1066666667,,,0.1961722488,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,,0.252173913,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,0.21,,,0.13,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,,0.1860465116,,,,,,,,
  3 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1082024433,,,0.04639175258,,,0.15625,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,,0.07407407407,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,0.09243697479,,,0.112,,,,,
  6 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.03488372093,0.3360655738,,,,0.1154791155,,,,0.1956521739,,,0.3537234043,0.01860465116,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.4671532847,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,0.1327433628,,
  2 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.06299212598,,,,0.09266409266,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.04132231405,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.02105263158,
  4 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.2290076336,,,,,0.3,,,,0.3344709898,,,0.4964539007,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.2333582648,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.3090909091,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.3636363636,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1485849057,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.1493506494,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2244897959,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.1597222222,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.245243129,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.3155893536,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,0.192513369,,,,,,0.2671755725,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,0.2321428571,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.5131233596,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.5632183908,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,0.6019900498,,,,,,,,
  5 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.357615894,,,,,0.3442622951,0.4236760125,,,0.4037940379,,,0.3953488372,,
  2 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,0.4375,,,0.2869565217,,,,,
  2 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.17,,,0.1533742331,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.4637681159,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1482649842,,,,,
  2 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | PAROXETINE HCL,,,,,,,,0.3381294964,,,,0.3169014085,,,,
  4 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.07826086957,,,,,0.226744186,,,0.07142857143,,,0.1078431373,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.04651162791,,,,,
  2 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.1927083333,,,0.05555555556,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.2790697674,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.328,,,,,,0.1523809524,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.09385113269,,,,,
  2 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.3403141361,,,0.09170305677,,,,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.07547169811,,,,,
  6 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1811594203,,,,0.05759162304,0.3488773748,,,0.124260355,,,0.1716981132,,0.1893491124
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,,,,,,,,0.1057692308,,
  1 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.1102362205,,,,,
  2 ,"Age: 13-19 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,0.25,,,0.168,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | RISPERIDONE,,,,,,,,,,,0.1287128713,,,,,
  1 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.4847250509,,,,,,,,
  6 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL,,0.05555555556,0.2723004695,,,,0.08656716418,0.272007913,,,0.1355932203,,,0.285313377,,
  3 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,0.219895288,,,0.1403508772,,,0.2430555556,,
  6 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | TRAZODONE HCL,,0.04395604396,,,,,0.09649122807,0.2597799511,,,0.1598207618,,,0.243902439,0.03076923077,
  2 ,Age: 13-19 | Gender: Female | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,0.3153153153,,,0.1564885496,,,,,
  2 ,Age: 13-19 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.03529411765,,,,,0.132183908,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.04807692308,,,,,,,,,
  6 ,Age: 13-19 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.4314720812,,,,0.1178451178,0.3407407407,,,,0.3035714286,,0.4143426295,,0.6015625
  5 ,Age: 13-19 | Gender: Female | HEADACHE (dxo:ICD9:7840),0.004850746269,0.03738317757,,,,,,0.3189655172,,0.02450408401,,,,0.4102564103,,
  2 ,"Age: 13-19 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.001739130435,,,,,,,,,0.04310344828,,,,,,
  1 ,"Age: 13-19 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",0,,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | HEADACHE (dxo:ICD9:7840) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0,,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | HEADACHE (dxo:ICD9:7840) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),0.006060606061,,,,,,,,,,,,,,,
  3 ,Age: 13-19 | Gender: Female | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.1464788732,0.3475609756,,,,,,0.3786407767,,
  1 ,Age: 13-19 | Gender: Female | IBUPROFEN,,,,,,,,,,,,,,0.42,,
  8 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.01408450704,0.1502145923,,,,0.05521472393,0.1134020619,,,0.09803921569,,,0.1438679245,0.01315789474,0.1590909091
  5 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.08653846154,,,,0.05769230769,0.09615384615,,,,,,0.1361702128,,0.185840708
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1196581197,,
  3 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.04444444444,0.08088235294,,,,,,0.1288659794,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.1610738255,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1790393013,,
  2 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.06422018349,,,,,,,0.1441441441,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.088,,,,,
  2 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,,,,,,0.09302325581,,,0.206779661,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.2075471698,,
  9 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.1756272401,,,0.1218274112,0.07672796449,0.1446679526,,,0.06779661017,0.1521961185,,0.1597287184,0.04419889503,0.1866501854
  3 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.07246376812,0.1074380165,,,,,,0.06722689076,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.06862745098,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.0396039604,,,,,
  3 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,0.05586592179,0.170212766,,,0.09803921569,,,,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,0.0572519084,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2393162393,,,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.152173913,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1361256545,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.2603174603,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.2717842324,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.09756097561,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.632,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1538461538,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29623) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1043478261,,
  3 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,,,,,0.05714285714,,,,,0.3212121212,,0.1875,,
  5 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1547619048,,,,,0.1232394366,,,,,,0.08602150538,0.05309734513,0.1266375546
  5 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1428571429,,,,0.08602150538,0.1135371179,,,,,,0.075,,0.1226415094
  2 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.04026845638,,,0.1811594203,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.1153846154,,
  2 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,0.1078431373,,,,,,0.2116788321,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.1612903226,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1711711712,,
  9 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1577484364,,,0.09836065574,0.07190710138,0.1324599709,,,0.1149897331,0.1390449438,,0.1469489415,0.02912621359,0.1381733021
  4 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,0.1506849315,,,,,0.1161103048,,,,0.1208791209,,0.1428571429,,
  4 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,0.2416666667,,,,,0.1904761905,,,0.1203007519,,,0.3085714286,,
  2 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.1225806452,,,,,,0.1419354839,,
  2 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.1460674157,,,,,,0.179245283,,
  6 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,0.2705882353,,,,0.06112469438,0.2213740458,,,0.1067961165,,,0.3150470219,,0.2014925373
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.2605042017,,
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3564356436
  5 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.1388888889,,,,0.07718120805,0.1279069767,,,,,,0.1089918256,,0.08870967742
  1 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1142857143,,
  2 ,"Age: 13-19 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,0.08870967742,,,0.2679738562,,
  3 ,"Age: 13-19 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.3615384615,,,,,,0.43359375,0.003875968992,
  7 ,Age: 13-19 | Gender: Female | LAMOTRIGINE,,,0.09547738693,,,0.07112970711,0.06761565836,0.1119631902,,,0.0648312611,,,0.1229050279,,0.1287128713
  1 ,Age: 13-19 | Gender: Female | LAMOTRIGINE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.06451612903,,
  1 ,"Age: 13-19 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.3162393162,,,,,
  3 ,Age: 13-19 | Gender: Female | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,0.0962962963,,,0.08196721311,,,0.1037181996,,
  1 ,Age: 13-19 | Gender: Female | LAMOTRIGINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,0.07272727273,,
  1 ,Age: 13-19 | Gender: Female | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.09549795362,,,,,
  2 ,Age: 13-19 | Gender: Female | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.0737704918,,,,,0.09502262443
  1 ,Age: 13-19 | Gender: Female | Last AD: Diff & No Remiss,,,,,,,,,,,,,,,0,
  1 ,"Age: 13-19 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5350318471,,
  3 ,Age: 13-19 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.0487804878,,,,,0.1157024793,,,,,,,0.3965517241,,
  2 ,"Age: 13-19 | Gender: Female | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.05454545455,0.104,,,,,,,,
  2 ,"Age: 13-19 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.05970149254,,,,0.1003584229,,,,,
  7 ,Age: 13-19 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02962962963,0.2371134021,,,,0.108892922,0.3342465753,,,0.1920903955,,,,0.02242152466,0.373015873
  1 ,Age: 13-19 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.009803921569,
  1 ,Age: 13-19 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2290502793,,,,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Diff & Remiss,,,,,,,,,,,,,,,0.1941176471,
  4 ,Age: 13-19 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL,,0.1267605634,,,,,0.2745098039,0.4375,,,0.3805555556,,,,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.1486486486,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss,,,,,,,,,,,0.08860759494,,,,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1056910569,,,,,,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.009803921569,,,,,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.38,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.2166666667,,,,
  1 ,"Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1761904762,,
  1 ,"Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.2523364486,,
  1 ,"Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.3148148148,,
  1 ,"Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.2319749216,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202) | SERTRALINE HCL,,,,,,,,,,,,,,0.3705583756,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.2669502127,,
  2 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1652173913,,,0.2358490566,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.009259259259,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.2774674115
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & Remiss,,,,,,,,,,,0.4403669725,,,,,
  1 ,"Age: 13-19 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.5620437956,,,,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.524691358,,,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & Remiss | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202) | SERTRALINE HCL,,,,,,,,,,,,,,0.5826771654,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5707317073,,
  1 ,Age: 13-19 | Gender: Female | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5151515152,,,,,
  2 ,Age: 13-19 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL,,,0.35,,,,,,,,,,,0.44397463,,
  1 ,Age: 13-19 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,,,,,,,0.4234234234,,
  1 ,Age: 13-19 | Gender: Female | LISDEXAMFETAMINE DIMESYLATE,,,,,,,,,,,,,,0.3445378151,,
  2 ,Age: 13-19 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,0.32,,,,,,0.3669724771,,
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.5330188679,,,,,
  5 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4651162791,,,,,0.5378787879,0.6216216216,,,0.5538461538,,,0.5777777778,,
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,,,,0.593495935,,
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.5348837209,,,,,
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,0.1844660194,,
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1441441441,,
  9 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3702531646,0.6213592233,,,0.4031620553,0.4161979753,0.442155309,,,0.4295857988,,,0.5070754717,0.2723004695,0.4263959391
  4 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,0.35,0.4316939891,,,0.4611398964,,,0.5055350554,,
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5046728972,,
  2 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3881334981,,,,0.253968254,
  2 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.4160583942,,,,,0.4708333333
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.06470588235,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1727272727,,
  1 ,"Age: 13-19 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.08823529412,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | METHYLPHENIDATE HCL,,,,,,,,,,,,,,0.380952381,,
  2 ,"Age: 13-19 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.007407407407,,,,,,0.09345794393,,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | MIRTAZAPINE,,,,,,,,,0.157323689,,0.1614035088,,,,,
  2 ,Age: 13-19 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.2051282051,,,0.2745098039,,
  1 ,Age: 13-19 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.1343873518,,,,,
  1 ,Age: 13-19 | Gender: Female | MONTELUKAST SODIUM,,,,,,,,0.3714285714,,,,,,,,
  5 ,Age: 13-19 | Gender: Female | MYOPIA (dxo:ICD9:3671),,0.05681818182,0.3560209424,,,,0.1560693642,0.4044117647,,,,,,0.4032786885,,
  2 ,Age: 13-19 | Gender: Female | MYOPIA (dxo:ICD9:3671) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.3643410853,,,,,,0.4375,,
  2 ,Age: 13-19 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.05418719212,,,,,0.1643835616,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | NORETHINDRONE-E.ESTRADIOL-IRON,,,,,,,0.1602209945,,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | NORGESTIMATE-ETHINYL ESTRADIOL,,,0.3495934959,,,,,,,,,,,0.4439834025,,
  2 ,Age: 13-19 | Gender: Female | NORTRIPTYLINE HCL,,,,,,,,,,0.05462184874,0.1953125,,,,,
  1 ,"Age: 13-19 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5367231638,,
  1 ,Age: 13-19 | Gender: Female | Num Previous Antidep: 4+,,,,,,,,,,,0.1666666667,,,,,
  1 ,Age: 13-19 | Gender: Female | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1556886228,,,,,
  1 ,Age: 13-19 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1075757576,,,,,
  1 ,Age: 13-19 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.1325301205,,,,,
  1 ,Age: 13-19 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1769911504,,,,,
  1 ,Age: 13-19 | Gender: Female | OMEPRAZOLE,,,,,,,0.2153846154,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | OTHER ACNE (dxo:ICD9:7061),,,0.3626373626,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | OTHER GENERAL COUNSELING AND ADVICE FOR CONTRACEPTIVE MANAGEMENT (dxo:ICD9:V2509),,,,,,,,0.2877697842,,,,,,,,
  4 ,Age: 13-19 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.05213270142,,,,,0.1355932203,0.3873873874,,,,,,0.525862069,,
  1 ,Age: 13-19 | Gender: Female | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,,,,,0.09166666667,,,,,,,,,
  2 ,Age: 13-19 | Gender: Female | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.1463414634,0.3366336634,,,,,,,,
  1 ,Age: 13-19 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,,,,,,,,,,,,,0.3986928105,,
  8 ,Age: 13-19 | Gender: Female | PAROXETINE HCL,,0.04318181818,0.2475247525,,,,0.09977827051,0.2563559322,,,0.1364452424,0.3100436681,,0.2961832061,0.03947368421,
  2 ,"Age: 13-19 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.06666666667,0.2487046632,,,,
  1 ,Age: 13-19 | Gender: Female | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1262135922,,,,,
  3 ,Age: 13-19 | Gender: Female | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.2254901961,0.2873563218,,0.3240223464,,
  3 ,Age: 13-19 | Gender: Female | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2164179104,0.2752293578,,,0.0652173913,
  10 ,"Age: 13-19 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04743833017,0.1804008909,,,0.1428571429,0.141509434,0.1215753425,,,0.07614213198,0.1062801932,,0.1119648738,0.02465753425,0.1531393568
  3 ,"Age: 13-19 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07746478873,0.0701754386,,,,,,0.1244019139,,
  1 ,"Age: 13-19 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.05418719212,,,,,
  4 ,"Age: 13-19 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,0.1,,,,,0.1428571429,,,0.06970509383,,,0.276504298,,
  2 ,"Age: 13-19 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1286549708,,,0.1629955947,,
  1 ,"Age: 13-19 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2097902098
  2 ,"Age: 13-19 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.145631068,,,,,0.2238095238
  1 ,Age: 13-19 | Gender: Female | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.247706422,,,,,
  1 ,"Age: 13-19 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.2243589744,,
  1 ,"Age: 13-19 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.3267973856,,
  2 ,Age: 13-19 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,0.09444444444,0.2744360902,,,,,,,,
  4 ,Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.1962616822,,,,0.1038647343,0.1758499414,,,,,,0.1981382979,,
  3 ,"Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.0325203252,0.1105769231,,,,,,0.1379310345,,
  5 ,"Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1282051282,,,,0.08205689278,0.1406326034,,,0.1203007519,,,0.1497560976,,
  3 ,"Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.07386363636,0.1413043478,,,,,,0.1367924528,,
  2 ,"Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.1151515152,,,,,,0.1511111111,,
  2 ,"Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,0.1183673469,,,,,,0.3076923077,,
  3 ,"Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.05,0.1596244131,,,,,,0.1231527094,,
  1 ,Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.1794871795,,,,,,,,
  3 ,Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792),,,,,,,0.09433962264,0.2355555556,,,,,,0.3333333333,,
  9 ,Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0.007142857143,0.05091649695,0.1581699346,,,,0.07915567282,0.1598746082,,,0.1216389245,0.1111111111,,0.1752321981,,0.2134831461
  2 ,Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.1590909091,,,,,,0.1975308642,,
  2 ,Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.1157024793,,,0.3357142857,,
  1 ,Age: 13-19 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1391304348,,,,,
  4 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,0.1260504202,,,0.06629834254,0.1304347826,,,,,,0.1683168317,,
  1 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.09900990099,,,,,,,,
  1 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.09243697479,,,,,
  2 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.09266409266,,,0.3846153846,,
  10 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1347150259,0.1361256545,,0.1195652174,0.08073770492,0.1472031403,,,0.09523809524,0.1488095238,,0.1478982875,0.02424242424,0.1574344023
  4 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.1216216216,,,,0.08115183246,0.1538461538,,,,,,0.1302170284,,
  1 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.2211538462,,
  1 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.1212121212,,,,,,,,
  6 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,0.1104294479,,,,0.08333333333,0.1631701632,,,0.1365187713,,,0.2931034483,,0.1711711712
  2 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1755725191,,,0.2572815534,,
  1 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3025210084
  3 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,0.075,0.1214285714,,,,,,0.0625,,
  3 ,"Age: 13-19 | Gender: Female | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.0652173913,0.152,,,,,,0.1656441718,,
  6 ,Age: 13-19 | Gender: Female | RISPERIDONE,,,0.09166666667,,,,0.0380952381,0.1013513514,,,0.1053484603,,,0.09595959596,,0.1366459627
  2 ,Age: 13-19 | Gender: Female | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.09401709402,,,0.1369294606,,
  1 ,Age: 13-19 | Gender: Female | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.08502024291,,,,,
  2 ,Age: 13-19 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,0.1052631579,,,,,,,0.4299065421,,
  5 ,Age: 13-19 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.0162601626,,,,,,0.1502145923,0.3895348837,,,0.1176470588,0.2872340426,,,,
  7 ,Age: 13-19 | Gender: Female | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),0.004777070064,,0.3292383292,,,,,0.3146034533,,,,0.2777777778,,0.3811063218,0.02491103203,0.4184100418
  1 ,Age: 13-19 | Gender: Female | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202) | SERTRALINE HCL,,,,,,,,,,,,,,0.552238806,,
  1 ,"Age: 13-19 | Gender: Female | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202) | UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",,,,,,,,,,,,,,0.3762376238,,
  2 ,Age: 13-19 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.3106508876,,,,,,,,,,,0.4086378738,,
  12 ,Age: 13-19 | Gender: Female | SERTRALINE HCL,0.01823708207,0.03808864266,0.2402968037,,,0.2538071066,0.1276302173,0.2431023912,0.08429118774,,0.1723209478,0.2412398922,,0.3413204037,0.02868852459,0.4219512195
  6 ,Age: 13-19 | Gender: Female | SERTRALINE HCL | TRAZODONE HCL,,0.07042253521,,,,,0.1194029851,0.152866242,,,0.2052052052,,,0.294653706,0.01213592233,
  2 ,Age: 13-19 | Gender: Female | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1700680272,,,0.347826087,,
  2 ,Age: 13-19 | Gender: Female | SUICIDAL IDEATION (dxo:ICD9:V6284),,,0.2869565217,,,,,,,,,,,0.2191780822,,
  1 ,Age: 13-19 | Gender: Female | SUMATRIPTAN SUCCINATE,,,,,,,,,,,,,,0.4473684211,,
  2 ,Age: 13-19 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.247706422,,,,,,0.3172413793,,
  1 ,Age: 13-19 | Gender: Female | TOPIRAMATE,,,,,,,,,,,,,,0.3839285714,,
  9 ,Age: 13-19 | Gender: Female | TRAZODONE HCL,,0.05752212389,0.2412060302,,,0.1842105263,0.05454545455,0.1577777778,,,0.1909752295,,,0.2326388889,0.02583798883,0.2005347594
  3 ,Age: 13-19 | Gender: Female | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1934156379,,,,0.02564102564,0.2696629213
  1 ,Age: 13-19 | Gender: Female | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,,,,,,,,,,,,0.3859649123,,
  4 ,Age: 13-19 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.2432432432,0.0979020979,0.3819444444,,,,,,0.3782991202,,
  1 ,Age: 13-19 | Gender: Female | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.453038674,,
  4 ,Age: 13-19 | Gender: Female | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3426966292,,,,0.1006289308,0.296819788,,,,,,0.3676767677,,
  1 ,"Age: 13-19 | Gender: Female | UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",,,,,,,,,,,,,,0.4162436548,,
  3 ,"Age: 13-19 | Gender: Female | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,0.131147541,0.3691588785,,,,,,0.3597359736,,
  7 ,Age: 13-19 | Gender: Female | VENLAFAXINE HCL,,0.04205607477,0.2392638037,,,,0.1489361702,0.2447916667,,,0.1628686327,,,0.2664907652,,0.3212335368
  1 ,Age: 13-19 | Gender: Female | VOMITING ALONE (dxo:ICD9:78703),,,,,,,,0.2857142857,,,,,,,,
  15 ,Age: 13-19 | Gender: Male,0.01156642432,0.05294588438,0.250501002,0.2644628099,0.1213720317,0.198920586,0.1392090166,0.2472190333,0.101762365,0.06037735849,0.1625669279,0.2470845481,,0.2687846204,0.02617018095,0.2629217516
  1 ,"Age: 13-19 | Gender: Male | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",,,,,,,,,,,,,,0.3551401869,,
  1 ,"Age: 13-19 | Gender: Male | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",,,,,,,,,,,,,,0.2162162162,,
  1 ,Age: 13-19 | Gender: Male | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659),,,,,,,,0.3486842105,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,0.02928870293,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,,,,0.1875,,
  4 ,"Age: 13-19 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1370967742,,,,0.09793814433,0.09545454545,,,,,,0.1424731183,,
  3 ,"Age: 13-19 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.0701754386,0.1339285714,,,,,,0.1515151515,,
  1 ,Age: 13-19 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,,,,0.1132075472,,
  1 ,"Age: 13-19 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.05769230769,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ALBUTEROL SULFATE,,,,,,,0.213740458,,,,,,,,,
  4 ,Age: 13-19 | Gender: Male | AMITRIPTYLINE HCL,0.00726744186,,,,,,,0.2403846154,,,0.1674641148,,,0.2222222222,,
  1 ,Age: 13-19 | Gender: Male | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,0,,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.006644518272,,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | AMITRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.3047619048,,
  1 ,Age: 13-19 | Gender: Male | AMITRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1588785047,,,,,
  3 ,"Age: 13-19 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.06470588235,,,,,0.1068376068,,,,,0.3116883117,,,,
  5 ,Age: 13-19 | Gender: Male | ARIPIPRAZOLE,,,0.1031746032,,,,0.1025641026,0.09770114943,,,,,,0.1115702479,,0.1538461538
  1 ,Age: 13-19 | Gender: Male | ARIPIPRAZOLE | FLUOXETINE HCL,,,,,,,,0.09,,,,,,,,
  2 ,Age: 13-19 | Gender: Male | ARIPIPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.1619047619,,,0.1133333333,,
  2 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401),,0.03564223268,,,,,,,0.04987531172,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.04081632653,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | METHYLPHENIDATE HCL,,0.04098360656,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.02459016393,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL,,0.02310231023,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | Last AD: Same & No Remiss,,0.02005730659,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.007092198582,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.02051282051,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.008474576271,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.03669724771,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | METHYLPHENIDATE HCL,,0.03829787234,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | MIRTAZAPINE,,,,,,,,,0.1355932203,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.02784810127,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02564102564,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.01668984701,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL,,0.01515151515,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL | Last AD: Same & No Remiss,,0.01379310345,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | METHYLPHENIDATE HCL,,0.007352941176,,,,,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Male | AZITHROMYCIN,,,,,,,0.1493506494,,,,,,,0.2784810127,,
  11 ,Age: 13-19 | Gender: Male | BUPROPION HCL,,0.03338795576,0.2184210526,,,0.1776649746,0.1218045113,0.2190860215,0.06730769231,,0.1881413911,0.2340425532,,0.2002902758,0.01724137931,0.228021978
  3 ,Age: 13-19 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,0.04666666667,0.2684563758,,,,,,,,0.1868131868,,,,,
  3 ,Age: 13-19 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE,,0.01069518717,,,,,0.2051835853,,,,0.1666666667,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.01503759398,,,,,,,,,,,,,,
  4 ,Age: 13-19 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL,,0.05542168675,,,,,,0.2518628912,,,0.1896869245,,,0.1782945736,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04761904762,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1440677966,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | LAMOTRIGINE,,,,,,,,,,,0.0956937799,,,,,
  3 ,Age: 13-19 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss,,,,,,,0.09345794393,,,,0.2071005917,,,,0,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.04225352113,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.02183406114,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss,,0.01453287197,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.0126984127,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss,,,,,,,,,,,0.4964539007,,,,,
  2 ,"Age: 13-19 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.2741312741,,,,,,,,,0.4413793103,,,,,
  1 ,"Age: 13-19 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3577235772,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | MIRTAZAPINE,,,,,,,,,,,0.1885964912,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1527093596,,,,,
  3 ,Age: 13-19 | Gender: Male | BUPROPION HCL | PAROXETINE HCL,,0.03623188406,,,,,,,,,0.1727272727,0.2397660819,,,,
  2 ,"Age: 13-19 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03166226913,,,,,,,,,0.09356725146,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.16,,,,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.08936170213,,,,,
  4 ,Age: 13-19 | Gender: Male | BUPROPION HCL | SERTRALINE HCL,,0.05378973105,,,,,,0.2192982456,,,0.188365651,,,0.2603174603,,
  1 ,Age: 13-19 | Gender: Male | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2293577982,,,,,
  3 ,Age: 13-19 | Gender: Male | BUPROPION HCL | TRAZODONE HCL,,0.0408997955,,,,,,,,,0.1571218796,,,,0.007352941176,
  2 ,Age: 13-19 | Gender: Male | BUPROPION HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1415929204,,,,,0.2612612613
  8 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE,,0.03361344538,0.2952860955,,,,0.1237113402,0.1867321867,,,0.1457627119,0.264516129,,0.2371541502,0.008771929825,
  2 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,,0.1983471074,,,,,,,,0.1366906475,,,,,
  1 ,"Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.380952381,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,0.2058823529,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.06930693069,,,,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.03351955307,,,,,,,,,0.21,,,,,
  1 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.2303370787,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.573964497,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2356020942,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,0.1,,,,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,,0.3006535948,,,,,,,,,,,0.2405063291,,
  2 ,Age: 13-19 | Gender: Male | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,0.2176470588,,,,,,,,0.1290322581,,,,,
  8 ,"Age: 13-19 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.03418803419,0.3767123288,,,,0.1617977528,0.3098591549,,,0.128,,,0.4375,0.01910828025,0.4069767442
  1 ,"Age: 13-19 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.46,,,,,,,,
  2 ,"Age: 13-19 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08653846154,0.06363636364,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.02906976744,,,,,,,,,,,,,,
  2 ,"Age: 13-19 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.2404371585,,,,,,0.4649122807,,
  1 ,Age: 13-19 | Gender: Male | DESVENLAFAXINE SUCCINATE,,,,0.29375,,,,,,,,,,,,
  3 ,Age: 13-19 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE,,,,,,,0.15,0.335443038,,,,,,0.3630136986,,
  1 ,Age: 13-19 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,,,,,,,0.4032258065,,
  1 ,Age: 13-19 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE | SERTRALINE HCL,,,,,,,,,,,,,,0.4965034965,,
  2 ,Age: 13-19 | Gender: Male | DULOXETINE HCL,,,,,,0.2403225806,,,,,0.1441048035,,,,,
  1 ,Age: 13-19 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.1337579618,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.2735849057,,,,,,,,,,
  10 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE,,0.02972399151,0.452173913,,,,0.1921406412,0.205834684,0.07382550336,,0.1301694915,0.219895288,,0.2233796296,0.02717391304,0.4247787611
  2 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,0.1464435146,,,,0.125,,,,,
  1 ,"Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1611111111,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1341991342,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1570247934,,,,,,,,,
  5 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.02,,,,,,0.3063063063,,,0.1596244131,,,0.4028776978,0.03149606299,
  1 ,"Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.09009009009,,,,,
  1 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1110320285,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.104,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.4885844749,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.3756345178,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1261261261,,,,,
  1 ,"Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.07518796992,,,,,
  1 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.06796116505,,,,,
  2 ,"Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.09239130435,,,0.1533333333,,
  1 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,,,,,0.06034482759,,,,,
  3 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,0.1497797357,,,,0.1333333333,,,0.29296875,,
  3 ,Age: 13-19 | Gender: Male | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.1487603306,,,,0.1229946524,,,,0.01973684211,
  2 ,"Age: 13-19 | Gender: Male | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1584158416,,,,,,,,,,,0.1030534351,,
  1 ,"Age: 13-19 | Gender: Male | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.09259259259,,
  11 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL,,0.04710920771,0.2165137615,,,0.1313868613,0.125120308,0.3002985075,0.0811965812,,0.1412300683,0.1890909091,,0.2125506073,0.01408450704,0.357615894
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,0.25,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,0.1794871795,,,,,,,,
  3 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1047619048,0.3358208955,,,,,,0.1981132075,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.2138728324,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2363636364,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2253521127,,,,,,,,
  2 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3358778626,,,0.1467889908,,,,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,0.1162790698,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.09090909091,,,,,,,,
  5 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.003039513678,,,,,0.09868421053,,,,0.135,,,0.3134328358,0,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.04807692308,,,,,
  1 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.2298507463,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1685393258,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2258064516,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2510822511,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.2739726027,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.5640394089,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.6796116505,,,,,,,,
  2 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.5245901639,,,0.427480916,,,,,
  2 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.2631578947,,,0.125,,,,,
  1 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1059907834,,,,,
  3 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2341920375,,,0.1020408163,,,0.1025641026,,
  1 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.296,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1363636364,,,,,
  2 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.1726618705,,,0.1166666667,,,,,
  4 ,"Age: 13-19 | Gender: Male | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1136363636,0.3252595156,,,0.1170731707,,,0.1920903955,,
  2 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | RISPERIDONE,,,,,,,,0.1165644172,,,0.08108108108,,,,,
  1 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.4705882353,,,,,,,,
  4 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | SERTRALINE HCL,,,,,,,0.06617647059,0.2574257426,,,0.1310679612,,,0.2638888889,,
  3 ,Age: 13-19 | Gender: Male | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.253814147,,,0.169527897,,,,0.0243902439,
  1 ,Age: 13-19 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.03333333333,,,,,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Male | HEADACHE (dxo:ICD9:7840),0.01321003963,,,,,,,,,0.03813559322,,,,,,
  1 ,"Age: 13-19 | Gender: Male | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.01183431953,,,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | HEADACHE (dxo:ICD9:7840) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),0.005649717514,,,,,,,,,,,,,,,
  3 ,Age: 13-19 | Gender: Male | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.1230769231,0.3015873016,,,,,,0.3541666667,,
  1 ,Age: 13-19 | Gender: Male | IBUPROFEN,,,,,,,,,,,,,,0.3537414966,,
  1 ,Age: 13-19 | Gender: Male | IMIPRAMINE HCL,,,,,,,,,,,0.03571428571,,,,,
  7 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.04237288136,0.149068323,,,,0.07831325301,0.111627907,,,,,,0.1224489796,0.01212121212,0.1052631579
  2 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.08125,,,,,,,0.08,,
  2 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08208955224,,,,,,,0.06611570248,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.1769911504,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1446540881,,
  2 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.06666666667,,,,,,,0.1634615385,,
  2 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,,,,,,0.07547169811,,,0.2410071942,,
  9 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.1588486141,,,0.1587301587,0.0880952381,0.1422643746,,,0.09160305344,0.1260229133,,0.1481012658,0.02962962963,0.1939252336
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.04716981132,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,0.04838709677,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1504424779,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.25,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.24,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,,,,,,,,,,0.419047619,,,,
  4 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.05511811024,,,,,0.1176470588,,,,,,0.1162079511,,0.08661417323
  3 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.0487804878,0.1153846154,,,,,,0.1029411765,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.1683168317,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1789473684,,
  7 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1492957746,,,,0.08488964346,0.1375494071,,,0.08921933086,0.1415929204,,0.1323692992,,0.1434599156
  3 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.1311953353,,,,0.1487603306,,0.1145833333,,
  2 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1261261261,,,0.2721893491,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.1739130435,,,,,,,,
  3 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,0.0752688172,0.1946902655,,,,,,0.3045977011,,
  4 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.07382550336,,,,0.06756756757,0.07575757576,,,,,,0.08150470219,,
  1 ,"Age: 13-19 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,,,,0.2158273381,,
  2 ,"Age: 13-19 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.3404255319,0.01276595745,
  6 ,Age: 13-19 | Gender: Male | LAMOTRIGINE,,,0.06134969325,,,,0.05109489051,0.0977443609,,,0.04380952381,,,0.1048034934,,0.119266055
  1 ,Age: 13-19 | Gender: Male | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,,,,0.07462686567,,
  1 ,Age: 13-19 | Gender: Male | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.0796812749,,,,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Diff & No Remiss,,,,,,,,,,,,,,,0,
  1 ,"Age: 13-19 | Gender: Male | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.09090909091,,,,,
  5 ,Age: 13-19 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.01794871795,,,,,0.1255411255,0.3172413793,,,0.1666666667,,,,0.04487179487,
  1 ,Age: 13-19 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.01538461538,
  2 ,Age: 13-19 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,0.34375,,,,0.3827160494,,,,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss,,,,,,,,,,,0.05172413793,,,,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.06418918919,,,,,,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.2936507937,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.2350230415,,,,
  1 ,"Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1848184818,,
  1 ,"Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.2677824268,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,,,,0.078125,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202) | SERTRALINE HCL,,,,,,,,,,,,,,0.3490566038,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.251984127,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.01052631579,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1921824104
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5656565657,,
  1 ,Age: 13-19 | Gender: Male | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.504,,,,,
  1 ,Age: 13-19 | Gender: Male | LISDEXAMFETAMINE DIMESYLATE,,,,,,,,,,,,,,0.3739837398,,
  2 ,"Age: 13-19 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4955752212,,,,,,,,,0.5451977401,,,,,
  7 ,"Age: 13-19 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3230769231,,,,,0.4285714286,0.464028777,,,0.4255319149,,,0.5288461538,0.2376237624,0.5384615385
  1 ,"Age: 13-19 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.5403225806,,
  1 ,"Age: 13-19 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3595505618,,,,,
  1 ,"Age: 13-19 | Gender: Male | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.05833333333,,,,,,,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.05504587156,,,,,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Male | METHYLPHENIDATE HCL,,0.009090909091,,,,,,,,,,,,0.3487179487,,
  1 ,Age: 13-19 | Gender: Male | METHYLPHENIDATE HCL | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,,,,,,,0.347107438,,
  2 ,Age: 13-19 | Gender: Male | MIRTAZAPINE,,,,,,,,,0.1302998966,,0.1421965318,,,,,
  3 ,Age: 13-19 | Gender: Male | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.1226415094,,0.1896551724,,,0.2922077922,,
  1 ,Age: 13-19 | Gender: Male | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.1687763713,,,,,
  3 ,Age: 13-19 | Gender: Male | MYOPIA (dxo:ICD9:3671),,0.009708737864,,,,,,0.3428571429,,,,,,0.4347826087,,
  1 ,Age: 13-19 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02659574468,,,,,,,,,,,,,,
  2 ,Age: 13-19 | Gender: Male | NORTRIPTYLINE HCL,,,,,,,,,,0.07784431138,0.1666666667,,,,,
  1 ,Age: 13-19 | Gender: Male | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1549295775,,,,,
  1 ,Age: 13-19 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.08863198459,,,,,
  1 ,Age: 13-19 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.08333333333,,,,,
  1 ,Age: 13-19 | Gender: Male | OTHER ACNE (dxo:ICD9:7061),,,0.3435114504,,,,,,,,,,,,,
  1 ,Age: 13-19 | Gender: Male | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.06,,,,,,,,,,,,,,
  8 ,Age: 13-19 | Gender: Male | PAROXETINE HCL,,0.06153846154,0.2443181818,,,,0.136,0.265917603,,,0.1401617251,0.2993630573,,0.2585227273,0.04587155963,
  1 ,"Age: 13-19 | Gender: Male | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.2571428571,,,,
  1 ,Age: 13-19 | Gender: Male | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.3333333333,,
  1 ,Age: 13-19 | Gender: Male | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.231884058,,,,
  8 ,"Age: 13-19 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03452855246,0.1120218579,,,,,0.1165644172,,,0.06334841629,0.07567567568,,0.1373555841,0.01098901099,0.108033241
  3 ,"Age: 13-19 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08333333333,0.08108108108,,,,,,0.1538461538,,
  1 ,"Age: 13-19 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.08737864078,,,,,
  3 ,"Age: 13-19 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,0.1833333333,,,0.0725388601,,,0.25,,
  1 ,"Age: 13-19 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.09174311927,,
  1 ,"Age: 13-19 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2196969697
  4 ,Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.2051282051,,,,0.07346938776,0.2062084257,,,,,,0.2121896163,,
  1 ,"Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.1495327103,,,,,,,,
  4 ,"Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1257142857,,,,0.05726872247,0.144766147,,,,,,0.1375,,
  2 ,"Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,,0.1298701299,,,,,,0.07643312102,,
  2 ,"Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",,,,,,,,0.1325966851,,,,,,0.1217391304,,
  3 ,Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792),,,,,,,0.1126760563,0.2179487179,,,,,,0.2896551724,,
  9 ,Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.04752475248,0.1354166667,,,,0.07620320856,0.1332560834,0.04424778761,,0.08502024291,0.1060606061,,0.1402671756,,0.1474358974
  2 ,Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,0.1388888889,,,,,,0.09900990099,,
  1 ,Age: 13-19 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.1111111111,,,,,
  2 ,"Age: 13-19 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.05217391304,0.1172413793,,,,,,,,
  1 ,"Age: 13-19 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.07258064516,,,,,
  7 ,"Age: 13-19 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1364829396,,,,0.07502287283,0.1504491018,,,0.1050228311,,,0.1326034063,0.007575757576,0.1769230769
  2 ,"Age: 13-19 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.1006289308,,,,,,,0.08374384236,,
  4 ,"Age: 13-19 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.05303030303,0.1807228916,,,0.1283185841,,,0.2865497076,,
  1 ,"Age: 13-19 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,0.07619047619,,,,,,,,
  2 ,"Age: 13-19 | Gender: Male | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.0796460177,,,,,,,0.1793103448,,
  6 ,Age: 13-19 | Gender: Male | RISPERIDONE,,,0.075,,,,0.05882352941,0.07782101167,,,0.06099110546,,,0.1160714286,,0.1377245509
  2 ,Age: 13-19 | Gender: Male | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.09166666667,,,0.1170212766,,
  1 ,Age: 13-19 | Gender: Male | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.09795918367,,,,,
  3 ,Age: 13-19 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.09900990099,,,,,0.1755725191,,,,,,,0.41,,
  7 ,Age: 13-19 | Gender: Male | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),0.007547169811,,0.3111111111,,,,,0.291087963,,,,0.3129032258,,0.3647944412,0.01276595745,0.3253968254
  1 ,Age: 13-19 | Gender: Male | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202) | SERTRALINE HCL,,,,,,,,,,,,,,0.5544871795,,
  11 ,Age: 13-19 | Gender: Male | SERTRALINE HCL,,0.04907306434,0.2116182573,,,0.1734104046,0.1191626409,0.2192439863,0.1239316239,,0.1669525443,0.226044226,,0.3194815882,0.02702702703,0.3828571429
  3 ,Age: 13-19 | Gender: Male | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1928721174,,,0.2689486553,0.02127659574,
  1 ,Age: 13-19 | Gender: Male | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,0.2844036697,,
  1 ,Age: 13-19 | Gender: Male | SUICIDAL IDEATION (dxo:ICD9:V6284),,,,,,,,,,,,,,0.204379562,,
  9 ,Age: 13-19 | Gender: Male | TRAZODONE HCL,,0.0572519084,0.1709401709,,,0.1531531532,0.09595959596,0.1855670103,,,0.164851671,,,0.1705882353,0.01706970128,0.1721854305
  2 ,Age: 13-19 | Gender: Male | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1490384615,,,,,0.2537313433
  1 ,Age: 13-19 | Gender: Male | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.3619047619,,
  1 ,"Age: 13-19 | Gender: Male | UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",,,,,,,,,,,,,,0.3392857143,,
  5 ,Age: 13-19 | Gender: Male | VENLAFAXINE HCL,,0.03703703704,,,,,0.1449275362,,,,0.1462333826,,,0.3111111111,,0.294197031
  16 ,Age: 20-40 | Gender: Female,0.01870076493,0.05587382085,0.4293897751,0.4398037138,0.1445163187,0.340869398,0.1809321283,0.4060326444,0.1508036691,0.06954302079,0.2731660462,0.3769337051,0.2183381089,0.4550471654,0.03394144345,0.4530869967
  7 ,"Age: 20-40 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",,0.01315789474,0.3963414634,,,,0.125,0.4390243902,,0.02777777778,,,,0.4588045234,,0.4826789838
  1 ,"Age: 20-40 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,,,,,,,,,,0.5290322581
  1 ,"Age: 20-40 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900) | SERTRALINE HCL",,,,,,,,,,,,,,0.5963855422,,
  1 ,"Age: 20-40 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",,,,,,,,,,,,,,0.4234234234,,
  1 ,"Age: 20-40 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.4511278195,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500),,,,,,,0.1134289439,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,,,,,,0.1914893617,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | ESCITALOPRAM OXALATE,,,,,,,0.298013245,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.0873015873,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.1230769231,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.125748503,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831),,0.02995008319,,,,,0.1438356164,,,,,0.387755102,,0.4847074468,,0.5161290323
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,0.03731343284,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.01628664495,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0.009708737864,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL,,0.04899135447,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.02027027027,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | Last AD: Same & No Remiss,,0.01948842875,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | CITALOPRAM HYDROBROMIDE,,0.02985074627,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.02380952381,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.05,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ESCITALOPRAM OXALATE,,0.01485148515,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.01612903226,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | FLUOXETINE HCL,,0.03684210526,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.009433962264,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.01680672269,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,0.3625,,0.5982905983,,
  1 ,"Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.4608695652,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.01333333333,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3803921569,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.599137931,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03873239437,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.02673796791,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.03571428571,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | PAROXETINE HCL,,,,,,,,,,,,0.5977653631,,,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | POLYCYSTIC OVARIES (dxo:ICD9:2564),,0.03333333333,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.05940594059,,,,,0.1730769231,,,,,0.3441558442,,,,
  2 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | SERTRALINE HCL,,0.02252252252,,,,,,,,,,,,0.6424242424,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.4406779661,,
  1 ,Age: 20-40 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | VENLAFAXINE HCL,,0.04587155963,,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260),,,0.4394904459,,,,0.123683005,,,,0.1181818182,,,0.436211115,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,,,,,,0.1229773463,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.09375,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.488,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5459183673,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.547008547,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4893617021,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5634920635,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4710743802,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5033783784,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ESCITALOPRAM OXALATE,,,,,,,0.252688172,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1422413793,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2363636364,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.125748503,,,,,,,0.5745856354,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.1386861314,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | IBUPROFEN | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4336283186,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1744966443,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.4452554745,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | Last AD: Same & No Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5740740741,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3638888889,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | Last AD: Same & No Remiss | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4842767296,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5339805825,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.09900990099,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | NORETHINDRONE | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4666666667,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | NORETHINDRONE | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5865921788,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.4310160428,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4178082192,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL",,,,,,,,,,,,,,0.6755319149,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.646875,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4644236073,,
  1 ,"Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,,,,,,,0.4403292181,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1293859649,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,,,,,,,,,,,,0.3706896552,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4785714286,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5431472081,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | SERTRALINE HCL,,,,,,,,,,,,,,0.6057803468,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.6837416481,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5017196905,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.4292682927,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.4045801527,,
  1 ,Age: 20-40 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.3890784983,,
  3 ,Age: 20-40 | Gender: Female | ACETAMINOPHEN WITH CODEINE,,,0.4,,,,,,,,,,,0.4285714286,,0.45
  1 ,Age: 20-40 | Gender: Female | ACUTE GASTRITIS WITHOUT MENTION OF HEMORRHAGE (dxo:ICD9:53500),,,0.3833333333,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",,,0.4693877551,,,,,,,,,,,0.5181818182,,
  2 ,"Age: 20-40 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619) | AZITHROMYCIN",,,0.4453125,,,,,,,,,,,0.5617283951,,
  1 ,"Age: 20-40 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619) | CITALOPRAM HYDROBROMIDE",,,0.6393442623,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,0.5495495495,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619) | SERTRALINE HCL",,,,,,,,,,,,,,0.5912408759,,
  1 ,Age: 20-40 | Gender: Female | ACUTE TONSILLITIS (dxo:ICD9:463),,,,,,,,,,,0.1363636364,,,,,
  2 ,Age: 20-40 | Gender: Female | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659),,,0.4933333333,,,,,0.4377289377,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659) | FLUOXETINE HCL,,,,,,,,0.6174496644,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.4070351759,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924),,,,,,,0.1401869159,,,,,,,0.4503311258,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,,,,0.19,,
  2 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07518796992,,,,,,,0.265,,
  5 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090),,0.02272727273,0.4270833333,,,,0.1126005362,0.4578947368,,,,,,0.484939759,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | FLUOXETINE HCL,,,,,,,,0.6,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.07432432432,0.2429906542,,,,,,0.3181818182,,
  4 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2278481013,,,,0.06859205776,0.1604278075,,,,,,0.1965065502,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.06086956522,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02362204724,,,,,0.09615384615,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1168831169,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | SERTRALINE HCL,,,,,,,,,,,,,,0.6451612903,,
  5 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,0.02713347921,0.4306220096,,,,0.1413043478,0.3928571429,,,,,,0.4345047923,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.009433962264,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.05982905983,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07666666667,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.08547008547,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.009433962264,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL,,0.0275862069,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.03773584906,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | Last AD: Same & No Remiss,,0.01520912548,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.01910828025,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.03370786517,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.384,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.28125,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2716049383,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.008474576271,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.01851851852,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE,,0.01769911504,,,,,0.1893939394,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1666666667,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1157894737,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1061946903,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2718446602,,,,0.1271676301,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.01183431953,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.09022556391,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1518987342,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1647058824,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.2105263158,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.3714285714,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.2732919255,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2415458937,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3601532567,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.06024096386,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.06666666667,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1917808219,,,,0.06115107914,,,,,,,,,
  7 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2438095238,,,,0.08183079057,0.2051282051,,,0.06086956522,0.23,,0.2277777778,,0.2677165354
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.2972027972,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.2780487805,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.05769230769,,,,,,,,,
  9 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.04545454545,0.2080223881,,,0.2096774194,0.06293222683,0.1946607341,,,0.1198347107,0.2,,0.1985915493,,0.2188841202
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.05367231638,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.3089171975,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2457627119,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.08823529412,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.3745318352,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.006756756757,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03141361257,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,0.1092436975,,,,,,,0.2413793103,,
  4 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1621621622,,,,0.071875,0.2045454545,,,,,,0.1995841996,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.09615384615,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.08609271523,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.4272727273,,
  5 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02606635071,0.2326283988,,,,0.06575963719,0.2508710801,,,,,,0.2798264642,,
  1 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.05,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2063492063,,,,0.07592407592,0.2949640288,,,,,,0.1933333333,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.06329113924,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.06603773585,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | SERTRALINE HCL,,0.05309734513,,,,,,,,,,,,0.593495935,,
  4 ,Age: 20-40 | Gender: Female | ALBUTEROL,,0.01954397394,0.4543889845,,,,,,,,,0.380952381,,,,0.5413533835
  1 ,Age: 20-40 | Gender: Female | ALBUTEROL | CITALOPRAM HYDROBROMIDE,,,0.575,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALBUTEROL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.4879518072,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ALBUTEROL SULFATE,,,,,,,0.1648351648,,,,,,,,,0.4637681159
  1 ,Age: 20-40 | Gender: Female | ALBUTEROL SULFATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1443298969,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALBUTEROL SULFATE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6833333333
  1 ,"Age: 20-40 | Gender: Female | ALLERGY, UNSPECIFIED NOT ELSEWHERE CLASSIFIED (dxo:ICD9:9953)",,,0.347826087,,,,,,,,,,,,,
  6 ,Age: 20-40 | Gender: Female | ALPRAZOLAM,,0.03333333333,0.4304635762,,,,0.1652360515,0.4529411765,,,,,,0.4571230982,,0.5015673981
  2 ,"Age: 20-40 | Gender: Female | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,,,,,,0.1659919028,0.3308823529,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,0.157480315,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1380952381,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | BUPROPION HCL,,0.05797101449,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | BUPROPION HCL | Last AD: Same & No Remiss,,0.01769911504,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | CITALOPRAM HYDROBROMIDE,,,0.602739726,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.4051724138,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ALPRAZOLAM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,0.5490196078,,,,,,,,,,,,,0.5438596491
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | ESCITALOPRAM OXALATE,,,,,,,0.2727272727,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.141509434,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | FLUOXETINE HCL,,,,,,,,0.5792349727,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,,,0.5515463918,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.1607142857,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4031746032,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5714285714,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,,,,,,,,,,,,,0.375,,
  2 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.0396039604,,,,,0.1135734072,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | SERTRALINE HCL,,,,,,,,,,,,,,0.5899705015,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.3928571429,,
  1 ,Age: 20-40 | Gender: Female | ALPRAZOLAM | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.4455445545,,
  14 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL,0.03101862676,0.03464947623,0.3827893175,0.4050632911,,0.3149405772,0.1343390805,0.3822393822,0.1900826446,0.0487804878,0.2982039986,0.2763915547,,0.409733124,0.01395348837,0.4077134986
  7 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL,0.04570383912,0.05882352941,,,,0.2857142857,0.1416666667,0.4761904762,,,0.2576656775,,,,,0.3666666667
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,,0.419047619,,,,,,,,0.2826086957,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL,,,,,,,,,,,0.2918660287,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE,,,,,,,0.2413793103,,,,0.2108843537,,,,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL,,0.03787878788,,,,,,0.4689655172,,,0.3185595568,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.4375,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | HEADACHE (dxo:ICD9:7840),0.03305785124,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | LAMOTRIGINE,,,,,,,,,,,0.1030042918,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1138211382,,,,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss,0.03333333333,0.05354330709,,,,,,,,,0.1532846715,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03862660944,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.1509433962,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss,,0.03378378378,,,,,,,,,0.1931818182,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.3902439024,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5065789474,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.5253164557,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4566473988,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2737430168,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2228070175,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.2666666667,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | PAROXETINE HCL,,,,,,,,,,,0.2105263158,,,,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | SERTRALINE HCL,,0.0487804878,,,,,,,,,0.3352769679,,,0.4383561644,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | TRAZODONE HCL,,0.07006369427,,,,,,,,,0.18230563,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2941176471,,,,,0.5047619048
  7 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE,0.01419878296,0.04545454545,0.5274803712,,,,0.1509433962,0.3421052632,,,0.3142857143,,,0.3333333333,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840),0.009523809524,,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,0.01851851852,,0.5977653631,,,,,,,,0.3688212928,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.6028368794,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.5744680851,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.5729166667,,,,,,,,0.2797202797,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,,0.6956521739,,,,,,,,0.320754717,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3416666667,,,,,,,,0.3166666667,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,,,,,,,,,0.4903225806,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5807860262,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,0.5533333333,,,,,,,,0.2478632479,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,,,,,,,,,,0.2571428571,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.03783783784,,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss",0.01333333333,,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",0.01709401709,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DESVENLAFAXINE SUCCINATE,,,,,,,,,,,0.2133333333,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DOXEPIN HCL,,,,,,,,,,,0.237804878,,,,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL,0.05167173252,,,,,0.4878640777,,,,,0.3248587571,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2571428571,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,0.5860465116,,,,,0.4387096774,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.375,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5357142857,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.3333333333,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.4013605442,,,,,0.2767857143,,,,,
  6 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE,0.03554868624,0.008064516129,0.5247524752,,,,0.2949956102,,,,0.2400722022,,,0.4112149533,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | HEADACHE (dxo:ICD9:7840),0.01652892562,,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0.01935483871,,,,,,0.3019230769,,,,0.2958801498,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3215130024,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.2872340426,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2976190476,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1642857143,,,,0.1902173913,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,,,,,0.248,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.2789115646,,,,0.1734693878,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,,,,,0.2037037037,,,,,
  5 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL,0.03364879075,0.04827586207,,,,,0.1619047619,0.5214408233,,,0.3045936396,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840),0.01481481481,,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,0.0243902439,,,,,,,,,,0.3533123028,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.5984095427,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.5448028674,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3017751479,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,0.7074829932,,,0.4074074074,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6956521739,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.2857142857,,,0.3160621762,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5816993464,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.5984095427,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.474137931,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.4836601307,,,0.2838427948,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2456140351,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,0.2913385827,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,,,,,0.2635658915,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840),0.01278772379,,,,,,,,,0.05670103093,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,,,,,,,,,,0.05882352941,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",,,,,,,,,,0.1,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,0.007610350076,,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.002739726027,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01242236025,,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.004716981132,,,,,,,,,0.07926829268,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | SERTRALINE HCL,0.02255639098,,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.05982905983,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1300813008,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.3571428571,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4059405941
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE,,,,,,,,,,,0.1056218058,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.06956521739,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.0730994152,,,,,
  11 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss,,0.032,0.3699421965,,,0.329305136,0.1140350877,0.3882352941,,0.02127659574,0.2580645161,0.222972973,,0.4450757576,0,0.4377358491
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5612244898,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6543624161,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2661290323,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.3756097561,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.3137254902,,,,,0.6206896552
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.3116883117,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,0.01948051948,,,,,,,,,,0.4296875,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.3,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.1928571429,,,,0,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3333333333,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4083769634,,,,,0.6666666667
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6754385965,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,0.03472222222,,,,,,,,,,0.4033613445,,,0.6694915254,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7165354331
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.01157024793,,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.006006006006,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,0.008968609865,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.3125,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01308900524,,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,0.01449275362,,,,,,,,,,0.410041841,,,0.4223602484,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.3818181818,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5409139214,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7166666667,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.593220339,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.4752475248,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.522875817,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.5966386555,,,,,
  2 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2690909091,,,,,,,,,,0.5028653295,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.3366336634,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.398255814,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.01886792453,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE,,,,,,,,,,,0.2604166667,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2710280374,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2101449275,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2372881356,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL,0.01923076923,,,,,,,,,,0.2989690722,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.6635514019,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6489028213,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2444987775,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2481315396,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2824427481,,,,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | PAROXETINE HCL,0.02184466019,,,,,,,,,,0.3135048232,0.4873501997,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2912621359
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4326923077,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1408450704,,,,,
  1 ,"Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.09482758621,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.3006756757,,,,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01307189542,,,,,,,,,,,,,,,
  9 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL,0.03083700441,0.02083333333,0.4153846154,,,0.3055555556,0.1144578313,0.376,,,0.3670143416,,,0.5477117819,,0.5660377358
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2883895131,,,0.512195122,,
  1 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4830508475,,
  3 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | TRAZODONE HCL,0.08906882591,,,,,0.1696428571,,,,,0.2361070273,,,,,
  2 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2647058824,,,,,0.5294117647
  4 ,Age: 20-40 | Gender: Female | AMITRIPTYLINE HCL | VENLAFAXINE HCL,0.04867256637,,,,,,0.1584158416,,,,0.3080324245,,,,,0.6186594203
  10 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",0.0243902439,0.02400662252,0.4280442804,,,,0.143972343,0.435105068,,0.06086956522,,0.3505908835,,0.4912280702,0.01941747573,0.5102880658
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",,0.03225806452,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL",,0.03228476821,,,,,0.1772151899,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss",,0.04395604396,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04046242775,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.04620462046,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.02692307692,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE",,,,,,,0.3138686131,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.03488372093,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03896103896,,,,,0.4615384615,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3383084577,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss",,0.02083333333,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.02307692308,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss",,0.009259259259,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss",,,,,,,0.1391941392,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.03636363636,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.04166666667,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.03225806452,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL",,0.04117647059,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0.01739130435,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02127659574,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02068965517,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUSPIRONE HCL",,,,,,,0.1442307692,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CETIRIZINE HCL",,,,,,,0.1777777778,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE",,0.04526748971,,,,,0.3047945205,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss",,0.01083032491,,,,,0.2184300341,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss",,0.06201550388,,,,,0.2928571429,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM",,0.02366863905,,,,,0.1639344262,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM | ESCITALOPRAM OXALATE",,,,,,,0.3333333333,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1181818182,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1935483871,,,,,,,,,
  7 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.02411347518,0.4097222222,,,,0.1379800853,0.442159383,,,,0.3716814159,,0.4832535885,,0.5294117647
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,0.2666666667,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.08421052632,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1366906475,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.3333333333,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.577092511,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.4193548387,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.5818181818,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,0.1666666667,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01801801802,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.04301075269,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.5,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1789709172,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.547008547,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,0.02517985612,,,,,0.3025276461,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1981981982,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.106557377,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1139240506,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.2237762238,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.01531728665,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.3220338983,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.3225806452,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1305578011,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,0.156424581,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,0.1105398458,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1067961165,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.108974359,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1251819505,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss",,,,,,,0.5642458101,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.6258064516,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,0.3161290323,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1779661017,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.33243607,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ETHINYL ESTRADIOL/DROSPIRENONE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1450777202,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL",,0.03529411765,,,,,0.2326732673,0.5835616438,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL | Last AD: Diff & No Remiss",,0.01169590643,,,,,0.1333333333,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL | Last AD: Diff & Remiss",,,,,,,0.3523809524,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.3956043956,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.615819209,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GABAPENTIN",,,,,,,0.1689189189,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,0.01127819549,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GUAIFENESIN/P-EPHED HCL",,,,,,,0.1848739496,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,0.1349325337,,,,,0.4146341463,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.04761904762,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL",,,,,,,,,,,,0.5313653137,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | HYDROCODONE/ACETAMINOPHEN",,,,,,,0.1803278689,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.08045977011,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.06793478261,,,,,0.1920529801,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.03553299492,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | PAROXETINE HCL",,0.01639344262,,,,,0.1789473684,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL",,,,,,,0.1678321678,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.02452316076,,,,,0.1670146138,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.1057692308,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,0.03149606299,,,,,0.1388888889,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & Remiss | SERTRALINE HCL",,0.04663212435,,,,,0.2754237288,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.3010471204,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.25,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.6101694915,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | LORAZEPAM",,0.02575107296,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | MORBID OBESITY (dxo:ICD9:27801)",,,,,,,0.1674641148,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | MYOPIA (dxo:ICD9:3671)",,0.03603603604,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02376910017,,,,,0.1389728097,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1714285714,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01156069364,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OMEPRAZOLE",,,,,,,0.09836065574,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.02158273381,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1226415094,,,,,0.343373494,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PALPITATIONS (dxo:ICD9:7851) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1135531136,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",,0.03418803419,,,,,,,,,,0.3618421053,,,,
  3 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL",,0.03184713376,,,,,0.2448979592,,,,,0.5240641711,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.5021645022,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,0.1243781095,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",,,,,,,0.0932642487,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.07643312102,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.03614457831,,,,,0.09653465347,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.09,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.09722222222,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.007142857143,,,,,0.1466666667,,,,,0.2868020305,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL",,,,,,,0.2357142857,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,0.1666666667,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,0.1052631579,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SERTRALINE HCL",,0.02102102102,,,,,0.2555331992,,,,,,,0.7170731707,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.006060606061,,,,,,,,,,0.3398058252,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",,,,,,,0.09900990099,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,0.1409395973,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,0.1768707483,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | VALACYCLOVIR HCL",,0.02608695652,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | VENLAFAXINE HCL",,0.02836879433,,,,,0.2569832402,,,,,,,,,
  8 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE,,,0.1436170213,0.1417910448,,0.1565656566,0.1,0.1328671329,,,0.1383928571,,,0.1421319797,,0.2142857143
  3 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL,,,,,,0.1126760563,,,,,0.09293680297,,,,,0.1862745098
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.1363636364,,,,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | FLUOXETINE HCL,,,,,,,,,,,0.1470588235,,,,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | LAMOTRIGINE,,,,,,,,,,,0.06542056075,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | SERTRALINE HCL,,,,,,,,,,,0.1708860759,,,0.1764705882,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | TRAZODONE HCL,,,,,,,,,,,0.06306306306,,,,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.2702702703
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | CITALOPRAM HYDROBROMIDE,,,0.1843971631,,,,,,,,0.135483871,,,,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.1160714286,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | DESVENLAFAXINE SUCCINATE,,,,0.1973684211,,,,,,,0.1262135922,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL,,,,,,0.1843971631,,,,,0.1513513514,,,,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.1096774194,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.2013422819,,,,,0.1637931034,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | ESCITALOPRAM OXALATE,,,,,,,0.1544715447,,,,0.1360294118,,,,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.07425742574,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.1047619048,,,,0.1386861314,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | FLUOXETINE HCL,,,,,,,,0.2151394422,,,0.1265822785,,,,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.101910828,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.1869158879,,,0.1415929204,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | LAMOTRIGINE,,,,0.1160714286,,0.09448818898,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.1337209302,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.2,,,0.2045454545,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1160714286,,,0.2076923077,,
  1 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | TRAZODONE HCL,,,,,,,,,,,0.1450381679,,,,,
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1296296296,,,,,0.1523178808
  2 ,Age: 20-40 | Gender: Female | ARIPIPRAZOLE | VENLAFAXINE HCL,,,,,,,,,,,0.1563981043,,,,,0.1898734177
  2 ,Age: 20-40 | Gender: Female | ATORVASTATIN CALCIUM,,,,,,,,0.5178571429,,,,,,0.5327380952,,
  1 ,Age: 20-40 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL,,,,,,,,0.6197916667,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.6535433071,,
  2 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401),,0.0342405619,,,,,,,,,,,,,0.05921052632,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.03951367781,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL,,0.03846153846,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL | Last AD: Same & No Remiss,,0.04854368932,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL,,0.05072463768,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | Last AD: Same & No Remiss,,0.0378250591,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01428571429,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04895104895,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.03758290346,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL,,0.06138613861,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL | Last AD: Same & No Remiss,,0.0248447205,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | METHYLPHENIDATE HCL,,0.03816793893,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.008849557522,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.0546875,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AZELASTINE HCL,,,0.4696969697,,,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | AZITHROMYCIN,,,0.4340527578,,,,0.1304347826,,,,0.2342342342,,,0.4920634921,,0.4651162791
  1 ,Age: 20-40 | Gender: Female | AZITHROMYCIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1363636364,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | AZITHROMYCIN | SERTRALINE HCL,,,,,,,,,,,,,,0.6172839506,,
  1 ,Age: 20-40 | Gender: Female | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113),,,,,,,,0.4368932039,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)",,,,,,,0.1461538462,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1181102362,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)",,,0.3771929825,,,,,0.2679738562,,,,,,0.4473684211,,
  2 ,"Age: 20-40 | Gender: Female | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",,,0.3347826087,,,,0.1677852349,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1165644172,,,,,,,,,
  15 ,Age: 20-40 | Gender: Female | BUPROPION HCL,0.02487562189,0.04659252767,0.3897275724,0.5585696671,0.08755760369,0.3216833096,0.1429707921,0.360377108,0.08095238095,0.06649616368,0.2929067019,0.3284278536,,0.4061499039,0.01616458486,0.4416761042
  10 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,0.05313496281,0.4618625599,,,0.3140495868,0.1958405546,0.3919129082,,,0.3246349798,0.356557377,,0.4366197183,0.01408450704,0.5876923077
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,,,,,0.5213675214,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+",,,,,,,,,,,0.4649122807,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,,,,,,,,,0.2876106195,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,0.05519480519,0.5257731959,,,,0.2829457364,,,,0.2317979198,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.04918032787,,,,,0.3644067797,,,,0.297029703,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,,,,,0.3695652174,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2314049587,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.1913043478,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,0.06607929515,0.4736842105,,,,,0.4,,,0.2605790646,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.05555555556,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.5892857143,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.2375,,,,,,,,0.1707317073,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1121495327,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.3774193548,,,,,,,,0.2366412214,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2307692308,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3468208092,,,,,,,,0.1897810219,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.1959459459,,,,,,,,0.1130952381,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1650485437,,,,,,,,0.07829181495,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.05555555556,,,,,
  6 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.04229017567,0.6515679443,,,,0.2180451128,,,,0.4285714286,,,,0.01652892562,0.5287356322
  5 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04491725768,0.6682926829,,,,0.2727272727,0.5042016807,,,,,,0.4786324786,,
  4 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.02976190476,0.5652173913,,,,,0.54,,,,,,0.4716981132,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.564,,,,,,,,0.4320137694,,,,,0.4660194175
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03652968037,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03409090909,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.01321585903,,,,,,,,,0.2920353982,,,,0.01234567901,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.075,0.6054852321,,,,,,,,0.5122807018,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.05365853659,0.6209386282,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,0.5948275862,,,,,,,,0.52,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,0.0252764613,0.3289817232,,,,,,,,0.3427719821,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,0.02307692308,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.3962264151,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.4186046512,,,,,,,,0.3991596639,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4794520548,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.09848484848,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1551724138,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4040697674,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.5912408759,,,,,,,,0.55859375,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6899224806,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.6129032258,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.4789473684,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,0.6929133858,,,,,,,,0.625,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.452173913,0.5990990991,,,,,,,,0.5688487585,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4774774775,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 2,3",,,,,,,,0.5042016807,,,,,,0.4789915966,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2274881517,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2016129032,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5764499121,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+,,,0.6355140187,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,0.05357142857,0.3916666667,,,,,,,,0.2278481013,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.07407407407,0.2766497462,,,,,,,,0.136915078,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1044776119,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1304347826,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2380952381,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1631205674,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2598039216,,,,,,,,0.1839464883,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,0.05198776758,0.411311054,,,,,,,,0.2857142857,,,0.414893617,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.03201970443,0.36875,,,,,,,,0.2597212032,,,,0.01117318436,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,0.05590062112,0.3918367347,,,,,,,,0.2666666667,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CLONAZEPAM,,0.06976744186,,,,,,,,,0.2331288344,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CLONAZEPAM | Last AD: Diff & No Remiss,,,,,,,,,,,0.1885714286,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | CLONAZEPAM | Last AD: Same & No Remiss,,0.01379310345,,,,,,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.048,,,,,,0.5762711864,,,0.303030303,,,,,0.595959596
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,,,,,0.384057971,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,,,,,,,,,,0.375,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+",,,,,,,,,,,0.3235294118,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.5766423358,,,0.4833333333,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7207207207,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.5491803279,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,,,,,,,0.4970760234,,,0.2625215889,,,,,0.5335820896
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,0.404109589,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,0.3036649215,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7445255474
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.01411764706,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,0.03125,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01694915254,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01593625498,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.005714285714,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.05504587156,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.06349206349,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.05535055351,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.05789473684,,,,,,,,,0.3037974684,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,0.6097560976,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.674796748
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE,,0.02521008403,,0.6297577855,,,,,,,0.2742616034,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2592592593,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE,,,,,,,,,,,0.06666666667,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Diff & No Remiss,,0.02013422819,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Same & Remiss,,,,,,,,,,,0.5089285714,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.125,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.1807909605,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | VENLAFAXINE HCL,,,,,,,,,,,0.2727272727,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DOXEPIN HCL,,0.07831325301,,,,,,,,,0.2549019608,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | Last AD: Diff & No Remiss,,0.07575757576,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1875,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.168,,,,,
  7 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL,,0.04268292683,0.3216783217,,,0.397260274,0.1214574899,0.3295454545,,,0.2566402208,,,0.4022346369,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,,0.01408450704,,,,,0.2727272727,,,,0.2280701754,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.01960784314,,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL,,0.04504504505,,,,0.4347826087,,0.358778626,,,0.1965811966,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,,,,0.1666666667,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.07070707071,,,,,0.07396449704,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.05844155844,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.03902439024,,,,0.498245614,,,,,0.345276873,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04081632653,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3742331288,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.0380952381,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.08461538462,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss,,0.08275862069,,,,0.6513761468,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss,,0.03260869565,,,,0.2651162791,,,,,0.251572327,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3189655172,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.4978165939,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5747126437,,,,,0.4527559055,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.25,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2272727273,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.256097561,,,,,0.1218274112,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1165048544,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | SERTRALINE HCL,,0.03571428571,,,,0.3981481481,,,,,0.3195488722,,,0.4935897436,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL,,0.07831325301,,,,0.2871287129,,,,,0.1859605911,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2558139535,,,,,
  11 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE,0.01785714286,0.04067630483,0.5135869565,,,0.4535714286,0.2618151893,0.3550624133,,,0.2428426653,0.3915857605,,0.4083250743,0.02136752137,0.5821782178
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,0.05050505051,,,,,0.2101265823,0.3888888889,,,0.211038961,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.03846153846,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1637931034,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.06796116505,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.02487562189,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.01680672269,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,0.2549019608,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,,,,0.1051212938,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.1454545455,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss",,0.01398601399,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,,,,0.09649122807,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08695652174,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.08849557522,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1529235382,,,,0.2034883721,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.152917505,,,,0.201754386,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1417910448,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1255230126,,,,0.1376811594,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1554404145,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.1169590643,,,,0.1174377224,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,0.07555555556,,,,0.08924485126,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.05921052632,,,,,
  6 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.03688212928,,,,0.4383561644,0.3103609939,,,,0.2986928105,,,,0.02272727273,0.5971731449
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.04504504505,,,,,,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03504043127,,,,,0.3230769231,0.4527027027,,,,,,0.49375,,
  4 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.02702702703,,,,,0.2783375315,0.5,,,,,,0.4825174825,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.2333333333,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.253164557,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.3223140496,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2797029703,,,,,0.5555555556
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.06624605678,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.2169811321,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2486187845,,,,0.1403508772,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.01824817518,,,,,0.2868217054,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.03880597015,,,,,0.3418803419,,,,,,,,0.005208333333,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.06077348066,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.1002132196,,,,,0.5760456274,,,,0.5194174757,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5661764706,,,,,0.7196261682,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.08965517241,,,,,0.6075581395,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,0.03017832647,,,,,0.1677943166,,,,0.23246878,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,0.04605263158,,,,,0.2093023256,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.04587155963,,,,,0.2139303483,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2528089888,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3430232558,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1218274112,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.09,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.112,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.15,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.198757764,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1886792453,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.3170731707,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3007712082,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.5190839695,,,,0.5515463918,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7058823529,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5595238095,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.625698324,,,,0.679245283,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.308988764,,,,,0.4973637961,,,,0.4755381605,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.2700729927,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,,,,,0.1538461538,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3",,,,,,,,0.4527027027,,,,,,0.493902439,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7227722772,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,0.2169811321,,,,0.149068323,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1596638655,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.5090909091,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1504854369,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PAROXETINE HCL,,,,,,,0.268907563,,,,0.2099447514,0.3706293706,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.08391608392,,,,,,,,,0.1396332863,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1483870968,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1201716738,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1684210526,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.1492537313,,,,0.1384083045,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.07142857143,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.202166065,,,,0.1984126984,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1847133758,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.368852459,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL,,0.02865329513,,,,,0.2254901961,0.3495145631,,,0.2233009709,,,0.4729411765,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,0.03892944039,,,,,0.2380952381,,,,0.191661481,,,,0.0078125,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,0.0593220339,,,,,0.2596153846,,,,0.2206148282,,,,,0.610619469
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ETONOGESTREL/ETHINYL ESTRADIOL,,0.02727272727,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ETONOGESTREL/ETHINYL ESTRADIOL | Last AD: Same & No Remiss,,0.02553191489,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUCONAZOLE,,0.04135338346,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUCONAZOLE | Last AD: Same & No Remiss,,0.0253164557,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUCONAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.01818181818,,,,,,,,,,,,,,
  11 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL,0.0625,0.05314312588,0.4061962134,,,0.3032258065,0.1545988258,0.4130170316,,,0.30878116,0.3190184049,,0.3512241055,0.01807228916,0.5338842975
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,0.234741784,,,0.1805157593,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss",,0.05714285714,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,,,,0.1803278689,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1121495327,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.1621621622,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.3597733711,,,0.21875,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.4059405941,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.4059405941,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2011494253,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1650485437,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3879781421,,,0.2435897436,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,0.2168674699,,,0.1314741036,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1241830065,,,0.07824427481,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,0.07407407407,,,0.07174887892,,,,,
  6 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04138321995,,,,,0.1468253968,0.6159695817,,,0.4162561576,,,,0.0162601626,0.5628140704
  4 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03683241252,,,,,0.16,0.5928045789,,,,,,0.4411764706,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.03846153846,,,,,,0.5135951662,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.5454545455,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3935810811,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04081632653,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2201834862,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03636363636,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.03643724696,,,,,,,,,,,,,0.01530612245,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.05063291139,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.09375,,,,,,0.5917602996,,,0.4349112426,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5655737705,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.09128630705,,,,,,0.594,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.4693877551,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3980582524,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,0.03851640514,,,,,,0.2905109489,,,0.3446475196,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,0.03731343284,,,,,,0.34375,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.3425414365,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.37109375,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4172661871,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1202531646,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1652173913,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3896103896,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.5914634146,,,0.5575980392,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.72,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5044247788,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4,,,,,,0.6544715447,,,0.619047619,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3612334802,,,,,,0.5682593857,,,0.5120967742,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,0.4621848739,,,0.2977099237,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.2013888889,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.2794117647,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.5915378356,,,,,,0.4380952381,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3 | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.5454545455,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,0.3333333333,,,0.15,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3793103448,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,0.301369863,,,0.178041543,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2328767123,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1415929204,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Remissions: 2+,,,,,,,,0.6078431373,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2264150943,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PAROXETINE HCL,,0.07567567568,,,,,,0.3829787234,,,0.3121019108,0.4676258993,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.07575757576,,,,,,0.28,,,0.1669106881,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.186440678,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1304347826,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.5117845118,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2730923695,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.2671755725,,,0.1515151515,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.08490566038,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2723004695,,,0.2077562327,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1981132075,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | RISPERIDONE,,,,,,,,,,,0.1304347826,,,,,
  5 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | SERTRALINE HCL,,0.05511811024,,,,,0.112,0.4082733813,,,0.3093812375,,,0.4272030651,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,0.04738562092,,,,,,0.3208333333,,,0.2258454106,,,,0.015625,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2037037037,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | VENLAFAXINE HCL,,0.04182509506,,,,,,0.3628318584,,,0.2333901193,,,,,0.58125
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.04615384615,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.04458598726,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05882352941,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,0.0195035461,,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,0.0394265233,,,,0.3983739837,,,,,0.2754237288,0.3212121212,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,0.1133333333,,,,0.2465116279,,,,,0.6339285714
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,0.009132420091,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,,,,,,,,,,0.6230769231,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | HEADACHE (dxo:ICD9:7840),0.009756097561,0.0625,,,,,,,,0.06153846154,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.01550387597,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,,0.02298850575,,,,,,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.07082152975,,,,,,,,,0.08768656716,,,,,0.1776649746
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06211180124,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.0462962963,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | TRAZODONE HCL",,0.04201680672,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,0.05300353357,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,0.1025641026,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL",,,,,,,,,,,0.09482758621,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05825242718,,,,,,,,,0.04545454545,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.15625,,,0.2242990654,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2079207921
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06884057971,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1650485437,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,,,,,,0.150997151,,,0.2798165138,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.180952381,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.03896103896,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,0.1871345029,,,,,0.2731707317
  8 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2705882353,,,0.2680412371,0.08571428571,0.2448979592,,,0.1418439716,0.1846153846,,0.2645502646,,0.3052434457
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.07788161994,,,,0.145,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08839779006,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.05365853659,0.2547169811,,,0.09840425532,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.25,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,,,,,0.2090909091,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.3533333333,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.3303571429,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,,,,,,,,,,0.4513888889,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.07874015748,,,,,0.1552795031
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06597222222,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1121495327,,,0.2212389381,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2404371585,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2133333333
  6 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2171428571,,,,0.1,0.2228915663,,,0.1119402985,,,0.244,,0.216080402
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.26875,,,0.3849206349,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1709401709,,,,,0.3664122137
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,0.1176470588,,,,0.2168674699,,,0.3543123543,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3448275862
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,0.08641975309,,,,,0.1351351351
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08527131783,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,0.1106719368,,,0.2590673575,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | VENLAFAXINE HCL",,,,,,,,,,,0.1615384615,,,,,0.2254901961
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.00826446281,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01117318436,
  7 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE,,,0.1634980989,,,0.1127272727,0.07913669065,0.1398305085,,,0.08446932814,,,0.1351351351,,0.1160714286
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4270462633,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.3272727273,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.380952381,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.1097560976,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.06481481481,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+,,,,,,,,,,,0.09042553191,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.08333333333,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.05185185185,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.0297029703,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | RISPERIDONE,,,,,,,,,,,0.08,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.02803738318,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,0.09385113269,,,0.1600831601,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.09032258065,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.07526408451,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.06278026906,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.07956989247,,,,,0.1014492754
  11 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss,0.007874015748,0.03317535545,0.4160263447,,,0.4007858546,0.1344717182,0.4422018349,,,0.2408482706,0.3129032258,,0.4681335357,0.01397712834,0.4926884139
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.2246376812,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.05882352941,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.04672897196,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | TRAZODONE HCL,,0.03225806452,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,0.04761904762,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5028248588,,,,
  4 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,0.04128440367,,,,,0.1398601399,0.4907407407,,,,,,0.561465721,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,0.05138339921,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,0.06329113924,,,,,,,,,,0.6889952153,,,,
  4 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.05418719212,,,,,0.1488095238,0.512,,,,,,0.6265533028,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5044247788,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.05652759085,,,,,,,,,,,,,0.009708737864,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,0.04830917874,,,,,,,,,,,,,,0.6930693069
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2300884956,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.3,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4036458333,,,,,0.46875
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1135135135,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4449339207,,,,,0.6196078431
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689) | TRAZODONE HCL,,0.05128205128,,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.05799648506,,,,,0.1392405063,,,,0.3349875931,,,,,0.610619469
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.03333333333,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.04195804196,,,,,,,,,0.2475247525,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,0.03973509934,,,,,,,,,,,,,0.007874015748,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,0.05223880597,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,,,,0.2314814815,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.1296296296,,,,0.103626943,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.08,,,,0.1209677419,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.2,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1245421245,,,,0.2775119617,0.31,,,,
  7 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.04360325827,,,,0.3720930233,0.1622911695,,,,0.4525547445,,,0.6046511628,0.02255639098,0.5381818182
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,0.39,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,0.04024767802,,,,,,,,,0.2945736434,,,,0.004784688995,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,0.03623188406,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,0.2200956938,,,0.5333333333,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05098039216,,,,,,,,,0.1074918567,,,,0.01075268817,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,0.04678362573,,,,,,,,,,,,,0.02777777778,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.05119047619,,,,,0.1633986928,,,,0.3992015968,,,,,0.6729651163
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss,,0.1103633917,,,,,,,,,0.6239316239,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5862068966,,,,,,,,,0.7024390244,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.5328467153,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.6581196581,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6611570248,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5625,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6535433071,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7254901961,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.06270627063,,,,,,,,,,,,0.6285714286,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4508196721,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.679245283,,,0.6390977444,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,0.0972972973,,,,,,,,,0.3953488372,0.7052023121,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,0.07803790412,,,,,,,,,0.4785894207,,,0.6315789474,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,0.4339622642,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.1016949153,,,,,,,,,0.3216080402,,,,,0.6753731343
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss,,0.02272962618,,,,,,,,,0.2433862434,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.1501706485,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.05031446541,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.02403846154,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MYOPIA (dxo:ICD9:3671),,0.01906779661,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01378446115,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,0.01680672269,,,,,,,,,,,,0.4535519126,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.01764705882,,,,,,,,,,,,0.441025641,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,0.02417582418,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.3545816733,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4387755102,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2011173184,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01290322581,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.02164502165,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02234636872,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.03529411765,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.03296703297,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,0.028125,,,,,,,,,0.3093220339,0.3026315789,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2946428571,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04866180049,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1832460733,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1333333333,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1565217391,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1296296296,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | POLYCYSTIC OVARIES (dxo:ICD9:2564),,0.04081632653,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,0.005524861878,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02639296188,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.2429906542,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.2079207921,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.01290322581,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.01904761905,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.01714285714,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,0.02394526796,,,,,,,,,0.3506988564,,,0.3751891074,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.412195122,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,0.03282828283,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,0.04265402844,,,,,,,,,0.1700819672,,,,0.03181818182,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4117647059,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | VALACYCLOVIR HCL,,0.006756756757,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,0.03235294118,,,,,,,,,0.3416370107,,,,,0.3287197232
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss,,0.4357298475,,,,,,,,,0.5464184731,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.7299270073,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4901960784,,,,,,,,,0.7475083056,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7606382979,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4696132597,,,,,,,,,0.7418677859,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.7068965517,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,0.7089552239,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7408759124,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.811827957,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5777777778,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5766423358,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.4772727273,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6595744681,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,0.510989011,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5436893204,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.5711086226,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5183673469,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5128,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4857142857,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5114822547,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LITHIUM CARBONATE,,,,,,,,,,,0.04672897196,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LORAZEPAM,,0.0790960452,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | LORAZEPAM | Last AD: Same & No Remiss,,0.005714285714,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.4490861619,,,,,,,,,0.6527590848,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.6762589928,,,,,,,,,0.7727272727,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6972477064,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.631372549,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4622844828,,,,,,0.6055045872,,,0.641025641,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4954954955,,,,,,,,,0.65,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6560509554,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.6142857143,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,0.4615384615,,,,,,,,,0.6260869565,,,0.7286821705,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,0.4056603774,,,,,,,,,0.616745283,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,0.6014492754,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.3495934959,,,,,
  8 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.367576244,0.5480769231,,,0.597826087,0.4452214452,0.5018181818,,,0.5400098184,,,0.5693430657,,0.6050420168
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.5257731959,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.5205992509,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4616895874,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,0.3705882353,,,,,,,,,,0.7024793388,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.53125,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7172413793
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.3634204276,,,,,,,,,0.5612745098,,,0.6323907455,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.3793103448,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.4030172414,,,,,,,,,0.4777190332,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.4068965517,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,0.3714285714,,,,,,,,,0.5251509054,,,,,0.6526610644
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.04402515723,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.05,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | METHYLPHENIDATE HCL,,0.1287128713,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | MIRTAZAPINE,,0.07446808511,,,,,,,0.1542857143,,0.193072955,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2283464567,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1677559913,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1153846154,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.3088235294,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.189258312,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.1485148515,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | MYOPIA (dxo:ICD9:3671),,0.05543237251,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03610108303,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL,,0.06609195402,,,,,,,,0.1011904762,0.2472906404,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2349726776,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2571428571,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.3238095238,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2323943662,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5138888889,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.695473251,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.297029703,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,0.5158730159,,,,,,0.6213191991,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5892857143,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5042735043,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2180397727,0.1779661017,,0.2596153846,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.3258426966,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.2888888889,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2835820896,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3691460055,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2098939929,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1973875181,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1646191646,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5131578947,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6433566434,,,0.6257309942,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.0406779661,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,0.01709401709,,,,,,,,,0.1669565217,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.1902654867,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1942446043,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.0462633452,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03669724771,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.07255520505,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.04716981132,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)",,0.07894736842,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.0395256917,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.05405405405,,,,,,,,,,,,,,
  9 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PAROXETINE HCL,,0.04971475143,0.4,,,0.3389830508,0.1368421053,0.3843648208,,,0.2827476038,0.4766073046,,0.4486803519,,0.6510067114
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1335504886,0.2635983264,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2718446602,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | SERTRALINE HCL,,0.02702702703,,,,,,,,,0.3333333333,0.4347826087,,0.4309392265,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | TRAZODONE HCL,,0.05140186916,,,,,,,,,0.2258883249,0.3367875648,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2551724138,,,,,
  7 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.06685768863,0.2057142857,,,0.1787439614,,0.1301369863,,,0.0831842576,,,0.1656050955,,0.2038664323
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.07272727273,,,,,,,,,0.06060606061,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1489361702,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.132231405,,,,,
  3 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.05426356589,,,,,,,,,0.1831869511,,,0.2665562914,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1286173633,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.06432748538,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1513761468,,,,,0.2244897959
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1719745223,,,,,0.2681281619
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | POLYCYSTIC OVARIES (dxo:ICD9:2564),,0.045,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,0.02919708029,,,,,,,,,0.3788487282,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.280334728,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.6991150442,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4968553459,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,0.03105590062,,,,,,0.3550295858,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.34,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02639296188,,0.21,,,,,,,0.118611379,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.25390625,,,0.4086956522,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1698113208,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,0.1657458564,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1130434783,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.0756302521,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.1538461538,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1452991453,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.0979020979,,,,,
  6 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.1960784314,0.08040201005,0.2333333333,,,0.1446469248,,,0.1802325581,,0.2580645161
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.2301790281,,,0.2882352941,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2807017544,,,,,
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.065,,,,,
  2 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.25,,,,,0.2978723404
  1 ,"Age: 20-40 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,,,,0.106918239,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.103875969,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.08026755853,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.1555555556,,,,,
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL,,0.05882352941,,,,,,,,,0.2935871743,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2243767313,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.05699481865,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.04109589041,,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.04419191919,,0.6331877729,,,0.1349693252,,,,0.3054393305,,,,,
  11 ,Age: 20-40 | Gender: Female | BUPROPION HCL | SERTRALINE HCL,0.02068965517,0.04806177119,0.3864678899,,,0.2965641953,0.1621187801,0.3953917051,,,0.3542816702,0.3418079096,,0.4632159986,0.02525252525,0.5533230294
  2 ,Age: 20-40 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,0.384180791,,,0.5792811839,,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,0.05692307692,,,,,,,,,0.2626325639,,,0.3445255474,0.003571428571,
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | VENLAFAXINE HCL,,0.05813953488,,,,,,,,,0.2619589977,,,0.4927113703,,0.6492537313
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.246031746,,,,,
  3 ,Age: 20-40 | Gender: Female | BUPROPION HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,0.03992740472,,,,,,,,,0.234828496,,,0.4861111111,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | TOPIRAMATE,,,,,,,,,,,0.2288135593,,,,,
  9 ,Age: 20-40 | Gender: Female | BUPROPION HCL | TRAZODONE HCL,,0.05852282743,0.2560386473,,,0.2575250836,0.1428571429,0.2441471572,,,0.2369779243,,,0.2905027933,0.01693719125,0.3042505593
  4 ,Age: 20-40 | Gender: Female | BUPROPION HCL | TRAZODONE HCL | VENLAFAXINE HCL,,0.06360424028,,,,,,,,,0.2328767123,,,,0.01875,0.3577817531
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,0.07547169811,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUPROPION HCL | VALACYCLOVIR HCL,,0.04438642298,,,,,,,,,,,,,,
  10 ,Age: 20-40 | Gender: Female | BUPROPION HCL | VENLAFAXINE HCL,,0.06390243902,0.3976261128,,,0.4491525424,0.1378600823,0.3469387755,,,0.2599126955,0.3538461538,,0.4366972477,0.03571428571,0.4937978358
  4 ,Age: 20-40 | Gender: Female | BUSPIRONE HCL,,,0.4210526316,,,,0.1594684385,,,,0.1363636364,,,0.4776119403,,
  1 ,Age: 20-40 | Gender: Female | BUSPIRONE HCL | ESCITALOPRAM OXALATE,,,,,,,0.3969849246,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUSPIRONE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.2272727273,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | BUSPIRONE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.6814814815,,
  1 ,Age: 20-40 | Gender: Female | CANDIDIASIS OF VULVA AND VAGINA (dxo:ICD9:1121),,,,,,,,0.4347826087,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CANDIDIASIS OF VULVA AND VAGINA (dxo:ICD9:1121) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.407079646,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | CARISOPRODOL,0.01224489796,,,,,,,,,,,,,0.56,0.0157480315,
  1 ,Age: 20-40 | Gender: Female | CARISOPRODOL | HEADACHE (dxo:ICD9:7840),0,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CEFDINIR,,,,,,,0.2049689441,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CEFDINIR | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1367521368,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CELECOXIB,,,0.4294478528,,,,,0.4890510949,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CERVICALGIA (dxo:ICD9:7231),,,,,,,,0.4444444444,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | CETIRIZINE HCL,,,0.511589404,,0.1359223301,,0.1344667697,,,,,,,0.5564516129,,0.5869565217
  1 ,Age: 20-40 | Gender: Female | CETIRIZINE HCL | CITALOPRAM HYDROBROMIDE,,,0.5800711744,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CETIRIZINE HCL | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.5688073394,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CETIRIZINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3565217391,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CETIRIZINE HCL | ESCITALOPRAM OXALATE,,,,,,,0.2608695652,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CETIRIZINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1470588235,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CETIRIZINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.5547945205,,,,0.1005586592,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CETIRIZINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1174089069,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CHEST PAIN, OTHER (dxo:ICD9:78659)",,,,,,,,,,,,,,,,0.4363636364
  1 ,"Age: 20-40 | Gender: Female | CHEST PAIN, OTHER (dxo:ICD9:78659) | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,,,,,,,,0.4230769231,,
  4 ,"Age: 20-40 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,0.4196428571,,,,0.1153846154,0.381294964,,,,,,0.4527972028,,
  1 ,"Age: 20-40 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,,,,,,,,0.448,,
  1 ,"Age: 20-40 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.09465020576,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | SERTRALINE HCL",,,,,,,,,,,,,,0.5918367347,,
  1 ,"Age: 20-40 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.03361344538,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071),,,0.4166666667,,,,,,,,,,,0.3949579832,,
  15 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE,0.01210898083,0.03191828918,0.4700887503,0.5667655786,0.07731958763,0.3453757225,0.2158582423,0.4122751323,0.09736842105,0.05479452055,0.2576716664,0.3520804755,,0.4266544678,0.01962533452,0.5527522936
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM,,,0.514619883,,,,,,,,0.3333333333,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM | Last AD: Diff & No Remiss,,,,,,,,,,,0.2389380531,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM | Last AD: Same & No Remiss,,,0.2631578947,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016),,,0.6075268817,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | Last AD: Same & No Remiss,,,0.2892561983,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.6015625,,,,,,,,,,,,,
  5 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.03301886792,0.5794117647,,,,,0.6046511628,,,0.352688172,,,,,0.6193548387
  4 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,0.02380952381,,,,,,0.375,,,0.2753036437,,,,,0.4681818182
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss",,,,,,,,,,,0.4236453202,,,,,0.5782312925
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,,0.3817663818,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss",,,0.6200607903,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,0.3225806452,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DESVENLAFAXINE SUCCINATE,,,0.52,,,,,,,,0.2406015038,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEXTROAMPHETAMINE/AMPHETAMINE,,,0.5941176471,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL,,,0.5670103093,,,,,,,,0.2074468085,,,,,
  5 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,0.02542372881,0.5145985401,,,0.4548022599,,,,,0.2337434095,,,0.4253731343,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.214953271,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2,,,,,
  9 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,0.01657458564,0.6116811365,,,,0.3101851852,0.4082191781,,,0.2132545932,0.3917050691,,0.4370860927,0.01834862385,0.6386554622
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.4852941176,,,,0.2307692308,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.2375,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.01838235294,0.6777777778,,,,0.3399693721,,,,0.2703488372,,,,,0.6461538462
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.7102803738,,,,0.3571428571,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.5828877005,,,,0.316,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.5816326531,,,,,,,,0.2236842105,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,0.4600938967,,,,0.3450980392,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,0.3673965937,,,,0.1703406814,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.1483870968,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.375,,,,0.1597222222,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.3727272727,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,0.6144578313,,,,0.5535714286,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,0.5555555556,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3",,,,,,,,,,,,,,0.49,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.5821596244,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.08108108108,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,,,,,0.2100840336,,,0.4833333333,,
  4 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,0.4035087719,,,,0.2663316583,,,,0.2431077694,,,,0.03571428571,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,,,,,0.2,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM,,,0.6447368421,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.6228070175,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ETHINYL ESTRADIOL/DROSPIRENONE,,,0.6768292683,,,,,,,,,,,,,
  9 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,0.02955665025,0.4432717678,,,0.2910447761,0.2006920415,0.5025380711,,,0.213592233,0.3017751479,,0.4180327869,,0.5828571429
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.01030927835,,,,,0.1759259259,,,,0.2615384615,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6540540541,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.3741935484,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,0.3601694915,,,,,0.296819788,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.5673076923,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6540540541,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | SERTRALINE HCL,,,0.3712121212,,,,,,,,0.252173913,,,,,
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | TRAZODONE HCL,,,0.3434343434,,,,,0.3623188406,,,0.1959064327,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.188034188,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.01,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.02222222222,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GUAIFENESIN/PHENYLEPHRINE HCL,,,0.5925925926,,,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.5954716981,,,,0.2166666667,,,,0.3076923077,0.5147928994,,,,0.6701570681
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,0.1782178218,,,,0.3524590164,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss,,,,,,,0.12,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,,0.4086294416,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.3189655172,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss,,,0.5670886076,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.5398230088,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840),0.008510638298,,,,,,,,,0.02173913043,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.01492537313,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | IBUPROFEN,,,0.4901960784,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.2449494949,,,,,,,,0.1096774194,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.1129032258,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,0.1910569106,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.234375,,,,,,,,0.09708737864,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07058823529,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,0.1818181818,,,,,,,,0.1209677419,,,,,
  8 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.379525593,,,0.2317073171,0.1097744361,0.2629969419,,,0.1558441558,0.2613636364,,0.2656587473,,0.296875
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.07492795389,,,,0.1461538462,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08620689655,,,,,
  5 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07177033493,0.1946902655,,,0.1378205128,,,0.1904761905,,0.2300884956
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,0.2858575727,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2180851064,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.224,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2859744991,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.456,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1979166667,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2025316456,,,,,,,,0.1116751269,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2307692308,,,,,,,,,,,,,
  7 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3620283019,,,,0.1625,0.2373737374,,,0.1448763251,0.2252252252,,0.2614379085,,0.2462121212
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,0.261627907,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,0.2909090909,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.2100840336,,,,,,,,0.03797468354,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,0.1461988304,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,0.2376237624,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.6074766355,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0.02521008403,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01342281879,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",,,0.3636363636,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss",,,0.5043478261,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | IRREGULAR MENSTRUAL CYCLE (dxo:ICD9:6264),,,0.65,,,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1287188828,,,,0.07692307692,0.1134751773,,,0.07676348548,,,0.1728395062,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | Last AD: Same & No Remiss,,,0.08965517241,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | TRAZODONE HCL,,,0.1335616438,,,,,,,,0.07883817427,,,,,
  10 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,0.009009009009,0.02171903882,,,,0.2930513595,0.1848505907,0.3796909492,,,0.2761953204,0.323782235,,0.4227467811,0.01870503597,0.4573829532
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02732240437,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,0.6296296296,,,,,,,,,,,0.5441176471,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.5675,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6244725738,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.6028169014,,,,,,,,,,,,0.007575757576,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2722513089,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.6272727273,,,,,,,,0.2348484848,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.564792176,,,,,,,,0.3746130031,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.01886792453,,,,,,,,,0.2478632479,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.025,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01941747573,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1240875912,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1520737327,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2095808383,,,,,0.2857142857,,,,
  5 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.01910828025,0.6050420168,,,,0.1387283237,,,,0.25,,,,,0.51875
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.02941176471,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4086956522,,
  4 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.01986754967,0.601965602,,,,,,,,0.3731617647,,,,0.01512859304,
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.03409090909,,,,,,,,,0.26875,,,,,0.6666666667
  11 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,0.0462962963,0.05839416058,,0.5688073394,,0.4713375796,0.2806804374,0.5636743215,,,0.3629712999,0.4791666667,,0.5407801418,0.09356725146,0.5523809524
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6390532544,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.6086956522,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2808219178,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | SERTRALINE HCL,,0.0796460177,,,,,,,,,0.2777777778,,,,,
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | TRAZODONE HCL,,,0.5481481481,,,,,,,,0.3596491228,,,,0.04090909091,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4125874126,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3366705279,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.4285714286,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | NORGESTIMATE-ETHINYL ESTRADIOL,,,0.4121212121,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.4019607843,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.3665031535,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4647887324,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PAROXETINE HCL,,,0.2589928058,,,,,,,,,0.3333333333,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2338709677,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,0.4764705882,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.3186813187,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.3173076923,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.2914285714,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.152,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2336769759,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242),,,0.4351851852,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.3313609467,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SERTRALINE HCL,,,0.3265306122,,,,,,,,,,,0.367816092,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,0.3897058824,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,0.305019305,,,,,,,,0.3451536643,,,,0.02298850575,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.2736842105,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,0.2946428571,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.5969005166,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.6228070175,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | NORGESTIMATE-ETHINYL ESTRADIOL,,,0.6569767442,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,0.4609053498,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,0.7454545455,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,0.7413793103,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,0.6330275229,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.6074074074,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.4862385321,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.6293436293,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SERTRALINE HCL,,,0.625,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5408970976,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.6097560976,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVONORGESTREL-ETHIN ESTRADIOL,,,0.6475409836,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVONORGESTREL-ETHIN ESTRADIOL | Last AD: Same & No Remiss,,,0.3233082707,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVONORGESTREL-ETHIN ESTRADIOL | Last AD: Same & Remiss,,,0.6030534351,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVOTHYROXINE SODIUM,,,0.7025316456,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LORATADINE,,,0.6387096774,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | LORAZEPAM,,,0.5495495495,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,0.6791171477,,,,,,,,0.5706214689,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.6554621849,,,,,,,,,,,,,
  7 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4309623431,0.6143437077,,,0.5784313725,0.5574712644,0.5438596491,,,0.5522827688,,,0.5251798561,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.676056338,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,0.6376146789,,,,,,,,0.5511111111,,,,,
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,0.4117647059,,,,,,0.1363636364,,0.1966759003,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2142857143,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MONTELUKAST SODIUM,,,0.4953271028,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | MYOPIA (dxo:ICD9:3671),,,0.6344537815,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03488372093,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORGESTIMATE-ETHINYL ESTRADIOL,,,0.6252983294,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,0.5501355014,,,,,,,0.1555555556,0.345646438,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5728476821,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.6461538462,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5783664459,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+,,,0.7413793103,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1607843137,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.6374269006,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,0.5859375,,,,,,,,,,,,,
  7 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,0.02822580645,0.464333782,,,,0.2222222222,0.4098360656,,,0.1891304348,0.4573002755,,0.4891774892,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL | TRAZODONE HCL,,,0.4263565891,,,,,,,,0.2307692308,,,,,
  6 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05769230769,0.280148423,,,0.1100917431,,0.1778846154,,,0.1065693431,,,0.1791044776,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2835820896,,,,,,,,0.09748427673,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1188118812,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2317708333,,,,,,,,0.1886792453,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1048387097,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,0.6470588235,,,,,,,,0.4362416107,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,0.6422222222,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,0.6625,,,,,,,,,,,0.4675324675,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.5769230769,,,,,0.4140127389,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.3591160221,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.4214285714,,,,,,,,0.1468860165,,,0.2441860465,,0.2741935484
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.2421875,,,,,
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.2441860465,,,,,,,,0.09677419355,,,,,
  7 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.3531073446,,,0.18,0.1542288557,0.26,,,0.1902173913,,,0.1744680851,,0.213740458
  2 ,"Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,0.2662721893,,,,,,,,0.1962025316,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,0.1531100478,,,,,,,,0.07947019868,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,0.5418326693,,,,,,,,0.4382022472,,,,,
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.6057142857,,,0.3093220339,,,,0.3316582915,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242),,,0.6330935252,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.5485362096,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.5267175573,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.6493506494,,,,,,,,,,,,,
  10 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,0.03878583474,0.4536328872,,,0.4277456647,0.1759259259,0.3727272727,,,0.2203672788,0.3163636364,,0.4712411705,0.01960784314,0.5110294118
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.572815534,,
  4 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | TRAZODONE HCL,,,0.4184100418,,,,,,,,0.2613636364,,,0.4126394052,0.02631578947,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2212389381,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.5128205128,,,,,
  3 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,0.6085526316,,,,,,,,0.2616033755,,,0.4721780604,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | TOPIRAMATE,,,0.623655914,,,,,,,,,,,,,
  10 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.05405405405,0.429031516,,,0.2047244094,0.2208333333,0.2651515152,,,0.2921137339,0.2692307692,,0.321969697,0.02289281998,0.4684684685
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL | VENLAFAXINE HCL,,,0.3987341772,,,,,,,,0.2650273224,,,,,
  2 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,0.6363636364,,,0.4803921569,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.5586353945,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | VALACYCLOVIR HCL,,,0.5968992248,,,,,,,,,,,,,
  8 ,Age: 20-40 | Gender: Female | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,0.04347826087,0.4689597315,,,,0.2510822511,0.3820224719,,,0.2326565144,0.3388429752,,0.4108280255,,0.6120481928
  1 ,Age: 20-40 | Gender: Female | CLINDAMYCIN HCL,,,0.4339622642,,,,,,,,,,,,,
  10 ,Age: 20-40 | Gender: Female | CLONAZEPAM,0.006944444444,0.01983002833,0.390070922,,,,0.1781609195,0.3480662983,0.07339449541,,0.170212766,,,0.4712643678,0.0102739726,0.4610778443
  2 ,Age: 20-40 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE,,,,,,,0.3085106383,,,,0.286407767,,,,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,,,,,0.1732673267,,,,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1625,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CLONAZEPAM | FLUOXETINE HCL,,,,,,,,0.6074766355,,,0.3453608247,,,,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.3358208955,,,,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.3357664234,,,,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4330708661,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6054421769,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | PAROXETINE HCL,,,,,,,,,,,0.2056074766,,,,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1851851852,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | CLONAZEPAM | SERTRALINE HCL,,,,,,,,,,,0.3313432836,,,0.6162162162,,
  1 ,Age: 20-40 | Gender: Female | CLONAZEPAM | VENLAFAXINE HCL,,,,,,,,,,,0.3854166667,,,,,
  1 ,Age: 20-40 | Gender: Female | CLOTRIMAZOLE/BETAMETHASONE DIP,,,0.3857142857,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | CODEINE PHOSPHATE/GUAIFENESIN,,,0.3921568627,,,,,,,,,,,,0.01127819549,0.4423076923
  1 ,"Age: 20-40 | Gender: Female | CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)",,,,,0.0701754386,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016),,0.0511627907,0.3564463705,,,,,0.3581514763,,,,,,0.3927747886,,0.359223301
  1 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | FLUOXETINE HCL,,,,,,,,0.5209302326,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3333333333,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3495575221,,
  1 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5,,
  1 ,"Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4621212121,,
  2 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.309178744,,,,,,,,,,,0.4356435644,,
  1 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | SERTRALINE HCL,,,,,,,,,,,,,,0.5364431487,,
  1 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4590163934,,
  3 ,Age: 20-40 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3439490446,,,,,0.3801169591,,,,,,0.3394833948,,
  3 ,Age: 20-40 | Gender: Female | CYCLOBENZAPRINE HCL,,,,,,,0.1129032258,0.4625,,,,,,,0.009009009009,
  5 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.3716814159,,,,0.1779661017,0.3614457831,,,,0.4330708661,,0.3457943925,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.6148648649,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.6084656085,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.6826923077,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5785714286,,
  14 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.01243523316,0.02541189612,0.4684431978,0.591943958,0.1370967742,0.4069767442,0.1319514661,0.4684002633,,0.02870813397,0.2629716981,0.4081632653,,0.514455152,0.009118541033,0.5313199105
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DESVENLAFAXINE SUCCINATE",,,,0.6050955414,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DESVENLAFAXINE SUCCINATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,0.6538461538,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL",,,,,,0.5671641791,,,,,,,,,,0.7122302158
  6 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,0.02577319588,0.6517857143,,,,0.265917603,0.5649350649,,,0.3202099738,,,,,0.618902439
  6 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",0.01,0.007575757576,0.6598639456,,,,,0.5497835498,,,0.1796246649,,,,,0.5433070866
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,0.2233009709,,,,,
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss",,,,,,,,,,,0.4380952381,,,,,0.637254902
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1090146751,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1277258567,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss",,,,,,,0.5321100917,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.3350923483,,,,0.2336448598,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,,,,,,,,,,,,,,0.5445544554
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ETHINYL ESTRADIOL/DROSPIRENONE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1162790698,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ETONOGESTREL/ETHINYL ESTRADIOL",,0.08737864078,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUCONAZOLE",,0.02797202797,,,,,,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,0.03535353535,,,,,,0.59030837,,,0.3740831296,,,,,0.6369636964
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,,,,,,,0.4672897196,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,,0.6385542169,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.5333333333,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss",,0.05405405405,,,,,,,,,0.2876106195,,,,,0.5480225989
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & Remiss",,,,,,,,,,,0.3630952381,,,,,0.64
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.3864278982,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,,0.4184100418,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,0.35,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.5746192893,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | MYOPIA (dxo:ICD9:3671)",,,,,,,,0.5892857143,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,,,,,,,0.5145631068,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,0.6385542169,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,0.6114649682,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,,0.5583333333,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,0.6033519553,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,0.03821656051,,,,,,0.4912280702,,,,,,,,
  8 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,0.01127819549,0.5773809524,,,,0.1076320939,0.4752747253,,,0.2564102564,0.4569892473,,0.6538461538,,0.5863267671
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,,,0.1844660194
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL",,,,,,,,,,,,0.5071428571,,,,
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL",,,,,,,,,,,,,,0.6170212766,,0.6347826087
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.615658363
  3 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840)",0.008169934641,0.01098901099,,,,,,,,0.03086419753,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.01570680628,,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HYDROCODONE/ACETAMINOPHEN",,,,,,,0.1416309013,,,,,,,0.4224137931,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HYDROCODONE/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1515151515,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,,,,,0.03428571429,0.335483871
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.1890547264,,,,,,,,0.2369942197
  3 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,0.01754385965,,,,,,0.358974359,,,,,,,0.02147239264,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.009009009009,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,,,,,,,,,,0.3603603604
  4 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.01401869159,,,,,,0.4161490683,,,0.3189368771,,,,,0.5074074074
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.3148148148,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6237623762
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,0.1747572816,,,,,
  4 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | SERTRALINE HCL",,0.04651162791,,,,,,0.5961538462,,,0.4121863799,,,,,0.6117021277
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | VENLAFAXINE HCL",,,,,,,,,,,0.3716814159,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.373015873,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.303030303
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4026666667,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01129943503,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4255319149
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.5898734177,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5863377609
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.03225806452,,,,,,,0.4607843137,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MYOPIA (dxo:ICD9:3671)",,0.03311258278,,,,,,0.5507246377,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01385681293,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NORGESTIMATE-ETHINYL ESTRADIOL",,,0.4454545455,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.02461538462,,,,,,,,,,,,,,
  6 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.02214452214,,,,0.4066666667,0.08187134503,0.449197861,,,,,,0.5663716814,,0.6168831169
  3 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.006993006993,,0.6666666667,,0.4718309859,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)",,0.03731343284,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.02285714286,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,,0.4621848739,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,0.01754385965,,,,,,,,,0.2783505155,0.5974025974,,,,0.6720430108
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.4298245614,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.03485254692,,,,,,0.2213114754,,,,,,,,0.2677595628
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,,0.01941747573,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.03921568627,,,,,,,,,,,,,,
  8 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0,0.03009259259,,0.6365159129,,0.4425675676,0.1423699915,0.4970414201,,,0.2244897959,0.4351851852,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL",,,,,,,,,,,0.3961038961,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,0.1166666667,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",,,,,,,,,,,,,,,,0.4411764706
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",,,0.5523809524,,,,,,,,,,,,,0.5870967742
  6 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,0.02491103203,,,,,0.2264150943,0.5550458716,,,0.3668261563,,,0.645026178,,0.651416122
  2 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,0.4711538462,,,,,,,,0.5391705069
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,,0.4848484848,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,0.2118644068,0.4257028112,,,,,,,,0.5338345865
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.5339805825,,
  1 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VALACYCLOVIR HCL",,0.03086419753,,,,,,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,0.03797468354,,,,,,0.5042735043,,,0.3663101604,,,,,0.6222076216
  1 ,Age: 20-40 | Gender: Female | DERMATOPHYTOSIS OF FOOT (dxo:ICD9:1104),,,,,,,,0.4172661871,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.4406779661,,,,0.1023622047,0.4208754209,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | FLUOXETINE HCL,,,,,,,,0.5476190476,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1013513514,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DESLORATADINE,,,,,,,0.1382978723,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DESLORATADINE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.1397058824,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DESOGESTREL-ETHINYL ESTRADIOL,,,,,,,,,,,,,,0.515729266,,
  1 ,Age: 20-40 | Gender: Female | DESOGESTREL-ETHINYL ESTRADIOL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,,,0.6239316239,,
  1 ,Age: 20-40 | Gender: Female | DESOGESTREL-ETHINYL ESTRADIOL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4689655172,,
  1 ,Age: 20-40 | Gender: Female | DESOGESTREL-ETHINYL ESTRADIOL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6904761905,,
  1 ,Age: 20-40 | Gender: Female | DESOGESTREL-ETHINYL ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.6622807018,,
  9 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE,,0.04012345679,0.4378698225,0.4571773221,,0.4436090226,0.1926977688,0.3402061856,,,0.2437174016,,,0.5143603133,,0.6346153846
  1 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | DULOXETINE HCL,,,,,,,,,,,0.2326732673,,,,,
  2 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | ESCITALOPRAM OXALATE,,,,,,,0.297188755,,,,0.2252252252,,,,,
  2 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | FLUOXETINE HCL,,,,,,,,0.4857142857,,,0.2046511628,,,,,
  2 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE,,,,0.1045576408,,,,,,,0.09322033898,,,,,
  1 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.06976744186,,,,,
  2 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Diff & No Remiss,,0.04761904762,,,,,,,,,0.3921568627,,,,,
  1 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Diff & Remiss,,,,,,,,,,,0.3230769231,,,,,
  1 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss,,,,0.4214559387,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.4615384615,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,0.6992481203,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,0.5635738832,,,,,,,0.4444444444,,,,,
  1 ,"Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.2679738562,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,0.5043478261,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,0.1929133858,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,0.1551724138,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,0.2724252492,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.6666666667,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | SERTRALINE HCL,,,,,,,,,,,0.2426035503,,,0.5222222222,,
  2 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,0.5475409836,,,,,,,0.2183333333,,,,,
  1 ,Age: 20-40 | Gender: Female | DESVENLAFAXINE SUCCINATE | VENLAFAXINE HCL,,,,,,,,,,,0.2,,,,,
  6 ,Age: 20-40 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE,,,0.442455243,,,,0.18767507,0.4449760766,,,,,,0.4289156627,0.01176470588,0.3529411765
  1 ,Age: 20-40 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | FLUOXETINE HCL,,,,,,,,0.6028037383,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3583815029,,
  1 ,Age: 20-40 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6666666667,,
  1 ,Age: 20-40 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1717171717,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | SERTRALINE HCL,,,,,,,,,,,,,,0.6115107914,,
  1 ,"Age: 20-40 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.009852216749,,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | DIAZEPAM,,,0.3663366337,,,,,0.449704142,,,,,,0.4903846154,,0.4585987261
  1 ,Age: 20-40 | Gender: Female | DIAZEPAM | FLUOXETINE HCL,,,,,,,,0.4690265487,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DIFFUSE CYSTIC MASTOPATHY (dxo:ICD9:6101),,,,,,,,0.3947368421,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820),,,,,,,,,,0.05263157895,,,,,,
  1 ,Age: 20-40 | Gender: Female | DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820) | HEADACHE (dxo:ICD9:7840),,,,,,,,,,0.01801801802,,,,,,
  6 ,Age: 20-40 | Gender: Female | DIZZINESS AND GIDDINESS (dxo:ICD9:7804),,,0.4083333333,,,,0.1472081218,0.398,,,0.1496062992,,,0.4846153846,,0.3913043478
  1 ,Age: 20-40 | Gender: Female | DIZZINESS AND GIDDINESS (dxo:ICD9:7804) | FLUOXETINE HCL,,,,,,,,0.5377358491,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DIZZINESS AND GIDDINESS (dxo:ICD9:7804) | HEADACHE (dxo:ICD9:7840),,,,,,,,,,0.0495049505,,,,,,
  6 ,Age: 20-40 | Gender: Female | DOXEPIN HCL,,,0.3846153846,,0.2503144654,,0.1052631579,0.3039215686,,,0.2416422287,,,0.4081632653,,
  2 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | DULOXETINE HCL,,,,,,0.5096153846,,,,,0.2165605096,,,,,
  2 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE,,,,,,,0.2311111111,,,,0.2035928144,,,,,
  1 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.25,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL,,,,,0.262295082,,,0.4907407407,,,0.2763819095,,,,,
  1 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | LAMOTRIGINE,,,,,,,,,,,0.08125,,,,,
  1 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.198019802,,,,,
  1 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | Last AD: Same & No Remiss,,,,,0.146039604,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | Last AD: Same & Remiss,,,,,,,,,,,0.4905660377,,,,,
  1 ,"Age: 20-40 | Gender: Female | DOXEPIN HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.35,,,,,
  1 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1532846715,,,,,
  1 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | PAROXETINE HCL,,,,,,,,,,,,0.5794392523,,,,
  3 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | SERTRALINE HCL,,,,,0.2156862745,,,,,,0.3,,,0.5882352941,,
  1 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.2344689379,,,,,
  2 ,Age: 20-40 | Gender: Female | DOXEPIN HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2698412698,,,,,0.6736111111
  1 ,Age: 20-40 | Gender: Female | DOXYCYCLINE HYCLATE,,,,,,,,0.4338235294,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DOXYCYCLINE MONOHYDRATE,,,0.4196428571,,,,,,,,,,,,,
  14 ,Age: 20-40 | Gender: Female | DULOXETINE HCL,0.01073345259,0.03210649961,0.4388185654,,0.09565217391,0.3731695332,0.1796733212,0.407804878,0.07843137255,0.0495049505,0.2325929963,0.3457446809,,0.4460916442,0.04405286344,0.6011235955
  6 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE,,0.0253164557,,,,0.4761904762,0.3129161119,0.3548387097,,,0.2110091743,,,0.38,,
  4 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.0234375,,,,0.5048543689,0.3580786026,,,,0.25,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.38,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,,,,,0.3823529412,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1901408451,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.3550724638,,,,0.2252559727,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,,,,,0.1923076923,,,,,
  7 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL,,0.007874015748,0.4356435644,,,0.4136253041,0.1493506494,0.5276752768,,,0.2153465347,,,0.4275362319,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.009803921569,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7580645161,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3482142857,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.752,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,0.3148148148,,,,,0.25,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | HEADACHE (dxo:ICD9:7840),0.006535947712,,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,0.1862068966,,,,,0.09032258065,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,0.1379310345,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,0.2746478873,0.1390728477,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,0.2178988327,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,0.223880597,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.1764705882,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,0.2803030303,,,,,0.1506849315,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,0.2773109244,,,,,0.04,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.1074380165,,,,,0.08154506438,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,0.06930693069,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.4203821656,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,0.1277777778,,,,,0.08045977011,,,,,
  9 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss,0,0.03120124805,0.4259259259,,,,0.1560846561,0.4734513274,,,0.2429022082,,,0.5,0.003355704698,0.5083056478
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6036585366,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3986928105,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,0.447761194,,,,,0.3071428571,,,,,
  3 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.5194444444,,,,,0.4041811847,,,,0.01405152225,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4661016949,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,0.5769230769,,,,,,,,,,0.7394957983
  6 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss,,0.07960199005,,,,,0.2302631579,0.5964912281,,,0.3406193078,,,0.6280991736,,0.6030534351
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.4402985075,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,0.5277777778,,,,,,,,,0.02941176471,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.2483081728,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,0.2608695652,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.2827586207,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.1785714286,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.1857142857,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.1952662722,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,0.2774193548,,,,,,,,0.3839285714,,
  3 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,0.2580645161,,,,,0.3,,,,0.01,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3270440252,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,0.540166205,,,,,0.5826086957,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.54,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5875,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.532967033,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,0.6052631579,,,,,0.5811965812,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5245901639,,,,,0.5038910506,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,0.5304347826,,,,,0.4669811321,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.2857142857,,,,,0.1879432624,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | NORTRIPTYLINE HCL,,,,,,0.5461538462,,,,,0.306122449,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5783783784,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.185483871,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1450381679,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.487804878,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | PAROXETINE HCL,,,,,,0.4,,,,,0.2391304348,0.4587628866,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.2514619883,,,,,0.1167883212,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,0.1818181818,,,,,0.1138211382,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,0.4596774194,,,,,0.3474576271,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1404958678,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.07894736842,,,,,
  1 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1619047619,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.2558922559,,,,,0.1466666667,,,,,
  2 ,"Age: 20-40 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,0.255033557,,,,,0.1407407407,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | RISPERIDONE,,,,,,,,,,,0.0826446281,,,,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL,,,,,,0.3818770227,,,,,0.3122171946,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.5135951662,,,,,,,,,,
  7 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | SERTRALINE HCL,,0.02189781022,0.4086956522,,,0.4196428571,0.2256637168,0.3181818182,,,0.2680151707,,,0.5167714885,,
  3 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,0.3103448276,,,,,0.2683982684,,,0.3846153846,,
  2 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,0.5851851852,,,,,,,,0.4897959184,,
  4 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.3432048682,0.1531531532,,,,0.2595359811,,,,0.03825136612,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2164948454,,,,,
  1 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5307017544,,,,,,,,,,
  7 ,Age: 20-40 | Gender: Female | DULOXETINE HCL | VENLAFAXINE HCL,,0.03921568627,,,,0.5714285714,0.1678832117,0.4351851852,,,0.2297297297,,,0.4112903226,,0.6833333333
  1 ,Age: 20-40 | Gender: Female | DYSMETABOLIC SYNDROME X (dxo:ICD9:2777),,0.04046242775,,,,,,,,,,,,,,
  7 ,Age: 20-40 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004),0,,0.4901960784,,,,,0.4086538462,,,0.2476190476,,,0.5130890052,0.00826446281,0.5881006865
  1 ,Age: 20-40 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | FLUOXETINE HCL,,,,,,,,0.6046511628,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,,,,,0.6260869565
  1 ,Age: 20-40 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | SERTRALINE HCL,,,,,,,,,,,,,,0.6071428571,,
  1 ,Age: 20-40 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6322580645
  1 ,"Age: 20-40 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)",,,,,,,,,,,,,,0.5481171548,,
  1 ,"Age: 20-40 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5140186916,,
  1 ,"Age: 20-40 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.5551724138,,
  1 ,"Age: 20-40 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5136842105,,
  1 ,"Age: 20-40 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.525862069,,
  1 ,"Age: 20-40 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.7124183007,,
  1 ,"Age: 20-40 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5526315789,,
  1 ,Age: 20-40 | Gender: Female | ELETRIPTAN HYDROBROMIDE,,,0.4318181818,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869),,,,,,,0.1739130435,0.4588235294,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2074074074,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889),,,0.3758389262,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288),,,,,,,,,,,,,,0.6335403727,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288) | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5970149254,,
  1 ,"Age: 20-40 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.5418719212,,
  1 ,"Age: 20-40 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5714285714,,
  1 ,"Age: 20-40 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5046439628,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.572327044,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5807228916,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283),,,,,,,,,,,,,,0.527027027,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | IBUPROFEN | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.496350365,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | NORETHINDRONE | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.6204379562,,
  1 ,"Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.4635193133,,
  1 ,"Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5260115607,,
  1 ,"Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5036900369,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4285714286,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286),,,,,,,,,,,,,,0.5648148148,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5494880546,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.595890411,,
  1 ,Age: 20-40 | Gender: Female | ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5234541578,,
  14 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE,0.02072141213,0.020657277,0.57859375,,0.08778625954,0.451843044,0.2496772806,0.3946012776,0.111627907,0.03873239437,0.2015220889,0.3569979716,,0.4310285121,0.01480263158,0.5428488709
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ETHINYL ESTRADIOL/DROSPIRENONE,,,,,,,0.3086419753,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ETHINYL ESTRADIOL/DROSPIRENONE | Last AD: Same & No Remiss,,,,,,,0.214953271,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ETHINYL ESTRADIOL/DROSPIRENONE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1173184358,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ETHINYL ESTRADIOL/DROSPIRENONE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2269230769,,,,,,,,,
  9 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,0.01591511936,0.5520361991,,,,0.2297226583,0.4937106918,,,0.1737193764,0.3368421053,,0.4266211604,0.01680672269,0.5194805195
  5 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.01071428571,,,,,0.2958199357,0.6036036036,,,0.1974248927,,,,,0.4583333333
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3157894737,0.6511627907,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3185840708,0.5815602837,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2181818182,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.2371794872,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,0.1679012346,0.3174157303,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.3944954128,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.4038461538,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.5663716814,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.4051724138,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6511627907,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.46,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | SERTRALINE HCL,,,,,,,0.2709677419,,,,0.1351351351,,,0.4603174603,,
  4 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,0.1882352941,0.343220339,,,0.2144578313,,,,0.03875968992,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1578947368,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN,,,,,,,0.4551282051,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,0.184,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.04285714286,,,,,0.3591836735,,,,0.2980769231,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.02164502165,,,,,,,,,0.1504424779,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,,,,,,0.137254902,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1787709497,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3189189189,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GUAIFENESIN/P-EPHED HCL,,,,,,,0.2613636364,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GUAIFENESIN/P-EPHED HCL | Last AD: Same & No Remiss,,,,,,,0.1486486486,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GUAIFENESIN/PHENYLEPHRINE HCL,,,,,,,0.2789115646,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GUAIFENESIN/PHENYLEPHRINE HCL | Last AD: Same & No Remiss,,,,,,,0.0962962963,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.6603773585,,,,0.1915966387,,,,,0.4957264957,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,,,,,0.1172413793,,,,,0.544
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,,,,,,0.0821529745,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | HEADACHE (dxo:ICD9:7840),0.003558718861,,,,,,,,,0.01342281879,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.005681818182,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.3167701863,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss,,,,,,,0.07643312102,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1551724138,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2627737226,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.2670454545,,,,0.2028571429,,,,0.06443914081,,,0.2205882353,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1256544503,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.08962264151,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.06081081081,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.05517241379,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,0.09202453988,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08411214953,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.05691056911,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.08148148148,,,,,
  8 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.364902507,,,0.2713178295,0.1807407407,0.2200557103,,,0.1385041551,0.2372881356,,0.2618595825,,0.2829076621
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.1132075472,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,0.1438848921,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,,,,,0.1194029851,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,0.212962963,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.02259887006,,,,,
  6 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3357142857,,,0.2580645161,,0.2213740458,,,0.07304785894,,,0.1851851852,,0.2409638554
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,0.1737288136,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.1827160494,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1054407423,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,0.07,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1369047619,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1093474427,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss",,,,,,,0.4042553191,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.5,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1780821918,,,,0.1397058824,,,,,,,0.1440677966,,0.0737704918
  4 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.128440367,,,,0.1296296296,,,,0.04296875,,,,,0.06862745098
  8 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3333333333,,,0.2511848341,0.1751207729,0.1866028708,,,0.09523809524,0.225,,0.248603352,,0.2836676218
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1962616822,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,0.1417322835,,,,,,,0.3534482759,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,0.1806722689,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.1369863014,,,,0.09915014164,,,0.1100917431,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,0.1185983827,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.09448818898,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,0.4676258993,0.01351351351,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  4 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,0.06871609403,0.1675977654,,,0.06069802731,,,0.1046511628,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,0.05633802817,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,0.06910569106,,,,0.05405405405,,,,,
  11 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0.00790513834,0.01605442177,0.5733041575,,,0.394437421,,0.4625706215,0.06557377049,,0.168784029,0.3812785388,,0.4843902439,0.01226993865,0.4982130093
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.2066115702,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,0.3274336283,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01673640167,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,,0.2774566474,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,,,,,,0.2734375,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,0.2606060606,,,,,,,0.6086956522,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.3367139959,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,0.4,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.1581632653,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,0.3125,,,,,,,0.6676923077,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.3229873909,,,,,,,,0.004854368932,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,0.3673469388,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.502617801,,,,,,,,0.1991525424,,,0.5,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.2033898305,,,,,0.5887096774
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2303206997,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.2788461538,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02857142857,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.03076923077,,,,,0.3483870968,,,,0.28125,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.005025125628,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0.007246376812,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,,,,0.1386138614,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.07894736842,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.01960784314,,,,,,,,,0.07236842105,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,0.213592233,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.08196721311,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.1735159817,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,0.1974522293,0.4013605442,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.5700934579,,,,,,,,,,,,,
  6 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02597402597,,,,,0.2886178862,,,,0.2203791469,,,0.674796748,0,0.5229357798
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,0,,,,,,,,,0.1354166667,,,0.5666666667,,
  4 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.01324503311,,,,,0.2982583454,,,,0.2685025818,,,,0.007972665148,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3839285714,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.5137614679,,,,,,,,,,,0.4455445545,,
  4 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.02928870293,,,,,0.3333333333,,,,0.2636363636,,,,,0.6868686869
  8 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.09090909091,0.7078085642,,,0.5231481481,,0.5543071161,,,0.4170812604,,,0.6,0.1544117647,0.6455331412
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.675,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.5755813953,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.26,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,0.4409937888,,,,0.4098360656,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,0.61,,,,0.4122137405,,,,0.07647058824,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,0.3565217391,,,,0.3625730994,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1300087813,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.2296819788,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.1418439716,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.1666666667,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,0.1351351351,,,,,,,0.416,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,0.1361256545,,,,,,,0.4029850746,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.1524050633,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1416837782,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2873563218,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1885245902,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OMEPRAZOLE,,,,,,,0.1203703704,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.09844559585,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,0.1696428571,,,,,0.243697479,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,0.197761194,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1221374046,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,0.06878306878,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,0.1196581197,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1293103448,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.1257995736,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.1153846154,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1308724832,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.1357142857,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1238938053,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,0.03846153846,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1213266163,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.07207207207,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,0.08609271523,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,0.1571856287,,,,0.17,,,0.3497854077,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TOPIRAMATE,,,,,,,0.08,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,0.1658163265,,,,0.2271880819,,,,0.004291845494,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.1693548387,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,0.1851851852,,,,,,,,,0.476635514
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.5457875458,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.5815602837,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.5392156863,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,0.4657534247,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.6466552316,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,0.4622641509,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5490196078,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.5981794538,,,,0.593220339,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.3909090909,,,,,
  5 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3,,,,,0.4285714286,0.5952380952,,,0.4868913858,,,0.582010582,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,0.4036697248,,,,0.4732142857,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,0.435530086,,,,0.4017467249,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.4503816794,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.2732240437,,0.1955555556,,0.1932773109,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2164179104,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.3349753695,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02631578947,,,,,0.3227665706,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2946428571,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | NORETHINDRONE-E.ESTRADIOL-IRON | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | NORTRIPTYLINE HCL,,,,,,,0.3060686016,,,0.1128205128,0.2338709677,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6343825666,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.4778325123,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.4615384615,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1222222222,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1025641026,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.426035503,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | OMEPRAZOLE,,,,,,,0.313253012,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.5,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.2387387387,,,,,,,,,
  8 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PAROXETINE HCL,,0.02127659574,0.5955882353,,,,0.2150537634,0.3895348837,,,0.1881390593,0.4588796186,,0.4131944444,,0.5185185185
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,0.2,,,,0.2314049587,,,,,
  7 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.06766917293,0.228125,,,,0.2742857143,0.1782178218,,,0.06674473068,,,0.1925675676,,0.2252252252
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1782178218,,,,0.04491725768,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.05982905983,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.0996978852,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1230769231,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,0.3409090909,,,,0.3816793893,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.5,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.504587156,,
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.6573426573,,,,0.2382445141,0.4038461538,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2018348624,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2176165803,0.1959459459,,,0.15,,,0.1784037559,,
  6 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.3505154639,,,,0.2154195011,0.1964285714,,,0.09528907923,,,0.1773049645,,0.3071895425
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.141509434,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.152,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.2062937063,,,,0.09307359307,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.0625,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,0.1102941176,,,,0.1288888889,,,,,
  7 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2155172414,,,0.1282051282,0.2073578595,0.2172284644,,,0.1237113402,,,0.1877729258,,0.2339449541
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.1764705882,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.1388888889,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.1766917293,,,,0.147766323,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,0.1063829787,,,,0.05185185185,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,,,,,0.09036144578,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,0.3403361345,,,,0.3661202186,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,0.3235294118,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.5461538462,0.2956760049,,,,0.2474226804,0.4596774194,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.275862069,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,0.3106796117,,,,,,,,,
  11 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL,0,0.03300330033,0.5578947368,,,0.3846153846,0.2277265745,0.3526119403,,,0.223628692,0.3161094225,,0.4774074074,0.006172839506,0.5236907731
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5888888889,,
  4 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,0.2471590909,,,,0.1956521739,,,0.3767605634,0.02,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.22,,,0.4609929078,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.26,,,,,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,0.2055555556,,,0.5019556714,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | TOPIRAMATE,,,,,,,0.3120567376,,,,,,,,,
  8 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | TRAZODONE HCL,,0.02109704641,0.4812030075,,,,0.2541956611,0.2401746725,,,0.2083555082,,,0.3523489933,0.01484828922,0.4224137931
  3 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,0.2692307692,,,,0.206235012,,,,0.01481481481,
  2 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5955882353,0.237037037,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,0.2133333333,,,,,,,,,
  8 ,Age: 20-40 | Gender: Female | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,0.02555910543,0.4795321637,,,,0.2836004932,0.3666666667,,,0.223880597,0.3624161074,,0.375,,0.6181102362
  3 ,Age: 20-40 | Gender: Female | ESOMEPRAZOLE MAGNESIUM,,,0.4250764526,,,,0.1340206186,0.3916449086,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESOMEPRAZOLE MAGNESIUM | FLUOXETINE HCL,,,,,,,,0.5436893204,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.4617117117,,,,,,,,,,,,,0.5352697095
  1 ,Age: 20-40 | Gender: Female | ESTRADIOL,,,,,,,,0.3726415094,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESTRADIOL | FLUOXETINE HCL,,,,,,,,0.5724637681,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE",,0.03883495146,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ESZOPICLONE,,,0.4033149171,,,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE,,,0.4636363636,,,,0.141337386,,0.1262135922,,,0.3069767442,,0.5078630897,,
  3 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.1111111111,,,,,0.3591549296,,0.6341463415,,
  1 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.407079646,,
  1 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6025641026,,
  1 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | PAROXETINE HCL,,,,,,,,,,,,0.5324675325,,,,
  3 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.6181818182,,,0.1274601687,,,,,0.2985915493,,,,
  1 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,0.1142857143,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,,,,,,,,,,,,0.4563106796,,
  1 ,Age: 20-40 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | SERTRALINE HCL,,,,,,,,,,,,,,0.6818181818,,
  3 ,Age: 20-40 | Gender: Female | ETONOGESTREL/ETHINYL ESTRADIOL,,0.04152249135,,,,,,0.4094827586,,,,0.3274336283,,,,
  1 ,Age: 20-40 | Gender: Female | ETONOGESTREL/ETHINYL ESTRADIOL | FLUOXETINE HCL,,,,,,,,0.5362903226,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ETONOGESTREL/ETHINYL ESTRADIOL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3783783784,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ETONOGESTREL/ETHINYL ESTRADIOL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.5544554455,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ETONOGESTREL/ETHINYL ESTRADIOL | PAROXETINE HCL,,,,,,,,,,,,0.5272727273,,,,
  2 ,Age: 20-40 | Gender: Female | ETONOGESTREL/ETHINYL ESTRADIOL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.04444444444,,,,,,,,,,0.359375,,,,
  1 ,Age: 20-40 | Gender: Female | EXAMINATION OF EYES AND VISION (dxo:ICD9:V720),,,0.5111111111,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1804511278,,,,,,,,,,,0.2615384615,,
  1 ,Age: 20-40 | Gender: Female | FEVER AND OTHER PHYSIOLOGIC DISTURBANCES OF TEMPERATURE REGULATION (dxo:ICD9:7806),,,0.4382978723,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FEVER, UNSPECIFIED (dxo:ICD9:78060)",,,,,,,,,,,,,,,,0.4305555556
  1 ,Age: 20-40 | Gender: Female | FEXOFENADINE HCL,,,,,,,,,,,,,,,0.006060606061,
  1 ,Age: 20-40 | Gender: Female | FEXOFENADINE/PSEUDOEPHEDRINE,,,0.5,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)",,,,,,,0.1067961165,,,,,,,0.3955555556,,
  2 ,Age: 20-40 | Gender: Female | FLUCONAZOLE,,0.03461538462,,,,,,,,,,,,0.4887218045,,
  1 ,Age: 20-40 | Gender: Female | FLUCONAZOLE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,0.03738317757,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUCONAZOLE | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.05188679245,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUCONAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.0380952381,,,,,,,,,,,,,,
  15 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL,0.02055702918,0.03838261919,0.4163522013,0.5011990408,0.09966777409,0.3473451327,0.158988764,0.4415876131,0.123119015,0.07086614173,0.2364811246,0.36508994,,0.4246386054,0.01814183617,0.5270582201
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.5909090909,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss,,,,,,,,0.640776699,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,,,,,,,0.6023622047,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,,,,,,,0.3106796117,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & Remiss,,,,,,,,0.5666666667,,,,,,,,
  7 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.5166666667,,,,0.1866666667,0.5557074504,,,0.3219178082,0.5034246575,,0.7096774194,,0.6945606695
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,0.09900990099,,,,0.2325581395,,,,,0.6285714286
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss,,,,,,,,,,,0.2483660131,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,,,,,,,0.2764705882,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.25,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.2222222222,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss,,,,,,,,0.5808383234,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.4854368932,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.414084507,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.5480769231,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840),0.01310043668,,,,,,,0.5031055901,,0.06707317073,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.01818181818,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,,,,,,,,0.3962264151,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | HYDROCODONE/ACETAMINOPHEN,,,,,,,,0.5845070423,,,,,,,,
  4 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,0.3113069016,,,0.0942408377,,,0.1981132075,,0.1531531532
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.2009569378,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.1551724138,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,0.1872146119,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1465517241,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2912087912,,,0.1029411765,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06629834254,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,0.2467532468,,,0.1470588235,,,,,
  8 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2908587258,,,0.2847222222,0.1060329068,0.3815484469,,,0.1858974359,0.2487804878,,0.2762148338,,0.3023255814
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.09523809524,,,,0.1960784314,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.2192982456,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08653846154,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08045977011,,,,0.1201413428,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.2492378049,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1507352941,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.1610738255,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.1733333333,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2435158501,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss",,,,,,,,0.3828125,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3958333333,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.5882352941,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.224137931,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2192982456,,,,,,0.1862745098,,0.1793103448
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2036199095,,,0.09045226131,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.2125984252,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.2192513369,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.3537414966,,,,,,,,
  7 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2941176471,,,,0.0875,0.3706563707,,,0.1692307692,0.2196969697,,0.2307692308,,0.2699115044
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.2532467532,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,0.3571428571,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,,0.2891986063,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.06,0.2431818182,,,0.07301587302,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,,0.1722222222,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.05769230769,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,0.1603053435,,,0.09482758621,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.5464566929,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.5869565217,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6641221374,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.02307692308,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",,,,,,,,0.3470588235,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss",,,,,,,,0.5159010601,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE,,,0.1736111111,,,,0.1047619048,0.1348028826,,,0.07202881152,,,0.1897810219,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,,0.07991803279,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.3697916667,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,0.1333333333,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,0.09357798165,,,0.05642023346,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.09523809524,,,,,
  10 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss,0.009950248756,0.02396931927,0.4009360374,,,0.3558718861,0.1201413428,,,,0.2512868507,0.3362831858,,0.4363791631,0.01313868613,0.5081967213
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01481481481,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6034482759,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,0.5952380952,,,,,,0.6578947368,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.5270833333,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,0.6352941176,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,0.629969419,,,,,,0.6698564593,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5916069601,,,,,,,0.006993006993,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6244131455,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,0.119266055,,,,0.2469135802,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.287037037,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3558282209,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.04166666667,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.02127659574,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01801801802,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,0.137254902,,,,0.167539267,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1203007519,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.06153846154,,,,0.07392996109,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1538461538,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03146853147,,,,,0.1461988304,,,,0.256,,,,,0.4626865672
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,0.2296296296,,,0.4782608696,,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05333333333,,,,,,,,,0.3928571429,,,,0.01342281879,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.01657458564,,,,,,,,,0.3282051282,,,,,0.5916230366
  10 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss,0.05555555556,0.064,0.5375,,,0.4141791045,0.2316890882,,,,0.3215903372,0.5142857143,,0.5714285714,0.08267716535,0.5863539446
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6756756757,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6083916084,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.2547169811,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,,,,0.3039215686,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.3053435115,,,,,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,0.1100917431,,,,,,0.6974789916,,,0.3838862559,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,0.3689320388,,,,,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,0.6012861736,,,0.3876651982,,,,0.06840390879,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.3728813559,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3006253722,,,0.2735042735,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.4057377049,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MASTODYNIA (dxo:ICD9:61171),,,,,,,,0.3389830508,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MYOPIA (dxo:ICD9:3671),,,,,,,,0.3448275862,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,0.4,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,0.4,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.3725490196,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.3216350124,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.2165450122,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.2804232804,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4166666667,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.3305785124,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,,,0.3777777778,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.3290322581,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,0.3051643192,,,,0.3032786885,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.210467706,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2252252252,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1683168317,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.2207953604,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.1774193548,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,,0.3162393162,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2837370242,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,0.2489270386,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.2274368231,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2476038339,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,0.170212766,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.3172268908,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,0.3428571429,,,,,,0.3333333333,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.460251046,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | TOPIRAMATE,,,,,,,,0.4,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,0.2819905213,,,0.3090128755,,,,0.004329004329,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.2864864865,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.3481953291,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,0.2583333333,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,0.3235294118,,,,,,,,0.4537815126
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | ZOLPIDEM TARTRATE,,,,,,,,0.3301886792,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.5853137517,,,0.4710743802,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.6115107914,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MYOPIA (dxo:ICD9:3671),,,,,,,,0.6887417219,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,0.4987212276,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,0.696,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,,0.696969697,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.619047619,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.5350756534,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,0.4722222222,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.5878594249,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,0.6283185841,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.6217765043,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | TOPIRAMATE,,,,,,,,0.6940298507,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5679012346,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.6038961039,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.5719063545,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,0.5119047619,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | Last AD: Same & No Remiss",,,,,,,,0.2956521739,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LEVOTHYROXINE SODIUM,,,,,,,,0.6813880126,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LEVOTHYROXINE SODIUM | Last AD: Same & No Remiss,,,,,,,,0.3863636364,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LITHIUM CARBONATE,,,,,,,,0.1468926554,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LITHIUM CARBONATE | Last AD: Same & No Remiss,,,,,,,,0.07476635514,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LORAZEPAM,,,,,,,,0.5095541401,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,0.5545454545,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.4814814815,,,,,
  3 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,0.654676259,,,0.5514018692,,,0.6725663717,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.6826923077,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,0.5847457627,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.6255924171,,,0.3303571429,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2307692308,,,,,,,,
  7 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4457831325,0.5950413223,,,0.519379845,0.3821428571,0.5702592087,,,0.5367647059,,,0.5962732919,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.6218905473,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,0.4731182796,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,0.5351812367,,,0.450617284,,,,0.16,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.4748201439,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | MASTODYNIA (dxo:ICD9:61171),,,,,,,,0.5585585586,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",,,,,,,,0.5434782609,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.3651315789,0.1576923077,,0.2361445783,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.1470588235,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | MONTELUKAST SODIUM,,,,,,,,0.5925925926,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,,0.6470588235,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | MYOPIA (dxo:ICD9:3671),,,,,,,,0.6302521008,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.007751937984,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,0.5254988914,,0.1144781145,0.2998027613,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6034482759,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,0.6352941176,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,0.6291793313,,,,,,0.6299212598,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5916496945,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6214953271,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.2848484848,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,0.2965517241,,,0.1449275362,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1754385965,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | Num Previous Remissions: 2+,,,,,,,,0.690647482,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1449275362,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1461988304,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | OTHER GENERAL COUNSELING AND ADVICE FOR CONTRACEPTIVE MANAGEMENT (dxo:ICD9:V2509),,,,,,,,0.5652173913,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.05660377358,,,,,,0.633744856,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.6006825939,,,,,,,,
  7 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PAROXETINE HCL,,0.05089820359,0.3684210526,,,,0.1832460733,0.4817767654,,,0.1804670913,0.4210526316,,0.4124513619,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,0.3333333333,,,0.2598425197,,,,,
  8 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.06944444444,0.2083333333,,,0.168,,0.3079406068,,,0.1077283372,0.2413793103,,0.2196078431,,0.2349206349
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.295,,,0.09418282548,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.126984127,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.2208333333,,,0.1675531915,,,,,
  3 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,0.2767857143,,,0.1161290323,,,,,0.214953271
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,0.4534161491,,,0.3493975904,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.5539568345,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5675675676,,
  4 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.524691358,,,,0.157480315,0.4471236652,,,0.3317073171,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.3821138211,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | SERTRALINE HCL,,,,,,,,0.42,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | TRAZODONE HCL,,,,,,,,0.3962264151,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.3333333333,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,,0.4433497537,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.3333333333,,,,,,0.2403846154,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,0.2672413793,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.3113207547,,,,,0.40625,,,0.1584385763,,,0.26,,0.2444444444
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1759259259,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.3619302949,,,0.1452784504,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2704918033,,,0.09448818898,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,0.2727272727,,,0.09230769231,,,,,
  7 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1550387597,,,0.2166666667,0.09777777778,0.3337378641,,,0.1531914894,,,0.233463035,,0.2461538462
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,0.313304721,,,0.2112676056,,,,,
  2 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,0.3222222222,,,0.09708737864,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | RISPERIDONE,,,,,,,,0.1705426357,,,0.1106382979,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1180555556,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | RIZATRIPTAN BENZOATE,,,,,,,,0.6379310345,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,0.4492753623,,,0.3291925466,,,,,
  4 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.4885496183,,,0.2068965517,0.5673758865,,,0.2975609756,,,,,
  10 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL,,0.04270986745,0.3747412008,,,0.2931937173,0.1561996779,0.4344507136,,,0.2214342002,0.3015873016,,0.439864657,0.006849315068,0.5178571429
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5117647059,,
  4 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,0.3121546961,,,0.2156334232,,,0.4448818898,0.02380952381,
  2 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2912621359,,,0.5409836066,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.619047619,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.6182795699,,,0.2307692308,,,0.5125148987,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | TERCONAZOLE,,,,,,,,0.6134453782,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | TOPIRAMATE,,,,,,,,0.615625,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | TRAMADOL HCL/ACETAMINOPHEN,,,,,,,,0.5242718447,,,,,,,,
  9 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | TRAZODONE HCL,,0.05960264901,0.2730769231,,,0.2585034014,0.1,0.3893960674,,,0.2598134895,,,0.3664122137,0.01831896552,0.329787234
  4 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,0.3368421053,,,0.2093023256,,,,0.03816793893,0.5267857143
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED ALOPECIA (dxo:ICD9:70400),,,,,,,,0.475,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.5888223553,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,0.5663716814,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.5323275862,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | FLUOXETINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,0.5545851528,,,,,,,,
  9 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | VENLAFAXINE HCL,,0.03243243243,0.406779661,,,,0.2173913043,0.4716342083,,,0.249017038,0.3863636364,,0.4538258575,0.02255639098,0.5662650602
  1 ,Age: 20-40 | Gender: Female | FLUOXETINE HCL | ZOLPIDEM TARTRATE,,,,,,,,0.5138888889,,,,,,,,
  8 ,Age: 20-40 | Gender: Female | GABAPENTIN,,0.02857142857,0.4674329502,,,0.3195020747,0.1689373297,0.4708520179,,0.04109589041,0.2060606061,,,0.467961165,,
  1 ,Age: 20-40 | Gender: Female | GABAPENTIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2169811321,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GABAPENTIN | SERTRALINE HCL,,,,,,,,,,,,,,0.6363636364,,
  1 ,Age: 20-40 | Gender: Female | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3510971787,,,,,,,,,,
  6 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),0.01388888889,0.03189703414,,,,,0.1511035654,0.3788300836,,,0.1957671958,,,0.4926686217,,
  1 ,"Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.07627118644,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.01463414634,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4074074074,,
  1 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5607476636,,
  1 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01675977654,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.0350877193,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.01769911504,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.09649122807,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.04453441296,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1703703704,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | SERTRALINE HCL,,0.06097560976,,,,,,,,,0.3310344828,,,0.6789667897,,
  4 ,Age: 20-40 | Gender: Female | GUAIFENESIN/P-EPHED HCL,,,0.4491803279,,,0.3720930233,0.1346423562,,,,,,,,,0.5401459854
  1 ,Age: 20-40 | Gender: Female | GUAIFENESIN/P-EPHED HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1165048544,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | GUAIFENESIN/PHENYLEPHRINE HCL,,,0.4579124579,,,,0.1635514019,,,,,,,,,0.6043165468
  1 ,Age: 20-40 | Gender: Female | GUAIFENESIN/PHENYLEPHRINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.1228070175,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GUAIFENESIN/PHENYLEPHRINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1597222222,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | GUAIFENESIN/PSEUDOEPHEDRNE HCL,,,,,,,,,,,,0.395480226,,,,0.5739130435
  2 ,Age: 20-40 | Gender: Female | GUAIFENESIN/PSEUDOEPHEDRNE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,0.3881748072,,,,0.5575221239
  1 ,Age: 20-40 | Gender: Female | GUAIFENESIN/PSEUDOEPHEDRNE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,,,,,,,,,,0.5671641791,,,,
  1 ,Age: 20-40 | Gender: Female | GUAIFENESIN/PSEUDOEPHEDRNE HCL | PAROXETINE HCL,,,,,,,,,,,,0.4930555556,,,,
  10 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),0.003968253968,0.01355932203,0.5394984326,,,0.3560864619,0.1152388173,0.4379643388,,,0.1998231653,0.4014848658,,0.568321392,,0.5681285571
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | HEADACHE (dxo:ICD9:7840),,,,,,,,0.4,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.09523809524,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | IBUPROFEN,,,,,,,,,,,,,,0.5943396226,,
  4 ,"Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.263803681,,,,0.078125,,,,,0.237388724,,,,0.365
  1 ,"Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,,,,,,,,,,0.3421052632,,,,
  1 ,"Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,0.3783783784,,,,
  5 ,"Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.170212766,,,,0.06305309735,,,,,0.1572815534,,0.2580645161,,0.227027027
  1 ,"Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.5875706215,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LABORATORY EXAMINATION (dxo:ICD9:V726),,,0.5083333333,,,,,,,,,0.3595505618,,,,
  3 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,0.1550387597,,,,0.2159090909,,,,,0.5221238938
  4 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,0.1418439716,,,,0.3021978022,0.4299065421,,,,0.5826771654
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2865853659,,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.2912621359,,,,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.3870967742,,,,,0.7064220183
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.3083333333,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.390070922,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.3425797503,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3619047619,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4175257732
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.5785123967,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5511482255,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.601010101
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LEVONORGESTREL-ETHIN ESTRADIOL,,,0.6363636364,,,,,,,,,,,0.5680751174,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LEVONORGESTREL-ETHIN ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.6993006993,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LEVOTHYROXINE SODIUM,,,,,,,,0.5436893204,,,,,,0.625,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LORATADINE,,,0.6184971098,,,,,,,,,0.4810126582,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LORATADINE | PAROXETINE HCL,,,,,,,,,,,,0.5514018692,,,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | MYOPIA (dxo:ICD9:3671),,,,,,,,0.5163043478,,,,,,0.4834437086,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | NORETHINDRONE-ETHIN. ESTRADIOL,,,,,,,,,,,,,,0.5253164557,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | NORGESTIMATE-ETHINYL ESTRADIOL,,,0.5588235294,,,,,,,,,,,0.5084745763,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01621621622,,,,,,0.4478527607,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,,,,,0.1478599222,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.119047619,,,,,0.392,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,,,,,,,,,,,0.4822335025,,,,
  5 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,0.55,,,,0.1945701357,,,,0.2626865672,0.5400410678,,,,0.7022222222
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.5955882353,,,,
  1 ,"Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,0.4821428571,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.5371428571,,,,0.09929078014,0.3710144928,,,,0.3333333333,,,,
  4 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.2242424242,,,,0.06787330317,,,,,0.1897810219,,,,0.1975308642
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | ROFECOXIB,,,,,,,0.1328125,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.02702702703,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,,,,,,,,,,,,0.4571428571,,
  3 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,,,,,,,,,,0.3689320388,,0.5573770492,,0.573964497
  6 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL,,,0.6339285714,,,,0.2006802721,,,,0.3142144638,0.4713804714,,0.6175226586,,0.6415770609
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.584,,
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.6,,
  4 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.5191256831,,,,0.4488636364,,0.5412844037,,0.4392523364
  1 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.6878980892,,
  2 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,0.4322033898,,,,,,0.506993007,,
  6 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.4703389831,,,,0.06763285024,0.4410646388,,,,0.4245283019,,0.5326315789,,0.4869565217
  2 ,"Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,0.4125874126,,,,,,0.5850340136,,
  4 ,Age: 20-40 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | VENLAFAXINE HCL,,,,,,,0.2213114754,,,,0.3672566372,0.4770642202,,,,0.6051454139
  7 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840),0.006966329408,0.0255839822,0.5034965035,,,,0.1293103448,0.3772070626,,0.04239326518,,,,0.4778761062,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | SERTRALINE HCL,0.0125,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | TRAZODONE HCL,0.0223880597,,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | NORTRIPTYLINE HCL",,,,,,,,,,0.05696202532,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.04587155963,,,,,,
  1 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",,,,,,,,,,0.0306122449,,,,,,
  1 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",,,,,,,,,,0.04861111111,,,,,,
  2 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.004216444132,,,,,,,,,0.05580558056,,,,,,
  1 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | NORTRIPTYLINE HCL",,,,,,,,,,0.1475409836,,,,,,
  1 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.00495049505,,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | SUMATRIPTAN SUCCINATE",0.006369426752,,,,,,,,,0.0325203252,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02857142857,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL,0,,,,,,,,,0.1455108359,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02346041056,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)",0,,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",0,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OXYCODONE HCL,0.007692307692,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | PAROXETINE HCL,0,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0.02142857143,,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.005736137667,0.01648351648,,,,,,0.3504273504,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | SERTRALINE HCL,0.01215805471,,,,,,,,,0.04411764706,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | SUMATRIPTAN SUCCINATE,0,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,0.0303030303,,,,,,
  2 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | TRAZODONE HCL,0.03015075377,,,,,,,,,0.07272727273,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),0,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEADACHE (dxo:ICD9:7840) | VENLAFAXINE HCL,0.01550387597,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HEMATURIA (dxo:ICD9:5997),,,0.4782608696,,,,,,,,,,,,,
  10 ,Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN,0.002487562189,0.03982300885,,,,0.3393939394,0.1355653128,0.4432624113,,0,0.1591448931,0.3247863248,,0.4926605505,0.01126126126,
  1 ,Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | IBUPROFEN,,,,,,,,,,,,,,0.4854014599,,
  1 ,Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | OXYCODONE HCL/ACETAMINOPHEN,,,,,,,0.1307692308,,,,,,,,,
  6 ,Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01047120419,0.03174603175,,,,0.3271889401,0.1423728814,0.4454976303,,,0.2301587302,,,,,
  1 ,Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,0.05714285714,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | SERTRALINE HCL,,,,,,,,,,,,,,0.6056338028,,
  1 ,Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | TRAMADOL HCL,,,,,,,0.1089108911,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,0.1121495327,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,0.1293103448,,,,,,,0.4166666667,,
  2 ,Age: 20-40 | Gender: Female | HYDROCODONE/HOMATROPINE,,,0.4231738035,,,,0.1290322581,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | HYDROXYCHLOROQUINE SULFATE,,,,,,,0.07751937984,,,,,,,0.5329341317,,
  1 ,Age: 20-40 | Gender: Female | HYDROXYCHLOROQUINE SULFATE | SERTRALINE HCL,,,,,,,,,,,,,,0.6759259259,,
  2 ,Age: 20-40 | Gender: Female | HYDROXYZINE HCL,,0.05405405405,,,0.1028368794,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HYDROXYZINE HCL | UNSPECIFIED URTICARIA (dxo:ICD9:7089),,,,,0.2014925373,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HYOSCYAMINE SULFATE,0,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | HYOSCYAMINE SULFATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | IBUPROFEN,,,0.3982300885,,,,,,,,,0.3081761006,,0.4337623013,0.006389776358,0.4255319149
  1 ,Age: 20-40 | Gender: Female | IBUPROFEN | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3907284768,,
  1 ,Age: 20-40 | Gender: Female | IBUPROFEN | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.536,,
  1 ,Age: 20-40 | Gender: Female | IBUPROFEN | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,,,,,,,,0.43,,
  1 ,"Age: 20-40 | Gender: Female | IBUPROFEN | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5222929936,,
  1 ,Age: 20-40 | Gender: Female | IBUPROFEN | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,,,,,,,,,,,,0.4649122807,,
  1 ,Age: 20-40 | Gender: Female | IBUPROFEN | SERTRALINE HCL,,,,,,,,,,,,,,0.5878787879,,
  2 ,Age: 20-40 | Gender: Female | IBUPROFEN | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,0.4496124031,,,,,,,,,,,0.4892601432,,
  1 ,Age: 20-40 | Gender: Female | IBUPROFEN | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.406779661,,
  1 ,Age: 20-40 | Gender: Female | IMIPRAMINE HCL,,,,,,,,,,,0.1846153846,,,,,
  1 ,Age: 20-40 | Gender: Female | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.1083743842,,,,,
  12 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",0.03846153846,0.05186721992,0.1938610662,0.1666666667,,0.10626703,0.07120253165,0.159453303,,,0.1086350975,0.1341463415,,0.1561051005,0.01572327044,0.1776470588
  6 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.1403508772,,,0.1056338028,0.03579952267,0.1139240506,,,,,,0.0989010989,,0.09966777409
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1489361702,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,,0.1926605505
  5 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1450381679,,,,0.02279202279,0.119266055,,,,,,0.09734513274,,0.06766917293
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.07792207792,,,0.2049180328,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.2122641509,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.1282051282,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.21
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2317880795
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,,,,,,0.149122807
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2095238095,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1881188119,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.008,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1790123457
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,,,,,,0.7064220183
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL",,,,,,,,,,,0.08080808081,0.2904761905,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.05660377358,,,,,
  6 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.01818181818,0.1493506494,,,0.04424778761,,,,,,,,0.168,0.04255319149,0.1992882562
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.09604519774,,,0.2402234637,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.25
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.07575757576,,,,,0.2216981132
  8 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.07086614173,0.1428571429,0.1282051282,,,0.0537084399,0.141509434,,,0.09714285714,,,0.1693989071,,0.161971831
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.08463949843,,,0.3162393162,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.0875,,,,,
  5 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,0.1826086957,,,0.1403508772,,0.1764705882,,,0.1021194605,,,0.3065693431,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1542553191,,,0.1992337165,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.07692307692,,,,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.119047619,,,,,0.2818181818
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,0.1072555205,,,,,0.2631578947
  12 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,0.09,0.215496368,0.304526749,0.03521126761,0.2143671608,0.07061480037,0.2023322422,,,0.1187384045,0.1795570698,,0.2110197791,0.03149606299,0.269481933
  4 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.05633802817,0.06422018349,,,,,,0.0843373494,,0.126984127
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.04395604396,,,,,,,0.08130081301,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.009708737864,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | LAMOTRIGINE",,,,,,,0.06140350877,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.2897196262,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,0.07305936073,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08450704225,,,,0.1059602649,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.04545454545,,,,,
  4 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,0.081232493,0.1688311688,,,0.114713217,,,,,0.2692307692
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1402439024,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1287878788,,,,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,0.08,,,,0.1567567568,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.04651162791,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,0.0612244898,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2408906883,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,0.2272727273,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.2028985507,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1884984026,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1870503597
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.272073922,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4038461538,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3688888889
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.2646223737,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.3823529412,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01360544218,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.320083682
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.3333333333,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4457831325,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.2571428571,,,,,,0.2384615385,,
  4 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1932773109,,,,,0.1923076923,,,0.09701492537,,,0.1519756839,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.4150943396,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.1650485437,,,,,,0.09923664122,,
  5 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.6470588235,,,,0.5701219512,0.6260162602,,,,,,0.652173913,,0.6355140187
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,,0.637254902
  3 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.6036866359,,,,,,,0.6524822695,,0.6442307692
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.7063492063,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1901840491,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29623) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1844660194,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.1843971631,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.313253012,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3981481481,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.0396039604,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",,,,,,,0.06837606838,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,0.1403508772,,,,
  6 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,0.2789855072,,,,0.1032258065,0.236453202,,,0.09743589744,0.345124283,,0.2906666667,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.1948717949,,,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.05309734513,0.2100840336,,,,
  7 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2670157068,,,,0.1578947368,0.2113821138,,,0.1572700297,0.3835051546,,0.2530120482,,0.3571428571
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.3684210526,,,,
  7 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1337047354,,,0.1134020619,,0.1639344262,,,,0.1363636364,,0.1115537849,0.0414507772,0.1231593039
  9 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1313868613,0.1014492754,,0.1176470588,0.06682577566,0.1317073171,,,0.04545454545,0.1533742331,,0.1060606061,,0.1228571429
  3 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.07534246575,,,0.2338709677,,0.1652173913
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.1979695431,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1639344262
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.09473684211,,,,,0.2717391304
  4 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,0.1165048544,,,0.1487603306,,,0.2425531915,,0.1623376623
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.206405694,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1935483871
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2549019608
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)",,,,,,,,,,,,,,0.1842105263,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1703703704,,,,,,,,,,,0.1628959276,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.277027027,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.2661290323,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2193548387,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2777777778,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.2084507042,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07432432432,0.2254901961,,,,,,,,
  11 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.05084745763,0.1986265188,0.2550607287,,0.1973415133,0.06544460524,0.1875796178,,,0.1056268509,0.164495114,,0.2000388802,0.03233830846,0.2393665158
  3 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,0.2670454545,,,0.07089552239,,,,,0.1379310345,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",,,0.1951219512,,,,,,,,,,,,,
  8 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,0.228125,,,0.2253521127,0.09954751131,0.1895910781,,,0.1272727273,0.2146596859,,0.3452647278,,0.3056300268
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.3777777778,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3288288288,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2646657572,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1623931624,,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3806451613
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.2578125,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,0.1869158879,,,,,,0.1964285714,,
  5 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,0.3304347826,,,,0.11,,,,0.1540540541,,,0.2824427481,,0.4174107143
  4 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1118881119,,,,0.05479452055,0.1167883212,,,,,,0.2,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1042345277,,,,,0.1235294118,,,,
  8 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,0.2453222453,,,0.2277992278,0.08847736626,0.2449438202,,,0.18,0.2190812721,,0.3598499062,,0.3076923077
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4249084249,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3648293963,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2927818329,,
  5 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,0.04320987654,,,,0.1636363636,,,0.25,0,0.3116883117
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3387096774
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,,,,,,,0.2403846154,,
  8 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,0.3273809524,,,0.2777777778,0.1027190332,0.3176470588,,,0.1772151899,0.23,,0.2955665025,,0.4042179262
  10 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.1096408318,0.1531531532,,0.1067961165,0.06150341686,0.1279826464,,,0.08487084871,0.1111111111,,0.1360448808,0.007299270073,0.1609848485
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1581632653,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1881188119
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PAROXETINE HCL",,,,,,,,,,,0.06896551724,0.2695035461,,,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,,0.1538461538
  5 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.0297029703,0.1165048544,,,,0.04424778761,0.08910891089,,,,,,0.1089108911,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.05223880597,,,,,
  3 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,0.07857142857,,,,0.07196029777,,,0.2589928058,,
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1503759398,,,0.2285714286,,
  1 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2830188679
  2 ,"Age: 20-40 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | VENLAFAXINE HCL",,,,,,,,,,,0.07920792079,,,,,0.2643678161
  7 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",0.005263157895,0.02996254682,0.4331797235,,,,,0.3965517241,0.1386138614,,,,,0.4483801296,0.01098498718,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6271186441,,
  2 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5966850829,0.01,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,,0.006993006993,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.005376344086,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,0.392,,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.3924050633,,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.006003430532,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.5316804408,,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01234567901,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.3230769231,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,,,,,,,,,,,,,,0.009900990099,
  2 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.5743589744,0,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6285714286,,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01117318436,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,,,,,,,,0.4587155963,,
  1 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,,,,,,,0.3541666667,,
  3 ,"Age: 20-40 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,0.4125,,,,,,0.4722222222,0.007075471698,
  2 ,Age: 20-40 | Gender: Female | IRREGULAR MENSTRUAL CYCLE (dxo:ICD9:6264),,,0.3943661972,,,,,,,,,,,0.4819277108,,
  3 ,Age: 20-40 | Gender: Female | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641),0.01734104046,0.04968944099,,,,,,,,0.0152284264,,,,,,
  1 ,Age: 20-40 | Gender: Female | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ISOMETHEPT/DICHLPHN/ACETAMINOP,,,,,,,,,,,,,,0.4872727273,,
  1 ,Age: 20-40 | Gender: Female | ISOMETHEPT/DICHLPHN/ACETAMINOP | SERTRALINE HCL,,,,,,,,,,,,,,0.5785123967,,
  1 ,Age: 20-40 | Gender: Female | KETOCONAZOLE,,,,,,,,,,,,,,0.4583333333,,
  4 ,Age: 20-40 | Gender: Female | LABORATORY EXAMINATION (dxo:ICD9:V726),,,0.4613003096,,,,0.145631068,,,,0.1296296296,0.3314285714,,,,
  1 ,Age: 20-40 | Gender: Female | LABORATORY EXAMINATION (dxo:ICD9:V726) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.125,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | LABORATORY EXAMINATION, UNSPECIFIED (dxo:ICD9:V7260)",,,0.4491525424,,,,,,,,,,,0.4899328859,,
  11 ,Age: 20-40 | Gender: Female | LAMOTRIGINE,,,0.140709561,0.1141045959,,0.109375,0.05525460455,0.1293604651,0.04255319149,,0.07380298872,0.1100917431,,0.1415929204,0.02762430939,0.1613316261
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.09821428571,,
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.144
  1 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.4868421053,,,,,
  1 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.4705882353,,,,,
  4 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.3677419355,,0.3644859813,,,0.4226950355,,,,,0.4304635762
  1 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3655913978,,,,,
  2 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.424,,,,,0.375
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.08407079646,,,,,
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.09389671362,,,,,
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.08938547486,,,,,
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.09811320755,,,,,
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.03669724771,,,,,
  2 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | PAROXETINE HCL,,,,,,,,,,,0.04098360656,0.168,,,,
  5 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.04672897196,0.09090909091,,0.03773584906,,0.02857142857,,,,,,,,0.07558139535
  1 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.06542056075,,
  1 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1126760563
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.1388888889,,,,,
  1 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.04807692308,,,,,
  1 ,"Age: 20-40 | Gender: Female | LAMOTRIGINE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,,,0.05357142857
  2 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | RISPERIDONE,,,,,,,,,,,0.06071428571,,,,,0.1553398058
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.05579399142,,,,,
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1226415094
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | ROPINIROLE HCL,,,,,,,,,,,0.08510638298,,,,,
  1 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.06422018349,,,,,
  5 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | SERTRALINE HCL,,,0.1764705882,,,,0.1073825503,0.1582278481,,,0.08443708609,,,0.1423712342,,
  2 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.07714285714,,,0.1465517241,,
  4 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | TRAZODONE HCL,,,,,,0.1208791209,,0.137254902,,,0.08116723884,,,,,0.1158536585
  2 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.08469055375,,,,,0.1252747253
  5 ,Age: 20-40 | Gender: Female | LAMOTRIGINE | VENLAFAXINE HCL,,,0.1739130435,,,,,0.1293103448,,,0.06776379477,,,0.1823529412,,0.1543443065
  4 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss,,0.04188481675,,,,,0.213740458,,,,,,,0.4615384615,0.005259203606,
  3 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.0350877193,,,,,,,,,0.1791907514,,,,0.01639344262,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.005376344086,,,,,,,,,,,,,,
  9 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,0.02112676056,0.2931034483,,,0.2949640288,0.1151832461,0.4098360656,,,0.2410501193,,,0.4739884393,0.009433962264,0.4508196721
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6793478261,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.4761904762,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.4491525424,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5953846154,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.6610169492,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.661971831,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6038961039,,,,
  2 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6159143076,0.01136363636,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.72265625,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6285714286
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3677419355,,,,,
  3 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.4757281553,,,,0.1589403974,,,,0.2685950413,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4088541667,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3796296296,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2158273381,,,,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3352601156,,,,,0.6305970149
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.03883495146,,,,,,,,,,,,,,
  10 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL,0.009174311927,0.02809573361,0.3974025974,,,0.3333333333,0.1389548694,0.4090019569,,,0.1958115183,,,0.4475138122,0.01823708207,0.4609053498
  2 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | SERTRALINE HCL,,0.04098360656,,,,,,,,,0.2595419847,,,,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4176245211,,,,0.02255639098,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2596153846,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.09734513274,,,,,
  2 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.03205128205,,,,,,,,,,,,,0.01960784314,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.007936507937,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL",,,0.3365384615,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,0.2673267327,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | SERTRALINE HCL,,,,,,,,0.3706896552,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.1130434783,,,,0.1929824561,,,,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,0.08641975309,,,,0.1533742331,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1487603306,,,,,
  2 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.08580858086,,,,0.1555023923,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.16,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1205673759,,,,,
  3 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL,,,,,,,0.1507352941,,,,0.2635135135,0.2777777778,,,,
  11 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL,0.01498127341,0.02190974493,0.3714953271,,,0.3092369478,0.1484407484,0.3958009331,0.1228070175,,0.26179941,0.3272357724,,,0.01261829653,0.4595086442
  4 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,0.01960784314,,,,,,0.4375,,,0.2556818182,,,,,0.3728813559
  4 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,0.01020408163,,,,,0.1157024793,,,,0.4206896552,,,,0.009977827051,
  4 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,0.05347593583,,,,,0.2027027027,,,,0.348,,,,,0.7183098592
  12 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL,0.008583690987,0.03549382716,0.3130699088,,,0.2628571429,0.145631068,0.3432835821,0.07339449541,,0.2686104218,0.2882882883,,0.3773987207,0.01307847082,0.48
  3 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3780487805,,,,0.01785714286,0.6360655738
  10 ,Age: 20-40 | Gender: Female | Last AD: Diff & No Remiss | VENLAFAXINE HCL,0.02884615385,0.02889576883,0.3677419355,,,0.3348214286,0.1520979021,0.452173913,,,0.2370540852,0.4117647059,,0.4608695652,0.01095890411,
  6 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss,,0.0901734104,,0.5540983607,,0.499047619,,,0.2814371257,,,,,,0.1085201794,0.623255814
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,,,,,0.5048543689,
  2 ,"Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.6220472441,,,,,,,,,,,,,0.489539749,
  3 ,"Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.5,,,,,0.56,,,,0.6875,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.450617284,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.7222222222,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE,,,,,,,,,0.4509803922,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5833333333,,
  2 ,"Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.634085213,0.05084745763,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3953488372,,,,,
  9 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL,,0.05288461538,0.7066115702,,,0.4594594595,0.235,0.5714285714,,,0.2679012346,,,0.63125,0.1507936508,0.649122807
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.3243243243,,,,,
  3 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4150943396,0.5438596491,,,0.104,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.2641509434,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,0.2,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.2941176471,,,,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL,,,,,,,0.1925465839,,,,0.3125,,,,,
  11 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL,0.03012048193,0.05246523388,0.5962643678,0.6092715232,,0.4621359223,0.225,0.5204513399,,,0.3675970048,0.4829721362,,,0.09278350515,0.606271777
  2 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,0.364,,,,,0.5963302752
  3 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4092307692,,,0.6368038741,0.04455445545,
  4 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,0.1442307692,,,,,,,,,0.35546875,,,0.7247706422,,0.79
  1 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.06609947644,
  3 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4181818182,,,,0.09722222222,0.68
  8 ,Age: 20-40 | Gender: Female | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.0625,0.6470588235,,,0.4862385321,0.1949860724,0.5219298246,,,0.3291814947,,,0.5795918367,0.125984252,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss,,,,,,,,,,,0.1364190012,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.3918367347,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4444444444
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | MASTODYNIA (dxo:ICD9:61171) | SERTRALINE HCL,,,,,,,,,,,,,,0.3671875,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | NORTRIPTYLINE HCL",,,,,,,,,,0.04385964912,,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1265822785,,,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,0.125,,,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | MYOPIA (dxo:ICD9:3671) | SERTRALINE HCL,,,,,,,,,,,,,,0.3271028037,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,,,,,,,,,,,,,0.4910714286,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | NORETHINDRONE | SERTRALINE HCL,,,,,,,,,,,,,,0.4319526627,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.04699093157,,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3663366337,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.3090128755,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.2252747253,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3685478321,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4375,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.381443299,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.3032258065,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,,,,,0.003861003861,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3074141049
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PAROXETINE HCL,,,,,,,,,,,,0.2977099237,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | SERTRALINE HCL,,,,,,,,,,,,,,0.3953488372,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.2856117689,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.1883561644,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,,0.2347826087,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,0.2155172414,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.2741935484,,,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,,0.2988505747,,0.4117647059,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2857142857,0.2857142857,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.1711229947,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2081316554,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1408450704,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0.008086253369,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2278761062
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL",,,,,,,,,,,,,,0.4334140436,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4678571429,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.3027027027,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SERTRALINE HCL,,,,,,,,,,,,,,0.36,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,,,,0.3235294118,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1634615385,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3660714286
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,,,,0.2275132275,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01834862385,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.2222222222,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.257889991,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.3554216867,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1559633028,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,,,,,0.007462686567,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2311557789
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836) | SERTRALINE HCL",,,,,,,,,,,,,,0.1418918919,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,,,,0.1568627451,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,,,0.1791044776,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SERTRALINE HCL,,,,,,,,,,,,,,0.3904761905,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.2461538462,,,0.3563010393,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.4347252747,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | TOPIRAMATE,,,,,,,,,,,,,,0.4337349398,,
  3 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3203252033,,,0.3039443155,0.008333333333,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.3901515152,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.3869346734,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.3462282398,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.4482758621,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,0.3990147783,,0.4436090226
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4954954955
  2 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2479338843,,,,0.009691629956,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.008620689655,
  3 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3438596491,,,,0.007142857143,0.28515625
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3443404556
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss,,,,,,,,,,,0.4907407407,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7066666667,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,,,,0.593495935,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7324414716,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.6214285714,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.7363636364,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7170068027,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.743315508,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MASTODYNIA (dxo:ICD9:61171) | SERTRALINE HCL,,,,,,,,,,,,,,0.6756756757,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,0.4809160305,,0.5,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | MYOPIA (dxo:ICD9:3671) | SERTRALINE HCL,,,,,,,,,,,,,,0.6721311475,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | NORETHINDRONE | SERTRALINE HCL,,,,,,,,,,,,,,0.6022099448,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | NORGESTIMATE-ETHINYL ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.6310679612,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.468401487,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.7954545455,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4885654886,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.7946428571,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | SERTRALINE HCL,,,,,,,,,,,,,,0.5765765766,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.5639374425,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.5434173669,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5797101449,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4882154882,,,,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL",,,,,,,,,,,,,,0.5684647303,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.6170212766,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,,,,0.4387096774,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5507246377,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SERTRALINE HCL,,,,,,,,,,,,,,0.625,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762) | SERTRALINE HCL,,,,,,,,,,,,,,0.62,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6066216084,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,,,,0.6601941748,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.6472114137,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | TOPIRAMATE,,,,,,,,,,,,,,0.6467391304,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5454545455,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.6348547718,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.5757575758,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.5904977376,,
  1 ,"Age: 20-40 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.4827586207,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5501156515,,,,,
  1 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5330661323,,,,,
  2 ,Age: 20-40 | Gender: Female | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4977578475,,,,,0.6001959824
  4 ,"Age: 20-40 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,0.3950617284,,,0.1165048544,,,0.4943181818,,0.4645669291
  1 ,"Age: 20-40 | Gender: Female | LEUKORRHEA, NOT SPECIFIED AS INFECTIVE (dxo:ICD9:6235)",,,0.3137254902,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | LEVOFLOXACIN,,,,,,,0.1186440678,0.4060150376,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | LEVOFLOXACIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.125,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL,,,0.476984127,,,,,,,,,,,0.5381561535,,
  1 ,Age: 20-40 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.408,,
  1 ,Age: 20-40 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6418918919,,
  2 ,Age: 20-40 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.4295774648,,,,,,,,,,,0.5481927711,,
  1 ,Age: 20-40 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.6727272727,,
  1 ,Age: 20-40 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.4807692308,,
  5 ,Age: 20-40 | Gender: Female | LEVOTHYROXINE SODIUM,,,0.5098039216,,,,0.156462585,0.4384384384,,,0.1813471503,,,0.5343839542,,
  1 ,Age: 20-40 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4730290456,,
  1 ,Age: 20-40 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.677852349,,
  2 ,Age: 20-40 | Gender: Female | LEVOTHYROXINE SODIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.08235294118,0.4173913043,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.6697986577,,
  1 ,Age: 20-40 | Gender: Female | LEVOTHYROXINE SODIUM | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5691056911,,
  2 ,Age: 20-40 | Gender: Female | LISDEXAMFETAMINE DIMESYLATE,,,0.4237288136,,,,,,,,,,,0.4453781513,,
  1 ,Age: 20-40 | Gender: Female | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.4570446735,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | LITHIUM CARBONATE,,,,,,,0.06666666667,0.09316770186,,,,,,,0.06363636364,0.1777777778
  1 ,Age: 20-40 | Gender: Female | LITHIUM CARBONATE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1543209877
  3 ,Age: 20-40 | Gender: Female | LORATADINE,,,0.5464480874,,,,0.1179245283,,,,,0.4946921444,,,,
  1 ,Age: 20-40 | Gender: Female | LORATADINE | PAROXETINE HCL,,,,,,,,,,,,0.5762711864,,,,
  5 ,Age: 20-40 | Gender: Female | LORAZEPAM,0,0.0253164557,0.4132492114,,,,,0.4224422442,,,,,,0.4833333333,,
  1 ,Age: 20-40 | Gender: Female | LORAZEPAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5904761905,,
  1 ,Age: 20-40 | Gender: Female | LORAZEPAM | SERTRALINE HCL,,,,,,,,,,,,,,0.6086956522,,
  7 ,Age: 20-40 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321),,0.0223880597,0.4065934066,,,,,0.3602484472,0.09556313993,,,0.2695652174,,0.4639498433,,0.58
  1 ,Age: 20-40 | Gender: Female | LUMBAGO (dxo:ICD9:7242),,,,,,,,,,,,,,,0,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.4606741573,,,,,,,,,0.6303571429,,,,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.6748768473,,,,,,,,,0.7226107226,,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7049808429,,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.6323296355,,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | VENLAFAXINE HCL",,,,,,,,,,,0.6194690265,,,,,
  10 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.5052816901,0.6598837209,0.6339869281,,0.5890410959,0.5751391466,0.6370808679,,,0.626399776,,,0.631840796,0.4050632911,0.6796116505
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.524691358,,,,,,,,,0.6678571429,,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.5862068966,,,,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,0.645631068,,,0.668207024,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6428571429,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.5964233929,,,,0.3571428571,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.6603773585,,,,,0.6862745098
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,0.582781457,,,,,0.6505139501
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MILD (dxo:ICD9:29631)",,,,,,,0.1171171171,,,,,,,,,
  5 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.4186046512,,,,,0.422907489,,,0.2710280374,,,0.4701986755,,0.5346534653
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",,,,,,,,,,,,,,0.179245283,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.1965811966,,,,,,0.1904761905,,
  4 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1781609195,,,,,0.1440677966,,,0.1984126984,,,0.2131782946,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1278195489,,,,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,0.3669064748,,,0.602739726,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",,,,,,,,,,,0.2483221477,,,0.3818181818,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1089108911,,,,,,,0.1804511278,,
  15 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2186046512,0.3898048707,0.593824228,0.5959933222,0.298245614,0.5479532164,0.4779915227,0.5629531971,0.399103139,0.3361702128,0.5102158606,0.5837438424,,0.6042402827,0.3039399625,0.601843318
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.375,,0.4432071269,,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.4868421053,,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | NORTRIPTYLINE HCL",,,,,,,,,,,0.5072463768,,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.422310757,,,,,
  4 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,0.4444444444,,,,,0.5636363636,,,,0.6192893401,0.624567474,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.616,,,,
  5 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.6129032258,0.6388888889,,,0.6310679612,,,,,,,,0.6568627451,,0.6582278481
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.5779816514,,,0.6909871245,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5850340136
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.5145631068,,,,,0.6481481481
  4 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.6976744186,,,,,0.6436781609,,,,0.7008547009,,,0.7586206897,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2719298246,,,,,,,,,0.3275862069
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | RISPERIDONE",,,,,,,,,,,0.3620689655,,,,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.4850746269,,,,,
  8 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.3721590909,0.5838926174,,,0.6474820144,0.5160493827,0.4864864865,,,0.5531400966,0.6339285714,,0.6420807453,,
  3 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.4760273973,,,0.6115485564,0.2058823529,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5894039735,,
  6 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.323699422,,,,0.4968944099,0.4953271028,,,,0.4833295532,,,,0.2695346795,0.5505050505
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.418972332,,,,,0.5853174603
  5 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,0.4127906977,,,,,0.5259259259,0.525862069,,,0.5293132328,,,,,0.6023185484
  3 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.04647160069,,,,,,0.5043478261,,,,,,0.5167286245,,
  2 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.04761904762,,,,,,,,,,,,0.1700680272,,
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | SERTRALINE HCL",,,,,,,,,,,,,,0.6165413534,,
  3 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.05300859599,,,,,,,,,,,,0.5743243243,,0.6100628931
  1 ,"Age: 20-40 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.06481481481,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,,,0.3939393939
  1 ,"Age: 20-40 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5774647887
  5 ,Age: 20-40 | Gender: Female | MASTODYNIA (dxo:ICD9:61171),,,,,,,0.09473684211,0.3678343949,,,0.1610169492,,,0.4282828283,,0.4635416667
  1 ,Age: 20-40 | Gender: Female | MASTODYNIA (dxo:ICD9:61171) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1231527094,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MASTODYNIA (dxo:ICD9:61171) | SERTRALINE HCL,,,,,,,,,,,,,,0.6301369863,,
  1 ,Age: 20-40 | Gender: Female | MASTODYNIA (dxo:ICD9:61171) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.2520325203,,
  1 ,Age: 20-40 | Gender: Female | MEDROXYPROGESTERONE ACETATE,,,,,,,0.1619433198,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MEDROXYPROGESTERONE ACETATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1343283582,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MELOXICAM,,,,,,0.347826087,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | METAXALONE,,,0.4220779221,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | METFORMIN HCL,,,,,,,,,,,,,,0.485,,
  1 ,Age: 20-40 | Gender: Female | METHYLPHENIDATE HCL,,0.02580645161,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | METOCLOPRAMIDE HCL,,,,,,,,0.4331797235,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | METOCLOPRAMIDE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.3825503356,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | METRONIDAZOLE,,,0.4967741935,,,,,0.3253588517,,,,,,0.4714285714,,0.5405405405
  1 ,Age: 20-40 | Gender: Female | METRONIDAZOLE | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.3137254902,,
  3 ,Age: 20-40 | Gender: Female | METRONIDAZOLE | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3488372093,,,,,0.3243243243,,,,,,0.4,,
  1 ,"Age: 20-40 | Gender: Female | MIGRAINE WITHOUT AURA, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34611)",,,,,,,,,,,,,,0.4696969697,,
  3 ,"Age: 20-40 | Gender: Female | MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",,,0.3983739837,,,,,,,0.02614379085,,,,0.48125,,
  7 ,"Age: 20-40 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.007575757576,0.02597402597,0.4335664336,,,,0.1786542923,0.3942857143,,0.04041916168,,,,0.4724137931,,
  1 ,"Age: 20-40 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | NORTRIPTYLINE HCL",,,,,,,,,,0.1517857143,,,,,,
  2 ,"Age: 20-40 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.008356545961,,,,,,0.1635802469,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | SERTRALINE HCL",,,,,,,,,,,,,,0.6378378378,,
  2 ,"Age: 20-40 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | SUMATRIPTAN SUCCINATE",0,,,,,,,,,,,,,0.4965034965,,
  10 ,Age: 20-40 | Gender: Female | MIRTAZAPINE,,0.03977272727,0.2694300518,,,0.2023346304,0.1361702128,0.2789115646,0.2091836735,,0.2179236043,0.2342342342,,0.2653846154,,0.4181818182
  1 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.2314049587,,,,,
  1 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2371794872,,,,,
  1 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1986607143,,,,,
  1 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1755725191,,,,,
  2 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,,,0.2380952381,0.4285714286,,,,
  1 ,"Age: 20-40 | Gender: Female | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1274509804,,,,,
  1 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.07407407407,,,,,
  3 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.1860465116,,0.2242268041,,,0.4192229039,,
  1 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.232,,,,,
  2 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.2,,0.2102839601,,,,,
  1 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1964285714,,,,,
  2 ,Age: 20-40 | Gender: Female | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.1884984026,,,,,0.5189189189
  4 ,Age: 20-40 | Gender: Female | MONTELUKAST SODIUM,,,0.4672897196,,,,,0.4613003096,,,0.2085561497,,,0.4833333333,,
  2 ,Age: 20-40 | Gender: Female | MORBID OBESITY (dxo:ICD9:27801),,0.02721088435,,,,,0.1738122827,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | MORBID OBESITY (dxo:ICD9:27801) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.04,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MORBID OBESITY (dxo:ICD9:27801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1466666667,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MOXIFLOXACIN HCL,,,,,,,0.1265822785,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MOXIFLOXACIN HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1215686275,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,0.1295336788,0.4189944134,,,,,,0.4846153846,,
  6 ,Age: 20-40 | Gender: Female | MYOPIA (dxo:ICD9:3671),,0.04015799868,0.5166666667,,,,0.1577464789,0.4931506849,,,,0.3904761905,,0.5374077977,,
  1 ,Age: 20-40 | Gender: Female | MYOPIA (dxo:ICD9:3671) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02617801047,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MYOPIA (dxo:ICD9:3671) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.04587155963,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MYOPIA (dxo:ICD9:3671) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.3410404624,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MYOPIA (dxo:ICD9:3671) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.04716981132,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MYOPIA (dxo:ICD9:3671) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1919191919,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | MYOPIA (dxo:ICD9:3671) | SERTRALINE HCL,,,,,,,,,,,,,,0.675,,
  2 ,Age: 20-40 | Gender: Female | MYOPIA (dxo:ICD9:3671) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,0.01941747573,,,,,,0.4803921569,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | NAPROXEN,0.006993006993,,,,,,0.162601626,,,,,,,0.4845938375,,
  1 ,Age: 20-40 | Gender: Female | NAPROXEN | SERTRALINE HCL,,,,,,,,,,,,,,0.5555555556,,
  1 ,Age: 20-40 | Gender: Female | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382),,0.03151862464,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.04790419162,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | NONALLOPATHIC LESION OF CERVICAL REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7391)",,,,,,,,,,,,,,0.5,,
  1 ,"Age: 20-40 | Gender: Female | NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)",,,,,,,,,,,,0.3582089552,,,,
  1 ,"Age: 20-40 | Gender: Female | NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",,,,,,,,0.3605442177,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02003704327,,,,,0.1419784726,0.4373626374,,,,,,0.4457323498,0.01287553648,
  1 ,"Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01327433628,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01324503311,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.01829268293,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.09565217391,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.02564102564,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.01869158879,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02962962963,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.008928571429,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.02822580645,,,,,0.1491053678,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.03015075377,,,,,,,,,,,,0.5948275862,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,0.006134969325,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VALACYCLOVIR HCL,,0,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VARENICLINE TARTRATE,,0.02678571429,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | NORETHINDRONE,,,,,,,,,,,,,,0.5486590038,,
  1 ,"Age: 20-40 | Gender: Female | NORETHINDRONE | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.582781457,,
  1 ,"Age: 20-40 | Gender: Female | NORETHINDRONE | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5273159145,,
  1 ,Age: 20-40 | Gender: Female | NORETHINDRONE | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5985915493,,
  1 ,Age: 20-40 | Gender: Female | NORETHINDRONE | SERTRALINE HCL,,,,,,,,,,,,,,0.6298850575,,
  1 ,Age: 20-40 | Gender: Female | NORETHINDRONE | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.7021276596,,
  1 ,Age: 20-40 | Gender: Female | NORETHINDRONE | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5777331996,,
  2 ,Age: 20-40 | Gender: Female | NORETHINDRONE-E.ESTRADIOL-IRON,,,,,,,0.1411483254,,,,,0.404494382,,,,
  2 ,Age: 20-40 | Gender: Female | NORETHINDRONE-E.ESTRADIOL-IRON | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1518796992,,,,,0.391509434,,,,
  1 ,Age: 20-40 | Gender: Female | NORETHINDRONE-ETHIN. ESTRADIOL,,,,,,,,,,,,,,0.4816955684,,
  1 ,Age: 20-40 | Gender: Female | NORETHINDRONE-ETHIN. ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.6864864865,,
  2 ,Age: 20-40 | Gender: Female | NORGESTIMATE-ETHINYL ESTRADIOL,,,0.4780876494,,,,,,,,,,,0.5614430665,,
  1 ,Age: 20-40 | Gender: Female | NORGESTIMATE-ETHINYL ESTRADIOL | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.395480226,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | NORGESTIMATE-ETHINYL ESTRADIOL | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.6030534351,,,,,,,,,,,0.5392156863,,
  1 ,Age: 20-40 | Gender: Female | NORGESTIMATE-ETHINYL ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.6979865772,,
  1 ,Age: 20-40 | Gender: Female | NORGESTIMATE-ETHINYL ESTRADIOL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3719008264,,,,,,,,,,,,,
  11 ,Age: 20-40 | Gender: Female | NORTRIPTYLINE HCL,0,0.0329218107,0.3385093168,,,0.3068965517,0.1173469388,0.3493150685,,0.1267423851,0.3004333173,0.3053892216,,0.391509434,,0.4680851064
  1 ,"Age: 20-40 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6601941748,,
  1 ,Age: 20-40 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2073170732,,,,,
  2 ,Age: 20-40 | Gender: Female | NORTRIPTYLINE HCL | PAROXETINE HCL,,,,,,,,,,,0.3571428571,0.4838709677,,,,
  3 ,Age: 20-40 | Gender: Female | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,0.1059322034,0.3470319635,,,0.5933333333,,
  2 ,Age: 20-40 | Gender: Female | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,0.2,0.2640949555,,,,,
  3 ,Age: 20-40 | Gender: Female | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,0.1553398058,0.2884160757,,,,,0.7083333333
  1 ,"Age: 20-40 | Gender: Female | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.4436090226,,,,
  1 ,"Age: 20-40 | Gender: Female | Num Previous Antidep: 2,3 | PAROXETINE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.6379310345,,
  1 ,"Age: 20-40 | Gender: Female | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6136363636,,,,
  1 ,"Age: 20-40 | Gender: Female | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3275862069,,
  1 ,"Age: 20-40 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6112676056,,
  1 ,"Age: 20-40 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.7006802721,,
  2 ,Age: 20-40 | Gender: Female | Num Previous Antidep: 4+,,,,,,,,,,,0.1992753623,0.1805555556,,,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.3212435233,,,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.243902439,,,,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3694915254,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1990202082,,,,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1895604396,,,,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1458333333,,,,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.4184397163,,,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.4824561404,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.7695473251,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,0.6349206349,,
  1 ,Age: 20-40 | Gender: Female | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.75
  2 ,"Age: 20-40 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.03555878084,,,,,,0.5192307692,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.009523809524,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800) | POLYCYSTIC OVARIES (dxo:ICD9:2564)",,0.04032258065,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.03418803419,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.02884615385,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,0.03669724771,,,,,0.1612903226,,,,0.1367574257,,,,,
  1 ,Age: 20-40 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PAROXETINE HCL,,,,,,,,,,,0.1222222222,,,,,
  1 ,"Age: 20-40 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1088435374,,,,,
  1 ,Age: 20-40 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.06140350877,,,,,
  1 ,Age: 20-40 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.1712328767,,,,,
  1 ,Age: 20-40 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1973684211,,,,,
  1 ,Age: 20-40 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1731343284,,,,,
  1 ,Age: 20-40 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | VENLAFAXINE HCL,,,,,,,,,,,0.1538461538,,,,,
  4 ,Age: 20-40 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.4505494505,,,,0.1974358974,0.4811320755,,,,,,0.512195122,,
  1 ,Age: 20-40 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.698630137,,
  3 ,Age: 20-40 | Gender: Female | OMEPRAZOLE,,,,,,,0.1466208477,0.485,,,0.1673640167,,,,,
  1 ,Age: 20-40 | Gender: Female | OMEPRAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1468926554,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | OPIOID TYPE DEPENDENCE, UNSPECIFIED (dxo:ICD9:30400)",,,,,,,,,,,,,,,0.02762430939,
  3 ,Age: 20-40 | Gender: Female | OSELTAMIVIR PHOSPHATE,,,0.3645833333,,,,0.1333333333,,,,,0.3643410853,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER ACNE (dxo:ICD9:7061),,,0.4769975787,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.0331010453,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03141361257,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER ANXIETY STATES (dxo:ICD9:30009),,,,,,,,,,,0.29,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER CONVULSIONS (dxo:ICD9:78039),,0.05617977528,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER DYSCHROMIA (dxo:ICD9:70909),,,,,,,,0.421875,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,,,0.2752293578,,,
  1 ,Age: 20-40 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,,,0.3856502242,,,
  2 ,Age: 20-40 | Gender: Female | OTHER GENERAL COUNSELING AND ADVICE FOR CONTRACEPTIVE MANAGEMENT (dxo:ICD9:V2509),,,0.4308300395,,,,,0.4353182752,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER GENERAL COUNSELING AND ADVICE FOR CONTRACEPTIVE MANAGEMENT (dxo:ICD9:V2509) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.3941605839,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER GENERAL SYMPTOMS (dxo:ICD9:78099),,,0.401459854,,,,,,,,,,,,,
  10 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02783235102,0.4487179487,0.5357142857,,0.3646511628,0.1333333333,0.4282722513,,,,0.3888888889,,0.4989059081,0.007380073801,0.5246376812
  2 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,0,,,,,,0.3503649635,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.03816793893,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.05524861878,,,,,0.1650485437,,,,,,,,0.009433962264,
  1 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.006289308176,,,,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.01833333333,,0.6091370558,,0.3853754941,0.1732283465,0.4633431085,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | SERTRALINE HCL,,0.06611570248,,,,,,,,,,,,0.648,,
  2 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,0.02857142857,,,,0.3611111111,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | VALACYCLOVIR HCL,,0.0243902439,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,0.4375,,,,0.1266666667,,,,,,,,,0.5636363636
  2 ,Age: 20-40 | Gender: Female | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.04296875,0.375,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0,,,,,,,,,,,,,0.4974874372,,
  1 ,Age: 20-40 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.006535947712,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | OTHER SPECIFIED DISEASE OF SEBACEOUS GLANDS (dxo:ICD9:7068),,,,,,,,0.3973509934,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | OTHER SPECIFIED NONINFLAMMATORY DISORDER OF VAGINA (dxo:ICD9:6238),,,0.3573883162,,,0.2396694215,,,,,,,,,,0.3443708609
  1 ,Age: 20-40 | Gender: Female | OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283),,,0.4797979798,,,,,,,,,,,,,
  5 ,"Age: 20-40 | Gender: Female | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)",0.005555555556,0.02309468822,,,0.05,,,,0.08227848101,,,,,,0.01164483261,
  1 ,"Age: 20-40 | Gender: Female | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,0.01374570447,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.02173913043,,,,,,,,,,,,,0.009523809524,
  1 ,"Age: 20-40 | Gender: Female | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.01960784314,,,,,,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",0.001828153565,0.03077930583,,,,,,,,,,,,,0.01336898396,
  1 ,"Age: 20-40 | Gender: Female | OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | VALACYCLOVIR HCL",,0.03738317757,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | OVERWEIGHT (dxo:ICD9:27802),,0.0251572327,,,,,,,,,,,,0.4573170732,,
  2 ,Age: 20-40 | Gender: Female | OXYCODONE HCL,0.007874015748,,,,,,0.1449704142,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | OXYCODONE HCL/ACETAMINOPHEN,,0.05042016807,,,,,0.113253012,,,,,,,,0.006060606061,
  1 ,Age: 20-40 | Gender: Female | OXYCODONE HCL/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1235955056,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.277992278,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.3275862069,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",,,,,,0.3333333333,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | PAIN IN SOFT TISSUES OF LIMB (dxo:ICD9:7295),,,0.5,,,,0.1238095238,0.4108527132,,,,,,0.4814814815,,0.4385964912
  7 ,Age: 20-40 | Gender: Female | PALPITATIONS (dxo:ICD9:7851),,,0.4103967168,,,0.356097561,0.1147426982,0.3987049029,,,0.1798780488,0.3741007194,,0.4782608696,,
  1 ,Age: 20-40 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.305785124,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.104283054,,,,,0.2898550725,,,,
  1 ,Age: 20-40 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | SERTRALINE HCL,,,,,,,,,,,0.431372549,,,,,
  1 ,Age: 20-40 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.4160583942,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.2547169811,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.02711323764,0.4620689655,,,,,0.375,,,,0.3306709265,,0.4692913386,,
  1 ,Age: 20-40 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PAROXETINE HCL,,,,,,,,,,,,0.5153846154,,,,
  1 ,Age: 20-40 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.2785714286,,,,
  1 ,Age: 20-40 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | SERTRALINE HCL,,,,,,,,,,,,,,0.6376146789,,
  1 ,Age: 20-40 | Gender: Female | PANTOPRAZOLE SODIUM,,,,,,,,0.4471544715,,,,,,,,
  14 ,Age: 20-40 | Gender: Female | PAROXETINE HCL,0.01984126984,0.03503480278,0.4510891089,0.578680203,,0.3414414414,0.176487748,0.4010500808,0.1185770751,0.04779411765,0.2075923393,0.4434667698,,0.4600951374,0.03783783784,0.5775862069
  5 ,"Age: 20-40 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1615384615,,,,,0.1588785047,,,0.08349514563,0.28125,,0.2663043478,,
  1 ,"Age: 20-40 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06912442396,,,,,
  2 ,"Age: 20-40 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1238938053,0.2468619247,,,,
  1 ,"Age: 20-40 | Gender: Female | PAROXETINE HCL | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.52,,
  1 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.4468085106,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1447368421,0.3483146067,,0.2564102564,,
  2 ,"Age: 20-40 | Gender: Female | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1463414634,0.2781065089,,,,
  2 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2,,,,,0.5201716738,,,,
  8 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | SERTRALINE HCL,,0.05031446541,0.4208333333,,,,0.1433691756,0.3473282443,,,0.1990291262,0.4496253122,,0.5186360032,,0.4905660377
  3 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2397260274,0.3931623932,,0.4586466165,,
  3 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,0.25,0.5322580645,,0.5,,
  8 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | TRAZODONE HCL,,0.02232142857,0.2543859649,,,,0.1214285714,0.2260869565,,,0.2929984779,0.3989873418,,0.3174603175,0.02697674419,
  1 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2272727273,,,,,
  8 ,Age: 20-40 | Gender: Female | PAROXETINE HCL | VENLAFAXINE HCL,,0.04326923077,0.5,,,,0.1822660099,0.3923076923,,,0.2330677291,0.4925093633,,0.4257425743,,0.59375
  2 ,Age: 20-40 | Gender: Female | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742),,,,,,,,,,,,,,0.4740740741,0,
  12 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",0.02631578947,0.04444444444,0.1930983847,0.1596045198,,0.1404421326,0.1315789474,0.1993127148,,,0.1228070175,0.1337792642,,0.1809045226,0.03200883002,0.1943434343
  10 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.04739336493,0.1302325581,0.156626506,,0.1171875,0.0675990676,0.1656050955,,,0.07669616519,0.103030303,,0.1588541667,,0.1353135314
  2 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.08646616541,,,0.2994923858,,
  2 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.09285714286,,,0.2608695652,,
  1 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.06040268456,,,,,
  2 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1015873016,,,,,0.2920353982
  8 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.06043956044,0.1687242798,,,0.1810344828,,0.1794871795,,,0.1129170231,0.1557377049,,0.3197071385,,0.2960893855
  1 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.3664122137,,
  2 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.131826742,,,0.26,,
  1 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.05072463768,,,,,
  1 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2173913043,,
  3 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.08831908832,,,,0.07207207207,0.1801470588
  2 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1409574468,,,,,0.249660787
  6 ,"Age: 20-40 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,0.04098360656,0.1923076923,,,,,0.1056338028,,,0.1268844221,,,0.2457142857,,0.2924120913
  1 ,Age: 20-40 | Gender: Female | POLYCYSTIC OVARIES (dxo:ICD9:2564),,0.03015075377,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | POLYETHYLENE GLYCOL 3350,,,,,,,,0.4197530864,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981),,,,,,,,,,,,,,0.3720930233,,
  1 ,"Age: 20-40 | Gender: Female | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,0.2363636364,,
  2 ,Age: 20-40 | Gender: Female | PRAMIPEXOLE DI-HCL,,0.08490566038,,,,,,,,,0.3690226265,,,,,
  1 ,Age: 20-40 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.3773987207,,,,,
  1 ,Age: 20-40 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3394495413,,,,,
  2 ,Age: 20-40 | Gender: Female | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.4621848739,,,0.5257731959,,
  1 ,Age: 20-40 | Gender: Female | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3341288783,,,,,
  2 ,Age: 20-40 | Gender: Female | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3125,,,,,0.5170068027
  5 ,Age: 20-40 | Gender: Female | PREGABALIN,,0.02777777778,0.373015873,,,0.375,,0.3773584906,,,,,,0.5167785235,,
  1 ,Age: 20-40 | Gender: Female | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4089068826,,,,,,,,,,
  5 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,0.006622516556,0.418892186,,,0.3243243243,,,,,0.1769911504,,,0.4855415352,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2363636364,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.2413793103,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2789473684,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2690763052,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242)",,,0.4360902256,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,0.4329896907,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",,,0.3608247423,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4819277108,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)",,,,,,,,,,,,,,0.55,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5324675325,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SECOND-DEGREE PERINEAL LACERATION, WITH DELIVERY (dxi:ICD9:66411) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4305555556,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL",,,,,,,,,,,,,,0.6363636364,,
  2 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,0.2884615385,,,0.641350211,,
  5 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,0.006289308176,0.4335664336,,,0.3063583815,,,,,0.140625,,,0.4772658838,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,,,,,,,,0.4033613445,,
  1 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,,,,,,,0.4021447721,,
  2 ,"Age: 20-40 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,0.3412698413,,,,,,,,,,,0.4423076923,,
  8 ,Age: 20-40 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),0,0.008403361345,0.472166998,,,,0.1074335323,0.3170892328,,,0.1718061674,0.339673913,,,0.005235602094,
  4 ,Age: 20-40 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.009174311927,,,,,0.1,0.2713178295,,,,0.3046875,,,,
  3 ,Age: 20-40 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | SERTRALINE HCL,,,0.5140186916,,,,,0.4132947977,,,0.2888888889,,,,,
  1 ,Age: 20-40 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.4418604651,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.3025210084,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.2785145889,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | VENLAFAXINE HCL,,,,,,,,0.4,,,,,,,,
  1 ,"Age: 20-40 | Gender: Female | PROGESTERONE, MICRONIZED",,,0.4213483146,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | PROMETHAZINE HCL,0.005524861878,,,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | PROPOXYPHENE NAP/ACETAMINOPHEN,0.01149425287,,,,,,0.1288343558,,,,0.1964285714,0.3,,,,
  1 ,Age: 20-40 | Gender: Female | PROPRANOLOL HCL,,,0.4854368932,,,,,,,,,,,,,
  7 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.248046875,,,,0.1044776119,0.236,,,0.1202185792,0.1733333333,,0.2401960784,,0.2763819095
  1 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.06034482759,,,,,,,,,
  8 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1854460094,,,0.1212121212,0.07650273224,0.1826215022,,,0.1142857143,0.2238095238,,0.1975497703,,0.1768292683
  4 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.2012987013,,,,0.07480314961,0.1696428571,,,,,,0.1787878788,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.297029703,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.09375,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,0.1856287425,,,0.1782178218,,,0.36,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3375796178,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.1991701245,,
  4 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.2719298246,,,,0.09803921569,0.1721311475,,,,,,0.2103174603,,
  1 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1260504202,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SERTRALINE HCL,,,,,,,,,,,,,,0.4589041096,,
  1 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.2481751825,,
  5 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792),,,0.1943127962,,,,0.1160092807,0.2596491228,,,0.2196969697,,,0.318452381,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.08928571429,,,,,,,,,,,,,
  14 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0.008720930233,0.03938185444,0.2069126576,0.2427807487,,0.1724137931,0.08121246783,0.2011615628,0.1104294479,0.02521008403,0.1073684211,0.1803571429,,0.2215693052,0.01824817518,0.2289473684
  3 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.008928571429,,,,,,0.06837606838,,,,,0.1614906832,,,,
  6 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,0.2164948454,,,,0.119205298,0.1653543307,,,0.1456628478,,,0.4254062038,,0.2941176471
  1 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2058823529,,,,,
  1 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.2946635731,,
  1 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1462264151,,,,,
  1 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.2038834951,,
  2 ,Age: 20-40 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,0.1483979764,,,,,0.4466403162
  9 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.1043956044,0.146627566,,0.1680672269,0.06571428571,0.2341772152,,,0.1384976526,,,0.2044444444,0.02839116719,0.2155172414
  4 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,0.12,,,,,,,0.1057692308,,,0.1037735849,,0.1417910448
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.1459854015,,,0.2788461538,,
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.137295082,,,0.3212851406,,
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1459227468,,,0.3203883495,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.0942408377,,,,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1272727273,,,,,
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | VENLAFAXINE HCL",,,,,,,,,,,0.1029411765,,,,,0.3714285714
  12 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1831802803,0.209375,0.03100775194,0.1521984216,0.07721073471,0.1931769723,,0.01515151515,0.1238645747,0.1700819672,,0.2008776207,0.01610305958,0.2173006774
  6 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.2059925094,,,,0.06462585034,0.1967213115,,,0.09489051095,,,0.1744186047,,0.1764705882
  1 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.2702702703,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.06748466258,,,,,,,,,
  7 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,0.252173913,,,0.1666666667,0.1062124248,0.2101694915,,,0.1800180018,,,0.3464309103,,0.3151750973
  1 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.3666666667,,
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.173374613,,,0.3215859031,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.2337349398,,
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1580645161,,,,,0.1278195489
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1666666667,,,,,0.2862318841
  1 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.2212389381,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.216802168,,,,,0.3316498316
  4 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,0.05737704918,0.03829787234,0.0987654321,,,,,,0.1245283019,,
  2 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836) | SERTRALINE HCL",,,,,,,,,,,0.08064516129,,,0.2553191489,,
  5 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.2831050228,,,,0.09443099274,0.2592592593,,,0.1818181818,,,0.2546296296,,
  1 ,"Age: 20-40 | Gender: Female | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.4276315789,,
  1 ,Age: 20-40 | Gender: Female | RANITIDINE HCL,,,,,,,0.134502924,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.3081395349,,0.1834319527,,,
  2 ,Age: 20-40 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.4416666667,,0.3510971787,,,
  7 ,Age: 20-40 | Gender: Female | RISPERIDONE,,,0.1290322581,,,0.2027972028,0.1168831169,0.1755725191,,,0.1007259528,,,0.170212766,,0.1641791045
  2 ,Age: 20-40 | Gender: Female | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.125,,,0.2036474164,,
  1 ,Age: 20-40 | Gender: Female | RISPERIDONE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,0.2248062016,,
  1 ,Age: 20-40 | Gender: Female | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1090604027,,,,,
  2 ,Age: 20-40 | Gender: Female | RISPERIDONE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1666666667,,,,,0.1886792453
  2 ,Age: 20-40 | Gender: Female | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.122324159,,,,,0.1949367089
  2 ,Age: 20-40 | Gender: Female | RIZATRIPTAN BENZOATE,,,,,,,,0.423580786,,,,,,0.5201149425,,
  1 ,Age: 20-40 | Gender: Female | RIZATRIPTAN BENZOATE | SERTRALINE HCL,,,,,,,,,,,,,,0.6,,
  1 ,Age: 20-40 | Gender: Female | ROFECOXIB,,,,,,,0.1441441441,,,,,,,,,
  9 ,Age: 20-40 | Gender: Female | ROPINIROLE HCL,,0.05263157895,0.2881355932,,,0.2666666667,0.1441441441,0.3923076923,,,0.318356608,,0.3003144654,0.3571428571,,0.2368421053
  2 ,Age: 20-40 | Gender: Female | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.4464285714,,,0.5619047619,,
  2 ,Age: 20-40 | Gender: Female | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2365930599,,,,0.0347826087,
  2 ,Age: 20-40 | Gender: Female | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4155251142,,,,,0.5447154472
  5 ,Age: 20-40 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.03229813665,,,,,0.1336717428,,,,,0.3297491039,,0.4751381215,0.01201602136,
  3 ,Age: 20-40 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.02688172043,,,,,0.1492537313,,,,,0.421875,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,,,,,,,,,,,,0.5701754386,,
  10 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.003262051468,0.03389830508,,0.6104928458,0.09049773756,0.3659985152,0.1354859752,0.4234711912,0.1088435374,,0.1920623671,0.3451598774,,,,
  4 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,,,,0.3051948052,0.1024498886,,,,0.1916167665,0.3370786517,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,,,,,,,,,,0.303030303,,,,
  6 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL,,0.01785714286,,0.6267281106,,0.5371900826,0.1918465228,,,,0.4131054131,0.4827586207,,,,
  1 ,"Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",,,,,,,,,,,,0.3407407407,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SUMATRIPTAN SUCCINATE,,,,,,,0.179245283,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.4416243655,,,,0.3833333333,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TOPIRAMATE,,,,,,,0.1666666667,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAMADOL HCL,,,,,,,0.1596958175,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,,,,,0.09701492537,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0,,,,,0.3644067797,0.1461412151,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),0.003846153846,,,,,,,0.4351851852,,,,,,,,
  5 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,0.2960526316,0.1030756442,0.3821138211,,,0.1455696203,0.2878787879,,,,
  2 ,"Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,0.1530944625,0.4367346939,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VALACYCLOVIR HCL,,0.01351351351,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VENLAFAXINE HCL,,,,,,,0.1967213115,,,,0.2715231788,,,,,
  4 ,Age: 20-40 | Gender: Female | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,0.4132231405,,,,,0.4243323442,,,,0.3741007194,,0.5048543689,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,0.4846153846,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242),,,0.4882780922,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242) | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.4705882353,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,0.4798464491,,,,,,,,,,,,,
  6 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.370140477,,,0.2820512821,0.1511111111,,,,,0.3161764706,,0.4456029012,,0.3858784893
  1 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.44,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SERTRALINE HCL,,,,,,,,,,,,,,0.614,,
  1 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.5897435897,,
  2 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,0.4175257732,,,,,,,,,,,0.4216524217,,
  1 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SURVEILLANCE OF PREVIOUSLY PRESCRIBED CONTRACEPTIVE PILL (dxo:ICD9:V2541),,,,,,,,,,,,,,0.5048543689,,
  1 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.3941605839,,
  2 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3381642512,,,,,,,,,,,0.3695299838,,
  1 ,"Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.4297520661,,
  1 ,Age: 20-40 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6134453782
  3 ,Age: 20-40 | Gender: Female | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.462915601,,,,,,,,,,,0.531824611,,0.5551257253
  1 ,Age: 20-40 | Gender: Female | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762) | SERTRALINE HCL,,,,,,,,,,,,,,0.6837606838,,
  1 ,Age: 20-40 | Gender: Female | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6268656716
  1 ,Age: 20-40 | Gender: Female | SCREENING FOR UNSPECIFIED CONDITION (dxo:ICD9:V829),,,0.4861111111,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286),,,,,,,,,,,,,,0.5417558887,,
  1 ,Age: 20-40 | Gender: Female | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.6355932203,,
  1 ,Age: 20-40 | Gender: Female | SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.5354767184,,
  1 ,"Age: 20-40 | Gender: Female | SECOND-DEGREE PERINEAL LACERATION, WITH DELIVERY (dxi:ICD9:66411)",,,,,,,,,,,,,,0.5777777778,,
  1 ,"Age: 20-40 | Gender: Female | SECOND-DEGREE PERINEAL LACERATION, WITH DELIVERY (dxi:ICD9:66411) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5650793651,,
  16 ,Age: 20-40 | Gender: Female | SERTRALINE HCL,0.01329923274,0.03444203897,0.4133946159,0.5982008996,0.1142061281,0.3661355826,0.1673819742,0.3867149758,0.1136624569,0.04347826087,0.2711166495,0.3555555556,0.1388888889,0.4931548497,0.01638554217,0.5483061481
  1 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7074468085,,
  2 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.4171779141,,,0.6393442623,,
  6 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,0.02678571429,,,,0.3333333333,,0.5739130435,,,0.2821576763,,,0.6059903382,,0.6095238095
  1 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | TRAZODONE HCL,,,,,,,,,,,,,,0.4734693878,,
  1 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | VENLAFAXINE HCL,,,,,,,,,,,,,,0.5564516129,,
  1 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | SURVEILLANCE OF PREVIOUSLY PRESCRIBED CONTRACEPTIVE PILL (dxo:ICD9:V2541),,,,,,,,,,,,,,0.65,,
  2 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | TOPIRAMATE,,,,,,,,,,,0.4180327869,,,0.6258351893,,
  11 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | TRAZODONE HCL,0.01652892562,0.03754940711,0.2524271845,,,0.2771084337,0.1323210412,0.2853717026,,,0.2988794878,0.2553191489,,0.4481792717,0.01336760925,0.367816092
  4 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2164179104,,,0.3665158371,0.007462686567,0.6115702479
  2 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4583333333,,,,,,,,0.5982404692,,
  1 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.5915178571,,
  1 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.5963699222,,
  1 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.640776699,,
  1 ,"Age: 20-40 | Gender: Female | SERTRALINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.6317280453,,
  9 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | VENLAFAXINE HCL,,0.06807511737,0.3986710963,,,,0.1918465228,0.3782894737,,,0.2655538695,0.3987730061,,0.4983213429,0.02752293578,0.6599423631
  1 ,Age: 20-40 | Gender: Female | SERTRALINE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,0.6697247706,,
  1 ,Age: 20-40 | Gender: Female | SILVER SULFADIAZINE,,,,,,,,0.4015748031,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | SIMVASTATIN,,,0.5251396648,,,,,0.5548780488,,,,,,0.5433962264,,
  1 ,"Age: 20-40 | Gender: Female | SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",,,,,,,,,,,,,,,,0.427672956
  1 ,Age: 20-40 | Gender: Female | SPECIAL SCREENING FOR OTHER SPECIFIED CONDITIONS (dxo:ICD9:V8289),,,0.4186046512,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | SUICIDAL IDEATION (dxo:ICD9:V6284),,,0.2213114754,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | SULFAMETHOXAZOLE/TRIMETHOPRIM,,,0.4641148325,,,,,,,,,,,,,
  7 ,Age: 20-40 | Gender: Female | SUMATRIPTAN SUCCINATE,0,,0.4149659864,,,,0.1585365854,0.4336734694,,,0.1666666667,0.3402777778,,0.5158227848,,
  1 ,Age: 20-40 | Gender: Female | SUMATRIPTAN SUCCINATE | VENLAFAXINE HCL,,,,,,,,,,,0.3305084746,,,,,
  11 ,Age: 20-40 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),0.002614379085,0.0274952919,0.456681351,,,0.3287671233,,0.4366298608,,0.03761755486,0.1745689655,0.3700954401,,0.4669550589,0.01398601399,0.4761549925
  1 ,Age: 20-40 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | TERCONAZOLE,,,,,,,,0.4036697248,,,,,,,,
  2 ,Age: 20-40 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.4095238095,,,,,,0.4463276836,,
  2 ,Age: 20-40 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,0.39,,,,,,0.5255474453,,
  3 ,Age: 20-40 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3577981651,,,,,0.3913043478,,,,,,0.4857685009,,
  1 ,"Age: 20-40 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,0.4,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | VALACYCLOVIR HCL,,0.02941176471,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221) | VENLAFAXINE HCL,,,,,,,,,,,0.2410714286,,,0.5830618893,,0.6791907514
  1 ,Age: 20-40 | Gender: Female | SURVEILLANCE OF PREVIOUSLY PRESCRIBED CONTRACEPTIVE PILL (dxo:ICD9:V2541),,,,,,,,,,,,,,0.5289672544,,
  1 ,Age: 20-40 | Gender: Female | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.4757575758
  1 ,Age: 20-40 | Gender: Female | TERBINAFINE HCL,,0.01470588235,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | TERCONAZOLE,,,0.3956834532,,,,,0.4581939799,,,,,,,,0.4532374101
  1 ,Age: 20-40 | Gender: Female | TERCONAZOLE | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.3149171271,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | TIETZE'S DISEASE (dxo:ICD9:7336),,,,,,,,,,,,0.3115942029,,,,
  2 ,Age: 20-40 | Gender: Female | TIZANIDINE HCL,,,0.4329268293,,,,,0.4112149533,,,,,,,,
  6 ,Age: 20-40 | Gender: Female | TOPIRAMATE,,,0.4439655172,,,,0.1689587426,0.4956521739,,,0.176744186,0.3225806452,,0.516801854,,
  1 ,Age: 20-40 | Gender: Female | TOPIRAMATE | VENLAFAXINE HCL,,,,,,,,,,,0.3366336634,,,,,
  7 ,Age: 20-40 | Gender: Female | TRAMADOL HCL,,0.02803738318,,,,0.3333333333,0.1622276029,0.4524590164,,,,,,0.4232804233,0.007843137255,0.4876033058
  1 ,Age: 20-40 | Gender: Female | TRAMADOL HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3878787879,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | TRAMADOL HCL/ACETAMINOPHEN,,,0.4017094017,,,0.396039604,,0.3917050691,,,,,,,,
  14 ,Age: 20-40 | Gender: Female | TRAZODONE HCL,0.02653631285,0.04388349515,0.3050139276,0.3979591837,,0.2419724771,0.132518797,0.2714285714,0.06440677966,0.05703422053,0.2601175024,0.2402044293,,0.3263795424,0.01929442921,0.3189655172
  8 ,Age: 20-40 | Gender: Female | TRAZODONE HCL | VENLAFAXINE HCL,,0.03846153846,0.2748091603,,,,0.135678392,0.3185840708,,,0.252856846,,,0.3333333333,0.01873935264,0.4233399515
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089),,,,,,,0.1316872428,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED ADJUSTMENT REACTION (dxo:ICD9:3099),,,,,,,,,,,,,,0.5323741007,,
  2 ,Age: 20-40 | Gender: Female | UNSPECIFIED ALOPECIA (dxo:ICD9:70400),,0.02857142857,,,,,,0.3605442177,,,,,,,,
  4 ,Age: 20-40 | Gender: Female | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,0.4017094017,,,,0.15,0.37109375,,,,,,0.4108527132,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599),,0.01005025126,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690),,0.01388888889,,,,,,,,,,,,,,
  11 ,Age: 20-40 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.01016949153,0.0350877193,0.3926470588,,,0.3541076487,0.1513944223,0.4493783304,,0.02777777778,,0.3483146067,,0.4890899415,0.01608579088,0.4825870647
  2 ,Age: 20-40 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.3716814159,,,,,,0.4293193717,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | VENLAFAXINE HCL,,,,,,0.5882352941,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED OTALGIA (dxo:ICD9:38870),,,,,,,,,,,,,,0.5480769231,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED SEBORRHEIC DERMATITIS (dxo:ICD9:69010),,,0.4188034188,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.01438848921,
  5 ,Age: 20-40 | Gender: Female | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),0,,0.3991935484,,,,,0.3790322581,,,,0.3008849558,,0.4505978603,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.362745098,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515),,,,,,,,0.3944444444,,,,,,,,
  1 ,Age: 20-40 | Gender: Female | UNSPECIFIED URTICARIA (dxo:ICD9:7089),,,,,0.1637279597,,,,,,,,,,,
  8 ,Age: 20-40 | Gender: Female | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3667502089,,,0.3201970443,0.1415841584,0.38791423,,,0.1884057971,0.3511111111,,0.4322828963,,0.45
  2 ,"Age: 20-40 | Gender: Female | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,0.3490566038,,,,,,0.4285714286,,
  1 ,"Age: 20-40 | Gender: Female | UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",,,,,,,,,,,,,,0.4371428571,,
  2 ,Age: 20-40 | Gender: Female | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.447761194,,0.408839779
  5 ,"Age: 20-40 | Gender: Female | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,0.4213836478,,,,0.1513157895,0.3920386007,,,0.2079207921,,,0.4582664526,,
  4 ,Age: 20-40 | Gender: Female | VALACYCLOVIR HCL,,0.02361489555,0.4632516704,,,,,,,,,0.3636363636,,0.4817518248,,
  2 ,Age: 20-40 | Gender: Female | VARENICLINE TARTRATE,,0.02912621359,0.4191919192,,,,,,,,,,,,,
  14 ,Age: 20-40 | Gender: Female | VENLAFAXINE HCL,0.02390438247,0.03891708968,0.4332472007,,0.1218274112,0.4874213836,0.1785940469,0.3965201465,0.06719367589,0.072,0.2473902654,0.3762376238,,0.4527059971,0.02537593985,0.4725055786
  1 ,Age: 20-40 | Gender: Female | VILAZODONE HCL,,,,,,,,,,,0.6476868327,,,,,
  2 ,Age: 20-40 | Gender: Female | VOMITING ALONE (dxo:ICD9:78703),,,0.3542857143,,,,,0.3510638298,,,,,,,,
  3 ,Age: 20-40 | Gender: Female | ZOLPIDEM TARTRATE,,,,,,,,0.4481327801,,,,,,0.5176470588,0.008650519031,
  16 ,Age: 20-40 | Gender: Male,0.02423620431,0.05839434423,0.4138391584,0.413699505,0.1427209154,0.3203483255,0.1880092738,0.391023648,0.1539758608,0.08697601435,0.2474260229,0.3821123391,0.242979243,0.4220917708,0.03033107136,0.4261613127
  6 ,"Age: 20-40 | Gender: Male | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",,0.05882352941,0.3649635036,,,,0.1355932203,0.358490566,,,,,,0.4391304348,,0.4644808743
  3 ,Age: 20-40 | Gender: Male | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831),,0.02676399027,,,,,,,,,,0.512,,0.5076923077,,
  1 ,Age: 20-40 | Gender: Male | ACETAMINOPHEN WITH CODEINE,,,,,,,,,,,,,,0.4301675978,,
  3 ,"Age: 20-40 | Gender: Male | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",,,0.4676724138,,,,,,0.1386138614,,,,,0.5013550136,,
  1 ,"Age: 20-40 | Gender: Male | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619) | AZITHROMYCIN",,,,,,,,,,,,,,0.5811965812,,
  3 ,Age: 20-40 | Gender: Male | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659),,,0.3956834532,,,,,0.4262820513,,,,0.3577981651,,,,
  3 ,Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090),,0.01550387597,,,,,0.1776315789,,,,,,,0.4640522876,,
  2 ,"Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.05194805195,,,,,,,0.1935483871,,
  4 ,Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,0.03767123288,0.3928571429,,,,0.1498127341,,,,,,,0.4558823529,,
  1 ,"Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.0396039604,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.06474820144,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL,,0.0350877193,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | Last AD: Same & No Remiss,,0.01428571429,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08823529412,,,,,,,,,
  5 ,"Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.1891891892,,,,0.08098591549,0.2727272727,,,,0.246031746,,0.2333333333,,
  7 ,"Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2022727273,,,,0.06258692629,0.1472868217,,,0.06944444444,0.116,,0.1704718417,,0.2177419355
  1 ,Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.04316546763,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,0.08490566038,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1538461538,,,,0.07294832827,,,,,,,0.1255411255,,
  4 ,Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.03359173127,0.2485875706,,,,0.05263157895,,,,,,,0.224137931,,
  2 ,"Age: 20-40 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.06163021869,,,,,,,0.2252252252,,
  3 ,Age: 20-40 | Gender: Male | ALBUTEROL,,0.0275862069,0.4861660079,,,,,,,,,0.4157303371,,,,
  3 ,Age: 20-40 | Gender: Male | ALBUTEROL SULFATE,,,,,,,0.146875,,,,,0.3617021277,,,,0.3775510204
  5 ,Age: 20-40 | Gender: Male | ALPRAZOLAM,,0.007874015748,0.4514285714,,,,0.152,,,,,,,0.4724324324,,0.4534161491
  1 ,"Age: 20-40 | Gender: Male | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,,,,,,0.1474820144,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ALPRAZOLAM | CITALOPRAM HYDROBROMIDE,,,0.6258992806,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ALPRAZOLAM | ESCITALOPRAM OXALATE,,,,,,,0.3181818182,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ALPRAZOLAM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5196850394,,
  1 ,Age: 20-40 | Gender: Male | ALPRAZOLAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6482758621,,
  1 ,Age: 20-40 | Gender: Male | ALPRAZOLAM | SERTRALINE HCL,,,,,,,,,,,,,,0.5898305085,,
  10 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL,0.04238329238,0.03869047619,0.3496503497,,,0.2826086957,0.1598062954,0.3109243697,,,0.2561764706,0.2916666667,,0.3304093567,,0.3345864662
  3 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL,0.05072463768,0.05479452055,,,,,,,,,0.1930635838,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss,,0.02793296089,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.1908396947,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1825396825,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | TRAZODONE HCL,,,,,,,,,,,0.1846153846,,,,,
  3 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE,0.05970149254,,0.5613496933,,,,,,,,0.2517241379,,,,,
  2 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL,,,,,,0.4825174825,,,,,0.2857142857,,,,,
  3 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE,0.03246753247,,,,,,0.3253424658,,,,0.2205323194,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.3571428571,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3559322034,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL,0.08843537415,,,,,,,0.4501845018,,,0.2933333333,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840),0.006060606061,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,0.01587301587,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | LAMOTRIGINE,,,,,,,,,,,0.1333333333,,,,,
  7 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss,,0.05298013245,0.3333333333,,,0.3303571429,0.1754385965,,,,0.2210526316,,,0.3461538462,0,
  1 ,"Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6510067114,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.02092414996,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.487012987,,,,,
  1 ,"Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4772727273,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | MIRTAZAPINE,,,,,,,,,,,0.2435897436,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.2788461538,,,,,
  1 ,"Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6516129032,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.23,,,,,
  1 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1711229947,,,,,
  3 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | PAROXETINE HCL,0.03846153846,,,,,,,,,,0.2292993631,0.4931506849,,,,
  3 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | SERTRALINE HCL,0.03947368421,,,,,,,,,,0.3444444444,,,0.5160550459,,
  2 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | TRAZODONE HCL,0.04854368932,,,,,,,,,,0.1850060459,,,,,
  2 ,Age: 20-40 | Gender: Male | AMITRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2520325203,,,,,0.545045045
  8 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.02753977968,0.4223826715,,,,0.1683399486,0.4898550725,,,,0.3894783378,,0.5856777494,0.007194244604,0.611814346
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",,0.02479338843,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL",,0.03448275862,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.04545454545,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.05504587156,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss",,,,,,,0.1176470588,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0.01995012469,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUSPIRONE HCL",,,,,,,0.1597222222,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,0.1729323308,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE",,,0.6086956522,,,,0.3253968254,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss",,0.024,,,,,0.231884058,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM",,,,,,,0.1355140187,,,,,,,,,
  7 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.008771929825,0.5251798561,,,,0.1935953421,0.435,,,,0.4489164087,,0.5294117647,,0.6019900498
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,0.2648648649,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1365853659,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.5061728395,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.641509434,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,,,,,,0.3045112782,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.005405405405,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1533804238,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,0.1403508772,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss",,,,,,,0.5603448276,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL",,,,,,,,0.5668789809,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,0.04316546763,,,,,0.1153846154,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | HYDROCODONE/ACETAMINOPHEN",,,,,,,0.1869158879,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1158536585,,,,,0.1981132075,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.05670103093,,,,,0.1913875598,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,0.1826923077,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.02919708029,,,,,0.1550802139,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.3544973545,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.5704918033,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | LORAZEPAM",,0.06,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.03426791277,,,,,0.1582733813,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.2366412214,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OMEPRAZOLE",,,,,,,0.1376146789,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01834862385,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1301369863,,,,,0.3826530612,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",,,,,,,,,,,,0.4019607843,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL",,,,,,,0.2307692308,,,,,0.568868981,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",,,,,,,0.1470588235,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.05,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.04395604396,,,,,0.07818930041,,,,,0.1879699248,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.08181818182,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,,,,,,0.1287128713,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SERTRALINE HCL",,,,,,,0.1965317919,,,,,,,0.6836734694,,
  1 ,"Age: 20-40 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,0.1531531532,,,,,,,,,
  8 ,Age: 20-40 | Gender: Male | ARIPIPRAZOLE,,,0.08035714286,0.2313432836,,0.1516853933,0.08383233533,0.1428571429,,,0.1167883212,,,0.1012658228,,0.1690821256
  1 ,Age: 20-40 | Gender: Male | ARIPIPRAZOLE | BUPROPION HCL,,,,,,,,,,,0.1204819277,,,,,
  1 ,Age: 20-40 | Gender: Male | ARIPIPRAZOLE | DULOXETINE HCL,,,,,,0.185840708,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | ARIPIPRAZOLE | ESCITALOPRAM OXALATE,,,,,,,0.1111111111,,,,0.1317829457,,,,,
  1 ,Age: 20-40 | Gender: Male | ARIPIPRAZOLE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.05737704918,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ARIPIPRAZOLE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.1206896552,,
  2 ,Age: 20-40 | Gender: Male | ARIPIPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.1205673759,,,0.1516853933,,
  1 ,Age: 20-40 | Gender: Male | ARIPIPRAZOLE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.2589928058
  3 ,Age: 20-40 | Gender: Male | ATORVASTATIN CALCIUM,,,0.5172413793,,,,,0.5414634146,,,,,,0.5540540541,,
  1 ,Age: 20-40 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL,,,,,,,,0.7175572519,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.70995671,,
  3 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401),,0.03328173375,,,,,,,0.08139534884,,,,,,0,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.03631961259,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL,,0.08571428571,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL | Last AD: Same & No Remiss,,0.0380952381,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL,,0.07715133531,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | Last AD: Same & No Remiss,,0.02191780822,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.04458598726,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03211009174,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.04446240905,,,,,,,,,,0.3703703704,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL,,0.0505952381,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL | Last AD: Same & No Remiss,,0.02432432432,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | METHYLPHENIDATE HCL,,0.06666666667,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01538461538,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03333333333,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.06363636364,,,,,,,,,,,,,,
  6 ,Age: 20-40 | Gender: Male | AZITHROMYCIN,,,0.4744318182,,,,0.1666666667,,,,0.1391304348,0.4358974359,,0.4771863118,,0.5035971223
  1 ,"Age: 20-40 | Gender: Male | BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)",,,,,,,0.1476510067,,,,,,,,,
  14 ,Age: 20-40 | Gender: Male | BUPROPION HCL,0.009677419355,0.04797584433,0.3488714426,0.5315789474,,0.2741935484,0.1419733993,0.3168067227,0.1048951049,0.08108108108,0.273733338,0.3271028037,,0.3510840624,0.01122019635,0.3887841659
  8 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,0.05197827773,0.4465011287,,,0.2232142857,0.2227488152,0.3463687151,,,0.3473299863,,,0.3360995851,,0.4915254237
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,0.03921568627,,,,,,,,,0.2166666667,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,,,,,,,,,,0.2389380531,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.04166666667,0.6686390533,,,,,,,,0.481865285,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03623188406,0.7142857143,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.5642458101,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.5519125683,,,,,,,,0.4950980392,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.09132420091,0.5833333333,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,0.04306220096,0.3333333333,,,,,,,,0.358490566,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3064516129,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,,,,,,,,,0.560483871,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.5114503817,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5284974093,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2617449664,,,,,,,,0.2115384615,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,,0.3119266055,,,,,,,,0.1908396947,,,0.3853211009,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.06289308176,0.3937823834,,,,,,,,0.2150537634,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,,,,,,,,,,0.1806451613,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.05333333333,,,,,,,,,0.3153153153,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,,,,,,,,,,0.2668918919,,,,,0.5826771654
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.01268115942,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | DESVENLAFAXINE SUCCINATE,,,,,,,,,,,0.2407407407,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | DOXEPIN HCL,,,,,,,,,,,0.192893401,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | DULOXETINE HCL,,0.04597701149,,,,0.3786078098,,,,,0.2474804031,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2129032258,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.05777777778,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.2277227723,,,,,0.2047619048,,,,,
  8 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE,,0.03886925795,0.4601769912,,,,0.2571524739,0.356097561,,,0.2222599253,0.2803738318,,0.3344594595,,0.5111111111
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,0.2156862745,,,,0.1726190476,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,,,,0.1329479769,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1891891892,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.1773049645,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,0.09937888199,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,,,,,0.04938271605,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.03798882682,,,,,0.311844078,,,,0.2844827586,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04347826087,,,,,0.3550420168,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.2976744186,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2589641434,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04026845638,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.06722689076,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.1290322581,,,,,0.5778894472,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,0.6201550388,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,0.02953586498,,,,,0.1300813008,,,,0.2465373961,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2408759124,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.1895424837,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,,,,,0.5188284519,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.4690265487,,,,0.4945054945,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1698113208,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1165048544,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1486486486,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2192982456,,,,0.1709401709,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,0.1931034483,,,,0.1833333333,,,0.3643410853,,
  4 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,0.0487804878,,,,,0.2579365079,,,,0.1786283892,,,,0.02521008403,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,,,,,0.203125,,,,,
  9 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL,,0.04512195122,0.3496503497,,,0.2983870968,0.1721311475,0.3905325444,,,0.3051796547,0.3539823009,,0.2875399361,,0.4677419355
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.08396946565,,,0.07317073171,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.02974828375,,,,,,,,,0.5265017668,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.008064516129,,,,,,0.5755395683,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.4459459459,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4785714286,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.08823529412,,,,,,0.5811965812,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.5765765766,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,0.03680981595,,,,,,0.3777777778,,,0.3125,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3738317757,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.600896861,,,,,
  3 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3507462687,,,,,,0.5314685315,,,0.4756097561,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.1441441441,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.5729537367,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2095238095,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2335329341,,,0.1990521327,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1262135922,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.224,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | SERTRALINE HCL,,,,,,,,0.3448275862,,,0.1946902655,,,0.3451327434,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,0.03883495146,,,,,,0.2928176796,,,0.2080924855,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2447552448,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.04278074866,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,0.04285714286,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.0790960452,,,,,,,,,0.04615384615,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,0.01333333333,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.02649006623,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,,,,,,0.1557377049,,,0.2522522523,,
  5 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2233009709,,,,0.06896551724,,,,0.1605839416,,,0.268907563,,0.3352272727
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.06329113924,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.01904761905,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.06603773585,,,,0.1088435374,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.04545454545,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1028806584,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.3949579832,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,0.04721030043,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,,,,0.1650485437,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | LAMOTRIGINE,,,,,,,,0.1385542169,,,0.06221045665,,,0.1101694915,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4659685864,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.03773584906,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1317365269,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,0.06603773585,,,0.1865671642,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.09615384615,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.04430379747,,,,,
  10 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss,,,0.4,,,0.3783783784,0.1298527443,0.4548022599,0.09649122807,,0.2450687388,0.4583333333,,0.4844357977,0.01128668172,0.505988024
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.04455445545,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5407407407,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5918367347,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7165354331,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.02547770701,,,,,,,,,,,,0.6546275395,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.05905511811,,,,,,,,,,,,,0.01851851852,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2115384615,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.3962264151,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4611872146,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1398601399,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.03260869565,,,,,,,,,0.4021164021,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,0.04320987654,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.09051724138,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03523489933,,,,,0.1442307692,,,,0.4705882353,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,0.02380952381,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.053420806,,,,,,,,,0.1260504202,,,,0.01154734411,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.03846153846,,,,,,,,,0.4444444444,,,,,0.6632653061
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss,,0.1513944223,,,,,,,,,0.584,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6304347826,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.5625,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,0.09727626459,,,,,,,,,0.4778761062,,,0.6335078534,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.1078431373,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss,,0.02597402597,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.1610738255,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01642935378,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,0.02752293578,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.0297029703,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01388888889,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,0.0162601626,,,,,,,,,0.3394495413,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04517453799,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02547770701,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.03149606299,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,0.04761904762,,,,,,,,,0.3443396226,,,0.3333333333,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4045801527,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | SILDENAFIL CITRATE,,0.03883495146,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,0.04232804233,,,,,,,,,0.1531100478,,,,0.04,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,0.02459016393,,,,,,,,,0.2980769231,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss,,0.4218009479,,,,,,,,,0.5708185053,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.7307692308,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3964497041,,,,,,,,,0.7269624573,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.686746988,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.6109090909,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5731132075,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5705128205,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.3903743316,,,,,,,,,0.616,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.75,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4768786127,,,,,,,,,0.6613603473,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6334519573,,,,,
  5 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3381642512,,,,,0.3936170213,0.452991453,,,0.5298340063,,,,,0.522875817
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.5,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.4836065574,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4716157205,,,,,
  3 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.3253968254,,,,,,,,,0.5378151261,,,0.6050420168,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.3317073171,,,,,,,,,0.4062165059,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.5168539326,,,,,0.652173913
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | MIRTAZAPINE,,0.04255319149,,,,,,,0.1561181435,,0.201843318,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.1367521368,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1887417219,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.1538461538,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.1408450704,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.028125,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.261682243,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5592105263,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7094594595,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6519916143,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.1469115192,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.305785124,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1918443003,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1834862385,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1338582677,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5555555556,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2128279883,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.184,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.04615384615,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.06211180124,,,,,,,,,,,,,,
  7 ,Age: 20-40 | Gender: Male | BUPROPION HCL | PAROXETINE HCL,,0.0409252669,0.3465346535,,,,0.1863354037,0.4368932039,,,0.2861806311,0.441588785,,0.3969465649,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1265822785,0.320610687,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | PAROXETINE HCL | TRAZODONE HCL,,0.06201550388,,,,,,,,,0.2240437158,,,,,
  3 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.06814580032,,,,,,,,,0.09239130435,,,,,0.2086956522
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07251908397,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.180887372,,,0.2723404255,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1133333333,,,,,
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1173184358,,,,,0.243697479
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3073394495,,,,,
  2 ,Age: 20-40 | Gender: Male | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.05797101449,,,,,,,,,0.09582309582,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.08865248227,,,,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.1230769231,,,,,
  3 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1,,,,0.1330561331,,,,,0.2064516129
  2 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.2242424242,,,0.25,,
  1 ,"Age: 20-40 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1052631579,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.1146788991,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.0612244898,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL,,,,,,,,,,,0.2433234421,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.27,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.04444444444,,,,,,,,,,,,,,
  9 ,Age: 20-40 | Gender: Male | BUPROPION HCL | SERTRALINE HCL,,0.0527201346,0.3183673469,,,0.2937062937,0.1312849162,0.2965517241,,,0.3351134846,0.3422818792,,0.4225007643,,0.5405405405
  4 ,Age: 20-40 | Gender: Male | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,0.02822580645,,,,,,,,,0.231372549,,,0.3333333333,0.03278688525,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2857142857,,,,,
  1 ,Age: 20-40 | Gender: Male | BUPROPION HCL | SILDENAFIL CITRATE,,0.06956521739,,,,,,,,,,,,,,
  7 ,Age: 20-40 | Gender: Male | BUPROPION HCL | TRAZODONE HCL,,0.0597979798,,,,0.2142857143,0.07638888889,0.188034188,,,0.2174447174,,,,0.01740506329,0.2142857143
  3 ,Age: 20-40 | Gender: Male | BUPROPION HCL | TRAZODONE HCL | VENLAFAXINE HCL,,0.04545454545,,,,,,,,,0.1759036145,,,,,0.3719806763
  6 ,Age: 20-40 | Gender: Male | BUPROPION HCL | VENLAFAXINE HCL,,0.05371900826,0.3728813559,,,,0.1847133758,,,,0.2400424854,,,0.3353293413,,0.460639127
  3 ,Age: 20-40 | Gender: Male | BUSPIRONE HCL,,,0.3783783784,,,,0.1858736059,,,,,,,0.4662921348,,
  1 ,Age: 20-40 | Gender: Male | CARISOPRODOL,0.009433962264,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CEFDINIR,,,,,,,0.1603773585,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | CETIRIZINE HCL,,,0.4822695035,,,,0.1680672269,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CHEST PAIN, OTHER (dxo:ICD9:78659) | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,,,,,,,,0.4532374101,,
  5 ,"Age: 20-40 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,0.3665338645,,,,0.1270491803,0.4090909091,,,,0.400862069,,0.4812030075,,
  1 ,"Age: 20-40 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,0.14,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,,,,,,,,0.431372549,,
  1 ,"Age: 20-40 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | SERTRALINE HCL",,,,,,,,,,,,,,0.6635514019,,
  13 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE,0.03968253968,0.04210069444,0.4667832168,,,0.3443804035,0.2223255814,0.3583941606,0.1032258065,0.07438016529,0.2412208126,0.3585858586,,0.4100887436,0.01025641026,0.5262582057
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | CLONAZEPAM,,,0.592920354,,,,,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,0.6161825726,,,,,,,,0.3229813665,,,,,0.5762711864
  2 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,,,,,,,,,,0.2605633803,,,,,0.3923076923
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss",,,,,,,,,,,0.4851485149,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,,0.3678756477,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss",,,0.5690607735,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEXTROAMPHETAMINE/AMPHETAMINE,,,0.5961538462,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,0.5392156863,,,0.4905660377,,,,,0.2397660819,,,,,
  6 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,0.02097902098,0.6703056769,,,,0.3421516755,0.3039215686,,,0.1827111984,,,0.3636363636,,
  3 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.02777777778,,,,,0.4280155642,,,,0.2362204724,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.4425287356,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,0.4566929134,,,,0.1594202899,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.2359550562,,,,,
  5 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,0.06504065041,0.4088669951,,,,,0.4488188976,,,0.1782178218,,,0.4056603774,,
  2 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.3039647577,,,,,,,,0.09285714286,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,0.1538461538,,,,,,,,,,,,,
  4 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.388308977,,,,0.09333333333,,,,0.1923076923,,,0.2517482517,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.05384615385,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07692307692,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,0.2711370262,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2397959184,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2096774194,,,,,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3595041322,,,,,,,,0.06965174129,,,0.25,,
  2 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.232,,,,,,,,0.06862745098,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.5725806452,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1143410853,,,,,,,,0.07534246575,,,,,
  10 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.02659574468,,,,0.4051724138,0.2032374101,0.4,0.1043478261,,0.2450549451,0.3467336683,,0.4093686354,0.007712082262,0.4041916168
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.537037037,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.5414012739,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5325443787,,,,,,,,0.3925233645,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.0198019802,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,0.5478723404,,,,,,,,0.4255319149,,,,0.02341137124,
  7 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.08176100629,,,,0.4854368932,0.3059701493,0.5170068027,,,0.4261006289,,,0.5238095238,,0.6086956522
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | TRAZODONE HCL,,,0.5565217391,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3415547236,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.3705772812,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2294117647,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2107623318,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3921568627,,
  2 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,0.3488372093,,,,,,,,0.2594594595,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.5927561837,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,0.5841584158,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5074626866,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,0.6815920398,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.6038961039,,,,,,,,0.5294117647,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,0.57,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,0.4488888889,,,,,,0.145631068,,0.2093862816,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,,,,,,,,,0.2868852459,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5397727273,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.09090909091,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.6584158416,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,,0.4557823129,,,,,,,,0.1818181818,0.428125,,,,
  2 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.3108614232,,,,,,,,0.121875,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.115942029,,,,,
  2 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2984293194,,,,,,,,0.152866242,,,,,
  2 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.3964497041,,,,,,,,0.08841463415,,,,,
  2 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.2568807339,,,,,,,,0.1261261261,,,,,
  2 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2964169381,,,,,,,,0.1553784861,,,,,
  1 ,"Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.15,,,,,
  2 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,0.1822916667,,,,,,,,0.132231405,,,,,
  1 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,0.5181818182,,,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,0.04022988506,0.3959044369,,,,,0.3673469388,,,0.1880108992,,,0.4375,,
  2 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1729323308,,,0.35,,
  6 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.09154929577,0.4074844075,,,,0.2566371681,,,,0.2561290323,,,0.3407407407,0.02455357143,
  4 ,Age: 20-40 | Gender: Male | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,0.06086956522,0.5090909091,,,,,,,,0.2203389831,,,,,0.618705036
  8 ,Age: 20-40 | Gender: Male | CLONAZEPAM,,0.02547770701,0.3757961783,,,,0.18359375,,0.1005586592,,0.1977186312,,,0.4337349398,0.01449275362,0.3781512605
  2 ,Age: 20-40 | Gender: Male | CLONAZEPAM | ESCITALOPRAM OXALATE,,,,,,,0.359223301,,,,0.2761904762,,,,,
  1 ,Age: 20-40 | Gender: Male | CLONAZEPAM | SERTRALINE HCL,,,,,,,,,,,,,,0.5505617978,,
  1 ,Age: 20-40 | Gender: Male | CLOTRIMAZOLE/BETAMETHASONE DIP,,,0.4433962264,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | CODEINE PHOSPHATE/GUAIFENESIN,,,0.3623188406,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016),,,0.4163265306,,,,,0.3333333333,,,,,,0.3275862069,,
  3 ,Age: 20-40 | Gender: Male | CYCLOBENZAPRINE HCL,,,,,,,0.119266055,0.3805309735,,,,,,,0.004166666667,
  2 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.4285714286,,,,,,,,,,,0.3472222222,,
  12 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.01510574018,0.03816793893,0.4761459308,0.6214689266,,0.4289156627,0.1497775581,0.4558359621,,,0.2310838446,0.4576023392,,0.5285053929,0.01729559748,0.5468594217
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL",,,,,,0.4563106796,,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,0.2979683973,,,,0.3269230769,,,,,0.5873015873
  3 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.007299270073,,,,,,,,,0.1831683168,,,,,0.5238095238
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.0962962963,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.5879120879,,,0.3739130435,,,,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss",,,,,,,,,,,0.2892561983,,,,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.3914285714,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.57771261,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,,,,,,0.1587301587,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840)",0.00826446281,,,,,,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HYDROCODONE/ACETAMINOPHEN",,,,,,,0.1434599156,,,,,,,0.4661016949,,
  2 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.0859375,,,,,,,,,0.2064777328
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.02040816327,
  2 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,,,,,0.2679738562,,,,,0.5563909774
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | SERTRALINE HCL",,,,,,,,,,,0.2920353982,,,,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2666666667,,,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4117647059,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4549356223
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.5692883895,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5959183673
  2 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01162790698,,,,,0.1130434783,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.04854368932,,,,,,,,,,,,,,
  5 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.04383561644,,,,0.435483871,0.1340782123,,,,,,,0.5675675676,,0.5765765766
  3 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,0.2276422764,0.6282051282,,,,0.6666666667
  4 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.04731861199,,,,,0.1016949153,0.1869158879,,,,,,,,0.2183098592
  2 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.03902439024,,,,,0.2183098592,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,0.3302325581,,,0.612654321,,0.6193181818
  2 ,"Age: 20-40 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,0.3333333333,,,,,0.6466380544
  2 ,Age: 20-40 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.375,,,,0.08720930233,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | DESLORATADINE,,,,,,,0.1171171171,,,,,,,,,
  5 ,Age: 20-40 | Gender: Male | DESVENLAFAXINE SUCCINATE,,0.06,,0.4285714286,,,0.1517241379,,,,0.2278287462,,,,,0.7101449275
  1 ,Age: 20-40 | Gender: Male | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE,,,,0.0737704918,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss,,,,0.4695121951,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | DESVENLAFAXINE SUCCINATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.2440944882,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,0.2362204724,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,0.4360902256,,,,,,,0.2588832487,,,,,
  1 ,Age: 20-40 | Gender: Male | DESVENLAFAXINE SUCCINATE | VENLAFAXINE HCL,,,,,,,,,,,0.2336448598,,,,,
  6 ,Age: 20-40 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE,,,0.4136904762,,,,0.1659574468,0.414893617,,,,,,0.4585798817,0.02255639098,0.3846153846
  1 ,Age: 20-40 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE | ESCITALOPRAM OXALATE,,,,,,,0.3693693694,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.419047619,,
  1 ,Age: 20-40 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE | SERTRALINE HCL,,,,,,,,,,,,,,0.6,,
  1 ,"Age: 20-40 | Gender: Male | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.05844155844,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | DIAZEPAM,,,,,,,,0.4594594595,,,,,,0.4713375796,,
  3 ,Age: 20-40 | Gender: Male | DIZZINESS AND GIDDINESS (dxo:ICD9:7804),,,,,,,0.147826087,0.4470588235,,,,,,0.5192307692,,
  2 ,Age: 20-40 | Gender: Male | DOXEPIN HCL,,,,,0.2395128552,,,,,,0.2262996942,,,,,
  1 ,Age: 20-40 | Gender: Male | DOXEPIN HCL | Last AD: Same & No Remiss,,,,,0.1434599156,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | DOXEPIN HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.5196078431,,
  1 ,Age: 20-40 | Gender: Male | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.1904761905,,,,,
  1 ,Age: 20-40 | Gender: Male | DOXYCYCLINE HYCLATE,,,,,,,,0.407079646,,,,,,,,
  11 ,Age: 20-40 | Gender: Male | DULOXETINE HCL,0.02173913043,0.03432494279,0.4520884521,,,0.3671406003,0.1923076923,0.3873239437,0.08333333333,,0.2157519899,0.3313253012,,0.4533678756,,0.5594059406
  2 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,0.2977777778,,,,0.1714285714,,,,,
  2 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | FLUOXETINE HCL,,,,,,,,0.480620155,,,0.2311557789,,,,,
  2 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.08465608466,,,,,0.06918238994,,,,,
  4 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.0474137931,,,,,0.1278195489,,,,0.2076271186,,,,0.007142857143,
  2 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.4455445545,,,,,,,,,0.02521008403,
  1 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.3580246914,,,,,
  1 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.2573705179,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,0.5815217391,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,0.6578947368,,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5053191489,,,,,0.4910179641,,,,,
  2 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.3271028037,,,,,0.1925465839,,,,,
  1 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | PAROXETINE HCL,,,,,,,,,,,,0.56,,,,
  2 ,"Age: 20-40 | Gender: Male | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.2428571429,,,,,0.09756097561,,,,,
  2 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.2300469484,,,0.5042735043,,
  2 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.2981530343,,,,,0.2010723861,,,,,
  1 ,Age: 20-40 | Gender: Male | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.24,,,,,
  4 ,Age: 20-40 | Gender: Male | DYSTHYMIC DISORDER (dxo:ICD9:3004),,,0.4666666667,,,,,0.4615384615,,,,,,0.5977653631,,0.5548387097
  1 ,Age: 20-40 | Gender: Male | DYSTHYMIC DISORDER (dxo:ICD9:3004) | SERTRALINE HCL,,,,,,,,,,,,,,0.6336633663,,
  3 ,Age: 20-40 | Gender: Male | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869),,0.05084745763,,,,,0.1698113208,0.4380952381,,,,,,,,
  14 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE,0.02051282051,0.0238758456,0.5809110629,,0.1,0.3916666667,0.2565072692,0.3510638298,0.1142355009,0.06164383562,0.1990109396,0.328936521,,0.3753112771,0.01616915423,0.5353946298
  4 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,0.22265625,0.4816176471,,,0.2022160665,,,0.3805970149,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,0.1339285714,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.125,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,,,,,,0.3922651934,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.0198019802,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,,,,,,0.1167883212,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.2983425414,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss,,,,,,,0.1495327103,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.2608695652,,,,0.2176165803,,,,0.06989247312,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1147540984,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,0.1375661376,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06140350877,,,,,
  6 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.3033707865,,,,0.159122085,0.31,,,0.2142857143,,,0.2681564246,,0.2311827957
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1140939597,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,0.1274509804,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.1242937853,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1060773481,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08411214953,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.09598214286,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06194690265,,,,,
  5 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.29375,,,,0.1666666667,,,,0.123853211,,,0.2222222222,,0.2063492063
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,0.1401869159,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.1957671958,,,,0.04787234043,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,0.1390374332,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,0.116751269,,,,0.0704845815,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,0.04761904762,,,,,,,,,
  11 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0,0.01602136182,0.5746835443,,,0.3372434018,,0.4447058824,0.08666666667,,0.1724386724,0.3534136546,,0.4212707182,0.01408450704,0.4898373984
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.024,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.3240740741,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,0.3301886792,,,,,,,0.6886792453,,
  2 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.320083682,,,,,,,,0.01869158879,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2752293578,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.0347826087,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1386138614,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1036789298,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.1730769231,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.007692307692,,,,,0.3082706767,,,,0.2142857143,,,,,
  3 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.2973805855,,,,0.311627907,,,,0.0198019802,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.01869158879,,,,,,,,,,,,,,
  5 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.1225490196,0.7106918239,,,,,,,,0.4386694387,,,0.6141732283,,0.6016949153
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,0.6538461538,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1361262758,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.3008130081,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.1587301587,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.1494920174,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.2051282051,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,0.1428571429,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,0.172972973,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.1161825726,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.1343283582,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1407035176,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,0.1027027027,,,,,,,0.3669724771,,
  2 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,0.1511627907,,,,0.1791044776,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.5536277603,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.4797687861,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.568627451,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.5743243243,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.4205714286,,,,0.4351585014,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,0.362962963,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.2622222222,,0.1601941748,,0.1973244147,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.137254902,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.3905325444,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6439393939,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.0873015873,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.4862385321,,,,,,,,,
  4 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PAROXETINE HCL,,,,,,,0.2791666667,,,,0.1635514019,0.4599542334,,0.3859649123,,
  4 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2768361582,,,,0.2520325203,,,,0.07109004739,,,0.1379310345,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06930693069,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1466666667,,,,,
  2 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.2121212121,,,,0.1291208791,,,,,
  2 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.2686567164,,,,0.1010830325,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1009174312,,,,,
  5 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1860465116,0.2086956522,,,0.1608133087,,,0.2513368984,,0.2452830189
  2 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.1652892562,,,,0.1111111111,,,,,
  1 ,"Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,,,,0.02830188679,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,,,,,0.09459459459,,,,,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,0.33,,,,,,,,,
  7 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | SERTRALINE HCL,,0.03370786517,,,,,0.2140127389,0.2695035461,,,0.1766917293,0.3055555556,,0.4409030544,,0.5514018692
  3 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,0.1590909091,,,,0.2,,,0.2719298246,,
  6 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | TRAZODONE HCL,,0.02816901408,,,,,0.2483660131,0.2056074766,,,0.1954299459,,,0.3571428571,0.02322206096,
  1 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1951219512,,,,,
  5 ,Age: 20-40 | Gender: Male | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,0.01526717557,,,,,0.2364217252,,,,0.1398467433,,,0.3797468354,,0.6555555556
  3 ,Age: 20-40 | Gender: Male | ESOMEPRAZOLE MAGNESIUM,,,0.3902439024,,,,0.148,0.4758064516,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.515970516,,,,,,,,,,,0.5535714286,,0.563559322
  1 ,Age: 20-40 | Gender: Male | EXAMINATION OF EYES AND VISION (dxo:ICD9:V720),,,0.4846153846,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | FEVER AND OTHER PHYSIOLOGIC DISTURBANCES OF TEMPERATURE REGULATION (dxo:ICD9:7806),,,0.5,,,,,,,,,0.3425925926,,,,
  1 ,"Age: 20-40 | Gender: Male | FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)",,,,,,,,,,,,,,0.4,,
  13 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL,0.01538461538,0.04016430853,0.3621123219,,,0.2932454695,0.1701644923,0.4456626451,0.09879518072,0.06034482759,0.2238413277,0.3272910373,,0.3510784764,0.02852348993,0.501146789
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,,,,,,,0.5785123967,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,0.288,,,0.1086956522,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,0.2608695652,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.07207207207,0.3356973995,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.2470119522,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2695035461,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2352941176,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.320754717,,,0.125,,,,,
  2 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,0.2179487179,,,0.06603773585,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,,0.1344537815,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.5853658537,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1333333333,,,0.09913793103,,,,,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,,0.05844155844,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,0.1081081081,,,,,,,,
  8 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.03095975232,0.3627906977,,,,0.1715976331,,,,0.2394578313,0.4108527132,,0.4285714286,0.02678571429,0.5058139535
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.4855072464,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5207667732,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1481481481,,,,,
  2 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.397260274,,,,0.008658008658,
  5 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.07894736842,,,,,0.2176870748,,,,0.3804347826,,,0.6033057851,,0.5403225806
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.1467889908,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3274209012,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.3752711497,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1913043478,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2972972973,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.2621359223,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2869565217,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,0.223880597,,,0.2405063291,,,,0,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.6085313175,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,0.5480769231,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5524475524,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,0.6945337621,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3798449612,,,,,,0.5818965517,,,0.536121673,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,0.5782312925,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.3714285714,0.1523809524,,0.1631944444,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5191082803,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1390374332,,,,,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1386138614,,,,,
  4 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | PAROXETINE HCL,,0.06481481481,,,,,,0.3964285714,,,0.1741935484,0.4755784062,,,,
  2 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3181818182,,,0.1278688525,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08450704225,,,,,
  2 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.2716049383,,,0.1698113208,,,,,
  1 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.336,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,0.4371257485,,,0.1282051282,,,,,
  2 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.3133333333,,,0.125748503,,,,,
  2 ,"Age: 20-40 | Gender: Male | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.375,,,0.1659574468,,,,,
  2 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | RISPERIDONE,,,,,,,,0.08928571429,,,0.1005586592,,,,,
  6 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | SERTRALINE HCL,,0.04081632653,0.2920353982,,,,0.1438848921,0.3969594595,,,0.2129963899,,,0.401062417,,
  2 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,0.3389830508,,,0.1788617886,,,,,
  5 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | TRAZODONE HCL,,0.05325443787,,,,,0.1388888889,0.3611584327,,,0.2251420455,,,,0.01754385965,
  1 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2058823529,,,,,
  4 ,Age: 20-40 | Gender: Male | FLUOXETINE HCL | VENLAFAXINE HCL,,0.07476635514,,,,,,0.463878327,,,0.2309711286,,,,,0.5823529412
  8 ,Age: 20-40 | Gender: Male | GABAPENTIN,,0.04316546763,0.3414634146,,,0.2959183673,0.1436950147,0.3823529412,,0.05217391304,0.17,,,0.428057554,,
  6 ,Age: 20-40 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),0.008695652174,0.03905325444,,,,,0.1683848797,0.4043715847,,,0.2222222222,,,0.496835443,,
  1 ,"Age: 20-40 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.04237288136,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6981132075,,
  1 ,"Age: 20-40 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1078431373,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.01724137931,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | SERTRALINE HCL,,,,,,,,,,,,,,0.6033519553,,
  1 ,Age: 20-40 | Gender: Male | GUAIFENESIN/P-EPHED HCL,,,,,,,0.1688311688,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | GUAIFENESIN/PHENYLEPHRINE HCL,,,,,,,0.1814345992,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | GUAIFENESIN/PSEUDOEPHEDRNE HCL,,,,,,,,,,,,0.4060606061,,,,
  6 ,Age: 20-40 | Gender: Male | HEADACHE (dxo:ICD9:7840),0.009339559706,0.03260869565,0.4347826087,,,,,0.45,,0.05829015544,,,,0.4734299517,,
  2 ,"Age: 20-40 | Gender: Male | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.01255230126,,,,,,,,,0.09411764706,,,,,,
  10 ,Age: 20-40 | Gender: Male | HYDROCODONE/ACETAMINOPHEN,0.005602240896,0.03260869565,,,,0.2848101266,0.1622257053,0.4267990074,0.201754386,,0.1720647773,0.3674033149,,0.4401622718,0.006734006734,
  1 ,Age: 20-40 | Gender: Male | HYDROCODONE/ACETAMINOPHEN | IBUPROFEN,,,,,,,,,,,,,,0.4555555556,,
  1 ,Age: 20-40 | Gender: Male | HYDROCODONE/ACETAMINOPHEN | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.1214953271,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | HYDROCODONE/ACETAMINOPHEN | SERTRALINE HCL,,,,,,,,,,,,,,0.6524390244,,
  1 ,Age: 20-40 | Gender: Male | HYDROCODONE/HOMATROPINE,,,0.4621212121,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | HYDROXYZINE HCL,,,,,0.125,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Male | IBUPROFEN,,,0.369193154,,,,,,,,,0.3303571429,,0.4354005168,0.006666666667,
  1 ,Age: 20-40 | Gender: Male | IBUPROFEN | SERTRALINE HCL,,,,,,,,,,,,,,0.5705521472,,
  1 ,Age: 20-40 | Gender: Male | IMIPRAMINE HCL,,,,,,,,,,,0.1810344828,,,,,
  1 ,Age: 20-40 | Gender: Male | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.1081081081,,,,,
  2 ,Age: 20-40 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784),,0.02966101695,,,,,,,,,,,,0.3881278539,,
  11 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.05763688761,0.1914893617,0.1446540881,,0.1318681319,0.08020050125,0.1461187215,,,0.1210762332,0.1391752577,,0.1184210526,0.01872659176,0.1356321839
  3 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.03636363636,,,,,,,0.08695652174,,0.06451612903
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.02590673575,,,,,,,0.07079646018,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1946564885,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL",,,,,,,,,,,0.09016393443,0.3613861386,,,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,0.1067961165,,0.1428571429
  4 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.06086956522,,,,,0.05263157895,,,,0.09433962264,,,0.1142857143,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.0564516129,,,,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,,,,,,0.1066666667,,,0.3178082192,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.25,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,0.1181102362,,,,,0.284
  9 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2080098079,,,0.2006472492,0.07640344747,0.18359375,,,0.1299638989,0.1730429665,,0.2038449802,0.01194539249,0.2315380344
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.0523255814,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.01851851852,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,0.09174311927,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1176470588,,,,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,0.1428571429,,,,0.1216216216,,,,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,0.123655914,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2683823529,,,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,0.2569444444,,,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1923076923,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.3094462541,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.2983725136,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3087248322
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2090909091,,,,,,,,,,,0.1298701299,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.65,,,,,,,,,
  5 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,0.3039215686,,,,0.08878504673,,,,0.1584158416,0.3638170974,,0.2447552448,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.2276422764,,,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.125,0.3505535055,,,,
  6 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1139896373,,,0.125,,0.1111111111,,,,0.1172413793,,0.09578544061,,0.1445086705
  7 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.09615384615,,,,0.04761904762,0.1111111111,,,0.0495049505,0.12,,0.08256880734,,0.1122994652
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.03305785124,,,0.1932773109,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2089552239,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1920529801
  11 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.05147058824,0.198019802,0.2681564246,,0.1712158809,0.06870229008,0.157016683,,,0.1084337349,0.1595466434,,0.1752711497,0.008438818565,0.2063329928
  4 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,0.2075471698,,,,,,,,0.1131221719,,,0.369193154,,0.2672413793
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1052631579,,,,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1409395973,,,,,0.4026845638
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.03759398496,,,,,,,,,
  6 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,0.2356687898,,,,0.1192982456,,,,0.2231404959,0.201754386,,0.3657635468,,0.2747252747
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.273381295,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,0.1557377049,,,,,,,,,0.3861111111
  10 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.1387096774,0.07,,0.1022727273,0.05755395683,0.09865470852,,,0.06282722513,0.108974359,,0.1470588235,0.01941747573,0.16796875
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1542553191,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PAROXETINE HCL",,,,,,,,,,,,0.2068965517,,,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.05855855856,,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,0.09467455621,,,0.2693877551,,
  1 ,"Age: 20-40 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1842105263
  9 ,"Age: 20-40 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",0.01257861635,0.0243902439,0.4422735346,,,,0.1736526946,0.4198895028,0.1675977654,,,0.4318181818,,0.4641954507,0.01330248699,
  1 ,"Age: 20-40 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.3658536585,,
  1 ,"Age: 20-40 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.007552870091,
  1 ,"Age: 20-40 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.5714285714,,
  1 ,"Age: 20-40 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.634375,,
  1 ,"Age: 20-40 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01851851852,
  2 ,"Age: 20-40 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,0.4716981132,0.007299270073,
  1 ,Age: 20-40 | Gender: Male | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641),0,,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | KETOCONAZOLE,,,,,,,,,,,,,,0.4938271605,,
  2 ,Age: 20-40 | Gender: Male | LABORATORY EXAMINATION (dxo:ICD9:V726),,,0.4205607477,,,,,,,,,0.3826086957,,,,
  10 ,Age: 20-40 | Gender: Male | LAMOTRIGINE,,,0.1137123746,0.1216216216,,0.1069042316,0.05656108597,0.1378254211,0.0564516129,,0.0768566494,0.09836065574,,0.1233974359,,0.1420560748
  1 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.1290322581,,
  1 ,"Age: 20-40 | Gender: Male | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4,,,,,
  1 ,"Age: 20-40 | Gender: Male | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3066666667,,,,,
  1 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.1052631579,,,,,
  1 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | RISPERIDONE,,,,,,,,,,,0.05882352941,,,,,
  1 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.04716981132,,,,,
  2 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,0.07182320442,,,0.1447562777,,
  1 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,0.1074380165,,
  1 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.08096085409,,,,,
  2 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.05072463768,,,,,0.0756302521
  2 ,Age: 20-40 | Gender: Male | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.08223684211,,,,,0.1373626374
  2 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss,,0.009523809524,,,,,,,,,,,,,0.01179941003,
  3 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.025,,,,,,,,,0.2392638037,,,,0.02739726027,
  1 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.2843137255,,,,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6024590164,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.5727272727,,,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6015779093,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.2450980392,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3818181818,,,,,
  8 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.01618705036,0.3939393939,,,,0.1278772379,0.4514285714,,,0.2036363636,,,0.4176829268,0.004608294931,0.4671532847
  2 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3709677419,,,,0.03546099291,
  1 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.128440367,,,,,
  2 ,"Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.09615384615,,,,0.1065989848,,,,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.09090909091,,,,,
  10 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02274715661,0.35,,,0.3157894737,0.1614123581,0.3323529412,0.09558823529,,0.2459893048,0.3686440678,,,0.01342281879,0.4734042553
  2 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.416,,,,0.01550387597,
  8 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | TRAZODONE HCL,0.0162601626,0.02427184466,0.3548387097,,,,0.186746988,,0.1025641026,,0.2053675613,,,0.3136363636,0.01781170483,
  3 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4464285714,,,,0.01764705882,0.6807511737
  7 ,Age: 20-40 | Gender: Male | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.03203661327,0.4910714286,,,,0.1576763485,0.4117647059,,,0.18,,,0.4790419162,0.005917159763,
  5 ,Age: 20-40 | Gender: Male | Last AD: Diff & Remiss,,0.1291390728,,,,0.5,,,0.2926829268,,,,,,0.1218390805,0.6631016043
  1 ,"Age: 20-40 | Gender: Male | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,,,,,0.4462809917,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.3873873874,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6458333333,,
  5 ,Age: 20-40 | Gender: Male | Last AD: Diff & Remiss | PAROXETINE HCL,,0.1137724551,,,,,0.3742331288,,,,0.2798982188,,,0.6462585034,,0.640625
  9 ,Age: 20-40 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL,,0.09571788413,0.5925925926,,,0.4812030075,0.2144846797,0.5629139073,,,0.3718104496,0.6178861789,,,0.09523809524,0.5458333333
  2 ,Age: 20-40 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,0.6623376623,0.07894736842,
  1 ,Age: 20-40 | Gender: Male | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.0888030888,
  3 ,Age: 20-40 | Gender: Male | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.1081081081,,,,,0.3064516129,,,,0.3099730458,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss,,,,,,,,,,,0.1171366594,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.09452054795,,,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.09230769231,,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.3366336634,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3880597015,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4175824176
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.3187560739,,,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.2274881517,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3362831858,,,,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1913439636,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0.008620689655,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2467532468
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.3066666667,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,,,,0.2977099237,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,,,,,0.009523809524,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.2668329177,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,,,,0.1238938053,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,,,0.1261261261,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3482493099,,
  3 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2742616034,,,0.3602484472,0.02419354839,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.01092544987,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3464720195
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss,,,,,,,,,,,0.5,,,,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6837606838,,,,,
  1 ,"Age: 20-40 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6546391753,,,,,
  2 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,0.4186046512,,0.5853658537,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.5714285714,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.5646711013,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5755395683,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6155793026,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5606060606,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5241460542,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.488372093,,,,,
  1 ,Age: 20-40 | Gender: Male | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6200527704
  1 ,Age: 20-40 | Gender: Male | LEVOFLOXACIN,,,,,,,0.1726384365,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.5625,,
  2 ,Age: 20-40 | Gender: Male | LISDEXAMFETAMINE DIMESYLATE,,,0.4028776978,,,,,,,,,,,0.4051724138,,
  1 ,Age: 20-40 | Gender: Male | LISINOPRIL,,,0.416,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.5271966527,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | LITHIUM CARBONATE,,,,,,,,0.096,,,,,,,,0.176
  2 ,Age: 20-40 | Gender: Male | LORATADINE,,,0.5619047619,,,,,,,,,0.4556213018,,,,
  4 ,Age: 20-40 | Gender: Male | LORAZEPAM,,0.05,0.3925233645,,,,,0.5333333333,,,,,,0.4555555556,,
  1 ,Age: 20-40 | Gender: Male | LORAZEPAM | SERTRALINE HCL,,,,,,,,,,,,,,0.6336633663,,
  6 ,Age: 20-40 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321),,0.05217391304,0.3604060914,,,,,0.3785714286,0.1538461538,,,0.3043478261,,0.4672897196,,
  2 ,Age: 20-40 | Gender: Male | LUMBAGO (dxo:ICD9:7242),,,,,,,0.1981132075,0.4485981308,,,,,,,,
  2 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.3985765125,,,,,,,,,0.6257521059,,,,,
  2 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.6116504854,,,,,,,,,0.7170868347,,,,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.6392156863,,,,,
  9 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.5172413793,0.6349206349,,,0.6666666667,0.5955555556,0.5732484076,,,0.6453061224,,,0.579787234,0.3736842105,0.5921052632
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,,,,0.6598837209,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6325203252,,,,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6746987952
  4 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.5619834711,,,,,0.4571428571,,,0.2052980132,,,0.4748201439,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1438848921,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",,,,,,,,,,,0.203539823,,,,,
  13 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2481751825,0.3569364162,0.5664160401,0.5441860465,,0.5284697509,0.4683641975,0.5062611807,0.345844504,,0.4957002457,0.5550847458,,0.5334728033,0.2718446602,0.5779467681
  2 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.3592814371,,0.4481605351,,,,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4363636364,,,,,
  2 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,,,,,,,,,,0.6454545455,0.5696202532,,,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,,0.6422018349
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6698113208
  5 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.335483871,,,,,0.4615384615,0.52,,,0.5201465201,,,0.6349557522,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5677966102,,
  2 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4286786787,,,,0.2327790974,
  2 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.4385964912,,,,,0.5526315789
  2 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.5324074074,,,,,0.6046176046
  2 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.05705705706,,,,,,,,,,,,0.4797297297,,
  1 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.08870967742,,,,,,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.04155844156,,,,,,,,,,,,0.480620155,,0.5523809524
  1 ,Age: 20-40 | Gender: Male | METAXALONE,,,0.3731343284,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | METHYLPHENIDATE HCL,,0.04132231405,0.48,,,,,,,,,,,0.5149253731,,
  1 ,Age: 20-40 | Gender: Male | METRONIDAZOLE,,,,,,,,,,,,,,0.4552845528,,
  4 ,"Age: 20-40 | Gender: Male | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0,,,,,,0.1693548387,,,0.05,,,,0.4769230769,,
  10 ,Age: 20-40 | Gender: Male | MIRTAZAPINE,,0.04102564103,0.2365591398,,,0.2865853659,0.07555555556,0.1860465116,0.2111879321,,0.2155172414,0.2295081967,,0.3903508772,,0.376
  1 ,Age: 20-40 | Gender: Male | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.1320754717,,,,,
  1 ,Age: 20-40 | Gender: Male | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1870503597,,,,,
  2 ,Age: 20-40 | Gender: Male | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,,,0.25,0.3966942149,,,,
  1 ,"Age: 20-40 | Gender: Male | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.05970149254,,,,,
  1 ,Age: 20-40 | Gender: Male | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.1261261261,,,,,
  3 ,Age: 20-40 | Gender: Male | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.2033898305,,0.2350993377,,,0.3434650456,,
  2 ,Age: 20-40 | Gender: Male | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1824817518,,0.1793814433,,,,,
  1 ,Age: 20-40 | Gender: Male | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2113821138,,,,,
  3 ,Age: 20-40 | Gender: Male | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,0.13,,0.204954955,,,,,0.5490196078
  4 ,Age: 20-40 | Gender: Male | MONTELUKAST SODIUM,,,0.5185185185,,,,,0.4583333333,,,0.28,,,0.3725490196,,
  2 ,Age: 20-40 | Gender: Male | MORBID OBESITY (dxo:ICD9:27801),,0.02083333333,,,,,0.2020725389,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | MOXIFLOXACIN HCL,,,,,,,0.1210526316,,,,,,,,,
  6 ,Age: 20-40 | Gender: Male | MYOPIA (dxo:ICD9:3671),,0.04914529915,0.4297297297,,,,0.1552511416,0.4696969697,,,,0.4525547445,,0.5298013245,,
  1 ,Age: 20-40 | Gender: Male | MYOPIA (dxo:ICD9:3671) | SERTRALINE HCL,,,,,,,,,,,,,,0.6446280992,,
  3 ,Age: 20-40 | Gender: Male | NAPROXEN,0,,,,,,0.168,,,,,,,0.4705882353,,
  1 ,Age: 20-40 | Gender: Male | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382),,0.02877697842,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | NONALLOPATHIC LESION OF CERVICAL REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7391)",,,,,,,,,,,,,,0.5633802817,,
  1 ,"Age: 20-40 | Gender: Male | NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)",,,,,,,,,,,,0.3791208791,,,,
  3 ,"Age: 20-40 | Gender: Male | NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",,,0.3617021277,,,,,0.3291139241,,,,,,,0.01369863014,
  7 ,Age: 20-40 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02578947368,0.3545454545,,,,0.1311619718,0.3875,0.1478873239,,,,,0.4184675835,0.015625,
  1 ,"Age: 20-40 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.0462962963,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01714285714,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.05357142857,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.006097560976,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,,,,,,,,,,,,,0.625,,
  1 ,Age: 20-40 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VARENICLINE TARTRATE,,0.02884615385,,,,,,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | NORTRIPTYLINE HCL,,,,,,,,,,0.1539923954,0.2618069815,,,,,
  2 ,Age: 20-40 | Gender: Male | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.3398058252,,,0.5846153846,,
  1 ,Age: 20-40 | Gender: Male | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1849710983,,,,,
  1 ,"Age: 20-40 | Gender: Male | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.54,,,,
  1 ,"Age: 20-40 | Gender: Male | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.5511811024,,,,
  1 ,"Age: 20-40 | Gender: Male | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5879120879,,
  1 ,"Age: 20-40 | Gender: Male | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.76,,
  1 ,Age: 20-40 | Gender: Male | Num Previous Antidep: 4+,,,,,,,,,,,0.1291666667,,,,,
  1 ,Age: 20-40 | Gender: Male | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.3052631579,,,,
  1 ,Age: 20-40 | Gender: Male | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1854304636,,,,,
  1 ,Age: 20-40 | Gender: Male | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1775700935,,,,,
  1 ,Age: 20-40 | Gender: Male | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.5428571429,,,,
  1 ,"Age: 20-40 | Gender: Male | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.03846153846,,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,0.05521472393,,,,,0.3039215686,,,,0.141563786,,,,,
  1 ,Age: 20-40 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PAROXETINE HCL,,,,,,,,,,,0.1776315789,,,,,
  1 ,"Age: 20-40 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1160714286,,,,,
  1 ,Age: 20-40 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.1387283237,,,,,
  1 ,Age: 20-40 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1142857143,,,,,
  1 ,Age: 20-40 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | VENLAFAXINE HCL,,,,,,,,,,,0.1736111111,,,,,
  6 ,Age: 20-40 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.4872665535,,,,0.2109038737,0.5185185185,,,0.2259887006,0.3868613139,,0.5105932203,,
  1 ,Age: 20-40 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.6359223301,,
  4 ,Age: 20-40 | Gender: Male | OMEPRAZOLE,,0.05,,,,,0.1769041769,0.4772727273,,,0.1690140845,,,,,
  1 ,"Age: 20-40 | Gender: Male | OPIOID TYPE DEPENDENCE, UNSPECIFIED (dxo:ICD9:30400)",,,,,,,,,,,,,,,0.02153110048,
  2 ,Age: 20-40 | Gender: Male | OSELTAMIVIR PHOSPHATE,,,0.4718309859,,,,0.1428571429,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | OTHER ACNE (dxo:ICD9:7061),,,0.3859649123,,,,,,,,,,,,,
  3 ,"Age: 20-40 | Gender: Male | OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30390)",,0.06930693069,0.3302752294,,,,,,,,,,,0.3657142857,,
  1 ,Age: 20-40 | Gender: Male | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.03003003003,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | OTHER CONVULSIONS (dxo:ICD9:78039),,0.02542372881,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,,,0.2884615385,,,
  1 ,Age: 20-40 | Gender: Male | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,,,0.4201680672,,,
  10 ,Age: 20-40 | Gender: Male | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.03059440559,0.4959349593,0.5245901639,,0.4071428571,0.1655629139,0.408496732,,,,0.43,,0.5122699387,0,0.558685446
  2 ,Age: 20-40 | Gender: Male | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.01098901099,,,,,0.1417322835,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,,,,,0.1483253589,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.01990049751,0.4086956522,,,,,,,,,,,,,
  4 ,Age: 20-40 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,,0.480620155,,,,0.1815181518,,,,,0.3309859155,,0.478,,
  1 ,Age: 20-40 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SERTRALINE HCL,,,,,,,,,,,,,,0.660130719,,
  2 ,Age: 20-40 | Gender: Male | OXYCODONE HCL,0.01739130435,,,,,,0.15625,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | OXYCODONE HCL/ACETAMINOPHEN,,0.05479452055,,,,,0.1827411168,,,,,,,,,
  4 ,Age: 20-40 | Gender: Male | PAIN IN SOFT TISSUES OF LIMB (dxo:ICD9:7295),,,0.3411764706,,,,0.1465517241,,,,,0.3457943925,,0.452991453,,
  6 ,Age: 20-40 | Gender: Male | PALPITATIONS (dxo:ICD9:7851),,,0.4304812834,,,,0.142599278,0.3963636364,,,0.1782945736,0.3873239437,,0.4914675768,,
  4 ,Age: 20-40 | Gender: Male | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.05136986301,0.4158415842,,,,,,,,,0.4016393443,,0.4523160763,,
  1 ,Age: 20-40 | Gender: Male | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PAROXETINE HCL,,,,,,,,,,,,0.567839196,,,,
  1 ,Age: 20-40 | Gender: Male | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | SERTRALINE HCL,,,,,,,,,,,,,,0.572815534,,
  12 ,Age: 20-40 | Gender: Male | PAROXETINE HCL,0.01818181818,0.03779527559,0.4285714286,,,0.3223140496,0.1842439644,0.3668831169,0.1505376344,,0.2133634603,0.4554420152,,0.4315436242,0.03801652893,0.5516129032
  3 ,"Age: 20-40 | Gender: Male | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.09655172414,0.3072289157,,0.2803738318,,
  1 ,"Age: 20-40 | Gender: Male | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07633587786,,,,,
  2 ,"Age: 20-40 | Gender: Male | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1485148515,0.2972972973,,,,
  2 ,Age: 20-40 | Gender: Male | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1174496644,0.4516129032,,,,
  2 ,"Age: 20-40 | Gender: Male | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1746031746,0.2568807339,,,,
  1 ,Age: 20-40 | Gender: Male | PAROXETINE HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,0.6861313869,,,,
  5 ,Age: 20-40 | Gender: Male | PAROXETINE HCL | SERTRALINE HCL,,0.03225806452,,,,,0.1315789474,,,,0.1949458484,0.4383301708,,0.4757281553,,
  4 ,Age: 20-40 | Gender: Male | PAROXETINE HCL | TRAZODONE HCL,,0.03636363636,,,,,,,,,0.2735703246,0.388638413,,,0.03353057199,
  2 ,Age: 20-40 | Gender: Male | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1981981982,0.4961538462,,,,
  1 ,Age: 20-40 | Gender: Male | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742),,,,,,,,,,,,,,,0.008474576271,
  12 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",0.02752293578,0.03421052632,0.1958384333,0.1635220126,,0.1503759398,0.1314553991,0.1530172414,,,0.102003643,0.1828703704,,0.1634146341,0.02777777778,0.1842576029
  9 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.0351758794,0.1315789474,0.1751824818,,,0.07164179104,0.1130434783,,,0.06603773585,0.1538461538,,0.168,,0.1559139785
  2 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.0652173913,,,0.2673267327,,
  1 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1025641026,,,,,
  3 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,0.1538461538,,,,,,,,0.1026694045,,,0.344783715,,
  2 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1443850267,,,0.2520661157,,
  3 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.11,,,,0.03225806452,0.1553398058
  2 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1274509804,,,,,0.2314049587
  2 ,"Age: 20-40 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1124260355,,,,,0.2687022901
  1 ,Age: 20-40 | Gender: Male | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3396689148,,,,,
  1 ,Age: 20-40 | Gender: Male | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.3063583815,,,,,
  1 ,Age: 20-40 | Gender: Male | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.237037037,,,,,
  1 ,Age: 20-40 | Gender: Male | PREGABALIN,,,,,,0.2910447761,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | PROPOXYPHENE NAP/ACETAMINOPHEN,,,,,,,,,,,,0.4333333333,,,,
  7 ,Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.275659824,,,,0.1003649635,0.2482100239,,,0.1264367816,0.1666666667,,0.246130031,,0.2192982456
  1 ,"Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.0625,,,,,,,,,
  7 ,"Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1703056769,,,,0.08743169399,0.1626139818,,,0.08602150538,0.1489361702,,0.1731481481,,0.1485148515
  3 ,"Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.09090909091,0.1714285714,,,,,,0.1452513966,,
  1 ,"Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.3276836158,,
  1 ,"Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,,,,,,,,0.1810344828,,
  1 ,Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SERTRALINE HCL,,,,,,,,,,,,,,0.5166666667,,
  5 ,Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792),,,0.2024539877,,,,0.1243243243,0.2819148936,,,0.1678832117,,,0.2410714286,,
  13 ,Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0.005780346821,0.04844814534,0.202681388,0.2857142857,,0.1683168317,0.07614213198,0.1944444444,0.08653846154,,0.0974025974,0.1466030989,,0.1836141778,0.03431372549,0.2040816327
  2 ,Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.1204819277,,,0.4425087108,,
  1 ,Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.09090909091,,,,,
  2 ,Age: 20-40 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,0.1416666667,,,,,0.5
  8 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.1707317073,0.1614583333,,,0.08424908425,0.1383647799,,,0.09708737864,,,0.1904761905,0.03401360544,0.2340425532
  2 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.1093117409,,,0.3525641026,,
  1 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1485148515,,,,,
  1 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1103896104,,,,,
  1 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | VENLAFAXINE HCL",,,,,,,,,,,0.1666666667,,,,,
  11 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1788018433,0.2186234818,,0.1397058824,0.08232445521,0.1858490566,0.0490797546,,0.1106442577,0.1403940887,,0.1817288802,0.01670146138,0.1971365639
  3 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.1337579618,,,,0.06589147287,,,,,,,0.1529411765,,
  4 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.08974358974,,,,0.1627906977,,,0.3451327434,,0.2038834951
  2 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1794871795,,,0.3105263158,,
  1 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1201923077,,,,,
  1 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3382352941
  2 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.1748251748,,,,,0.3765690377
  3 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,0.08737864078,0.1138211382,,,,,,0.07586206897,,
  2 ,"Age: 20-40 | Gender: Male | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.09090909091,,,,,,,0.1605504587,,
  1 ,Age: 20-40 | Gender: Male | RABEPRAZOLE SODIUM,,,,,,,0.1465517241,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,,,0.2167832168,,,
  1 ,Age: 20-40 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.40625,,,
  7 ,Age: 20-40 | Gender: Male | RISPERIDONE,,,0.1052631579,,,0.1627906977,0.06435643564,0.09322033898,,,0.1013171226,,,0.1161616162,,0.1490909091
  2 ,Age: 20-40 | Gender: Male | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.1103448276,,,0.1237785016,,
  1 ,Age: 20-40 | Gender: Male | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.07352941176,,,,,
  2 ,Age: 20-40 | Gender: Male | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.1346153846,,,,,0.1859296482
  1 ,Age: 20-40 | Gender: Male | ROFECOXIB,,,,,,,0.1428571429,,,,,,,,,
  2 ,Age: 20-40 | Gender: Male | ROPINIROLE HCL,,,,,,,,,,,0.3087414755,,0.3237924866,,,
  1 ,Age: 20-40 | Gender: Male | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.472,,
  1 ,Age: 20-40 | Gender: Male | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2404092072,,,,,
  5 ,Age: 20-40 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.0260782347,,,,,0.1583236321,,,,,0.3936170213,,0.4756097561,0.01,
  1 ,Age: 20-40 | Gender: Male | ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202),,,,,,,,,,,,,,0.4925373134,,
  3 ,Age: 20-40 | Gender: Male | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.3290322581,,,,0.1504424779,,,,,,,0.3865814696,,
  1 ,Age: 20-40 | Gender: Male | SCREENING FOR LIPOID DISORDERS (dxo:ICD9:V7791),,,,,,,,,,,,0.4035087719,,,,
  15 ,Age: 20-40 | Gender: Male | SERTRALINE HCL,0.02012072435,0.03865814696,0.3731609452,0.5950920245,0.1045751634,0.3567567568,0.164019548,0.3392773346,0.1096681097,0.08465608466,0.2406099518,0.3398294762,,0.4717045649,0.01799775028,0.530726257
  1 ,Age: 20-40 | Gender: Male | SERTRALINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,,,,0.5818181818,,
  1 ,Age: 20-40 | Gender: Male | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.688172043,,
  7 ,Age: 20-40 | Gender: Male | SERTRALINE HCL | TRAZODONE HCL,,0.05405405405,0.2113821138,,,,0.125,0.2907801418,,,0.2694204686,,,0.4206225681,0.02408111534,
  1 ,Age: 20-40 | Gender: Male | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2100840336,,,,,
  1 ,Age: 20-40 | Gender: Male | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.6369047619,,
  5 ,Age: 20-40 | Gender: Male | SERTRALINE HCL | VENLAFAXINE HCL,,0.078125,,,,,0.1238095238,,,,0.2216748768,,,0.4798061389,,0.5833333333
  4 ,Age: 20-40 | Gender: Male | SILDENAFIL CITRATE,,0.03857566766,0.3837837838,,,,,,,,,0.392,,0.4379310345,,
  4 ,Age: 20-40 | Gender: Male | SIMVASTATIN,,,0.5274725275,,,,0.1527777778,0.5740740741,,,,,,0.5503355705,,
  2 ,Age: 20-40 | Gender: Male | SUICIDAL IDEATION (dxo:ICD9:V6284),,,0.2203389831,,,,,,,,,,,0.2767857143,,
  1 ,Age: 20-40 | Gender: Male | SULFAMETHOXAZOLE/TRIMETHOPRIM,,,0.3823529412,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | SUMATRIPTAN SUCCINATE,,,,,,,,,,,,,,0.4545454545,,
  1 ,Age: 20-40 | Gender: Male | TADALAFIL,,0.03968253968,,,,,,,,,,,,,,
  1 ,"Age: 20-40 | Gender: Male | THORACIC OR LUMBOSACRAL NEURITIS OR RADICULITIS, UNSPECIFIED (dxo:ICD9:7244)",,,0.4711538462,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | TOPIRAMATE,,,,,,,,,,,,,,0.4260869565,,
  7 ,Age: 20-40 | Gender: Male | TRAMADOL HCL,,0.04504504505,,,,0.3138075314,0.178470255,0.480620155,,,,0.3663366337,,0.5149253731,0.01167315175,
  13 ,Age: 20-40 | Gender: Male | TRAZODONE HCL,0.01993355482,0.04636785162,0.2843137255,0.3431372549,,0.2065868263,0.1583011583,0.2228739003,0.08875739645,,0.2281075028,0.25,,0.2571428571,0.0209761163,0.2737843552
  3 ,Age: 20-40 | Gender: Male | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2395251397,,,,0.01736972705,0.4286644951
  2 ,Age: 20-40 | Gender: Male | UNLISTED PSYCHIATRIC SERVICE OR PROCEDURE (px:CPT4:90899),,,,,,,,,0.08396946565,,,,,,0.03007518797,
  1 ,Age: 20-40 | Gender: Male | UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089),,,,,,,0.1487603306,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | UNSPECIFIED BACKACHE (dxo:ICD9:7245),,0.03389830508,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,,,,,,,,,,,,0.4423076923,,
  1 ,Age: 20-40 | Gender: Male | UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690),,0.02884615385,,,,,,,,,,,,,,
  1 ,Age: 20-40 | Gender: Male | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.01360544218,,,,,,,,,,,,,,
  9 ,Age: 20-40 | Gender: Male | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.02222222222,0.06417112299,0.4441087613,,,0.3676767677,0.1552795031,0.4536741214,,,,0.4015151515,,0.426323319,0.03305785124,
  1 ,Age: 20-40 | Gender: Male | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.01111111111,
  1 ,"Age: 20-40 | Gender: Male | UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",,,,,,,,,,,,,,0.4621848739,,
  1 ,"Age: 20-40 | Gender: Male | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.5044247788,,
  3 ,Age: 20-40 | Gender: Male | VALACYCLOVIR HCL,,0.04761904762,0.4259259259,,,,,,,,,0.3495934959,,,,
  1 ,Age: 20-40 | Gender: Male | VARENICLINE TARTRATE,,,0.3619047619,,,,,,,,,,,,,
  12 ,Age: 20-40 | Gender: Male | VENLAFAXINE HCL,0.02564102564,0.04204204204,0.4042288557,,,0.4358974359,0.198011599,0.3520871143,0.1282051282,,0.2132366274,0.3461538462,,0.4126602564,0.01401869159,0.4667421669
  1 ,Age: 20-40 | Gender: Male | VILAZODONE HCL,,,,,,,,,,,0.6730769231,,,,,
  1 ,Age: 20-40 | Gender: Male | VOMITING ALONE (dxo:ICD9:78703),,,0.4,,,,,,,,,,,,,
  3 ,Age: 20-40 | Gender: Male | ZOLPIDEM TARTRATE,,,,,,,,0.5058823529,,,,,,0.4472361809,0.008823529412,
  16 ,Age: 41-64 | Gender: Female,0.03225199719,0.0634887853,0.5212089173,0.5150548355,0.207826087,0.4196903973,0.228410287,0.5023723441,0.1959708232,0.1014889285,0.3640137947,0.4637828118,0.3206006065,0.5432607158,0.0345615241,0.5105027377
  7 ,"Age: 41-64 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",0.009803921569,0.01886792453,0.4135338346,,,,,0.4758064516,,0.02702702703,,,,0.4879807692,,0.477124183
  1 ,"Age: 41-64 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,,,,,,,,,,0.5323741007
  1 ,"Age: 41-64 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900) | SERTRALINE HCL",,,,,,,,,,,,,,0.7185929648,,
  1 ,"Age: 41-64 | Gender: Female | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.696969697
  1 ,Age: 41-64 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500),,,,,,,0.1298174442,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | ESCITALOPRAM OXALATE,,,,,,,0.3410404624,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1206896552,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.09708737864,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1273584906,,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831),,0.0273155416,,,,,0.1652892562,,0.08490566038,,,0.4022988506,,0.5300621977,,0.5153374233
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,0.04310344828,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.009523809524,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL",,0.048,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ATORVASTATIN CALCIUM,,,,,,,,,,,,,,0.504587156,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8415841584,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL,,0.05657093124,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.04385964912,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.06818181818,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.01818181818,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.02,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.03448275862,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.0593220339,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.06666666667,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | Last AD: Same & No Remiss,,0.02521008403,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.008333333333,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | CITALOPRAM HYDROBROMIDE,,0.03428571429,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.009900990099,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.02941176471,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01639344262,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ESCITALOPRAM OXALATE,,0.01408450704,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.0197044335,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | FLUOXETINE HCL,,0.03333333333,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.009803921569,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,0.4193548387,,0.6842105263,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,,,,,,,,,,0.6842105263,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.4787878788,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02884615385,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.4184397163,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4545454545,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.7185185185,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6873239437,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.4482758621,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01257861635,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01435406699,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.04702970297,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | PAROXETINE HCL,,,,,,,,,,,,0.6636971047,,,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.6451612903,,,,
  3 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0,,,,,0.1769911504,,,,,0.4102564103,,,,
  2 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | SERTRALINE HCL,,0.04102564103,,,,,,,,,,,,0.7235294118,,
  1 ,Age: 41-64 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | VENLAFAXINE HCL,,0.05747126437,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260),,,,,,,0.116,,,,0.2052980132,,,0.4635416667,,
  1 ,Age: 41-64 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ESCITALOPRAM OXALATE,,,,,,,0.3178294574,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4829931973,,
  1 ,Age: 41-64 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7016574586,,
  1 ,Age: 41-64 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.08988764045,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ABSENCE OF MENSTRUATION (dxo:ICD9:6260) | SERTRALINE HCL,,,,,,,,,,,,,,0.6526548673,,
  3 ,Age: 41-64 | Gender: Female | ACETAMINOPHEN WITH CODEINE,,,0.4814814815,,,,,,,,,,,0.5028248588,,0.3965517241
  1 ,Age: 41-64 | Gender: Female | ACTINIC KERATOSIS (dxo:ICD9:7020),,,,,,,,,,,,,,0.5401234568,,
  1 ,Age: 41-64 | Gender: Female | ACTINIC KERATOSIS (dxo:ICD9:7020) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,,,,,,,,,,,,0.5454545455,,
  1 ,Age: 41-64 | Gender: Female | ACTINIC KERATOSIS (dxo:ICD9:7020) | SERTRALINE HCL,,,,,,,,,,,,,,0.7636363636,,
  2 ,Age: 41-64 | Gender: Female | ACUTE GASTRITIS WITHOUT MENTION OF HEMORRHAGE (dxo:ICD9:53500),,,0.3922261484,,,,,,,,,0.3565891473,,,,
  3 ,"Age: 41-64 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",,,0.4953271028,,,,,,0.1666666667,,,,,0.5875486381,,
  1 ,"Age: 41-64 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619) | CITALOPRAM HYDROBROMIDE",,,0.6855670103,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,0.5702479339,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619) | SERTRALINE HCL",,,,,,,,,,,,,,0.6126126126,,
  1 ,Age: 41-64 | Gender: Female | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659),,,,,,,,0.5161290323,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659) | FLUOXETINE HCL,,,,,,,,0.6458333333,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.4818181818,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ACUTE, BUT ILL-DEFINED, CEREBROVASCULAR DISEASE (dxo:ICD9:436)",,0.01666666667,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924),,,,,,,0.09,,,,,,,0.4768211921,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,,,,0.3267326733,,
  2 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.09523809524,,,,,,,0.2214285714,,
  6 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090),,0.03404255319,0.4211711712,,,,0.12,0.492248062,,,0.2547169811,,,0.5034642032,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,,,,,,0.1746031746,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | CITALOPRAM HYDROBROMIDE,,,0.6202531646,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | ESCITALOPRAM OXALATE,,,,,,,0.3333333333,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.08403361345,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | FLUOXETINE HCL,,,,,,,,0.7098445596,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1194029851,0.2336448598,,,,,,0.2820512821,,
  4 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2148760331,,,,0.07834101382,0.1570247934,,,,,,0.2206896552,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.09039548023,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | SERTRALINE HCL,,,,,,,,,,,,,,0.6735751295,,
  7 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,0.02010968921,0.4384384384,,,,0.1283987915,0.4384615385,,,0.2545454545,,,0.4563591022,,0.5
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.01716738197,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0.04,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.05785123967,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07627118644,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL,,0.04831460674,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.02941176471,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.01212121212,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,0.1415929204,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1388888889,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.04032258065,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05673758865,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | Last AD: Same & No Remiss,,0.02759526938,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02197802198,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02941176471,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE,,,0.6242774566,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.392,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,0.2689655172,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2941176471,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.4480874317,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.009803921569,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE,,0.01666666667,,,,,0.3177570093,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.2103658537,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1271186441,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1292517007,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3858267717,,,,0.1693548387,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.01595744681,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1333333333,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1052631579,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2342342342,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.16,,
  2 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL,,0.01801801802,,,,,,0.6032608696,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.3892405063,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.2689393939,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.277486911,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.4,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.02816901408,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.05925925926,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07179487179,,,,,,,,,
  6 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2546689304,,,,0.06257242178,0.2229166667,,,0.1337209302,,,0.2466124661,,0.2302631579
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.2915129151,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.3023255814,,
  9 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.05,0.1962095875,,,0.1714285714,0.05764611689,0.2012779553,,,0.106557377,0.1755725191,,0.2023608769,,0.2555555556
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.04511278195,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.4430769231,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.05633802817,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,0.2233009709,,,0.3716381418,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | Last AD: Diff & No Remiss | SERTRALINE HCL,,0,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3875968992,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6492537313,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01704545455,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.008928571429,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,0.05789473684,,,,,,,0.2170542636,,
  4 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2033898305,,,,0.05627705628,0.2215568862,,,,,,0.2305389222,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.4485981308,,
  5 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02518518519,0.2613240418,,,,0.09536784741,0.2331606218,,,,,,0.286908078,,
  1 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,,,,0.568,,
  4 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1908396947,,,,0.06913580247,0.2244897959,,,,,,0.1964285714,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.05479452055,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.3786407767,,
  2 ,Age: 41-64 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | SERTRALINE HCL,,0.03883495146,,,,,,,,,,,,0.6318181818,,
  4 ,Age: 41-64 | Gender: Female | ALBUTEROL,,0.01212121212,0.5055096419,,,,,,,,,0.4051094891,,,,0.5267857143
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL | BUPROPION HCL,,0.04597701149,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL | BUPROPION HCL | Last AD: Same & No Remiss,,0.02941176471,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL | CITALOPRAM HYDROBROMIDE,,,0.6861111111,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.6981132075,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.48,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.6888888889,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.572327044,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL | PAROXETINE HCL,,,,,,,,,,,,0.6484018265,,,,
  3 ,Age: 41-64 | Gender: Female | ALBUTEROL SULFATE,,,,,,,0.1521126761,,,,,0.4158415842,,,,0.4216281896
  1 ,"Age: 41-64 | Gender: Female | ALBUTEROL SULFATE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,,,,,,,,,,0.55
  1 ,"Age: 41-64 | Gender: Female | ALBUTEROL SULFATE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7586206897
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL SULFATE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4621848739
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL SULFATE | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7299270073
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL SULFATE | PAROXETINE HCL,,,,,,,,,,,,0.6433566434,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL SULFATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1142857143,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL SULFATE | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.401459854
  1 ,Age: 41-64 | Gender: Female | ALBUTEROL SULFATE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6915708812
  1 ,"Age: 41-64 | Gender: Female | ALLERGY, UNSPECIFIED NOT ELSEWHERE CLASSIFIED (dxo:ICD9:9953)",,,0.4725274725,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALLOPURINOL,,,,,,,,0.55,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALLOPURINOL | FLUOXETINE HCL,,,,,,,,0.7368421053,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | ALPRAZOLAM,,0.01837672282,0.4570093458,,,,0.15625,0.4597902098,,,0.3660714286,0.42,,0.4889415482,0.01520912548,0.4884210526
  4 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.03333333333,,,,,0.1436314363,0.4420289855,,,,,,0.4830508475,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,0.1437125749,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1727272727,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,,,,,,0.4326923077,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1182795699,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ATORVASTATIN CALCIUM,,,,,,,,,,,,,,0.5474860335,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7425149701,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | BUPROPION HCL,,0.072,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | BUPROPION HCL | Last AD: Same & No Remiss,,0.01597444089,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.008695652174,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | BUPROPION HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.05384615385,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,,,,,,,,0.4537815126,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | CITALOPRAM HYDROBROMIDE,,,0.6816479401,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,0.6616541353,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.4430379747,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.6465116279,,,,,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,0.4339622642,,,,0.1590909091,,,,,,,0.5925925926,,0.6083333333
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.6692913386,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7314814815
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ESCITALOPRAM OXALATE,,,,,,,0.3782051282,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,,,,,,,,0.5,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1542288557,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1578947368,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3517786561,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.5105263158,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ESTRADIOL,,,,,,,,,,,,,,0.504,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | FLUOXETINE HCL,,,,,,,,0.6625,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3846153846,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7177419355,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,,,,,,0.1666666667,,,,,,,0.5039370079,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,,,0.546875,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL,,,,,,,,,,,,,,0.6356589147,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.1574074074,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | IBUPROFEN,,,,,,,,,,,,,,0.487394958,,
  2 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.4150943396,,,,,,,,,,,0.4978354978,,
  1 ,"Age: 41-64 | Gender: Female | ALPRAZOLAM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.7272727273,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3468208092,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3895652174,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7060702875,,
  2 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | LEVOTHYROXINE SODIUM,,,0.5142857143,,,,,,,,,,,0.4508474576,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7731092437,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7710843373,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,,,,,,,,0.4802259887,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01818181818,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,,,,,,,,,,,,0.5813953488,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | PALPITATIONS (dxo:ICD9:7851),,,,,,,,,,,,,,0.3980582524,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,,,,,,,,,,,,,0.5700934579,,
  3 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.01680672269,,,,,0.1261682243,0.4571428571,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | SERTRALINE HCL,,,,,,,,,,,,,,0.6922530206,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7768595041,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | SIMVASTATIN,,,,,,,,,,,,,,0.509202454,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.4117647059,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.4519230769,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.4513274336,,
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6782945736
  1 ,Age: 41-64 | Gender: Female | ALPRAZOLAM | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,0.4285714286,,
  16 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL,0.04929732587,0.03116011505,0.384057971,0.4807692308,0.2387096774,0.3367768595,0.1441969519,0.3871359223,0.1432664756,0.0808678501,0.3986167693,0.327184466,0.2419354839,0.4090168387,0.01967213115,0.428769018
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | AMLODIPINE BESYLATE,0.02,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss",,0.03723404255,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.02923976608,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss",,,,,,,0.1138211382,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ARIPIPRAZOLE | DULOXETINE HCL,,,,,,0.1652892562,,,,,0.192,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ATORVASTATIN CALCIUM,,,,,,,,,,,0.4016393443,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.6509433962,,
  9 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL,0.05866050808,0.05897370437,0.3307086614,,,0.3015384615,0.1822916667,0.3802816901,,,0.3010957936,,,0.4,,0.4497991968
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,0.07602339181,0.03913043478,0.5093632959,,,,,,,,0.4071428571,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.04761904762,,,,,,,,,0.4871794872,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,,,,,,,,,0.4590163934,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4343434343,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,,,,,,,,,0.5829787234,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+,,,,,,,,,,,0.2796610169,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2307692308,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,,,,,,,,,0.3203883495,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.04901960784,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",0.0347826087,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DESVENLAFAXINE SUCCINATE,,,,,,,,,,,0.3428571429,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DOXEPIN HCL,,,,,,,,,,,0.3523809524,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DOXEPIN HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2132352941,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL,0.04545454545,0.02366863905,,,,0.4402515723,,,,,0.3111332008,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.02919708029,,,,,,,,,0.358974359,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.3722627737,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3594771242,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.4742857143,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2919708029,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2533936652,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3304347826,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE,0.06341463415,0.03921568627,,,,,0.3493975904,,,,0.2777232581,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.05031446541,,,,,0.4260869565,,,,0.2368421053,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.44,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.218487395,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,,,,,0.3298429319,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3594470046,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,,,,,0.5555555556,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2289156627,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL,0.08212560386,0.05338078292,,,,,,0.4896142433,,,0.3894736842,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.03149606299,,,,,,,,,0.3852459016,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6435643564,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.5558912387,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5503355705,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5533980583,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6435643564,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2585034014,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2713567839,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2248062016,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | HEADACHE (dxo:ICD9:7840),0.04421768707,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.03125,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | LAMOTRIGINE,,,,,,,,,,,0.08043875686,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4711538462,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+,,,,,,,,,,,0.1228070175,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.12,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.09602649007,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss,0.03510895884,0.05657492355,,,,,,,,,0.1260162602,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03910614525,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.06098964327,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.04761904762,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5964912281,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,0.03370786517,,,,,,,,,,0.1260387812,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4077669903,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03289473684,,,,,,,,,0.4635761589,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.07,,,,,,,,,0.1428571429,,,,0.02419354839,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.01851851852,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & Remiss,,0.4059405941,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss,0.01785714286,0.02352941176,,,,,,,,,0.1677943166,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,0.01818181818,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.1876923077,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.3458646617,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4715025907,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.09433962264,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4018691589,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.3761904762,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4730538922,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.09782608696,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.3943661972,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5435745938,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7434782609,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+,,,,,,,,,,,0.5409836066,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.4867256637,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.5799086758,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5324675325,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.6623931624,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.5153846154,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3481012658,,,,,,,,,0.541705717,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.5373134328,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.5215517241,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4746136865,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MIRTAZAPINE,,,,,,,,,,,0.2446351931,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.3159851301,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.214953271,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.2956989247,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.303030303,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2666666667,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5897435897,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.3021947102,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.40234375,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.261682243,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.4100719424,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.296875,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3521126761,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.277924828,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2680851064,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.2647058824,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | PAROXETINE HCL,0.04464285714,0.03546099291,,,,,,,,,0.341356674,0.5512820513,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1333333333,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.141509434,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3876404494,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.2406015038,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.09482758621,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ROPINIROLE HCL,,,,,,,,,,,0.3821656051,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2983425414,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | SERTRALINE HCL,0.04608294931,0.04270462633,,,,,,,,,0.3569165787,,,0.5384615385,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | TRAZODONE HCL,0.01739130435,0.05486284289,,,,,,,,,0.2376108503,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2671755725,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | VENLAFAXINE HCL,0.05333333333,0.02873563218,,,,,,,,,0.3249427918,,,,,0.5480427046
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CARISOPRODOL,0.09950248756,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CARISOPRODOL | Last AD: Same & No Remiss,0.01834862385,,,,,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE,0.05188679245,0.01990049751,0.5835495589,,,0.3177570093,0.200913242,0.3771428571,,,0.448836684,,,0.4,,0.5403225806
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.05755395683,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",0.03243243243,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss",0.02542372881,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,0.5671641791,,,0.4583333333,,,,,0.41191067,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.4920634921,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,0.03821656051,,0.544,,,,0.3308270677,,,,0.3370165746,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,,,,,,,0.5172413793,,,0.3358208955,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840),0.07053941909,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.06206896552,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & Remiss,0.009433962264,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.4417177914,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,,,,,,,,,0.08771929825,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,0.02783300199,,0.6813380282,,,,,,,,0.5309661437,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.7002398082,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.5882352941,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,0,,0.5918727915,,,,,,,,0.4933726068,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3398058252,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3493150685,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,0.03361344538,,0.664516129,,,,,,,,0.5096952909,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,0.6733870968,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6239316239,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,0.625,,,,,,,,0.4047619048,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,0.009090909091,,0.4188034188,,,,,,,,0.3668528864,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.5238095238,,,,,,,,0.4166666667,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4642857143,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.46875,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.6637168142,,,,,,,,0.6286149163,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.637254902,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.527607362,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6178861789,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,,,,,,,,,0.380952381,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,,,,,,,,,0.3831775701,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2231404959,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5899843505,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5675675676,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+,,,0.7121212121,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,,,,,,,,,,0.3958333333,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2666666667,,,,,,,,0.196969697,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2844827586,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,,,,,,,,,0.4258373206,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,,,,,,,,,,0.3473684211,,,0.3706896552,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,0.04761904762,,0.5071633238,,,,,,,,0.3672768879,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,0.04587155963,,0.61,,,,,,,,0.4070512821,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CLONAZEPAM,0.03305785124,,,,,,,,,,0.3048780488,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CLONAZEPAM | Last AD: Diff & No Remiss,,,,,,,,,,,0.3586956522,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | CLONAZEPAM | Last AD: Same & No Remiss,0.01785714286,,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.07947805457,,,,,,,,,,0.3379310345,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Diff & No Remiss",0.06,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",0.02525252525,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",0.04651162791,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss",0.05590062112,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840)",0.08846153846,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss",0.0101010101,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,,,,,,,,,,0.3269230769,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.8461538462
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5873015873
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | PAROXETINE HCL",0.02941176471,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | SERTRALINE HCL",0.02127659574,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.8106508876
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | SERTRALINE HCL",0.05607476636,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",0.01550387597,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",0.008474576271,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",0.03278688525,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",0.07092198582,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6830985915
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DESVENLAFAXINE SUCCINATE,0.03816793893,,,0.6506849315,,,,,,,0.3961456103,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.2792792793,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED (dxo:ICD9:25001)",0.1140939597,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DOXEPIN HCL,0.07407407407,,,,,,,,,,0.3562005277,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DOXEPIN HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5693430657,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DOXEPIN HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2843137255,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3154362416,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.2083333333,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DOXEPIN HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3119266055,,,,,
  7 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL,0.06201550388,0.04237288136,0.380952381,,,0.5195389373,0.2228571429,,,,0.4119857595,,,0.384,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,0.05555555556,,,,,,0.3566878981,,,,0.3404761905,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,,,,,0.45625,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | FLUOXETINE HCL,0.03,,,,,0.4895104895,,0.6387096774,,,0.3989637306,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.4782608696,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & No Remiss,,,,,,0.6371681416,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5042735043,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | HEADACHE (dxo:ICD9:7840),0.06050955414,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.04060913706,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,0.35,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | LAMOTRIGINE,,,,,,,,,,,0.08,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1008403361,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,0.04924242424,,,,,0.5674157303,,,,,0.4703668862,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,0.04273504274,,,,,0.5294117647,,,,,0.4331103679,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.71,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.546875,,,,,0.362962963,,,,0.016,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5669291339,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & Remiss,0.075,,,,,0.6652078775,,,,,0.5427509294,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4310344828,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6685714286,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss,0.01746724891,,,,,0.3155893536,,,,,0.3386727689,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3948717949,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.43125,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.5961538462,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4228187919,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4476190476,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5827538248,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5348837209,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.6289308176,,,,,0.4622222222,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.3703703704,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.35,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.3619047619,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2648083624,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2621359223,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | PAROXETINE HCL,,,,,,,,,,,0.4645669291,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.2479338843,,,,,0.1565217391,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4215246637,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.3653846154,,,,,0.2189781022,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.4460227273,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | SERTRALINE HCL,0.04901960784,,,,,0.5,,,,,0.4057142857,,,0.5652173913,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | TRAZODONE HCL,0.06870229008,,,,,0.4606741573,,,,,0.3545210385,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6061946903,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | VENLAFAXINE HCL,0.08823529412,,,,,,,,,,0.42,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DYSTHYMIC DISORDER (dxo:ICD9:3004),0.05673758865,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | DYSTHYMIC DISORDER (dxo:ICD9:3004) | Last AD: Same & No Remiss,0.01360544218,,,,,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE,0.05094736842,0.02597402597,0.4725274725,,,0.3966942149,0.3553398058,0.3620689655,,,0.3191374663,,,0.3757961783,,0.4692307692
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL,0.09523809524,,,,,,,0.5588235294,,,0.3273542601,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | HEADACHE (dxo:ICD9:7840),0.05211726384,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.03827751196,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1893491124,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.1891891892,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,,,,,0.1,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0.02512562814,0.04,,,,,0.3278008299,,,,0.3060156931,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3283972125,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3001808318,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.4237288136,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,0.01851851852,,,,,,,,,,0.2788906009,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.3866666667,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,0.1261261261,,,,,,0.7173144876,,,,0.513368984,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,0.7448979592,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,0.003623188406,,,,,,0.2162162162,,,,0.2910798122,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.2418300654,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.2388059701,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2913385827,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3773584906,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3686868687,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,,,,,0.5457142857,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.547826087,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | PAROXETINE HCL,,,,,,,,,,,0.4195804196,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1985294118,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1711711712,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2358490566,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,,,,,0.364640884,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL,0.04516129032,,,,,,,,,,0.3098039216,,,0.5454545455,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,0.03361344538,,,,,,0.358974359,,,,0.2814070352,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,0.06451612903,,,,,,,,,,0.3197026022,,,,,
  9 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL,0.05428226779,0.04938271605,0.4335664336,,,0.356,0.1739130435,0.5909892262,,,0.448603352,,,0.4848484848,,0.5238095238
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.5636363636,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,0.6752136752,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840),0.07333333333,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.07284768212,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.3789473684,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.5576923077,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1111111111,,,0.1085271318,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,0.03515625,0.04504504505,,,,,,0.63,,,0.5226950355,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6360026473,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.574002574,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.6380952381,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6106870229,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,0.02654867257,,,,,,,,,,0.4651773982,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4660194175,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4896551724,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,0.03539823009,,,,,,,0.6847662142,,,0.4565701559,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6893203883,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.6219512195,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+",,,,,,,,0.5849056604,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,,,,0.4705882353,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+,,,,,,,,0.5950413223,,,0.4537815126,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,0.01650165017,,,,,,,0.4154411765,,,0.3762711864,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.4803149606,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.4695652174,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.418699187,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5371900826,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.6293706294,,,0.5906666667,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6732673267,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5813953488,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5838150289,,,,,
  3 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2571428571,,,,,,,0.6894736842,,,0.5631578947,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3700787402,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,0.64,,,0.3885350318,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.635883905,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6015037594,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2307692308,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Num Previous Remissions: 2+,,,,,,,,0.5868263473,,,0.4897959184,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | PAROXETINE HCL,0.08928571429,,,,,,,,,,0.3850574713,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3576642336,,,0.1794871795,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.3194444444,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2621359223,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5120481928,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | SERTRALINE HCL,0.07453416149,,,,,,,,,,0.3645833333,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | TRAZODONE HCL,0.07086614173,,,,,,,0.4534606205,,,0.3936052922,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | VENLAFAXINE HCL,0.07207207207,,,,,,,0.59375,,,0.4237288136,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | GABAPENTIN,,,,,,,,,,,0.3757961783,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | GABAPENTIN | Last AD: Diff & No Remiss,,,,,,0.3333333333,,,,,0.225,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),0.04032258065,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,0.02040816327,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,0.3618090452,0.4285714286,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,,,,,0.2755905512,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,,,,,,,,,,0.6,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840),0.05205047319,,,,,,,,,0.0752688172,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,,,,,,,,,,0.0518134715,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | SERTRALINE HCL,0.03401360544,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | TRAZODONE HCL,0.08805031447,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | VENLAFAXINE HCL,0.03603603604,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & Remiss | SERTRALINE HCL,0.06796116505,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,0.0101999184,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.007125890736,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | Num Previous Episodes: 2+,0.01298701299,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.004854368932,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.03821656051,,,,,,,,,0.09375,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.01047120419,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | PAROXETINE HCL,0.05202312139,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.004739336493,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | SERTRALINE HCL,0.04,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | TRAZODONE HCL,0.09871244635,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | VENLAFAXINE HCL,0.0396039604,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HYDROCODONE/ACETAMINOPHEN,0.04385964912,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss,0.01904761905,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HYOSCYAMINE SULFATE,0.009259259259,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | HYOSCYAMINE SULFATE | Last AD: Same & No Remiss,0.008403361345,,,,,,,,,,,,,,,
  5 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.1923076923,,,,0.1071428571,,,,0.1494252874,,,0.2268907563,,0.2295081967
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.173553719,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,,,,,,,,,,0.2903225806,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1395348837,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.3689320388,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.4243902439,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",0.03759398496,,,,,,,,,,,,,,0.01948051948,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,0.4018691589,0.006389776358,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.004545454545,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE,,,,,,,,,,,0.09546377793,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3474576271,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.1081081081,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.06926406926,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | ROPINIROLE HCL,,,,,,,,,,,0.1171171171,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.07920792079,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.1212121212,,,,,
  12 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss,,0.02243211334,0.4050847458,,,0.3380782918,0.1235632184,0.4319419238,0.1265822785,0.04702194357,0.2917025553,0.3028391167,,0.4178240741,0.007174887892,0.4091778203
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,0.03225806452,,,,,,,,,,0.1625,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5662650602,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6155747837,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5779816514,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0.007936507937,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5217391304
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.6976744186,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6830065359,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6164383562,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.006825938567,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7403846154
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2549019608,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.3994845361,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,0.008333333333,,,,,,,,,,0.4957507082,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,0.05691056911,,,,,,,,,,0.1875,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4667931689,,,,,0.5603271984
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,0.03761755486,,,,,,,,,,0.4736842105,,,,,
  4 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,0.02550091075,0.01818181818,,,,,,,,,0.5498923187,,,0.6485148515,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4225352113,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SIMVASTATIN,,,,,,,,,,,0.3455882353,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.2962962963,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | TOPIRAMATE,,,,,,,,,,,0.2454545455,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,0.05765407555,,,,,,,,,,0.2006125574,,,,0.01187335092,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4601769912,,,,,0.6078431373
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3387978142,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,0.05821917808,,,,,,,,,,0.5271565495,,,,,0.6607744108
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.5114503817,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6390977444,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6952380952,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6408450704,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7230046948,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7361702128,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7886178862
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.3865546218,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4600938967,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.3819444444,,,,,0.6744186047
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.5247524752,,,0.6462585034,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4705882353,,,,,0.68
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | PAROXETINE HCL,0.06730769231,,,,,,,,,,0.4769230769,0.7026239067,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,0.06680584551,,,,,,,,,,0.5106837607,,,0.7342465753,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,0.05660377358,,,,,,,,,,0.4447674419,,,,,0.7137096774
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.01386229609,,,,,,,,,,0.204379562,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.01343570058,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | MORPHINE SULFATE,0.02684563758,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.4171779141,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.4195402299,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,0.01210428305,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.009132420091,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.009433962264,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.4125874126,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.008955223881,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4700460829,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5284552846,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2340425532,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4222222222,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4331210191,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.008221993834,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.006345177665,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | OXYCODONE HCL,0.01538461538,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | PAROXETINE HCL,0.05095541401,,,,,,,,,,0.3746397695,0.3867403315,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3411764706,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",0.04918032787,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572),0.02912621359,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.005331302361,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,0.03076923077,,,,,,,,,,0.4470134875,,,0.4419354839,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5094339623,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,0.01860465116,,,,,,,,,,0.2662721893,,,,0.01477832512,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4646840149,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.04347826087,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,0.01851851852,,,,,,,,,,0.4015151515,,,,,0.3615819209
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6072368421,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.7339449541,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7211055276,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7055214724,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.5666666667,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.5766423358,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.7226890756,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7235772358,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.5268292683,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.7209302326,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,0.612716763,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6253101737,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5765199161,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.683982684,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5704697987,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5477099237,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5476190476,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5847797063,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.6759776536,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.6186252772,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6180257511,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2779487179,,,,,,,,,,0.5629432624,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.562962963,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.4649122807,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4776632302,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.5472972973,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.4571428571,,,,,
  3 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",0.2596153846,,,,,,,,,,0.6666666667,,,0.7016129032,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.468627451,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.5582524272,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5977653631
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.0706401766,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.04807692308,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE,0.07514450867,,,,,,,,0.2975206612,,0.3322411533,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2180232558,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2405857741,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.3307086614,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2336182336,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.2698412698,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | MORPHINE SULFATE,0.0974025974,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL,0.04458598726,,,,,,,,,0.1391304348,0.3340926348,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2780487805,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.3571428571,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2512077295,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3833333333,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.563002681,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.6957671958,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6870546318,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6291390728,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2865400495,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.375,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3198380567,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.375,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3631961259,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2819321876,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2644230769,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.2948207171,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5593667546,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Remissions: 2+ | SERTRALINE HCL,0.06306306306,,,,,,,,,,0.5172413793,,,0.6387434555,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4603174603,,,,,0.6879432624
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2568807339,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.4397163121,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | OMEPRAZOLE,,,,,,,,,,,0.3677419355,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.03445229682,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.02114803625,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.03539823009,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | OXYCODONE HCL,0.08260869565,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PALPITATIONS (dxo:ICD9:7851),,,,,,,,,,,0.219047619,,,,,
  9 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PAROXETINE HCL,0.04978488015,0.02777777778,0.4571428571,,,0.3153846154,0.1719745223,0.297029703,,,0.444185142,0.5725868726,,0.4086956522,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.2123893805,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PAROXETINE HCL | SERTRALINE HCL,0.07920792079,,,,,,,,,,0.3642384106,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3251231527,0.4691943128,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3846153846,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",0.09574468085,,,,,,,,,,0.09049773756,,,,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1595092025,,,0.344,,
  2 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.2176470588,,,,,0.253164557
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,0.0594795539,,,,,,,,,,0.4673807205,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5526315789,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.412244898,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.4485294118,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3525773196,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4068965517,,,,,
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0.009090909091,,,,,,,,,,0.1566820276,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.3170731707,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1153846154,,,,,
  1 ,"Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.180952381,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.3700787402,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | RISPERIDONE,,,,,,,,,,,0.1323943662,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1494252874,,,,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ROPINIROLE HCL,0.06150341686,,,,,,,,,,0.4478632479,,0.4363636364,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.4480874317,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3520599251,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4790419162,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.02019230769,,,,,,,,,,,,,,,
  10 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL,0.04759071981,0.02371541502,0.4109589041,,,0.3319672131,0.1943319838,0.4113924051,,,0.494288225,0.3663366337,,0.6183724995,,0.4561403509
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL | TRAZODONE HCL,0.05673758865,,,,,,,,,,0.3873659118,,,0.5296912114,,
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL | VENLAFAXINE HCL,0.04347826087,,,,,,,,,,0.3888888889,,,0.4745762712,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | SIMVASTATIN,,,,,,,,,,,0.3623853211,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.390625,,,,,
  1 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | TOPIRAMATE,,,,,,,,,,,0.3150684932,,,,,
  9 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | TRAZODONE HCL,0.08163265306,0.03636363636,,,,0.2614840989,0.1875,0.3673469388,,,0.3110101252,,,0.3613445378,0.009615384615,0.3367875648
  3 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,0.09565217391,,,,,,,,,,0.3581818182,,,,,0.5240793201
  2 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.0310880829,,,,,0.4404145078,,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | AMITRIPTYLINE HCL | VENLAFAXINE HCL,0.06297918949,0.04242424242,0.4579439252,,,,0.2195121951,0.396039604,,,0.4259223858,,,0.4392523364,,0.6299039781
  3 ,Age: 41-64 | Gender: Female | AMLODIPINE BESYLATE,0.003875968992,,,,,,0.125,,,,,,,,0.004926108374,
  1 ,Age: 41-64 | Gender: Female | AMLODIPINE BESYLATE | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AMLODIPINE BESYLATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1037735849,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | AMLODIPINE BESYLATE/BENAZEPRIL,,,,,,,0.08675799087,,,,,,,,,0.4596774194
  1 ,Age: 41-64 | Gender: Female | ANOREXIA (dxo:ICD9:7830),,,,,,,,,0.1333333333,,,,,,,
  11 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",0,0.0242465443,0.5674603175,,,,0.1420926899,0.4719101124,,0.03015075377,,0.3976646124,0.2571428571,0.6144927536,0.009708737864,0.5714285714
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL",,0.0584725537,,,,,0.1843137255,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE",,0.03592814371,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss",,0.06069364162,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.05900621118,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.03418803419,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss",,0.08556149733,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.08139534884,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CLONAZEPAM",,0.09659090909,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | CLONAZEPAM | Last AD: Same & No Remiss",,0.03870967742,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.06533575318,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.0114416476,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss",,0.06474820144,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.07086614173,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE",,0.05882352941,,,,,0.347826087,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.03278688525,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03248259861,,,,,0.3948497854,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.01492537313,,,,,0.2883895131,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss",,0.0796460177,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.07476635514,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | FLUOXETINE HCL",,0.05617977528,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss",,0.05327868852,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04910714286,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss",,0.07086614173,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.0756302521,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | GABAPENTIN",,0.08,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,0.06626506024,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss",,0.01324503311,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss",,,,,,,0.1272189349,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,0.06451612903,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,0.06451612903,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.05263157895,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.04611650485,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,0.04195804196,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL",,0.05555555556,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.05033557047,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL",,0.04618937644,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,0.04402515723,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.09615384615,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & Remiss | SERTRALINE HCL",,0.08771929825,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0.02132998745,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02144772118,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,0.05627705628,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.02189781022,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01526717557,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | LORAZEPAM",,0.04329004329,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | LORAZEPAM | Last AD: Same & No Remiss",,0.02597402597,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.06428571429,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.08965517241,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.05487804878,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | SERTRALINE HCL",,0.0523255814,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | TRAZODONE HCL",,0.08771929825,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | VALACYCLOVIR HCL",,0.03787878788,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUSPIRONE HCL",,,,,,,0.1661538462,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUSPIRONE HCL | ESCITALOPRAM OXALATE",,,,,,,0.5087719298,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CETIRIZINE HCL",,,,,,,0.1408450704,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,0.1111111111,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.02409638554,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01169590643,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE",,0.0412371134,0.6052631579,,,,0.3444730077,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3301886792,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss",,0.015625,,,,,0.2,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss",,0.03418803419,,,,,0.2916666667,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM",,0.03174603175,,,,,0.1704834606,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM | ESCITALOPRAM OXALATE",,,,,,,0.4068965517,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1103448276,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.2147651007,,,,,,,,,
  8 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.02408111534,0.5652173913,,,,0.1436464088,0.5559006211,,,,0.4225352113,,0.625,0.008333333333,0.56875
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,0.3492647059,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.03846153846,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1762114537,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.2054794521,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.3426966292,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.6590163934,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.4,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.6935483871,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,0.2018348624,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02205882353,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01923076923,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.02843601896,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.6847457627,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1639344262,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.6666666667,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",,,,,,,0.1369047619,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DULOXETINE HCL",,0.03389830508,,,,,0.2450331126,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DULOXETINE HCL | Last AD: Diff & No Remiss",,,,,,,0.1568627451,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,0.03790087464,,,,,0.3655259823,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | GABAPENTIN",,,,,,,0.4734299517,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & No Remiss",,,,,,,0.1842105263,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1985294118,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1690140845,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.185483871,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.2019230769,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.02340425532,,,,,,,,,,0.4159292035,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.3049327354,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.3722222222,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1376146789,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,0.1512915129,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,0.1956181534,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1494252874,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.1142857143,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OMEPRAZOLE",,,,,,,0.1,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1282051282,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1343490305,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SIMVASTATIN",,,,,,,0.1238095238,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss",,,,,,,0.6767200754,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.6920415225,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | MORBID OBESITY (dxo:ICD9:27801)",,,,,,,0.3883495146,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,0.3855799373,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.4010989011,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | OMEPRAZOLE",,,,,,,0.3756906077,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.3577586207,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.3325867861,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | SIMVASTATIN",,,,,,,0.3928571429,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | TRAZODONE HCL",,,,,,,0.362962963,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESOMEPRAZOLE MAGNESIUM",,,,,,,0.1058201058,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESTROGEN,CON/M-PROGEST ACET",,,,,,,0.16,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL",,0.05555555556,,,,,0.2417218543,0.641723356,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL | Last AD: Diff & No Remiss",,0.01754385965,,,,,0.1503267974,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.2810810811,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.7216981132,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GABAPENTIN",,0.04310344828,,,,,0.1742738589,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,0.0243902439,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GUAIFENESIN/P-EPHED HCL",,,,,,,0.1034482759,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,0.1426448737,,,,,0.4459295261,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.3053435115,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL",,,,,,,,,,,,0.6365853659,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.07055214724,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07352941176,,,,,0.216,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.0495049505,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,0.02564102564,,,,,,,,,,,,,0.007246376812,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | PAROXETINE HCL",,0.01342281879,,,,,0.1475409836,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.01550387597,,,,,0.1358974359,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.1621621622,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,0.007299270073,,,,,0.1700680272,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & Remiss | SERTRALINE HCL",,0.01342281879,,,,,0.2405063291,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.375,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.2782608696,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.3370646766,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.3181818182,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.6666666667,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.6959459459,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7905405405,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | LORAZEPAM",,0.02927927928,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",,,,,,,0.1619047619,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | MORBID OBESITY (dxo:ICD9:27801)",,,,,,,0.1516587678,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | MYOPIA (dxo:ICD9:3671)",,0.0564516129,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02066590126,,,,,0.1476709613,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1333333333,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1296296296,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01498127341,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.1547169811,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OMEPRAZOLE",,,,,,,0.1393939394,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OMEPRAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1730769231,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01597444089,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",,,,,,,,,,,,,,0.6363636364,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OXYCODONE HCL",,,,,,,0.2242990654,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1231964484,,,,,0.393129771,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PALPITATIONS (dxo:ICD9:7851) | PAROXETINE HCL",,,,,,,,,,,,0.48,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PALPITATIONS (dxo:ICD9:7851) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1152542373,,,,,0.2857142857,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",,0.0297029703,,,,,,,,,,0.393442623,,,,
  3 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL",,0.02551020408,,,,,0.2692307692,,,,,0.6235955056,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.6144414169,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,0.1142857143,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",,,,,,,0.07476635514,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.08465608466,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.02822580645,,,,,0.08306709265,,,,,0.1634615385,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.06626506024,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | RISEDRONATE SODIUM",,,,,,,0.1359223301,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,,,,,,,,,,,0.3518518519,,,0,
  3 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.01515151515,,,,,0.1340979268,,,,,0.3475285171,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,0.1292517007,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,0.07299270073,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SERTRALINE HCL",,0.02996254682,,,,,0.2299107143,,,,,0.5135135135,,0.797029703,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SIMVASTATIN",,,,,,,0.149321267,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",,,,,,,0.1209677419,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,0.182320442,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | VALACYCLOVIR HCL",,0.01360544218,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | VALSARTAN",,,,,,,0.1071428571,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | VENLAFAXINE HCL",,0.03139013453,,,,,0.2546125461,,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE,,,0.2091254753,0.2095435685,,0.2058823529,0.1225490196,0.2307692308,,,0.1541353383,,,0.15625,0.05833333333,0.2390891841
  3 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL,,,,,,0.1703296703,,,,,0.1326530612,,,,,0.2151898734
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,,,,,,,,,,0.1737089202,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,,,,,,,,,0.1056338028,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | DESVENLAFAXINE SUCCINATE,,,,,,,,,,,0.16,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | DULOXETINE HCL,,,,,,0.2261904762,,,,,0.1678657074,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2277227723,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1506024096,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | ESCITALOPRAM OXALATE,,,,,,,0.1366120219,,,,0.1370558376,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.1744186047,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | FLUOXETINE HCL,,,,,,,,0.1971830986,,,0.1678657074,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.08444444444,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | LAMOTRIGINE,,,,,,,,,,,0.05844155844,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.05,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | SERTRALINE HCL,,,,,,,,,,,0.1672727273,,,0.2906976744,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1602564103,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | TRAZODONE HCL,,,,,,,,,,,0.1043956044,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1666666667,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | BUPROPION HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1894736842,,,,,0.2325581395
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | CITALOPRAM HYDROBROMIDE,,,0.3097643098,,,,,,,,0.1729559748,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.1710526316,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,0.255033557,,,,,,,,0.1832061069,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DESVENLAFAXINE SUCCINATE,,,,0.1737451737,,,,,,,0.2303921569,,,,,
  1 ,"Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DESVENLAFAXINE SUCCINATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.08870967742,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.1333333333,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL,,,,,,0.2090909091,,,,,0.1751085384,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.1834862385,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.09433962264,,,,,0.06837606838,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,0.1584158416,,,,,0.07272727273,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.1714285714,,,,,0.1584158416,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.1699716714,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5396825397,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.1588785047,,,,,0.119266055,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.1751412429,,,,,0.1742957746,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | ESCITALOPRAM OXALATE,,,,,,,0.1563342318,,,,0.1289640592,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1603053435,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.1379310345,,,,0.1271477663,,,,,
  3 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | FLUOXETINE HCL,,,,,,0.2545454545,,0.2666666667,,,0.1476190476,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.2173913043,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.2131147541,,,0.1380208333,,,,,
  3 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | LAMOTRIGINE,,,,0.1382113821,,0.1151515152,,,,,0.08,,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.04724409449,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.09482758621,,,,,0.1074380165
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.0737704918
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.1312056738,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.2388888889
  1 ,"Age: 41-64 | Gender: Female | ARIPIPRAZOLE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4711538462
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | PAROXETINE HCL,,,,,,,,,,,0.158974359,0.2402597403,,,,
  1 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1691176471,,,,,
  1 ,"Age: 41-64 | Gender: Female | ARIPIPRAZOLE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.1044776119,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ARIPIPRAZOLE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1897810219
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.1901408451,,,0.2114014252,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1651090343,,,0.1696428571,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | TRAZODONE HCL,,,,,,0.237704918,,,,,0.1601830664,,,,,
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1711229947,,,,,0.2016574586
  2 ,Age: 41-64 | Gender: Female | ARIPIPRAZOLE | VENLAFAXINE HCL,,,,,,,,,,,0.1726755218,,,,,0.2258064516
  1 ,Age: 41-64 | Gender: Female | ATENOLOL,,0.01333333333,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATENOLOL | BUPROPION HCL,,0.05555555556,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400),,,,,,,,,,,,,,,0.01851851852,
  7 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM,,,0.5406943654,,,,0.1303370787,0.5519455988,,,0.2580645161,0.4861111111,,0.5863049661,,0.4796747967
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL,,,,,,,,,,,0.3432835821,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.53,,,,,
  2 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | FLUOXETINE HCL,,,,,,,,0.6377952756,,,0.6226415094,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.702970297,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.6339285714,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.2937062937,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6478873239,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.8344827586,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7304347826,,
  2 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | BUPROPION HCL | SERTRALINE HCL,,,,,,,,,,,0.8037383178,,,0.6559139785,,
  3 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE,,,0.7420168067,,,,,,,,0.4503311258,,,0.7058823529,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,0.7757009346,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.7126436782,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.4644808743,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.7959183673,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,,0.63507109,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.7506361323,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.7534246575,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,0.4049586777,,,0.8230088496,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | DULOXETINE HCL,,,,,,,,,,,0.465648855,,,,,
  4 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESCITALOPRAM OXALATE,,,0.75,,,,0.3870967742,,,,0.3468013468,,,0.6439393939,,
  2 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,,,,,0.1833333333,,,0.5169491525,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.19,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.4135338346,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESOMEPRAZOLE MAGNESIUM,,,,,,,,0.456,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESOMEPRAZOLE MAGNESIUM | FLUOXETINE HCL,,,,,,,,0.7424242424,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.5641025641,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESTRADIOL,,,,,,,,0.5428571429,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESTRADIOL | FLUOXETINE HCL,,,,,,,,0.7586206897,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESTROGEN,CON/M-PROGEST ACET",,,,,,,,,,,,,,0.696,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESTROGEN,CON/M-PROGEST ACET | FLUOXETINE HCL",,,,,,,,0.7398843931,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESTROGEN,CON/M-PROGEST ACET | SERTRALINE HCL",,,,,,,,,,,,,,0.8344827586,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESTROGENS, CONJUGATED | FLUOXETINE HCL",,,,,,,,0.8226950355,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ESTROGENS, CONJUGATED | SERTRALINE HCL",,,,,,,,,,,,,,0.7909090909,,
  3 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL,,,,,,,,0.7479576399,,,0.4468085106,,,0.6754385965,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.7238095238,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.6953125,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.4708276798,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.3976833977,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7807435653,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | LEVOTHYROXINE SODIUM,,,,,,,,0.7230769231,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.6993464052,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.7391304348,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | GABAPENTIN,,,,,,,,0.5754189944,,,,,,0.5476190476,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | GABAPENTIN | SERTRALINE HCL,,,,,,,,,,,,,,0.75,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,,,0.6692607004,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL,,,,,,,,,,,,,,0.7971014493,,
  2 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.5163398693,,,,,,0.4784313725,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.8212560386,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5563909774,,
  1 ,"Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.7818181818,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.4757281553,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4267676768,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4780534351,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.9596774194,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8157068063,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.6324324324,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8131868132,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7987288136,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.5619047619,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | METFORMIN HCL,,,,,,,,,,,,,,0.58,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,,,,,,,,0.5754716981,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,,,,0.5868263473,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.8039215686,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.8532110092,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.4901960784,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | PAROXETINE HCL,,,,,,,,,,,0.4014869888,0.6747572816,,0.6936936937,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | RAMIPRIL,,,,,,,,,,,,,,0.5982905983,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1462264151,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,0.4511627907,,,0.7870603015,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7409090909,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,0.6503496503,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.8118811881,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.7435897436,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | SIMVASTATIN,,,,,,,,,,,,,,0.6193181818,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | TRAZODONE HCL,,,,,,,,,,,0.3666666667,,,,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.5597826087,,
  1 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.524137931,,
  2 ,Age: 41-64 | Gender: Female | ATORVASTATIN CALCIUM | VENLAFAXINE HCL,,,,,,,,,,,0.43,,,,,0.7226027397
  2 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401),,0.02898550725,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.04268292683,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL,,0.08695652174,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL,,0.08863636364,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05769230769,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | Last AD: Same & No Remiss,,0.03021148036,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.03380588877,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL,,0.06761006289,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL | Last AD: Same & No Remiss,,0.03811252269,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL | METHYLPHENIDATE HCL,,0.1090909091,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | METHYLPHENIDATE HCL,,0.02479338843,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.07207207207,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AZELASTINE HCL,,,0.5092592593,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AZELASTINE HCL | CITALOPRAM HYDROBROMIDE,,,0.7165354331,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | AZITHROMYCIN,,,0.5087719298,,,,0.1356932153,,,,,,,0.5309734513,,0.4057971014
  1 ,Age: 41-64 | Gender: Female | AZITHROMYCIN | ESCITALOPRAM OXALATE,,,,,,,0.3137254902,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AZITHROMYCIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1753246753,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | AZITHROMYCIN | SERTRALINE HCL,,,,,,,,,,,,,,0.7032258065,,
  1 ,Age: 41-64 | Gender: Female | BACLOFEN,0.01058201058,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BARIATRIC SURGERY STATUS (dxo:ICD9:V4586),,,,,,,,,,,0.3168316832,,,,,
  1 ,Age: 41-64 | Gender: Female | BARIATRIC SURGERY STATUS (dxo:ICD9:V4586) | CITALOPRAM HYDROBROMIDE,,,,,,,,,,,0.4495412844,,,,,
  1 ,Age: 41-64 | Gender: Female | BARIATRIC SURGERY STATUS (dxo:ICD9:V4586) | DULOXETINE HCL,,,,,,,,,,,0.4811320755,,,,,
  1 ,Age: 41-64 | Gender: Female | BARIATRIC SURGERY STATUS (dxo:ICD9:V4586) | ESCITALOPRAM OXALATE,,,,,,,,,,,0.4074074074,,,,,
  1 ,Age: 41-64 | Gender: Female | BARIATRIC SURGERY STATUS (dxo:ICD9:V4586) | FLUOXETINE HCL,,,,,,,,,,,0.5135135135,,,,,
  1 ,Age: 41-64 | Gender: Female | BARIATRIC SURGERY STATUS (dxo:ICD9:V4586) | SERTRALINE HCL,,,,,,,,,,,0.4385964912,,,,,
  1 ,Age: 41-64 | Gender: Female | BENIGN HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE (dxo:ICD9:40210),,,0.4510869565,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113),,,,,,,,0.5151515152,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.731092437,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113) | FLUOXETINE HCL,,,,,,,,0.697167756,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113) | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.450617284,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113) | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7604166667,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)",,,,,,,0.1714285714,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.3603603604,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1152416357,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BENZONATATE,,,,,,,,,,,,0.4244186047,,,,
  1 ,Age: 41-64 | Gender: Female | BENZONATATE | PAROXETINE HCL,,,,,,,,,,,,0.6492537313,,,,
  4 ,"Age: 41-64 | Gender: Female | BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)",,,0.393442623,,,,,0.3766233766,,,0.2748091603,,,0.4338235294,,
  1 ,"Age: 41-64 | Gender: Female | BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680) | CITALOPRAM HYDROBROMIDE",,,0.6336633663,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680) | FLUOXETINE HCL",,,,,,,,0.6519607843,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680) | SERTRALINE HCL",,,,,,,,,,,,,,0.6171428571,,
  1 ,"Age: 41-64 | Gender: Female | BLEPHARITIS, UNSPECIFIED (dxo:ICD9:37300)",,,0.3882352941,,,,,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",,,0.3943217666,,,0.226519337,0.08181818182,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851) | CITALOPRAM HYDROBROMIDE",,,0.6807228916,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.09352517986,,,,,,,,,
  16 ,Age: 41-64 | Gender: Female | BUPROPION HCL,0.02188295165,0.05630760083,0.4398025524,0.6282151208,0.1183673469,0.371966991,0.1619741636,0.4020849681,0.1188118812,0.05505952381,0.3690932728,0.3779214321,0.2148760331,0.4440898345,0.01890221738,0.4810254114
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | BUSPIRONE HCL,,,,,,,,,,,0.3274853801,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.04416961131,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | Last AD: Same & No Remiss",,0.0198019802,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.007389162562,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02325581395,,,,,,,,,,,,,,
  12 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,0.03645833333,0.05872072702,0.535719514,,,0.4249649369,0.2233128834,0.4344023324,0.06666666667,,0.4419911682,0.3674121406,,0.4553072626,0.02272727273,0.6094890511
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | CLONAZEPAM,,,,,,,,,,,0.6086956522,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | CLONAZEPAM | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5925925926,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.05392156863,,,,,,,,,0.6176470588,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,,,,,,,,,,0.5755395683,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.05426356589,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.01986754967,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+",,,,,,,,,,,0.4827586207,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.03278688525,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss",,,,,,,,,,,0.7475728155,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DESVENLAFAXINE SUCCINATE,,,,,,,,,,,0.3302752294,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL,,,,,,,,,,,0.3644067797,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,0.04444444444,0.5364963504,,,0.4690265487,,,,,0.3465346535,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.04285714286,,,,,,,,,0.4038461538,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.552,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3052208835,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2727272727,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,0.04642166344,0.6172106825,,,,0.3080684597,,,,0.3568376068,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.05301204819,,,,,0.2947368421,,,,0.48,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.08661417323,,,,,0.3384615385,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6470588235,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.6666666667,,,,,,,,0.4577114428,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.08870967742,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,,,,,0.4637223975,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4810126582,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,,,,,0.5904761905,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2218309859,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.6713286713,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1608040201,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.2382978723,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,0.05660377358,0.436997319,,,,,0.424437299,,,0.3088023088,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04864864865,,,,,,,,,0.416,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.4306569343,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2896174863,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1584158416,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.255033557,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.0625,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.7032258065,,,,,,,,0.4918032787,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.2664233577,,,,,,,,0.1761252446,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss",,0.05072463768,,,,,,,,,0.2178217822,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,,,,0.1984732824,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.2086330935,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2156862745,,,,,,,,0.1555555556,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.119266055,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.1842105263,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.3812785388,,,,,,,,0.328358209,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,,,,,0.3101265823,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.2482758621,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1642857143,,,,,,,,0.162601626,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1238095238,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.4529147982,,,,,,,,0.2556053812,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.2259887006,,,,,,,,0.125,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.1357142857,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1592039801,,,,,,,,0.09746588694,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.07570977918,,,,,
  8 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.05408805031,0.7025641026,,,0.49,0.2011019284,,,,0.5736478711,,,0.6,0.01485148515,0.6045751634
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03524229075,,,,,,,,,,,,,,
  5 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.05013428827,0.7247007617,,,,0.2275862069,0.495412844,,,,,,0.5443037975,,
  4 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.04042553191,0.5758969641,,,,0.2203389831,,,,,,,0.5255474453,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.55,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.07,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.04379562044,,,,,,,,,,,,,0.008928571429,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.5751978892,,,,,,,,0.5379853686,,,,,0.6103896104
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SIMVASTATIN,,,,,,,,,,,0.6343283582,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5197368421,,,,,,,,0.3181818182,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4752475248,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.07301587302,,,,,,,,,0.2631578947,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.3176470588,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03351955307,,,,,,,,,0.4827586207,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.04291845494,,,,,,,,,0.3227383863,,,,0.006849315068,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.06470588235,,,,,,,,,0.4797297297,,,,,
  5 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.06836327345,0.6622902991,,,0.5818181818,0.375,,,,0.5856966708,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.6143497758,,,,,,,,,0.8235294118,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.05714285714,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.06933333333,0.6829896907,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.05579399142,0.6052631579,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+",,,0.6266094421,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+",,0.06930693069,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,0.6120689655,,,,,,,,0.5201342282,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,0.6102941176,,,,,,,,0.5773195876,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Remissions: 2+,,0.08762886598,0.6111111111,,,,,,,,0.5589519651,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.06481481481,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,0.02016129032,0.4488054608,,,,,,,,0.3928067701,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,0.01860465116,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.02424242424,0.5213270142,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.5365853659,,,,,,,,0.4633699634,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4568690096,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1572052402,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1948881789,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2321428571,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.248,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1967213115,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4390243902,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4442649435,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.525,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.6709265176,,,,,,,,0.6535326087,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.75,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7511737089,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6343283582,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,0.6303030303,,,,,,,,0.6511627907,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,,,,0.7577639752,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.547008547,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4782608696,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,,,,,0.7121212121,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5730994152,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6715328467,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5267175573,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5276872964,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.7923076923,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4615384615,0.7342342342,,,,,,,,0.6708333333,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.472392638,0.6854460094,,,,,,,,0.6503144654,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+",,,,,,,,,,,0.6727272727,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.7289719626,,,,,,,,0.6981132075,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.5113636364,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,,,,,,,,,0.2974504249,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2578125,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.08759124088,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,,,,,,,,,0.3664122137,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 2,3",,,,,,,,0.5045045045,,,,,,0.5337423313,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2673267327,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.219123506,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2155172414,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.214953271,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5869565217,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.527173913,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+,,,0.6005586592,,,,,,,,0.5967741935,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.7391304348,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | OMEPRAZOLE,,,,,,,,,,,0.619047619,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,0.06289308176,0.4773869347,,,,,,,,0.3309352518,0.44,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.1016042781,0.2755775578,,,,,,,,0.1918443003,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1516853933,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.24,,,,,,,,0.1616871705,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4494382022,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2626865672,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.2352941176,,,,,,,,0.209375,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1307189542,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.3443983402,,,,,,,,0.2772277228,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2045454545,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,,,,,,,,,0.08152173913,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1117647059,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,0.5047619048,,,,,,,,0.4208037825,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,0.04076086957,0.5,,,,,,,,0.3577512777,,,0.5117647059,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2457627119,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | SIMVASTATIN,,,,,,,,,,,0.7358490566,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.07151664612,0.4122211445,,,,,,,,0.3135864593,,,,0.01286764706,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2527472527,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,0.06031746032,0.5170068027,,,,,,,,0.3358681876,,,,,0.7185185185
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM,,0.07465277778,,,,,,,,,0.3107890499,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | ESCITALOPRAM OXALATE,,,,,,,,,,,0.4424242424,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,,,,,0.3962264151,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3286713287,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | FLUOXETINE HCL,,,,,,,,,,,0.5738636364,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5042016807,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | Last AD: Diff & No Remiss,,,,,,,,,,,0.2823834197,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.5135135135,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1470588235,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | Last AD: Same & No Remiss,,0.02247191011,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | SERTRALINE HCL,,,,,,,,,,,0.6455696203,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | CLONAZEPAM | TRAZODONE HCL,,,,,,,,,,,0.2403846154,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,,,,,,,,,0.2756410256,,,,,
  6 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.009900990099,0.06518561824,,0.6460674157,,,,,,,0.3070088845,,,,0.02272727273,0.6254180602
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.0701754386,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | Last AD: Same & No Remiss",,0.04316546763,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,0.08510638298,,,,,,,,,0.4747081712,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,,,,,,,,,,0.3439153439,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03314917127,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.04306220096,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+",,,,,,,,,,,0.3628691983,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,,,,,0.29,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUCONAZOLE",,0.05357142857,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,0.06278026906,,,,,,0.6036866359,,,0.6595744681,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss",,,,,,,,,,,0.5612903226,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.06086956522,,,,,,0.7006802721,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.04294478528,,,,,,0.6755319149,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+",,,,,,,,,,,0.552238806,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7248322148,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,0.05607476636,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,0.05882352941,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840)",,0.04929577465,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss",,0.01,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,0.09322033898,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0.02941176471,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01630434783,
  5 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",0.006622516556,,,,,,,0.4910179641,,,0.3205804749,,,,0.006060606061,0.5386996904
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,0.05347593583,,,,,,,,,,,,,0.01142857143,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5986842105
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.0511627907,,,,,,,,,,,,,0.009404388715,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.820754717
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,0.5071090047,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,0.1677018634,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6084656085
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,0.2972972973,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,,,,,0.6124031008,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.775862069
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.03738317757,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7299270073
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7210526316
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.02127659574,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02028985507,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,0.02591792657,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01960784314,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.02637362637,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.04575163399,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.02158273381,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | VALACYCLOVIR HCL",,0.02857142857,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,0.6850393701,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | LEVOTHYROXINE SODIUM",,,,,,,,,,,0.2752808989,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MYOPIA (dxo:ICD9:3671)",,0.08661417323,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.04296875,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.05685618729,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.06003752345,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.08,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.06172839506,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.06466512702,,0.7058823529,,,,,,,0.3300492611,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,0.05434782609,,,,,,,,,0.6690140845,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,0.1503759398,,,,,,,,,0.2,,,,0.03684210526,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VALACYCLOVIR HCL",,0.07567567568,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,0.5538461538,,,,,0.6293706294
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE,,0.06704980843,,0.6879535559,,,0.1851851852,,,,0.3494377343,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | DULOXETINE HCL,,,,,,,,,,,0.314159292,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | ESCITALOPRAM OXALATE,,,,,,,0.32,,,,0.2465116279,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | FLUOXETINE HCL,,,,,,,,,,,0.3121387283,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE,,,,,,,,,,,0.07718120805,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Diff & No Remiss,,0.06430868167,,,,,,,,,0.5476190476,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5267175573,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Diff & Remiss,,0.1132075472,,0.6524822695,,,,,,,0.5288461538,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss,,,,,,,,,,,0.4347826087,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Same & Remiss,,,,,,,,,,,0.5890410959,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5072463768,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.5771428571,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Num Previous Antidep: 4+,,,,,,,,,,,0.2253521127,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2124183007,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1666666667,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1965811966,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.7123287671,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | SERTRALINE HCL,,,,,,,,,,,0.3178807947,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.2621231979,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | VENLAFAXINE HCL,,,,,,,,,,,0.3846153846,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DEXLANSOPRAZOLE,,,,,,,,,,,0.2920353982,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.06924643585,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | Last AD: Same & No Remiss",,0.02424242424,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL,,0.06488549618,,,0.3790322581,,,,,,0.3387096774,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | DULOXETINE HCL,,,,,,,,,,,0.3348017621,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.213592233,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2923728814,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | FLUOXETINE HCL,,,,,,,,,,,0.3796610169,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | LAMOTRIGINE,,,,,,,,,,,0.09090909091,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | Last AD: Diff & No Remiss,,0.06352941176,,,,,,,,,0.3263888889,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04458598726,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5088235294,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.3846153846,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.3021276596,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2167042889,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1775700935,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | SERTRALINE HCL,,,,,,,,,,,0.3619047619,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.2407862408,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DOXEPIN HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3220338983,,,,,
  10 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL,0.02307692308,0.05631958088,0.4310344828,,,0.469762419,0.196969697,0.4456140351,,,0.3617730705,0.3113207547,,0.4464831804,,0.5582822086
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,,0.04049844237,,,,,0.3569230769,,,,0.2880490296,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.04924242424,,,,,0.4274193548,,,,0.4037267081,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3490566038,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,,,,,0.3842105263,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4907407407,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2396694215,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1320754717,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.2740384615,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL,,0.04219409283,,,,0.4261168385,,0.5288461538,,,0.3289328933,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,,,,0.09803921569,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04494382022,,,,,,,,,0.4736842105,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6310679612,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5090909091,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.4804469274,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6379310345,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.625,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2926829268,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.303030303,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3026315789,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & No Remiss,,,,,,0.536,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,0.2415730337,,,,,0.1666666667,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.07438016529,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.100591716,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,0.3686635945,,,,,0.2037037037,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.2881355932,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,0.1492537313,,,,,0.1050228311,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.09243697479,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.1317991632,,,,,0.07918552036,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.452991453,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.06701030928,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,0.1463414634,,,,,0.06616257089,,,,,
  6 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.04523424879,,,,0.5535987749,0.2,,,,0.4844444444,,,,0,0.5572519084
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.04310344828,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04573804574,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.04827586207,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.009345794393,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,0.4695340502,,,,,0.4474034621,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.354368932,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.3069306931,,,,,0.2374100719,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.05325443787,,,,,,,,,0.5909090909,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05278592375,,,,0.4894736842,,,,,0.3702422145,,,,0.03055555556,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6031746032,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.05294117647,,,,,,,,,0.4406779661,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss,,0.1069444444,,,,0.6709677419,,,,,0.5578703704,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5755395683,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.05741626794,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5447154472,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+,,,,,,0.671641791,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6623376623,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss,,0.03147699758,,,,0.3022774327,,,,,0.3918699187,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4141414141,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4396984925,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.115942029,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1747572816,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2164179104,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4233128834,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4331428571,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.48,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,0.686746988,,,,,0.6008298755,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.743772242,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.7475728155,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7528957529,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.4840425532,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.6377952756,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4462809917,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.520661157,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5247524752,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5149253731,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.5789473684,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5006858711,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.7049180328,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,0.7079207921,,,,,0.6612244898,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.48,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3064516129,,,,0.5881294964,,,,,0.5682352941,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,0.537037037,,,,,0.4344023324,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.3417721519,,,,,0.2789317507,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2206896552,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2513368984,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.3142857143,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.3039215686,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2595155709,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3394495413,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.3311688312,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2463054187,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2824074074,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2785774767,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2361111111,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.3027027027,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Remissions: 2+,,,,,,0.6513157895,,,,,0.5462184874,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PAROXETINE HCL,,,,,,0.5,,,,,0.3791469194,0.53,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.2486910995,,,,,0.1695804196,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.16,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1647398844,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.37,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2978723404,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1802816901,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1235521236,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.30651341,,,,,0.2572815534,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2157676349,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5363636364,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | RISPERIDONE,,,,,,,,,,,0.1079545455,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ROPINIROLE HCL,,,,,,0.4083333333,,,,,0.374789916,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | SERTRALINE HCL,,0.04347826087,,,,0.480620155,,,,,0.3264746228,,,0.562962963,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2795031056,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL,,0.04888888889,,,,0.3367252544,,,,,0.2965383684,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2587719298,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5634517766,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | VENLAFAXINE HCL,,0.06018518519,,,,,,,,,0.3391812865,,,,,0.7169811321
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DYSMETABOLIC SYNDROME X (dxo:ICD9:2777),,0.07428571429,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DYSMETABOLIC SYNDROME X (dxo:ICD9:2777) | Last AD: Same & No Remiss,,0.02040816327,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | DYSTHYMIC DISORDER (dxo:ICD9:3004),,,,,,,,,,,0.3064516129,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869),,0.1150442478,,,,,,,,,,,,,,
  12 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE,0.0380952381,0.03826975817,0.5615763547,,,0.4535637149,0.3004898917,0.4243243243,0.1466666667,,0.3033296744,0.3544973545,,0.4155578301,0.02247191011,0.6125186289
  5 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,0.03970223325,,,,,0.2637362637,0.4322033898,,,0.3214285714,,,0.42,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.02250803859,,,,,0.347107438,,,,0.4491017964,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.640776699,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4609375,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.4734042553,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5545454545,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.640776699,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1818181818,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1439393939,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2130177515,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.0703125,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.02651515152,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.01657458564,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,0.2661870504,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.2735042735,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,,,,0.1251908397,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,0.09734513274,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss",,0.03070175439,,,,,0.1549295775,,,,0.1615384615,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.05217391304,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,,,,0.1123595506,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.118556701,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1165919283,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1203703704,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.0985915493,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.1277372263,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1944809461,,,,0.2205882353,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.1798941799,,,,0.2019230769,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.18125,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.08,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.2019704433,,,,0.1675675676,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1203703704,,,,0.2012987013,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1739130435,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1299435028,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08843537415,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.2290909091,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.1333333333,,,,0.08673469388,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Diff & No Remiss",,,,,,,0.1428571429,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,,,,,0.07086614173,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.06878306878,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,0.1189710611,,,,0.06614785992,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.024,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.05596107056,,,,,
  8 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.03052382828,0.5925925926,,,0.4329268293,0.318608784,,,,0.341813602,,,0.5811965812,0.0153256705,0.6117318436
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.3385826772,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.1746031746,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.006872852234,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | Num Previous Antidep: 2,3",,,,,,,0.4,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03665521191,,,,,0.341222183,0.53125,,,,,,0.5027624309,,
  5 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.03212290503,0.6074074074,,,,0.3019578313,0.5073529412,,,,,,0.5,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.2731707317,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5825242718,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.3045977011,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.4026845638,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04469273743,,,,,0.1904761905,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2191011236,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.3581395349,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6062992126,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.05555555556,,,,,0.2825112108,,,,,,,,0.01204819277,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,0.3606557377,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.5973154362,,,0.3873873874,,,,,0.3212713936,,,,,0.5751295337
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.3555555556,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2777777778,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4423076923,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.008,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03730017762,,,,,0.1764705882,,,,0.1929133858,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.2314814815,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2211981567,,,,0.1868131868,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03344481605,,,,,0.325,,,,0.3757225434,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05354058722,,,,,0.2610062893,,,,0.2827586207,,,,0.01785714286,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.03278688525,,,,,0.3251533742,,,,0.4825174825,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.1023215821,,,,,0.6112054329,,,,0.5328185328,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5787234043,,,,,0.6811594203,,,,0.7826086957,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.08076009501,,,,,0.6403940887,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.02158273381,,,,,0.6082474227,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+",,,,,,,0.6307692308,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+",,,,,,,0.6137931034,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,,,,0.6764705882,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Remissions: 2+,,0.125,,,,,0.6219512195,,,,0.6586826347,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,0.5,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,0.03235294118,,,,,0.1711956522,,,,0.2645190563,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,0.02822580645,,,,,0.1906005222,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.02590673575,,,,,0.1810344828,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2748387097,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.380952381,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2952755906,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1312849162,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.09917355372,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1034482759,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1333333333,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1730769231,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.2058823529,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1666666667,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1802325581,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.462962963,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.3891891892,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2985685072,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4258064516,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.5842293907,,,,0.6367989056,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.7788461538,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7525773196,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+ | TRAZODONE HCL",,,,,,,,,,,0.8849557522,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7932489451,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Antidep: 2,3",,,,,,,0.6380952381,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.63,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.6404958678,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,,,,0.7391304348,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4812030075,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,,,,,0.7121212121,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.610619469,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5467625899,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6635514019,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.6315789474,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | LORAZEPAM | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.01886792453,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.6818181818,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.641025641,,,,0.6524590164,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.4814814815,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.512195122,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3219814241,,,,,0.506263048,,,,0.563772776,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.625,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,0.4769230769,,,,0.4367088608,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.2476190476,,,,0.1926345609,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1794871795,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.05172413793,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | NORTRIPTYLINE HCL,,,,,,,,,,,0.222614841,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3",,,,,,,,0.53125,,,,,,0.5,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5971223022,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+,,,,,,,0.2538461538,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2290502793,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,0.2849462366,,,,0.2058823529,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.21484375,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.5722543353,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Remissions: 2+,,,,,,,,,,,0.6484018265,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.25,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.5118110236,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PAROXETINE HCL,,0.01960784314,,,,,0.3081395349,,,,0.2623906706,0.5148514851,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.0572519084,,,,,,,,,0.1558265583,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.114893617,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.125,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1430842607,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1153846154,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4236311239,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2338308458,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.1214285714,,,,0.1550925926,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.07619047619,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1377952756,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2208955224,,,,0.2051983584,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.197080292,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,,,,0.1120689655,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.3363636364,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.4247787611,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,,,,,0.1317365269,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.04511278195,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,0.2954545455,,,,0.375,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3681318681,,,,0.51,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL,,0.03421052632,,,,,0.2179226069,,,,0.2914147521,,,0.4825327511,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2061068702,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | SIMVASTATIN,,,,,,,,,,,0.5945945946,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,0.05764411028,,,,,0.2674418605,,,,0.2372347132,,,,0.01878612717,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1216931217,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,0.03395061728,,,,,0.2587209302,,,,0.2929782082,,,,,0.6923076923
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESTROGEN,ESTER/ME-TESTOSTERONE",,0.07802547771,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | ESTROGEN,ESTER/ME-TESTOSTERONE | Last AD: Same & No Remiss",,0.01268498943,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUCONAZOLE,,0.07506702413,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUCONAZOLE | Last AD: Same & No Remiss,,0.01736111111,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUCONAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.06956521739,,,,,,,,,,,,,,
  13 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL,0.01578947368,0.05372475264,0.4350132626,0.6170212766,,0.3795966785,0.1823076923,0.4856840434,0.08490566038,,0.4084442927,0.3624454148,,0.4225092251,0.03246753247,0.5451174289
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.5904761905,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.05147058824,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,0.5182926829,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,,,,,0.4824561404,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4482758621,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,0.2328358209,,,0.1812596006,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss",,0.08474576271,,,,,,,,,0.2435897436,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,,,,0.1666666667,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.141025641,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3185840708,,,0.1581196581,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1388888889,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1150442478,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.1444759207,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.3885017422,,,0.2819672131,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,,,,,0.2752808989,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.2695652174,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3706293706,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.2555555556,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,,,,0.2,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3",,,,,,,,0.2672413793,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3680555556,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2246696035,,,0.1798561151,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2307692308,,,0.09090909091,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3869731801,,,0.2679245283,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,0.2075471698,,,0.1413721414,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.1238095238,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.6226415094,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.6115702479,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1564039409,,,0.07299270073,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.02912621359,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,0.1818181818,,,0.06787330317,,,,,
  7 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04939367051,,,,0.4893617021,0.2150837989,0.6333333333,,,0.5412453433,,,,0.02403846154,0.5854545455
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.4962406015,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.04278074866,,,,,,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04173486088,,,,,0.2191780822,0.6222768798,,,,,,0.4736842105,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.04054054054,,,,,0.2068965517,0.58203125,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.4511627907,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,0.6636363636,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04794520548,,,,,,0.3262032086,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.5673076923,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.02941176471,,,,,,0.4631578947,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6518518519,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5299417064,,,,,0.4814814815
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.377245509,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.3796296296,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04028436019,,,,,,,,,0.2619926199,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,0.05940594059,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2393617021,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02688172043,,,,,,,,,0.4,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.0418760469,,,,,,,,,0.3561643836,,,,0.01750972763,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.04390243902,,,,,,,,,0.44,,,,,
  5 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.07955182073,,,,0.5495495495,0.2782608696,0.660944206,,,0.5227765727,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5298804781,,,,,,,,,0.7445255474,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.06276747504,,,,,,0.6664482307,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.0487804878,,,,,,0.6243781095,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+",,,,,,,,0.6666666667,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+",,,,,,,,0.670411985,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4542682927,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,,,,0.6875,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+,,0.1299435028,,,,,,0.647260274,,,0.6746987952,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,0.1181818182,,,,,,,,,,,,,0.06569343066,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,0.02502502503,,,,,,0.3518312986,,,0.3695652174,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,0.02941176471,,,,,,0.3948220065,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.01612903226,,,,,,0.3979591837,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4227642276,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4767616192,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.175,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1652173913,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1496062992,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1752021563,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2300884956,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2127659574,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1941176471,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4655172414,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4557721139,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5057471264,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.6504065041,,,0.6332029552,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.8016528926,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7962962963,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7469879518,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+ | TRAZODONE HCL",,,,,,,,,,,0.8041958042,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.8139534884,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6634615385,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.67,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.6416666667,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,,,,0.7444444444,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5971223022,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5152838428,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,,,,,0.7013574661,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.552238806,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5933333333,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.549950544,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5523809524,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.6776315789,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4827586207,,,,,,0.6744186047,,,0.6825396825,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6610169492,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.6048387097,,,,,
  4 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4201388889,,,,,0.4869565217,0.6413662239,,,0.5638489209,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+",,,,,,,,,,,0.6991150442,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.7558139535,,,0.6233766234,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.3650793651,,,,,,0.5087719298,,,0.4852216749,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,0.7,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.4528301887,,,0.3062827225,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1920529801,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.06722689076,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.3372093023,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6214511041,,,,,,0.4827586207,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3210526316,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3 | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.5673076923,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.4620689655,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6518518519,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,0.3917050691,,,0.2335025381,,,0.3302752294,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2937062937,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3255813953,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2695035461,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,0.3020408163,,,0.2449922958,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2319277108,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1849710983,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Episodes: 2+,,,0.47,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Remissions: 2+,,,,,,,,0.6657608696,,,0.6885245902,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2556053812,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1698113208,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.6666666667,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | OMEPRAZOLE,,,,,,,,,,,0.6759259259,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PAROXETINE HCL,,0.06374501992,,,,,,0.4577114428,,,0.3439716312,0.472972973,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.06593406593,,,,,,0.3054587689,,,0.2053571429,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1222707424,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.1824817518,,,0.1692708333,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.128,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,0.3942307692,,,0.4142857143,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.5451263538,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.3157894737,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,0.5229357798,,,0.2710997442,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.19375,,,0.1932059448,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.2230215827,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.3019480519,,,0.2715447154,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1707317073,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,,,,0.1666666667,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5289256198,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | RISPERIDONE,,,,,,,,0.1495327103,,,0.1284722222,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.09420289855,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | ROPINIROLE HCL,,0.03636363636,,,,,,0.4512195122,,,0.3876404494,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,0.6585365854,,,,,
  5 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | SERTRALINE HCL,,0.05066079295,,,,,0.2,0.4170940171,,,0.298136646,,,0.403960396,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.188976378,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.5714285714,,,0.64,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,0.04938271605,,,,,,0.3549019608,,,0.3045438154,,,,0.01990811639,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2746781116,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | VENLAFAXINE HCL,,0.05759162304,,,,,,0.4796954315,,,0.3116634799,,,,,0.5803921569
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GABAPENTIN,,0.0852173913,,,,,,,,,0.2833333333,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GABAPENTIN | Last AD: Diff & No Remiss,,,,,,,,,,,0.2374429224,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | GABAPENTIN | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.04201680672,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GABAPENTIN | Last AD: Same & No Remiss,,0.03308823529,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.06797116375,,,,,,,,,0.314516129,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.03773584906,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02614379085,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.03433476395,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,0.0231277533,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01769911504,,,,,,,,,,,,,,
  7 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,0.046875,0.5755395683,,,0.336492891,0.1111111111,,,,0.2700892857,0.5283018868,,,,0.6
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,0.1202185792,,,,0.2351274788,,,,,0.5460992908
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.6380952381,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4705882353,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.08108108108,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,0.01834862385,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5593220339,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.6280991736,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5593220339,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,,,,,,,,,,0.6041131105,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL,,,,,,,,,,,0.576,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | HEADACHE (dxo:ICD9:7840),0.008645533141,0.06094808126,,,,,,,,0.04651162791,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,,0.02112676056,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01941747573,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | HEADACHE (dxo:ICD9:7840) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.05405405405,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | HYDROCODONE/ACETAMINOPHEN,,0.0972972973,,,,,,,,,0.25,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss,,0.02912621359,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.1592356688,,,,,
  4 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.06283662478,,,,0.1886792453,,,,,0.1187270502,,,,,0.1674208145
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,0.1138211382,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08917197452,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.1714285714,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,0.1088435374,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss",,,,,,,,,,,0.1623931624,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.009615384615,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.05555555556,,,,,,,,,0.2222222222,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | TRAZODONE HCL",,0.03381642512,,,,,,,,,0.05357142857,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,0.03856041131,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.08737864078,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,0.1503267974,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1700680272,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.1066666667,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1341463415,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,0.09848484848,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL",,,,,,,,,,,0.1483253589,0.2651515152,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1034482759,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04964539007,,,,,,,,,0.09225092251,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1358695652,,,0.22,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1376146789,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.07333333333,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.08035714286,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1226993865,,,,,0.2049689441
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08633093525,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.185840708,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,,,,,,0.1971326165,,,0.2634730539,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.171314741,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.078125,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1367521368,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,0.154822335,,,,,0.2377850163
  8 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2490974729,,,0.2604501608,0.07865168539,0.2337164751,,,0.1321909425,0.2253521127,,0.2591093117,,0.3039723661
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.07692307692,,,,0.1297935103,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.3884297521,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06756756757,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.05660377358,,,,0.100456621,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.253164557,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1818181818,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,,,,,0.2545454545,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.08870967742,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,0.2596153846,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.3986928105,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.375,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,,,,,,,,,0.2222222222,0.390070922,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.185840708,0.4071428571,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.08095238095,,,,,0.1446540881
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06319702602,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1463414634,,,0.173553719,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1636363636,,,,,0.1727272727
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1259259259,,,0.192139738,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.06481481481,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.125,,,,,0.1694214876
  7 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.231884058,,,0.231292517,0.05128205128,0.2089552239,,,0.1340909091,,,0.2450331126,,0.2368421053
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.2761506276,,,0.4126394052,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.05442176871,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1829268293,,,,,0.380952381
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,0.2985074627,,,0.4007352941,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,,,,,0.1212121212,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,0.2025316456,,,,,0.4271356784
  4 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,0.06569343066,,,,0.1333333333,,,,,0.09265175719,,,,,0.15625
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,0.04761904762,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PAROXETINE HCL",,,,,,,,,,,0.1397058824,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06060606061,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,0.1335149864,,,0.1690821256,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1183431953,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.05761316872,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.07382550336,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | VENLAFAXINE HCL",,,,,,,,,,,0.1493055556,,,,,0.224852071
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,0.07407407407,,,,,,,,,,,,,0.03174603175,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,0.4380952381,0.01694915254,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01395348837,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01296596434,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",,0.01595744681,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.02139037433,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641),,0.04166666667,,,,,,,,,,,,,,
  7 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE,,,0.1939163498,,,0.1040609137,0.1007194245,0.1395348837,,,0.092547616,,,0.1145833333,,0.1254901961
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Last AD: Diff & No Remiss,,,,,,,,,,,0.1238938053,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.01904761905,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Last AD: Same & Remiss,,,,,,,,,,,0.465648855,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6290322581,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6853932584,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5142857143,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.5,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.5196078431,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.5874439462,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4460887949,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.3738738739,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3947990544,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.1113801453,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.128440367,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.08212560386,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.0625,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.0972972973,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+,,,,,,,,,,,0.1096605744,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.125984252,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.08193484699,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.05084745763,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PAROXETINE HCL,,,,,,,,,,,0.07258064516,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.05208333333,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.02702702703,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.1320132013,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.125,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.05405405405,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.07339449541,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | RISPERIDONE,,,,,,,,,,,0.08771929825,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.09734513274,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | ROPINIROLE HCL,,,,,,,,,,,0.1216216216,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.1072961373,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,0.09864603482,,,0.1361161525,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.07067137809,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.07853810264,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.07076350093,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.1065217391,,,,,0.1150895141
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LANSOPRAZOLE,,0.06299212598,,,,,,,,,,,,,,
  13 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss,0.01129943503,0.06688417618,0.4756995582,,,0.3767482517,0.1460580913,0.4783765802,0.112244898,0.03053435115,0.2786249677,0.4140625,,0.535359116,0.01037344398,0.5227781927
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.3220338983,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,0.5526315789,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.3564356436,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.2155688623,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7053571429
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.0531496063,,,,,,,0.2168674699,,0.2953367876,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,0.06015037594,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+,,,,,,,,,,,0.2254901961,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,0.032,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MONTELUKAST SODIUM,,,,,,,,,,,0.2342342342,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MYOPIA (dxo:ICD9:3671) | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.09708737864,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MYOPIA (dxo:ICD9:3671) | TRAZODONE HCL,,0.08527131783,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.1572327044,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.0490797546,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.01886792453,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | TRAZODONE HCL,,0.03325415677,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VENLAFAXINE HCL,,0.04697986577,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,0.06148867314,,,,,,,,0.1494252874,0.1736334405,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,0.05283018868,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Episodes: 2+,,,,,,,,,,,0.1413612565,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.07692307692,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,0.03496503497,,,,,,,,,,0.563071298,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.4796747967,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,0.03421052632,,,,,0.1914893617,,,,,,,0.6350032531,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5660377358,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,0.04031209363,,,,,,,,,,,,,0.004357298475,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,0.03619909502,,,,,,,,,,,,,,0.588
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | TRAZODONE HCL",,0.03883495146,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,0.0234375,,,,,,,,,,0.7042459736,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.7,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.05172413793,,,,,,,,,,,,0.2923976608,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,0.05988023952,,,,,,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.03816793893,,,,,0.2032967033,0.5169491525,,,,,,0.6969899666,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,0.04166666667,,,,,,,,,,,,0.5691699605,0.007633587786,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.6607142857,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.04730679157,,,,,0.1851851852,,,,,,,,0.009708737864,
  4 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,0.05,,,,,0.2407407407,,,,,,,0.5544554455,,0.7653061224
  6 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.4379084967,,,,0.1895424837,0.5294117647,,,0.2386495925,,,0.4407894737,,0.5813953488
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.438247012,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2619047619,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.5522740697,,,,,0.5448275862
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4090909091,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.58
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1200923788,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4069264069,,,,,0.5487804878
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4425087108,,,,,0.5842696629
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.3135135135,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | OMEPRAZOLE,,,,,,,,,,,0.28125,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689) | TRAZODONE HCL,,0.02985074627,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,,,,,0.2685714286,,,,,
  6 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.04511278195,,,,,0.175,,,,0.4741557547,0.6443298969,,,0.01639344262,0.6529411765
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05839416058,,,,,,,,,0.2181818182,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,0.05607476636,,,,,,,,,0.2692307692,,,,0.02173913043,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1461187215,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1449275362,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.05352112676,,,,,,,,,0.2657004831,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,0.06126482213,,,,,,,,,0.09677419355,,,,0.03345724907,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,0.0460251046,,,,,,,,,0.2195121951,,,,,0.2805755396
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PRAMIPEXOLE DI-HCL,,0.04761904762,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.05714285714,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1642512077,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.075,,,,0.09685230024,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.2164948454,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.06756756757,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | ROPINIROLE HCL,,0.04416403785,,,,,,,,,0.446969697,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1856060606,,,,0.2903225806,0.3647798742,,,,
  7 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.04468718967,,,,0.4291666667,0.1911764706,,,,0.5882181394,,,0.6722408027,0.03349282297,0.5650684932
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,0.05240174672,,,,,,,,,0.3880266075,,,,0.02257336343,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,0.07731958763,,,,,,,,,0.4318181818,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SIMVASTATIN,,,,,,,,,,,0.3258928571,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.2524752475,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.5317919075
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.70625
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | TOPIRAMATE,,,,,,,,,,,0.3178807947,,,,,
  5 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05068790731,,,,0.42,0.1477272727,,,,0.1217687075,,,,0.01630595909,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,0.06382978723,,,,,,,,,0.3962848297,,,,0.01546391753,0.5477386935
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3281853282,,,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.04677754678,,,,0.4659685864,0.2188679245,,,,0.4727171492,,,,0.01734104046,0.6817204301
  5 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss,,0.1140766251,,,,0.5751295337,,,,,0.5729613734,,,,0.1451612903,0.675862069
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.6666666667,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5950920245,,,,,,,,,0.6543624161,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+ | SERTRALINE HCL",,,,,,,,,,,0.7407407407,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.6116071429,,,,,,,,,0.8285714286,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.6655172414,,,,,,,,,,,,,0.5620437956,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,0.6101694915,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.04761904762,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.6388888889,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6624605678,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.6230769231,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,0.0643776824,,,,,,,,,,,,0.6579572447,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+ | SERTRALINE HCL",,0.07920792079,,,,,,,,,,,,0.6554878049,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,0.07453416149,,,,,,,,,,0.6868932039,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.05706874189,,,,,,,,,,,,0.7067624177,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | SIMVASTATIN",,,,,,,,,,,,,,0.7314814815,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,0.07117437722,,,,,,,,,,,,,,0.7699530516
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.6388888889,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6791666667,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.5588235294,,,,,0.6754385965
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.4024390244,0.6240601504,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4765100671,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.43,,,,,0.6436170213
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.6470588235,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,0.0931372549,,,,,,,,,0.6853146853,,,0.6586826347,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.5462184874,,,,,0.6985294118
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,0.07307692308,,,,,,,,,0.4560570071,0.6756756757,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL,,0.05785123967,,,,,,,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,0.07626262626,,,,0.5740740741,0.2769230769,,,,0.5750551876,,,0.7059848925,,0.679245283
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL,,0.1523809524,,,,,,,,,,,,,0.0826446281,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,0.4285714286,,,,,,,,,0.4761904762,,,,0.1146496815,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.1034090909,,,,,,,,,0.5008605852,,,,,0.7283105023
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss,,0.02534191472,,,,,,,,,0.2088091354,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.1722689076,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.01530612245,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.0261627907,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,0.04934210526,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | METHYLPHENIDATE HCL,,0.0462962963,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MIRTAZAPINE,,0.03,,,,,,,,,0.2782608696,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.24,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MORBID OBESITY (dxo:ICD9:27801),,0.02362204724,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MYOPIA (dxo:ICD9:3671),,0.02647975078,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382),,0.01485148515,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01397515528,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | Num Previous Episodes: 2+,,0.01276595745,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01398601399,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.01117318436,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.009523809524,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.1772151899,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.2924528302,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.4094488189,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,0.0253164557,,,,,,,,,,,,0.4713375796,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,0.05109489051,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.02926829268,,,,,,,,,,,,0.473354232,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.04945054945,,,,,,,,,,,,,0.016,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,0.03636363636,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,0.03268514688,,,,,,,,,0.2083333333,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.02542372881,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.03555555556,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.3872180451,0.4198473282,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4527027027,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.02727272727,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.01652892562,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.5376569038,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.490832158,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1759149941,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4622641509,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VALACYCLOVIR HCL,,0.05940594059,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.4484126984,,,,,0.4696969697
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.02281879195,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.0480349345,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01746031746,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.01886792453,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.01477832512,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.02255639098,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,0.03579418345,,,,,,,,,0.380952381,0.3715170279,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1558441558,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1917808219,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4232715008,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04404873477,,,,,,,,,0.1147540984,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1132075472,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1043478261,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1714285714,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1688741722,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1440217391,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.08510638298,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1494565217,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1219512195,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4970414201,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PREGABALIN,,0.03211009174,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,0.0101010101,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.03693931398,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.2477876106,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1583333333,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.1925465839,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2734375,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.05,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1908396947,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.02546296296,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.008875739645,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.02145214521,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,0.02363823227,,,,,,,,,0.4320241692,,,0.4013986014,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4841498559,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4236111111,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | TERBINAFINE HCL,,0.0223880597,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,0.04743083004,,,,,,,,,0.1765530126,,,,0.008080808081,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4725274725,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599),,0.03550295858,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690),,0.01709401709,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,0.04081632653,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,0.0350877193,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | VALACYCLOVIR HCL,,0.02388535032,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,0.03626943005,,,,,,,,,0.3601108033,,,,,0.3608695652
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss,,0.5570328901,,,,,,,,,0.6342415616,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.8083067093,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.7986111111,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.8214285714,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.7871621622,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.5555555556,,,,,,,,,0.7930535456,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7768595041,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.8705035971,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.7669902913,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7780821918,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7671232877,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,0.7727272727,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4939341421,,,,,,,,,0.754601227,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.7831325301,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.7692307692,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.8090909091,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.7618025751,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7647058824,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.8073394495,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7459016393,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.6923076923,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.7851239669,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,0.7456140351,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.7658536585,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7708547889,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7379518072,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.7806788512,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.5847457627,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.5234899329,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.5583333333,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6703296703,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6702508961,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+,,,,,,,,,,,0.5352941176,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.5419354839,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.4651162791,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5185185185,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.4910096819,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4798206278,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.7771428571,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5918367347,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6138613861,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.6198347107,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6628895184,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.52734375,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4672131148,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.6901408451,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.752293578,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5803108808,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.593495935,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.6226415094,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,0.631496063,0.6845637584,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5282392027,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5801056338,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.5771812081,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5454545455,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5993520518,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6101694915,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.568627451,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.6776119403,,,0.7126436782,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5253699789,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.637254902,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5249827705,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5143979058,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.6217990808,,,,,0.6744186047
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,,,,0.2582781457,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LEVOTHYROXINE SODIUM,,,,,,,,,,,0.2771428571,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LEVOTHYROXINE SODIUM | Last AD: Diff & No Remiss,,,,,,,,,,,0.3295454545,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LITHIUM CARBONATE,,,,,,,,,,,0.08947368421,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LITHIUM CARBONATE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.2038834951
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LORAZEPAM,,0.07412587413,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | LORAZEPAM | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.04580152672,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LORAZEPAM | Last AD: Same & No Remiss,,0.02130898021,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LOSS OF WEIGHT (dxo:ICD9:78321),,0.0974025974,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | LOSS OF WEIGHT (dxo:ICD9:78321) | Last AD: Same & No Remiss,,0.03875968992,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.5288985823,,,,,,,,,0.6990595611,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.687804878,,,,,,,,,0.7793880837,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7316384181,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7102272727,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7083333333,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | SERTRALINE HCL",,,,,,,,,,,0.7342657343,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,0.5593220339,,,,,,,,,0.6613545817,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | VENLAFAXINE HCL",,,,,,,,,,,0.6617647059,,,,,
  6 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.5165929204,,,,0.6779661017,0.6025641026,0.6666666667,,,0.6759348035,,,0.6576576577,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5593220339,,,,,,,,,0.6801705757,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6690647482,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE",,,,,,,,,,,0.6428571429,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | Num Previous Antidep: 4+",,,,,,,,,,,0.5555555556,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.6685552408,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.6231884058,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | ROPINIROLE HCL",,,,,,,,,,,0.612565445,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.5555555556,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,0.5112359551,,,,,,,,,0.7423076923,,,0.6950146628,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.5603448276,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,0.4930555556,,,,,,,,,0.6427068724,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.54,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,0.6886446886,,,,,0.7784090909
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.3501945525,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1454545455,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2232142857,,,,,
  8 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4097462514,0.6776859504,,,0.6167664671,0.4748784441,0.567251462,,,0.5900007598,,,0.5877192982,,0.6033755274
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.5434380776,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+",,,,,,,,,,,0.4210526316,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.5151515152,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.5572139303,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | NORTRIPTYLINE HCL",,,,,,,,,,,0.6007194245,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.5204918033,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.5443786982,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.5297101449,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.3216374269,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+ | SERTRALINE HCL",,,,,,,,,,,0.6814814815,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,0.4176245211,,,,,,,,,0.66359447,0.6188925081,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,0.5643564356,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.5671641791,,,,,,,,,0.660944206,,,,,0.6551724138
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.6507936508,,,0.7426470588,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.6666666667,,,,,0.7643979058
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.5233160622,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL | TRAZODONE HCL",,,,,,,,,,,0.461928934,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2972972973,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | RISPERIDONE",,,,,,,,,,,0.4893617021,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.5700757576,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.5227272727,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.425795053,,,,,,,,,0.6291989664,,,0.6864564007,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.4898648649,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.4251805986,,,,,,,,,0.5484657851,,,,0.2631578947,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.4541062802,,,,,0.6180555556
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,0.4423592493,,,,,,,,,0.5745697897,,,,,0.6963087248
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.07731958763,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.08114558473,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,0.05602240896,,,,,,,,,,,,,,0.5409356725
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6151419558
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | METHYLPHENIDATE HCL,,0.1195652174,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",,0.01886792453,,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE,,0.05758426966,,,,0.2177419355,,,0.2046263345,,0.2909903552,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2243667069,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.2426470588,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2309250506,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1676136364,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1834862385,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,,,0.3385826772,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1020408163,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.07086614173,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,,,0.26,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.2848837209,,,0.4732142857,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | TRAZODONE HCL,,0.03921568627,,,,,,,,,0.2056074766,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1677018634,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.2714285714,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MODAFINIL,,0.1203007519,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MONTELUKAST SODIUM,,,,,,,,,,,0.2816901408,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MORBID OBESITY (dxo:ICD9:27801),,0.07878787879,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,,,,,0.2635658915,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | MYOPIA (dxo:ICD9:3671),,0.07520564042,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382),,0.05309734513,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.06474820144,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.04136163982,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.06306306306,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.03448275862,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.04511278195,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | TRAZODONE HCL,,0.06666666667,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL,,0.06592039801,,,,,,,,0.1772151899,0.3058093995,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2631578947,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2628676471,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1818181818,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | PAROXETINE HCL,,,,,,,,,,,0.3515625,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.3254901961,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2274590164,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3436293436,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5600649351,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.6967320261,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.3021978022,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,0.5169491525,,,,,,0.6943020802,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5610687023,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.6666666667,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,,,,,,,0.5631067961,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2546959567,0.3189189189,,0.289017341,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.3966005666,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3538704581,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4188679245,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.1964285714,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3355176933,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2962962963,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.09523809524,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.3358116481,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3180076628,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3023255814,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3129770992,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3644859813,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1923076923,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2311827957,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,0.3831775701,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2553584627,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2176258993,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.2225475842,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Episodes: 2+,,,0.4411764706,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5564387917,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,0.525,0.6543209877,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6739130435,,,0.6713947991,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.5390070922,,,,,0.7032967033
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.06896551724,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2106299213,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.2909090909,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1884057971,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.3382789318,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,0.7272727273,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OMEPRAZOLE,,,,,,,,,,,0.3402061856,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.06451612903,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05217391304,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OTHER ANXIETY STATES (dxo:ICD9:30009),,,,,,,,,,,0.4160583942,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OTHER CONVULSIONS (dxo:ICD9:78039),,0.07407407407,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,0.3609022556,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.0724160632,,,,0.4956521739,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.06637168142,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.04098360656,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | OXYBUTYNIN CHLORIDE,,,,,,,,,,,0.3149606299,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PALPITATIONS (dxo:ICD9:7851),,,,,,,,,,,0.2701421801,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.08536585366,,,,,,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL,0.0325203252,0.04870199528,0.4664879357,,,0.4435695538,0.1722846442,0.3916913947,,,0.3929968701,0.5175036056,,0.4986737401,0.01829268293,0.6309012876
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05504587156,,,,,,,,,0.1652892562,0.291005291,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1186440678,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1509433962,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2234636872,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2366412214,0.3693693694,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.3988095238,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.5454545455,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | SERTRALINE HCL,,0.03846153846,,,,,,,,,0.3433962264,0.4946808511,,0.4588235294,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | TRAZODONE HCL,,0.07300884956,,,,,,,,,0.3046783626,0.4003590664,,,0.03813559322,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | VENLAFAXINE HCL,,0.02816901408,,,,,,,,,0.2986577181,0.4864864865,,,,
  7 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.0848733744,0.164893617,,,0.1681957187,,0.1641791045,,,0.1181102362,,,0.2374100719,,0.2051671733
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.09145129225,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1747572816,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.07857142857,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1443850267,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.09045226131,,,,,,,,,0.1964430073,,,0.2757697456,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1432835821,,,0.2892561983,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1166666667,,,,,
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,0.11875,,,,,,,,,0.08548931384,,,,,0.1465517241
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1627565982,,,,,0.1769911504
  3 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,0.05479452055,,,,,,,,,0.1630769231,,,,,0.258097166
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,0.0452920143,,,,,,,,,0.4341609051,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5446808511,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.4672897196,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4202453988,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2275132275,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.4404432133,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.329175705,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.380794702,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PREGABALIN,,0.08943089431,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,0.03910614525,,,,,,0.303030303,,,0.2325581395,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PROPOXYPHENE NAP/ACETAMINOPHEN,,,,,,,,,,,0.3701298701,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1634615385,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.05714285714,,0.2761904762,,,,,,,0.1436090226,,,,,0.3039215686
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.3076923077,,,0.5611510791,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.08733624454,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,0.2204081633,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1336206897,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1063829787,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,,,,0.03883495146,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.1693989071,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.153526971,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.102739726,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1684782609,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | VENLAFAXINE HCL",,,,,,,,,,,0.1908713693,,,,,
  6 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.1914893617,0.085,0.2268907563,,,0.1333333333,,,0.2230769231,,0.1993006993
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.236453202,,,0.2865497076,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2638297872,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.07954545455,,,,,
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.2056074766,,,,,
  2 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.2147435897,,,,,0.325732899
  1 ,"Age: 41-64 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,,,,0.08854166667,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,0.05825242718,,,,,,,,,0.3248945148,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.4145299145,,0.465648855,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.488,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.1077147016,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.1169590643,,,0.1550387597,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RISPERIDONE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.09734513274,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.0786163522,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RISPERIDONE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1237623762,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.1219512195,,,,,0.2236024845
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL,,0.05447154472,,,,,,,,,0.406295272,,0.4488636364,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.4473684211,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL | TRAZODONE HCL,,0.05504587156,,,,,,,,,0.3239875389,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3897849462,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROSUVASTATIN CALCIUM,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.08542713568,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.05957446809,,,,,,,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.05850746269,,0.6513157895,,0.5294117647,0.1714285714,,,,0.287037037,0.3846153846,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL,,,,,,,,,,,0.7345132743,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,0.07,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VALACYCLOVIR HCL,,0.007751937984,,,,,,,,,,,,,,
  13 ,Age: 41-64 | Gender: Female | BUPROPION HCL | SERTRALINE HCL,0.01538461538,0.05178319565,0.4284009547,0.6541353383,,0.3840490798,0.1643835616,0.3959341723,0.1267605634,,0.4666617386,0.4089834515,,0.535193032,0.02950819672,0.5767511177
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.6942675159,,,0.6740740741,,
  5 ,Age: 41-64 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,0.06435137896,,,,,0.1101694915,,,,0.3374858437,,,0.4203323558,0.02260869565,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2485549133,,,,,
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | VENLAFAXINE HCL,,0.07076923077,,,,,,,,,0.3015214385,,,0.5119305857,,0.5789473684
  3 ,Age: 41-64 | Gender: Female | BUPROPION HCL | SIMVASTATIN,,0.109375,,,,,,,,,0.3719912473,,,0.5961538462,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.2905027933,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.614973262
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | TERBINAFINE HCL,,0.08108108108,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | TOPIRAMATE,,,,,,,,,,,0.2711864407,,,,,
  11 ,Age: 41-64 | Gender: Female | BUPROPION HCL | TRAZODONE HCL,0.04861111111,0.06799623116,0.3219373219,,,0.2774018945,0.1511254019,0.2641129032,,,0.2907771193,0.3088235294,,0.3758865248,0.01856556576,0.2899159664
  4 ,Age: 41-64 | Gender: Female | BUPROPION HCL | TRAZODONE HCL | VENLAFAXINE HCL,,0.073089701,,,,,,,,,0.281504065,,,,0.01945525292,0.3682460515
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | TRAZODONE HCL | VILAZODONE HCL,,,,,,,,,,,0.3302752294,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599),,0.07468879668,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690),,0.06034482759,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.07913669065,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | BUPROPION HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,0.06034482759,,,,0.4712643678,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,0.06329113924,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | VALACYCLOVIR HCL,,0.06948640483,,,,,,,,,,,,,,
  12 ,Age: 41-64 | Gender: Female | BUPROPION HCL | VENLAFAXINE HCL,0.006024096386,0.06323083586,0.4468085106,,,0.4848484848,0.2016806723,0.4572072072,0.1338582677,,0.3482211613,0.3989071038,,0.4485294118,0.02092050209,0.5452847806
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | VERAPAMIL HCL,,0.05825242718,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUPROPION HCL | VILAZODONE HCL,,,,,,,,,,,0.5844594595,,,,,
  4 ,Age: 41-64 | Gender: Female | BUSPIRONE HCL,,,0.4926108374,,,,0.1623376623,,,,0.2892156863,,,0.571875,,
  2 ,Age: 41-64 | Gender: Female | BUSPIRONE HCL | CITALOPRAM HYDROBROMIDE,,,0.6809815951,,,,,,,,0.4640522876,,,,,
  2 ,Age: 41-64 | Gender: Female | BUSPIRONE HCL | ESCITALOPRAM OXALATE,,,,,,,0.4811594203,,,,0.3783783784,,,,,
  1 ,Age: 41-64 | Gender: Female | BUSPIRONE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.2,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | BUSPIRONE HCL | FLUOXETINE HCL,,,,,,,,,,,0.4335664336,,,,,
  1 ,Age: 41-64 | Gender: Female | BUSPIRONE HCL | PAROXETINE HCL,,,,,,,,,,,0.3465346535,,,,,
  2 ,Age: 41-64 | Gender: Female | BUSPIRONE HCL | SERTRALINE HCL,,,,,,,,,,,0.4413793103,,,0.7297297297,,
  1 ,Age: 41-64 | Gender: Female | BUSPIRONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4375,,,,,
  1 ,Age: 41-64 | Gender: Female | CANDIDIASIS OF VULVA AND VAGINA (dxo:ICD9:1121),,,,,,,,0.4272727273,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | CARISOPRODOL,0.01157024793,,,,,,0.1647058824,,,,,,,0.5527950311,0.02090592334,
  1 ,Age: 41-64 | Gender: Female | CARISOPRODOL | HEADACHE (dxo:ICD9:7840),0.005464480874,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CARISOPRODOL | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.02830188679,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CARISOPRODOL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CEFDINIR,,,,,,,0.1142857143,,,,,0.3557692308,,,,
  3 ,Age: 41-64 | Gender: Female | CELECOXIB,,,0.5065104167,,,,,0.5183946488,,,,,,0.5742574257,,
  1 ,Age: 41-64 | Gender: Female | CELECOXIB | CITALOPRAM HYDROBROMIDE,,,0.7092198582,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CELECOXIB | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.5151515152,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CELECOXIB | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.7252747253,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CELECOXIB | FLUOXETINE HCL,,,,,,,,0.6851851852,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CELECOXIB | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7211538462,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CERVICALGIA (dxo:ICD9:7231),,,,,,,,0.49,,0.02857142857,,,,,,
  6 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL,,,0.5370152761,,0.1342281879,0.4455445545,0.120665742,,,,,,,0.6260869565,,0.4790419162
  1 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | CITALOPRAM HYDROBROMIDE,,,0.6913793103,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.7042253521,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.429245283,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.6893617021,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | ESCITALOPRAM OXALATE,,,0.6742857143,,,,0.2732919255,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.09708737864,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.5179487179,,,,0.05454545455,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1116071429,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CETIRIZINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6605504587
  2 ,"Age: 41-64 | Gender: Female | CHEST PAIN, OTHER (dxo:ICD9:78659)",,,,,,,,,,,,,,0.4710743802,,0.4542372881
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, OTHER (dxo:ICD9:78659) | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,,,,,,,,0.5194174757,,
  5 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,0.4714285714,,,,0.1356932153,0.5389048991,,,,0.358974359,,0.5317220544,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,0.1242236025,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | ESCITALOPRAM OXALATE",,,,,,,0.3426573427,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1962616822,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | FLUOXETINE HCL",,,,,,,,0.6338028169,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4484848485,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7255813953,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | LEVOTHYROXINE SODIUM",,,,,,,,,,,,,,0.5462184874,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,,,,,,,,0.5,,
  2 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1442307692,,,,,,,0.5058823529,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1236263736,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | SERTRALINE HCL",,,,,,,,,,,,,,0.6977329975,,
  1 ,"Age: 41-64 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.02521008403,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.03571428571,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01846965699,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",,0.01652892562,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071),,,0.4466292135,,,,,,,,,,,0.5348837209,,
  1 ,Age: 41-64 | Gender: Female | CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071) | CITALOPRAM HYDROBROMIDE,,,0.6474358974,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CHRONIC PAIN SYNDROME (dxo:ICD9:3384),,0.01709401709,0.4449541284,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CHRONIC PAIN SYNDROME (dxo:ICD9:3384) | CITALOPRAM HYDROBROMIDE,,,0.7235772358,,,,,,,,,,,,,
  16 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE,0.01992846193,0.03480656066,0.5718607714,0.6374045802,0.1544117647,0.4318466028,0.2534385839,0.4737238651,0.1280653951,0.05646173149,0.3363855943,0.4199576869,0.1762917933,0.4815481548,0.01774123756,0.6062413951
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM,,,0.6531531532,,,,,,,,0.3996865204,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM | Last AD: Diff & No Remiss,,,,,,,,,,,0.3546511628,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM | Last AD: Diff & Remiss,,,,,,,,,,,0.4521276596,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM | Last AD: Same & No Remiss,,,0.5025641026,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM | Last AD: Same & Remiss,,,0.6261682243,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM | TRAZODONE HCL,,,,,,,,,,,0.6041666667,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | CODEINE PHOSPHATE/GUAIFENESIN,,,0.6344086022,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.7261146497,,,,,,,,0.4222222222,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & No Remiss",,,0.4121621622,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & Remiss",,,0.7142857143,,,,,,,,,,,,,
  9 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0,0.03179190751,0.681780709,0.5736434109,,,0.2695652174,0.6046511628,,,0.3771186441,,,,0.02395209581,0.6498194946
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.6449704142,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.009345794393,
  6 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",0,0.01913875598,,,,,,0.5267857143,,,0.2965517241,,,,0,0.4428571429
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.004329004329,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,0.4496124031,,,,,
  3 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss",,0.04895104895,,,,,,,,,0.3888888889,,,,,0.6497695853
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.006944444444,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,,0.4082474227,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,0.2727272727,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss",,,0.6994727592,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | LEVOTHYROXINE SODIUM",,,0.7011494253,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,0.362962963,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SIMVASTATIN",,,0.7295081967,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,,,,,,,,,,0.5395683453,,,,0.00495049505,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.7020648968,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | Last AD: Same & No Remiss,,,0.3507462687,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | Last AD: Same & Remiss,,,0.7297297297,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DESVENLAFAXINE SUCCINATE,,,0.5964912281,,,,,,,,0.2996108949,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.3023255814,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEXLANSOPRAZOLE,,,,,,,,,,,0.3861386139,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEXTROAMPHETAMINE/AMPHETAMINE,,,0.6824324324,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE (dxo:ICD9:5533),,,0.6862745098,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL,,,0.6313432836,,0.3543307087,,,,,,0.3773584906,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL | Last AD: Diff & No Remiss,,,0.8510638298,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.858490566,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL | Num Previous Episodes: 2+,,,0.6725663717,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.3238636364,,,,,
  8 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,0.03703703704,0.6073871409,,,0.5273522976,0.3376623377,0.4578313253,,,0.3411829135,,,0.4975845411,,0.5486725664
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.246835443,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | LAMOTRIGINE,,,,,,,,,,,0.09565217391,,,,,
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.03759398496,0.7877237852,,,0.6034912718,,,,,0.3938679245,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.8009049774,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.7572815534,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.7590909091,,,,,,,,0.3828828829,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5428571429,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4896551724,,,,0.01639344262,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5984251969,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & Remiss,,,0.6513761468,,,0.611814346,,,,,0.4429065744,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & No Remiss,,,0.4183673469,,,0.2585551331,,,,,0.3760683761,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5315315315,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4978354978,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & Remiss,,,0.6203703704,,,,,,,,0.4812030075,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6019900498,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.5886075949,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3168316832,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.3243243243,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3518518519,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Num Previous Episodes: 2+,,,0.7594936709,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.384,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.4819277108,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | TRAZODONE HCL,,,0.4366197183,,,0.3788395904,,,,,0.3606729758,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3706293706,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ELETRIPTAN HYDROBROMIDE,,,0.7692307692,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889),,,0.7387755102,,,,,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,0.01652892562,0.02672605791,0.6863792446,,,0.4658385093,0.368861024,0.4210526316,,,0.2685934489,0.4244604317,,0.5388513514,0.03289473684,0.6191950464
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,,0.5643564356,,,0.2307692308,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.3806451613,,,,0.1866028708,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.1797752809,,,,,,,,,
  7 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.02259887006,0.7298969072,,,0.4566929134,0.3893016345,,,,0.3190839695,,,,0.04098360656,0.5977653631
  3 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.7574626866,,,,0.4105263158,,,,,,,0.5909090909,,
  3 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6450704225,,,,0.3468950749,,,,,,,0.572815534,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.2592592593,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.65625,,,,,,,,0.2809364548,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4256756757,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.3073170732,,,,0.4759615385,,,,0.01503759398,
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.03571428571,0.7941176471,,,,0.4860883797,,,,0.3456561922,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,0.4810606061,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3611111111,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3378378378,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,0.4855072464,,,,0.2036553525,,,,0.3005780347,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.2024793388,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.4927536232,,,,0.2096069869,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.5109034268,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4520547945,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4139072848,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,0.7432188065,,,,0.6313559322,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6325301205,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,0.6515151515,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5925925926,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.6,,,,0.5227272727,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,,,,,0.2796610169,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | NORTRIPTYLINE HCL,,,,,,,,,,,0.3653846154,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3",,,,,,,,,,,,,,0.5909090909,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.649321267,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.6666666667,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.3082706767,,,,,,,,0.07407407407,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1307692308,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5431034483,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,,,,,0.4427480916,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,,,,,0.2101449275,,,0.5441176471,,
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,0.5962962963,,,,0.3096330275,,,,0.3339070568,,,,0.01290322581,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,0.3551401869,,,,0.2727272727,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM,,,0.7,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM | Last AD: Same & No Remiss,,,0.456928839,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM | Last AD: Same & Remiss,,,0.7588235294,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.6895705521,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & No Remiss",,,0.4074074074,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & Remiss",,,0.7135802469,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & Remiss | SIMVASTATIN",,,0.85,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LISINOPRIL/HYDROCHLOROTHIAZIDE",,,0.6237623762,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SIMVASTATIN",,,0.7772511848,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESTROGEN,CON/M-PROGEST ACET",,,0.7469879518,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESTROGEN,CON/M-PROGEST ACET | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,0.7337662338,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESTROGEN,CON/M-PROGEST ACET | Last AD: Same & No Remiss",,,0.4215686275,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESTROGEN,CON/M-PROGEST ACET | Last AD: Same & Remiss",,,0.7614678899,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESTROGENS, CONJUGATED",,,0.775862069,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESZOPICLONE,,,0.6728110599,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESZOPICLONE | Last AD: Same & Remiss,,,0.7881355932,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | EXAMINATION OF EYES AND VISION (dxo:ICD9:V720),,,0.688172043,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | EZETIMIBE/SIMVASTATIN,,,0.7175572519,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | EZETIMIBE/SIMVASTATIN | Last AD: Same & Remiss,,,0.7522123894,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FENOFIBRATE,,,0.6960784314,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FEXOFENADINE/PSEUDOEPHEDRINE,,,0.7232142857,,,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,0.05630630631,0.5391891892,,,0.3470319635,0.2522796353,0.5540393013,,,0.2715803453,0.3725490196,,0.442455243,,0.5953488372
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.03738317757,0.75,,,,0.2926829268,,,,0.3170731707,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7076923077,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6363636364,,,,,0.6807228916,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.6357142857,,,,,,,,0.2977099237,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.03149606299,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Diff & Remiss,,,0.71875,,,,,0.7142857143,,,0.3712121212,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,0.3755274262,,,,,0.3846153846,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.4,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.3963963964,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5074626866,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & Remiss,,,0.7401574803,,,,,0.6746031746,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6237623762,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.731092437,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.7085889571,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | Num Previous Episodes: 2+,,,0.6211180124,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.141509434,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | SERTRALINE HCL,,,0.4642857143,,,,,0.5094339623,,,0.2410714286,,,,,
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | TRAZODONE HCL,,,0.4006622517,,,,,0.4014336918,,,0.3333333333,,,,0.03311258278,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | VENLAFAXINE HCL,,,0.4358974359,,,,,,,,0.1728395062,,,,,
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN,,,0.6893203883,,,0.476635514,0.3714285714,,,,0.448441247,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | Last AD: Diff & No Remiss,,,,,,,,,,,0.4563106796,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | Last AD: Diff & Remiss,,,,,,,,,,,0.4598540146,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | Last AD: Same & No Remiss,,,0.4324324324,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | Last AD: Same & Remiss,,,0.7177419355,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | SIMVASTATIN,,,0.7168141593,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | TRAZODONE HCL,,,,,,,,,,,0.5588235294,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GEMFIBROZIL,,,0.7236842105,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.0380952381,,,,,,,,,0.3137254902,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.02586206897,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GUAIFENESIN/P-EPHED HCL,,,0.674796748,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GUAIFENESIN/PHENYLEPHRINE HCL,,,0.6655844156,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.6952975048,,,,0.2454873646,,,,0.3620071685,0.4708737864,,,,0.734082397
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.4285714286,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,0.1315789474,,,,0.381294964,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss,,,,,,,0.1879194631,,,,0.2901554404,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,,0.4307359307,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.43125,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss,,,0.6552845528,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LORATADINE,,,0.75,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | TRAZODONE HCL,,,0.6513761468,,,,,,,,0.6206896552,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840),0.01457725948,,,,,,,,,0.06467661692,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.0119047619,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL,,,,,,,,,,0.1640625,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HEMATURIA (dxo:ICD9:5997),,,0.6802721088,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HYDROCODONE/ACETAMINOPHEN,,,,,,,,,,,0.504950495,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HYDROCODONE/HOMATROPINE,,,0.7238493724,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HYDROCODONE/HOMATROPINE | Last AD: Same & No Remiss,,,0.4,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HYDROCODONE/HOMATROPINE | Last AD: Same & Remiss,,,0.6788990826,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | HYDROXYCHLOROQUINE SULFATE,,,0.6666666667,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | IBUPROFEN,,,0.7210884354,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.47,,,,,
  3 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.3477537438,,,,0.1962616822,,,,0.1152941176,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2314049587,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,0.2149253731,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1061946903,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.7128712871,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2429378531,,,,,,,,0.07602339181,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2547169811,,,,,,,,0.1172413793,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07432432432,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,0.2660944206,,,,,,,,0.1353846154,,,,,
  8 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.4202101051,,,0.25,0.1195335277,0.2372881356,,,0.1857410882,0.2838709677,,0.2736842105,,0.4015151515
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.09027777778,,,,0.1518324607,,,,,
  3 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.09032258065,,,,0.1174496644,,,,,0.2403846154
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.25,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,0.3012820513,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1899441341,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3025641026,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss",,,0.5733333333,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3982300885,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2044728435,,,,,,,,0.1102362205,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2137931034,,,,,,,,0.1176470588,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2023121387,,,,,,,,,,,,,
  7 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.4197080292,,,0.1774193548,0.1315789474,0.2196969697,,,0.1603174603,,,0.2260869565,,0.2619047619
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,0.3612334802,,,,,,,,0.243902439,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,0.3348314607,,,,,,,,0.3333333333,,,,,
  3 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.2442159383,,,,0.09558823529,,,,0.1254237288,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,0.1793721973,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,0.2265625,,,,,,,,0.1555555556,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.68288854,,,,,,,,,,,,0.02843601896,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,0.3739837398,0.009389671362,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.6120689655,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.6363636364,,,,,,,,,,,,0.02032520325,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01785714286,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01169590643,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.009132420091,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",,,0.4218181818,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01724137931,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss",,,0.6757679181,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01694915254,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | IRREGULAR MENSTRUAL CYCLE (dxo:ICD9:6264),,,0.6923076923,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LABORATORY EXAMINATION (dxo:ICD9:V726),,,0.6900584795,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LABORATORY EXAMINATION, UNSPECIFIED (dxo:ICD9:V7260)",,,0.77,,,,,,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1492103076,,,0.1583333333,0.1127819549,0.1052631579,,,0.08920863309,,,0.2125984252,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | Last AD: Same & No Remiss,,,0.06984126984,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | TRAZODONE HCL,,,0.1293103448,,,,,,,,0.07692307692,,,,,
  12 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,0.006880733945,0.01764199656,,,,0.373540856,0.1839407745,0.4386363636,0.1237623762,0.02419354839,0.3151738997,0.3446475196,,0.4276184123,0.008885298869,0.4781783681
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,,,0.2162162162,,0.5681818182,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01327433628,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,0.7300613497,,,,,,,0.1333333333,0.4965517241,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,,0.7264957265,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.5859872611,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Episodes: 2+,,,0.6,,,,,,,,0.464516129,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,0.6315789474,,,,,,,,,,,0.7158469945,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.5568281938,,,,,,,,,,,,0.01556420233,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,0.6648351648,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,0.775,,,,,,,,,,,0.7320441989,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.6364665912,,,,,,,,,,,,0.007518796992,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,0.768907563,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,0.2773722628,,,,0.2619047619,,,0.464,,0.5172413793
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | ROPINIROLE HCL,,,,,,,,,,,0.4952380952,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.6242038217,,,,,,,,0.2953020134,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5527847049,,,,,,,,0.5003548616,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,0.6614583333,,,,,,,,0.4739336493,,,,,0.6553672316
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.008620689655,0.7570093458,,,,,,,,0.2625698324,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.02459016393,,,,,,,,,0.1308411215,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.2586206897,,,,0.02212389381,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.1619047619,,,,0.1560283688,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.179245283,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2264150943,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6376811594,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5953757225,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1656804734,,,,,0.314516129,,,,
  6 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.01746724891,0.7529411765,,,,0.1770833333,,,,0.3054755043,,,,0,0.4637681159
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4836065574,,,,0.005813953488,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SIMVASTATIN,,,,,,,,,,,0.4051724138,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.4086956522
  5 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.02164502165,0.627017842,,,,0.2068965517,,,,0.5460683082,,,,0.01484230056,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5,,,,0.01162790698,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3824884793,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.01860465116,0.7507507508,,,,0.2121212121,,,,0.4515418502,,,,,0.6870897155
  12 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,0.04,0.06397058824,,0.6554054054,,0.5110837438,0.3235059761,0.6408934708,0.2421875,,0.412591051,0.5532646048,,0.6279411765,0.03956043956,0.6414201183
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5047619048,,,,,,,,,0.7072072072,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.06060606061,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | NORTRIPTYLINE HCL,,,0.7070063694,,,,,,,,0.6019417476,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL",,,0.6129032258,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.5571428571,,,,,,,,,,,,0.006622516556,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.6589285714,,,,,,,,,,,,0.01268498943,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3732394366,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,0.625498008,,,,,,,,0.4806629834,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5446428571,,,,,,,,0.3591331269,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,0.6278195489,,,,,,,,0.5047619048,,,,0.04273504274,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.5073529412,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | OMEPRAZOLE,,,,,,,,,,,0.4701986755,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.3295454545,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL,,,0.5887850467,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2875816993,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | ROPINIROLE HCL,,,0.6506024096,,,,,,,,0.5217391304,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3302752294,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | SERTRALINE HCL,,0.07,0.75,,,,0.3235294118,,,,0.4459930314,,,0.7770700637,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | SIMVASTATIN,,,,,,,,,,,0.4277777778,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | TRAZODONE HCL,,,0.6165137615,,,,,,,,0.4913580247,,,,0.02827521206,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4897959184,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,0.7111111111,,,,0.3421052632,,,,0.417989418,,,,,0.7442922374
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3926009815,,,,,,,,0.4196078431,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.3921568627,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.5095057034,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.3035714286,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MONTELUKAST SODIUM,,,0.4095238095,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MYOPIA (dxo:ICD9:3671),,,0.3902439024,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.3931034483,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5042735043,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.449704142,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.4957983193,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.3929320156,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.462962963,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SIMVASTATIN,,,0.4107142857,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.4328358209,,,,,,,,0.4383561644,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5140186916,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.4411764706,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.4748358862,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,0.4355828221,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PAROXETINE HCL,,,0.3865979381,,,,,,,,,0.3290322581,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4122807018,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2343541944,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.2217391304,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5388127854,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6725663717,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PRAVASTATIN SODIUM,,,0.4322033898,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.3068181818,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PROGESTERONE, MICRONIZED",,,0.4579439252,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.3,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.3540669856,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.2426470588,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.2252747253,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2540983607,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | RISPERIDONE,,,0.1147540984,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.4234234234,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.376146789,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SERTRALINE HCL,,,0.3987341772,,,,,,,,0.237704918,,,0.4203821656,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4873417722,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SIMVASTATIN,,,0.4486607143,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TOPIRAMATE,,,0.512605042,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,0.3858921162,,,,,,,,0.4044233807,,,,0.0119047619,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5085470085,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,0.3968253968,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3630363036,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | VALACYCLOVIR HCL,,,0.3300970874,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,0.3955555556,,,,,,,,0.3015873016,,,,,0.4615384615
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.7175115507,,,,,,,,0.4946996466,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.7142857143,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.7047244094,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7281553398,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | METAXALONE,,,0.6730769231,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.5777777778,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MONTELUKAST SODIUM,,,0.7731092437,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MYOPIA (dxo:ICD9:3671),,,0.8097560976,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.6046511628,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.7196261682,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,0.5907111756,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,0.8656716418,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5877862595,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.7131782946,,,,,,,,0.6338983051,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,0.8652094718,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5878787879,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.8067978533,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,0.7874015748,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PALPITATIONS (dxo:ICD9:7851),,,0.6538461538,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6050955414,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6641791045,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PRAVASTATIN SODIUM,,,0.7310344828,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PREGABALIN,,,0.7254901961,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.6173913043,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PROGESTERONE, MICRONIZED",,,0.6909090909,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.5531914894,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.5483870968,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6509433962,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6327160494,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5503875969,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | ROSUVASTATIN CALCIUM,,,0.7394957983,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.7281553398,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.7804878049,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SERTRALINE HCL,,,0.6896551724,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SIMVASTATIN,,,0.7886524823,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TOPIRAMATE,,,0.6643356643,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,0.7122641509,,,,,,,,0.6170960187,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5268817204,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,0.7393617021,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.6898954704,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | VALACYCLOVIR HCL,,,0.735042735,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | VENLAFAXINE HCL,,,0.5961538462,,,,,,,,0.6100628931,,,,,0.6694214876
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,,,,0.4,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVONORGESTREL-ETHIN ESTRADIOL,,,0.6830601093,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVOTHYROXINE SODIUM,,,0.7045075125,,,,,,,,0.3992248062,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVOTHYROXINE SODIUM | Last AD: Same & No Remiss,,,0.4210526316,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss,,,0.8125,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL,,,0.7462686567,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.7052868391,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE | Last AD: Same & No Remiss,,,0.4297082228,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE | Last AD: Same & Remiss,,,0.6734693878,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE | SIMVASTATIN,,,0.7540983607,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LORATADINE,,,0.7547770701,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LORAZEPAM,,,0.6373626374,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LORAZEPAM | Last AD: Same & No Remiss,,,0.4426229508,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOSS OF WEIGHT (dxo:ICD9:78321),,,0.6494252874,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOVASTATIN,,,0.7185354691,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOVASTATIN | Last AD: Same & No Remiss,,,0.4214285714,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOVASTATIN | Last AD: Same & Remiss,,,0.7934782609,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.7024793388,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,0.7290909091,,,,,,,,0.6652719665,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,0.6923076923,,,,,,,,0.688,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.7252747253,,,,,,,,0.4578947368,,,,,
  8 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4273858921,0.7063074901,,,0.5543478261,0.5846774194,0.7267759563,,,0.5815412186,0.6568627451,,0.6756756757,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.7229437229,,,,,,,,0.6116504854,,,,,
  3 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,0.6425233645,,,,,,,,0.5981595092,,,,0.2461538462,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.5657894737,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,,,0.5762711864
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | METAXALONE,,,0.6616541353,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",,,0.641025641,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,0.4932502596,,,,,,0.2112676056,,0.3136942675,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1176470588,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | TRAZODONE HCL,,,0.456043956,,,,,,,,0.3215962441,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.2695035461,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MONTELUKAST SODIUM,,,0.73,,,,,,,,0.3885714286,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,,,,,0.4311926606,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | MYOPIA (dxo:ICD9:3671),,,0.7115384615,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.05014749263,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,0.5821205821,,,,,,,0.1511627907,0.4539419087,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL | Num Previous Episodes: 2+,,,0.6022099448,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.34375,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3465346535,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.700913242,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2336448598,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3046357616,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | PAROXETINE HCL,,,0.6846846847,,,,,,,,,0.6435643564,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.6228571429,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5605947955,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,0.6529680365,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+,,,0.852173913,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+ | TRAZODONE HCL,,,0.6094182825,,,,,,,,0.5128205128,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1674418605,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.2695652174,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.7567024129,,,,0.4347826087,,,,0.5106382979,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SIMVASTATIN,,,0.7952755906,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OMEPRAZOLE,,,,,,,0.2897196262,,,,0.4365853659,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER ANXIETY STATES (dxo:ICD9:30009),,,,,,,,,,,0.465648855,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,0.4620689655,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02777777778,,,,0.5,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,0.6293706294,,,,0.2269503546,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319),,,0.6511627907,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,,0.7605042017,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,0.6568627451,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283),,,0.736196319,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | OXYBUTYNIN CHLORIDE,,,,,,,,,,,0.3986928105,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PALPITATIONS (dxo:ICD9:7851),,,0.6631205674,,,,,,,,0.3825136612,,,,,
  9 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,0.02536231884,0.5616547335,,,0.3913043478,0.2222222222,0.4356435644,,,0.2659430122,0.5405017921,,0.5055350554,,0.6206896552
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL | TRAZODONE HCL,,,0.494047619,,,,,,,,0.3239875389,0.4964539007,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PEN NEEDLE, DIABETIC",,,0.722513089,,,,,,,,,,,,,
  6 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.06796116505,0.3249490143,,,0.2054054054,,0.1729323308,,,0.1205400193,,,0.2294117647,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3333333333,,,,,,,,0.1404682274,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1866666667,,,,,
  3 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2679640719,,,,,,,,0.1980413493,,,,0.0625,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1267605634,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,0.2727272727,,,,,,,,0.13,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,0.5501813785,,,,,,,,0.5240770465,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,0.6166666667,,,,,,,,0.5858585859,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.520661157,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4279835391,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAVASTATIN SODIUM,,,0.7643312102,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PREGABALIN,,,0.7012448133,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.6366666667,,,,,0.4122807018,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PROGESTERONE, MICRONIZED",,,0.6784565916,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PROPOXYPHENE NAP/ACETAMINOPHEN,,,,,,,,,,,0.3826086957,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.6117647059,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.3695652174,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.52734375,,,,,,,,0.178,,,0.272,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,0.4957983193,,,,,,,,0.2804428044,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.3104693141,,,,,,,,0.153256705,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,0.2666666667,,,,,,,,0.1884816754,,,,,
  6 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.3642039542,,,0.1395348837,0.1526315789,0.1764705882,,,0.216066482,,,0.1882352941,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.3047619048,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,0.2161290323,,,,,,,,0.2245430809,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,0.7121212121,,,,,,,,0.5,,0.1881188119,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,0.649122807,,,,,,,,0.600536193,,0.3884297521,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5142857143,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,0.1660447761,,,,,,,,0.1111111111,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | RISPERIDONE | TRAZODONE HCL,,,0.2471910112,,,,,,,,0.09538461538,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROFECOXIB,,,0.7419354839,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,0.5717455621,,,,,,,,0.531372549,,0.4039735099,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4160583942,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4672897196,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROSUVASTATIN CALCIUM,,,0.7122302158,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.6634615385,,0.5483870968,0.3273273273,,,,0.3571428571,0.5214723926,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.7131147541,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.6445182724,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SCREENING FOR UNSPECIFIED CONDITION (dxo:ICD9:V829),,,0.6929824561,,,,,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,0.01904761905,0.02845528455,0.53125,,,0.3438914027,0.2168674699,0.4153846154,,,0.2799442897,0.4200743494,,0.5427852349,0,0.5267175573
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | TRAZODONE HCL,,,0.4314285714,,,,,,,,0.350148368,,,0.4550408719,0.01442307692,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | VENLAFAXINE HCL,,,0.48,,,,,,,,0.2127659574,,,0.5503875969,,
  3 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SIMVASTATIN,,,0.7529274005,,,,,,,,0.4469565217,,,0.6934306569,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.6870229008,,,,,
  1 ,"Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SODIUM, POTASSIUM,MAG SULFATES",,,0.6886792453,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SUMATRIPTAN SUCCINATE,,,0.6532258065,,,,,,,,0.4496644295,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.688034188
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | TIZANIDINE HCL,,,0.7043010753,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | TOPIRAMATE,,,0.7028571429,,,,,,,,0.4732142857,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAMADOL HCL/ACETAMINOPHEN,,,0.6827956989,,,,,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,0.02645502646,0.03731343284,0.5034866189,,,0.2865853659,0.2240184758,0.3612716763,,,0.4186464201,0.3410404624,,0.3285302594,0.02131336406,0.4120603015
  4 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL | VENLAFAXINE HCL,,,0.4328358209,,,,,,,,0.3601108033,,,,0.01401869159,0.6038961039
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,0.6825396825,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,0.7027027027,,,0.5560640732,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,0.6336633663,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515),,,0.6689655172,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.6464968153,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | VALACYCLOVIR HCL,,,0.6972789116,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | VARENICLINE TARTRATE,,,0.7333333333,,,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,0.02877697842,0.5597964377,,,0.4957264957,0.2707774799,0.4703703704,,,0.3214876033,0.4429530201,,0.4143518519,,0.6845513414
  10 ,Age: 41-64 | Gender: Female | CLONAZEPAM,0.01168224299,0.03337612323,0.4487021014,,,,0.1868556701,0.4077253219,0.1546391753,,0.2639175258,,,0.5427901524,0.006720430108,0.4545454545
  2 ,"Age: 41-64 | Gender: Female | CLONAZEPAM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,,,,,,,,,0.015625,0.5242718447
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | DESVENLAFAXINE SUCCINATE,,,,,,,,,,,0.375,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | DULOXETINE HCL,,,,,,,,,,,0.3947368421,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.3272727273,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4098360656,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | DULOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.299270073,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5609756098,,,,,
  2 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE,,,,,,,0.375,,,,0.34767642,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,,,,,0.2116788321,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,,,,,0.3642857143,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1589958159,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.6785714286,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3774834437,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.4761904762,,,,,
  2 ,Age: 41-64 | Gender: Female | CLONAZEPAM | FLUOXETINE HCL,,,,,,,,0.6567164179,,,0.4267310789,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | FLUOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.3257575758,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.3523809524,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5032679739,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | HEADACHE (dxo:ICD9:7840),0.008474576271,,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | CLONAZEPAM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.4466019417,,,,,,,,,,,0.5405405405,0.007067137809,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5153846154,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5196078431,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.3,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.308988764,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2931034483,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.4090909091,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.4429824561,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.3949044586,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4794520548,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.004524886878,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6943521595,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02884615385,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | PAROXETINE HCL,,,,,,,,,,,0.3925233645,,,,,
  2 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01459854015,,,,,,0.1927710843,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | CLONAZEPAM | SERTRALINE HCL,,,,,,,,,,,0.4363885089,,,0.6746794872,,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5815217391,,,,,
  2 ,Age: 41-64 | Gender: Female | CLONAZEPAM | TRAZODONE HCL,,,,,,,,,,,0.3254593176,,,,0.02118644068,
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5310734463,,,,,
  2 ,Age: 41-64 | Gender: Female | CLONAZEPAM | VENLAFAXINE HCL,,,,,,,,,,,0.4150141643,,,,,0.6859504132
  1 ,Age: 41-64 | Gender: Female | CLONAZEPAM | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.01666666667,
  1 ,Age: 41-64 | Gender: Female | CLONIDINE HCL,,,,,,,,,,,,,,,0.01379310345,
  1 ,Age: 41-64 | Gender: Female | CLOTRIMAZOLE/BETAMETHASONE DIP,,,0.3867403315,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CODEINE PHOSPHATE/GUAIFENESIN,,,0.4714912281,,,,,,,,,,,,0.006423982869,0.3452380952
  1 ,Age: 41-64 | Gender: Female | CODEINE PHOSPHATE/GUAIFENESIN | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.007874015748,
  1 ,Age: 41-64 | Gender: Female | CODEINE PHOSPHATE/GUAIFENESIN | TRAZODONE HCL,,,,,,,,,,,,,,,0.01,
  2 ,"Age: 41-64 | Gender: Female | CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)",,0.01754385965,,,,,,0.5592105263,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280) | FLUOXETINE HCL",,,,,,,,0.6796116505,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)",,,,,0.07439824945,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929) | HYDROXYZINE HCL",,,,,0.1153846154,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016),,,0.3984063745,,,,,0.4278074866,,,,,,0.425257732,,
  1 ,Age: 41-64 | Gender: Female | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016) | SERTRALINE HCL,,,,,,,,,,,,,,0.7260273973,,
  4 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL,,,,,,,0.1844660194,0.4774193548,,,,,0.2433862434,,0.005958291956,
  1 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | HYDROCODONE/ACETAMINOPHEN,,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | IBUPROFEN,,,,,,,,,,,,,,,0.007692307692,
  1 ,"Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.003802281369,
  1 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | TRAMADOL HCL,,,,,,,,,,,,,,,0.01442307692,
  1 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.01234567901,
  1 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,,0.005,
  1 ,Age: 41-64 | Gender: Female | CYCLOBENZAPRINE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0,
  6 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.4875207987,,,,0.1683168317,0.5551330798,,,0.3263598326,0.4868804665,,0.5351351351,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | DULOXETINE HCL",,,,,,,,,,,0.3706896552,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,,,,,0.3435582822,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.7282913165,,,0.4386792453,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.768,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.4677419355,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4785714286,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.7402597403,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7302904564,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,0.3560606061,0.7081545064,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,0.4484304933,,,0.7140115163,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,0.4558823529,,,,,
  15 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.01685891748,0.02424612877,0.5359028511,0.6473526474,0.1840659341,0.4495515695,0.1572383073,0.5676406926,,0.0625,0.3155949741,0.482,0.3187250996,0.6114285714,0.01431670282,0.5755208333
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DESVENLAFAXINE SUCCINATE",,,,0.7455752212,,,,,,,,,,,,0.7986111111
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss",,,,0.4504504505,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DESVENLAFAXINE SUCCINATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,0.7667731629,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.02643171806,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DOXEPIN HCL",,,,,0.5652173913,,,,,,,,,,,
  5 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL",0,,,,,0.6110019646,,,,,0.389261745,,,,0.009009009009,0.721822542
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | HYDROCODONE/ACETAMINOPHEN",,,,,,0.6129032258,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Diff & No Remiss",0.01739130435,,,,,,,,,,,,,,0,0.5265957447
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01587301587,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7435897436
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Diff & Remiss",,,,,,,,,,,,,,,,0.6746031746
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01941747573,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Same & No Remiss",,,,,,0.3018018018,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,0.2321428571,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Same & Remiss",,,,,,0.7150537634,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,,,,,0.6645962733,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,0.5550660793,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.01775147929,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DYSTHYMIC DISORDER (dxo:ICD9:3004)",,,,,,,,,,,,,,,,0.5480769231
  8 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",0.008403361345,0.06271777003,0.8285714286,,,,0.3480769231,0.6624203822,,,0.3217115689,,,,0.03448275862,0.6747252747
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN",,,,,,,0.3238095238,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.02564102564,
  7 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",0.02197802198,0.01898734177,0.5974842767,,,,,0.509202454,,,0.1891252955,,,,0.01910828025,0.5572139303
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01265822785,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,0.2745098039,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss",,,,,,,,,,,0.5,,,,,0.6633663366
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1214574899,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,0.2097902098,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.147826087,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.09221311475,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss",,,,,,,0.7658730159,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.7412935323,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.3194444444,,,,0.4076923077,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | TRAZODONE HCL",,,,,,,,,,,0.5042016807,,,,0.01369863014,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.5305466238,,,,,,,,,,,,,0.6317626527
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7207792208
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7530562347
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESTRADIOL",,,,,,,,0.5863874346,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESTRADIOL | FLUOXETINE HCL",,,,,,,,0.7491408935,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESTRADIOL | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.7641509434,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESTROGEN,CON/M-PROGEST ACET | FLUOXETINE HCL",,,,,,,,0.75,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESTROGENS, CONJUGATED",,,,,,,,0.496350365,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESTROGENS, CONJUGATED | FLUOXETINE HCL",,,,,,,,0.7126436782,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUCONAZOLE",,0,,,,,,,,,,,,,,
  7 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",0.03759398496,0.02313624679,,0.649122807,,,,0.6977016886,,,0.419001218,,,,0.01234567901,0.7008130081
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | GABAPENTIN",,,,,,,,0.6902654867,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,,,,,,,0.6666666667,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,,0.7067307692,,,0.4038461538,,,,,0.7394957983
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.656779661,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss",,,,,,,,0.6168224299,,,,,,,,
  5 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss",0.009009009009,0.02173913043,,,,,,,,,0.3357933579,,,,0,0.4894736842
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0.02255639098,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6909090909,,,,,,,0.01421800948,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,0.4100719424,,,,,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & Remiss",,0.07079646018,,,,,,,,,0.4139344262,,,,,0.6927710843
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.0253164557,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.4107526882,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,,0.421875,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.6660305344,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss | SIMVASTATIN",,,,,,,,0.7272727273,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,0.7058823529,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | LEVOTHYROXINE SODIUM",,,,,,,,0.707641196,,,0.4537815126,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | MYOPIA (dxo:ICD9:3671)",,,,,,,,0.7535211268,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,,0.6972477064,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,,,,,,,0.6222222222,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | PALPITATIONS (dxo:ICD9:7851)",,,,,,,,0.6826923077,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,0.6807511737,,,0.4285714286,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | SIMVASTATIN",,,,,,,,0.774691358,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | TRAZODONE HCL",,,,,,,,0.5405405405,,,0.6107784431,,,,0.02392344498,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,,0.6816326531,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",,,,,,,,0.7115384615,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,0.6194690265,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | ZOLPIDEM TARTRATE",,,,,,,,0.6463414634,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",0.02631578947,0.03164556962,,,,,0.1705426357,0.5625,,,,,,,,
  8 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,0.03501945525,0.7054263566,,,,0.1160714286,0.5183823529,,,0.2470588235,0.4959349593,,0.6761133603,,0.6701986755
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL",,,,,,,,,,,,0.6415929204,,,,0.7669902913
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL",,,,,,,,,,,,,,0.7450980392,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",,,,,,,,,,,,,,,,0.7228915663
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6666666667
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.747311828
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840)",0.01616628176,0.01639344262,,,,,,,,0.04897959184,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.02030456853,,,,,,,,,0.04347826087,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.008,,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HYDROCODONE/ACETAMINOPHEN",,,,,,0.4467005076,0.1907216495,,,,,,,0.625,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HYDROCODONE/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1714285714,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HYDROCODONE/ACETAMINOPHEN | SERTRALINE HCL",,,,,,,,,,,,,,0.75,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,,,,,0.02380952381,0.288372093
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,,,0.2857142857
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3565217391
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.401459854
  4 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,0.01058201058,0.4714285714,,,,,0.5226480836,,,,,,,0.006976744186,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.004444444444,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.009174311927,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.02661596958,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.005494505495,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,,,0.6371681416,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5825688073
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.01395348837,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.02564102564,0.7387387387
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.5424836601,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6043165468
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,,,,,0.2446043165,,,,,0.5104895105
  6 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | SERTRALINE HCL",0.006802721088,0.02083333333,,,,,,0.4473684211,,,0.375,,,,0.01351351351,0.4779411765
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.3914893617,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7086092715
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,0.0347826087,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.0127388535,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.03846153846,0.64
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | PAROXETINE HCL",,,,,,,,,,,0.3833333333,,,,,0.6435643564
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | SERTRALINE HCL",,0.01898734177,,,,,,,,,0.4064516129,,,,,0.6898148148
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.671875
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | VENLAFAXINE HCL",,,,,,,,,,,0.3936170213,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | NORTRIPTYLINE HCL",,,,,,,,,,0.1027027027,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.3564356436,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.3952095808,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.392
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL",,,,,,,,,,,,,,0.4716981132,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.4075342466,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4655532359,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3855421687
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.005340453939,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4205518554
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL",,,,,,,,,,,,,,0.7445255474,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.6897810219,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7258064516,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7584541063
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7329105004
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | LEVOFLOXACIN",,,,,,,0.1782178218,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | LEVOTHYROXINE SODIUM",,,0.6306818182,,,,,0.5755813953,,,,,,0.6447368421,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | LEVOTHYROXINE SODIUM | SERTRALINE HCL",,,,,,,,,,,0.3071428571,,,0.7833333333,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | LEVOTHYROXINE SODIUM | VENLAFAXINE HCL",,,,,,,,,,,0.452173913,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | LORAZEPAM",,0.01515151515,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,,,0.4618644068
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7260273973
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.03105590062,,,,,,,0.5363636364,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MORBID OBESITY (dxo:ICD9:27801)",,0.008130081301,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MYOPIA (dxo:ICD9:3671)",,0.01935483871,,,,,,0.568,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01536312849,,,,,0.2279411765,0.4859813084,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NORTRIPTYLINE HCL",,,,,,,,,,0.2378854626,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.0297029703,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OBESITY, UNSPECIFIED (dxo:ICD9:27800) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.03773584906,,,,,,,,,,,,,,
  6 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.02782608696,,0.6503496503,,0.4428571429,0.1417910448,0.5030674847,,,,,,,,0.6382978723
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.0275862069,,0.6692913386,,0.4652406417,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",0.009836065574,,0.5190839695,,,,,,,,,,,0.6168831169,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.01052631579,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL",,,,,,,,,,,,,,0.7712418301,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OXYCODONE HCL",0.04098360656,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,,0.462585034,,,,,,,,
  6 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",0.02727272727,0.03370786517,,,,,,,,,0.3325791855,0.6649899396,,,0.02,0.6965174129
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.6192468619,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.009090909091,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",0.01754385965,0.01857585139,,,,,,,,,,,,,,0.2803030303
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,,0.006849315068,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.04693140794,,,,,0.1666666667,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.01169590643,,,,,,,,,,,,,,
  8 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.005797101449,0.01503759398,,0.7069892473,,0.4750499002,0.1471282455,0.5853658537,,,0.316017316,0.4531835206,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL",,,,,,,,,,,0.464516129,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VENLAFAXINE HCL",,,,,,,,,,,0.2426470588,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",,,0.5808823529,,,,,,,,,,,,,0.6916666667
  10 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",0.005882352941,0.01671309192,,0.6216216216,,0.5871559633,0.2277227723,0.6086956522,,,0.4161979753,,,0.7476432197,0.005988023952,0.6814580032
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL | SIMVASTATIN",,,,,,,,,,,0.4230769231,,,,,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.6769230769,,,,0.03083700441,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SIMVASTATIN",,,0.6116504854,,,,,0.6359223301,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",,,,,,,,,,,,,,,,0.5673076923
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7125
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAMADOL HCL",,,,,,,,,,,,,,,0.005494505495,
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,,,,,,,,,,0.3821138211,,,,0.02479338843,
  3 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.6,,,,0.03896103896,0.582781457
  4 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.4579439252,0.1650485437,0.5024154589,,,,,,,0.03703703704,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,0.4341085271,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",,,,,,,,,,,,,,,,0.497005988
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7336244541
  1 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VALACYCLOVIR HCL",,0.0206185567,,,,,,,,,,,,,,
  7 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,0.03422053232,,0.7603305785,,0.6095238095,,0.6165413534,,,0.3451327434,,,,0.01492537313,0.7125965251
  2 ,"Age: 41-64 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ZOLPIDEM TARTRATE",,,,,,,,0.5289256198,,,,,,,0.00956937799,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF FOOT (dxo:ICD9:1104),,,,,,,,0.4378378378,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF FOOT (dxo:ICD9:1104) | FLUOXETINE HCL,,,,,,,,0.6638655462,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.4839108911,,,,0.1334816463,0.4763458401,,,0.2126436782,0.40562249,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ESCITALOPRAM OXALATE,,,,,,,0.335483871,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.09223300971,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2627118644,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | FLUOXETINE HCL,,,,,,,,0.6806930693,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3655172414,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.6714285714,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.1274509804,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | PAROXETINE HCL,,,,,,,,,,,,0.6845637584,,,,
  2 ,Age: 41-64 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1464285714,,,,,0.3333333333,,,,
  1 ,Age: 41-64 | Gender: Female | DESLORATADINE,,,,,,,0.09965635739,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESLORATADINE | ESCITALOPRAM OXALATE,,,,,,,0.2079207921,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESLORATADINE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.1139896373,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESOGESTREL-ETHINYL ESTRADIOL,,,,,,,,,,,,,,0.6170212766,,
  1 ,Age: 41-64 | Gender: Female | DESOGESTREL-ETHINYL ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.7593984962,,
  12 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE,0.02614379085,0.04310344828,0.5134020619,0.5272464814,,0.5782493369,0.2075718016,0.472972973,,,0.3152997187,0.39375,,0.5592105263,0.04716981132,0.717368962
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | DOXEPIN HCL,,,,,,,,,,,0.3602484472,,,,,
  2 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | DULOXETINE HCL,,,,,,0.6473988439,,,,,0.2670565302,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,0.6885245902,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2899159664,,,,,
  2 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | ESCITALOPRAM OXALATE,,,,,,,0.3567010309,,,,0.305764411,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.4695652174,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.2450331126,,,,,
  3 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | FLUOXETINE HCL,,,,0.6976744186,,,,0.5806451613,,,0.3173076923,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3502824859,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,0.2805755396,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,0.1888888889,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE,,,,0.1291793313,,,,,,,0.08838383838,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.04587155963,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.07331378299,,,,,
  4 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Diff & No Remiss,,0.02010050251,,,,,,,,,0.3278688525,,,,0.02702702703,0.568
  2 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.6264367816,,,,0.02966101695,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7608695652
  5 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Diff & Remiss,,0.04545454545,,0.8106060606,,0.6017699115,,,,,0.3742690058,,,,,0.7272727273
  2 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,0.6637931034,,,,,,,,,,,0.06666666667,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss,,,,0.4600840336,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.1538461538,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.5205479452,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Same & Remiss,,,,,,,,,,,0.5327868852,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5779467681,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,0.7086614173,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,0.6014084507,,,,,,,0.5482954545,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.7156862745,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4482758621,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | MIRTAZAPINE,,,,,,,,,,,0.2575107296,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | NORTRIPTYLINE HCL,,,,,,,,,,,0.4117647059,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2167832168,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | Num Previous Remissions: 2+,,,,0.8362068966,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PAROXETINE HCL,,,,,,,,,,,,0.5333333333,,,,
  2 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.2067736185,,,,,,,0.1709401709,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,0.185840708,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PRAMIPEXOLE DI-HCL,,,,0.5092592593,,,,,,,0.4600938967,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,0.4860335196,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,0.2465753425,,,,,,,0.1337209302,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,0.1596638655,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1282051282,,,,,
  2 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,0.3099630996,,,,,,,0.1891891892,,,,,
  1 ,"Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,0.2685185185,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | ROPINIROLE HCL,,,,0.515625,,,,,,,0.5034482759,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | ROSUVASTATIN CALCIUM,,,,0.7464788732,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.745472837,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL,,,,0.6956521739,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | SERTRALINE HCL,,,,0.7345132743,,,,,,,0.3688212928,,,0.6053412463,,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2822580645,,,,,
  3 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,0.5731132075,,,,,,,0.34137577,,,,0.05882352941,
  1 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3553113553,,,,,
  2 ,Age: 41-64 | Gender: Female | DESVENLAFAXINE SUCCINATE | VENLAFAXINE HCL,,,,,,,,,,,0.275,,,,,0.751572327
  1 ,Age: 41-64 | Gender: Female | DEXAMETHASONE,,,,,,,,,,,,,,,,0.3714285714
  1 ,"Age: 41-64 | Gender: Female | DEXAMETHASONE | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,,,0.3879310345
  1 ,Age: 41-64 | Gender: Female | DEXLANSOPRAZOLE,,,,,,,,,,,0.2670454545,,,,,
  1 ,Age: 41-64 | Gender: Female | DEXLANSOPRAZOLE | DULOXETINE HCL,,,,,,,,,,,0.4746835443,,,,,
  1 ,Age: 41-64 | Gender: Female | DEXLANSOPRAZOLE | ESCITALOPRAM OXALATE,,,,,,,,,,,0.3539823009,,,,,
  1 ,Age: 41-64 | Gender: Female | DEXLANSOPRAZOLE | VENLAFAXINE HCL,,,,,,,,,,,0.4173913043,,,,,
  6 ,Age: 41-64 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE,,,0.4923076923,,,,0.1907894737,0.4464285714,,,,,,0.487804878,0,0.4841269841
  1 ,Age: 41-64 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | FLUOXETINE HCL,,,,,,,,0.641025641,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7194244604,,
  1 ,Age: 41-64 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | SERTRALINE HCL,,,,,,,,,,,,,,0.6881028939,,
  1 ,Age: 41-64 | Gender: Female | DEXTROAMPHETAMINE/AMPHETAMINE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7364341085
  1 ,"Age: 41-64 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED (dxo:ICD9:25001)",0.02243589744,,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.02770330652,,,,,,,,,,,0.2698412698,,,
  1 ,"Age: 41-64 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01360544218,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.03424657534,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.03174603175,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.02721088435,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE (dxo:ICD9:5533),,,0.5584415584,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | DIAZEPAM,,,0.5081967213,,,,,0.4447439353,,,,,,0.5255474453,0.01030927835,0.4235294118
  1 ,Age: 41-64 | Gender: Female | DIAZEPAM | FLUOXETINE HCL,,,,,,,,0.6587677725,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DIAZEPAM | SERTRALINE HCL,,,,,,,,,,,,,,0.640625,,
  1 ,Age: 41-64 | Gender: Female | DIAZEPAM | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7156862745
  2 ,Age: 41-64 | Gender: Female | DIFFUSE CYSTIC MASTOPATHY (dxo:ICD9:6101),,,0.4696969697,,,,,0.4211956522,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DIFFUSE CYSTIC MASTOPATHY (dxo:ICD9:6101) | FLUOXETINE HCL,,,,,,,,0.6842105263,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820),0,,,,,,,,,0.02027027027,,,,,,
  1 ,Age: 41-64 | Gender: Female | DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820) | GABAPENTIN,,,,,,,,,,0.06611570248,,,,,,
  1 ,Age: 41-64 | Gender: Female | DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820) | HEADACHE (dxo:ICD9:7840),,,,,,,,,,0.01764705882,,,,,,
  7 ,Age: 41-64 | Gender: Female | DIZZINESS AND GIDDINESS (dxo:ICD9:7804),,,0.5234899329,,,,0.1075268817,0.4195519348,,0.0376344086,0.216374269,,,0.5159817352,,0.4342105263
  1 ,Age: 41-64 | Gender: Female | DIZZINESS AND GIDDINESS (dxo:ICD9:7804) | FLUOXETINE HCL,,,,,,,,0.6387434555,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DIZZINESS AND GIDDINESS (dxo:ICD9:7804) | HEADACHE (dxo:ICD9:7840),,,,,,,,,,0.03246753247,,,,,,
  11 ,Age: 41-64 | Gender: Female | DOXEPIN HCL,0.01826484018,0.02525252525,0.4327272727,,0.3381649731,0.3229571984,0.1393939394,0.306122449,,,0.3692285632,0.3597122302,,0.3919753086,,0.447257384
  3 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | DULOXETINE HCL,,,,,0.3788546256,0.570977918,,,,,0.3762376238,,,,,
  2 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,0.6614785992,,,,,0.4930555556,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | DULOXETINE HCL | Last AD: Diff & Remiss,,,,,,0.66,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5797101449,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3519163763,,,,,
  3 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE,,,,,0.3700787402,,0.3514285714,,,,0.3328,,,,,
  2 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.3833333333,,,,0.3354037267,,,,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3931034483,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3262411348,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.3010752688,,,,,
  3 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL,,,,,0.2733485194,,,0.5748218527,,,0.4190821256,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.5367231638,,,,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.67752443,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.5405405405,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5614035088,,,,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.67752443,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.4297520661,,,0.2962962963,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | HYDROXYZINE HCL,,,,,0.3771929825,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | HYDROXYZINE HCL | Last AD: Same & No Remiss,,,,,0.2051282051,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | LAMOTRIGINE,,,,,,,,,,,0.1037974684,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.06043956044,,,,,
  5 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss,,0.01449275362,,,,,0.1436781609,,,,0.2943037975,,,0.4315068493,0.005747126437,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6220930233,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7375328084,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.431372549,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7227722772
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.4406779661,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.525,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.01438848921,
  2 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4958677686,,,,,0.7374100719
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.4666666667,,,,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7090909091,,
  2 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.4907407407,,,0.6956521739,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Same & No Remiss,,,,,0.1482611348,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,0.1891891892,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4444444444,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Same & No Remiss | UNSPECIFIED URTICARIA (dxo:ICD9:7089),,,,,0.1557377049,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Same & Remiss,,,,,0.6109422492,,,,,,0.5596072931,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.580952381,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5683453237,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5203252033,,,,,
  2 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,0.5031847134,,,,,,0.4626865672,,,,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3888888889,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | MIRTAZAPINE,,,,,,,,,,,0.2704402516,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2340425532,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.3259259259,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.3372093023,,,,,
  1 ,"Age: 41-64 | Gender: Female | DOXEPIN HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7367149758,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2444444444,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2026315789,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1897810219,,,,,
  3 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | PAROXETINE HCL,,,,,0.3191489362,,,,,,0.3944954128,0.6157024793,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4392523364,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4436090226,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | RISPERIDONE,,,,,,,,,,,0.1550387597,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | ROPINIROLE HCL,,,,,,,,,,,0.4088785047,,,,,
  3 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | SERTRALINE HCL,,,,,0.358490566,,,,,,0.4222503161,,,0.6437941473,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3387096774,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.3139303483,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.364548495,,,,,
  1 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | UNSPECIFIED URTICARIA (dxo:ICD9:7089),,,,,0.3392857143,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DOXEPIN HCL | VENLAFAXINE HCL,,,,,0.2974683544,,,,,,0.3729308666,,,,,0.6980519481
  1 ,Age: 41-64 | Gender: Female | DOXYCYCLINE MONOHYDRATE,,,0.5390070922,,,,,,,,,,,,,
  15 ,Age: 41-64 | Gender: Female | DULOXETINE HCL,0.01965923984,0.03352559481,0.5088776157,,0.08333333333,0.4681513947,0.2244467861,0.5056938001,0.123100304,0.05974842767,0.3330772652,0.406185567,0.2130434783,0.5034709536,0.02073170732,0.6371115174
  10 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE,0.009803921569,0.02536231884,0.644549763,,,0.584496124,0.3785259327,0.4031007752,,,0.3048729696,0.4057971014,,0.4350649351,,0.598540146
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,,,,,0.2529411765,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.224137931,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.24,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,,,,,0.06832298137,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.09259259259,,,,,
  6 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.01754385965,,,,0.5758835759,0.4367245658,,,,0.3492063492,,,,0.009090909091,0.5740740741
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.4517374517,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3632286996,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,0.5882352941,,,,,0.3319327731,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.3714285714,,,,0.4140625,,,,0.009433962264,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5479452055,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,0.6203208556,0.5331010453,,,,0.4336283186,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,0.5,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4761904762,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,0.3631284916,0.1967741935,,,,0.2772277228,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.219047619,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3768115942,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3617021277,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,0.6568627451,,,,,0.5461538462,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.472392638,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.546875,,,,0.4972375691,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,,,,,0.2809917355,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | NORTRIPTYLINE HCL,,,,,,,,,,,0.32,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.09638554217,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1538461538,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3983050847,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.28,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,,,,,0.3915343915,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,,,,,0.2580645161,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,0.4727272727,0.2886597938,,,,0.2925890279,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,,,,,0.21875,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ESZOPICLONE,,,,,,0.6515151515,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | EZETIMIBE/SIMVASTATIN,,,,,,0.6296296296,,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL,,0.02380952381,0.4198113208,,,0.499377335,0.25,0.6036757776,,,0.3174120712,,,0.4608294931,,0.5779816514
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.41,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,,,,0.1,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1031746032,,,,,
  4 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.01666666667,,,,0.587962963,,0.7009803922,,,0.4015151515,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7429078014,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.6779661017,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3595505618,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5496688742,,,,0.01604278075,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.598540146,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,0.6392694064,,0.7238095238,,,0.4481012658,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6954022989,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.375,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.3616071429,,0.3776824034,,,0.3677419355,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5338983051,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5054151625,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7045454545,,,0.5928571429,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5550847458,,,,,
  3 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.6237623762,,0.756302521,,,0.5291262136,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3925233645,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.3173076923,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.7429577465,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.237804878,,,,,
  3 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.2547169811,,0.2710280374,,,0.09027777778,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1904761905,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.368852459,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.2264150943,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,0.3571428571,,0.454248366,,,0.3617193836,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2780487805,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN,,,,,,0.609141791,0.2403846154,,,,0.4677419355,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & No Remiss,,,,,,,,,,,0.2857142857,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4455445545,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.5023255814,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & No Remiss | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5925925926,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & Remiss,,,,,,,,,,,0.4488188976,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss,,,,,,0.3436960276,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3173333333,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss,,,,,,0.6506666667,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6625514403,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.7,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.641509434,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | TRAMADOL HCL,,,,,,0.5170068027,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | TRAZODONE HCL,,,,,,0.5158730159,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6605633803,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,0.4237288136,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | HEADACHE (dxo:ICD9:7840),0.01515151515,,,,,,,,,0.05217391304,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.02272727273,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL,,,,,,,,,,0.1475409836,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | HYDROCODONE/ACETAMINOPHEN,,,,,,0.5948553055,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss,,,,,,0.3490566038,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | HYDROCODONE/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.5727272727,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,0.2853185596,,,,,0.1089385475,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,0.1228070175,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,0.1568627451,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.2211538462,,,,,0.104,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.0775862069,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,0.2511210762,,,,,0.1604477612,,,,,
  6 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.3113207547,,,0.3568345324,0.1161616162,0.362962963,,,0.1632653061,,,0.3172413793,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1826923077,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,0.2323651452,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.1503759398,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,0.2512077295,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss",,,,,,0.4854368932,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.1862745098,,,,,0.1132075472,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,0.1756756757,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,0.3417721519,,,,,0.2170818505,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,0.3406113537,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,0.2902097902,,,,,0.1137931034,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,0.1843971631,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,0.1617647059,,,,,0.1149425287,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.02614379085,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.009756097561,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.005714285714,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.009009009009,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.006993006993,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.02162162162,
  6 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE,,,0.1834862385,,,0.1275757576,0.09708737864,0.1428571429,,,0.08361204013,,,0.188034188,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,0.1132404181,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.4450127877,,,,,0.4355828221,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,0.4132231405,,,,,0.2833333333,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.1015625,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.1176470588,,,,,0.07920792079,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.04385964912,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.04464285714,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.07272727273,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.09803921569,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | ROPINIROLE HCL,,,,,,0.1441441441,,,,,0.09375,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.0495049505,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,0.1228070175,,,0.1634615385,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,0.125,,,,,0.09397024276,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.09615384615,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.07926829268,,,,,
  12 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss,0.007575757576,0.02211981567,0.4568138196,,,0.6044776119,0.189987163,0.5206286837,,0.05479452055,0.2970195272,0.3522727273,,0.4798711755,0.009592326139,0.5076708508
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,0.5212121212,,,0.203539823,,0.4538461538,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02752293578,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,0.5910652921,,,,0.1261261261,0.5179282869,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Episodes: 2+,,,,,,,,,,,0.4897959184,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6056338028,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5377358491,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.7322175732,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0.03913043478,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7426470588,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7699115044,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.02931034483,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3486590038,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | ROPINIROLE HCL,,,,,,,,,,,0.5247524752,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4166666667,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,0.5047619048,,,,,0.4569045412,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5189873418,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.3604060914,,,,,0.6733668342
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.4158415842,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,0.567251462,,,,,0.4221105528,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.2363636364,,,,0.05084745763,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,0.5364583333,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1575342466,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,0.2958579882,,,,,0.2164179104,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5555555556,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,0.5844155844,,,,,0.550802139,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | ROPINIROLE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5491803279,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.01704545455,,,,0.5744680851,0.2432432432,,,,0.4553571429,,,0.7605633803,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5182481752,,,,0.01515151515,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6136363636,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.02040816327,,,,0.5338097856,,,,,0.5066144047,,,,0.02223371251,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5579470199,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,0.5871559633,,,,,0.4379562044,,,,0.02285714286,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | VENLAFAXINE HCL,,,,,,0.5882352941,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.01169590643,,,,0.6512915129,,,,,0.3734015345,,,,,0.7236614853
  11 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss,0.02727272727,0.06798245614,0.5858208955,,,0.6718213058,0.2838196286,0.6156351792,,,0.4246169056,0.5192307692,,0.6594982079,0.04198473282,0.6581986143
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6944444444,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | NORTRIPTYLINE HCL,,,,,,0.609375,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0.02,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7245508982,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01719197708,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6573426573,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4306930693,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,0.6037735849,,,,,0.6374269006,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.4428571429,0.6923076923,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL,,,,,,0.5891472868,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | ROPINIROLE HCL,,,,,,0.5754189944,,,,,0.5660377358,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,0.5924528302,,,,,0.4712328767,,,0.7661538462,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,0.5840286055,,,,,0.5195530726,,,,0.0350877193,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5871886121,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | VENLAFAXINE HCL,,,,,,0.7087378641,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,0.7054545455,,,,,0.3636363636,,,,,0.7816593886
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.2952019757,,,,,0.3559322034,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.4153846154,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.4642857143,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.375,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,0.3773265651,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4871794872,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4590643275,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4098360656,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3136094675,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.2783171521,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.2695652174,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.2158273381,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.2937062937,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,0.3208955224,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.58,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.1834319527,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1857142857,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5828877005,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PREGABALIN,,,,,,0.3875968992,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4639175258,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.178313253,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2314814815,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | RISPERIDONE,,,,,,0.1339285714,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.4090909091,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5241935484,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.2567567568,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,0.3470790378,,,,,0.328358209,,,0.4195121951,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4879725086,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | TRAMADOL HCL,,,,,,0.335078534,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,0.3272727273,,,,,0.3899082569,,,,0.0135501355,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4372623574,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3392122281,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,0.3726708075,,,,,0.4,,,,,0.5214285714
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,0.6657645467,,,,,0.5803698435,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.8376068376,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.6594594595,,,,,0.7469879518,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7777777778,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.5608108108,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.5542857143,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,0.6230769231,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.7009345794,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6564102564,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,0.7786259542,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6511627907,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.6966292135,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.7333333333,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5866935484,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6610169492,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | PREGABALIN,,,,,,0.6227272727,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6700507614,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5639534884,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5735294118,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.6789667897,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,0.5775862069,,,,,0.7131782946,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5309278351,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | TRAMADOL HCL,,,,,,0.7011494253,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,0.7191780822,,,,,0.575328084,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5561497326,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6497220016,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,0.64,,,,,0.615942029,,,,,0.6862745098
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | LEVOTHYROXINE SODIUM,,,,,,,,,,,0.3113207547,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.7162162162,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.6923076923,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,0.6914979757,,,,,0.660326087,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.762962963,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,0.6666666667,,,,,0.6498054475,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.4663461538,,,,,
  4 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4038461538,,,,0.5785732419,0.4545454545,,,,0.529739777,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,0.626984127,,,,,0.4366197183,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.734375,,,,,0.7431192661,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,0.75,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,0.4752475248,,,,,0.4356435644,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,0.512195122,,,0.6916666667,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,0.5552941176,,,,,0.5259095921,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.427184466,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.5573770492,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MELOXICAM,,,,,,0.6085106383,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.4443319838,,,0.2041237113,,0.3205882353,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2543859649,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.09900990099,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,,,0.3173076923,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.3059701493,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,0.3629893238,,,,,0.2751798561,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.2746478873,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MONTELUKAST SODIUM,,,,,,,,,,,0.43,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,0.6916666667,,,,,0.4468085106,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03086419753,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | NORTRIPTYLINE HCL,,,,,,0.5933908046,,,,0.1683168317,0.3880484115,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3554216867,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.390625,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5299145299,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7466666667,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7642405063,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3070175439,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2522123894,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2678132678,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2847457627,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5403225806,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,0.5863453815,,,,,0.6301369863,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2215909091,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.4566326531,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | OMEPRAZOLE,,,,,,,,,,,0.4337899543,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,0.4259259259,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.5944055944,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.5494505495,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6073619632,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | OXYBUTYNIN CHLORIDE,,,,,,,,,,,0.4628099174,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.645320197,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.5727272727,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",,,,,,0.5818181818,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PALPITATIONS (dxo:ICD9:7851),,,,,,0.6341463415,,,,,0.3448275862,,,,,
  6 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PAROXETINE HCL,,,0.4485981308,,,0.5028328612,0.2727272727,,,,0.3773049645,0.5621621622,,0.4774774775,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,0.4375,,,,,0.4534534535,0.3829787234,,,,
  4 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2264150943,,,0.2712456345,,0.2136752137,,,0.1325966851,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1322751323,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1459854015,,,,,
  3 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,0.2231237323,,,,,0.1807228916,,,,0.03571428571,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1869158879,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1428571429,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,0.4427412083,,,,,0.4716763006,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5944272446,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,0.4224137931,,,,,0.4797687861,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.3622047244,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4041994751,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4821428571,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PREGABALIN,,,,,,0.6516853933,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6861063465,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,0.5172413793,,,,,0.2283464567,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.2944444444,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,0.3125,,,,,0.1404958678,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.08,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,0.2857142857,,,,,0.1596638655,,,,,
  3 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.3148148148,0.1404958678,,,,0.1659693166,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.1666666667,,,,,
  2 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,0.2917705736,,,,,0.2079646018,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.35,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,0.1587301587,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4262295082,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5629820051,,0.4364261168,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5963855422,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | TRAZODONE HCL,,,,,,,,,,,0.4615384615,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | RHEUMATOID ARTHRITIS (dxo:ICD9:7140),,,,,,0.5754716981,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | RISPERIDONE,,,,,,0.1444043321,,,,,0.1181318681,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,0.1962025316,,,,,0.1448467967,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL,,,,,,0.4538461538,,,,,0.473993668,,0.4200542005,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.4534161491,,,,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,0.3405405405,,,,,0.4042553191,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4884792627,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ROSUVASTATIN CALCIUM,,,,,,0.6507936508,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.5774193548,0.3106796117,,,,0.3652173913,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6220472441,,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | SERTRALINE HCL,,0.02252252252,0.3805309735,,,0.509054326,0.2044728435,0.4126984127,,,0.3598389532,,,0.6330690827,,0.5833333333
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,0.4113475177,,,,,0.3494208494,,,0.4651162791,,
  2 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3267973856,,,0.5238095238,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | SIMVASTATIN,,,,,,,,,,,0.4309210526,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.4427860697,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.7261904762
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | TIZANIDINE HCL,,,,,,,,,,,0.4245283019,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | TOPIRAMATE,,,,,,,,,,,0.4808362369,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | TRAMADOL HCL,,,,,,0.6336996337,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | TRAMADOL HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.7136363636,,,,,,,,,,
  10 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL,0.03260869565,0.030651341,0.3191489362,,,0.4222861842,0.1711409396,0.2974683544,,,0.3789358544,,,0.2794117647,0.03246753247,0.419047619
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5749235474,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,0.5661764706,,,,,0.3207843137,,,,,0.6603773585
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),,,,,,0.5779816514,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6386806597,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,0.5972222222,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | VALSARTAN/HYDROCHLOROTHIAZIDE,,,,,,0.728,,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | DULOXETINE HCL | VENLAFAXINE HCL,,0.0269058296,0.5034965035,,,0.635538262,0.2337662338,0.4766839378,,,0.3080704629,,,0.5076923077,,0.7216374269
  1 ,Age: 41-64 | Gender: Female | DYSFUNCTION OF EUSTACHIAN TUBE (dxo:ICD9:38181),,,,,0.05940594059,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | DYSMETABOLIC SYNDROME X (dxo:ICD9:2777),,0.04021447721,,,,0.4653465347,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DYSPHAGIA (dxo:ICD9:7872),,,0.5235602094,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | DYSPHAGIA, UNSPECIFIED (dxo:ICD9:78720)",,,,,,,,,,,,,,,,0.4235294118
  1 ,"Age: 41-64 | Gender: Female | DYSPHAGIA, UNSPECIFIED (dxo:ICD9:78720) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7339449541
  6 ,Age: 41-64 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004),0.0113960114,,,,,,,0.5591397849,,,0.3445945946,,,0.5777777778,0.01006711409,0.5782918149
  1 ,"Age: 41-64 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,,,,,,,,,,,,,,0.6132075472
  1 ,Age: 41-64 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | FLUOXETINE HCL,,,,,,,,0.7108433735,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,,,,,0.64
  1 ,Age: 41-64 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | HEADACHE (dxo:ICD9:7840),0.01869158879,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6440677966
  1 ,Age: 41-64 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01960784314,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6864608076
  1 ,"Age: 41-64 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5238095238,,
  1 ,"Age: 41-64 | Gender: Female | ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.4920634921,,
  1 ,Age: 41-64 | Gender: Female | ELETRIPTAN HYDROBROMIDE,,,0.446969697,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869),,0.02702702703,0.5570776256,,,,0.1775956284,0.5533596838,,,0.4390243902,,,,,
  1 ,Age: 41-64 | Gender: Female | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869) | ESCITALOPRAM OXALATE,,,,,,,0.4117647059,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869) | FLUOXETINE HCL,,,,,,,,0.7272727273,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.02678571429,,,,,0.2274509804,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889),,,0.4913793103,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ERGOCALCIFEROL (VITAMIN D2),,,,,,,,,,,,0.3109243697,,,,
  15 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE,0.02189781022,0.02566086396,0.653901919,,0.1182608696,0.495026178,0.3111506004,0.4584597876,0.1309620049,0.06176783813,0.252783664,0.4116962467,0.1865889213,0.4768811206,0.02155172414,0.582324198
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESOMEPRAZOLE MAGNESIUM,,,0.7137681159,,,,0.3134715026,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESOMEPRAZOLE MAGNESIUM | Last AD: Diff & No Remiss,,,0.6857142857,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESOMEPRAZOLE MAGNESIUM | Last AD: Same & No Remiss,,,,,,,0.1161971831,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESOMEPRAZOLE MAGNESIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3391304348,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.7549019608,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Diff & No Remiss",,,0.6549295775,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESTROGEN,CON/M-PROGEST ACET",,,,,,,0.3911671924,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESTROGEN,CON/M-PROGEST ACET | Last AD: Same & No Remiss",,,,,,,0.1571428571,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ESTROGEN,CON/M-PROGEST ACET | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.38,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | EZETIMIBE,,,,,,,0.3461538462,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | EZETIMIBE/SIMVASTATIN,,,0.8064516129,,,,0.4083044983,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | EZETIMIBE/SIMVASTATIN | Last AD: Same & No Remiss,,,,,,,0.08053691275,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FENOFIBRATE NANOCRYSTALLIZED,,,,,,,0.4651162791,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FENOFIBRATE NANOCRYSTALLIZED | Last AD: Same & No Remiss,,,,,,,0.188976378,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL,0.02752293578,0.02475247525,0.6395348837,,,0.488372093,0.2799704906,0.5759377859,,,0.2501368363,0.352173913,,0.4503042596,0.006666666667,0.5904059041
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.2075471698,0.3703703704,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.02931596091,,,,0.4485981308,0.375,0.6666666667,,,0.3010989011,,,,,0.5144927536
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3958333333,0.6686159844,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3424657534,0.6263736264,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3235294118,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.01639344262,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,,0.4406779661,0.7612903226,,,0.4097222222,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,0.166023166,0.3546910755,,,0.218487395,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.1450381679,0.4265734266,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.1382113821,0.4130434783,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3850574713,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,0.5123966942,0.6467065868,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.4678362573,0.6568627451,,,0.4769230769,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6692607004,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3245614035,,,0.06569343066,,,,,
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | SERTRALINE HCL,,,,,,,0.253164557,0.4545454545,,,0.223880597,,,0.5137614679,,
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,0.2895522388,0.440397351,,,0.2796005706,,,,0.02430555556,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,0.3457943925,0.552,,,0.2739726027,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN,,,,,,0.5459770115,0.4203581527,,,,0.3405017921,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Diff & No Remiss,,,,,,0.4424778761,,,,,0.1851851852,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.37,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,0.1607142857,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.2246376812,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & Remiss,,,,,,,0.7165991903,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.4454545455,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.4117647059,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.02083333333,,,,,0.3395522388,,,,0.3089430894,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.01485148515,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,,,,,,0.1634241245,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.07643312102,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3456221198,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GUAIFENESIN/P-EPHED HCL,,,,,,,0.2682926829,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GUAIFENESIN/P-EPHED HCL | Last AD: Same & No Remiss,,,,,,,0.1121076233,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GUAIFENESIN/PHENYLEPHRINE HCL,,,,,,,0.2957746479,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GUAIFENESIN/PHENYLEPHRINE HCL | Last AD: Same & No Remiss,,,,,,,0.1232227488,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.6507936508,,,,0.225974026,,,,0.2275862069,0.4489795918,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,,,,,0.1692307692,,,,,0.5644171779
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.2352941176,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,,,,,,0.1075514874,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss,,,,,,,0.5284552846,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HEADACHE (dxo:ICD9:7840),0.02261306533,,,,,,,,,0.06018518519,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.0202020202,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL,,,,,,,,,,0.162601626,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.286908078,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss,,,,,,,0.1557788945,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.135483871,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3531746032,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HYDROCODONE/HOMATROPINE,,,,,,,0.3965517241,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | HYDROXYCHLOROQUINE SULFATE,,,,,,,0.3592814371,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.2884615385,,,,0.2145669291,,,,0.1073943662,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.09954751131,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.08267716535,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.09160305344,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.02290076336,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,0.1361702128,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.09392265193,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.05882352941,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.1395348837,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,0.1287128713,,,,,
  8 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.3748584371,,,0.1901840491,0.1832091016,0.247706422,,,0.1314475874,0.248447205,,0.2866972477,,0.3056133056
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.106557377,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,0.08474576271,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,,,,,0.1071428571,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,0.2052980132,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.1913043478,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.0593220339,,,,,
  3 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3684210526,,,,,,,,0.08847184987,,,,,0.252173913
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,0.1832061069,,,,0.1538461538,,,,,
  3 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.1589648799,,,,0.1965811966,,,,0.009708737864,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.117147708,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,0.1315789474,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,0.08965517241,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07926829268,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1235294118,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1047619048,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss",,,,,,,0.504950495,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.55,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1293103448,,,,0.1036585366,,,,0.09523809524,,,,,0.1531531532
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06730769231,,,,,
  8 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3703703704,,,0.2376237624,0.1890660592,0.2386363636,,,0.1004497751,0.2277227723,,0.304029304,,0.2960288809
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1987951807,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1586206897,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,0.1743119266,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,0.1619496855,,,,0.2096774194,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,0.1774193548,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.1461377871,,,,0.06516853933,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,0.09150326797,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.0487804878,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,0.1278195489,,,,0.07906976744,,,,,
  4 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.7614678899,,,,,0.6120689655,,,,,,0.5486725664,0.0351758794,
  4 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,0.5982142857,,,,,0.4890510949,,,,,,0.4770114943,0.01379310345,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.009933774834,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01271186441,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01923076923,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.009615384615,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01081081081,
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,0.08153846154,0.1073825503,,,0.06807511737,,,0.1464646465,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,0.06367924528,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,0.09657320872,,,,0.08099173554,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.07857142857,,,,,
  13 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0.01230228471,0.01903520209,0.6050993181,,,0.4101587302,0.359832636,0.4873026767,0.09523809524,0.05844155844,0.1903335331,0.4352941176,,0.5040723982,0.01451187335,0.5177570093
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.1544117647,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,0.3380782918,,0.2296296296,,0.343373494,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,0.3945945946,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01337792642,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,,0.3544973545,,,0.08910891089,0.3553719008,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,,,,,,0.3609271523,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.2847682119,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Episodes: 2+,,,,,,,,,,,0.362962963,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3536585366,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,0.3009708738,,,,,0.5476190476,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL",,,,,,,0.1928571429,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,0.3179487179,,,,,,,0.6367041199,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.2990492653,,,,,,,,0.0101010101,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,0.3434343434,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | TRAZODONE HCL",,,,,,,0.3333333333,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,0.3721973094,,,,,0.7416666667,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,0.185483871,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.2,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | ROPINIROLE HCL",,,,,,,0.3951612903,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL",,,,,,,0.2945736434,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,0.3759791123,,,,,,,0.7064777328,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.3280254777,,,,,,,,0.01297016861,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,0.3642384106,,,,,,,,,
  7 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,0.008403361345,0.5989304813,,,0.42,,0.3798449612,,,0.2132796781,,,0.4936708861,,0.5811965812
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.2702702703,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.2561983471,,,,,0.4411764706
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2669616519,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.3333333333,,,,,0.5473684211
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.1810344828,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | OMEPRAZOLE,,,,,,,,,,,0.2321428571,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.04195804196,,,,0.4071428571,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,,,,,0.1357142857,,,,,
  5 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.01282051282,,,,,0.3170731707,,,,0.2395437262,0.6916666667,,,,0.5819672131
  3 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.0218579235,,,,,,,,,0.1428571429,,,,0.06194690265,
  3 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,0.1860465116,,,,0.1353383459,,,,0.03738317757,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,0.4273504274,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1666666667,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.0790960452,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,0.2258064516,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.121761658,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.1960784314,,,,0.1538461538,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,0.3039215686,,,,0.5172413793,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,,0.3974358974,,,,0.6023391813,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.3611111111,,,,,0.1581920904,0.4074074074,,,,
  8 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02325581395,0.6635514019,,,0.4262295082,0.3731617647,,,,0.2842741935,,,0.7794117647,0.01709401709,0.5138121547
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,0.2162162162,,,,0.3162393162,,,,0.01117318436,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SIMVASTATIN,,,0.7328244275,,,,,,,,0.1596638655,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.2352941176,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.4663461538
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TOPIRAMATE,,,,,,,,,,,0.2761904762,,,,,
  5 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.01119402985,,,,0.3879310345,0.3134747349,,,,0.3229166667,,,,0.01406752412,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,0.2719298246,,,,0.3828125,,,,0.0218579235,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4080996885,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.0365448505,,,,0.4925373134,0.3517915309,,,,0.3474576271,,,,,0.6477495108
  11 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,0.025,0.09379310345,0.7332535885,,,0.5440528634,,0.5563380282,0.296,,0.4157245632,0.5487804878,,0.6666666667,0.07763975155,0.6405228758
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5238095238,,,,,,,,,0.6714285714,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,0.7333333333,,,,,,,,0.54,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | NORTRIPTYLINE HCL,,,,,,,0.6055045872,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL",,,,,,,0.6274509804,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.5704697987,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+ | TRAZODONE HCL",,,,,,,0.6101694915,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,0.380952381,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.6504854369,,,,,,,,0.02380952381,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,0.3398058252,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.467032967,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,0.6081081081,,,,0.5350877193,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,0.4678899083,,,,0.4533333333,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,0.3986928105,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | ROPINIROLE HCL,,,,,,,0.4134078212,,,,0.5566037736,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,0.3720930233,,,,0.4186851211,,,0.7898550725,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,0.6175,,,,0.5162037037,,,,0.05061559508,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5098039216,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.1261261261,,,,,0.4351464435,,,,0.4032786885,,,,,0.7443181818
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1399505766,,,,0.3378378378,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.291954023,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.2568807339,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.1492537313,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.1661016949,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | Num Previous Episodes: 2+,,,,,,,0.1641791045,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1239669421,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.288590604,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,0.11,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,0.1684782609,,,,,,,0.3841059603,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.1754385965,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,0.1984126984,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,0.1100917431,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,0.1732673267,,,,,,,0.3949044586,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.1814671815,,,,,,,,0.008196721311,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,0.1870503597,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.1843600818,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1458333333,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OMEPRAZOLE,,,,,,,0.1833333333,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1662024141,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SIMVASTATIN,,,,,,,0.1315789474,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2818671454,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1467181467,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OLMESARTAN MEDOXOMIL,,,,,,,0.1557788945,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OMEPRAZOLE,,,,,,,0.1544117647,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OMEPRAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1449275362,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,,,,,0.1125827815,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.1178861789,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.09868421053,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,0.1062355658,,,,,0.3138297872,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4019607843,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,0.147826087,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1531531532,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.13,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5694444444,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PREGABALIN,,,,,,,0.2019230769,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,0.08196721311,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1092436975,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.145631068,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.1336032389,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1641791045,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.1102362205,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1035137702,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.09523809524,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1470588235,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,0.1034482759,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | RAMIPRIL,,,,,,,0.1551724138,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,0.2086956522,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | RISEDRONATE SODIUM,,,,,,,0.1074380165,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | RISPERIDONE,,,,,,,0.06802721088,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.33,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1160714286,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1103896104,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SIMVASTATIN,,,,,,,0.1458333333,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.1255411255,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,0.1242236025,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,0.1553090333,,,,0.262295082,,,0.3472584856,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4124293785,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SIMVASTATIN,,,,,,,0.1391076115,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TOPIRAMATE,,,,,,,0.1666666667,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAMADOL HCL,,,,,,,0.1531531532,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,0.1673699015,,,,0.2851323829,,,,0.01178781925,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3957446809,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.1402714932,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | VALSARTAN,,,,,,,0.1436464088,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | VALSARTAN/HYDROCHLOROTHIAZIDE,,,,,,,0.144,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,0.1724941725,,,,0.2795031056,,,,,0.4452054795
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.6841704074,,,,0.5268292683,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.5810055866,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.6300984529,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7329545455,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.7416666667,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.7479338843,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.5631067961,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,0.541025641,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,0.866,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.9047619048,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6569767442,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,0.8554006969,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.7432024169,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | OMEPRAZOLE,,,,,,,0.7514124294,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.7482993197,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5853018373,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6019417476,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.5,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.5315315315,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6259541985,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.755240027,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,0.5904761905,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | SIMVASTATIN,,,,,,,0.7568807339,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,0.5794871795,,,,0.593814433,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5693430657,,,,,0.7256637168
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,,,,0.308411215,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LEVOFLOXACIN,,,,,,,0.2914285714,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LEVOFLOXACIN | Last AD: Same & No Remiss,,,,,,,0.1759259259,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LEVOFLOXACIN | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1262135922,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LEVOFLOXACIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3308823529,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LEVOTHYROXINE SODIUM,,,,,,,0.3857142857,,,,0.3346456693,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LEVOTHYROXINE SODIUM | Last AD: Same & No Remiss,,,,,,,0.1150442478,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LEVOTHYROXINE SODIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3006993007,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.6713286713,,,,0.3661971831,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LITHIUM CARBONATE,,,,,,,,,,,0.1176470588,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LOVASTATIN,,,,,,,0.3835616438,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | LOVASTATIN | Last AD: Same & No Remiss,,,,,,,0.1690140845,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.5625,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.628332064,,,,0.6413043478,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.6991150442,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,0.6666666667,,,,0.6231884058,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MILD (dxo:ICD9:29631)",,,,,,,0.3925233645,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.30472103,,,,,
  9 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3064516129,0.69375,,,,0.4957542458,0.6602564103,0.4818181818,,0.5323159785,0.6607142857,,0.6274509804,0.1932773109,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.6153846154,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,0.4256756757,,,,0.4554455446,,,,,
  3 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,0.4833597464,,,,0.5107142857,,,,0.2091503268,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.5745856354,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,,,0.5413533835
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",,,,,,,0.4237288136,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.347826087,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.290201005,,0.2228915663,,0.2435185185,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1090909091,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.1578947368,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,0.2628205128,,,,0.2395833333,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.2727272727,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MONTELUKAST SODIUM,,,,,,,,,,,0.3348837209,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.4446902655,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MORBID OBESITY (dxo:ICD9:27801) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.4462809917,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MOXIFLOXACIN HCL,,,,,,,0.2857142857,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MOXIFLOXACIN HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2991452991,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,0.4223300971,,,,0.4173913043,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01712328767,,,,,0.3975084938,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3620689655,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | NORTRIPTYLINE HCL,,,,,,,0.3739445115,,,0.147107438,0.3360995851,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3301886792,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5704697987,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7286821705,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7064676617,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5865384615,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.419047619,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,0.2638888889,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.5954773869,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5555555556,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.5882352941,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.4601769912,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5333333333,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1407407407,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.7538461538,,,,0.4274691358,,,,0.3882352941,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3907284768,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OLMESARTAN MEDOXOMIL,,,,,,,0.359375,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OMEPRAZOLE,,,,,,,0.4215304799,,,,0.3503401361,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OMEPRAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3901345291,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OTHER ANXIETY STATES (dxo:ICD9:30009),,,,,,,,,,,0.3138686131,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,0.4572864322,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,,,0.4087591241,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01481481481,,,,0.5520833333,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OXYBUTYNIN CHLORIDE,,,,,,,0.4214285714,,,,0.3853211009,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | OXYCODONE HCL,,,,,,,0.4205128205,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.3317230274,,,,0.2735849057,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PALPITATIONS (dxo:ICD9:7851) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3076923077,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PAROXETINE HCL,,0.0297029703,0.6188118812,,,,0.3059701493,0.5111111111,,,0.2627824019,0.5296610169,,0.4709141274,,0.5637583893
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,0.2229299363,,,,0.3130699088,0.4173913043,,,0.01910828025,
  8 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.04081632653,0.2486910995,,,0.2718446602,0.284965035,0.2259887006,,,0.1070826307,,,0.1519607843,,0.314516129
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07427055703,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1408450704,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.08888888889,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1447902571,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1954022989,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.0987654321,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,0.3639947438,,,,0.5093632959,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,0.4396551724,,,,0.5637065637,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4910714286,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4183673469,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PRAVASTATIN SODIUM,,,,,,,0.4036697248,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PREGABALIN,,,,,,,0.4263959391,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,0.2724358974,0.3785714286,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.213592233,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PROPOXYPHENE NAP/ACETAMINOPHEN,,,,,,,,,,,0.253968254,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,0.3203883495,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2091836735,,,,0.1982758621,,,0.2115384615,,
  6 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.4851485149,,,0.2672413793,0.2776470588,,,,0.108365019,,,0.3082706767,,0.2832369942
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.2170212766,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.2405498282,,,,0.1327967807,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1333333333,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,0.1971830986,,,,0.1346704871,,,,,
  6 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.2071428571,0.2135135135,0.2266666667,,,0.1672760512,,,0.18359375,,0.2298850575
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.1523809524,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.1948424069,,,,0.1731207289,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,0.1503267974,,,,0.07746478873,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,0.3174603175,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | RAMIPRIL,,,,,,,0.391959799,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | RANITIDINE HCL,,,,,,,0.25,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,0.4402985075,,,,0.4428571429,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,0.3270440252,,,,0.5147928994,,0.4131147541,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | RISEDRONATE SODIUM,,,,,,,0.2961783439,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,0.09271523179,,,,0.1333333333,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1030927835,,,,,
  3 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,0.3070539419,,,,0.4850115296,,0.3535791757,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3950276243,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROSUVASTATIN CALCIUM,,,,,,,,,,,0.4017857143,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,0.3493975904,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.3910614525,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.03816793893,,,,0.5728643216,0.3385771718,,,,0.2431077694,0.5405405405,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SIMVASTATIN,,,,,,,0.4136690647,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAMADOL HCL,,,,,,,0.4504504505,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL,,,,,,,0.3365384615,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.3503401361,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,0.2287234043,,,,,,,,,
  12 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL,0.01298701299,0.02494331066,0.619047619,,,0.4437086093,0.2520325203,0.3987473904,0.1307692308,,0.246685879,0.3480825959,,0.560461285,0.01621621622,0.5637393768
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,0.2089552239,,,,0.2859116022,,,0.4727272727,0.01893939394,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2944162437,,,0.5384615385,,
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | SIMVASTATIN,,,0.787755102,,,,0.4031209363,,,,0.2950819672,,,0.7339449541,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.3676975945,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.6363636364
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | TOPIRAMATE,,,,,,,0.3744075829,,,,0.4188679245,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | TRAMADOL HCL,,,,,,,0.3511904762,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | TRAZODONE HCL,0.03726708075,0.02094240838,0.4554140127,,,0.3716216216,0.2980172852,0.3633333333,,,0.298186167,0.2810810811,,0.3575418994,0.01643348879,0.4656862745
  4 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,0.2622377622,,,,0.2884071631,,,,0.02105263158,0.5949367089
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5658153242,0.3712737127,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.6638655462,,,,0.3454545455,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | VALSARTAN,,,,,,,0.3601398601,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | VALSARTAN/HYDROCHLOROTHIAZIDE,,,,,,,0.3279569892,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,0.04225352113,0.03667481663,0.6170212766,,,0.4905660377,0.3189407024,0.4333333333,,,0.2817311694,0.4489795918,,0.4380610413,0.02068965517,0.6721170396
  3 ,Age: 41-64 | Gender: Female | ESOMEPRAZOLE MAGNESIUM,,,0.487862177,,,,0.1185929648,0.4761904762,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESOMEPRAZOLE MAGNESIUM | FLUOXETINE HCL,,,,,,,,0.6795977011,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESOMEPRAZOLE MAGNESIUM | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.376984127,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESOMEPRAZOLE MAGNESIUM | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.39,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESOMEPRAZOLE MAGNESIUM | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.6728624535,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESOMEPRAZOLE MAGNESIUM | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.552,,,,0.1363636364,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESOMEPRAZOLE MAGNESIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.09722222222,,,,,,,,,
  8 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,0.02739726027,0.4892703863,,,0.4174757282,,0.5871559633,,,0.311627907,0.4801762115,,0.6048387097,,0.5374479889
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,,,,,,,,,,0.6241610738
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.4769230769,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4666666667
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7811447811
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LEVOTHYROXINE SODIUM",,,0.5163398693,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LISINOPRIL",,,0.5202312139,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LISINOPRIL/HYDROCHLOROTHIAZIDE",,,0.5437788018,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",,,,,,,,,,,,,,0.731884058,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | PALPITATIONS (dxo:ICD9:7851)",,,0.4649681529,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | PRAVASTATIN SODIUM",,,0.5546875,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | ROSUVASTATIN CALCIUM",,,0.5135135135,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,0.3423423423,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SERTRALINE HCL",,,,,,,,,,,,,,0.7920792079,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SIMVASTATIN",,,0.5573333333,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",,,,,,,,,,,,,,,,0.5488958991
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.702970297
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,0.4745762712,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",,,,,,,,,,,,,,,,0.4358974359
  1 ,"Age: 41-64 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7361111111
  3 ,Age: 41-64 | Gender: Female | ESTRADIOL,,,0.568,,,,,0.5157480315,,,,,,0.5917431193,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | FLUOXETINE HCL,,,,,,,,0.6878936319,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,0.7346938776,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3922077922,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.2992125984,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7386609071,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.7744360902,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | FLUOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.6287878788,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ESTRADIOL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,0.4711538462,,,,,,0.7391304348,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL,,,,,,,,,,,,,,0.7678571429,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.5085714286,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7958477509,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.5855263158,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8260869565,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,,,,,,,,,,,,0.6725663717,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.7548076923,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.5,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ESTRADIOL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.4380952381,,,,,,,,
  5 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET",,,0.5803571429,,,,0.1421383648,0.539184953,,,,0.463022508,,0.6320206585,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | FLUOXETINE HCL",,,,,,,,0.7477160928,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,,0.7748344371,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.4939759036,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.6916996047,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,0.6688963211,,,,0.0931372549,,,,,0.425,,0.6869300912,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL",,,,,,,,,,,,0.7295597484,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL",,,,,,,,,,,,,,0.7768924303,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.5081300813,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7801608579,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | PAROXETINE HCL",,,,,,,,,,,,0.6703703704,,,,
  2 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.152284264,,,,,0.3805970149,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | SERTRALINE HCL",,,,,,,,,,,,,,0.7735849057,,
  3 ,"Age: 41-64 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE",,0.01317523057,,,,,,0.536407767,,,,,,0.5742725881,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE | FLUOXETINE HCL",,,,,,,,0.7044025157,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.4390243902,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.6948051948,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,,,,,,,,0.5583333333,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4786324786,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7627118644,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGEN,ESTER/ME-TESTOSTERONE | SERTRALINE HCL",,,,,,,,,,,,,,0.7256637168,,
  3 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED",,,0.5144694534,,,,,0.5298507463,,,,,,0.5802752294,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | FLUOXETINE HCL",,,,,,,,0.7199017199,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,,0.75,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.4090909091,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.7175572519,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",,,,,,,,0.5153846154,,,,,,0.6175438596,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL",,,,,,,,,,,,,,0.7727272727,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4142011834,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7391304348,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | LEVOTHYROXINE SODIUM",,,,,,,,,,,,,,0.5637583893,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | LEVOTHYROXINE SODIUM | SERTRALINE HCL",,,,,,,,,,,,,,0.7109375,,
  1 ,"Age: 41-64 | Gender: Female | ESTROGENS, CONJUGATED | SERTRALINE HCL",,,,,,,,,,,,,,0.7639097744,,
  5 ,Age: 41-64 | Gender: Female | ESZOPICLONE,,,0.4885057471,,,0.3943089431,,0.476,,,,,,0.4813278008,0,
  1 ,Age: 41-64 | Gender: Female | ESZOPICLONE | FLUOXETINE HCL,,,,,,,,0.6755319149,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | ESZOPICLONE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.4715447154,,,,,,0.5287356322,0.008333333333,
  1 ,Age: 41-64 | Gender: Female | ESZOPICLONE | SERTRALINE HCL,,,,,,,,,,,,,,0.8088235294,,
  2 ,Age: 41-64 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE,,,0.5454545455,,,,,,,,,,,0.5764705882,,
  1 ,Age: 41-64 | Gender: Female | ETHINYL ESTRADIOL/DROSPIRENONE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1461988304,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ETONOGESTREL/ETHINYL ESTRADIOL,,0.05035971223,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | EXAMINATION OF EYES AND VISION (dxo:ICD9:V720),,,0.5302713987,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | EZETIMIBE,,,,,,,0.1851851852,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | EZETIMIBE/SIMVASTATIN,,,0.5271966527,,,0.4953703704,0.1633986928,0.5562700965,,,,0.4576271186,,0.606557377,0.02816901408,0.6462882096
  1 ,Age: 41-64 | Gender: Female | EZETIMIBE/SIMVASTATIN | FLUOXETINE HCL,,,,,,,,0.7444168734,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | EZETIMIBE/SIMVASTATIN | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7894736842,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | EZETIMIBE/SIMVASTATIN | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8171428571,,
  1 ,Age: 41-64 | Gender: Female | EZETIMIBE/SIMVASTATIN | PAROXETINE HCL,,,,,,,,,,,,0.7459016393,,,,
  1 ,Age: 41-64 | Gender: Female | EZETIMIBE/SIMVASTATIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1739130435,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | EZETIMIBE/SIMVASTATIN | SERTRALINE HCL,,,,,,,,,,,,,,0.7576601671,,
  1 ,Age: 41-64 | Gender: Female | EZETIMIBE/SIMVASTATIN | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7653429603
  2 ,"Age: 41-64 | Gender: Female | FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1619047619,,,,,,,,,,,0.2293577982,,
  1 ,Age: 41-64 | Gender: Female | FAMOTIDINE,,,,,,,0.1240875912,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | FENOFIBRATE,,,0.6141732283,,,,,0.576,,,,,,0.5528169014,,
  1 ,Age: 41-64 | Gender: Female | FENOFIBRATE | FLUOXETINE HCL,,,,,,,,0.7938931298,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FENOFIBRATE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.814516129,,
  1 ,Age: 41-64 | Gender: Female | FENOFIBRATE | SERTRALINE HCL,,,,,,,,,,,,,,0.77734375,,
  1 ,Age: 41-64 | Gender: Female | FENOFIBRATE NANOCRYSTALLIZED,,,,,,,0.1722972973,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FENOFIBRATE,MICRONIZED",,,,,,,,,,,,,,0.6460176991,,
  1 ,Age: 41-64 | Gender: Female | FENTANYL,,,,,,,0.1748251748,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FEVER AND OTHER PHYSIOLOGIC DISTURBANCES OF TEMPERATURE REGULATION (dxo:ICD9:7806),,,0.5384615385,,,,,,,,,0.4545454545,,,,
  1 ,"Age: 41-64 | Gender: Female | FEVER, UNSPECIFIED (dxo:ICD9:78060)",,,,,,,,,,,,,,,,0.4345794393
  1 ,"Age: 41-64 | Gender: Female | FEVER, UNSPECIFIED (dxo:ICD9:78060) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6896551724
  2 ,Age: 41-64 | Gender: Female | FEXOFENADINE HCL,,,,,,,,,,,,,,,0.005509641873,0.4682539683
  1 ,Age: 41-64 | Gender: Female | FEXOFENADINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | FEXOFENADINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  2 ,Age: 41-64 | Gender: Female | FEXOFENADINE/PSEUDOEPHEDRINE,,,0.552238806,,,,,,,,,0.4132231405,,,,
  1 ,Age: 41-64 | Gender: Female | FEXOFENADINE/PSEUDOEPHEDRINE | PAROXETINE HCL,,,,,,,,,,,,0.7211538462,,,,
  1 ,Age: 41-64 | Gender: Female | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxi:ICD9:V5881),,0.05128205128,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881),,,,,,,,,,,,,,0.5142180095,,
  1 ,Age: 41-64 | Gender: Female | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7943925234,,
  1 ,Age: 41-64 | Gender: Female | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881) | SERTRALINE HCL,,,,,,,,,,,,,,0.7603686636,,
  3 ,"Age: 41-64 | Gender: Female | FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)",,,,,,,0.1374045802,,,,,0.3378378378,,0.4224422442,,
  2 ,"Age: 41-64 | Gender: Female | FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.1451612903,,,,,0.2389380531,,,,
  1 ,"Age: 41-64 | Gender: Female | FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873) | SERTRALINE HCL",,,,,,,,,,,,,,0.7571428571,,
  1 ,Age: 41-64 | Gender: Female | FLUCONAZOLE,,0.02127659574,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUCONAZOLE | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.0207253886,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUCONAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.01403508772,,,,,,,,,,,,,,
  16 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL,0.02012148823,0.03353019623,0.5178008822,0.6648501362,0.09752066116,0.4347391565,0.1979624665,0.5421570955,0.1291118421,0.0547309833,0.3207589144,0.4268229167,0.1452513966,0.4729652817,0.02001356852,0.582229018
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN,,,,,,0.5263157895,,0.6989730424,,,0.4138817481,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.6910569106,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | Last AD: Diff & Remiss,,,,,,,,,,,0.425,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,,0.4074889868,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.4042553191,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss,,,,,,,,0.7074468085,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | SIMVASTATIN,,,,,,,,0.7142857143,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | TRAZODONE HCL,,,,,,,,,,,0.5648148148,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.738317757,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,,,,,,,0.6341463415,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,,,,,,,0.375,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & Remiss,,,,,,,,0.6782608696,,,,,,,,
  7 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,0.6448979592,,,,0.2125748503,0.6473302571,,,0.3498419389,0.507082153,,0.6814814815,,0.7122302158
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss,,,,,,,0.1510791367,,,,0.3020408163,,,,,0.5396825397
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.375,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.6287878788,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss,,,,,,,,,,,0.3874172185,,,,,0.6639344262
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,,,,,,,0.3004115226,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.3081081081,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.2214765101,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss,,,,,,,,0.5884146341,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LEVOTHYROXINE SODIUM,,,,,,,,0.6666666667,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,,,,,,,,,,0.5739130435,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.5281385281,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | TRAZODONE HCL,,,,,,,,,,,0.5789473684,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840),0.006269592476,,,,,,,0.6628571429,,0.03181818182,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss,0.006993006993,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,,,,,,,,0.3076923077,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL,,,,,,,,,,0.1484375,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | HYDROCODONE/ACETAMINOPHEN,,,,,,,,0.6766467066,,,0.3008849558,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.3790322581,,,,,
  4 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,0.1092436975,,0.3379310345,,,0.142599278,,,,,0.1833333333
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.2081218274,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.1119402985,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,,0.2118644068,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,0.2327586207,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.2692307692,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,0.1551724138,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1507936508,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.1481481481,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.762295082,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2603305785,,,0.08717948718,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.2745098039,,,0.09523809524,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1212121212,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,0.2660550459,,,0.2051282051,,,,,
  8 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2798742138,,,0.2655737705,0.09183673469,0.4073932927,,,0.2182163188,0.253164557,,0.2946428571,,0.2966101695
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.07258064516,,,,0.2346368715,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.357615894,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.2710280374,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.04424778761,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07462686567,,,,0.09960159363,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.2660550459,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.2931034483,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.2667501565,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,,0.2327586207,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1732851986,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2347826087,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.1578947368,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2975830816,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss",,,,,,,,0.4782608696,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.375,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.3539823009,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.72,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.357615894,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.2710280374,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2126789366,,,0.1283783784,,,,,0.1869918699
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2268518519,,,0.08032128514,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.1186440678,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.186770428,,,0.1481481481,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.2815533981,,,,,,,,
  7 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.247311828,,,0.2551724138,0.09944751381,0.4045936396,,,0.1445966514,,,0.2647058824,,0.2627118644
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.3362831858,,,0.2637362637,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,,0.3444444444,,,0.3224043716,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,0.3650793651,,,,,,,,0.3896103896
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,0.259391771,,,0.1167048055,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,,0.1721311475,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,0.2090163934,,,0.1217105263,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.6889487871,,,,,,,0.02285714286,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.5960451977,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6607669617,,,,,,,0.005154639175,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01212121212,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6689655172,,,,,,,0.006622516556,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01595744681,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",,,,,,,,0.3812233286,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,,0.4039408867,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss",,,,,,,,0.6728476821,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,0.5193133047,,,,,,,0.01687763713,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,0.6363636364,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LABORATORY EXAMINATION (dxo:ICD9:V726),,,,,,,,,,,0.3805970149,,,,,
  6 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE,,,0.1973684211,,,0.1283783784,0.088,0.1474714519,,,0.09519038076,,,0.1794871795,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,,0.100308642,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.4193548387,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.09677419355,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.1071428571,,,0.05940594059,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.03773584906,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,0.2142857143,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,0.102484472,,,0.08872901679,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.07079646018,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.09459459459,,,,,
  12 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss,0.008130081301,0.01614310646,0.4663923182,,,0.4089347079,0.1466666667,,0.09923664122,0.03846153846,0.2980656506,0.367816092,,0.4743049705,0.01145038168,0.4822771214
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.4413407821,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,,0.6274509804,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.6,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.009389671362,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.5,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6658097686,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.632183908,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Episodes: 2+,,,,,,,,,,,0.4064516129,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.5970873786,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.5333333333,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,0.6533333333,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,0.5909090909,,,,,,0.5748502994,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.5585885486,,,,,,,0.03115264798,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,0.6422764228,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,0.7107142857,,,,0.7898550725,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.2901234568,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | ROPINIROLE HCL",,,,,,,,0.6405228758,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,0.6676557864,,,,,,0.696485623,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5991486343,,,,,,,0.02037845706,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6833046472,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,0.02631578947,,,,,,,,,0.2692307692,,,0.4931506849,,0.4405594406
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.3144654088,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.4653465347,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4829443447,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5309734513,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.354368932,,,,,0.6666666667
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.0198019802,,,,,,,,,0.285046729,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.025,,,,,,,,,0.1474358974,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.2376237624,,,,0.03418803419,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,,,,0.1941747573,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1451612903,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1810344828,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.272,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6026490066,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5689655172,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2137931034,,,,0.2820512821,,,,,
  5 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02127659574,,,,,0.1705426357,0.6601941748,,,0.325648415,,,,,0.5964912281
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4666666667,,,,0.006097560976,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.4553571429
  5 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.01809954751,,,,,0.1869918699,0.5770609319,,,0.5357142857,,,,0.0236001851,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5454545455,,,,0,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4513888889,,,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.004566210046,,,,,0.1748251748,0.6845637584,,,0.4189814815,,,,0.02,0.7253668763
  12 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss,0.03272727273,0.05397301349,0.6666666667,0.6319444444,,0.4834532374,0.2387732749,,0.2209302326,,0.4132588265,0.58125,,0.6078431373,0.06896551724,0.655396619
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.6138613861,,,,,,,,,0.6481481481,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.5278969957,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | NORTRIPTYLINE HCL,,,,,,,,0.6604938272,,,0.4740740741,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6845637584,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL",,,,,,,,0.533557047,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.5053763441,,,,,,,0.03246753247,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+ | TRAZODONE HCL",,,,,,,,0.5414012739,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6100993377,,,,,,,0.0303030303,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6754966887,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3157894737,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.56,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3615384615,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.2909090909,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,0.556547619,,,0.5397350993,,,,0.03968253968,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.5546218487,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,0.7807017544,,,0.3471502591,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,0.5964912281,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2472527473,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | ROPINIROLE HCL,,,,,,,,0.5524861878,,,0.5568181818,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,0.7483870968,,,0.3925925926,,,0.7214285714,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | SIMVASTATIN,,,,,,,,,,,0.4675324675,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.3883495146,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,0.6084615385,,,0.4623541888,,,,0.04581673307,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4071428571,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.07079646018,,,,,,0.7087378641,,,0.3995098039,,,,,0.6896551724
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.344167054,,,0.3251533742,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.3985507246,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.5042492918,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,0.4847161572,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MASTODYNIA (dxo:ICD9:61171),,,,,,,,0.3963414634,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.362745098,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MONTELUKAST SODIUM,,,,,,,,0.3577981651,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,,0.5205479452,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MYOPIA (dxo:ICD9:3671),,,,,,,,0.3544303797,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.4444444444,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.3431372549,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.4207920792,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.3461538462,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.4225352113,,,,,,,0.008547008547,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.3751280475,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2051282051,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.2279069767,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.3231939163,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SIMVASTATIN,,,,,,,,0.4358974359,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4686468647,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4910714286,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.3291139241,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.368852459,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,,,0.2891566265,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.3710691824,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,0.3888888889,,,,0.3542857143,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2174320525,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.2252252252,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.162055336,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5691489362,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5789473684,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4545454545,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PREGABALIN,,,,,,,,0.4352941176,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.2185658153,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.1611111111,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,,0.3818181818,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2369477912,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,0.2789855072,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.2123893805,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.2392344498,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.224011713,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,0.1627906977,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | RISPERIDONE,,,,,,,,0.09219858156,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5392156863,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.2985074627,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,0.3873626374,,,,,,0.3470031546,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4297520661,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | SIMVASTATIN,,,,,,,,0.466179159,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | TOPIRAMATE,,,,,,,,0.4470588235,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,0.3541033435,,,0.4202090592,,,,0.01838235294,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4796747967,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.3681818182,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,0.4630541872,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.2732919255,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,0.3245614035,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,0.4111842105,,,0.3406593407,,,,,0.4166666667
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | ZOLPIDEM TARTRATE,,,,,,,,0.4109589041,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7022352941,,,0.4662576687,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.8047337278,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.7263157895,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7745454545,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,0.6745098039,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MASTODYNIA (dxo:ICD9:61171),,,,,,,,0.5873015873,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.5752212389,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MONTELUKAST SODIUM,,,,,,,,0.7745098039,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,,0.7828947368,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MYOPIA (dxo:ICD9:3671),,,,,,,,0.7222222222,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.6335403727,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.6666666667,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6549295775,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,0.526429342,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,0.8374291115,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.7486631016,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6175637394,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,,0.8369175627,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.7708333333,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,0.7142857143,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,,,0.6808510638,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.7228464419,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.4863013699,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6015625,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PREGABALIN,,,,,,,,0.7167630058,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,0.5422535211,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,0.5524861878,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5945945946,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.6229508197,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | ROSUVASTATIN CALCIUM,,,,,,,,0.8214285714,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.7450110865,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,0.65,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | SIMVASTATIN,,,,,,,,0.7760479042,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | TIZANIDINE HCL,,,,,,,,0.7457627119,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | TOPIRAMATE,,,,,,,,0.7023809524,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,0.6543778802,,,0.6383507203,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5820895522,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.684596577,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,0.7276785714,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.6594202899,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,0.6218487395,,,0.5611111111,,,,,0.6261682243
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | ZOLPIDEM TARTRATE,,,,,,,,0.6791666667,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,0.6621803499,,,0.3410852713,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | Last AD: Same & No Remiss",,,,,,,,0.2861736334,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,,0.4017857143,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | Last AD: Same & Remiss",,,,,,,,0.6533864542,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LEVOTHYROXINE SODIUM,,,,,,,,0.6924708378,,,0.4481481481,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LEVOTHYROXINE SODIUM | Last AD: Same & No Remiss,,,,,,,,0.3848580442,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss,,,,,,,,0.7359050445,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LEVOTHYROXINE SODIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.6956521739,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LITHIUM CARBONATE,,,,,,,,0.1531531532,,,0.1041666667,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LITHIUM CARBONATE | Last AD: Same & No Remiss,,,,,,,,0.09271523179,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LITHIUM CARBONATE | TRAZODONE HCL,,,,,,,,0.09016393443,,,0.07936507937,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LORAZEPAM,,,,,,,,0.6666666667,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LORAZEPAM | Last AD: Same & No Remiss,,,,,,,,0.3414634146,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LORAZEPAM | Last AD: Same & Remiss,,,,,,,,0.7207207207,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,0.7237569061,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | LOVASTATIN,,,,,,,,0.7412587413,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.6909090909,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.7142857143,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,0.7012195122,,,0.6151515152,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.7096774194,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,0.6951219512,,,0.6652173913,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.6984615385,,,0.4556962025,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3413173653,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",,,,,,,,0.625,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3333333333,,,,,,,,
  10 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4658227848,0.7054263566,,,0.6408163265,0.532967033,0.6576620825,0.4347826087,,0.5659745479,,,0.7391304348,0.2362204724,0.7202797203
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.520661157,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+ | TRAZODONE HCL",,,,,,,,,,,0.6666666667,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.7595907928,,,0.6455696203,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.6312056738,,,0.5849056604,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,0.5762711864,,,,,,,,
  3 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,0.6039488966,,,0.5195402299,,,,0.2044609665,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.4672897196,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,0.602739726,,,0.5423728814,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,,,,,,,0.7130434783,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,0.7279596977,,,,,,,,0.5353159851
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | TRAZODONE HCL",,,,,,,,0.5940594059,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | MASTODYNIA (dxo:ICD9:61171),,,,,,,,0.6181818182,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | METOPROLOL SUCCINATE,,,,,,,,0.6598639456,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | METRONIDAZOLE,,,,,,,,0.68,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",,,,,,,,0.6666666667,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.4938132733,0.2002617801,,0.3123486683,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,,0.6292682927,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1962616822,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,0.4795321637,,,0.3116591928,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.2317880795,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | MONTELUKAST SODIUM,,,,,,,,0.6691729323,,,0.4161849711,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,,0.7418699187,,,0.4266666667,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | MYOPIA (dxo:ICD9:3671),,,,,,,,0.677734375,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",,,,,,,,0.6380952381,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02371541502,,,,,,0.6961325967,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,0.6075949367,,0.1541916168,0.4455370651,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6641221374,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,0.4915254237,,,0.3492647059,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3366336634,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.5990338164,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.55,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,0.7117437722,,,,0.7935483871,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.28,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | ROPINIROLE HCL",,,,,,,,0.6405228758,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,0.6656804734,,,,,,0.6580976864,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5981638418,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6843910806,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 4+,,,,,,,,0.406504065,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.4035087719,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4175257732,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,0.3805668016,,,0.225433526,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2488038278,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Episodes: 2+,,,0.5142857143,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5700934579,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Remissions: 2+,,,,,,,,0.8310580205,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,0.5727699531,,,0.556122449,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1740139211,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.2242990654,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,0.7461928934,,,0.4518716578,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OLANZAPINE,,,,,,,,0.6548672566,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OMEPRAZOLE,,,,,,,,0.6927083333,,,0.4397905759,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OTHER DYSCHROMIA (dxo:ICD9:70909),,,,,,,,0.5833333333,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,0.649122807,,,0.4491525424,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,,,0.4237288136,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.03846153846,,,,0.5864197531,,0.6747311828,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.6929133858,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OTHER SPECIFIED DISEASE OF SEBACEOUS GLANDS (dxo:ICD9:7068),,,,,,,,0.6540880503,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | OXYBUTYNIN CHLORIDE,,,,,,,,0.7381818182,,,0.5111111111,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.6827195467,,,0.3560209424,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PANTOPRAZOLE SODIUM,,,,,,,,0.6803278689,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PAROXETINE HCL,,0.04733727811,0.5421052632,,,0.2741935484,0.2212765957,0.5754231052,,,0.280952381,0.5164066703,,0.4580152672,0.009433962264,
  4 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,0.4696969697,,,0.3495702006,0.426035503,,,0.02525252525,
  8 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05369127517,0.2462311558,,,0.1811320755,,0.3291079812,,,0.1329437546,0.1981981982,,0.251497006,,0.2145214521
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3294797688,,,0.09478672986,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,0.2807017544,,,0.1602209945,,,,,
  3 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.2707581227,,,0.1862003781,,,,0.01324503311,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1550802139,,,,,
  3 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,0.2042253521,,,0.1008064516,,,,,0.297752809
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | POLYETHYLENE GLYCOL 3350,,,,,,,,0.6536312849,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,0.5359828142,,,0.5110384301,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,0.6126126126,,,0.5753424658,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4770114943,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3873626374,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PREGABALIN,,,,,,,,0.7323600973,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.5416666667,,,,,0.4988929889,,,0.335078534,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,0.4552238806,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | TRAZODONE HCL,,,,,,,,0.4081632653,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PROPOXYPHENE NAP/ACETAMINOPHEN,,,,,,,,,,,0.4010989011,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,,0.546031746,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.4360313316,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,0.3178294574,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.1403508772,0.5170603675,,,0.1599264706,,,0.2752293578,,0.3237410072
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,0.4416666667,,,0.2684563758,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.3661971831,,,0.1290322581,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.04958677686,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,0.2474747475,,,0.1804878049,,,,,
  6 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.223880597,0.1292134831,0.3896103896,,,0.2005012531,,,0.2094594595,,0.2802547771
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,0.3403614458,,,0.2620689655,,,,,
  2 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,0.2897727273,,,0.1118421053,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,0.7481481481,,,0.4753521127,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,0.6042780749,,,0.5983606557,,0.3958868895,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4903846154,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | RISPERIDONE,,,,,,,,0.2218181818,,,0.1304347826,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,0.2097902098,,,0.1487603306,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | RIZATRIPTAN BENZOATE,,,,,,,,0.6425339367,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,0.5073170732,,,0.5295214419,,0.3741794311,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4145658263,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | ROSUVASTATIN CALCIUM,,,,,,,,0.7829457364,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.6926605505,,0.5320512821,0.2598425197,0.6522108844,,,0.3908045977,0.5681818182,,,,
  12 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL,0.02836879433,0.029143898,0.4,,,0.3125,0.168784029,0.5114379085,0.1176470588,,0.2721936904,0.3843537415,,0.4874213836,0.02173913043,0.5964912281
  4 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,0.3333333333,,,0.3407155026,,,0.4430379747,0.0223880597,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,0.62,,,0.3197278912,,,0.504,,
  3 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.7575480329,,,0.4084507042,,,0.7222222222,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.7047619048,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,0.7021276596,,,0.416909621,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.6513409962
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | TIZANIDINE HCL,,,,,,,,0.7010676157,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | TOPIRAMATE,,,,,,,,0.6494252874,,,0.469924812,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | TRAMADOL HCL,,,,,,,,0.6725663717,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | TRAMADOL HCL/ACETAMINOPHEN,,,,,,,,0.6902654867,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | TRAZODONE HCL,0.02127659574,0.03664122137,0.3636363636,,,0.2910662824,0.1956947162,0.4679009558,,,0.404714725,0.3109756098,,0.3488372093,0.02303976217,0.4451410658
  4 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,0.4,,,0.3476531424,,,,0.0216802168,0.5036764706
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED ALOPECIA (dxo:ICD9:70400),,,,,,,,0.661971831,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5961945032,,0.6449511401,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,0.6731707317,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515),,,,,,,,0.6602870813,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359),,,,,,,,0.6855345912,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.6584093872,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | FLUOXETINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,0.6666666667,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | VENLAFAXINE HCL,0.02727272727,0.03023758099,0.4568965517,,,0.4910714286,0.1641468683,0.5615167406,,,0.303030303,0.4413407821,,0.4470046083,0.01630434783,0.6394517282
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | VERAPAMIL HCL,,,,,,,,0.702970297,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | FLUOXETINE HCL | ZOLPIDEM TARTRATE,,,,,,,,0.6624113475,,,,,,,,
  10 ,Age: 41-64 | Gender: Female | GABAPENTIN,0.006622516556,0.03356367226,0.5130597015,,,0.3487621098,0.180078125,0.5255952381,,0.05169628433,0.2761087268,0.3981900452,,0.4943011398,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.1666666667,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | HEADACHE (dxo:ICD9:7840),,,,,,,,,,0.07582938389,,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | HYDROCODONE/ACETAMINOPHEN,,,,,,0.3731343284,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | GABAPENTIN | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.5185185185,,,,,,0.4569536424,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.4351145038,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.0826446281,,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3770491803,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.426035503,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.7570093458,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7461706783,,
  2 ,Age: 41-64 | Gender: Female | GABAPENTIN | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02127659574,,,,,0.2175925926,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | NORTRIPTYLINE HCL,,,,,,,,,,0.1703703704,,,,,,
  2 ,Age: 41-64 | Gender: Female | GABAPENTIN | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1843575419,,,,,,,0.6285714286,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | OMEPRAZOLE,,,,,,,0.1886792453,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | GABAPENTIN | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01851851852,,,,0.3652694611,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | GABAPENTIN | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.3786982249,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | GABAPENTIN | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.3651452282,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | GABAPENTIN | PAROXETINE HCL,,,,,,,,,,,0.393129771,0.6990595611,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | PREGABALIN,,,,,,0.4255952381,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3842592593,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | GABAPENTIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.3404255319,0.1375,,,,,0.3728813559,,,,
  4 ,Age: 41-64 | Gender: Female | GABAPENTIN | SERTRALINE HCL,,,,,,0.5670103093,0.3203883495,,,,0.4462809917,,,0.7137511693,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7413793103,,
  2 ,Age: 41-64 | Gender: Female | GABAPENTIN | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6116504854,,,,,,,,0.7076923077,,
  3 ,Age: 41-64 | Gender: Female | GABAPENTIN | SIMVASTATIN,,,0.5479452055,,,,,0.6140350877,,,,,,0.5675675676,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | TRAMADOL HCL,,,,,,0.328358209,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | TRAMADOL HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3826530612,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | TRAZODONE HCL,,,,,,,,,,,0.3866666667,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),,,,,,0.3831417625,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GABAPENTIN | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3142857143,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3679565513,,0.5234899329,,,,,,0.4528301887,,
  2 ,Age: 41-64 | Gender: Female | GABAPENTIN | VENLAFAXINE HCL,,,,,,0.5872093023,,,,,0.4633507853,,,,,
  3 ,Age: 41-64 | Gender: Female | GEMFIBROZIL,,,0.5229357798,,,,,,,,,0.3818181818,,0.6014492754,,
  1 ,Age: 41-64 | Gender: Female | GEMFIBROZIL | PAROXETINE HCL,,,,,,,,,,,,0.7089552239,,,,
  1 ,Age: 41-64 | Gender: Female | GEMFIBROZIL | SERTRALINE HCL,,,,,,,,,,,,,,0.7410714286,,
  6 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),0.03048780488,0.02815315315,,,,,0.1430842607,0.4985994398,,,0.2633928571,,,0.5628571429,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | HEADACHE (dxo:ICD9:7840),0.01104972376,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.01666666667,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4864864865,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6642335766,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | LORAZEPAM,,0.04,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02380952381,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.008928571429,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.04761904762,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.04424778761,,,,,,0.1305418719,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | SERTRALINE HCL,,0.04166666667,,,,,,,,,0.4214285714,,,0.6769230769,,
  1 ,Age: 41-64 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | VENLAFAXINE HCL,,,,,,,,,,,0.4158415842,,,,,
  4 ,Age: 41-64 | Gender: Female | GUAIFENESIN/P-EPHED HCL,,,0.4364261168,,,0.4130434783,0.1234735414,,,,,,,,,0.4701986755
  1 ,Age: 41-64 | Gender: Female | GUAIFENESIN/P-EPHED HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.09826589595,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | GUAIFENESIN/PHENYLEPHRINE HCL,,,0.5250737463,,,,0.1529411765,,,,,,,,,0.5263157895
  1 ,Age: 41-64 | Gender: Female | GUAIFENESIN/PHENYLEPHRINE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.106918239,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GUAIFENESIN/PHENYLEPHRINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1517857143,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | GUAIFENESIN/PSEUDOEPHEDRNE HCL,,,,,,0.4485294118,,,,,,0.4571428571,,,,0.5901639344
  1 ,Age: 41-64 | Gender: Female | GUAIFENESIN/PSEUDOEPHEDRNE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,,,,,,0.4084880637,,,,
  1 ,Age: 41-64 | Gender: Female | GUAIFENESIN/PSEUDOEPHEDRNE HCL | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,,,,,,,,,,0.6971153846,,,,
  1 ,Age: 41-64 | Gender: Female | GUAIFENESIN/PSEUDOEPHEDRNE HCL | PAROXETINE HCL,,,,,,,,,,,,0.6643835616,,,,
  10 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),0,0.02239641657,0.5998851894,,,0.3958051421,0.1148864592,0.5072212594,,,0.2180094787,0.4201376313,,0.6056930693,,0.6015392254
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.09,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | IMIPRAMINE HCL,,,,,,,,,,,0.2025862069,,,,,
  4 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2561983471,,,,0.07672634271,,,,,0.2207792208,,,,0.2876712329
  1 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,,,,,,,,,,0.374301676,,,,
  1 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,0.3802816901,,,,
  4 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2138728324,,,,0.05601317957,,,,,0.1954314721,,,,0.2565055762
  1 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2718446602
  1 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.5810810811,,
  3 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LABORATORY EXAMINATION (dxo:ICD9:V726),,,0.5821917808,,,,,,,,0.2101449275,0.4509803922,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LABORATORY EXAMINATION (dxo:ICD9:V726) | PAROXETINE HCL,,,,,,,,,,,,0.6639344262,,,,
  3 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,0.1133333333,,,,0.2,,,,,0.5043478261
  3 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,0.1317829457,,,,0.3209876543,,,,,0.5373134328
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3784860558,,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.3495934959,,,,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.2995780591,,,,,0.7009345794
  3 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,0.2115384615,,,,0.3852140078,,,,,0.652892562
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.3855421687,,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss,,,,,,,,,,,0.09139784946,,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.2768595041,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3350253807,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.3153564899,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4378109453,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4158730159
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.6733067729,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6918604651,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6759776536
  1 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,,,,,,,0.5673076923,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LEVONORGESTREL-ETHIN ESTRADIOL,,,,,,,,,,,,,,0.6203703704,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LEVOTHYROXINE SODIUM,,,,,,,,0.53,,,,,,0.6066481994,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7875457875,,
  3 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LORATADINE,,,0.631372549,,,,0.1009174312,,,,,0.459807074,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | LORATADINE | PAROXETINE HCL,,,,,,,,,,,,0.6923076923,,,,
  1 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,,,0.4748201439
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | MASTODYNIA (dxo:ICD9:61171),,,,,,,,,,,,,,0.4952380952,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | MYOPIA (dxo:ICD9:3671),,,,,,,,,,,,,,0.6206896552,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01769911504,,,,,0.1367521368,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02051282051,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,,,,,0.09893048128,,,,,,,,,0.555
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.005714285714,,,,,,,,,,,,,0.6,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.6961325967,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.07407407407,,,,,0.4090909091,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,,,,,,,,,,,0.5089820359,,,,
  5 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,0.6296296296,,,,0.2110817942,,,,0.2962962963,0.6491136601,,,,0.7133956386
  1 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.3620689655,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL | ROFECOXIB,,,,,,,,,,,,0.6393442623,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,0.6435643564,,,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5950413223,0.6271186441,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,0.5825242718,,,,
  1 ,"Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3162393162
  4 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,0.6721311475,,,,0.08866995074,0.3882352941,,,,0.3028169014,,,,
  4 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.2391304348,,,,0.07142857143,,,,,0.2259887006,,,,0.2314814815
  3 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | ROFECOXIB,,,0.6312056738,,,,0.101754386,,,,,0.4802631579,,,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.01785714286,,,,,,,,,,0.4901960784,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,,,,,,,,,,,,,,0.5338345865
  6 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL,,,0.6650717703,,,,0.1868852459,,,,0.3702239789,0.491638796,,0.7096279248,,0.7183908046
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6341463415,,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.7333333333,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.6018518519,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.6369426752,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,0.524822695,,,,0.5976900866
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6705202312
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | TRAZODONE HCL,,,,,,,,,,,0.3911764706,0.3490566038,,,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5178571429,,,,,
  2 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.09677419355,,,,,,,0.6,,
  1 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.585106383,,
  3 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.4444444444,,,,0.1206896552,,,,,,,0.5608695652,,
  4 ,Age: 41-64 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | VENLAFAXINE HCL,,,,,,,0.2272727273,,,,0.3477321814,0.5301204819,,,,0.703163017
  6 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840),0.009523809524,0.02896995708,0.5140186916,,,,,0.4583333333,,0.0512755102,,,,0.52734375,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | HYDROCODONE/ACETAMINOPHEN,0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | HYOSCYAMINE SULFATE,0.009615384615,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641),,,,,,,,,,0.01923076923,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,0.007575757576,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | SERTRALINE HCL,0.01376146789,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | TRAZODONE HCL,0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Diff & No Remiss | VENLAFAXINE HCL,0.01709401709,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | NORTRIPTYLINE HCL",,,,,,,,,,0.05855855856,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.0457433291,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",,,,,,,,,,0.04069767442,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",,,,,,,,,,0.05691056911,,,,,,
  2 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.006451612903,,,,,,,,,0.06488549618,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | NORTRIPTYLINE HCL",,,,,,,,,,0.1804878049,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",0,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.005405405405,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.005934718101,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | SUMATRIPTAN SUCCINATE",,,,,,,,,,0.0347826087,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | MORPHINE SULFATE,0.016,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02702702703,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL,0.005025125628,,,,,,,,,0.1642651297,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,0.1232876712,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.03064066852,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.01094890511,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.005319148936,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OXYCODONE HCL,0.01716738197,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | PAROXETINE HCL,0.01020408163,,,,,,,,,0.08196721311,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0.02727272727,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,0.03603603604,,,,,,
  2 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.004811547715,0.03378378378,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | SERTRALINE HCL,0.01639344262,,,,,,,,,0.05426356589,,,,,,
  2 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | TRAZODONE HCL,0.00296735905,,,,,,,,,0.07878787879,,,,,,
  1 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.008403361345,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | HEADACHE (dxo:ICD9:7840) | VENLAFAXINE HCL,0.015625,,,,,,,,,0.06474820144,,,,,,
  2 ,Age: 41-64 | Gender: Female | HEMATURIA (dxo:ICD9:5997),,,0.5216400911,,,,,,,,,0.4305555556,,,,
  1 ,Age: 41-64 | Gender: Female | HEMATURIA (dxo:ICD9:5997) | PAROXETINE HCL,,,,,,,,,,,,0.603960396,,,,
  1 ,"Age: 41-64 | Gender: Female | HEMATURIA, UNSPECIFIED (dxo:ICD9:59970)",,,0.4504504505,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HERPES ZOSTER WITHOUT MENTION OF COMPLICATION (dxo:ICD9:0539),0.006172839506,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364),,,,,,,,,,,,,,,0.01265822785,
  1 ,Age: 41-64 | Gender: Female | HYDRALAZINE HCL,,,,,,,,,,,,,,0.3942857143,,
  11 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN,0.02123893805,0.03144654088,,,,0.3284883721,0.1474103586,0.5105263158,,0.07142857143,0.2854122622,0.4460784314,0.2397476341,0.5266940452,0.01037613489,
  2 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | IBUPROFEN,,,,,,,,,,,,,,0.5037037037,0.01709401709,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4592592593,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7530120482,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | LUMBAGO (dxo:ICD9:7242),,,,,,0.2810457516,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.3785310734,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.3018867925,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0,,,,,,,,,,,,,0.5701754386,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.0119760479,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.7821782178,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,,0.01818181818,
  6 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,0.02739726027,,,,0.3563636364,0.1573033708,0.3867924528,,,0.2231404959,,,,,
  2 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | SERTRALINE HCL,,,,,,,,,,,0.3777777778,,,0.7251184834,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | TRAMADOL HCL,,,,,,0.3709677419,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | TRAZODONE HCL,,,,,,,,,,,,,,,0.006097560976,
  1 ,Age: 41-64 | Gender: Female | HYDROCODONE/ACETAMINOPHEN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3689320388,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | HYDROCODONE/HOMATROPINE,,,0.4721780604,,,,0.144486692,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | HYDROCORTISONE,,,,,,0.4117647059,,,,,,,,,,0.5135135135
  3 ,Age: 41-64 | Gender: Female | HYDROXYCHLOROQUINE SULFATE,,,0.5075757576,,,,0.1428571429,,,,,,,0.5590062112,,
  1 ,Age: 41-64 | Gender: Female | HYDROXYCHLOROQUINE SULFATE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8034682081,,
  1 ,Age: 41-64 | Gender: Female | HYDROXYCHLOROQUINE SULFATE | SERTRALINE HCL,,,,,,,,,,,,,,0.7609756098,,
  2 ,Age: 41-64 | Gender: Female | HYDROXYZINE HCL,,0.02803738318,,,0.1620029455,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HYDROXYZINE HCL | UNSPECIFIED PRURITIC DISORDER (dxo:ICD9:6989),,,,,0.1643835616,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HYDROXYZINE HCL | UNSPECIFIED URTICARIA (dxo:ICD9:7089),,,,,0.1912350598,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | HYOSCYAMINE SULFATE,0.006072874494,,,,,,,,,,0.1909090909,,,,,
  1 ,Age: 41-64 | Gender: Female | HYOSCYAMINE SULFATE | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.009090909091,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HYOSCYAMINE SULFATE | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | HYOSCYAMINE SULFATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.005882352941,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | HYPERSOMNIA WITH SLEEP APNEA, UNSPECIFIED (dxo:ICD9:78053)",,,,,,,,,,,,,0.2781954887,,,
  1 ,Age: 41-64 | Gender: Female | HYPERTROPHY OF NASAL TURBINATES (dxo:ICD9:4780),,,,,,,,,,,,,,,,0.4227642276
  4 ,Age: 41-64 | Gender: Female | IBUPROFEN,0.02608695652,,0.4500846024,,,,,,,,,,,0.4744588745,0.009049773756,
  1 ,Age: 41-64 | Gender: Female | IBUPROFEN | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.385,,
  1 ,Age: 41-64 | Gender: Female | IBUPROFEN | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.01639344262,
  1 ,Age: 41-64 | Gender: Female | IBUPROFEN | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7170542636,,
  1 ,Age: 41-64 | Gender: Female | IBUPROFEN | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.4876033058,,
  1 ,Age: 41-64 | Gender: Female | IBUPROFEN | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,,,,,,,,0.5283018868,,
  1 ,Age: 41-64 | Gender: Female | IBUPROFEN | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,,0.007352941176,
  1 ,Age: 41-64 | Gender: Female | IBUPROFEN | SERTRALINE HCL,,,,,,,,,,,,,,0.699410609,,
  1 ,Age: 41-64 | Gender: Female | IBUPROFEN | TRAZODONE HCL,,,,,,,,,,,,,,,0.007518796992,
  1 ,Age: 41-64 | Gender: Female | IMIPRAMINE HCL,,,,,,,,,,,0.2245762712,,,,,
  1 ,Age: 41-64 | Gender: Female | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.1176470588,,,,,
  1 ,Age: 41-64 | Gender: Female | IMIPRAMINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.1205673759,,,,,
  1 ,Age: 41-64 | Gender: Female | IMIPRAMINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4642857143,,,,,
  1 ,Age: 41-64 | Gender: Female | IMIPRAMINE HCL | SERTRALINE HCL,,,,,,,,,,,0.43,,,,,
  12 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",0.01764705882,0.03237410072,0.2182361734,0.2045454545,,0.1622073579,0.08061749571,0.1920529801,,,0.1301703163,0.15625,,0.1447876448,0.03255813953,0.1823085221
  6 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.1111111111,,,0.08854166667,0.07210031348,0.1140350877,,,,,,0.08152173913,,0.1125827815
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1677852349,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.119266055
  4 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08372093023,,,,0.09708737864,,,0.06617647059,,0.09322033898
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.07438016529,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.05357142857,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.236453202,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1525423729
  3 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,0.126984127,,,,,0.05263157895,,,,,0.1510791367
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,0.06,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2153846154
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.33
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,,,,0.09580838323,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2277227723,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.188976378,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.200811359,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1363636364,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.02631578947,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1825396825,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1706349206
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,,,,,,0.7391304348
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.701754386,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.693877551
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | MIRTAZAPINE",,,,,,,,,,,0.1226415094,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL",,,,,,,,,,,0.1314984709,0.3613861386,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.048,0.32,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.132231405,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1317073171,0.2034883721,,,,
  9 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.02985074627,0.1727748691,0.131147541,,0.1893491124,,0.1150442478,,,0.112033195,,,0.1428571429,0.01298701299,0.1433691756
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1322751323,,,0.3052631579,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1875,,,0.2403846154,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.0390625,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1395348837,,,,,0.164021164
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.09952606635,,,,,0.2209944751
  8 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.02272727273,0.09259259259,0.1384615385,,0.1111111111,0.07171314741,,,,0.08064516129,,,0.1127819549,,0.1764705882
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.08823529412,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.05882352941,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1015228426,,,,,
  3 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,0.1612903226,,,,,0.1142857143,,,0.3570581257,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1984536082,,,0.2958199357,,
  3 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.100795756,,,,0.04430379747,0.1351351351
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1756440281,,,,,0.2394014963
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,0.1077441077,,,,,0.2652123995
  12 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,0.03448275862,0.2262479871,0.3095890411,0.02517985612,0.222752931,0.07160282996,0.2217664753,,,0.1555555556,0.1879762913,,0.2340820807,0.01548205489,0.2799210872
  3 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.05627705628,,,,,,,0.04504504505,,0.06862745098
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.02830188679,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.01907356948,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.006711409396,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3709677419,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,0.05164319249,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.0671641791,,,,0.1007194245,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.05970149254,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,0.05349794239,,,,0.1389728097,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2413793103,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,0.05405405405,,,,0.1559633028,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.141025641,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,0.05679012346,,,,0.1446808511,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2721088435,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.04444444444,,,,0.1791044776,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.25,,,,,0.325
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,0.0890052356,,,,0.1605839416,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,,,,0.05714285714,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.2444444444,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2379032258,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.1487603306,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,0.2233009709,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.2156862745,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.1578947368,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1754385965,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1741573034
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.3093858633,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3050314465
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.2932369644,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.004716981132,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2972258917
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.5853658537,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.4484536082,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.5317460317,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.198019802,,,,,,0.2672413793,,
  4 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1741935484,,,,,0.1666666667,,,0.144,,,0.2318181818,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,,,,0.3603603604,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1923076923,,
  5 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.6822429907,,,,0.6262626263,0.7565217391,,,,,,0.75,,0.6453488372
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,,0.6336633663
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7285714286
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.6345177665,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.6356589147,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6764705882
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1147540984,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,,,0.2624584718
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,,,0.28125
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3645833333,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3191489362,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",,,,,,,0.04379562044,,,,,,,,,
  8 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,0.2943548387,,,0.2571428571,0.07912087912,0.2258064516,,,0.1501501502,0.3860977288,,0.2910958904,,0.3739837398
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.2364341085,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.08333333333,0.2764227642,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,0.2384615385,,,,
  6 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2797202797,,,,0.1101694915,,,,0.1310679612,0.3682373473,,0.2916666667,,0.25
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.2561983471,0.4233576642,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.3178294574,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,0.243697479,0.3626373626,,,,
  9 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.143812709,,,0.1148459384,0.1060606061,0.1516393443,,,0.09405940594,0.1071428571,,0.1033519553,0.0396039604,0.1344165436
  9 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1675675676,0.1092436975,,0.1011904762,0.0547112462,0.1449275362,,,0.06481481481,0.06481481481,,0.09543568465,,0.1491525424
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.09318996416,,,0.2204301075,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1166666667,,,0.2272727273,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.04201680672,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.08411214953,,,,,0.2
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.0622406639,,,,,0.222826087
  3 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.08823529412,,,0.2250580046,,0.0701754386
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.16,,,0.2016460905,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1052631579,,,,,0.1890243902
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.07881773399,,,,,0.1981818182
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1538461538,,,,,,,,,,,0.2127659574,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.1836734694,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.1826923077,,,,,,,,
  10 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1982578397,0.2853932584,,0.20657277,0.06689759688,0.2010282776,,,0.1274298056,0.1809045226,,0.2150724638,0.01401869159,0.2474720596
  3 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,0.2907801418,,,0.06389776358,,,,,0.1412639405,,,,
  8 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,0.2336065574,,,0.2091503268,0.1111111111,0.2325581395,,,0.1725601132,0.2260869565,,0.4108469539,,0.2739273927
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2808988764,,,0.3722627737,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",,,,,,,,,,,,,,,,0.2119565217
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1525,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.3284671533,,,,,0.4074074074
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.2283105023,,,,,,,,,,
  6 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,0.3739837398,,,0.2413793103,0.1461538462,,,,0.2115732369,,,0.2264150943,,0.3694721826
  5 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1310344828,,,,0.04225352113,0.1559633028,,,,,,0.1571428571,,0.14
  3 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,0.298245614,,,0.07307692308,,,,,0.1450777202,,,,
  8 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,0.2455696203,,,0.2294117647,0.07361111111,0.24,,,0.1739130435,0.2270531401,,0.4136092819,,0.315696649
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2938596491,,,0.3575525813,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.4471544715,,0.46
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",,,,,,,,,,,,,,,,0.2771084337
  7 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,0.2285714286,,,0.1714285714,0.05668016194,,,,0.1810584958,,,0.253968254,0.02536231884,0.2908163265
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.2620320856,,,,,0.3814655172
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.1947368421,,,,,,,,,,
  7 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,0.3253588517,,,0.2689393939,0.1206896552,0.2288557214,,,0.2574850299,,,0.269035533,,0.4
  10 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.1639676113,0.1062271062,,0.1403846154,0.06633906634,0.1401869159,,,0.07471264368,0.1090047393,,0.1350364964,0.005649717514,0.1694915254
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.1935483871,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.1798941799,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.02803738318,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1790123457
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PAROXETINE HCL",,,,,,,,,,,0.08095238095,0.2181069959,,,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,,0.1067961165
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.05982905983,,,,,,,0.1196581197,,
  3 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,0.08333333333,,,,0.07804878049,,,0.2533589251,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1063829787,,,0.1853658537,,
  1 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.08,,,,,
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1513944223,,,,,0.1861702128
  2 ,"Age: 41-64 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | VENLAFAXINE HCL",,,,,,,,,,,0.09736842105,,,,,0.2279909707
  10 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",0.008174386921,0.02524271845,0.4557575758,,0.1181102362,,0.1732283465,0.4744551626,0.1361867704,,,0.425,,0.496196319,0.00850701829,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0.008064516129,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6344827586,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.009174311927,
  2 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.7394366197,0.004201680672,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,,,,,,,,,0.009708737864,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.005813953488,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,,0.008771929825,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.01485148515,
  4 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,0.3925233645,,,,,0.390625,,,,,,0.4163265306,0.01869158879,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.004329004329,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.016,
  2 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6642857143,0.02525252525,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.02100840336,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.01492537313,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.4299065421,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0.0025,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,,,,,0.016,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4077791719,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.008547008547,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAMADOL HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.006435366536,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.006079027356,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.6896551724,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | LEVOTHYROXINE SODIUM",,,,,,,,,,,,,,0.461038961,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,,,,,,,,0.4921875,,
  2 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01935483871,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",0,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.005649717514,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | PAROXETINE HCL",,,,,,,,,,,,,,,0.009803921569,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",,,,,,,,,,,,,,,0.008333333333,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,0.02419354839,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.3278688525,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,,0.015625,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,,,,,,,,,,,,,,0.006269592476,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL",,,,,,,,,,,,,,,0.009345794393,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.007299270073,
  2 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.008695652174,,,,,,,,0.1037735849,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.7052054795,0.01339285714,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL | SIMVASTATIN",,,,,,,,,,,,,,0.7065868263,,
  2 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6348314607,0.03097345133,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,,,,,,,,0.6446280992,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,0.7192982456,,
  3 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SIMVASTATIN",,,0.4059405941,,,,,0.5048543689,,,,,,0.5720720721,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TEMAZEPAM",,,,,,,,,,,,,,,0.01445086705,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TEMAZEPAM | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAMADOL HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAMADOL HCL | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.02469135802,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01216931217,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.02298850575,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0,
  3 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,,0.54,,,,,,0.4761904762,0,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",,,,,,,,,,,,,,,0.005714285714,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",,,,,,,,,,,,,,0.4526315789,,
  1 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.03496503497,
  3 ,"Age: 41-64 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,0.4935483871,,,,,,0.5340314136,0.009679821296,
  1 ,Age: 41-64 | Gender: Female | IRREGULAR MENSTRUAL CYCLE (dxo:ICD9:6264),,,0.4206349206,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641),0.004672897196,0.02074688797,,,,,,,,0.05882352941,,,,,,
  1 ,Age: 41-64 | Gender: Female | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641) | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.04761904762,,,,,,
  1 ,Age: 41-64 | Gender: Female | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.006172839506,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01398601399,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ISOMETHEPT/DICHLPHN/ACETAMINOP,,,,,,,,,,,,,,0.5463414634,,
  1 ,Age: 41-64 | Gender: Female | ISOMETHEPT/DICHLPHN/ACETAMINOP | SERTRALINE HCL,,,,,,,,,,,,,,0.6956521739,,
  1 ,Age: 41-64 | Gender: Female | KETOCONAZOLE,,,,,,,,,,,,,,0.5384615385,,
  3 ,Age: 41-64 | Gender: Female | LABORATORY EXAMINATION (dxo:ICD9:V726),,,0.5036319613,,,,,,,,0.1912751678,0.4692307692,,,,
  2 ,Age: 41-64 | Gender: Female | LABORATORY EXAMINATION (dxo:ICD9:V726) | PAROXETINE HCL,,,,,,,,,,,0.2641509434,0.5882352941,,,,
  1 ,Age: 41-64 | Gender: Female | LABORATORY EXAMINATION (dxo:ICD9:V726) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.3963963964,,,,
  1 ,Age: 41-64 | Gender: Female | LABORATORY EXAMINATION (dxo:ICD9:V726) | SERTRALINE HCL,,,,,,,,,,,0.3937007874,,,,,
  1 ,Age: 41-64 | Gender: Female | LABORATORY EXAMINATION (dxo:ICD9:V726) | VENLAFAXINE HCL,,,,,,,,,,,0.3859649123,,,,,
  3 ,"Age: 41-64 | Gender: Female | LABORATORY EXAMINATION, UNSPECIFIED (dxo:ICD9:V7260)",,,0.4155844156,,,,,,,,,,,0.4588235294,,0.4099099099
  1 ,"Age: 41-64 | Gender: Female | LABORATORY EXAMINATION, UNSPECIFIED (dxo:ICD9:V7260) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7156862745
  2 ,Age: 41-64 | Gender: Female | LACTULOSE,,,0.3842105263,,,,0.1228070175,,,,,,,,,
  13 ,Age: 41-64 | Gender: Female | LAMOTRIGINE,,,0.1538461538,0.1256476684,0.03738317757,0.1082496726,0.06787878788,0.1415192508,0.03910614525,,0.08713074271,0.07582938389,0.1184210526,0.1607611549,0.02739726027,0.1541313559
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.1603053435,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.1221532091,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.07582938389
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7268041237,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5245901639,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.5587188612,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.5947136564,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6017699115
  4 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5042016807,,0.4765100671,,,0.4094754653,,,,,0.4184782609
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.4064516129,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4604316547,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.2636363636,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4185441941,,,,,
  2 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.3636363636,,,,,0.3629032258
  2 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.4312796209,,,,,0.4657534247
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.09698078683,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1314553991,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.08145580589,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.09743589744,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.08131868132,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1094527363,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | Num Previous Antidep: 4+,,,,,,,,,,,0.1307189542,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.1568627451,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1219081272,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1186440678,,,,,
  2 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | PAROXETINE HCL,,,,,,,,,,,0.05909090909,0.1354166667,,,,
  2 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1,0.09448818898,,,,
  4 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.07476635514,0.07317073171,,0.05696202532,,,,,,,,,,0.1210526316
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1188118812,,
  2 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.05,,,,,0.05072463768
  2 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.04402515723,,,,,0.09543568465
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.08625730994,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.09855072464,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.07692307692,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.04838709677,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | VENLAFAXINE HCL",,,,,,,,,,,0.07476635514,,,,,
  1 ,"Age: 41-64 | Gender: Female | LAMOTRIGINE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,,,0.07
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.2012195122,,,
  2 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | RISPERIDONE,,,,,,,,,,,0.06775700935,,,,,0.06930693069
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.05251641138,,,,,
  2 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.08088235294,,,,,0.1124260355
  2 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | ROPINIROLE HCL,,,,,,,,,,,0.1070395371,,0.1896955504,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.122324159,,,,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1118421053,,,,,
  6 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | SERTRALINE HCL,,,0.1612903226,,,0.09900990099,0.06349206349,0.1534883721,,,0.08183079057,,,0.1387656313,,
  2 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.08143939394,,,0.122605364,,
  1 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,0.1504424779,,
  5 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | TRAZODONE HCL,,,0.1588785047,,,0.08480565371,,0.1222222222,,,0.09446511104,,,,,0.08755760369
  2 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.0866851595,,,,,0.1180904523
  4 ,Age: 41-64 | Gender: Female | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,0.104,,,0.08238636364,,,0.2676056338,,0.1559063998
  2 ,Age: 41-64 | Gender: Female | LANSOPRAZOLE,,0.01923076923,0.4552845528,,,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss,0,0.02006688963,,0.5949367089,,0.2843137255,0.1764705882,0.5048543689,,,,,,0.5112359551,0.01004536617,0.5102040816
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.1095890411,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.625
  5 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.02369668246,,,,,0.1276595745,,,,0.26875,,,0.4117647059,0.003731343284,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5811965812,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6651982379,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.2033898305,,0.4043715847,,,,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.251497006,,0.2637362637,,,,0.02054794521,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,0.22,,0.5625,,,,,0.6844444444
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PAROXETINE HCL,,0.02325581395,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.01724137931,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | TRAZODONE HCL,,0.01136363636,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VENLAFAXINE HCL,,0.02097902098,,,,,,,,,,,,,,
  10 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,0.00518134715,0.0281124498,0.3272727273,,,0.3101265823,0.1262798635,0.3970588235,,,0.2904458599,,,0.4358974359,0.01851851852,0.2951807229
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6415929204,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7019230769,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7166666667,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.009433962264,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4761904762,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2125984252,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.3267326733,,,,,0.5583333333
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | PAROXETINE HCL,,,,,,,,,,,0.4971751412,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,0.1439393939,0.5248618785,,,,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,0.213740458,0.2526315789,,,,0.006097560976,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3095238095,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4514563107,,,,,0.6631944444
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL",,,,,,,,,,,,0.5211267606,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.664516129,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.5531197302,,,0.007575757576,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.2792792793,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | SIMVASTATIN | TRAZODONE HCL",,,,,,,,,,,,,,0.7008547009,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6213282248,0.01438848921,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.6605839416,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.01,0.5698005698
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL",,,,,,,,,,,,0.6141732283,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.7038327526,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6559714795,,,0.009404388715,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,0.75,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.303030303,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PRAMIPEXOLE DI-HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.7326732673,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.6592592593,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | ROPINIROLE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.6744186047,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.737704918,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6698049765,0.01697530864,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.7113043478,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.01826484018,0.7108433735
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.2272727273,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4309623431,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2992125984,,,,,0.5666666667
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2522522523
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5775862069,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.5573770492
  4 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.5471698113,,,,0.1476510067,,,,0.3271375465,,,,,0.5275590551
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5399879735,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3743842365,,,,,0.5652173913
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.5555555556
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2745098039,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5178571429,,,,,0.5895895896
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.2930232558,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | TRAZODONE HCL,,,,,,,,,,,0.4230769231,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | OMEPRAZOLE | TRAZODONE HCL,,,,,,,,,,,0.30625,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PALPITATIONS (dxo:ICD9:7851) | TRAZODONE HCL,,,,,,,,,,,0.35,,,,,
  11 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL,0.003610108303,0.02110817942,0.4455252918,,,0.353125,0.135734072,0.4501779359,0.1366906475,,0.253298153,,,0.4854368932,0.01282051282,0.4592696629
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1826923077,,,,0.05263157895,
  4 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | SERTRALINE HCL,,0.03816793893,,,,,0.1545454545,,,,0.3744075829,,,,,0.64
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.009900990099,
  4 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,0,,,,,,,,,0.5149963424,0.5688073394,,,0.01898734177,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | VENLAFAXINE HCL,,0.05,,,,,,,,,0.3321799308,,,,,0.654676259
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,0.01709401709,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.0275862069,,,,,,,,,0.102739726,,,,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.238317757,,,,0.02713178295,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1798561151,,,,0.03816793893,
  3 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.2167487685,,,,0.03488372093,0.2731707317
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,0.05,,,,,,,,,0.147826087,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.02362204724,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7368421053
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,0.05555555556,,,,0.1411042945,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1256544503,,,,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.1,,,,0.164874552,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.3216783217,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1531531532,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.2620689655,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.144,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.4592274678,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6447368421,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.4533762058,,,,0.024,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6313131313,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.01435406699,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.624,,,,,0.6767676768
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.6959459459,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL,,,,,,,0.1144278607,,,,0.3333333333,0.3032258065,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL,,,,,,,0.08571428571,,,,0.3766233766,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VENLAFAXINE HCL,,,,,,,0.1946902655,,,,,0.3465346535,,,,
  12 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL,0.00422832981,0.02127659574,0.4118705036,,,0.3569682152,0.123025371,0.4189602446,0.05581395349,0.01526717557,0.3337837838,0.3399209486,,,0.01444043321,0.4656820156
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.2820512821,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.3697478992
  5 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,0.02489626556,,,,,0.1488095238,,,,0.5722465477,,,0.6031746032,0.01710171017,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4561403509,,,,0.02,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3513513514,,,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,0.02202643172,,,,,0.23125,,,,0.4105960265,,,0.7323943662,0.009259259259,0.6864197531
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.3915662651,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SUMATRIPTAN SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.3538461538,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6571428571
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | TOPIRAMATE | TRAZODONE HCL,,,,,,,,,,,0.25,,,,,
  13 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL,0.001615508885,0.02278942571,0.4048843188,,,0.2745098039,0.1237541528,0.4050235479,0.09937888199,0.03448275862,0.3355365474,0.2871972318,,0.4196787149,0.01968205905,0.399185336
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3034188034,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,0.01829268293,,,,,,,,,0.5534441805,,,,0.02076970067,0.6378504673
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | VENLAFAXINE HCL,,,,,,0.3509933775,,,,,,,,,,
  13 ,Age: 41-64 | Gender: Female | Last AD: Diff & No Remiss | VENLAFAXINE HCL,0.007633587786,0.02658788774,0.4515539305,,,0.3597359736,0.1566380134,0.4256880734,0.1015625,0.05357142857,0.3099652375,0.3506944444,,0.5006587615,0.009685230024,0.7142857143
  6 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss,,0.08102345416,,0.6742301459,,0.5545746388,,,0.306,,,,,,0.06785589367,0.6511134677
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,,,,,0.609375,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,,,,,0.5690607735,
  3 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5333333333,,,,,,,0.6455696203,,,,,,0.4921348315,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.6708074534,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,,,,,,,,,,0.592920354,,,,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.6146788991,,,,,,,,,0.6204379562,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.4545454545,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.5181058496,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.5855263158,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.6881188119,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE,,,,,,,,,0.438247012,,0.4709677419,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.3103448276,,0.5148514851,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6176470588
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.04444444444,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.5396825397,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7254098361,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.4632352941,,,0.7215686275,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7565217391
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6952380952,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6167247387,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5871559633
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6184210526,,,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6414141414,0.0101010101,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6233766234,0.04273504274,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6366197183,,,0.005154639175,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6353297953,0.01739130435,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.7253521127,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.02229299363,0.6823529412
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.6952380952,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6304347826,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5688888889,,,,,0.5855513308
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4166666667,0.614379085,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.3701298701,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3753026634,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.397993311,,,,,0.615942029
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5483870968,0.6842105263,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4655172414,,,,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.624535316,,,0.6222910217,0.05325443787,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5534351145,,,,0.08653846154,0.5785714286
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,0.5172413793,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | OMEPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.427184466,,,,,
  10 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL,0.02352941176,0.04885993485,0.6666666667,,,0.536977492,0.2539964476,0.6203966006,,,0.3563278008,,,0.6684350133,0.09121621622,0.6486486486
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.4009661836,0.6759259259,,,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4788418708,0.6326889279,,,0.0501618123,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3714285714,0.6783216783,,,,0.7522123894
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.6850393701,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.03921568627,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.3048128342,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,0.1857142857,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5069767442,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5200892857,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5492227979,,,0.6412556054,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.07438016529,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5593220339,,,,,0.6516129032
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,0.6646706587,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL,,,,,,,,,,,0.401459854,,,,,
  12 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL,0.03333333333,0.04081632653,0.5813953488,0.75625,,0.5163934426,0.23117338,0.6269592476,0.2513089005,,0.418784029,0.4796747967,,,0.06293706294,0.6441207076
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.4833333333,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.4339622642,,,,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4944275583,,,0.6336489439,0.04619388419,
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4870466321,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,0.0593220339,,,,,0.3103448276,,,,0.4498777506,,,0.7734375,,0.7393162393
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | SIMVASTATIN | VENLAFAXINE HCL,,,,,,,,,,,0.3564356436,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,0.7075471698,,,,0.04888402027,
  3 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4969474969,,,,0.0522875817,0.6634050881
  1 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | VENLAFAXINE HCL,,,,,,0.5511811024,,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | Last AD: Diff & Remiss | VENLAFAXINE HCL,0.04571428571,0.06559139785,0.6304909561,,,0.5668276973,0.2517482517,0.6353887399,,,0.4000751315,0.6212121212,,0.6744186047,0.06578947368,0.7684729064
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss,,,,,,,,0.1111111111,,,0.1264667536,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,,,,0.424,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,,,,,,,,,,,0.4,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.4501424501,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.1278538813,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4558139535
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SERTRALINE HCL",,,,,,,,,,,,,,0.5074626866,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3439065109
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MASTODYNIA (dxo:ICD9:61171) | SERTRALINE HCL,,,,,,,,,,,,,,0.4185022026,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | NORTRIPTYLINE HCL",,,,,,,,,,0.05555555556,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1322241681,,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,0.1150895141,,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.4,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.223880597,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.3653846154,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | MYOPIA (dxo:ICD9:3671) | SERTRALINE HCL,,,,,,,,,,,,,,0.368,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,,,,,,,,,,,,,0.4449760766,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.06011960969,,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.4146341463,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.4,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.4598214286,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.4807692308,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.4618644068,0,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.4814814815,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.1215277778,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.407960199,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.3231818182,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.2829268293,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4063492063,0.3706896552,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2621359223,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.407651715,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.4380165289,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5121495327,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4554455446,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.4578947368,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.375,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4105960265
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAMADOL HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1560693642,,,,0.007674597084,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5046728972,,,,,0.3739130435
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3948317308
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.4675324675,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4296875,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,,,0.2598870056,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.3976190476,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851) | PAROXETINE HCL,,,,,,,,,,,,0.2991452991,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PAROXETINE HCL,,,,,,,,,,,,0.3209876543,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | SERTRALINE HCL,,,,,,,,,,,,,,0.396039604,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.2803738318,0.3250114521,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.199592668,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1294964029,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5943396226,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,,0.3687943262,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,0.1842105263,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,0.3185840708,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.3383545771,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,,0.3502824859,,0.3755656109,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4482758621,,,,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3646563815,0.3398058252,,,0.01038062284,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4125,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,0.3779527559,,,,0.4622641509
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742) | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.07216494845,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.2962962963,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.162601626,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2420948617,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1520912548,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0.02946593002,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1545064378,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2083936324
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3805147059,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4060150376,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.5172413793,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.5653846154,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5449101796,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.4545454545,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PREGABALIN | SERTRALINE HCL,,,,,,,,,,,,,,0.4607329843,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.4028776978,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SERTRALINE HCL,,,,,,,,,,,,,,0.3565891473,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1203703704,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,,,,0.3394833948,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2162162162,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3697478992
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,,,,0.2671232877,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,,,,,0.03333333333,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.2578125,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.296875,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2392638037,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01030927835,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.2782608696,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.225464191
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836) | SERTRALINE HCL",,,,,,,,,,,,,,0.1221374046,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.2316513761,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,,,,0.08127208481,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1342281879
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,,,0.2225705329,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5593220339,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.5070422535,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.3785714286,,,0.3973766225,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.4690663667,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,,,,0.497005988,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | TOPIRAMATE,,,,,,,,,,,,,,0.4652173913,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.435413643,,,0.3848920863,0.006980802792,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.48,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.4173387097,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.3730569948,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.3714285714,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.3119266055,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.4444444444,,
  3 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3965517241,,,0.4696356275,,0.4395604396
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,0.4528301887,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3657817109
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | TRAMADOL HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.007042253521,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2301740812,,,,0.008881803689,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,,0.008955223881,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0,
  3 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4215909091,,,,0.01975308642,0.3152941176
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.005602240896,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3255813953
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.367965368,,,,,0.3618623482
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss,,,,,,,,,,,0.5525062372,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.8063241107,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.7943548387,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.8064516129,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7900552486,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,,,,0.7715736041,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7157652474,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.7514619883,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.712,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.6929824561,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | NORTRIPTYLINE HCL",,,,,,,,,,,0.7611940299,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.7402597403,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,,,,,,,,,,,0.6571428571,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.7006802721,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.7222222222,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.7672413793,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.6968838527,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.7882352941,,,,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7531461762,,,,0.4396551724,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7323943662,,,,,
  2 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.7073170732,,,,,0.7739130435
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SERTRALINE HCL",,,,,,,,,,,,,,0.75,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7302052786
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MASTODYNIA (dxo:ICD9:61171) | SERTRALINE HCL,,,,,,,,,,,,,,0.7411764706,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | SERTRALINE HCL",,,,,,,,,,,,,,0.73,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,0.5426695842,,0.5632850242,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.4776119403,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,,,0.4910714286,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.5677966102,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.5822306238,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.5893719807,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MULTIPLE SCLEROSIS (dxo:ICD9:340) | SERTRALINE HCL,,,,,,,,,,,,,,0.7757009346,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | MYOPIA (dxo:ICD9:3671) | SERTRALINE HCL,,,,,,,,,,,,,,0.8058252427,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,,,,,,,,,,,,,0.7247706422,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.5649717514,0.6016042781,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4516129032,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5984848485,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.6413043478,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5386819484,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6358695652,,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6682926829,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6523809524,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.5742574257,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4275362319,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.5294117647,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5172413793,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.8519855596,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.8930434783,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.7451923077,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.8125,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.8423236515
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5265822785,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.5652173913,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6717557252,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.5778688525,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6480446927,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6349809886,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.560371517
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.8419354839,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.8907996561,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.719844358,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.7696969697,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.8448979592
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | PAROXETINE HCL,,,,,,,,,,,,0.8130841121,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.7749419954,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.7705977383,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PAROXETINE HCL,,,,,,,,,,,,0.6428571429,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | SERTRALINE HCL,,,,,,,,,,,,,,0.7047619048,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.7021391094,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.614213198,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.6818181818,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.7524691358,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6028257457,0.6126126126,,,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.5324675325,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5980861244,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5888501742,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.5813953488,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.5353535354,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.6073752711,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.623853211,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.5558510638,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6155844156,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.81640625,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PREGABALIN | SERTRALINE HCL,,,,,,,,,,,,,,0.7404255319,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,,,,0.6378600823,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | RAMIPRIL | SERTRALINE HCL,,,,,,,,,,,,,,0.86,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.6595744681,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,,,,0.7699115044,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | RIZATRIPTAN BENZOATE | SERTRALINE HCL,,,,,,,,,,,,,,0.7909090909,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6090008258,,0.6082949309,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6820987654,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5833333333,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.572640509,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6129032258,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6118598383,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8232445521,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.5025125628,,,0.7438822751,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8156073002,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,,,,0.7735849057,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | TOPIRAMATE,,,,,,,,,,,,,,0.7441077441,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6449567723,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5852272727,,,,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.730474732,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.6666666667,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.7055214724,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.8117647059,,
  1 ,"Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.7378640777,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5851851852,,,,,0.6923076923
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,0.7450980392,,
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7407407407
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.605558744,,,,,
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5889649273,,,,,0.6956521739
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7371134021
  2 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5643153527,,,,,0.7294045048
  1 ,Age: 41-64 | Gender: Female | Last AD: Same & Remiss | VILAZODONE HCL,,,,,,,,,,,0.6203703704,,,,,
  5 ,"Age: 41-64 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",,,,,,,,0.4329268293,,,0.2016348774,0.3497536946,,0.4833659491,,0.4036885246
  1 ,"Age: 41-64 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7368421053,,
  1 ,"Age: 41-64 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",,,,,,,,0.2891566265,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.3212435233,,,,
  2 ,"Age: 41-64 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | SERTRALINE HCL",,,,,,,,,,,0.3409090909,,,0.686746988,,
  1 ,"Age: 41-64 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",,,,,,,,,,,,,,,,0.4012738854
  1 ,"Age: 41-64 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",,,,,,,,,,,,,,0.446969697,,
  1 ,"Age: 41-64 | Gender: Female | LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6428571429
  1 ,Age: 41-64 | Gender: Female | LEVOCETIRIZINE DIHYDROCHLORIDE,,,,0.7450980392,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | LEVOFLOXACIN,,,0.4666666667,,,,0.1496881497,0.5197368421,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LEVOFLOXACIN | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1282798834,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL,,,0.5515320334,,,,,,,,,,,0.5756578947,,
  1 ,Age: 41-64 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6956521739,,
  1 ,Age: 41-64 | Gender: Female | LEVONORGESTREL-ETHIN ESTRADIOL | SERTRALINE HCL,,,,,,,,,,,,,,0.7455012853,,
  7 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM,,,0.5062656642,,,,0.1526418787,0.5249196141,,,0.2430213465,0.4022988506,,0.5513072814,,0.4563106796
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4933774834,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4700973574,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7948717949,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8387096774,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | LORAZEPAM,,,,,,,,,,,,,,0.4913793103,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | MYOPIA (dxo:ICD9:3671),,,,,,,,,,,,,,0.6116504854,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,,,,,,,,0.5044247788,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,,,,0.5392156863,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,,,0.519379845,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,,,,,,,,,,,,0.6283185841,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.8195876289,,
  2 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | PAROXETINE HCL,,,,,,,,,,,0.3293413174,0.6617647059,,,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | PRAVASTATIN SODIUM,,,,,,,,,,,,,,0.5607476636,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8387096774,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | ROSUVASTATIN CALCIUM,,,,,,,,,,,,,,0.59375,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8231707317,,
  3 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1184210526,0.4807692308,,,0.2340425532,,,,,
  2 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,0.4916943522,,,0.7731269785,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7865168539,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.7613636364,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.736,,
  2 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | SIMVASTATIN,,,0.5714285714,,,,,,,,,,,0.5722891566,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | TRAZODONE HCL,,,,,,,,,,,0.3798449612,,,,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.5258215962,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.5041322314,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.5945945946,,
  1 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.4709677419,,
  2 ,Age: 41-64 | Gender: Female | LEVOTHYROXINE SODIUM | VENLAFAXINE HCL,,,,,,,,,,,0.4458333333,,,,,0.7532467532
  1 ,Age: 41-64 | Gender: Female | LIDOCAINE,,,0.4761904762,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | LISINOPRIL,,,0.5164473684,,,,0.1267605634,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.4980214811,,,,0.1403508772,0.4776119403,,,,,,0.5789473684,,
  1 ,Age: 41-64 | Gender: Female | LISINOPRIL/HYDROCHLOROTHIAZIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.5089285714,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LISINOPRIL/HYDROCHLOROTHIAZIDE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1280788177,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LISINOPRIL/HYDROCHLOROTHIAZIDE | SIMVASTATIN,,,0.4618834081,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | LITHIUM CARBONATE,,,,,,,0.09150326797,0.1270718232,,,0.07894736842,,,,0.03067484663,0.1583710407
  1 ,Age: 41-64 | Gender: Female | LITHIUM CARBONATE | PAROXETINE HCL,,,,,,,,,,,,0.2330097087,,,,
  1 ,"Age: 41-64 | Gender: Female | LITHIUM CARBONATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1584158416
  1 ,Age: 41-64 | Gender: Female | LITHIUM CARBONATE | SERTRALINE HCL,,,,,,,,,,,0.125,,,,,
  1 ,Age: 41-64 | Gender: Female | LITHIUM CARBONATE | TRAZODONE HCL,,,,,,,,,,,0.09352517986,,,,,
  1 ,Age: 41-64 | Gender: Female | LITHIUM CARBONATE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1395348837
  2 ,Age: 41-64 | Gender: Female | LITHIUM CARBONATE | VENLAFAXINE HCL,,,,,,,,,,,0.1342281879,,,,,0.1605351171
  3 ,Age: 41-64 | Gender: Female | LORATADINE,,,0.6275862069,,,,0.1045751634,,,,,0.4697217676,,,,
  1 ,Age: 41-64 | Gender: Female | LORATADINE | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.4227642276,,,,
  1 ,Age: 41-64 | Gender: Female | LORATADINE | PAROXETINE HCL,,,,,,,,,,,,0.7131782946,,,,
  1 ,Age: 41-64 | Gender: Female | LORATADINE | SERTRALINE HCL,,,,,,,,,,,,,,0.7,,
  5 ,Age: 41-64 | Gender: Female | LORAZEPAM,0.006825938567,0.03433835846,0.4529505582,,,,,0.4459459459,,,,,,0.4790011351,,
  1 ,Age: 41-64 | Gender: Female | LORAZEPAM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3575418994,,
  1 ,Age: 41-64 | Gender: Female | LORAZEPAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.703125,,
  1 ,Age: 41-64 | Gender: Female | LORAZEPAM | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02027027027,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LORAZEPAM | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.05333333333,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LORAZEPAM | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.005714285714,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LORAZEPAM | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LORAZEPAM | SERTRALINE HCL,,,,,,,,,,,,,,0.7407407407,,
  7 ,Age: 41-64 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321),,0.02285714286,0.4251592357,,,,,0.4680851064,0.1165803109,,,0.3732057416,,0.4835443038,,0.5031055901
  1 ,Age: 41-64 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1277777778,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.255952381,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,0.1379310345,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | SERTRALINE HCL,,,,,,,,,,,,,,0.632,,
  4 ,Age: 41-64 | Gender: Female | LOVASTATIN,0.008583690987,,0.5218978102,,,,0.1472727273,0.4782608696,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | LUMBAGO (dxo:ICD9:7242),,,,,,0.3681818182,,0.45,,,,,,,0.004291845494,
  1 ,Age: 41-64 | Gender: Female | LUMBAGO (dxo:ICD9:7242) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.3652173913,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | LUMP OR MASS IN BREAST (dxo:ICD9:61172),,,,,,,,,,,,,,,,0.4351464435
  1 ,Age: 41-64 | Gender: Female | LUMP OR MASS IN BREAST (dxo:ICD9:61172) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6638655462
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.524137931,,,,,,,,,0.6795513112,,,,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.6754098361,,,,,,,,,0.763592233,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7619647355,,,,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.61,,,,,,,,,0.7068965517,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7022900763,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MIRTAZAPINE",,,,,,,,,,,0.7016129032,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.7677165354,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | ROPINIROLE HCL",,,,,,,,,,,0.6538461538,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.7087378641,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | SERTRALINE HCL",,,,,,,,,,,0.65,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.7716535433,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.6802443992,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.6764705882,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | VENLAFAXINE HCL",,,,,,,,,,,0.6200873362,,,,,
  12 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.5340755735,0.6765799257,0.7058823529,,0.6662404092,0.6429447853,0.6731707317,0.5596330275,0.4859813084,0.6733997468,,,0.662992126,0.4723435226,0.6821480406
  3 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5523012552,,,,,,,,,0.6779359431,,,,0.50625,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6888454012,,,,0.4821428571,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6802721088
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE",,,,,,,,,0.5914893617,,0.7055555556,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.6257309942,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | NORTRIPTYLINE HCL",,,,,,,,,,,0.6339869281,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.6489361702,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,,,,,0.6814814815
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.7297297297,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.734375
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.6265432099,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PRAMIPEXOLE DI-HCL | TRAZODONE HCL",,,,,,,,,,,0.5680473373,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | ROPINIROLE HCL",,,,,,,,,,,0.6268456376,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.6271777003,,,,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,0.7159090909,,,0.7171651495,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.6648044693,,,0.7423580786,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6619128817,,,,0.4643274854,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.6656346749,,,,,0.6976744186
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,0.6421232877,,,,,0.7134948097
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MILD (dxo:ICD9:29631)",,,,,,,0.2265625,,,,,,,,0.02941176471,
  8 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",0.01923076923,,0.5,,,0.375,,0.5304878049,,,0.3655913978,,,0.5169491525,0.03968253968,0.5197368421
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1909090909,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.3855421687,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.145631068,,,,,
  4 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1900826446,,,,,0.2063492063,,,0.1328125,,,0.1885714286,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2089552239,,,,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,0.4404761905,,,0.7613636364,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | VENLAFAXINE HCL",,,,,,,,,,,0.4444444444,,,,,0.7537313433
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",,,,,,,,,,,0.3015075377,,,0.4126984127,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1379310345,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633) | SERTRALINE HCL",,,,,,,,,,,,,,0.640776699,,
  15 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2948113208,0.4145352765,0.6567544605,0.6499429875,0.3346303502,0.5719221106,0.5060782241,0.6286516854,0.4626006904,0.423255814,0.5567137413,0.5938511327,,0.638996139,0.3295523597,0.6212389381
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.4616402116,,0.57001321,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4828660436,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.4836601307,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.3706896552,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | VENLAFAXINE HCL",,,,,,,,,,,0.5315315315,,,,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | NORTRIPTYLINE HCL",,,,,,,,,,0.4376811594,0.6180451128,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | NORTRIPTYLINE HCL | TRAZODONE HCL",,,,,,,,,,,0.5862068966,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.4232804233,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.4957264957,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4702842377,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.34,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.6761904762,,,,,
  5 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,0.4833333333,,,,0.6213592233,0.5347222222,,,,0.5968468468,0.6183844011,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.6879432624,,,,
  3 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,0.5633187773,0.5896656535,,,0.3081081081,
  8 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.6462585034,0.7622377622,0.75,,0.672985782,,0.6442307692,,,0.6898148148,,,0.6605504587,,0.7082294264
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.6713286713,,,0.7390029326,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.7692307692,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7155963303,,,,,0.7379032258
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.6467391304,,,,,0.7118320611
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.5482014388,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL | TRAZODONE HCL",,,,,,,,,,,0.5426829268,,,,,
  2 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.6524822695,,,,0.5940594059,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,,,0.4645669291
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5153846154
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | RISPERIDONE",,,,,,,,,,,0.4980544747,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | RISPERIDONE | TRAZODONE HCL",,,,,,,,,,,0.4222222222,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | RISPERIDONE | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5839416058
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.533,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.5365448505,,,,,
  7 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.4164222874,0.6478873239,,,0.5433789954,0.5404699739,0.5592105263,,,0.5605504587,,,0.7007077856,,
  3 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.576433121,,,0.6817288802,0.1957446809,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.552,,,,,
  7 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.3481781377,,,,0.505952381,0.506097561,0.5227272727,,,0.5454919381,,,,0.3284132841,0.52
  3 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.5339185954,,,,0.2,0.6464968153
  5 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,0.4248927039,,,,,0.5153061224,0.5826086957,,,0.5746753247,,,,,0.6615884116
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MILD (dxo:ICD9:29621)",,0.02586206897,,,,,,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.04821802935,,,,,,0.4957983193,,,0.45,,,0.5057471264,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.02040816327,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | SERTRALINE HCL",,,,,,,,,,,,,,0.6971428571,,
  5 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.05066666667,,,,0.4518518519,,,,,,,,0.4945652174,0.01694915254,0.6153846154
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620) | SERTRALINE HCL",,,,,,,,,,,,,,0.7433628319,,
  1 ,"Age: 41-64 | Gender: Female | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7481481481
  4 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,0.03741496599,,,,,,0.5135453475,,,,,,0.5092693566,,0.4431125131
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01818181818,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | PAROXETINE HCL",,,,,,,,,,,,,,,,0.5259259259
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,,,0.1644736842
  2 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SERTRALINE HCL",,,,,,,,,,,,,,0.752851711,,0.5710227273
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",,,,,,,,,,,,,,,,0.3947368421
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | TAMOXIFEN CITRATE",,,,,,,,,,,,,,,,0.4380952381
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.641025641
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | TAMOXIFEN CITRATE",,,,,,,,,,,,,,,,0.3694915254
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | TAMOXIFEN CITRATE | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6511627907
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | TRAZODONE HCL",,,,,,,,,,,,,,,,0.3469387755
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5516224189
  1 ,"Age: 41-64 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6721915285
  5 ,Age: 41-64 | Gender: Female | MASTODYNIA (dxo:ICD9:61171),,,,,,,0.1111111111,0.4303030303,,,0.2247191011,,,0.4586148649,,0.3537604457
  1 ,Age: 41-64 | Gender: Female | MASTODYNIA (dxo:ICD9:61171) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.09803921569,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MASTODYNIA (dxo:ICD9:61171) | SERTRALINE HCL,,,,,,,,,,,,,,0.6841155235,,
  1 ,Age: 41-64 | Gender: Female | MASTODYNIA (dxo:ICD9:61171) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.380952381
  1 ,Age: 41-64 | Gender: Female | MASTODYNIA (dxo:ICD9:61171) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6637168142
  1 ,Age: 41-64 | Gender: Female | MECLIZINE HCL,,,,,,,,,,,,,,0.4596774194,,
  1 ,Age: 41-64 | Gender: Female | MEDROXYPROGESTERONE ACETATE,,,,,,,0.1366459627,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MEDROXYPROGESTERONE ACETATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1734693878,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MELOXICAM,,,,,,0.3210116732,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MELOXICAM | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.2641509434,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MELOXICAM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.312,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MELOXICAM | TRAMADOL HCL,,,,,,0.3392857143,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MELOXICAM | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3907284768,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | METAXALONE,,,0.4756944444,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | METFORMIN HCL,,,,,,,,,,,0.287037037,0.4337899543,,0.568914956,,
  1 ,Age: 41-64 | Gender: Female | METFORMIN HCL | PAROXETINE HCL,,,,,,,,,,,,0.7216981132,,,,
  1 ,Age: 41-64 | Gender: Female | METFORMIN HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.7307692308,,
  1 ,Age: 41-64 | Gender: Female | METHOTREXATE SODIUM,,,,,,,,,,,,,,0.5639097744,,
  1 ,Age: 41-64 | Gender: Female | METHYLPHENIDATE HCL,,0.02857142857,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | METOCLOPRAMIDE HCL,,,,,,,,0.4388489209,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | METOPROLOL SUCCINATE,,,,,,,,0.5258964143,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | METRONIDAZOLE,,,0.4591194969,,,,,0.4270833333,,,,,,0.5126582278,,0.4307692308
  1 ,Age: 41-64 | Gender: Female | METRONIDAZOLE | SERTRALINE HCL,,,,,,,,,,,,,,0.7672955975,,
  1 ,"Age: 41-64 | Gender: Female | MIGRAINE WITHOUT AURA, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34611)",,,,,,,,,,,,,,0.4676258993,,
  3 ,"Age: 41-64 | Gender: Female | MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",,,0.4638157895,,,,,,,0.04,,,,0.5365853659,,
  8 ,"Age: 41-64 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.009071877181,0.03765690377,0.3909090909,,0.13,,0.1384615385,0.4450549451,,0.05375,,,,0.5294117647,,
  1 ,"Age: 41-64 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | NORTRIPTYLINE HCL",,,,,,,,,,0.2329317269,,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",0.01209677419,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0,,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",0.002457002457,,,,,,0.1726618705,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | SERTRALINE HCL",,,,,,,,,,,,,,0.7004830918,,
  3 ,"Age: 41-64 | Gender: Female | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690) | SUMATRIPTAN SUCCINATE",0.008695652174,,,,,,,,,0.04761904762,,,,0.4965034965,,
  12 ,Age: 41-64 | Gender: Female | MIRTAZAPINE,0.02592592593,0.02102102102,0.3489361702,,,0.3049853372,0.1493848858,0.3311897106,0.2618302174,,0.3093457265,0.3755274262,,0.367965368,0.006896551724,0.4005167959
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.3105882353,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | NORTRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2252252252,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2442748092,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2761904762,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6666666667,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2246376812,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.39,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3391304348,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.2960526316,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2376650452,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1961852861,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.2098765432,,,,,
  3 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,0.2075471698,,0.3024118738,0.5166340509,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3258426966,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1094339623,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1214285714,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1221374046,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1962616822,,,,,
  2 ,"Age: 41-64 | Gender: Female | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1413043478,,,,,0.2894736842
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4082969432,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.287037037,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1343283582,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIRTAZAPINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1428571429,,,,,
  1 ,"Age: 41-64 | Gender: Female | MIRTAZAPINE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1550387597,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.1237864078,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1259259259,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.171641791,,,,,
  2 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,0.2369942197,,0.3721264368,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3248407643,,,,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,0.3134796238,,,,,,,
  3 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.2095730918,,0.3234265734,,,0.5334538879,,
  2 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2863436123,,,0.3797468354,,
  1 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2452830189,,,,,
  3 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL,,,,,,0.1742424242,,,0.2576530612,,0.2933558559,,,,,
  2 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.251497006,,,,,0.564516129
  3 ,Age: 41-64 | Gender: Female | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,0.1782945736,,0.2963855422,,,,,0.6161764706
  1 ,Age: 41-64 | Gender: Female | MITRAL VALVE DISORDERS (dxo:ICD9:4240),,,,,,,0.1,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MITRAL VALVE DISORDERS (dxo:ICD9:4240) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.08270676692,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | MIXED HYPERLIPIDEMIA (dxo:ICD9:2722),0.01408450704,,,,,,,0.5181818182,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MIXED HYPERLIPIDEMIA (dxo:ICD9:2722) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | MODAFINIL,,0.02197802198,,,,,,,,,,,,0.6030534351,,
  1 ,Age: 41-64 | Gender: Female | MODAFINIL | SERTRALINE HCL,,,,,,,,,,,,,,0.7289156627,,
  3 ,Age: 41-64 | Gender: Female | MONONEURITIS OF UNSPECIFIED SITE (dxo:ICD9:3559),0.02479338843,,,,,0.3684210526,,,,,,,,0.5943396226,,
  3 ,Age: 41-64 | Gender: Female | MONTELUKAST SODIUM,,,0.4939759036,,,,,0.5054644809,,,0.2660550459,,,,,
  1 ,Age: 41-64 | Gender: Female | MONTELUKAST SODIUM | PAROXETINE HCL,,,,,,,,,,,0.3461538462,,,,,
  1 ,Age: 41-64 | Gender: Female | MONTELUKAST SODIUM | SERTRALINE HCL,,,,,,,,,,,0.4805825243,,,,,
  1 ,Age: 41-64 | Gender: Female | MONTELUKAST SODIUM | VENLAFAXINE HCL,,,,,,,,,,,0.4409937888,,,,,
  1 ,Age: 41-64 | Gender: Female | MORBID OBESITY (dxi:ICD9:27801),,,,,,,,,,,,,,0.5763888889,,
  3 ,Age: 41-64 | Gender: Female | MORBID OBESITY (dxo:ICD9:27801),,0.0329218107,,,,,0.1736363636,,0.056,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | MORBID OBESITY (dxo:ICD9:27801) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.02717391304,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MORBID OBESITY (dxo:ICD9:27801) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.2133891213,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MORBID OBESITY (dxo:ICD9:27801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1336898396,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MORPHINE SULFATE,0.01366120219,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MOXIFLOXACIN HCL,,,,,,,0.1059190031,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MOXIFLOXACIN HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1083333333,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,0.3904761905,0.1494252874,0.5521628499,,,0.3033707865,,,0.5487804878,,
  2 ,Age: 41-64 | Gender: Female | MULTIPLE SCLEROSIS (dxo:ICD9:340) | SERTRALINE HCL,,,,,,,,,,,0.4391891892,,,0.7794871795,,
  1 ,Age: 41-64 | Gender: Female | MULTIPLE SCLEROSIS (dxo:ICD9:340) | VENLAFAXINE HCL,,,,,,,,,,,0.4179104478,,,,,
  1 ,Age: 41-64 | Gender: Female | MUSCLE WEAKNESS (GENERALIZED) (dxo:ICD9:72887),,,,,,,,,,,,,,,,0.4444444444
  6 ,Age: 41-64 | Gender: Female | MYOPIA (dxo:ICD9:3671),,0.04048843188,0.5304621849,,,,0.152866242,0.5321336761,,,,0.4649122807,,0.5476477684,,
  1 ,Age: 41-64 | Gender: Female | MYOPIA (dxo:ICD9:3671) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01421800948,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MYOPIA (dxo:ICD9:3671) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.06206896552,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MYOPIA (dxo:ICD9:3671) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,,,,,,,,,,,,0.5840707965,,
  1 ,Age: 41-64 | Gender: Female | MYOPIA (dxo:ICD9:3671) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1620111732,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | MYOPIA (dxo:ICD9:3671) | SERTRALINE HCL,,,,,,,,,,,,,,0.7699316629,,
  3 ,Age: 41-64 | Gender: Female | NAPROXEN,0.005681818182,,,,,,0.1351351351,,,,,,,0.5297157623,,
  1 ,Age: 41-64 | Gender: Female | NAPROXEN | SERTRALINE HCL,,,,,,,,,,,,,,0.7557603687,,
  1 ,Age: 41-64 | Gender: Female | NECK SPRAIN AND STRAIN (dxo:ICD9:8470),,,,,,,,,,0.04672897196,,,,,,
  1 ,Age: 41-64 | Gender: Female | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382),,0.03951890034,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.008474576271,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.02777777778,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | NONALLOPATHIC LESION OF CERVICAL REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7391)",,,,,,,,,,,,,,0.664,,
  1 ,"Age: 41-64 | Gender: Female | NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)",,,,,,,,,,,,0.37109375,,,,
  1 ,"Age: 41-64 | Gender: Female | NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392) | PAROXETINE HCL",,,,,,,,,,,,0.690647482,,,,
  1 ,"Age: 41-64 | Gender: Female | NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.32,,,,
  2 ,"Age: 41-64 | Gender: Female | NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",,,,,,,,0.3850931677,,,,,,,0.01652892562,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxi:ICD9:3051),,,,,,,,,,,,,,,0.01851851852,
  6 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.0197,,,,,0.1647746818,0.4899193548,0.1516587678,,,,,0.4942704354,0.009596928983,
  1 ,"Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.0347826087,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OMEPRAZOLE,,,,,,,0.1342281879,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01782178218,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.01265822785,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.1352941176,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.05263157895,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PAROXETINE HCL,,0.01075268817,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.06481481481,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.0198019802,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.04032258065,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.02279202279,,,,,0.1619585687,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.03426791277,,,,,,,,,,,,0.6981132075,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SIMVASTATIN,,,,,,,0.125,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VALACYCLOVIR HCL,,0.02684563758,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VARENICLINE TARTRATE,,0.01568627451,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VENLAFAXINE HCL,,0.04329004329,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NORETHINDRONE,,,,,,,,,,,,,,0.5458167331,,
  1 ,Age: 41-64 | Gender: Female | NORETHINDRONE | SERTRALINE HCL,,,,,,,,,,,,,,0.75,,
  1 ,Age: 41-64 | Gender: Female | NORETHINDRONE-E.ESTRADIOL-IRON | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1302083333,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | NORETHINDRONE-ETHIN. ESTRADIOL,,,,,,,,,,,,,,0.5882352941,,
  1 ,Age: 41-64 | Gender: Female | NORGESTIMATE-ETHINYL ESTRADIOL,,,0.5114155251,,,,,,,,,,,,,
  12 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL,0.01315789474,0.03125,0.3874755382,,,0.3617021277,0.1229508197,0.3978494624,,0.1639983058,0.4024458477,0.311827957,,0.396460177,0.015625,0.3957528958
  1 ,"Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7192982456,,,,
  1 ,"Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7074235808,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.270531401,,,,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2975206612,,,,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2080536913,,,,,
  3 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | PAROXETINE HCL,,,,,,,,,,0.1300309598,0.4484451718,0.5446293495,,,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.380952381,,,,,
  1 ,"Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.08108108108,,,,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4816955684,,,,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1403508772,,,,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | RISPERIDONE,,,,,,,,,,,0.157480315,,,,,
  2 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | ROPINIROLE HCL,,,,,,,,,,0.1363636364,0.4416403785,,,,,
  3 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,0.1557591623,0.4512860483,,,0.6260043828,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3962264151,,,,,
  2 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,0.2064896755,0.3510145959,,,,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3469387755,,,,,
  1 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,0.18,,,,,,
  3 ,Age: 41-64 | Gender: Female | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,0.1552631579,0.3724088635,,,,,0.6679245283
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | SERTRALINE HCL",,,,,,,,,,,,0.5045045045,,,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.5499231951,,,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,0.6666666667,,,,
  2 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | PAROXETINE HCL | SERTRALINE HCL",,,,,,,,,,,,0.7788461538,,0.6957831325,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.658456486,,,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | PAROXETINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,0.7259259259,,,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | PRAMIPEXOLE DI-HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.7314814815,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.6571428571,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | ROPINIROLE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.6649484536,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7384615385,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6670765447,,
  1 ,"Age: 41-64 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.7175925926,,
  3 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+,,,,,,,,,,,0.2326103216,0.2970588235,,0.2419354839,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.378238342,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,,0.3305084746,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3780487805,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.456,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4214285714,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3472222222,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2644628099,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.339658444,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3240816327,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3611111111,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4206896552,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,0.46,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2621535666,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2598870056,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1512195122,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Episodes: 2+ | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,,0.5,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.5505279035,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Episodes: 2+ | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,0.6583333333,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.5327868852,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.8312883436,,,,
  2 ,Age: 41-64 | Gender: Female | Num Previous Remissions: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5541401274,0.6589595376,,,,
  2 ,Age: 41-64 | Gender: Female | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4761904762,,,0.8834710744,,
  2 ,Age: 41-64 | Gender: Female | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6321525886,,,0.6226851852,,
  2 ,Age: 41-64 | Gender: Female | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5568181818,,,,,0.5858310627
  1 ,Age: 41-64 | Gender: Female | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.784
  3 ,"Age: 41-64 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.03460207612,,,,,,0.6018518519,0.0946969697,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.0379403794,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,0.03680981595,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,0.04268292683,,,,,0.21,,,,0.178802589,,,,,
  1 ,Age: 41-64 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PAROXETINE HCL,,,,,,,,,,,0.1768292683,,,,,
  1 ,"Age: 41-64 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1438848921,,,,,
  1 ,Age: 41-64 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.1782729805,,,,,
  1 ,Age: 41-64 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2344827586,,,,,
  1 ,Age: 41-64 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.2317880795,,,,,
  1 ,Age: 41-64 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | VENLAFAXINE HCL,,,,,,,,,,,0.1900826446,,,,,
  10 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),0.004184100418,,0.5223413762,,,,0.1874371859,0.5679758308,,,0.3580246914,0.4402730375,0.2544378698,0.5528804815,0,0.5465838509
  2 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | PAROXETINE HCL,,,,,,,,,,,0.4223300971,0.7782258065,,,,
  1 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.7,,,,
  1 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4466019417,,,,,
  3 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,0.1790393013,,,,,0.3698630137,,,,
  2 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,0.5348837209,,,0.7790224033,,
  1 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8636363636,,
  2 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SIMVASTATIN,,,0.6089385475,,,,,,,,,,,0.6780821918,,
  1 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | TRAZODONE HCL,,,,,,,,,,,0.3228346457,,,,,
  2 ,Age: 41-64 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | VENLAFAXINE HCL,,,,,,,,,,,0.4578005115,,,,,0.8064516129
  1 ,Age: 41-64 | Gender: Female | OLMESARTAN MEDOXOMIL,,,,,,,0.1364421416,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OLMESARTAN/HYDROCHLOROTHIAZIDE,,,,,,0.4367088608,,,,,,,,,,0.5387931034
  1 ,Age: 41-64 | Gender: Female | OLMESARTAN/HYDROCHLOROTHIAZIDE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7764705882
  6 ,Age: 41-64 | Gender: Female | OMEPRAZOLE,,0.05172413793,0.4504504505,,,,0.1507788162,0.5326797386,,,0.2246696035,,,,,0.4714285714
  1 ,Age: 41-64 | Gender: Female | OMEPRAZOLE | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.1472868217,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OMEPRAZOLE | PAROXETINE HCL,,,,,,,,,,,0.3897435897,,,,,
  1 ,Age: 41-64 | Gender: Female | OMEPRAZOLE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1370967742,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OMEPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.4447174447,,,,,
  1 ,Age: 41-64 | Gender: Female | OMEPRAZOLE | SIMVASTATIN,,,,,,,0.1147540984,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OMEPRAZOLE | TRAZODONE HCL,,,,,,,,,,,0.316091954,,,,,
  1 ,Age: 41-64 | Gender: Female | OMEPRAZOLE | VENLAFAXINE HCL,,,,,,,,,,,0.3906705539,,,,,
  1 ,"Age: 41-64 | Gender: Female | OPIOID TYPE DEPENDENCE, UNSPECIFIED (dxo:ICD9:30400)",,,,,,,,,,,,,,,0.008064516129,
  3 ,Age: 41-64 | Gender: Female | OSELTAMIVIR PHOSPHATE,,,0.421875,,,,0.125,,,,,0.4074074074,,,,
  1 ,Age: 41-64 | Gender: Female | OSELTAMIVIR PHOSPHATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.2772277228,,,,
  1 ,"Age: 41-64 | Gender: Female | OSTEOARTHROSIS, UNSPECIFIED WHETHER GENERALIZED OR LOCALIZED, UNSPECIFIED SITE (dxo:ICD9:71590)",,0.01360544218,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER (ABNORMAL) FINDINGS ON RADIOLOGICAL EXAMINATION OF BREAST (dxo:ICD9:79389),,,,,,,,,,,,,,,,0.4437869822
  1 ,Age: 41-64 | Gender: Female | OTHER (ABNORMAL) FINDINGS ON RADIOLOGICAL EXAMINATION OF BREAST (dxo:ICD9:79389) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7467532468
  1 ,Age: 41-64 | Gender: Female | OTHER ACNE (dxo:ICD9:7061),,,0.4915254237,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30390)",,,,,,,,,,,,,,0.3555555556,,
  1 ,Age: 41-64 | Gender: Female | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.037470726,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.01538461538,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OTHER AND UNSPECIFIED HYPERLIPIDEMIA (dxo:ICD9:2724),,,,,,,,0.5487804878,,,,,,0.5772357724,,
  1 ,Age: 41-64 | Gender: Female | OTHER AND UNSPECIFIED HYPERLIPIDEMIA (dxo:ICD9:2724) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,,,,,,,,,,,,0.5673076923,,
  1 ,Age: 41-64 | Gender: Female | OTHER ANXIETY STATES (dxo:ICD9:30009),,,,,,,,,,,0.3202614379,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER ANXIETY STATES (dxo:ICD9:30009) | SERTRALINE HCL,,,,,,,,,,,0.4744525547,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER ANXIETY STATES (dxo:ICD9:30009) | VENLAFAXINE HCL,,,,,,,,,,,0.4260869565,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER ATOPIC DERMATITIS AND RELATED CONDITIONS (dxo:ICD9:6918),,,,,0.09467455621,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OTHER CHRONIC PAIN (dxo:ICD9:33829),,,0.4638554217,,,,,,,,,,,,,0.4292035398
  1 ,Age: 41-64 | Gender: Female | OTHER CHRONIC SINUSITIS (dxo:ICD9:4738),,,,,,,,,,,,,,,,0.427184466
  1 ,Age: 41-64 | Gender: Female | OTHER CONVULSIONS (dxo:ICD9:78039),,0.04705882353,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER DISORDERS OF BONE AND CARTILAGE (dxo:ICD9:73399),,,0.4489795918,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OTHER DYSCHROMIA (dxo:ICD9:70909),,,0.4626865672,,,,,0.395256917,,,,,,,,
  7 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,0.04310344828,0.5120481928,,,,0.1578947368,0.4351851852,,,0.4035532995,,0.3263239875,0.5722891566,,
  1 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | PAROXETINE HCL,,,,,,,,,,,0.4809160305,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5680473373,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,,,0.3875968992,,,
  1 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.5303643725,,,
  2 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,0.5145228216,,0.4341238472,,,
  1 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,,,0.475,,,
  1 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,0.4233576642,,,
  2 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | SERTRALINE HCL,,,,,,,,,,,0.5275590551,,,0.7264150943,,
  1 ,Age: 41-64 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | VENLAFAXINE HCL,,,,,,,,,,,0.4746543779,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER GENERAL SYMPTOMS (dxo:ICD9:78099),,,0.5,,,,,,,,,,,,,
  10 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),0.02,0.02392460126,,0.5807560137,,0.3960554371,0.1490514905,0.5055900621,,,,0.4378109453,,0.5766666667,0.003442340792,0.5250737463
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),,,,,,,,,,,,,,0.5846153846,,
  1 ,"Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.3571428571,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.5339805825,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | PALPITATIONS (dxo:ICD9:7851),,,,,,0.3851351351,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | PAROXETINE HCL,,,,,,,,,,,,0.6115702479,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.06060606061,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.0223880597,,,,,,,,,,,,,0.009756097561,
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.02304147465,,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.02222222222,,0.660944206,,0.3873626374,0.1343283582,0.4939271255,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4514285714,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | SERTRALINE HCL,,0.05696202532,,,,0.6420454545,,,,,,,,0.7425742574,,
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.4700854701
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | TRAMADOL HCL,,,,,,0.3152173913,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599),,0.006666666667,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,0.02873563218,,,,0.3953488372,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | VALACYCLOVIR HCL,,0.03043478261,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | VENLAFAXINE HCL,,0.02727272727,,,,0.6195652174,,,,,,,,,,0.6690140845
  3 ,Age: 41-64 | Gender: Female | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,0.4801980198,,,,0.09500489716,,,,,,,,,0.6048780488
  1 ,Age: 41-64 | Gender: Female | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999) | PAROXETINE HCL,,,,,,,0.1176470588,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999) | SERTRALINE HCL,,,,,,,0.1681415929,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319),,,0.4722222222,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.02127659574,0.4884910486,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.005356639414,,0.5036194416,,,,,,,,,,,0.5652985075,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | PROPOXYPHENE NAP/ACETAMINOPHEN,0.007042253521,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,0.5112359551,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.007291286912,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SUMATRIPTAN SUCCINATE,0.009090909091,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.004237288136,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),0.02068965517,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.5672727273,,,,,,,,,,,0.5375,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762) | SERTRALINE HCL,,,,,,,,,,,,,,0.7379310345,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.7347893916,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SUMATRIPTAN SUCCINATE,0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,0.5454545455,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.002949852507,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),0.005952380952,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.5727272727,,
  1 ,"Age: 41-64 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.5824175824,,
  1 ,Age: 41-64 | Gender: Female | OTHER SEBORRHEIC KERATOSIS (dxo:ICD9:70219),,,0.4696969697,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SPECIFIED CARDIAC DYSRHYTHMIAS (dxo:ICD9:42789),,,,,,,,,,,,,,,,0.4147727273
  1 ,Age: 41-64 | Gender: Female | OTHER SPECIFIED COUNSELING (dxo:ICD9:V6549),,,,,,0.3278688525,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | OTHER SPECIFIED DISEASE OF SEBACEOUS GLANDS (dxo:ICD9:7068),,,,,,,,0.4166666667,,,,,,,,
  3 ,Age: 41-64 | Gender: Female | OTHER SPECIFIED NONINFLAMMATORY DISORDER OF VAGINA (dxo:ICD9:6238),,,0.45,,,0.2283464567,,,,,,,,,,0.3101265823
  1 ,Age: 41-64 | Gender: Female | OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283),,,0.5109170306,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | OVERWEIGHT (dxo:ICD9:27802),,0.04680851064,,,,,,,,,,,,0.4136125654,,
  1 ,Age: 41-64 | Gender: Female | OVERWEIGHT (dxo:ICD9:27802) | SERTRALINE HCL,,,,,,,,,,,,,,0.696,,
  4 ,Age: 41-64 | Gender: Female | OXYBUTYNIN CHLORIDE,,,,,,,0.1634980989,0.5810810811,,,0.2961373391,,,0.6044776119,,
  2 ,Age: 41-64 | Gender: Female | OXYBUTYNIN CHLORIDE | SERTRALINE HCL,,,,,,,,,,,0.5753424658,,,0.78,,
  1 ,Age: 41-64 | Gender: Female | OXYBUTYNIN CHLORIDE | VENLAFAXINE HCL,,,,,,,,,,,0.4736842105,,,,,
  4 ,Age: 41-64 | Gender: Female | OXYCODONE HCL,0.01710526316,,,,,,0.1648106904,,,,,0.391025641,,,0.0119047619,
  3 ,Age: 41-64 | Gender: Female | OXYCODONE HCL/ACETAMINOPHEN,,0.02325581395,,,,,0.152173913,,,,,,,,0.003623188406,
  2 ,"Age: 41-64 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.3655006031,,,,,,,,0.5,,
  1 ,"Age: 41-64 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.4920634921,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | TRAMADOL HCL",,,,,,0.3611111111,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | TRAMADOL HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.3495145631,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.387755102,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | PAIN IN JOINT, SHOULDER REGION (dxo:ICD9:71941)",,,,,,,,,,,,,,,0.0223880597,
  1 ,"Age: 41-64 | Gender: Female | PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",,,,,,0.3908629442,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.4178082192,,,,,,,,,,
  6 ,Age: 41-64 | Gender: Female | PAIN IN SOFT TISSUES OF LIMB (dxo:ICD9:7295),,,0.4954954955,,,,0.1545454545,0.536,,0.05357142857,,0.5,,,,0.4412955466
  1 ,Age: 41-64 | Gender: Female | PAIN IN SOFT TISSUES OF LIMB (dxo:ICD9:7295) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7047619048
  7 ,Age: 41-64 | Gender: Female | PALPITATIONS (dxo:ICD9:7851),,,0.4491887276,,,0.3393213573,0.1282161235,0.4383763838,,,0.1824104235,0.3779904306,,0.5108153078,,
  2 ,Age: 41-64 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | PAROXETINE HCL,,,,,,,,,,,0.4015748031,0.5916955017,,,,
  1 ,Age: 41-64 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.6698113208,,,,
  3 ,Age: 41-64 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,0.3043478261,0.1265306122,,,,,0.338028169,,,,
  2 ,Age: 41-64 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | SERTRALINE HCL,,,,,,,,,,,0.3621399177,,,0.7546296296,,
  1 ,Age: 41-64 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | TRAZODONE HCL,,,,,,,,,,,0.373015873,,,,,
  1 ,Age: 41-64 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3090909091,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | VENLAFAXINE HCL,,,,,,,,,,,0.3025641026,,,,,
  5 ,Age: 41-64 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.04488330341,0.4146341463,,,,,0.5048543689,,,,0.399339934,,0.5093167702,,
  1 ,Age: 41-64 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PAROXETINE HCL,,,,,,,,,,,,0.6774193548,,,,
  1 ,Age: 41-64 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.3703703704,,,,
  1 ,Age: 41-64 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | SERTRALINE HCL,,,,,,,,,,,,,,0.6978723404,,
  3 ,Age: 41-64 | Gender: Female | PANTOPRAZOLE SODIUM,,,0.5217391304,,,,,0.5477386935,,,0.1779661017,,,,,
  2 ,Age: 41-64 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.480620155,,0.4210526316,,,
  1 ,Age: 41-64 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5643564356,,,,,
  1 ,Age: 41-64 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL,,,,,,,,,,,0.514084507,,,,,
  16 ,Age: 41-64 | Gender: Female | PAROXETINE HCL,0.01709943002,0.0321903429,0.5309597523,0.6272040302,0.1206225681,0.4292168675,0.1902205177,0.4875981162,0.1519274376,0.05133470226,0.2976068875,0.5336564419,0.1516393443,0.5120879121,0.02734012975,0.6102731349
  6 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2470588235,,,0.2016806723,,0.2523364486,,,0.0895140665,0.328081557,,0.1984732824,,
  2 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07346938776,0.2796610169,,,,
  1 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.145631068,,,,,
  2 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1614583333,0.2929061785,,,,
  1 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1102362205,,,,,
  1 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1343283582,,,,,
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.525,0.5096525097,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5734265734,,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | PRAVASTATIN SODIUM,,,,,,,,,,,,0.6875,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),,,,,,,,,,,,0.6140350877,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | PROPOXYPHENE NAP/ACETAMINOPHEN,,,,,,,,,,,0.347826087,,,,,
  3 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.1923076923,,,,0.1530612245,0.5226586103,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.3121693122,,,,,
  2 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1201413428,0.3097345133,,,,
  2 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.25625,0.2941176471,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4594594595,,,,,
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5517241379,,0.3933333333,,,
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | RISPERIDONE,,,,,,,,,,,0.1304347826,0.158974359,,,,
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1367521368,0.1553398058,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | ROFECOXIB,,,,,,,,,,,,0.6723163842,,,,
  3 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5275974026,0.529318542,0.3853904282,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4480519481,,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,0.625,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.6466666667,,,,
  3 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2298136646,,,,0.3435582822,0.6251129178,,,,
  1 ,"Age: 41-64 | Gender: Female | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",,,,,,,,,,,,0.5857142857,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,0.7033898305,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL,,,,,,,,,,,,0.5410958904,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | SCREENING MAMMOGRAM FOR HIGH-RISK PATIENT (dxo:ICD9:V7611),,,,,,,,,,,,0.6525423729,,,,
  11 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | SERTRALINE HCL,0.008403361345,0.03353658537,0.487804878,,,0.3577235772,0.1921824104,0.4166666667,,,0.3207317073,0.4958133971,,0.539346247,0.01851851852,0.6141732283
  4 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.323782235,0.4171428571,,0.375,0.01714285714,
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | SIMVASTATIN,,,,,,,,,,,0.4236111111,0.6954022989,,,,
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.4360465116,0.6140350877,,,,
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,0.6198830409,,,,0.6340206186
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | TOPIRAMATE,,,,,,,,,,,0.2777777778,0.7175572519,,,,
  10 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | TRAZODONE HCL,,0.03550295858,0.3743589744,,,0.2984293194,0.1729957806,0.3225806452,,,0.4250559284,0.4769515478,,0.3613861386,0.02382954864,0.419047619
  3 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3496503497,0.3888888889,,,0.01960784314,
  2 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.592920354,,,,,,0.6025104603,,,,
  1 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | VALACYCLOVIR HCL,,,,,,,,,,,,0.6158940397,,,,
  9 ,Age: 41-64 | Gender: Female | PAROXETINE HCL | VENLAFAXINE HCL,,0.05109489051,0.4921465969,,,,0.2012987013,0.4642857143,,,0.3180300501,0.5525902669,,0.4776119403,0.01785714286,0.6754098361
  1 ,"Age: 41-64 | Gender: Female | PEN NEEDLE, DIABETIC",,,0.4601226994,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742),,,0.4024390244,,0.1081081081,,,,,,,,,0.487012987,0.01489361702,
  1 ,Age: 41-64 | Gender: Female | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742) | SERTRALINE HCL,,,,,,,,,,,,,,0.7124183007,,
  1 ,Age: 41-64 | Gender: Female | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742) | TRAZODONE HCL,,,,,,,,,,,,,,,0.02013422819,
  13 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",0.04675324675,0.04542372881,0.2025658339,0.1659751037,,0.1797124601,0.1392694064,0.2037617555,0.1727272727,,0.1273148148,0.1971608833,,0.2015050167,0.03590192644,0.2006021829
  10 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.04294478528,0.1124260355,0.1246290801,,0.1390728477,0.08108108108,0.1812080537,,,0.08947368421,0.12,,0.1673306773,,0.140625
  2 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.09409190372,,,0.2990196078,,
  2 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1421568627,,,0.304,,
  1 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.06637168142,,,,,
  2 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1292134831,,,,,0.1941747573
  2 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.07425742574,,,,,0.3037974684
  1 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | RISPERIDONE",,,,,,,,,,,,,,,,0.08
  1 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | RISPERIDONE | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1119402985
  8 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.07142857143,0.2342857143,,,0.1846153846,,0.134502924,,,0.1296296296,0.1452991453,,0.3645937813,,0.3101265823
  3 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1920152091,,,0.2684085511,0.04511278195,
  1 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1474358974,,,,,
  2 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1363636364,,,0.265625,,
  5 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2307692308,,,0.1363636364,,,,,0.1055155875,,,,0.0636550308,0.1839762611
  3 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1736745887,,,,0.025,0.23878327
  7 ,"Age: 41-64 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,0.04929577465,0.2482758621,,,0.2093023256,,0.1304347826,,,0.1165600569,,,0.2357142857,,0.2867005814
  1 ,Age: 41-64 | Gender: Female | POLYCYSTIC OVARIES (dxo:ICD9:2564),,0.03012048193,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | POLYETHYLENE GLYCOL 3350,,,,,,,,0.4526748971,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572),0.007434944238,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981),,,,,,,,,,,,,,0.4366197183,,
  1 ,Age: 41-64 | Gender: Female | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981) | SERTRALINE HCL,,,,,,,,,,,,,,0.700729927,,
  11 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL,0.0197044335,0.04273504274,0.4208633094,,,0.3044496487,0.1211072664,0.3436293436,,,0.4617700493,0.3594771242,,0.4115523466,0.0368852459,0.3689320388
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5302267003,,,,,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.55,,,,,
  2 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.5656934307,,,0.7094594595,,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | TRAZODONE HCL,,,,,,,,,,,0.5833333333,,,,,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | VENLAFAXINE HCL,,,,,,,,,,,0.6136363636,,,,,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4384735202,,,,,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.4709302326,,,,,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3661800487,,,,,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5072463768,,,,,
  2 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.518734388,,,0.5714285714,,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4263565891,,,,,
  2 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3826709732,,,,0.02904564315,
  1 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3784530387,,,,,
  2 ,Age: 41-64 | Gender: Female | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4592696629,,,,,0.5388026608
  5 ,Age: 41-64 | Gender: Female | PRAVASTATIN SODIUM,,,0.5433526012,,,,0.152173913,,,,0.2714285714,0.4658634538,,0.5683563748,,
  1 ,Age: 41-64 | Gender: Female | PRAVASTATIN SODIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1229508197,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,0.3818181818,,,0.8058608059,,
  1 ,Age: 41-64 | Gender: Female | PREDNISONE,,,,,0.16,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | PREGABALIN,,0.04502369668,0.4949494949,,,0.4269662921,0.1754385965,0.4459459459,,,,0.4503816794,,0.5214285714,0.02205882353,0.5066666667
  1 ,Age: 41-64 | Gender: Female | PREGABALIN | SERTRALINE HCL,,,,,,,,,,,,,,0.7473309609,,
  1 ,Age: 41-64 | Gender: Female | PREGABALIN | TRAMADOL HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4150943396,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4401709402,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | PREGABALIN | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7302631579
  1 ,"Age: 41-64 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",,,,,,,,,,,,,,0.4776119403,,
  1 ,"Age: 41-64 | Gender: Female | PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222) | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",,,,,,,,,,,,,,0.5209302326,,
  8 ,Age: 41-64 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254),0.005376344086,0.02272727273,0.4768786127,,,,0.1019011407,0.3332421341,,,0.1627906977,0.2976190476,,,0.01339285714,
  3 ,Age: 41-64 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.09706546275,0.3069620253,,,,0.1962616822,,,,
  2 ,Age: 41-64 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | SERTRALINE HCL,,,,,,,,0.395480226,,,0.4159292035,,,,,
  1 ,Age: 41-64 | Gender: Female | PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,0.3070866142,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | PRESBYOPIA (dxo:ICD9:3674),,,,,,,0.1743119266,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511),,,,,,,,,,,,,,0.5038167939,,
  1 ,Age: 41-64 | Gender: Female | PROCHLORPERAZINE MALEATE,,,,,,,,,0.1088435374,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | PROGESTERONE, MICRONIZED",,,0.4677419355,,,,,,,,,0.4074074074,,,,
  1 ,"Age: 41-64 | Gender: Female | PROGESTERONE, MICRONIZED | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.2483660131,,,,
  1 ,Age: 41-64 | Gender: Female | PROMETHAZINE HCL,0.01169590643,,,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | PROPOXYPHENE NAP/ACETAMINOPHEN,0.003164556962,,,,,,0.1181102362,,,,0.2409972299,0.4285714286,,,,
  1 ,Age: 41-64 | Gender: Female | PROPOXYPHENE NAP/ACETAMINOPHEN | SERTRALINE HCL,,,,,,,,,,,0.324742268,,,,,
  1 ,Age: 41-64 | Gender: Female | PROPOXYPHENE NAP/ACETAMINOPHEN | VENLAFAXINE HCL,,,,,,,,,,,0.3356164384,,,,,
  2 ,Age: 41-64 | Gender: Female | PROPRANOLOL HCL,,0.01904761905,0.5136986301,,,,,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.2655502392,,,0.1730769231,0.1037037037,0.2483069977,,,0.1741573034,0.2229299363,,0.2684458399,,0.2657004831
  8 ,"Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2121710526,,,0.1573033708,0.08168028005,0.2330097087,,,0.1153846154,0.1346153846,,0.2127045236,,0.171875
  4 ,"Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.1944444444,,,,0.04237288136,0.203539823,,,,,,0.1616161616,,
  1 ,"Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.04385964912,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.4220779221,,
  1 ,"Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.2916666667,,
  2 ,"Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.2211538462,,,,,0.4476744186
  1 ,"Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,,,,,,,,0.1908396947,,
  1 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SERTRALINE HCL,,,,,,,,,,,,,,0.5372670807,,
  1 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6062992126
  5 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792),,,0.3018867925,,,,0.1367521368,0.2292993631,,,0.2147651007,,,0.3154761905,,
  14 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0.009111617312,0.0339869281,0.244057971,0.3016574586,,0.2332878581,0.0841263799,0.2433361995,0.1516587678,0.0756302521,0.1419354839,0.2033293698,,0.2542635659,0.01736111111,0.2811016144
  3 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,0.08762886598,,,,,0.1901408451,,,,
  5 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,0.2362204724,,,0.2596153846,,,,,0.1816623822,,,0.56272838,,0.3470588235
  2 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3236245955,,,0.4685314685,,
  1 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1464088398,,,,,
  2 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3625498008,,,,,0.5137614679
  1 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.2444444444,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,0.213963964,,,,,0.5795454545
  9 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.1895734597,0.1530054645,,0.1859296482,0.1119133574,0.2276422764,,,0.1424332344,,,0.1787709497,0.03235294118,0.231316726
  3 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,0.1151079137,,,,,,,0.08620689655,,,,,0.1304347826
  1 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.06730769231,,,,,
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.1177884615,,,0.3365695793,,
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2032085561,,,0.4057971014,,
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1666666667,,,,0.02142857143,
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.2179836512,,,,,0.3093922652
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | VENLAFAXINE HCL",,,,,,,,,,,0.1435523114,,,,,0.3223684211
  13 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1996424315,0.2400589102,0.05809128631,0.1560178306,0.07129572226,0.2156983931,0.07352941176,0.04347826087,0.1523588554,0.1292517007,,0.2016260163,0.01413427562,0.2013786312
  6 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.1706161137,,,,0.05867346939,0.25,,,0.1688311688,,,0.1875,,0.1811023622
  1 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.3096446701,,
  1 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.04424778761,,,,,,,,,
  7 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,0.1909090909,,,0.1720430108,0.111969112,0.1338582677,,,0.1952232606,,,0.3622895623,,0.2327044025
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2671755725,,,0.327510917,,
  3 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1883116883,,,,0.02409638554,0.2564102564
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.268442623,,,,,0.3168654174
  1 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.162601626,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.1944055944,,,,,0.3669064748
  1 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VILAZODONE HCL",,,,,,,,,,,0.2700729927,,,,,
  5 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,0.07647058824,0.05988023952,0.1151079137,,,0.07407407407,,,0.1044776119,,
  2 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836) | SERTRALINE HCL",,,,,,,,,,,0.1282051282,,,0.2487309645,,
  6 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.2169312169,,,,0.0824742268,0.2574257426,,,0.2123287671,,,0.2369477912,,0.2627737226
  1 ,"Age: 41-64 | Gender: Female | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837) | SERTRALINE HCL",,,,,,,,,,,,,,0.5031446541,,
  2 ,Age: 41-64 | Gender: Female | RABEPRAZOLE SODIUM,,,,,,,0.1534653465,,,,,,,0.5419847328,,
  1 ,Age: 41-64 | Gender: Female | RABEPRAZOLE SODIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1073825503,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | RABEPRAZOLE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8018018018,,
  3 ,Age: 41-64 | Gender: Female | RAMIPRIL,,,,,,,0.1631016043,,,,,,,0.5850746269,,0.5
  1 ,Age: 41-64 | Gender: Female | RAMIPRIL | SERTRALINE HCL,,,,,,,,,,,,,,0.7469879518,,
  1 ,Age: 41-64 | Gender: Female | RAMIPRIL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7719298246
  1 ,Age: 41-64 | Gender: Female | RANITIDINE HCL,,,,,,,0.09915014164,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | RASH AND OTHER NONSPECIFIC SKIN ERUPTION (dxo:ICD9:7821),,,,,0.1009174312,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,0.03349282297,0.5205882353,,,0.4085365854,0.1972789116,0.4885844749,,,0.4116930572,,0.2368804665,0.5121107266,,0.4551724138
  2 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.4781553398,,0.4427826087,,,
  3 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5980861244,,0.3888888889,0.6666666667,,
  1 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5392156863,,,,,
  2 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4121212121,,0.4966887417,,,
  1 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4862385321,,,,,
  2 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5689655172,,0.3872180451,,,
  3 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.4681440443,,0.2018348624,0.7639344262,,
  1 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | TRAZODONE HCL,,,,,,,,,,,0.3134328358,,,,,
  1 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3714285714,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | VENLAFAXINE HCL,,,,,,,,,,,0.4795539033,,,,,0.7058823529
  2 ,Age: 41-64 | Gender: Female | RHEUMATOID ARTHRITIS (dxo:ICD9:7140),,0.01639344262,,,,0.3460076046,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | RHEUMATOID ARTHRITIS (dxo:ICD9:7140) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3581081081,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | RISEDRONATE SODIUM,,,,,,,0.1367013373,,,,,0.4471544715,,,,
  1 ,Age: 41-64 | Gender: Female | RISEDRONATE SODIUM | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1428571429,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | RISPERIDONE,,,0.1586206897,,,0.1570680628,0.06726457399,0.1428571429,,,0.1169794849,0.1596638655,,0.1538461538,,0.163410302
  1 ,Age: 41-64 | Gender: Female | RISPERIDONE | ROPINIROLE HCL,,,,,,,,,,,0.1644736842,,,,,
  1 ,Age: 41-64 | Gender: Female | RISPERIDONE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.1333333333,,,,,
  2 ,Age: 41-64 | Gender: Female | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.09705882353,,,0.1675126904,,
  2 ,Age: 41-64 | Gender: Female | RISPERIDONE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1158940397,,,0.2074688797,,
  1 ,Age: 41-64 | Gender: Female | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1199611462,,,,,
  2 ,Age: 41-64 | Gender: Female | RISPERIDONE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1240601504,,,,,0.193220339
  2 ,Age: 41-64 | Gender: Female | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.1313269494,,,,,0.1946446962
  3 ,Age: 41-64 | Gender: Female | RIZATRIPTAN BENZOATE,,,,,,,,0.487704918,,,0.2288135593,,,0.515,,
  1 ,Age: 41-64 | Gender: Female | RIZATRIPTAN BENZOATE | SERTRALINE HCL,,,,,,,,,,,,,,0.7561837456,,
  4 ,Age: 41-64 | Gender: Female | ROFECOXIB,,,0.6064516129,,,0.3548387097,0.1038647343,,,,,0.3969849246,,,,
  14 ,Age: 41-64 | Gender: Female | ROPINIROLE HCL,0.03115264798,0.03968253968,0.4166666667,,,0.3064903846,0.1577726218,0.3316195373,0.1214285714,0.08064516129,0.4353624688,0.2933333333,0.3946988821,0.3909574468,0.02386117137,0.3608247423
  3 ,Age: 41-64 | Gender: Female | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5364154528,,0.3888888889,0.5507692308,,
  1 ,Age: 41-64 | Gender: Female | ROPINIROLE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4417989418,,,,,
  3 ,Age: 41-64 | Gender: Female | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3716893343,,0.4020618557,,0.03229813665,
  2 ,Age: 41-64 | Gender: Female | ROPINIROLE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3764478764,,,,,0.3813559322
  3 ,Age: 41-64 | Gender: Female | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4745581146,,0.3904761905,,,0.525887574
  8 ,Age: 41-64 | Gender: Female | ROSUVASTATIN CALCIUM,,,0.5586034913,0.685483871,,0.4485981308,,0.5658362989,,,0.35,,,0.5599489796,0.008510638298,0.547008547
  1 ,Age: 41-64 | Gender: Female | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7968217934,,
  2 ,Age: 41-64 | Gender: Female | ROSUVASTATIN CALCIUM | VENLAFAXINE HCL,,,,,,,,,,,0.4423076923,,,,,0.8468468468
  6 ,Age: 41-64 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.03312191684,,,0.1292517007,,0.1511627907,,,,,0.4094202899,,0.4772727273,0.008103727715,
  4 ,Age: 41-64 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,0.036598493,,,0.1363636364,,0.1033755274,,,,,0.3573883162,,,,
  1 ,"Age: 41-64 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",,,,,,,,,,,,,,,0.01413427562,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAMADOL HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL,,,,,,,,,,,,,,,0.002577319588,
  2 ,Age: 41-64 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.02290076336,,,,,,,,,,,,,0.005025125628,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.02293577982,
  10 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.006635273973,0.03220290681,,0.6735520454,0.1271820449,0.3878015476,0.1339946805,0.4680056049,0.1316225166,,0.2532517215,0.3573577502,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SCAR CONDITION AND FIBROSIS OF SKIN (dxo:ICD9:7092),,,,,,,0.16,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SCREENING FOR LIPOID DISORDERS (dxo:ICD9:V7791),,,,,,,,,,,,0.4485981308,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,,,,,,,,,,0.4615384615,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SCREENING MAMMOGRAM FOR HIGH-RISK PATIENT (dxo:ICD9:V7611),,,,,,,,,,,,0.4333333333,,,,
  6 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SERTRALINE HCL,,0.04464285714,,0.6974789916,,0.5652173913,0.2311827957,,,,0.4126213592,0.5105263158,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SIMVASTATIN,,,,,,,0.1299559471,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",,,,,,,,,,,,0.320754717,,,,
  2 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SUMATRIPTAN SUCCINATE,,,,,,,0.1481481481,,,,,0.3063063063,,,,
  2 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,0.03433476395,,,,,,,,,,0.3705357143,,,,
  2 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TOPIRAMATE,,,,,,,0.1550802139,,,,,0.4033613445,,,,
  2 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAMADOL HCL,,,,,,0.3369565217,0.1333333333,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | TRAZODONE HCL,,,,,,,,,,,0.347826087,,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089),,,,,,,0.1386138614,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,,,,,0.1212121212,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.05072463768,,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0,0.02898550725,,,,0.3483870968,0.1251758087,,,,,0.3050847458,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),0,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,0.2878787879,0.1300160514,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,0.1278538813,0.45,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VALACYCLOVIR HCL,,0.02702702703,,,,,,,,,,0.3046875,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VALSARTAN,,,,,,,0.1682242991,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VALSARTAN/HYDROCHLOROTHIAZIDE,,,,,,,0.072,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | VENLAFAXINE HCL,,,,0.8226950355,,0.6606060606,0.1917808219,,,,0.3461538462,0.4962406015,,,,
  1 ,Age: 41-64 | Gender: Female | SCAR CONDITION AND FIBROSIS OF SKIN (dxo:ICD9:7092),,,,,,,0.1136363636,,,,,,,,,
  4 ,Age: 41-64 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.4030683403,,,0.275862069,,,,,,,,0.4441747573,,0.4041450777
  1 ,Age: 41-64 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | SERTRALINE HCL,,,,,,,,,,,,,,0.7209302326,,
  2 ,Age: 41-64 | Gender: Female | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3481012658,,,,,,,,,,,0.390625,,
  1 ,Age: 41-64 | Gender: Female | SCREENING FOR LIPOID DISORDERS (dxo:ICD9:V7791),,,,,,,,,,,,0.375,,,,
  3 ,Age: 41-64 | Gender: Female | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762),,,0.5502336449,,,,,,,,,,,0.5109170306,,0.5748502994
  1 ,Age: 41-64 | Gender: Female | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762) | SERTRALINE HCL,,,,,,,,,,,,,,0.7565217391,,
  1 ,Age: 41-64 | Gender: Female | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.5032679739
  1 ,Age: 41-64 | Gender: Female | SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7034220532
  1 ,Age: 41-64 | Gender: Female | SCREENING FOR UNSPECIFIED CONDITION (dxo:ICD9:V829),,,0.4423791822,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | SCREENING MAMMOGRAM FOR HIGH-RISK PATIENT (dxo:ICD9:V7611),,,,,,,,,,,,0.4761904762,,,,
  16 ,Age: 41-64 | Gender: Female | SERTRALINE HCL,0.0178335535,0.02965841685,0.4708831469,0.6662420382,0.1314363144,0.4368700751,0.1785175406,0.4420437956,0.130952381,0.05098389982,0.3541067546,0.3984655958,0.1627358491,0.5959650419,0.01895734597,0.5973443697
  3 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | SIMVASTATIN,,,0.5940594059,,,,,,,,0.4473282443,,,0.7812941509,,
  2 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.7014925373,,,0.6307692308,,
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | SIMVASTATIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.8444444444,,
  2 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.4380165289,,,0.7375231054,,
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,,,,,,,,,,,,,0.6265060241,,
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.6369863014
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | TEMAZEPAM,,,,,,,,,,,,,,0.7251908397,,
  2 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | TOPIRAMATE,,,,,,,,,,,0.4229390681,,,0.7453051643,,
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | TRAMADOL HCL,,,,,,0.5188679245,,,,,,,,,,
  12 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | TRAZODONE HCL,0.03783783784,0.039408867,0.3410138249,,,0.3064935065,0.1510067114,0.318627451,0.1061946903,,0.4531453716,0.3127962085,,0.5246707917,0.02128556375,0.4430894309
  4 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3365079365,,,0.4249201278,0.025,0.5208333333
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,,,,,,,,,,,,0.6927374302,,
  2 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5667938931,,,,,,,,0.7278911565,,
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.7237113402,,
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.6726039016,,
  1 ,"Age: 41-64 | Gender: Female | SERTRALINE HCL | UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",,,,,,,,,,,,,,0.6754385965,,
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.7363896848,,
  1 ,"Age: 41-64 | Gender: Female | SERTRALINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.7130977131,,
  11 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | VENLAFAXINE HCL,0.0078125,0.02669404517,0.4812834225,,,0.4210526316,0.1975560081,0.4166666667,,,0.346826127,0.3591160221,,0.5699177438,0.005847953216,0.6792763158
  1 ,Age: 41-64 | Gender: Female | SERTRALINE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,0.7142857143,,
  1 ,Age: 41-64 | Gender: Female | SILVER SULFADIAZINE,,,,,,,,0.4637681159,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | SIMVASTATIN,,0.05365853659,0.5355093257,,,,0.147735709,0.5626794258,,,0.2692307692,0.3917525773,,0.5760869565,,0.5483870968
  1 ,Age: 41-64 | Gender: Female | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.4392523364,,,,,
  2 ,Age: 41-64 | Gender: Female | SIMVASTATIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.537037037,,,,,,0.5590062112,,
  2 ,Age: 41-64 | Gender: Female | SIMVASTATIN | VENLAFAXINE HCL,,,,,,,,,,,0.4423076923,,,,,0.6991150442
  1 ,"Age: 41-64 | Gender: Female | SODIUM, POTASSIUM,MAG SULFATES",,,0.5343915344,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Female | SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",,,,,,,,,,,,,,,,0.39375
  1 ,"Age: 41-64 | Gender: Female | SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381) | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",,,,,,,,,,,,,,,,0.3267326733
  1 ,"Age: 41-64 | Gender: Female | SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7365269461
  1 ,"Age: 41-64 | Gender: Female | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",,,,,,,,,,,,,,,0.009646302251,
  1 ,"Age: 41-64 | Gender: Female | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651) | TRAZODONE HCL",,,,,,,,,,,,,,,0.008,
  1 ,Age: 41-64 | Gender: Female | SPECIAL SCREENING FOR OTHER SPECIFIED CONDITIONS (dxo:ICD9:V8289),,,0.5206185567,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | SULFAMETHOXAZOLE/TRIMETHOPRIM,,,0.4350649351,,,,,,,,,,,,,
  8 ,Age: 41-64 | Gender: Female | SUMATRIPTAN SUCCINATE,0,,0.5303643725,,,,0.1538461538,0.5021276596,,0.04580152672,0.2196531792,0.4366812227,,0.5577172503,,
  1 ,Age: 41-64 | Gender: Female | SUMATRIPTAN SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.2926829268,,,,,
  1 ,Age: 41-64 | Gender: Female | SUMATRIPTAN SUCCINATE | VENLAFAXINE HCL,,,,,,,,,,,0.3760932945,,,,,
  3 ,Age: 41-64 | Gender: Female | SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221),,0.009433962264,,,,,,0.49375,,,,,,0.4293552812,,
  5 ,Age: 41-64 | Gender: Female | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,0.006097560976,0.5375722543,,,,,,,,,0.3724832215,,0.5384615385,,0.4719438878
  1 ,Age: 41-64 | Gender: Female | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6355932203
  1 ,Age: 41-64 | Gender: Female | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,,,0.4727272727
  1 ,Age: 41-64 | Gender: Female | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,,,0.3333333333
  1 ,Age: 41-64 | Gender: Female | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6887280248
  1 ,Age: 41-64 | Gender: Female | TAMOXIFEN CITRATE,,,,,,,,,,,,,,,,0.3823529412
  2 ,Age: 41-64 | Gender: Female | TEMAZEPAM,,,,,,,,,,,,,,0.5845410628,0.004264392324,
  1 ,Age: 41-64 | Gender: Female | TERBINAFINE HCL,,0.03663003663,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | TERCONAZOLE,,,,,,,,0.4014084507,,,,,,,,0.3358208955
  2 ,"Age: 41-64 | Gender: Female | THORACIC OR LUMBOSACRAL NEURITIS OR RADICULITIS, UNSPECIFIED (dxo:ICD9:7244)",,,0.5492227979,,,,,,,0.03398058252,,,,,,
  1 ,Age: 41-64 | Gender: Female | TIETZE'S DISEASE (dxo:ICD9:7336),,,,,,,,,,,,0.2447552448,,,,
  4 ,Age: 41-64 | Gender: Female | TIZANIDINE HCL,,,0.4879518072,,,,,0.4914772727,,,0.2359550562,,,0.5793650794,,
  1 ,Age: 41-64 | Gender: Female | TOLTERODINE TARTRATE,,,,,,,,,,,0.2090909091,,,,,
  6 ,Age: 41-64 | Gender: Female | TOPIRAMATE,,,0.5088028169,,,,0.1834451902,0.4951644101,,,0.2409972299,0.3789173789,,0.5763358779,,
  1 ,Age: 41-64 | Gender: Female | TOPIRAMATE | TRAZODONE HCL,,,,,,,,,,,0.3586206897,,,,,
  1 ,Age: 41-64 | Gender: Female | TOPIRAMATE | VENLAFAXINE HCL,,,,,,,,,,,0.411971831,,,,,
  9 ,Age: 41-64 | Gender: Female | TRAMADOL HCL,,0.01470588235,,,,0.3589364845,0.1648148148,0.4636363636,,,,0.3383838384,0.2398373984,0.5152838428,0.007952286282,0.4569892473
  1 ,Age: 41-64 | Gender: Female | TRAMADOL HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.02189781022,
  2 ,Age: 41-64 | Gender: Female | TRAMADOL HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3861607143,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Female | TRAMADOL HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7358490566
  1 ,Age: 41-64 | Gender: Female | TRAMADOL HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.01298701299,
  3 ,Age: 41-64 | Gender: Female | TRAMADOL HCL/ACETAMINOPHEN,,,0.474537037,,,0.3795918367,,0.4574132492,,,,,,,,
  16 ,Age: 41-64 | Gender: Female | TRAZODONE HCL,0.014015844,0.03208937485,0.3631086746,0.4373927959,0.1952054795,0.2779489437,0.1420311714,0.343083276,0.1122019635,0.0623853211,0.3482900548,0.2787427626,0.1547619048,0.3684210526,0.02175573049,0.3409627183
  2 ,Age: 41-64 | Gender: Female | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3513513514,,,,,,,,,0.02554744526,
  1 ,Age: 41-64 | Gender: Female | TRAZODONE HCL | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.006097560976,
  11 ,Age: 41-64 | Gender: Female | TRAZODONE HCL | VENLAFAXINE HCL,0.05,0.03768844221,0.3492647059,,,0.387755102,0.1518624642,0.3096446701,,,0.3753478184,0.40625,,0.3705357143,0.02417144281,0.4748268289
  1 ,Age: 41-64 | Gender: Female | TRAZODONE HCL | VILAZODONE HCL,,,,,,,,,,,0.4802259887,,,,,
  1 ,Age: 41-64 | Gender: Female | TRAZODONE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.01365187713,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED ABNORMAL MAMMOGRAM (dxo:ICD9:79380),,,,,,,,,,,,,,,,0.4913043478
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089),,,,,,,0.1538461538,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED ADJUSTMENT REACTION (dxo:ICD9:3099),,,,,,,,,,,,,,0.4058823529,,
  3 ,Age: 41-64 | Gender: Female | UNSPECIFIED ALOPECIA (dxo:ICD9:70400),,0.03414634146,,,,,,0.447761194,,,,,,,,0.4461538462
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED ANEMIA (dxi:ICD9:2859),,0.05309734513,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491),,,,,,,0.1732851986,,,,,,,,,
  5 ,Age: 41-64 | Gender: Female | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,0.3728813559,,,,0.2117647059,0.3944954128,,,,0.3653846154,,0.4422222222,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599),,0.02385321101,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY (dxo:ICD9:34590),,0.01739130435,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690),,0.02816901408,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | UNSPECIFIED ESSENTIAL HYPERTENSION (dxi:ICD9:4019),,0.04255319149,,,,,,,,,,,,,,0.5267857143
  5 ,Age: 41-64 | Gender: Female | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.04060913706,,,,,,0.591160221,0.1369047619,,,,,,0.004618937644,0.5308641975
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED HEARING LOSS (dxo:ICD9:3899),,,0.4565217391,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED HEMORRHOIDS WITHOUT MENTION OF COMPLICATION (dxo:ICD9:4556),,,,,,,,,,,,,,0.6371681416,,
  5 ,Age: 41-64 | Gender: Female | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),0.007518796992,0.01369863014,,,,0.4198473282,,,,0.08695652174,,,,0.4928571429,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4466019417,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED INFLAMMATORY AND TOXIC NEUROPATHY (dxo:ICD9:3579),,,0.4380165289,,,,,,,,,,,,,
  11 ,Age: 41-64 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.01486988848,0.02447552448,0.4485106383,,,0.3859697387,0.1638190955,0.4735547355,,0.05243445693,,0.4,,0.5096963044,0.005070993915,0.5121212121
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.4217687075,,
  2 ,Age: 41-64 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | VENLAFAXINE HCL,,,,,,0.6150870406,,,,,,,,,,0.6505376344
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0,
  4 ,Age: 41-64 | Gender: Female | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,0.01851851852,,,,,,0.4933333333,0.1451612903,,,,,,,0.525974026
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED PERIPHERAL VASCULAR DISEASE (dxo:ICD9:4439),,,,,,,0.0988372093,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED PRURITIC DISORDER (dxo:ICD9:6989),,,,,0.1062992126,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED SEBORRHEIC DERMATITIS (dxo:ICD9:69010),,,0.4892086331,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.008888888889,
  4 ,Age: 41-64 | Gender: Female | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),0.004672897196,,0.427244582,,,,,0.3854748603,,,,,,0.4654545455,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259) | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.3930635838,,
  3 ,Age: 41-64 | Gender: Female | UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515),,,0.4890282132,,,,,0.4816753927,,,,,,0.5294117647,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359),,,,,,,,0.4914529915,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED URTICARIA (dxo:ICD9:7089),,,,,0.1552795031,,,,,,,,,,,
  7 ,Age: 41-64 | Gender: Female | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.431510876,,,0.3272311213,0.1336302895,0.4114114114,,,,0.3540372671,,0.4611754612,,0.4059701493
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6016260163
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED VENOUS (PERIPHERAL) INSUFFICIENCY (dxo:ICD9:45981),,,,,,,,,,,,,,0.4591194969,,
  1 ,"Age: 41-64 | Gender: Female | UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",,,,,,,,,,,,,,0.5720720721,,
  4 ,Age: 41-64 | Gender: Female | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,0.1367521368,,,,,,,,0.1683168317,0.5216606498,,0.4285714286
  1 ,Age: 41-64 | Gender: Female | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7258979206
  4 ,"Age: 41-64 | Gender: Female | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,0.5174825175,,,,0.1802721088,0.481300813,,,,,,0.5392822502,,
  3 ,Age: 41-64 | Gender: Female | VALACYCLOVIR HCL,,0.0308310992,0.4588441331,,,,,,,,,0.3586956522,,,,
  1 ,Age: 41-64 | Gender: Female | VALSARTAN,,,,,,,0.1385642738,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | VALSARTAN/HYDROCHLOROTHIAZIDE,,,,,,0.3662790698,0.09510869565,,,,,,,,,
  2 ,Age: 41-64 | Gender: Female | VARENICLINE TARTRATE,,0.02723735409,0.4668508287,,,,,,,,,,,,,
  16 ,Age: 41-64 | Gender: Female | VENLAFAXINE HCL,0.02309058615,0.04022288003,0.508611049,0.7891156463,0.118852459,0.5509596294,0.2040594418,0.485705865,0.1254355401,0.0652173913,0.3186061328,0.4315569488,0.1605839416,0.5036292574,0.02303754266,0.5472819401
  3 ,Age: 41-64 | Gender: Female | VERAPAMIL HCL,,0.01369863014,,,,,0.175,0.5472972973,,,,,,,,
  1 ,Age: 41-64 | Gender: Female | VILAZODONE HCL,,,,,,,,,,,0.7032679739,,,,,
  1 ,Age: 41-64 | Gender: Female | ZALEPLON,,,0.4744525547,,,,,,,,,,,,,
  7 ,Age: 41-64 | Gender: Female | ZOLPIDEM TARTRATE,,0.05172413793,0.4437086093,,0.1338028169,,0.1162790698,0.4703296703,,,,,,0.5746691871,0.01185395922,
  16 ,Age: 41-64 | Gender: Male,0.039746963,0.06972467502,0.5077703027,0.4686668032,0.2190795781,0.3937961393,0.228310086,0.4966058475,0.2219643597,0.1173213359,0.3458687023,0.4660223411,0.3503593145,0.5226897749,0.03034837107,0.4989358092
  3 ,"Age: 41-64 | Gender: Male | ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",,,,,,,,,,0.04237288136,,,,0.492,,0.5333333333
  3 ,Age: 41-64 | Gender: Male | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831),,0.04356435644,,,,,,,,,,0.4161849711,,0.5416666667,,
  1 ,Age: 41-64 | Gender: Male | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL,,0.06145251397,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | BUPROPION HCL | Last AD: Same & No Remiss,,0.02985074627,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831) | PAROXETINE HCL,,,,,,,,,,,,0.6953125,,,,
  1 ,Age: 41-64 | Gender: Male | ACETAMINOPHEN WITH CODEINE,,,,,,,,,,,,,,0.5048543689,,
  1 ,Age: 41-64 | Gender: Male | ACTINIC KERATOSIS (dxo:ICD9:7020),,,,,,,,,,,,,,0.5422885572,,
  2 ,"Age: 41-64 | Gender: Male | ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",,,0.4701754386,,,,,,,,,,,0.525974026,,
  1 ,Age: 41-64 | Gender: Male | ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659),,,,,,,,0.4338235294,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ACUTE, BUT ILL-DEFINED, CEREBROVASCULAR DISEASE (dxo:ICD9:436)",,0.009090909091,,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090),,0.0243902439,0.4765625,,,,0.1131221719,,,,,,,0.5733333333,,
  1 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.04861111111,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,0.03140096618,0.4666666667,,,,0.1046153846,,0.1197183099,,,,,0.4768518519,,
  1 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07936507937,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL,,0.05982905983,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | BUPROPION HCL | Last AD: Same & No Remiss,,0.0237388724,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1346153846,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1074380165,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2556053812,,,,0.07692307692,0.1836734694,,,,,,0.2142857143,,
  7 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1716738197,,,,0.05968169761,0.1943319838,,,0.1134751773,0.1629213483,,0.1832191781,,0.1481481481
  1 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.5188679245,,
  1 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.4424778761,,
  1 ,Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1743119266,,,,0.07857142857,,,,,,,0.2052631579,,
  4 ,Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.03409090909,0.2234042553,,,,0.06818181818,,,,,,,0.2365591398,,
  2 ,"Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.07159353349,,,,,,,0.2314814815,,
  1 ,Age: 41-64 | Gender: Male | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928) | SILDENAFIL CITRATE,,0.01652892562,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | ALBUTEROL,,0.01449275362,0.5064102564,,,,,,,,,0.4117647059,,,,
  1 ,Age: 41-64 | Gender: Male | ALBUTEROL | CITALOPRAM HYDROBROMIDE,,,0.6454545455,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ALBUTEROL | PAROXETINE HCL,,,,,,,,,,,,0.625,,,,
  3 ,Age: 41-64 | Gender: Male | ALBUTEROL SULFATE,,,,,,,0.1741293532,,,,,0.4184397163,,,,0.4241245136
  1 ,Age: 41-64 | Gender: Male | ALBUTEROL SULFATE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7364864865
  2 ,Age: 41-64 | Gender: Male | ALLOPURINOL,,,,,,,,0.5337423313,,,,,,0.5422077922,,
  1 ,Age: 41-64 | Gender: Male | ALLOPURINOL | FLUOXETINE HCL,,,,,,,,0.7904761905,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ALLOPURINOL | SERTRALINE HCL,,,,,,,,,,,,,,0.7533333333,,
  8 ,Age: 41-64 | Gender: Male | ALPRAZOLAM,,0.05217391304,0.4625322997,,,,0.1710963455,0.4814814815,,,,0.4857142857,,0.5077910174,0.009803921569,0.4549763033
  1 ,"Age: 41-64 | Gender: Male | ALPRAZOLAM | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,,,,,,0.12,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ALPRAZOLAM | ATORVASTATIN CALCIUM,,,,,,,,,,,,,,0.5125,,
  1 ,Age: 41-64 | Gender: Male | ALPRAZOLAM | BUPROPION HCL,,0.02608695652,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ALPRAZOLAM | CITALOPRAM HYDROBROMIDE,,,0.6595744681,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ALPRAZOLAM | ESCITALOPRAM OXALATE,,,,,,,0.3661202186,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ALPRAZOLAM | FLUOXETINE HCL,,,,,,,,0.65,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ALPRAZOLAM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.4504504505,,
  1 ,Age: 41-64 | Gender: Male | ALPRAZOLAM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3854166667,,
  1 ,Age: 41-64 | Gender: Male | ALPRAZOLAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7109004739,,
  1 ,Age: 41-64 | Gender: Male | ALPRAZOLAM | SERTRALINE HCL,,,,,,,,,,,,,,0.662055336,,
  13 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL,0.06466657385,0.03667136812,0.3820395738,,,0.3137860082,0.1618421053,0.3995157385,0.141509434,0.1287553648,0.3782641823,0.3045685279,,0.3734939759,0.0110701107,0.4006968641
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | AMLODIPINE BESYLATE,0.06896551724,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL,0.07737226277,0.06255835668,,,,,,,,,0.2681139756,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,,,,,,,,,,0.3293650794,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL,,,,,,,,,,,0.2962962963,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2543103448,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL,,,,,,,,,,,0.3070175439,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | LAMOTRIGINE,,,,,,,,,,,0.08484848485,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss,0.05809128631,0.05805243446,,,,,,,,,0.1477987421,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.08670520231,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.1263736264,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss,,0.01886792453,,,,,,,,,0.1909090909,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss,,,,,,,,,,,0.524137931,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.5591054313,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | MIRTAZAPINE,,,,,,,,,,,0.2697368421,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2777777778,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2605932203,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2529880478,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | ROPINIROLE HCL,,,,,,,,,,,0.3227848101,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | SERTRALINE HCL,,,,,,,,,,,0.3393501805,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | TRAZODONE HCL,,0.04511278195,,,,,,,,,0.2083739046,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2608695652,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE,0.08480565371,,0.6009009009,,,,,,,,0.4466608846,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,0.1023622047,,0.7215189873,,,,,,,,0.4965753425,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.7213114754,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.60625,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.6107784431,,,,,,,,0.4727272727,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,0.0625,,0.7088607595,,,,,,,,0.5625,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,,,,,,,,,0.3969465649,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,,,,,,,,,0.6173469388,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.6022099448,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,0.4594594595,,,,,,,,0.3409961686,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.05295950156,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",0.01892744479,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DOXEPIN HCL,,,,,,,,,,,0.338028169,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL,0.1067761807,,,,,0.4794520548,,,,,0.3987291501,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2905982906,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,0.08510638298,,,,,0.4942965779,,,,,0.4409448819,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4366197183,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & Remiss,,,,,,0.5794392523,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.3454545455,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5949367089,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.4230769231,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.4465408805,,,,,0.3003194888,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4326923077,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE,0.06605222734,,,,,,0.3566878981,,,,0.3010146561,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0.03645833333,,,,,,0.3033707865,,,,0.26171875,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3186440678,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.2692307692,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2565789474,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,,,,,0.2790697674,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.2916666667,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL,0.05319148936,,,,,,,0.5584291188,,,0.4500860585,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,0.06557377049,,,,,,,,,,0.5775577558,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.642599278,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.5882352941,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5125,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,0.0396039604,,,,,,,0.6909090909,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6883116883,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.4202898551,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6623376623,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6357142857,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.419047619,,,0.3588516746,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | GABAPENTIN,,,,,,,,,,,0.3286713287,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | GABAPENTIN | Last AD: Diff & No Remiss,,,,,,,,,,,0.1981981982,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840),0.07623318386,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,0.0102739726,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | HYDROCODONE/ACETAMINOPHEN,0.0703125,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss,0.0347826087,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",0.04273504274,,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0.007352941176,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",0,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | LAMOTRIGINE,,,,,,,,,,,0.1304347826,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1458333333,,,,,
  11 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss,,0.04901960784,0.3739130435,,,0.2997118156,0.171875,0.4657534247,,0.05673758865,0.294214876,0.3404255319,,0.4557823129,0.00824742268,0.4413793103
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5267175573,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7096774194,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6729411765,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2868852459,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.4380165289,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4771573604,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1818181818,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,0.09,,,,,,,,,,0.4916666667,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,0.05357142857,,,,,,,,,,0.5145888594,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,0.06470588235,,,,,,,,,,0.186440678,,,,0.006666666667,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4882352941,,,,,0.7217391304
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7087912088,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.6699029126,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,0.078125,,,,,,,,,,0.5196850394,,,0.7135416667,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.01985878199,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | MORPHINE SULFATE,0.056,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,0.0243902439,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | OXYCODONE HCL,0.02173913043,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4262295082,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3564356436,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.1333333333,,,,0,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6001881468,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6666666667,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5454545455,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5833333333,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.622754491,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5576923077,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5632911392,,,,,
  2 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.3194888179,,,,,,,,,,0.5260115607,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4862385321,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.5045045045,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MIRTAZAPINE,,,,,,,,,,,0.2986842105,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2919254658,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2711864407,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2649006623,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.2242990654,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | MORPHINE SULFATE,0.1965811966,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.3463687151,,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5281690141,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7045454545,,,,
  1 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6631130064,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2994505495,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2706896552,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5281690141,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.42,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | OXYCODONE HCL,0.1073825503,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | PAROXETINE HCL,0.07058823529,,,,,,,,,,0.4249649369,0.5618811881,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4227642276,,,,,
  2 ,"Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",0.06930693069,,,,,,,,,,0.1028037383,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,0.08,,,,,,,,,,0.5190562613,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4238410596,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1122994652,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | RISPERIDONE,,,,,,,,,,,0.1012658228,,,,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ROPINIROLE HCL,0.07142857143,,,,,,,,,,0.4532577904,,,,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3658536585,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | SERTRALINE HCL,0.06623931624,,,,,,,,,,0.4840466926,,,0.6150656531,,
  2 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3079584775,,,0.4788732394,,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | SIMVASTATIN,,,,,,,,,,,0.4554455446,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | TRAZODONE HCL,0.09734513274,,,,,,,,,,0.288851821,,,,0.01834862385,
  1 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2912621359,,,,,
  3 ,Age: 41-64 | Gender: Male | AMITRIPTYLINE HCL | VENLAFAXINE HCL,0.1076923077,,,,,,,,,,0.3851784081,,,,,0.6478873239
  3 ,Age: 41-64 | Gender: Male | AMLODIPINE BESYLATE,0,,,,,,0.1666666667,,,,,,,,0.005586592179,
  1 ,Age: 41-64 | Gender: Male | AMLODIPINE BESYLATE/BENAZEPRIL,,,,,,,0.1415525114,,,,,,,,,
  9 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",0.01785714286,0.0265129683,0.5534591195,,,,0.1649144506,0.5196850394,,,,0.4116322702,,0.6914893617,0.01793721973,0.6322580645
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL",,0.07843137255,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.04635761589,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.06086956522,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.06015037594,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.06504065041,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss",,,,,,,0.1742424242,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.05517241379,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL",,0.0522875817,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0.02931596091,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.007575757576,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUSPIRONE HCL",,,,,,,0.1007194245,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,0.131147541,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE",,,,,,,0.35625,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss",,0.01834862385,,,,,0.2072072072,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CLONAZEPAM",,0.02459016393,,,,,0.1796116505,,,,,,,,,
  6 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.0178041543,,,,,0.1902268761,0.4566929134,,,,0.46105919,,0.62,,0.6635514019
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,0.3819095477,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.119047619,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.6651162791,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,,,,,,0.3932659933,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.01829268293,,,,,,,,,,0.4454545455,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.3050847458,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1464019851,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,0.1904761905,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,0.1608040201,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss",,,,,,,0.7024793388,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,0.4960629921,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.4268292683,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESOMEPRAZOLE MAGNESIUM",,,,,,,0.1472868217,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | FLUOXETINE HCL",,,,,,,,0.7212121212,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GABAPENTIN",,,,,,,0.1845238095,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,0.0325203252,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | HYDROCODONE/ACETAMINOPHEN",,,,,,,0.179245283,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.0875,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08813559322,,,,,0.1941176471,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,0.126984127,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.024,,,,,0.1241830065,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.4262295082,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.3920863309,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.6986027944,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | LORAZEPAM",,0.04375,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.0225,,,,,0.1739130435,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.1869158879,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OMEPRAZOLE",,,,,,,0.101910828,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.02631578947,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",,,,,,,0.176,,,,,0.4018691589,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1873015873,,,,,0.4179104478,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",,,,,,,,,,,,0.3076923077,,,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL",,,,,,,0.3211678832,,,,,0.6637816245,,,,
  3 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.04032258065,,,,,0.09210526316,,,,,0.1652173913,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,,,,,,,,,,,0.3823529412,,,,
  3 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SERTRALINE HCL",,0.05660377358,,,,,0.2222222222,,,,,,,0.7013888889,,
  2 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SILDENAFIL CITRATE",,0.05109489051,,,,,,,,,,0.3565891473,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SIMVASTATIN",,,,,,,0.1793478261,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,,0.17,,,,,,,,,
  7 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE,,,0.2089552239,0.1534090909,,0.1649122807,0.1353383459,,,,0.1215277778,,,0.1565217391,,0.1841004184
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | BUPROPION HCL,,,,,,,,,,,0.1588235294,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | BUPROPION HCL | DULOXETINE HCL,,,,,,,,,,,0.1883116883,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | BUPROPION HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.1437125749,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | BUPROPION HCL | FLUOXETINE HCL,,,,,,,,,,,0.1583333333,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | BUPROPION HCL | SERTRALINE HCL,,,,,,,,,,,0.1230769231,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | BUPROPION HCL | TRAZODONE HCL,,,,,,,,,,,0.1125,,,,,
  2 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | CITALOPRAM HYDROBROMIDE,,,0.2,,,,,,,,0.16,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,,,,,,,,,0.078125,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | DESVENLAFAXINE SUCCINATE,,,,0.1879194631,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | DULOXETINE HCL,,,,,,0.2412698413,,,,,0.1614349776,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.1666666667,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.2013888889,,,,,0.1166666667,,,,,
  2 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | ESCITALOPRAM OXALATE,,,,,,,0.1904761905,,,,0.1481481481,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.0593220339,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.1730769231,,,,,
  2 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | FLUOXETINE HCL,,,,,,,,0.2519685039,,,0.1357142857,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.1619047619,,
  2 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.1405405405,,,0.234939759,,
  2 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1875,,,0.1885245902,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | TRAZODONE HCL,,,,,,,,,,,0.1166666667,,,,,
  1 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1900826446
  2 ,Age: 41-64 | Gender: Male | ARIPIPRAZOLE | VENLAFAXINE HCL,,,,,,,,,,,0.1770833333,,,,,0.1628959276
  1 ,Age: 41-64 | Gender: Male | ATENOLOL,,0.04827586207,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400),,,,,,,,,,,,,,,0.01923076923,
  7 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM,,,0.540625,,,,0.1384408602,0.5620814013,,,0.2785046729,0.4581151832,,0.584073107,,0.536
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | BUPROPION HCL,,,,,,,,,,,0.2765957447,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | BUPROPION HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.2727272727,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | BUPROPION HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.6346153846,,
  1 ,"Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,,,,,,,,0.6197183099,,
  2 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE,,,0.7255813953,,,,,,,,0.4756097561,,,,,
  1 ,"Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.68,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.4641509434,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.8211382114,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.8235294118,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,0.1829268293,0.6166666667,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.7777777778,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.78,,
  3 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | ESCITALOPRAM OXALATE,,,0.75,,,,0.3694267516,,,,0.3455497382,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1552795031,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.5222222222,,,,,,,,,,,,,0.5145631068
  2 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL,,,,,,,,0.752303523,,,0.4203821656,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.6814159292,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.4689265537,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.4803149606,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7908256881,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL | SILDENAFIL CITRATE,,,,,,,,0.6902654867,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | GABAPENTIN,,,,,,,,0.5785123967,,,,,,0.5302013423,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784),,,,,,,,,,,,,,0.5825242718,,
  1 ,"Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.5894736842,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4263157895,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.4660194175,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4756493506,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8121387283,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,,,,,,,,0.5531914894,,
  2 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.6428571429,,,,,,,,,,,0.5917602996,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.7927927928,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,,,,,,,,,,,,,0.5568181818,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SERTRALINE HCL,,,,,,,,,,,,,,0.7730496454,,
  2 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | PAROXETINE HCL,,,,,,,,,,,0.2944444444,0.6368876081,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | RAMIPRIL,,,,,,,,,,,,,,0.6125,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | RAMIPRIL | SERTRALINE HCL,,,,,,,,,,,,,,0.8155339806,,
  2 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,0.4644351464,,,0.7895981087,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | SERTRALINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,,,,0.7610062893,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.820754717,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | SERTRALINE HCL | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,,,,,,,,,,,,0.9130434783,,
  3 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | SILDENAFIL CITRATE,,,0.4414414414,,,,,0.592920354,,,,,,0.5363984674,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | SIMVASTATIN,,,,,,,,,,,,,,0.515625,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,,,,,,,,,,,,0.6375,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | TRAZODONE HCL,,,,,,,,,,,0.431372549,,,,,
  1 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.5259259259,,
  2 ,Age: 41-64 | Gender: Male | ATORVASTATIN CALCIUM | VENLAFAXINE HCL,,,,,,,,,,,0.4217687075,,,,,0.6948356808
  1 ,Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401),,0.03736654804,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.02424242424,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL,,0.119047619,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | BUPROPION HCL | Last AD: Same & No Remiss,,0.02173913043,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.02884615385,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400),,0.0521609538,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL,,0.1005586592,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | BUPROPION HCL | Last AD: Same & No Remiss,,0.04918032787,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | METHYLPHENIDATE HCL,,0.07547169811,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.01886792453,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | AZELASTINE HCL,,,0.5242718447,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | AZITHROMYCIN,,,0.4829931973,,,,0.134529148,,,,,,,0.5576923077,,
  1 ,Age: 41-64 | Gender: Male | BACLOFEN,0.03149606299,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BENIGN HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE (dxo:ICD9:40210),,,0.4580152672,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113),,,,,,,,0.5027322404,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113) | FLUOXETINE HCL,,,,,,,,0.7566137566,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)",,,,,,,0.1454545455,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BENZONATATE,,,,,,,,,,,,0.4436090226,,,,
  1 ,"Age: 41-64 | Gender: Male | BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)",,,,,,,,,,,,,,0.48,,
  1 ,"Age: 41-64 | Gender: Male | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",,,,,,0.2450980392,,,,,,,,,,
  16 ,Age: 41-64 | Gender: Male | BUPROPION HCL,0.01624815362,0.06336014893,0.4204252577,0.6034482759,0.1347150259,0.3386648122,0.1627553238,0.3706451613,0.111409396,0.1004016064,0.3466855072,0.3542600897,0.2203389831,0.4147937411,0.01376811594,0.4456152277
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.04692082111,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | Last AD: Same & No Remiss",,0.01550387597,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02424242424,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.04608294931,,,,,,,,,,,,,,
  10 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,0.05874454515,0.5109784694,,,0.3558558559,0.1877256318,0.3591836735,,,0.4129135114,0.3138686131,,0.447761194,0.008333333333,0.5474860335
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,,,,,,,,,0.33,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,0.04651162791,0.6086956522,,,,0.2705882353,,,,0.3296703297,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.03703703704,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2385321101,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,0.06338028169,0.3529411765,,,,,,,,0.3301886792,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.29,,,,,,,,0.1893203883,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.3790322581,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,0.1214285714,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1875,,,,,,,,0.05202312139,,,,,
  5 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.0459670425,0.7067209776,,,,0.140625,,,,0.5515653775,,,,,0.5135135135
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.06406685237,0.7382352941,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.08450704225,0.5923076923,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.588377724,,,,,,,,0.5247349823,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2295081967,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.03012048193,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.07246376812,,,,,,,,,0.2976190476,,,,0.01176470588,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.07993966817,0.657635468,,,,,,,,0.5546218487,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.06829268293,0.6484018265,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6764705882,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+,,,0.65,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,0.04021447721,0.3194444444,,,,,,,,0.4202247191,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.44,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4504132231,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4477272727,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,,,,,,,,,0.6617210682,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7549019608,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5294117647,,,,,
  3 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4030612245,0.6744186047,,,,,,,,0.5481727575,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,,,,,,,,,0.2748815166,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2166666667,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5847826087,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,,,,,,,,,,0.2574257426,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.3392070485,,,,,,,,0.1850899743,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1393034826,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4545454545,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.2522522523,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.2214285714,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2415730337,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,,,,,,,,,0.08411214953,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,,,,,,,,,0.3956834532,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,0.06428571429,0.4322580645,,,,,,,,0.3288888889,,,0.4076923077,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.08554572271,0.375328084,,,,,,,,0.3140442133,,,,0.009803921569,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,,0.4426229508,,,,,,,,0.3043478261,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CLONAZEPAM,,0.103960396,,,,,,,,,0.3003952569,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CLONAZEPAM | Last AD: Diff & No Remiss,,,,,,,,,,,0.226993865,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | CLONAZEPAM | Last AD: Same & No Remiss,,0.04964539007,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.06494587843,,,,,,,,,0.3505154639,,,,,0.5744680851
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,,,,,,,,,,0.2653061224,,,,,0.5481481481
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01438848921,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.747826087
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.02279792746,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01724137931,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,0.03783783784,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.03144654088,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.024,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.07692307692,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.05263157895,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.06470588235,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SILDENAFIL CITRATE",,0.1333333333,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7115384615
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DESVENLAFAXINE SUCCINATE,,0.06701030928,,0.6606060606,,,,,,,0.3538230885,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | Last AD: Diff & No Remiss,,0.04273504274,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.2608695652,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.08450704225,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | Last AD: Same & No Remiss",,0.02450980392,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DOXEPIN HCL,,0.06172839506,,,0.3526011561,,,,,,0.3011889036,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DOXEPIN HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2924528302,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DOXEPIN HCL | Last AD: Diff & No Remiss,,0.07027027027,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1555555556,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.1973684211,,,,,
  5 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL,,0.07971656333,0.4230769231,,,0.4449130206,0.1736526946,,,,0.3295530354,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,,0.05263157895,,,,,,,,,0.2423312883,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL,,,,,,,,,,,0.3360655738,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.125,,,,,0.08494208494,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.06542056075,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.06857142857,,,,0.56167979,,,,,0.4787735849,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.06666666667,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3744075829,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.08653846154,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.0625,,,,,,,,,,,,,0.02803738318,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss,,0.1743589744,,,,0.7,,,,,0.5769230769,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss,,0.05594405594,,,,0.2670807453,,,,,0.2748538012,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3482142857,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3744075829,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6625,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5361445783,,,,,0.5034246575,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3195020747,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2600619195,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.2167832168,,,,,0.1435897436,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1188118812,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3076923077,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.2110091743,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.3225806452,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.3009259259,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL,,0.05732484076,,,,0.2717770035,,,,,0.2595628415,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2838983051,,,,,
  11 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE,,0.05617597293,0.55,,,0.4822695035,0.2797955831,0.3090909091,0.1261261261,,0.2986183074,0.3591160221,,0.3994252874,0.01724137931,0.587628866
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,0.01754385965,,,,,0.2320441989,,,,0.2809917355,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Diff & No Remiss,,0.02777777778,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,,,,0.1346153846,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss",,0.07476635514,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.1441441441,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1451104101,,,,0.3,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.1434262948,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1711711712,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.07633587786,,,,0.0830449827,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.05660377358,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,0.09219858156,,,,0.08208955224,,,,,
  6 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.05110274341,,,,0.5294117647,0.3265454545,,,,0.3654320988,,,,0,0.6306306306
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.0303030303,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04901960784,,,,,0.3458128079,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,0.04522613065,,,,,0.2963752665,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.3805309735,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3296178344,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2083333333,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05309734513,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.05825242718,,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.04363636364,,,,,0.2535211268,,,,0.186746988,,,,0.03947368421,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.1138014528,,,,,0.5835294118,,,,0.5767195767,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.6422018349,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.09677419355,,,,,0.59375,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,0.01846965699,,,,,0.1258907363,,,,0.2673130194,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.1503759398,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.1559633028,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2798507463,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2522522523,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1338028169,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1057692308,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2815315315,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,,,,,0.6384615385,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.75,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5585106383,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.5603448276,,,,0.68,,,,,
  3 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3021582734,,,,,0.5056818182,,,,0.5164556962,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4112903226,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,,,,,0.231092437,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1971830986,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PAROXETINE HCL,,,,,,,,,,,0.3184713376,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.0756302521,,,,,,,,,0.1433891993,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1485148515,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1024390244,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4298245614,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1729323308,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1666666667,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2672413793,,,,0.1976744186,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,,,,,0.1363636364,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,,,,,0.385620915,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL,,0.04195804196,,,,,0.2476190476,,,,0.3184931507,,,0.472972973,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,0.05637982196,,,,,0.245243129,,,,0.2052696078,,,,0.04609929078,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,0.07874015748,,,,,0.2796610169,,,,0.2668810289,,,,,
  9 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL,,0.06375545852,0.3619047619,,,0.3636363636,0.1746835443,0.4655751469,,,0.3942452222,0.4117647059,,0.3708791209,,0.527638191
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,0.2916666667,,,0.2574850299,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.4054054054,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,0.1724137931,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1467889908,,,0.0790513834,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04847207587,,,,,,0.6012658228,,,0.5535499398,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04743083004,,,,,,0.6606260297,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.6053412463,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5316455696,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.07142857143,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.0625,,,,,,,,,0.3467741935,,,,0.02873563218,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.1018957346,,,,,,0.6233421751,,,0.4931506849,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.08074534161,,,,,,0.6342857143,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,0.03597122302,,,,,,0.339055794,,,0.3929539295,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4093959732,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4709677419,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.2695652174,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1287128713,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4508474576,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6330935252,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5163934426,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,0.6434108527,,,,,,,,
  3 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4295302013,,,,,,0.6064981949,,,0.618556701,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4887218045,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.2376237624,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6606260297,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2033195021,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2452830189,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PAROXETINE HCL,,0.07843137255,,,,,,,,,0.3416666667,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3187919463,,,0.2065217391,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1621621622,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4016393443,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1845238095,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2391304348,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | RISPERIDONE,,,,,,,,,,,0.141509434,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.4609929078,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | SERTRALINE HCL,,0.06944444444,,,,,,0.4720496894,,,0.3073170732,,,0.4310344828,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,0.07352941176,,,,,,0.3565891473,,,0.2887624467,,,,0.02293577982,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | VENLAFAXINE HCL,,0.1282051282,,,,,,,,,0.3252595156,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | GABAPENTIN,,0.09565217391,,,,,,,,,0.2894736842,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | GABAPENTIN | Last AD: Same & No Remiss,,0.05357142857,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.05099150142,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,0.02250803859,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | HYDROCODONE/ACETAMINOPHEN,,0.07339449541,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784),,0.09537572254,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | Last AD: Same & No Remiss,,0.0221402214,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | SILDENAFIL CITRATE,,0.0390625,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.07647058824,,,,,,,,,0.09016393443,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Diff & No Remiss | TRAZODONE HCL",,0.03968253968,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,0.04119850187,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL",,,,,,,,,,,0.1391304348,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.02027027027,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.09836065574,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,,,,,,0.2610294118,,,0.3358778626,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.06787330317,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,0.1870503597,,,,,0.2554744526
  5 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,0.2454545455,0.07692307692,,,,0.1498371336,,,0.2348484848,,0.3125
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.05185185185,,,,0.1544117647,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.06626506024,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,,,,,,,,,,0.3823529412,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1171171171,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07006369427,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1163522013,,,,,0.2735849057
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.3673469388,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4580152672
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,,,,0.08695652174,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PAROXETINE HCL",,,,,,,,,,,0.18,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,0.1611111111,,,0.25,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.05882352941,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0.008474576271,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.02747252747,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.02573529412,
  6 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE,,,0.1698113208,,,0.127388535,,0.186440678,,,0.0910635406,,,0.2293577982,,0.1775700935
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.5213675214,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4193548387,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3930348259,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.1135531136,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.09523809524,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+,,,,,,,,,,,0.1217948718,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.08641975309,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.07462686567,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | RISPERIDONE,,,,,,,,,,,0.04166666667,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | ROPINIROLE HCL,,,,,,,,,,,0.1041666667,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,0.1030927835,,,0.1038251366,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.07485226527,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.04545454545,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.1282051282,,,,,0.1834862385
  12 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss,0.01796407186,0.0696969697,0.4584070796,,,0.3418604651,0.1752475248,0.4869215292,0.1398963731,,0.2804689911,0.4022988506,,0.5124835742,0.01415701416,0.5222222222
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.358974359,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.06763285024,,,,,,,0.2323232323,,0.2976190476,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05504587156,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.02803738318,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | TRAZODONE HCL,,0.04150943396,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,0.05263157895,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5056603774,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,0.04615384615,,,,,,,,,,,,0.6498993964,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,0.0594795539,,,,,,,,,,,,,0.02325581395,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,0.02083333333,,,,,,,,,,0.7201492537,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.04166666667,,,,,,,,,,,,0.7060773481,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.06258503401,,,,,,,,,,,,,0.02152641879,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,0.06024096386,,,,,,,,,,,,,,0.7317073171
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.251552795,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.4060402685,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.5108877722,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1043219076,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.5778688525,,,,,0.6571428571
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.3153153153,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | OMEPRAZOLE,,,,,,,,,,,0.2788461538,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.03292894281,,,,,0.2242990654,,,,0.4806070826,0.7075471698,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1241830065,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1009174312,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,0.06976744186,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,0.06168831169,,,,,,,,,,,,,0.02013422819,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,0.05982905983,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1059602649,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1386138614,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | ROPINIROLE HCL,,0.09448818898,,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03909643788,,,,,0.1985294118,,,,0.5488013699,,,0.7016574586,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,0.02840909091,,,,,,,,,0.4084507042,,,,0.005263157895,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SILDENAFIL CITRATE,,,,,,,,,,,0.2516129032,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SILDENAFIL CITRATE | TRAZODONE HCL,,0.07042253521,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SIMVASTATIN,,,,,,,,,,,0.3591549296,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.05308352849,,,,,,,,,0.1261410788,,,,0.021667761,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,0.02857142857,,,,,,,,,,,,,0.02380952381,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.05473372781,,,,,,,,,0.5287356322,,,,,0.6974169742
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss,,0.1403286979,,,,,,,,,0.5534883721,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.6559633028,,,,,,,,,0.7816901408,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.6610169492,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6043165468,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7055837563,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.07042253521,,,,,,,,,,,,0.66796875,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,0.1035856574,,,,,,,,,0.5,0.6727272727,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,0.09287925697,,,,,,,,,0.5496688742,,,0.6704545455,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,0.4418604651,,,,,,,,,,,,,0.1448275862,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.1176470588,,,,,,,,,0.5544041451,,,,,0.6555555556
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss,,0.0295626523,,,,,,,,,0.1901140684,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.1826484018,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.04968944099,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.2295081967,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | MYOPIA (dxo:ICD9:3671),,0.03603603604,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01582417582,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | Num Previous Episodes: 2+,,0,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.008333333333,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SILDENAFIL CITRATE,,0.01935483871,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.4095238095,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.4074074074,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,0.04156171285,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.46,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4945054945,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4920634921,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1661016949,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.05405405405,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.02325581395,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.03322259136,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.009009009009,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.07843137255,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,0.02463054187,,,,,,,,,0.3906810036,0.2721893491,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4587628866,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05803571429,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.2053571429,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1014492754,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1166666667,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.02793296089,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.02647058824,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,0.03867403315,,,,,,,,,0.4138655462,,,0.3561151079,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4743589744,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | SILDENAFIL CITRATE,,0.02319587629,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | SIMVASTATIN,,0.04672897196,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | TADALAFIL,,0.02431610942,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,0.04501607717,,,,,,,,,0.1691542289,,,,0.007380073801,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4896907216,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | VALACYCLOVIR HCL,,0.04761904762,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,0.03240740741,,,,,,,,,0.3857142857,,,,,0.355704698
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss,,0.5195195195,,,,,,,,,0.6457318636,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.72,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7904761905,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.5017667845,,,,,,,,,0.7402777778,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.7462686567,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.796875,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7839285714,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.811023622,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.5841924399,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.5462962963,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.6060606061,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6643356643,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,0.6487603306,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6114649682,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5095057034,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.6728571429,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5801526718,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5392702536,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5467980296,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.6247191011,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LITHIUM CARBONATE,,,,,,,,,,,0.03787878788,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LORAZEPAM,,0.06542056075,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | LORAZEPAM | Last AD: Same & No Remiss,,0.05294117647,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.5346062053,,,,,,,,,0.6929955291,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.6634615385,,,,,,,,,0.7512437811,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7674418605,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.6943521595,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.5282258065,,,,,,,,,0.6588693957,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6885245902,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6818181818,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE",,,,,,,,,,,0.5849056604,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.6198347107,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,,,,0.7096774194,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,0.5625,,,,,,,,,0.6582857143,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,0.6260162602,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.3418803419,,,,,
  6 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4066889632,,,,0.5879120879,0.5222672065,0.5,,,0.5638597905,,,,,0.6028037383
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.564231738,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4219653179,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.48,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.5238095238,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4703389831,,,,,
  3 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,0.3897058824,,,,,,,,,0.6315789474,0.6241610738,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.6090909091,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.6308724832,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.5404040404,,,,,
  3 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.4,,,,,,,,,0.6111111111,,,0.6823529412,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.5096153846,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.4074941452,,,,,,,,,0.5276098347,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.4285714286,,,,,
  3 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,0.5,,,,,,,,,0.5070422535,,,,,0.6666666667
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.06962025316,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | METHYLPHENIDATE HCL,,0.126984127,,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE,,0.07903225806,,,,0.2,,,0.2168674699,,0.2730189285,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2108843537,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2092696629,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1712328767,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1370967742,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,,,0.3423423423,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1123595506,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.1016949153,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.2772277228,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | TRAZODONE HCL,,0.02702702703,,,,,,,,,0.2096069869,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.2385964912,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | MYOPIA (dxo:ICD9:3671),,0.0871559633,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382),,0.06930693069,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.0486066105,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | NORTRIPTYLINE HCL,,0.05263157895,,,,,,,,0.1550802139,0.3402298851,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2868852459,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1712328767,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2307692308,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.519434629,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7331081081,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.706,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2336530078,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.3687943262,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.3694581281,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3155555556,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.3106382979,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2321981424,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3766816143,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2355802641,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.19348659,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | VENLAFAXINE HCL,,,,,,,,,,,0.1980676329,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5192982456,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.6754385965,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.08805031447,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1615598886,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.145631068,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.3429487179,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | OMEPRAZOLE,,,,,,,,,,,0.3046875,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.06918238994,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.0495049505,,,,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PAROXETINE HCL,,0.04939422181,0.4603174603,,,0.3870967742,0.1946902655,0.3684210526,,,0.3930348259,0.4914826498,,0.4060606061,,0.61
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1376811594,0.2623762376,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1592920354,,,,,
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PAROXETINE HCL | TRAZODONE HCL,,0.07936507937,,,,,,,,,0.3196721311,0.324742268,,,0.02586206897,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.234375,,,,,
  5 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.08463035019,,,,0.1141304348,,,,,0.1003976143,,,0.1666666667,,0.1651090343
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07301587302,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1975308642,,,0.2564102564,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1865284974,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.09037328094,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1401869159,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.173126615,,,,,0.2590673575
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,0.08139534884,,,,,,,,,0.425070688,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4205607477,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.406504065,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3434535104,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PREGABALIN,,0.07407407407,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.07189542484,,,,,,,,,0.1224489796,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.2522522523,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.09433962264,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1230769231,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.1822660099,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1592920354,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.07981220657,,,,,
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1609403255,,,,,0.2285714286
  2 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.2731481481,,,0.3529411765,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.132231405,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.09756097561,,,,,
  1 ,"Age: 41-64 | Gender: Male | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,,,,,0.08411214953,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.1166666667,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.09633027523,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.1052631579,,,,,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL,,0.06640625,,,,,,,,,0.3936842105,,0.4380165289,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.4305555556,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2701949861,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3931623932,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.0514541387,,,,,,,,,,,,,,
  11 ,Age: 41-64 | Gender: Male | BUPROPION HCL | SERTRALINE HCL,,0.05824972129,0.4123376623,,,0.3467741935,0.1678004535,0.3657142857,0.1153846154,,0.4324491055,0.3195876289,,0.5063721325,0.03787878788,0.5821596244
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,0.05053191489,,,,,,,,,0.3237311385,,,0.4168797954,0.008547008547,
  3 ,Age: 41-64 | Gender: Male | BUPROPION HCL | SERTRALINE HCL | VENLAFAXINE HCL,,0.04761904762,,,,,,,,,0.2874493927,,,0.5379746835,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | SILDENAFIL CITRATE,,0.07142857143,,,,,,,,,0.268722467,,,,,
  2 ,Age: 41-64 | Gender: Male | BUPROPION HCL | SIMVASTATIN,,0.04666666667,,,,,,,,,0.3927125506,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | TADALAFIL,,0.1008403361,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | TESTOSTERONE,,0.09523809524,,,,,,,,,,,,,,
  9 ,Age: 41-64 | Gender: Male | BUPROPION HCL | TRAZODONE HCL,,0.0720086627,0.2820512821,,,0.2830188679,0.1687242798,0.2426035503,,,0.268930665,,,0.2934131737,0.02235861464,0.2625
  4 ,Age: 41-64 | Gender: Male | BUPROPION HCL | TRAZODONE HCL | VENLAFAXINE HCL,,0.06382978723,,,,,,,,,0.2719568567,,,,0.03773584906,0.3988095238
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.09401709402,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | VALACYCLOVIR HCL,,0.09248554913,,,,,,,,,,,,,,
  7 ,Age: 41-64 | Gender: Male | BUPROPION HCL | VENLAFAXINE HCL,,0.06886045094,0.42,,,,0.2027027027,0.3728813559,,,0.3473833767,,,0.4601769912,,0.5207303157
  1 ,Age: 41-64 | Gender: Male | BUPROPION HCL | VILAZODONE HCL,,,,,,,,,,,0.6283185841,,,,,
  3 ,Age: 41-64 | Gender: Male | BUSPIRONE HCL,,,,,,,0.138028169,,,,0.2644628099,,,0.572327044,,
  1 ,Age: 41-64 | Gender: Male | BUSPIRONE HCL | ESCITALOPRAM OXALATE,,,,,,,0.4710743802,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CARBIDOPA/LEVODOPA | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.6171428571,,,,,
  1 ,Age: 41-64 | Gender: Male | CARBIDOPA/LEVODOPA | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6,,,,,
  4 ,Age: 41-64 | Gender: Male | CARISOPRODOL,0.009554140127,,,,,,0.2272727273,,,,,,,0.5283018868,0.005952380952,
  2 ,Age: 41-64 | Gender: Male | CELECOXIB,,,0.5258358663,,,,,0.5315315315,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CELECOXIB | CITALOPRAM HYDROBROMIDE,,,0.7251908397,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | CETIRIZINE HCL,,,0.5422885572,,,,0.1236749117,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CETIRIZINE HCL | CITALOPRAM HYDROBROMIDE,,,0.7416666667,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CHEST PAIN, OTHER (dxo:ICD9:78659)",,,,,,,,,,,,,,,,0.4251968504
  1 ,"Age: 41-64 | Gender: Male | CHEST PAIN, OTHER (dxo:ICD9:78659) | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,,,,,,,,0.6293706294,,
  5 ,"Age: 41-64 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,0.4308943089,,,,0.1485451761,0.490990991,,,,0.4095940959,,0.5064766839,,
  1 ,"Age: 41-64 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,0.1266666667,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | ESCITALOPRAM OXALATE",,,,,,,0.3035714286,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,0.1320754717,,,,,,,0.4569536424,,
  1 ,"Age: 41-64 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | SERTRALINE HCL",,,,,,,,,,,,,,0.6735751295,,
  1 ,"Age: 41-64 | Gender: Male | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.02327935223,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02148227712,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",,0.02,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071),,,0.5317460317,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CHRONIC PAIN SYNDROME (dxo:ICD9:3384),,,0.4619883041,,,,,,,,,,,,,
  16 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE,0.02613240418,0.04141018467,0.568129192,0.6204819277,0.1368421053,0.4064885496,0.2727272727,0.4599109131,0.1245421245,0.08778625954,0.3260909424,0.4269662921,0.196969697,0.470217239,0.01824817518,0.6038406828
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | CLONAZEPAM,,,0.6783625731,,,,,,,,0.4427860697,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.713592233,,,,,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.03389830508,0.6875,,,,,,,,0.4265402844,,,,,0.6559633028
  3 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss",,0.008695652174,,,,,,,,,0.3237410072,,,,,0.5172413793
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,,0.4017857143,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss",,,0.6816143498,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.7313432836,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL,,,0.54,,0.3773584906,,,,,,0.4154411765,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,0.6165884194,,,0.4836601307,,,,,0.3680672269,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,0.5725806452,,,,,0.464,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3205574913,,,,,
  8 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,0.02285714286,0.6867346939,,,,0.3776908023,0.4897959184,,,0.2417910448,0.5042735043,,0.5156950673,,0.6237623762
  4 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.007518796992,0.7346938776,,,,0.4107883817,,,,0.243697479,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.768,,,,0.436416185,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6928104575,,,,0.3899371069,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.6927710843,,,,,,,,0.2162162162,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.00826446281,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,0.4545454545,,,,0.37,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,0.4618181818,,,,0.1960784314,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.419047619,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.4330708661,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,0.7512195122,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.68,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.276119403,,,,0.2727272727,,,,0.01481481481,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM,,,0.7160883281,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM | Last AD: Same & Remiss,,,0.7899159664,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.6875,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & No Remiss",,,0.3533333333,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & Remiss",,,0.608974359,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SIMVASTATIN",,,0.7902097902,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | EZETIMIBE/SIMVASTATIN,,,0.7175141243,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | FENOFIBRATE,,,0.8015267176,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,0.01550387597,0.504950495,,,,,0.5360169492,,,0.2589641434,,,0.3829787234,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | TRAZODONE HCL,,,0.3303571429,,,,,,,,0.285,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | GABAPENTIN,,,0.7227272727,,,,,,,,0.4171779141,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | GEMFIBROZIL,,,0.7432432432,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.3083832335,,,,,,,,0.1287128713,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,0.293814433,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,0.1779661017,,,,,,,,0.1913580247,,,,,
  4 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.4269503546,,,,0.1182432432,,,,0.2297297297,,,0.2546583851,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,0.07643312102,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1132075472,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,0.2984749455,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3247863248,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2228915663,,,,,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.4097222222,,,,,,,,0.1535580524,,,0.2342342342,,0.2547169811
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,0.2782608696,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,0.2873563218,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.2259615385,,,,,,,,0.08805031447,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,0.1333333333,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.6755319149,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0.009009009009,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01063829787,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",,,0.3801652893,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1587802313,,,,,,,,0.09265175719,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | Last AD: Same & No Remiss,,,0.1126760563,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | TRAZODONE HCL,,,0.1402439024,,,,,,,,0.07482993197,,,,,
  11 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,0.007407407407,0.02491961415,,,,0.3712121212,0.2233766234,0.4557640751,0.09615384615,,0.3242271747,0.399122807,,0.4534711965,0.01768488746,0.5073891626
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,,,0.1844660194,,0.5221238938,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01481481481,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.551980198,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7071428571,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.6515151515,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3857142857,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5510688836,,,,,,,,0.4784313725,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1666666667,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02,,,,,,,,,0.2727272727,,,,,
  4 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.02631578947,0.6297169811,,,,,,,,0.5183946488,,,,0.01077586207,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.3619047619,,,,,0.686440678
  9 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.08318264014,,,,0.4353448276,0.3406374502,0.5966850829,,,0.419556172,0.6641791045,,0.6793103448,0.05529953917,0.6506024096
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7476635514,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.5905511811,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.65625,,,,,,,,,,,,0.01470588235,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5808823529,,,,,,,,0.5185185185,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.5196078431,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.3846153846,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | TRAZODONE HCL,,,0.6448598131,,,,,,,,0.5196850394,,,,0.03225806452,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3979381443,,,,,,,,0.3495145631,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.4528301887,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.4053826745,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4264705882,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.4502923977,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2655502392,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.3565217391,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.2296296296,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2807017544,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SERTRALINE HCL,,,0.4403669725,,,,,,,,,,,0.4285714286,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SILDENAFIL CITRATE,,,0.3526570048,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SIMVASTATIN,,,0.4719101124,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,0.3715846995,,,,,,,,0.3519855596,,,,0.004237288136,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.7287576021,,,,,,,,0.5913043478,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.68,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,0.54,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,0.880733945,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6153846154,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,0.8766519824,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.76,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5517241379,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6930693069,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SILDENAFIL CITRATE,,,0.72,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SIMVASTATIN,,,0.786407767,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6161290323,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | LISINOPRIL,,,0.6902654867,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.7215496368,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE | Last AD: Same & No Remiss,,,0.4705882353,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE | Last AD: Same & Remiss,,,0.7771428571,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | LOVASTATIN,,,0.7625570776,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,0.7088036117,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.671641791,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4318181818,0.7082706767,,,,,,,,0.5887096774,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.762295082,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,0.725,,,,,,,,0.5362903226,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,0.4836363636,,,,,,0.228125,,0.318128655,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1188118812,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2947019868,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02285714286,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,0.625,,,,,,,0.1807228916,0.4491803279,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6785714286,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5476190476,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+,,,0.8734177215,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6893203883,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2014925373,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.7785336357,,,,0.4296875,,,,0.4954682779,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SIMVASTATIN,,,0.7987012987,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | OMEPRAZOLE,,,,,,,,,,,0.4014084507,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,,0.723880597,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,,0.7469879518,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,0.02608695652,0.5601577909,,,,,,,,0.2607526882,0.5114235501,,0.3983739837,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3412698413,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.3171745152,,,,,,,,0.1419491525,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.09142857143,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2802547771,,,,,,,,0.2144638404,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,0.5482866044,,,,,,,,0.5435606061,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6260869565,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PRAVASTATIN SODIUM,,,0.7743902439,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.53125,,,,,,,,0.1747368421,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.2711864407,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.3197674419,,,,,,,,0.1404958678,,,,,
  1 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.2426470588,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.3408577878,,,,,,,,0.1777777778,,,,,
  2 ,"Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,0.303030303,,,,,,,,0.2142857143,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5785714286,,0.4626865672,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,0.1993464052,,,,,,,,0.1212121212,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | RISPERIDONE | TRAZODONE HCL,,,0.2288135593,,,,,,,,0.1307189542,,,,,
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,0.5589353612,,,,,,,,0.5357142857,,0.4743589744,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.376146789,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | ROSUVASTATIN CALCIUM,,,0.7083333333,,,,,,,,,,,,,
  8 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,0.06153846154,0.539184953,,,,0.2089552239,0.4031007752,,,0.2455858748,0.4159292035,,0.5215562566,,0.6074766355
  3 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | TRAZODONE HCL,,,0.3623188406,,,,,,,,0.3024193548,,,0.3708609272,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | SILDENAFIL CITRATE,,,0.6477987421,,,,,,,,0.407079646,,,,,
  2 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | SIMVASTATIN,,,0.7640562249,,,,,,,,0.4676806084,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,0.75,,,,,,,,,,,,,
  8 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.0347826087,0.4838076546,,,0.368852459,0.2015503876,0.3035714286,,,0.3876850461,,,0.2840236686,0.0100536193,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2941176471,,,,,
  1 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,0.6695652174,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,0.06626506024,0.5028328612,,,,,,,,0.2990264256,,,0.3649635036,,0.6707692308
  10 ,Age: 41-64 | Gender: Male | CLONAZEPAM,0.03846153846,0.05813953488,0.4598930481,,,,0.1658163265,0.4504504505,0.1703296703,,0.2551440329,,,0.4567901235,0.01257861635,0.4195402299
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | DULOXETINE HCL,,,,,,,,,,,0.404109589,,,,,
  2 ,Age: 41-64 | Gender: Male | CLONAZEPAM | ESCITALOPRAM OXALATE,,,,,,,0.3948717949,,,,0.3539823009,,,,,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,,,,,0.1843971631,,,,,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1666666667,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | FLUOXETINE HCL,,,,,,,,,,,0.3475935829,,,,,
  1 ,"Age: 41-64 | Gender: Male | CLONAZEPAM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.03816793893,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3464052288,,,,,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.4380952381,,,,,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.007575757576,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7345132743,,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | MIRTAZAPINE,,,,,,,,,0.277027027,,,,,,,
  1 ,Age: 41-64 | Gender: Male | CLONAZEPAM | PAROXETINE HCL,,,,,,,,,,,0.375,,,,,
  2 ,Age: 41-64 | Gender: Male | CLONAZEPAM | SERTRALINE HCL,,,,,,,,,,,0.4098360656,,,0.685106383,,
  2 ,Age: 41-64 | Gender: Male | CLONAZEPAM | TRAZODONE HCL,,,,,,,,,,,0.3311258278,,,,0.03448275862,
  2 ,Age: 41-64 | Gender: Male | CLONAZEPAM | VENLAFAXINE HCL,,,,,,,,,,,0.3837209302,,,,,0.6771653543
  1 ,Age: 41-64 | Gender: Male | CLOTRIMAZOLE/BETAMETHASONE DIP,,,0.4528301887,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | CODEINE PHOSPHATE/GUAIFENESIN,,,0.4609375,,,,,,,,,,,,0.009900990099,
  2 ,"Age: 41-64 | Gender: Male | CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)",,0.07633587786,,,,,,0.5357142857,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)",,,,,0.09239130435,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016),,,0.3904761905,,,,,,,,,,,0.3649635036,,
  1 ,Age: 41-64 | Gender: Male | CYCLOBENZAPRINE HCL,,,,,,,,,,,,,,,0.004073319756,
  1 ,Age: 41-64 | Gender: Male | CYCLOBENZAPRINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  6 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.4802259887,,,,0.1470588235,0.5596330275,,,0.3043478261,0.4146341463,,0.4669421488,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.7215189873,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.6972972973,,
  15 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.0247311828,0.03778337531,0.5537017727,0.6263345196,0.1065088757,0.4429223744,0.164594729,0.524738676,,0.1039755352,0.2893982808,0.4586288416,0.2820512821,0.6111675127,0.02187286398,0.5935809592
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DESVENLAFAXINE SUCCINATE",,,,0.6978723404,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.02469135802,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL",,,,,,0.5644599303,,,,,,,,,,0.6901408451
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL | Last AD: Same & No Remiss",,,,,,0.33,,,,,,,,,,
  4 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,0.02912621359,,,,,0.3371757925,,,,0.3209302326,,,,,0.6769230769
  3 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss",,0.006993006993,,,,,,,,,0.198019802,,,,,0.5682819383
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.130859375,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss",,,,,,,0.6862745098,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.5685279188,,,,,,,,,,,,,0.6246786632
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6926070039
  3 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.6845983788,,,0.4851485149,,,,,0.7315789474
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Diff & No Remiss",,,,,,,,,,,0.3302752294,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.4898989899,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,,0.3518518519,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.6832669323,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | SIMVASTATIN",,,,,,,,0.7692307692,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",,,,,,,0.145631068,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840)",0.01992031873,,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HYDROCODONE/ACETAMINOPHEN",,,,,,0.4379084967,0.1764705882,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)",,0.05487804878,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,,,,,,,,0.05072463768,0.2456140351
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,,,0.220657277
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.5575221239,,,,,,,0.008528784648,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.004366812227,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.04511278195,
  3 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | SERTRALINE HCL",,0.009009009009,,,,,,,,,0.3172413793,,,,,0.4964539007
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,0.375,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7227722772
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,,,0.7155963303
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3759398496
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.3720930233,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.5,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01035196687,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.495
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.719047619,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.7254901961,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7289377289
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",,,,,,,,,,,,,,,0.0297029703,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.03676470588,,,,,0.1578947368,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.05263157895,,,,,,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.02826086957,,,,0.4635193133,0.1544715447,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,0.3515151515,0.6743554953,,,,0.7028571429
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.03414634146,,,,,,,,,,,,,,0.288
  3 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.01858736059,,,,,0.1282051282,,,,,0.4867256637,,,,
  4 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,0.05042016807,,,,,,,,,0.4061433447,,,0.7405159332,,0.662601626
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SILDENAFIL CITRATE",,0.0245398773,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SIMVASTATIN",,,,,,,0.2265625,0.5118110236,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",,,0.593220339,,,,,,,,,,,0.623853211,,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,,,,,,,,,,0.41,,,,0.01449275362,
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5514018692
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",,0.04,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,0.4341463415,,,,,0.6938416422
  1 ,"Age: 41-64 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.04132231405,
  1 ,Age: 41-64 | Gender: Male | DERMATOPHYTOSIS OF FOOT (dxo:ICD9:1104),,,,,,,,0.4158415842,,,,,,,,
  6 ,Age: 41-64 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.5217391304,,,,0.1858190709,0.5813953488,0.1203703704,,0.2429906542,0.4526315789,,,,
  1 ,Age: 41-64 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ESCITALOPRAM OXALATE,,,,,,,0.368852459,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | PAROXETINE HCL,,,,,,,,,,,,0.6435643564,,,,
  1 ,Age: 41-64 | Gender: Male | DESLORATADINE,,,,,,,0.1124260355,,,,,,,,,
  8 ,Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE,,0.04395604396,0.4797297297,0.487928465,,,0.2434782609,0.3269230769,,,0.297532656,,,0.4444444444,,0.6911764706
  1 ,Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | DULOXETINE HCL,,,,,,,,,,,0.2937062937,,,,,
  2 ,Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | ESCITALOPRAM OXALATE,,,,,,,0.2983870968,,,,0.25,,,,,
  2 ,Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | LAMOTRIGINE,,,,0.1310043668,,,,,,,0.08333333333,,,,,
  1 ,Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss,,,,0.4714285714,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,0.5659574468,,,,,,,0.5076923077,,,,,
  1 ,Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | MIRTAZAPINE,,,,,,,,,,,0.224137931,,,,,
  1 ,"Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,0.228,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,0.1543209877,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,0.2675159236,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,0.5930232558,,,,,,,0.36,,,,,
  1 ,Age: 41-64 | Gender: Male | DESVENLAFAXINE SUCCINATE | VENLAFAXINE HCL,,,,,,,,,,,0.2941176471,,,,,
  3 ,Age: 41-64 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE,,,0.5462962963,,,,0.1583333333,,,,,,,0.5405405405,,
  1 ,Age: 41-64 | Gender: Male | DEXTROAMPHETAMINE/AMPHETAMINE | SERTRALINE HCL,,,,,,,,,,,,,,0.6315789474,,
  1 ,"Age: 41-64 | Gender: Male | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED (dxo:ICD9:25001)",0.01310043668,,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.02845528455,,,,,,,,,,0.5047619048,,,,
  1 ,"Age: 41-64 | Gender: Male | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.03100775194,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.02142857143,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,0.02941176471,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE (dxo:ICD9:5533),,,0.5084745763,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | DIAZEPAM,,,,,,,,0.4881889764,,,,,,0.4901960784,0.01242236025,0.5392156863
  2 ,Age: 41-64 | Gender: Male | DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820),0.01463414634,,,,,,,,,0.09016393443,,,,,,
  2 ,Age: 41-64 | Gender: Male | DIZZINESS AND GIDDINESS (dxo:ICD9:7804),,,,,,,,0.5582822086,,,,,,0.5514018692,,
  6 ,Age: 41-64 | Gender: Male | DOXEPIN HCL,,0.02654867257,,,0.3391699092,0.3069306931,0.1504424779,,,,0.3481298808,,,0.3846153846,,
  2 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | DULOXETINE HCL,,,,,,0.5310344828,,,,,0.3805309735,,,,,
  3 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | ESCITALOPRAM OXALATE,,,,,0.2377622378,,0.3258928571,,,,0.2751091703,,,,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.375,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3942307692,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | FLUOXETINE HCL,,,,,0.3237410072,,,0.5131578947,,,0.4166666667,,,,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3,,,,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | LAMOTRIGINE,,,,,,,,,,,0.1111111111,,,,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.3767123288,,,,,
  1 ,"Age: 41-64 | Gender: Male | DOXEPIN HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7739130435,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | Last AD: Same & No Remiss,,,,,0.1658767773,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | Last AD: Same & Remiss,,,,,0.5824175824,,,,,,0.5812807882,,,,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5865384615,,,,,
  1 ,"Age: 41-64 | Gender: Male | DOXEPIN HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.51,,,,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | MIRTAZAPINE,,,,,,,,,,,0.2925925926,,,,,
  1 ,"Age: 41-64 | Gender: Male | DOXEPIN HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.756097561,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1681415929,,,,,
  2 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | PAROXETINE HCL,,,,,,,,,,,0.3722627737,0.6744186047,,,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | ROPINIROLE HCL,,,,,,,,,,,0.3720930233,,,,,
  3 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | SERTRALINE HCL,,,,,0.356097561,,,,,,0.367816092,,,0.6169590643,,
  1 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.265141319,,,,,
  3 ,Age: 41-64 | Gender: Male | DOXEPIN HCL | VENLAFAXINE HCL,,,,,0.37,,,,,,0.326007326,,,,,0.7043478261
  15 ,Age: 41-64 | Gender: Male | DULOXETINE HCL,0.02401372213,0.03796296296,0.5005025126,,0.1409395973,0.4462746107,0.2021521906,0.4235294118,0.1578947368,0.1,0.3238291833,0.4334203655,0.1634615385,0.4907677357,0.02473498233,0.6467236467
  5 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE,,0.02777777778,,,,0.5048076923,0.3906020558,,,,0.2921052632,,,0.4571428571,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,0.4827586207,0.4765625,,,,0.303030303,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.5112359551,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3076923077,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,,,,,0.5,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.3209876543,,,,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | FLUOXETINE HCL,,,,,,0.4441340782,,0.575,,,0.3013937282,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.4455445545,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7087378641,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6822429907,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3043478261,,,,,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | GABAPENTIN,,,,,,0.6159844055,,,,,0.4480519481,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss,,,,,,0.3240740741,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss,,,,,,0.675,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6166666667,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | HYDROCODONE/ACETAMINOPHEN,,,,,,0.7073170732,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,0.275862069,,,,,0.09933774834,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,0.3,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,0.2085889571,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,0.1751824818,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.02884615385,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.1268292683,,,,,0.08436213992,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,0.08196721311,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.4036697248,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,0.1363636364,,,,,0.09818181818,,,,,
  9 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss,0.02702702703,0.03137254902,0.5195530726,,,,0.1619937695,0.5,,,0.3228021978,,,0.5041322314,0,0.5577689243
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7213114754,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01895734597,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,0.4907407407,,,,,0.4552529183,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.5147058824,,,,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.5054466231,,,,,0.4886363636,,,,0.01809954751,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,0.6746031746,,,,,,,,,,0.7213114754
  5 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & Remiss,,0.06779661017,,,,0.693877551,0.3014705882,,,,0.4309210526,,,,,0.6976744186
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01904761905,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.4818181818,,,0.7071428571,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,0.6008583691,,,,,0.536,,,,0.04016064257,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.292834891,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,0.3285714286,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5044247788,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.3786407767,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.1133603239,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | PREGABALIN,,,,,,0.4015748031,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.24,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,0.298136646,,,,,0.4006968641,,,,0.01398601399,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3859649123,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,0.6733897202,,,,,0.5701754386,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5714285714,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6638655462,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5631691649,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6481481481,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,0.6738609113,,,,,0.6637931034,,,,,
  2 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5736040609,,,,,0.5343035343,,,,,
  2 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,0.6036866359,,,,,0.4347826087,,,,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.3673469388,,,0.2514124294,,0.3354271357,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1666666667,,,,,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,0.3656716418,,,,,0.2604166667,,,,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | NORTRIPTYLINE HCL,,,,,,0.5656565657,,,,0.1603053435,0.4382352941,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7170731707,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2475247525,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.4304932735,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.5756302521,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | PAROXETINE HCL,,,,,,0.4679245283,,,,,0.3970037453,0.5726495726,,,,
  2 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.2727272727,,,,,0.09489051095,,,,,
  2 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,0.2574850299,,,,,0.1403508772,,,,,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,0.3967213115,,,,,0.4464692483,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3097345133,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | PREGABALIN,,,,,,0.5884773663,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1597938144,,,,,
  1 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1582278481,,,,,
  2 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.3217665615,,,,,0.194092827,,,,,
  2 ,"Age: 41-64 | Gender: Male | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,0.3109243697,,,,,0.2700729927,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6666666667,,,,,
  2 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | RISPERIDONE,,,,,,0.2682926829,,,,,0.1310344828,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.07518796992,,,,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | ROPINIROLE HCL,,,,,,0.426597582,,,,,0.4751655629,,0.3679245283,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4206349206,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | ROSUVASTATIN CALCIUM,,,,,,0.6884057971,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | SERTRALINE HCL,,,,,,0.487804878,0.1694915254,,,,0.3769968051,,,0.5984427141,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3540145985,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | TRAMADOL HCL,,,,,,0.6,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.3973294839,0.12,,,,0.358739255,,,,0.04362416107,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3,,,,,
  1 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5995423341,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,0.6519337017,,,,,0.331838565,,,,,0.7234042553
  1 ,Age: 41-64 | Gender: Male | DYSMETABOLIC SYNDROME X (dxo:ICD9:2777),,0.0223880597,,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | DYSTHYMIC DISORDER (dxo:ICD9:3004),0.01550387597,,,,,,,0.5794392523,,,0.3867924528,,,,0.01886792453,0.5717884131
  1 ,Age: 41-64 | Gender: Male | DYSTHYMIC DISORDER (dxo:ICD9:3004) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7258064516
  5 ,Age: 41-64 | Gender: Male | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869),,0.03626943005,0.5555555556,,,,0.1798107256,0.5885714286,,,0.2586206897,,,,,
  1 ,Age: 41-64 | Gender: Male | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869) | ESCITALOPRAM OXALATE,,,,,,,0.3644859813,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889),,,0.4514285714,,,,,,,,,,,,,
  15 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE,0.02002670227,0.0267910897,0.6785789808,,0.1565217391,0.4931921331,0.3142857143,0.4530005311,0.1391304348,0.07142857143,0.2454952895,0.4245283019,0.2727272727,0.4743202417,0.01795977011,0.5701275046
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | ESOMEPRAZOLE MAGNESIUM,,,,,,,0.3535353535,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | ESOMEPRAZOLE MAGNESIUM | Last AD: Same & No Remiss,,,,,,,0.1557377049,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | EZETIMIBE,,,,,,,0.3017241379,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | EZETIMIBE/SIMVASTATIN,,,,,,,0.3448275862,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | EZETIMIBE/SIMVASTATIN | Last AD: Same & No Remiss,,,,,,,0.1470588235,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | FENOFIBRATE NANOCRYSTALLIZED,,,,,,,0.4106280193,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | FENOFIBRATE NANOCRYSTALLIZED | Last AD: Same & No Remiss,,,,,,,0.1640625,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,0.04310344828,,,,,0.2793367347,0.5699152542,,,0.2183486239,,,0.43125,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,0.3827160494,,,,0.2464788732,,,,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3983739837,0.7477477477,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,0.1782945736,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.75,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,0.2231404959,,,,0.2886597938,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | GABAPENTIN,,,,,,,0.3957219251,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,0.1756756757,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,,,,,,0.3381642512,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,,,,,,0.1944444444,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN,,,,,,,0.2987012987,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | HYDROCODONE/ACETAMINOPHEN | Last AD: Same & No Remiss,,,,,,,0.1643835616,,,,,,,,,
  3 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,0.2313432836,,,,0.2206405694,,,,0.08303249097,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1130434783,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.07462686567,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,0.1254752852,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.05555555556,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.1055900621,,,,,
  6 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.3401759531,,,,0.1774193548,0.2621359223,,,0.2075471698,,,0.320754717,,0.3314606742
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss",,,,,,,,,,,0.1551724138,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1032608696,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,0.1260504202,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,0.134529148,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1136974038,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1181818182,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.1247484909,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.07299270073,,,,,
  5 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.3065326633,,,,0.1725067385,,,,0.1241610738,,,0.2941176471,,0.308411215
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,0.1494252874,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.1952191235,,,,0.06563706564,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,0.1157894737,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.05882352941,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.008230452675,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,0.09219858156,,,,0.05675675676,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,0.05381165919,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,0.08571428571,,,,0.0632183908,,,,,
  11 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0,0.02179836512,0.6650141643,,,0.4113712375,,0.5,0.1019417476,,0.1924798568,0.4519774011,,0.4994350282,0.01538461538,0.5392320534
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,0.3684210526,,0.2352941176,,0.3539823009,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,0.4363636364,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01398601399,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,,0.4117647059,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5925925926,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.3195876289,,,,,,,,0.008333333333,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,0.3883495146,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.2556390977,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,0.2976190476,,,,,,,0.6685714286,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.3155339806,,,,,,,,0.009345794393,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,0.347107438,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.6341463415,,,,,,,,0.24375,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.2211538462,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.280876494,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.2276422764,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,0.3724137931,,,,0.28125,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.006896551724,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01923076923,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.09322033898,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1223628692,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.2464788732,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.04,,,,,0.3236714976,,,,0.2475728155,,,,,
  4 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.015625,,,,,0.2969837587,,,,0.3230593607,,,,0.01112140871,
  4 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.02542372881,,,,,0.3414634146,,,,0.4076923077,,,,,0.7027027027
  8 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.1144781145,0.7762430939,,,0.5637583893,,0.6612903226,,,0.4244604317,,,0.6643356643,0.1304347826,0.6855345912
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6785714286,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.6418604651,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.3983739837,,,,,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,0.6222910217,,,,0.4733333333,,,,0.04501607717,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1461328615,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.2769230769,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.1216216216,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.170846395,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.2293577982,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3175965665,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1767371601,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OLMESARTAN MEDOXOMIL,,,,,,,0.1729323308,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OMEPRAZOLE,,,,,,,0.1408450704,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,,,,,,0.1516853933,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.1504424779,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,0.1224489796,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,0.1573033708,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.09345794393,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.1272084806,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.1038961039,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1326259947,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | RAMIPRIL,,,,,,,0.1619047619,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,0.1358024691,,,,,,,0.3529411765,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SIMVASTATIN,,,,,,,0.1360294118,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,0.2218309859,,,,0.26875,,,,0.004149377593,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.1681415929,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.6856886093,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.6329113924,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,0.5625,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,0.8859060403,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,0.876344086,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.7485207101,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6078431373,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | SIMVASTATIN,,,,,,,0.6788321168,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6056338028,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | LEVOFLOXACIN,,,,,,,0.2660550459,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,,,,,0.4672897196,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | LOVASTATIN,,,,,,,0.3211678832,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | LOVASTATIN | Last AD: Same & No Remiss,,,,,,,0.22,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.6558935361,,,,0.6791044776,,,,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.465085639,,,,0.5078431373,,,,,
  3 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,0.4034334764,,,,0.4774774775,,,,0.1696428571,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.3091247672,,0.2361809045,,0.2905660377,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2324723247,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.44,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03937007874,,,,,0.3736842105,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | NORTRIPTYLINE HCL,,,,,,,0.3901345291,,,0.2372881356,0.3261648746,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6575342466,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.6363636364,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1179487179,,,,,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.7700534759,,,,0.4577075099,,,,0.4047619048,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | OLMESARTAN MEDOXOMIL,,,,,,,0.36,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | OMEPRAZOLE,,,,,,,0.3754152824,,,,0.3425925926,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,,,,,,0.3464566929,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | OXYCODONE HCL,,,,,,,0.47,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.3223684211,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PAROXETINE HCL,,,,,,,0.3184210526,,,,0.2211055276,0.5488826816,,0.408,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2416666667,,,,,
  4 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.3021276596,,,,0.3179190751,,,,0.09302325581,,,0.2090909091,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.05928853755,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1147540984,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,0.28,,,,0.5020325203,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.3018867925,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.4807692308,,,,0.2465116279,,,,0.1324110672,,,,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,0.2,,,,0.08712121212,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1081081081,,,,,
  3 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.2346491228,,,,0.1804222649,,,0.1655172414,,
  2 ,"Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,0.2320441989,,,,0.1730769231,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | RAMIPRIL,,,,,,,0.3205128205,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4029850746,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5544554455,,,,,
  2 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,0.1018518519,,,,0.13,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.08450704225,,,,,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,0.3578336557,,,,0.4726477024,,0.3831168831,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,0.3798882682,,,,,,,,,
  8 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | SERTRALINE HCL,,0.04395604396,0.6306306306,,,,0.2544434051,0.3734939759,,,0.2412342216,0.3612903226,,0.5248667851,,0.5333333333
  4 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,0.2547770701,,,,0.2765957447,,,0.4297520661,0.01754385965,
  3 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | SIMVASTATIN,,,0.7397260274,,,,0.4071729958,,,,0.3040935673,,,,,
  7 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | TRAZODONE HCL,,0.01675977654,0.4586466165,,,,0.2968790302,0.2718446602,,,0.272889115,,,0.3404255319,0.01856763926,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2924528302,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,0.3169014085,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | VALSARTAN,,,,,,,0.2866242038,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,0.03012048193,,,,,0.3068893528,,,,0.2759084791,,,0.380952381,,0.6930379747
  3 ,Age: 41-64 | Gender: Male | ESOMEPRAZOLE MAGNESIUM,,,0.5,,,,0.1652754591,0.4730769231,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | ESOMEPRAZOLE MAGNESIUM | FLUOXETINE HCL,,,,,,,,0.693877551,,,,,,,,
  8 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,0.05434782609,0.4922839506,,,0.3666666667,,0.5879396985,,,0.3215686275,0.4331983806,,0.5769230769,,0.5730769231
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | HYDROCODONE/ACETAMINOPHEN",,,,,,0.3398058252,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4797297297
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7469135802
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LISINOPRIL",,,0.5170068027,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LISINOPRIL/HYDROCHLOROTHIAZIDE",,,0.5857142857,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,0.6019417476,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | PAROXETINE HCL",,,,,,,,,,,,0.6944444444,,,,
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SIMVASTATIN",,,0.5310344828,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",,,0.5075757576,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.741697417
  3 ,Age: 41-64 | Gender: Male | ESZOPICLONE,,,0.492,,,0.3356643357,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Male | EXAMINATION OF EYES AND VISION (dxo:ICD9:V720),,,0.4267515924,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | EZETIMIBE,,,,,,,0.1902439024,,,,,,,,,
  8 ,Age: 41-64 | Gender: Male | EZETIMIBE/SIMVASTATIN,,,0.5367483296,,,0.5,0.1559405941,0.5263157895,,,,0.4485294118,,0.548,0.02919708029,0.5268817204
  1 ,Age: 41-64 | Gender: Male | EZETIMIBE/SIMVASTATIN | FLUOXETINE HCL,,,,,,,,0.7676767677,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | EZETIMIBE/SIMVASTATIN | PAROXETINE HCL,,,,,,,,,,,,0.7154471545,,,,
  1 ,Age: 41-64 | Gender: Male | EZETIMIBE/SIMVASTATIN | SERTRALINE HCL,,,,,,,,,,,,,,0.8217821782,,
  1 ,Age: 41-64 | Gender: Male | EZETIMIBE/SIMVASTATIN | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.8089171975
  4 ,Age: 41-64 | Gender: Male | FENOFIBRATE,,,0.5536723164,,,,,0.6390977444,,,0.336,,,0.5582010582,,
  1 ,Age: 41-64 | Gender: Male | FENOFIBRATE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8348623853,,
  1 ,Age: 41-64 | Gender: Male | FENOFIBRATE | SERTRALINE HCL,,,,,,,,,,,,,,0.8333333333,,
  1 ,Age: 41-64 | Gender: Male | FENOFIBRATE NANOCRYSTALLIZED,,,,,,,0.20657277,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FENOFIBRATE,MICRONIZED",,,,,,,,,,,,,,0.6610169492,,
  1 ,Age: 41-64 | Gender: Male | FENTANYL,,,,,,,0.2358490566,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FEVER AND OTHER PHYSIOLOGIC DISTURBANCES OF TEMPERATURE REGULATION (dxo:ICD9:7806),,,0.5102040816,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FEXOFENADINE HCL,,,,,,,,,,,,,,,0.01265822785,
  1 ,Age: 41-64 | Gender: Male | FEXOFENADINE/PSEUDOEPHEDRINE,,,,,,,,,,,,0.4215686275,,,,
  1 ,Age: 41-64 | Gender: Male | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxi:ICD9:V5881),,0.02521008403,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881),,,,,,,,,,,,,,0.5596330275,,
  15 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL,0.03448275862,0.0426988266,0.4695906433,0.6666666667,0.1242937853,0.4165366615,0.2112794613,0.5508177304,0.1485013624,0.08474576271,0.3162230672,0.4321966693,,0.4382275629,0.02151639344,0.5639742673
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.706,,,0.4958677686,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,,0.4680851064,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss,,,,,,,,0.7298850575,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,0.3323782235,,,0.088,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss",,,,,,,,0.2080924855,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,0.3278688525,,,0.213836478,,,,,
  4 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.1492537313,0.3986013986,,,0.2642857143,,,,,0.3114754098
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.09433962264,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,,0.3076923077,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3469387755,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2189349112,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,0.3879003559,,,0.1212121212,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,,0.3305084746,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,,0.2690763052,,,0.0987654321,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss",,,,,,,,0.2085889571,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.1386138614,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.6326086957,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.6078431373,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01550387597,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",,,,,,,,0.4390243902,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss",,,,,,,,0.6298342541,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1353658537,,,0.08098591549,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | LAMOTRIGINE | Last AD: Same & No Remiss,,,,,,,,0.09933774834,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,0.08379888268,,,0.07843137255,,,,,
  10 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.03416557162,0.4309623431,,,0.4708994709,0.177184466,,0.1047619048,,0.3228271251,0.4480519481,,0.4986666667,0.0206185567,0.4464285714
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.5259067358,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6929824561,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5903954802,,,,,,,0.01530612245,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6699029126,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3760683761,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5695067265,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.580493537,,,,0.02005730659,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4150943396,,,,,0.7033898305
  8 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.06352941176,0.698630137,,,0.4784946237,0.3037974684,,,,0.4522522523,,,0.5947712418,0.06857142857,0.6402116402
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.5166666667,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.587628866,,,,,,,0.02298850575,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5048543689,,,,,
  3 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,0.5894988067,,,0.5866666667,,,,0.03695652174,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3858024691,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.4275132275,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.54375,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.2113821138,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.3006134969,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,0.4375,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | SILDENAFIL CITRATE,,,,,,,,0.4285714286,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | SIMVASTATIN,,,,,,,,0.4632034632,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,0.3373493976,,,0.4353233831,,,,0.01030927835,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.7210710128,,,0.5299145299,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,0.5825688073,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,0.8333333333,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,,0.8391608392,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6517857143,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | SILDENAFIL CITRATE,,,,,,,,0.7264150943,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | SIMVASTATIN,,,,,,,,0.8060606061,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6206225681,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | LITHIUM CARBONATE,,,,,,,,0.1715976331,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,0.7001897533,,,0.7037037037,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.7913669065,,,,,,,,
  4 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.4615384615,,,,,0.536,0.6721883173,,,0.5987525988,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.7777777778,,,,,,,,
  3 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,0.6153846154,,,0.5071428571,,,,0.19,
  3 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.4926004228,0.2090909091,,0.3355978261,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.310483871,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | MYOPIA (dxo:ICD9:3671),,,,,,,,0.7037037037,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,0.6008230453,,0.1459459459,0.4679487179,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6923076923,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5907172996,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,,0.6699029126,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Num Previous Remissions: 2+,,,,,,,,0.8113207547,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,0.5677966102,,,0.5135135135,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.1740740741,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,0.8139534884,,,0.4954954955,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | OMEPRAZOLE,,,,,,,,,,,0.4537037037,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.6616541353,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | PAROXETINE HCL,,0.03149606299,,,,,,0.5361305361,,,0.2668810289,0.5418994413,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.2900763359,,,,,
  3 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.3408833522,,,0.1214574899,,,,,0.2047244094
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1038961039,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,0.2581967213,,,0.1904761905,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,0.5581395349,,,0.4628099174,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,,0.5544554455,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,0.5371900826,,,0.1440443213,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,0.2978723404,,,0.1183431953,,,,,
  1 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.2016129032,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.3779527559,,,0.1794871795,,,,,
  2 ,"Age: 41-64 | Gender: Male | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,0.3359375,,,0.3153846154,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | RISPERIDONE,,,,,,,,0.09448818898,,,0.09502262443,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1437125749,,,,,
  3 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,0.5327510917,,,0.4806378132,,0.4097222222,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3277310924,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | ROSUVASTATIN CALCIUM,,,,,,,,0.7142857143,,,,,,,,
  6 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | SERTRALINE HCL,,0.0641025641,0.3582089552,,,,0.2080536913,0.4815229563,,,0.2721238938,,,0.5077910174,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,0.4191176471,,,0.3701657459,,,,,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | SILDENAFIL CITRATE,,,,,,,,0.6639344262,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.7730923695,,,0.4564102564,,,,,
  7 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | TRAZODONE HCL,,0.03225806452,,,,0.2788461538,0.152173913,0.4449528937,,,0.4170021312,,,0.3039215686,0.02378190255,
  2 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3461538462,,,,0.01960784314,
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,0.7011494253,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | VENLAFAXINE HCL,,0.01680672269,,,,,,0.537037037,,,0.3143669986,,,0.4035087719,,0.6538461538
  1 ,Age: 41-64 | Gender: Male | FLUOXETINE HCL | ZOLPIDEM TARTRATE,,,,,,,,0.6704545455,,,,,,,,
  10 ,Age: 41-64 | Gender: Male | GABAPENTIN,0.01015228426,0.01851851852,0.4531835206,,,0.3453422542,0.1583476764,0.4940397351,,0.05735660848,0.2463054187,0.398089172,,0.4927344782,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | HYDROCODONE/ACETAMINOPHEN,,,,,,0.3758865248,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2764227642,,,,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4953271028,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.6896551724,,
  2 ,Age: 41-64 | Gender: Male | GABAPENTIN | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03333333333,,,,,0.1846153846,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1883116883,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | GABAPENTIN | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.3465346535,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | GABAPENTIN | PAROXETINE HCL,,,,,,,,,,,0.362745098,0.7247191011,,,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | PREGABALIN,,,,,,0.3816254417,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | GABAPENTIN | SERTRALINE HCL,,,,,,,,,,,0.4805194805,,,0.6971428571,,
  2 ,Age: 41-64 | Gender: Male | GABAPENTIN | SIMVASTATIN,,,0.5,,,,,,,,,,,0.6428571429,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | TRAMADOL HCL,,,,,,0.3359683794,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | TRAZODONE HCL,,,,,,,,,,,0.3407407407,,,,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),,,,,,0.3531914894,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3461538462,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GABAPENTIN | VENLAFAXINE HCL,,,,,,,,,,,0.4188034188,,,,,
  3 ,Age: 41-64 | Gender: Male | GEMFIBROZIL,,,0.5729537367,,,,,,,,,0.4937759336,,0.5853658537,,
  1 ,Age: 41-64 | Gender: Male | GEMFIBROZIL | PAROXETINE HCL,,,,,,,,,,,,0.7333333333,,,,
  1 ,Age: 41-64 | Gender: Male | GEMFIBROZIL | SERTRALINE HCL,,,,,,,,,,,,,,0.7739130435,,
  5 ,Age: 41-64 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),0.009803921569,0.0455075846,,,,,0.1618625277,0.4186046512,,,,,,0.6060606061,,
  1 ,Age: 41-64 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03787878788,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.01785714286,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | SERTRALINE HCL,,,,,,,,,,,,,,0.731092437,,
  2 ,Age: 41-64 | Gender: Male | GUAIFENESIN/P-EPHED HCL,,,0.4018691589,,,,0.1877394636,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GUAIFENESIN/PHENYLEPHRINE HCL,,,,,,,0.1554878049,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | GUAIFENESIN/PSEUDOEPHEDRNE HCL,,,,,,,,,,,,0.4071428571,,,,
  1 ,Age: 41-64 | Gender: Male | GUAIFENESIN/PSEUDOEPHEDRNE HCL | PAROXETINE HCL,,,,,,,,,,,,0.5968992248,,,,
  4 ,Age: 41-64 | Gender: Male | HEADACHE (dxo:ICD9:7840),0.01683501684,0.04214559387,,,,,,0.5461538462,,0.06240126382,,,,,,
  1 ,Age: 41-64 | Gender: Male | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.04166666667,,,,,,
  2 ,"Age: 41-64 | Gender: Male | HEADACHE (dxo:ICD9:7840) | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.02325581395,,,,,,,,,0.07619047619,,,,,,
  1 ,Age: 41-64 | Gender: Male | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL,,,,,,,,,,0.1712707182,,,,,,
  1 ,Age: 41-64 | Gender: Male | HEADACHE (dxo:ICD9:7840) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.009523809524,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | HEADACHE (dxo:ICD9:7840) | OXYCODONE HCL,0.03100775194,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | HEADACHE (dxo:ICD9:7840) | TRAZODONE HCL,0.01754385965,,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | HEMATURIA (dxo:ICD9:5997),,,0.4278074866,,,,,,,,,0.4,,,,
  1 ,Age: 41-64 | Gender: Male | HERPES ZOSTER WITHOUT MENTION OF COMPLICATION (dxo:ICD9:0539),0.006289308176,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364),,,,,,,,,,,,,,,0.005882352941,
  1 ,Age: 41-64 | Gender: Male | HYDRALAZINE HCL,,,,,,,,,,,,,,0.4855769231,,
  11 ,Age: 41-64 | Gender: Male | HYDROCODONE/ACETAMINOPHEN,0.01477104874,0.04567307692,,,,0.3460365854,0.1689373297,0.4900990099,,0.0990990991,0.2526539278,0.4162895928,0.2802197802,0.5275482094,0.01590457256,
  1 ,Age: 41-64 | Gender: Male | HYDROCODONE/ACETAMINOPHEN | LUMBAGO (dxo:ICD9:7242),,,,,,0.2994011976,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | HYDROCODONE/ACETAMINOPHEN | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.3703703704,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | HYDROCODONE/ACETAMINOPHEN | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,,0.02027027027,
  1 ,Age: 41-64 | Gender: Male | HYDROCODONE/ACETAMINOPHEN | SERTRALINE HCL,,,,,,,,,,,,,,0.7154811715,,
  2 ,Age: 41-64 | Gender: Male | HYDROCODONE/HOMATROPINE,,,0.4747474747,,,,0.1588785047,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | HYDROXYZINE HCL,,,,,0.1648351648,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | HYOSCYAMINE SULFATE,0.01960784314,,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | HYPERSOMNIA WITH SLEEP APNEA, UNSPECIFIED (dxo:ICD9:78053)",,,,,,,,,,,,,0.2987804878,0.6349206349,,
  3 ,Age: 41-64 | Gender: Male | IBUPROFEN,,,0.4151785714,,,,,,,,,,,0.4775280899,0.009900990099,
  1 ,Age: 41-64 | Gender: Male | IBUPROFEN | SERTRALINE HCL,,,,,,,,,,,,,,0.6847826087,,
  1 ,Age: 41-64 | Gender: Male | IMIPRAMINE HCL,,,,,,,,,,,0.2410501193,,,,,
  1 ,Age: 41-64 | Gender: Male | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.096,,,,,
  2 ,Age: 41-64 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784),,0.03711790393,,,,,,,,,,,,0.4847094801,,
  1 ,Age: 41-64 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8071428571,,
  1 ,Age: 41-64 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01492537313,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02542372881,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,,,,,,,,,,,,,0.4552238806,,
  1 ,Age: 41-64 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | SERTRALINE HCL,,,,,,,,,,,,,,0.708994709,,
  2 ,Age: 41-64 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | SILDENAFIL CITRATE,,0.03448275862,,,,,,,,,,,,0.4088888889,,
  1 ,Age: 41-64 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | TADALAFIL,,0.02339181287,,,,,,,,,,,,,,
  11 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,0.0372960373,0.2197802198,0.1778846154,,0.1285714286,0.1015625,0.1605504587,,,0.1662971175,0.1420765027,,0.1671087533,0.04377104377,0.2093023256
  4 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,0.09259259259,0.07106598985,,,,,,,0.1018518519,,0.1353383459
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.07432432432,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2301587302,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.2354948805,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01388888889,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2463768116
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | MIRTAZAPINE",,,,,,,,,,,0.1157024793,,,,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PAROXETINE HCL",,,,,,,,,,,0.1593406593,0.3666666667,,,,
  6 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.05714285714,0.1603773585,,,0.145631068,,,,,0.09243697479,,,,0.02307692308,0.103030303
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.3305785124,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2091503268
  4 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,0.141509434,,,0.06770833333,,,,0.1386138614,,,0.1467889908,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1496062992,,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1,,,,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL",,,,,,,,,,,0.141025641,,,0.3844621514,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1747572816,,,0.2467532468,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL",,,,,,,,,,,0.1151832461,,,,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1857142857,,,,,0.3136094675
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,0.1462450593,,,,,0.3048245614
  11 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2066772655,0.3603603604,0.1086956522,0.2180451128,0.07598212185,0.2166910688,,,0.1401425178,0.1928571429,,0.2138945927,0.02065613609,0.2564102564
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,,,,,0.06578947368,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.009523809524,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PAROXETINE HCL",,,,,,,0.09523809524,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1377245509,,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1118012422,,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,0.1176470588,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2390670554,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,0.2654320988,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1692307692,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,,,,0.2809667674,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.2950075643,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.009523809524,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3092783505
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,,,,0.1428571429,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.6136363636,,,,,,,,,
  5 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL",,,0.2781954887,,,,0.08823529412,,,,0.132231405,0.411420205,,0.2429906542,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.2056737589,,,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1005586592,0.4296875,,,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.2549019608,,,,
  6 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.1333333333,,,0.1015228426,,0.1333333333,,,,0.1119402985,,0.1293532338,,0.1476923077
  5 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.06666666667,,,0.08490566038,0.05371900826,,,,,,,0.1088435374,,0.1258278146
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.09649122807,,,0.2110091743,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.1909090909,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.1826923077,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1968911917
  10 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.1849529781,0.2806122449,,0.2040816327,0.06754148977,0.1890547264,,,0.1147260274,0.1607981221,,0.1908690869,0.0119047619,0.220705347
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.1506849315,,,0.4429530201,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3852459016,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.12,,,,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1730769231,,,,,0.4454976303
  6 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,0.2335766423,,,0.2285714286,0.14,,,,0.1791907514,,,0.4424357755,,0.3045977011
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.3883495146,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL",,,,,,,,,,,0.1489361702,,,,0,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3571428571
  3 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,0.08441558442,,,,0.2323943662,,,,,0.4339622642
  10 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807)",,,0.1471389646,0.1533333333,,0.1386138614,0.06782608696,0.1264822134,,,0.1183800623,0.1569767442,,0.1657142857,0.02127659574,0.1964285714
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.174863388,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PAROXETINE HCL",,,,,,,,,,,0.09322033898,0.28125,,,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,0.08152173913,,,,,,,0.12,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL",,,,,,,,,,,0.0725388601,,,0.261589404,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1272727273,,,0.2019230769,,
  1 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | TRAZODONE HCL",,,,,,,,,,,0.1287878788,,,,,
  2 ,"Age: 41-64 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90807) | VENLAFAXINE HCL",,,,,,,,,,,0.1276595745,,,,,0.2159090909
  10 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",0.02222222222,0.02521008403,0.4350828729,,0.1707317073,,0.1494252874,0.4920792079,0.2317380353,,,0.4484304933,,0.5025510204,0.01136644428,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,,0.01869158879,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.01785714286,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0.004291845494,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.4043715847,,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.006641366224,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.6889952153,,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,,,,,,,,0.4901960784,,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.01886792453,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,,0.007751937984,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,,,,,,,,,,,,,,0.006097560976,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.6876267748,,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.009259259259,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SIMVASTATIN",,,,,,,,,,,,,,0.5460526316,,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TEMAZEPAM",,,,,,,,,,,,,,,0.009708737864,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.02592592593,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.009900990099,
  1 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",,,,,,,,,,,,,,,0.01960784314,
  3 ,"Age: 41-64 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,0.5403225806,,,,,,0.5362318841,0.009696969697,
  1 ,Age: 41-64 | Gender: Male | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641),0.01612903226,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | LABORATORY EXAMINATION (dxo:ICD9:V726),,,0.4697986577,,,,,,,,0.2118644068,0.4454976303,,,,
  1 ,Age: 41-64 | Gender: Male | LABORATORY EXAMINATION (dxo:ICD9:V726) | PAROXETINE HCL,,,,,,,,,,,,0.5882352941,,,,
  2 ,Age: 41-64 | Gender: Male | LACTULOSE,,,0.373015873,,,,0.1466666667,,,,,,,,,
  12 ,Age: 41-64 | Gender: Male | LAMOTRIGINE,,,0.1376262626,0.1125,,0.1248618785,0.07142857143,0.1343283582,0.04929577465,,0.08824940048,0.12,0.06542056075,0.1410437236,0.01769911504,0.1582633053
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.1161616162,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1158536585
  1 ,"Age: 41-64 | Gender: Male | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.5779816514,,,,,
  1 ,"Age: 41-64 | Gender: Male | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.3973799127,,,,,
  1 ,"Age: 41-64 | Gender: Male | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3342939481,,,,,
  1 ,"Age: 41-64 | Gender: Male | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4660194175
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.09844559585,,,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.1164658635,,,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.04761904762,,,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.06349206349,,,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.07954545455,,,,,
  2 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | PAROXETINE HCL,,,,,,,,,,,0.04672897196,0.2222222222,,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.132231405,,,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.125,,,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | RISPERIDONE,,,,,,,,,,,0.095,,,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.04242424242,,,,,
  2 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | ROPINIROLE HCL,,,,,,,,,,,0.1136363636,,0.1883116883,,,
  1 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.09090909091,,,,,
  2 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,0.08243727599,,,0.158008658,,
  2 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.09433962264,,,0.1455696203,,
  2 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | TRAZODONE HCL,,,,,,0.08910891089,,,,,0.09000793021,,,,,
  2 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.07647058824,,,,,0.1198156682
  2 ,Age: 41-64 | Gender: Male | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.1051724138,,,,,0.1683937824
  1 ,Age: 41-64 | Gender: Male | LANSOPRAZOLE,,0.04166666667,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss,,0.03846153846,,,,,,,,,,,,,0.004804392588,
  5 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.004807692308,,,,,0.16,,,,0.2756097561,,,0.42,0,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.69,,
  2 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.252173913,,0.5267175573,,,,,
  3 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.2658227848,,0.296969697,,,,0.008771929825,
  2 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,0.31,,0.4608695652,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.0303030303,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | TRAZODONE HCL,,0.04347826087,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,0.02830188679,,,,0.347107438,,,,,0.2751677852,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.4946619217,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6162790698,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5461538462
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.7570093458,,
  2 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6772908367,,,0.007633587786,
  2 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6434343434,0.01255230126,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.7852348993,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7603305785
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4676923077,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.3190184049,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5591397849,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2883895131,,,,,
  2 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5057471264,,,,,0.5261044177
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | TRAZODONE HCL,,,,,,,,,,,0.3006993007,,,,,
  11 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | PAROXETINE HCL,0,0.01437699681,0.4779874214,,,0.35,0.1578947368,0.4534412955,0.1007751938,,0.2907239819,,,0.4966139955,0.01714285714,0.5543859649
  2 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5201342282,,,,0.01149425287,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.04587155963,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.1226415094,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.168,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.1445783133,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1171875,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.4705882353,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.4055944056,,,,,
  11 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL,0.0119047619,0.02455871067,0.4007858546,,,0.3801916933,0.1573770492,0.4689119171,0.1135135135,,0.3254658385,0.3461538462,,,0.01499250375,0.4808988764
  3 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,0.01694915254,,,,,,,,,0.5578231293,,,,0.01923076923,
  2 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4135338346,,,,,0.6228070175
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.2910447761,,,,,
  12 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | TRAZODONE HCL,0.01941747573,0.02985074627,0.4081081081,,,0.2217898833,0.118902439,0.3622641509,0.1153846154,,0.3052754073,0.3222748815,,0.4365591398,0.01642335766,0.3819444444
  3 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5637065637,,,,0.01479915433,0.6379928315
  8 ,Age: 41-64 | Gender: Male | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.02572898799,0.4743589744,,,0.3888888889,0.2026143791,0.4179104478,,,0.3187919463,,,0.5454545455,0.02205882353,
  6 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss,,0.1031468531,,0.75,,0.5486725664,,,0.3897280967,,,,,,0.08385370205,0.6838709677
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,,,,,0.544,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,,,,,0.48,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.7037037037,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,0.6422764228,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.4577114428,
  2 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | MIRTAZAPINE,,,,,,,,,0.4570815451,,0.5113636364,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6054421769,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.7142857143,,,,
  2 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6554455446,0.02127659574,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.01785714286,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3816793893,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,0.5392156863,,,,,
  9 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | PAROXETINE HCL,,0.05821917808,0.641025641,,,0.487394958,0.2441860465,0.5606060606,,,0.3601953602,,,0.66,0.1408450704,0.6725146199
  3 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4610778443,0.6756756757,,,0.04705882353,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5477707006,,,,,
  11 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL,0.03738317757,0.07066052227,0.5854700855,,,0.5158730159,0.2588726514,0.579787234,0.3111111111,,0.4277456647,0.5064935065,,,0.05952380952,0.7166123779
  3 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5,,,0.65917603,0.04975922953,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4036697248,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.05309734513,
  3 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4615384615,,,,0.07278481013,0.6507936508
  9 ,Age: 41-64 | Gender: Male | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.07284768212,0.6261682243,,,0.5167785235,0.2352941176,0.5826771654,,,0.4231292517,,,0.637037037,0.1171171171,0.7142857143
  2 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss,,,,,,,,0.0564516129,,,0.1398026316,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.4421768707,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.1009174312,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1608430394,,,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,,,,,,,,,,,,,0.4455445545,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.06190885641,,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.1473214286,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.3496932515,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.408,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4016351559,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,,,,0.2897196262,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.4285714286,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4734299517,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,,,,,0.002735978112,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4244897959
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.5099009901,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | PAROXETINE HCL,,,,,,,,,,,,0.427184466,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SERTRALINE HCL,,,,,,,,,,,,,,0.4977973568,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5714285714,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.3365352208,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.2138554217,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,,0.3177570093,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,0.2325581395,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,0.3039215686,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,,0.2900763359,,,,
  3 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3518518519,0.3362831858,,,0,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742) | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.09923664122,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2452471483,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1559633028,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01647058824,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.1780487805
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4221453287,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4347826087,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.3916083916,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,,,,0.3432835821,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,,,,0.2767857143,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.3206650831,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.2283464567
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.2394957983,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,,,,0.1083333333,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,,,0.2382397572,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.3846153846,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  2 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.3944954128,,,0.3991931701,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,,,,0.3853211009,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.4928909953,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,,,,,,,,,,,,0.4818181818,,
  3 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4052173913,,,0.3823529412,0.01045296167,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.4166666667,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | TRAMADOL HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.005376344086,
  2 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2706422018,,,,0.007847996696,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.005882352941,
  3 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3855421687,,,,0.0275862069,0.3355704698
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.003759398496,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3730543506
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss,,,,,,,,,,,0.5820805773,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7783783784,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.7441860465,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.6826347305,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.7441860465,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.6929133858,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6961077844,,,,,
  1 ,"Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7372262774,,,,,
  2 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,0.5801687764,,0.5608974359,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.5369318182,,,,,
  2 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.5641025641,0.61003861,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5294117647,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.8817204301,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.8783783784,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.9074074074
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.6204819277,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.5695876289,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5727272727,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.593220339
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.8769230769,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.8806366048,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.9082568807
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | PAROXETINE HCL,,,,,,,,,,,,0.786163522,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.7714285714,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | PAROXETINE HCL,,,,,,,,,,,,0.8205128205,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SERTRALINE HCL,,,,,,,,,,,,,,0.7630922693,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6222222222,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.7194910353,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PAROXETINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,,0.7264150943,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6575342466,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6168831169,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6595744681,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.6341463415,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.6428571429,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.595505618,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6293706294,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8725490196,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,,,,0.45,,
  2 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6584022039,,0.5983606557,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.7358490566,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5560538117,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6363636364,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8101265823,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.7447085255,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,,,,0.7174515235,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7806191117,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,,,,,,,,,,,,0.7397260274,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6429699842,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.7105263158,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.614976102,,,,,
  1 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6296296296,,,,,
  2 ,Age: 41-64 | Gender: Male | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5875486381,,,,,0.7188073394
  1 ,Age: 41-64 | Gender: Male | LEVOFLOXACIN,,,,,,,0.1592039801,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | LEVOTHYROXINE SODIUM,,,0.5629139073,,,,0.1909090909,0.6273291925,,,0.2962962963,,,0.5427251732,,
  1 ,Age: 41-64 | Gender: Male | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8041237113,,
  2 ,Age: 41-64 | Gender: Male | LISINOPRIL,,,0.4915966387,,,,0.1887755102,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.5486381323,,,,0.1436619718,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | LISINOPRIL/HYDROCHLOROTHIAZIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.47,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | LISINOPRIL/HYDROCHLOROTHIAZIDE | SIMVASTATIN,,,0.5547445255,,,,,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | LITHIUM CARBONATE,,,,,,,,0.1739130435,,,0.09558823529,,,,0.0390625,0.1532846715
  1 ,Age: 41-64 | Gender: Male | LITHIUM CARBONATE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1409395973
  3 ,Age: 41-64 | Gender: Male | LORATADINE,,,0.5847953216,,,,0.1349206349,,,,,0.4410480349,,,,
  1 ,Age: 41-64 | Gender: Male | LORATADINE | PAROXETINE HCL,,,,,,,,,,,,0.6836734694,,,,
  5 ,Age: 41-64 | Gender: Male | LORAZEPAM,0.004566210046,0.0527638191,0.4208144796,,,,,0.4899328859,,,,,,0.5011820331,,
  1 ,Age: 41-64 | Gender: Male | LORAZEPAM | SERTRALINE HCL,,,,,,,,,,,,,,0.7191780822,,
  7 ,Age: 41-64 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321),,0.04390243902,0.4199475066,,,,,0.4777777778,0.1708967851,,,0.3333333333,,0.4208333333,,0.5412844037
  1 ,Age: 41-64 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.248,,,,,,,
  4 ,Age: 41-64 | Gender: Male | LOVASTATIN,0.008196721311,,0.562642369,,,,0.1798941799,0.4907407407,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | LUMBAGO (dxo:ICD9:7242),0.007407407407,,,,,0.320855615,,,,,,,,,0,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.5191986644,,,,,,,,,0.6878283713,,,,,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.6962025316,,,,,,,,,0.7569832402,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7509025271,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.6261682243,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.672823219,,,,,
  10 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.557844691,0.663507109,,,0.6418918919,0.587020649,0.6470588235,0.5517241379,,0.6649484536,,,0.692,0.472168906,0.6516853933
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.6779661017,,,,,,,,,0.7056074766,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6106870229,,,,,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE",,,,,,,,,0.5955555556,,0.6391304348,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.5904761905,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.648,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | ROPINIROLE HCL",,,,,,,,,,,0.6733668342,,,,,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,0.7154471545,,,0.7232289951,,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6381987578,,,,0.4375,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,0.6573033708,,,,,0.7361376673
  4 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.5390070922,,,,,0.6071428571,,,0.3010204082,,,0.522875817,,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2,,,,,,,,,,,0.1570247934,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,,,,0.7549019608,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",,,,,,,,,,,0.3148148148,,,,,
  15 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2803738318,0.4313684211,0.634551495,0.6177370031,0.3739130435,0.5735042735,0.5061804697,0.6264367816,0.4616724739,0.4225352113,0.5480225989,0.5897435897,,0.6010544815,0.2869995502,0.6354895105
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.5145797599,,0.528379773,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.3885714286,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.5184381779,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | VENLAFAXINE HCL",,,,,,,,,,,0.462962963,,,,,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | NORTRIPTYLINE HCL",,,,,,,,,,0.503875969,0.5983263598,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4090909091,,,,,
  3 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,0.4915254237,,,,,,,,,0.5445026178,0.6257961783,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6893939394,,,,
  3 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,0.6095238095,,,,,,,,,0.6055045872,,,,,0.6726190476
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.7785714286,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7606382979
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.5502008032,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL | TRAZODONE HCL",,,,,,,,,,,0.3909090909,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | RISPERIDONE",,,,,,,,,,,0.480620155,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.4756554307,,,,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.5031446541,,,,,
  5 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.4638554217,,,,,0.4296296296,0.5666666667,,,0.5913242009,,,0.6981865285,,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.5463917526,,,0.587628866,,
  4 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.4251968504,,,,,,,,,0.5114305916,,,,0.2807525326,0.5607476636
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.5709876543,,,,,0.5836065574
  3 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,0.5714285714,,,,,,,,,0.6073781291,,,,,0.6544776119
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",,0.04861111111,,,,,,,,,,,,0.5892857143,,
  1 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.07920792079,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",,0.0625,,,,,,,,,,,,,,0.6377952756
  1 ,Age: 41-64 | Gender: Male | MELOXICAM,,,,,,0.3067729084,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | METAXALONE,,,0.485106383,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | METFORMIN HCL,,,,,,,,,,,,0.4907407407,,0.5870646766,,
  1 ,Age: 41-64 | Gender: Male | METFORMIN HCL | PAROXETINE HCL,,,,,,,,,,,,0.7441860465,,,,
  1 ,Age: 41-64 | Gender: Male | METFORMIN HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.7087378641,,
  1 ,Age: 41-64 | Gender: Male | METHYLPHENIDATE HCL,,0.0612244898,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | METOPROLOL SUCCINATE,,,,,,,0.1538461538,0.5797101449,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | METOPROLOL TARTRATE,,0.04310344828,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | METRONIDAZOLE,,,,,,,,,,,,,,0.5037037037,,
  3 ,"Age: 41-64 | Gender: Male | MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",0.01025641026,,,,,,0.2450980392,,,0.06802721088,,,,,,
  12 ,Age: 41-64 | Gender: Male | MIRTAZAPINE,0.02083333333,0.01230769231,0.2884615385,,,0.2888888889,0.1628440367,0.2727272727,0.2916188289,,0.3079200592,0.253968254,,0.3434650456,0.01379310345,0.3444976077
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.2408163265,,,,,
  1 ,"Age: 41-64 | Gender: Male | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6724137931,,
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.1836065574,,,,,
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2206060606,,,,,
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1581196581,,,,,
  3 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,0.2752808989,,0.3156498674,0.46105919,,,,
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3205128205,,,,,
  2 ,"Age: 41-64 | Gender: Male | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,0.1721311475,,0.096,,,,,
  1 ,"Age: 41-64 | Gender: Male | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.09090909091,,,,,
  2 ,"Age: 41-64 | Gender: Male | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1374045802,,,,,0.2427184466
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4078014184,,,,,
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.185840708,,,,,
  1 ,"Age: 41-64 | Gender: Male | MIRTAZAPINE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1538461538,,,,,
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.07975460123,,,,,
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1176470588,,,,,
  2 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,0.2627118644,,0.3464788732,,,,,
  3 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.2207792208,,0.336461126,,,0.4976958525,,
  2 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3646209386,,,0.4903846154,,
  2 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.2647058824,,0.2902578797,,,,,
  1 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2488479263,,,,,
  3 ,Age: 41-64 | Gender: Male | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,0.2530487805,,0.2885572139,,,,,0.5545722714
  1 ,Age: 41-64 | Gender: Male | MITRAL VALVE DISORDERS (dxo:ICD9:4240),,,,,,,0.1343283582,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | MIXED HYPERLIPIDEMIA (dxo:ICD9:2722),0.0350877193,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | MODAFINIL,,0.05384615385,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | MONTELUKAST SODIUM,,,0.4968553459,,,,,,,,0.2061068702,,,,,
  2 ,Age: 41-64 | Gender: Male | MORBID OBESITY (dxo:ICD9:27801),,0.05161290323,,,,,0.1505102041,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | MORBID OBESITY (dxo:ICD9:27801) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.2159090909,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | MORPHINE SULFATE,0.01814058957,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | MORPHINE SULFATE | OXYCODONE HCL,0.01418439716,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | MOXIFLOXACIN HCL,,,,,,,0.131147541,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | MULTIPLE SCLEROSIS (dxo:ICD9:340),,,,,,,0.2083333333,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | MYOPIA (dxo:ICD9:3671),,0.05140186916,0.5536912752,,,,0.1703296703,0.5971563981,,,,,,0.509375,,
  1 ,Age: 41-64 | Gender: Male | MYOPIA (dxo:ICD9:3671) | SERTRALINE HCL,,,,,,,,,,,,,,0.7315436242,,
  2 ,Age: 41-64 | Gender: Male | NAPROXEN,0.005291005291,,,,,,,,,,,,,0.5752212389,,
  1 ,Age: 41-64 | Gender: Male | NAPROXEN | SERTRALINE HCL,,,,,,,,,,,,,,0.7297297297,,
  1 ,Age: 41-64 | Gender: Male | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382),,0.04391891892,,,,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)",,,,,,,,,,,,0.4666666667,,,,
  3 ,"Age: 41-64 | Gender: Male | NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",,,0.4375,,,,,0.4430379747,,,,,,,0.01226993865,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxi:ICD9:3051),,,,,,,,,,,,,,,0.01030927835,
  6 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02290851095,,,,,0.1607335491,0.5158730159,0.1788617886,,,,,0.4947589099,0.01398601399,
  1 ,"Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.045,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1928571429,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.007843137255,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.01608579088,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,0.01709401709,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.01498127341,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SERTRALINE HCL,,0.03472222222,,,,,,,,,,,,0.7192982456,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | SILDENAFIL CITRATE,,0.01875,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | TADALAFIL,,0.01515151515,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.01886792453,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | VARENICLINE TARTRATE,,0.02040816327,,,,,,,,,,,,,,
  11 ,Age: 41-64 | Gender: Male | NORTRIPTYLINE HCL,0.005524861878,0.02395209581,0.3981042654,,,0.3818897638,0.1398963731,0.3504273504,,0.1743304699,0.3864848844,0.3644859813,,0.397260274,,0.352
  1 ,Age: 41-64 | Gender: Male | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.308411215,,,,,
  2 ,Age: 41-64 | Gender: Male | NORTRIPTYLINE HCL | PAROXETINE HCL,,,,,,,,,,,0.4775280899,0.4844720497,,,,
  1 ,Age: 41-64 | Gender: Male | NORTRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.448,,,,,
  1 ,Age: 41-64 | Gender: Male | NORTRIPTYLINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.4230769231,,,,,
  3 ,Age: 41-64 | Gender: Male | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,0.1753554502,0.4495114007,,,0.6115942029,,
  2 ,Age: 41-64 | Gender: Male | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,0.2196969697,0.3094660194,,,,,
  2 ,Age: 41-64 | Gender: Male | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3682310469,,,,,0.6802721088
  1 ,"Age: 41-64 | Gender: Male | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.4983606557,,,,
  1 ,"Age: 41-64 | Gender: Male | Num Previous Antidep: 2,3 | PAROXETINE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.744,,
  1 ,"Age: 41-64 | Gender: Male | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6666666667,,,,
  1 ,"Age: 41-64 | Gender: Male | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6373626374,,
  1 ,"Age: 41-64 | Gender: Male | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.7743902439,,
  2 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+,,,,,,,,,,,0.1963302752,0.3133333333,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.3709677419,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.31,,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.37,,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3551912568,,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.3918918919,,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3225806452,,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.3515981735,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2149817296,,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1576763485,,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.4936305732,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.8640776699,,,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.8756345178,,
  2 ,Age: 41-64 | Gender: Male | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5533980583,,,0.7297297297,,
  1 ,Age: 41-64 | Gender: Male | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.5454545455
  1 ,Age: 41-64 | Gender: Male | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.8851351351
  2 ,"Age: 41-64 | Gender: Male | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.04859335038,,,,,,,0.2248803828,,,,,,,
  2 ,Age: 41-64 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,0.05511811024,,,,,,,,,0.1701492537,,,,,
  1 ,Age: 41-64 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PAROXETINE HCL,,,,,,,,,,,0.2142857143,,,,,
  1 ,"Age: 41-64 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1111111111,,,,,
  1 ,Age: 41-64 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | SERTRALINE HCL,,,,,,,,,,,0.1955555556,,,,,
  1 ,Age: 41-64 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | TRAZODONE HCL,,,,,,,,,,,0.1709401709,,,,,
  1 ,Age: 41-64 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003) | VENLAFAXINE HCL,,,,,,,,,,,0.07,,,,,
  11 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),0.008620689655,,0.5497728211,,,,0.1866458415,0.5628571429,0.1879194631,,0.3442622951,0.5058139535,0.2994923858,0.5715408805,0.006153846154,0.5680473373
  1 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | OMEPRAZOLE,,,,,,,0.1724137931,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,,,,,,0.1962616822,,,,,,,0.5960264901,,
  2 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | PAROXETINE HCL,,,,,,,,,,,0.4631578947,0.7452574526,,,,
  2 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,0.5221518987,,,0.7566063978,,
  1 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8323353293,,
  3 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SIMVASTATIN,,,0.5555555556,,,,0.2314814815,,,,,,,0.6507177033,,
  1 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | TRAZODONE HCL,,,,,,,,,,,0.323943662,,,,,
  2 ,Age: 41-64 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | VENLAFAXINE HCL,,,,,,,,,,,0.5088495575,,,,,0.796875
  1 ,Age: 41-64 | Gender: Male | OLMESARTAN MEDOXOMIL,,,,,,,0.1513859275,,,,,,,,,
  4 ,Age: 41-64 | Gender: Male | OMEPRAZOLE,,0.04861111111,,,,,0.1240951396,0.5433526012,,,0.2546419098,,,,,
  1 ,Age: 41-64 | Gender: Male | OMEPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.465648855,,,,,
  1 ,"Age: 41-64 | Gender: Male | OPIOID TYPE DEPENDENCE, UNSPECIFIED (dxo:ICD9:30400)",,,,,,,,,,,,,,,0.01764705882,
  2 ,Age: 41-64 | Gender: Male | OSELTAMIVIR PHOSPHATE,,,,,,,0.1165048544,,,,,0.3947368421,,,,
  1 ,"Age: 41-64 | Gender: Male | OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE, UNSPECIFIED DRUNKENNESS (dxi:ICD9:30390)",,,,,,,,,,,0.1871657754,,,,,
  6 ,"Age: 41-64 | Gender: Male | OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30390)",,0.04132231405,0.3450292398,,,,0.1574074074,,,,0.2719298246,,,0.389261745,0.02941176471,
  1 ,Age: 41-64 | Gender: Male | OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689),,0.03571428571,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | OTHER AND UNSPECIFIED HYPERLIPIDEMIA (dxo:ICD9:2724),,,0.5298507463,,,,,0.5257142857,,,,,,0.5269461078,,
  1 ,Age: 41-64 | Gender: Male | OTHER CHRONIC PAIN (dxo:ICD9:33829),,,,,,,,,,,,,,,,0.3884297521
  1 ,Age: 41-64 | Gender: Male | OTHER CONVULSIONS (dxo:ICD9:78039),,0.0375,,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,0.4419642857,,0.3796610169,,,
  1 ,Age: 41-64 | Gender: Male | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,,,0.5017857143,,,
  9 ,Age: 41-64 | Gender: Male | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.03109452736,,0.6326530612,,0.4076576577,0.1412742382,0.4968152866,,,,0.472826087,,0.5657894737,0.01041666667,0.6315789474
  1 ,Age: 41-64 | Gender: Male | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,0.02912621359,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.02173913043,,,,,0.125984252,,,,,,,,0.01,
  1 ,Age: 41-64 | Gender: Male | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3523809524,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999),,,,,,,0.137254902,,,,,,,,,0.5503875969
  1 ,Age: 41-64 | Gender: Male | OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319),,,0.4958677686,,,,,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.02865329513,0.4237288136,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | OTHER SPECIFIED CARDIAC DYSRHYTHMIAS (dxo:ICD9:42789),,,,,,,,,,,,,,,,0.5701754386
  1 ,Age: 41-64 | Gender: Male | OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283),,,0.4659685864,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,0.05263157895,0.4863013699,,,,0.1806930693,,,,,0.3719165085,,0.5364010989,,
  1 ,Age: 41-64 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | PAROXETINE HCL,,,,,,,,,,,,0.6890459364,,,,
  1 ,Age: 41-64 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SERTRALINE HCL,,,,,,,,,,,,,,0.7631887456,,
  1 ,Age: 41-64 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8269230769,,
  1 ,Age: 41-64 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SILDENAFIL CITRATE,,,,,,,,,,,,,,0.4406779661,,
  1 ,Age: 41-64 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SIMVASTATIN,,,,,,,,,,,,,,0.6025641026,,
  4 ,Age: 41-64 | Gender: Male | OXYCODONE HCL,0.02108433735,,,,,,0.1534653465,,,,,0.4010152284,,,0.01769911504,
  3 ,Age: 41-64 | Gender: Male | OXYCODONE HCL/ACETAMINOPHEN,,0,,,,,0.1985294118,,,,,,,,0.009756097561,
  1 ,"Age: 41-64 | Gender: Male | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.3730769231,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.424,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",,,,,,0.380952381,,,,,,,,,,
  7 ,Age: 41-64 | Gender: Male | PALPITATIONS (dxo:ICD9:7851),,,0.4393939394,,,0.3567567568,0.1453104359,0.487804878,,,0.2079207921,0.3810810811,,0.5115384615,,
  1 ,Age: 41-64 | Gender: Male | PALPITATIONS (dxo:ICD9:7851) | PAROXETINE HCL,,,,,,,,,,,,0.6612903226,,,,
  3 ,Age: 41-64 | Gender: Male | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,0.04850746269,,,,,,,,,,0.3976470588,,0.5981308411,,
  1 ,Age: 41-64 | Gender: Male | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PAROXETINE HCL,,,,,,,,,,,,0.711790393,,,,
  2 ,Age: 41-64 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.5589430894,,0.5129310345,,,
  1 ,Age: 41-64 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5322580645,,,,,
  2 ,Age: 41-64 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL,,,,,,,,,,,0.5497835498,,0.6478873239,,,
  1 ,Age: 41-64 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | SERTRALINE HCL,,,,,,,,,,,0.4841269841,,,,,
  16 ,Age: 41-64 | Gender: Male | PAROXETINE HCL,0.01715265866,0.03462709285,0.5030599755,0.6774193548,0.1467889908,0.4247871334,0.2,0.4636290967,0.1335149864,0.05952380952,0.3025477707,0.5405924921,0.2222222222,0.484398977,0.03745318352,0.6600698487
  2 ,"Age: 41-64 | Gender: Male | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1187904968,0.3410958904,,,,
  1 ,"Age: 41-64 | Gender: Male | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,,,,,,,,,0.1090909091,,,,,
  2 ,"Age: 41-64 | Gender: Male | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.2007168459,0.2577777778,,,,
  2 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5193133047,0.5378486056,,,,
  1 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | PRAVASTATIN SODIUM,,,,,,,,,,,,0.6965811966,,,,
  2 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1253731343,0.5174418605,,,,
  2 ,"Age: 41-64 | Gender: Male | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2285714286,0.3943661972,,,,
  1 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | RISPERIDONE,,,,,,,,,,,,0.1176470588,,,,
  3 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5171102662,0.6214689266,0.4583333333,,,
  1 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,0.6568627451,,,,
  6 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | SERTRALINE HCL,,0.04255319149,0.4326923077,,,,0.2403100775,,,,0.2772020725,0.4769230769,,0.5110192837,,
  2 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3488372093,,,0.3861386139,,
  2 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,0.3762376238,0.5971014493,,,,
  2 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | SIMVASTATIN,,,,,,,,,,,0.3894736842,0.7467248908,,,,
  1 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | TADALAFIL,,,,,,,,,,,,0.5968586387,,,,
  5 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | TRAZODONE HCL,,0.03550295858,,,,,0.1067961165,,,,0.4131205674,0.4646988432,,,0.02138690862,
  1 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2941176471,,,,,
  1 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,0.6796116505,,,,
  3 ,Age: 41-64 | Gender: Male | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2567901235,0.5564304462,,,,0.6984924623
  2 ,Age: 41-64 | Gender: Male | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742),,,,,,,,,,,,,,0.4594594595,0.006896551724,
  1 ,Age: 41-64 | Gender: Male | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742) | TRAZODONE HCL,,,,,,,,,,,,,,,0.01869158879,
  13 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",0.03167420814,0.04636920385,0.236673774,0.160944206,,0.1711840228,0.1419354839,0.2101010101,0.1164021164,,0.1302998966,0.1897233202,,0.2053231939,0.02171290712,0.1981200289
  9 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,0.02857142857,0.1959459459,0.1059602649,,0.1666666667,0.109540636,,,,0.1228070175,0.175,,0.1170212766,,0.2119565217
  1 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL",,,,,,,,,,,0.08333333333,,,,,
  1 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL",,,,,,,,,,,0.1360544218,,,,,
  1 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL",,,,,,,,,,,0.1058823529,,,,,
  3 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,0.1363636364,,,,,0.1294117647,,,0.375711575,,
  2 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.19,,,0.2915451895,,
  3 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1502242152,,,,0.02573529412,0.1640625
  2 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1531531532,,,,,0.2386363636
  2 ,"Age: 41-64 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.1247672253,,,,,0.2833186231
  1 ,Age: 41-64 | Gender: Male | POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572),0.01321585903,,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981),,,,,,,,,,,,,,0.3987730061,,
  1 ,Age: 41-64 | Gender: Male | POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981) | SERTRALINE HCL,,,,,,,,,,,,,,0.641509434,,
  8 ,Age: 41-64 | Gender: Male | PRAMIPEXOLE DI-HCL,,0.01459854015,0.4095238095,,,0.328358209,0.1165644172,,,,0.4770929818,,,0.3695652174,0.006535947712,0.358490566
  1 ,Age: 41-64 | Gender: Male | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5754985755,,,,,
  1 ,Age: 41-64 | Gender: Male | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.5727272727,,,,,
  1 ,Age: 41-64 | Gender: Male | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4782608696,,,,,
  1 ,Age: 41-64 | Gender: Male | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3566433566,,,,,
  2 ,Age: 41-64 | Gender: Male | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.53125,,,0.5643340858,,
  2 ,Age: 41-64 | Gender: Male | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3913234005,,,,0.02564102564,
  2 ,Age: 41-64 | Gender: Male | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.475,,,,,0.5113268608
  6 ,Age: 41-64 | Gender: Male | PRAVASTATIN SODIUM,,,0.564738292,,,,0.1694214876,0.5514018692,,,0.336,0.4148148148,,0.5231481481,,
  1 ,Age: 41-64 | Gender: Male | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7753164557,,
  7 ,Age: 41-64 | Gender: Male | PREGABALIN,,0.03255813953,0.4916666667,,,0.3978996499,0.1707317073,0.5063291139,,,,,,0.5464480874,,0.4622641509
  1 ,Age: 41-64 | Gender: Male | PREGABALIN | SERTRALINE HCL,,,,,,,,,,,,,,0.761627907,,
  1 ,Age: 41-64 | Gender: Male | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3950617284,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | PROCHLORPERAZINE MALEATE,,,,,,,,,0.1133333333,,,,,,,
  1 ,Age: 41-64 | Gender: Male | PROMETHAZINE HCL,0.0162601626,,,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | PROPOXYPHENE NAP/ACETAMINOPHEN,0.02314814815,,,,,,,,,,0.1869918699,0.4411764706,,,,
  6 ,Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.2910216718,,,,0.1084337349,0.3019480519,,,0.2057142857,0.2321428571,,0.2782101167,,
  8 ,"Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.214673913,,,0.180952381,0.09285714286,0.2022160665,,,0.1225806452,0.1086956522,,0.2254160363,,0.2027027027
  1 ,"Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,,,,,,,,,,,,0.2195121951,,
  1 ,"Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.4387755102,,
  1 ,Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SERTRALINE HCL,,,,,,,,,,,,,,0.5730994152,,
  5 ,Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792),,,0.325203252,,,,0.08673469388,0.2991452991,,,0.2727272727,,,0.3191489362,,
  13 ,Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),0.02868852459,0.03744292237,0.2315541601,0.2530413625,,0.240234375,0.09100204499,0.2171945701,0.1387434555,,0.1348314607,0.1835883171,,0.2348484848,0.04263565891,0.2466165414
  2 ,Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.1747211896,,,0.5175202156,,
  1 ,Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3492063492,,,,,
  1 ,Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.1481481481,,,,,
  2 ,Age: 41-64 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | VENLAFAXINE HCL,,,,,,,,,,,0.1627118644,,,,,0.4842767296
  9 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,0.2183098592,0.1260504202,,0.08490566038,0.07843137255,0.1677419355,,,0.1445783133,,,0.2361111111,0.01652892562,0.1544715447
  2 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.1410788382,,,0.4301075269,,
  1 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.1935483871,,,,,
  1 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1708333333,,,,,
  1 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.1339285714,,,,,
  2 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | VENLAFAXINE HCL",,,,,,,,,,,0.1324503311,,,,,0.3015873016
  12 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.21069869,0.1826086957,0.02586206897,0.1928104575,0.08724461623,0.212962963,0.0641025641,,0.1516393443,0.142394822,,0.212,0.01230228471,0.2222222222
  3 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.1826923077,,,,0.1018518519,,,,,,,0.206185567,,
  3 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,0.072,,,,0.1725768322,,,0.3733333333,,
  2 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2701421801,,,0.2798353909,,
  2 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1725239617,,,,0.01886792453,
  2 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.2211538462,,,,,0.3391812865
  2 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.1659388646,,,,,0.3526170799
  3 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",,,,,,,0.119047619,,,,0.09821428571,,,0.1666666667,,
  1 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836) | SERTRALINE HCL",,,,,,,,,,,,,,0.2636363636,,
  3 ,"Age: 41-64 | Gender: Male | PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",,,0.2745098039,,,,0.09743589744,,,,,,,0.2176470588,,
  2 ,Age: 41-64 | Gender: Male | RABEPRAZOLE SODIUM,,,,,,,0.1624365482,,,,,,,0.5882352941,,
  3 ,Age: 41-64 | Gender: Male | RAMIPRIL,,,,,,,0.1484375,,,,,,,0.6124567474,,0.5972222222
  1 ,Age: 41-64 | Gender: Male | RAMIPRIL | SERTRALINE HCL,,,,,,,,,,,,,,0.7388059701,,
  1 ,Age: 41-64 | Gender: Male | RANITIDINE HCL,,,,,,,0.1347826087,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,0.5080645161,,,,0.1545454545,,,,0.4375,,0.3033707865,0.4927536232,,
  2 ,Age: 41-64 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5359116022,,0.4899894626,,,
  2 ,Age: 41-64 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5847457627,,0.4672131148,,,
  2 ,Age: 41-64 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.3965517241,,,0.7480916031,,
  7 ,Age: 41-64 | Gender: Male | RISPERIDONE,,,0.1407035176,,,0.1473684211,0.06622516556,0.1074380165,,,0.1154138193,,,0.1950207469,,0.1820895522
  2 ,Age: 41-64 | Gender: Male | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.1333333333,,,0.162962963,,
  2 ,Age: 41-64 | Gender: Male | RISPERIDONE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1418439716,,,0.2279411765,,
  1 ,Age: 41-64 | Gender: Male | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1128871129,,,,,
  2 ,Age: 41-64 | Gender: Male | RISPERIDONE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.07692307692,,,,,0.1982758621
  2 ,Age: 41-64 | Gender: Male | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.1076388889,,,,,0.1856148492
  3 ,Age: 41-64 | Gender: Male | ROFECOXIB,,,0.65,,,,0.1784511785,,,,,0.4777777778,,,,
  11 ,Age: 41-64 | Gender: Male | ROPINIROLE HCL,0.01680672269,0.04219409283,0.3812154696,,,0.3162055336,0.1351351351,0.2972972973,,,0.433998762,,0.4263817928,0.404494382,0.01149425287,0.3333333333
  3 ,Age: 41-64 | Gender: Male | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5328467153,,0.4009009009,0.5606060606,,
  1 ,Age: 41-64 | Gender: Male | ROPINIROLE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4534161491,,,,,
  2 ,Age: 41-64 | Gender: Male | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3514800953,,,,0.02285714286,
  1 ,Age: 41-64 | Gender: Male | ROPINIROLE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3358778626,,,,,
  3 ,Age: 41-64 | Gender: Male | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5050505051,,0.4564102564,,,0.5208845209
  8 ,Age: 41-64 | Gender: Male | ROSUVASTATIN CALCIUM,,,0.4893617021,0.6695652174,,0.48,0.162962963,0.6099585062,,,0.2535211268,,,0.5090361446,0,
  1 ,Age: 41-64 | Gender: Male | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7748344371,,
  7 ,Age: 41-64 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),0,0.03599712023,,,0.1233766234,,0.156641604,,,,,0.4389489954,,0.5220883534,0.01011959522,
  1 ,Age: 41-64 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | SERTRALINE HCL,,,,,,,,,,,,,,0.73,,
  1 ,"Age: 41-64 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",,,,,,,,,,,,,,,0.008,
  1 ,Age: 41-64 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL,,,,,,,,,,,,,,,0.0198019802,
  2 ,Age: 41-64 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.02312138728,,,,,,,,,,,,,0,
  1 ,Age: 41-64 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.01351351351,
  1 ,Age: 41-64 | Gender: Male | SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745),,,0.4615384615,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | SCREENING FOR LIPOID DISORDERS (dxo:ICD9:V7791),,,,,,,,,,,,0.5,,,,
  16 ,Age: 41-64 | Gender: Male | SERTRALINE HCL,0.02553626149,0.04325095057,0.4285213735,0.6328502415,0.1258064516,0.420678337,0.197466468,0.4254215305,0.1551561022,0.1015228426,0.3452186536,0.391634981,0.2573099415,0.5852682739,0.01943699732,0.5964724746
  2 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,0.3801652893,,,0.6926454446,,
  2 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.4872611465,,,0.7860752386,,
  1 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,,,,,,,,,,,,0.7758112094,,
  1 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | TOPIRAMATE,,,,,,,,,,,,,,0.731092437,,
  8 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | TRAZODONE HCL,,0.04980842912,0.2662721893,,,0.3805309735,0.1769911504,0.2763157895,,,0.4204570185,,,0.5030953364,0.01954887218,
  3 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2950310559,,,0.3925233645,0.02777777778,
  1 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.6555891239,,
  6 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | VENLAFAXINE HCL,,0.05813953488,0.359223301,,,,0.2700729927,,,,0.3323657475,,,0.5322580645,,0.6483516484
  1 ,Age: 41-64 | Gender: Male | SERTRALINE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,0.7777777778,,
  7 ,Age: 41-64 | Gender: Male | SILDENAFIL CITRATE,,0.03052631579,0.4637096774,,,,,0.4942528736,,,0.2084063047,0.3636363636,,0.4881012658,,0.4780487805
  2 ,Age: 41-64 | Gender: Male | SILDENAFIL CITRATE | SIMVASTATIN,,,0.431372549,,,,,,,,,,,0.5780346821,,
  1 ,Age: 41-64 | Gender: Male | SILDENAFIL CITRATE | TADALAFIL,,0.02097902098,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | SILDENAFIL CITRATE | TRAZODONE HCL,,,,,,,,,,,0.3925233645,,,,,
  1 ,Age: 41-64 | Gender: Male | SILDENAFIL CITRATE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6991869919
  7 ,Age: 41-64 | Gender: Male | SIMVASTATIN,,0.05351170569,0.5337701613,,,,0.1824267782,0.5387509406,,,0.3339552239,0.4581939799,,0.5850340136,,
  1 ,Age: 41-64 | Gender: Male | SIMVASTATIN | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,,,,,,,,,,,,0.6071428571,,
  1 ,Age: 41-64 | Gender: Male | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.2446043165,,,,,
  1 ,Age: 41-64 | Gender: Male | SIMVASTATIN | VENLAFAXINE HCL,,,,,,,,,,,0.3353293413,,,,,
  1 ,"Age: 41-64 | Gender: Male | SODIUM, POTASSIUM,MAG SULFATES",,,0.45625,,,,,,,,,,,,,
  3 ,Age: 41-64 | Gender: Male | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,0.489539749,,,,,,0.1489361702,,,,,0.5460829493,,
  1 ,"Age: 41-64 | Gender: Male | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",,,,,,,,,,,,,,,0.01140684411,
  1 ,Age: 41-64 | Gender: Male | SUMATRIPTAN SUCCINATE,,,,,,,,,,,0.2627118644,,,,,
  2 ,Age: 41-64 | Gender: Male | TADALAFIL,,0.03256936068,,,,,,,,,,0.3925729443,,,,
  1 ,Age: 41-64 | Gender: Male | TAMSULOSIN HCL,,,,,,,,,,,,0.4956521739,,,,
  2 ,Age: 41-64 | Gender: Male | TEMAZEPAM,,,,,,,,,,,,,,0.4,0.005747126437,
  1 ,Age: 41-64 | Gender: Male | TERBINAFINE HCL,,0.02840909091,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | TESTOSTERONE,,0.01731601732,,,,,,,,,,,,,,
  2 ,"Age: 41-64 | Gender: Male | THORACIC OR LUMBOSACRAL NEURITIS OR RADICULITIS, UNSPECIFIED (dxo:ICD9:7244)",,,0.5,,,,,,,0.05633802817,,,,,,
  2 ,Age: 41-64 | Gender: Male | TIZANIDINE HCL,,,0.5034965035,,,,,0.5188679245,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | TOPIRAMATE,,,,,,,,,,,,,,0.4736842105,,
  7 ,Age: 41-64 | Gender: Male | TRAMADOL HCL,,,,,,0.3461538462,0.171875,0.5041322314,,,,0.4068965517,0.3606557377,0.4402985075,0.007072135785,
  1 ,Age: 41-64 | Gender: Male | TRAMADOL HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.005952380952,
  1 ,Age: 41-64 | Gender: Male | TRAMADOL HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3177570093,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | TRAMADOL HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0,
  2 ,Age: 41-64 | Gender: Male | TRAMADOL HCL/ACETAMINOPHEN,,,0.4337349398,,,0.3925233645,,,,,,,,,,
  16 ,Age: 41-64 | Gender: Male | TRAZODONE HCL,0.02219321149,0.04358237548,0.3474240423,0.4886363636,0.1845238095,0.2763395545,0.128190899,0.2921348315,0.1240544629,0.05531914894,0.3261116894,0.2649434572,0.2352941176,0.3584752636,0.01988574958,0.3067700987
  5 ,Age: 41-64 | Gender: Male | TRAZODONE HCL | VENLAFAXINE HCL,,0.08552631579,,,,,0.1788617886,,,,0.3373599824,,,,0.02342487884,0.4505462061
  1 ,Age: 41-64 | Gender: Male | TRAZODONE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.01257861635,
  1 ,Age: 41-64 | Gender: Male | UNLISTED PSYCHIATRIC SERVICE OR PROCEDURE (px:CPT4:90899),,,,,,,,,,,,,,,0.009523809524,
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089),,,,,,,0.1692307692,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491),,,,,,,0.1468926554,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,0.4528301887,,,,,,,,,,,0.4810126582,,
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690),,0.09615384615,,,,,,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED ESSENTIAL HYPERTENSION (dxi:ICD9:4019),,0.02314814815,,,,,,,,,,,,,,
  5 ,Age: 41-64 | Gender: Male | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,0.02542372881,,,,,,0.6330935252,0.2247706422,,,,,,0.009009009009,0.5158730159
  4 ,Age: 41-64 | Gender: Male | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),0.007142857143,,,,,0.4317180617,,,,0.07317073171,,,,0.5480769231,,
  10 ,Age: 41-64 | Gender: Male | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.006451612903,0.02590673575,0.4590163934,,,0.3611751152,0.1455223881,0.4589235127,,,,0.3971962617,,0.5137844612,0.008849557522,0.5619047619
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED PERIPHERAL VASCULAR DISEASE (dxo:ICD9:4439),,,,,,,0.1650485437,,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED PSYCHOSIS (dxi:ICD9:2989),,,,,,,,,,,,,,,0.0198019802,
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.01063829787,
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359),,,,,,,,0.4919354839,,,,,,,,
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED URTICARIA (dxo:ICD9:7089),,,,,0.1592356688,,,,,,,,,,,
  1 ,"Age: 41-64 | Gender: Male | UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",,,,,,,,,,,,,,0.5523809524,,
  2 ,Age: 41-64 | Gender: Male | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.4700854701,,0.4784946237
  1 ,Age: 41-64 | Gender: Male | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.8086956522
  1 ,"Age: 41-64 | Gender: Male | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.4959349593,,
  3 ,Age: 41-64 | Gender: Male | VALACYCLOVIR HCL,,0.0272479564,0.4671052632,,,,,,,,,0.4388489209,,,,
  1 ,Age: 41-64 | Gender: Male | VALSARTAN,,,,,,,0.1674528302,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | VALSARTAN/HYDROCHLOROTHIAZIDE,,,,,,0.4150943396,0.1649484536,,,,,,,,,
  2 ,Age: 41-64 | Gender: Male | VARENICLINE TARTRATE,,0.02173913043,0.4673366834,,,,,,,,,,,,,
  15 ,Age: 41-64 | Gender: Male | VENLAFAXINE HCL,0.03594080338,0.03836571998,0.4750593824,,0.1020408163,0.5427841635,0.2111913357,0.4243458476,0.187150838,0.1278195489,0.3033728861,0.4238095238,0.2173913043,0.4755952381,0.02346805737,0.535256195
  1 ,Age: 41-64 | Gender: Male | VILAZODONE HCL,,,,,,,,,,,0.704,,,,,
  6 ,Age: 41-64 | Gender: Male | ZOLPIDEM TARTRATE,,,,,0.2173913043,,0.1328671329,0.4401114206,0.157480315,,,,,0.5239726027,0.007451564829,
  16 ,Age: 65-79 | Gender: Female,0.03368322669,0.0635703459,0.5510872926,0.5292199649,0.289806369,0.4235847625,0.2258417707,0.5860887097,0.1759479414,0.1050494534,0.4486772677,0.5303445835,0.3512897137,0.5842777626,0.0268722467,0.5459596093
  3 ,Age: 65-79 | Gender: Female | ABNORMAL WEIGHT GAIN (dxo:ICD9:7831),,0.04635761589,,,,,,,,,,0.4311926606,,0.4941176471,,
  1 ,Age: 65-79 | Gender: Female | ACTINIC KERATOSIS (dxo:ICD9:7020),,,,,,,,,,,,,,0.4603174603,,
  3 ,Age: 65-79 | Gender: Female | ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090),,,0.4054054054,,,,0.1,,,,,,,0.3277310924,,
  2 ,Age: 65-79 | Gender: Female | ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928),,,,,,,0.05442176871,,,,,,,0.4054054054,,
  1 ,Age: 65-79 | Gender: Female | ALBUTEROL,,,0.4039735099,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ALBUTEROL SULFATE,,,,,,,,,,,,,,,,0.3888888889
  1 ,Age: 65-79 | Gender: Female | ALBUTEROL SULFATE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7582417582
  2 ,Age: 65-79 | Gender: Female | ALLOPURINOL,,,,,,,,0.496124031,,,,,,0.4863013699,,
  1 ,Age: 65-79 | Gender: Female | ALLOPURINOL | FLUOXETINE HCL,,,,,,,,0.72,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | ALPRAZOLAM,,,0.4112903226,,,,0.04784688995,,,,,,,0.4458333333,,
  1 ,Age: 65-79 | Gender: Female | ALPRAZOLAM | ATORVASTATIN CALCIUM,,,,,,,,,,,,,,0.4765625,,
  1 ,Age: 65-79 | Gender: Female | ALPRAZOLAM | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8235294118,,
  1 ,Age: 65-79 | Gender: Female | ALPRAZOLAM | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.4566929134,,
  1 ,Age: 65-79 | Gender: Female | ALPRAZOLAM | SERTRALINE HCL,,,,,,,,,,,,,,0.7598039216,,
  1 ,Age: 65-79 | Gender: Female | ALPRAZOLAM | SIMVASTATIN,,,,,,,,,,,,,,0.4864864865,,
  4 ,Age: 65-79 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310),,,,,,0.2313432836,,0.4517766497,,,0.2142857143,0.3080808081,,,,
  1 ,Age: 65-79 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | CITALOPRAM HYDROBROMIDE,,,,,,,,,,,0.4545454545,,,,,
  1 ,Age: 65-79 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2671755725,,,,,
  1 ,Age: 65-79 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | FLUOXETINE HCL,,,,,,,,0.6949152542,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | PAROXETINE HCL,,,,,,,,,,,,0.5759493671,,,,
  1 ,Age: 65-79 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | SERTRALINE HCL,,,,,,,,,,,0.4679487179,,,,,
  13 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL,0.04459608492,0.05839416058,0.3397129187,,,0.3428571429,0.1107692308,0.3391812865,0.1328413284,0.1103202847,0.4622382851,0.3076923077,,0.3869499241,0.01208459215,0.3774104683
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL,0.05581395349,0.03636363636,,,,,,,,,0.3603254552,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,,,,,,,,,,0.4517766497,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | DULOXETINE HCL,,,,,,,,,,,0.4153846154,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.3630136986,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | FLUOXETINE HCL,,,,,,,,,,,0.4092827004,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss,0.01183431953,0.02232142857,,,,,,,,,0.09452736318,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.09649122807,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.1517857143,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Same & Remiss,,,,,,,,,,,0.600660066,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.5181818182,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.3522012579,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3493150685,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | ROPINIROLE HCL,,,,,,,,,,,0.3811881188,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | SERTRALINE HCL,,,,,,,,,,,0.4806629834,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | TRAZODONE HCL,,,,,,,,,,,0.308411215,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3731343284,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE,0.03720930233,,0.6288888889,,,,,,,,0.5606694561,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,,,,,,,,,0.4489795918,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,,,,,,,,,,0.4765625,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,0.02314814815,,0.6698113208,,,,,,,,0.5975855131,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.7058823529,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.5340909091,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.5368421053,,,,,,,,0.5590551181,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,0.04060913706,,0.7457627119,,,,,,,,0.5535714286,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,0.803030303,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,,,,,,,,,0.4345238095,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,,,,,,,,,0.6804511278,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5330188679,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,,,,,,,,,0.5317460317,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,,,,,,,,,0.4574468085,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.07481296758,,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",0.01871657754,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DOXEPIN HCL,,,,,,,,,,,0.4159663866,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL,0.07262569832,,,,,0.5422535211,,,,,0.4663178548,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.45,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | FLUOXETINE HCL,,,,,,,,,,,0.5660377358,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,0.04864864865,,,,,0.5159235669,,,,,0.4542682927,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4049079755,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.47,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & Remiss,0.08,,,,,0.6766917293,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3805309735,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.5726872247,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.4698795181,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.4903846154,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.4660194175,,,,,0.382183908,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE,0.03273809524,,,,,,0.338770389,,,,0.3089005236,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0.02183406114,,,,,,0.2791878173,,,,0.2830188679,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.2769230769,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3076923077,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2450980392,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,,,,,0.2173913043,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,,,,,0.5849056604,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.3212669683,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL,0.0467404674,,,,,,,0.643728223,,,0.5453885258,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,0.0234375,,,,,,,,,,0.6149870801,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7007042254,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.6319444444,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.5939086294,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,0.04054054054,,,,,,,0.7222222222,,,0.5643564356,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7206703911,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.3970588235,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6402116402,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.698245614,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5106382979,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | GABAPENTIN,,,,,,,,,,,0.3472222222,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840),0.0498687664,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,0.02544529262,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | LAMOTRIGINE,,,,,,,,,,,0.1422018349,,,,,
  9 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss,,,0.3684210526,,,0.3039215686,0.07207207207,0.3211009174,0.1028037383,0.07272727273,0.3004484305,,,0.4356060606,0.003412969283,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5045045045,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6178010471,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6617283951,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.009090909091,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2169811321,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.5066666667,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6054421769,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.08387096774,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.5486725664,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,0.01960784314,,,,,,,,,,0.5463576159,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,0.04522613065,,,,,,,,,,0.6518650089,,,0.702970297,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,0.04609929078,,,,,,,,,,0.1371841155,,,,0.0036900369,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.599078341,,,,,0.6420454545
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7440944882,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.7076923077,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,0.03603603604,,,,,,,,,,0.5625,,,0.7490494297,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.01565708419,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,0.01340482574,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.002178649237,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.3119266055,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4819277108,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5428571429,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.1538461538,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6505263158,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.6504854369,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,0.6803278689,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5741626794,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5845588235,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.7567567568,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5130890052,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.6220930233,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | LOVASTATIN,0.1,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | LOVASTATIN | Last AD: Same & No Remiss,0.02325581395,,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.6,,,,,
  2 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2332268371,,,,,,,,,,0.5543644717,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4697508897,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE,0.03361344538,,,,,,,,,,0.3897058824,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.3774834437,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3169398907,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.3333333333,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL,0.03636363636,,,,,,,,,,0.448441247,,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.68,,,,
  1 ,"Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6704805492,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.3913043478,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4158415842,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.5054347826,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3769633508,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3716814159,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | OMEPRAZOLE,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.02508960573,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.02097902098,,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | PAROXETINE HCL,0.03198294243,,,,,,,,,,0.53125,0.6228070175,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5772357724,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572),0.06,,,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,0.03759398496,,,,,,,,,,0.5417956656,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.53125,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4679802956,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5086206897,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | RISPERIDONE,,,,,,,,,,,0.1266666667,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ROPINIROLE HCL,0.04263565891,,,,,,,,,,0.5083591331,,0.4803921569,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4135135135,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01960784314,,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL,0.0450928382,,,,,,,,,,0.6123778502,,,0.6737726098,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5053380783,,,0.5689655172,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | SIMVASTATIN,,,,,,,,,,,0.3365853659,,,,,
  2 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | TRAZODONE HCL,0.04961832061,,,,,,,,,,0.3786381109,,,,,
  1 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4528301887,,,,,
  3 ,Age: 65-79 | Gender: Female | AMITRIPTYLINE HCL | VENLAFAXINE HCL,0.07219251337,,,,,,,,,,0.5088702148,,,,,0.6544901065
  3 ,Age: 65-79 | Gender: Female | AMLODIPINE BESYLATE,0,,,,,,0.1139896373,,,,,,,,0.005970149254,
  1 ,Age: 65-79 | Gender: Female | AMLODIPINE BESYLATE | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.01973684211,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | AMLODIPINE BESYLATE | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,,0.01,
  1 ,Age: 65-79 | Gender: Female | AMLODIPINE BESYLATE | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,,,,,,,0,
  1 ,Age: 65-79 | Gender: Female | AMLODIPINE BESYLATE/BENAZEPRIL,,,,,,,0.1274509804,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ANOREXIA (dxo:ICD9:7830),,,,,,,,,0.1090909091,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ANOREXIA (dxo:ICD9:7830) | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.1180555556,,,,,,,
  6 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.04077253219,,,,,0.1052820697,,,0.05660377358,,0.3571966843,0.2233009709,,0.01945525292,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL",,0.04960835509,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0.009584664537,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUSPIRONE HCL",,,,,,,0.1037735849,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01923076923,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE",,,,,,,0.4472049689,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss",,,,,,,0.2232142857,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.7288135593,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,0.1621621622,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.7619047619,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",,,,,,,0.1232876712,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,,,,,,0.3641346907,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | GABAPENTIN",,,,,,,0.5042735043,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1007583965,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+",,,,,,,0.1504424779,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & Remiss",,,,,,,0.7268907563,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | OMEPRAZOLE",,,,,,,0.4621848739,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | GABAPENTIN",,,,,,,0.1098484848,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,0.1034482759,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.3202416918,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.7737068966,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,,,,,,0.08370044053,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",,,,,,,0.1310344828,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | OMEPRAZOLE",,,,,,,0.08962264151,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PALPITATIONS (dxo:ICD9:7851)",,,,,,,0.1132075472,,,,,0.3271028037,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL",,,,,,,,,,,,0.6862745098,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,,,,,,0.6358024691,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | RANITIDINE HCL",,,,,,,0.05357142857,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",,,,,,,0.07194244604,,,,,0.4099378882,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SERTRALINE HCL",,,,,,,0.1932773109,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | SIMVASTATIN",,,,,,,0.1071428571,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | ARIPIPRAZOLE,,,,,,0.25,,,,,0.1791044776,,,,,0.3302752294
  1 ,Age: 65-79 | Gender: Female | ARIPIPRAZOLE | CITALOPRAM HYDROBROMIDE,,,,,,,,,,,0.1651376147,,,,,
  2 ,Age: 65-79 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL,,,,,,0.1871921182,,,,,0.223880597,,,,,
  2 ,Age: 65-79 | Gender: Female | ARIPIPRAZOLE | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.197080292,,,,,0.1830065359,,,,,
  1 ,Age: 65-79 | Gender: Female | ARIPIPRAZOLE | ESCITALOPRAM OXALATE,,,,,,,,,,,0.1746031746,,,,,
  2 ,Age: 65-79 | Gender: Female | ARIPIPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.2307692308,,,0.3557692308,,
  1 ,Age: 65-79 | Gender: Female | ARIPIPRAZOLE | TRAZODONE HCL,,,,,,,,,,,0.2,,,,,
  2 ,Age: 65-79 | Gender: Female | ARIPIPRAZOLE | VENLAFAXINE HCL,,,,,,,,,,,0.1727272727,,,,,0.2710843373
  2 ,Age: 65-79 | Gender: Female | ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400),,,,,,,,,,0.01818181818,,,,,0.03645833333,
  4 ,"Age: 65-79 | Gender: Female | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)",,,0.3547297297,,,,,0.4407894737,,,0.2403846154,,,0.423255814,,
  1 ,"Age: 65-79 | Gender: Female | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020) | CITALOPRAM HYDROBROMIDE",,,0.6355140187,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020) | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",,,0.3543307087,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020) | FLUOXETINE HCL",,,,,,,,0.7348484848,,,,,,,,
  6 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM,,,0.4669172932,,,,0.1194029851,0.5319320938,,,0.2479338843,0.5114942529,,0.504391468,,
  3 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE,,,0.7739130435,,,,,,,,0.4411764706,,,0.675,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.7804878049,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3552123552,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.8729016787,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.7851851852,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.7883597884,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.3425925926,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | DULOXETINE HCL,,,,,,,,,,,0.5,,,,,
  4 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | ESCITALOPRAM OXALATE,,,0.73,,,,0.3065326633,,,,0.3263888889,,,0.623853211,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.4749034749,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL,,,,,,,,0.7962604771,,,0.4966887417,,,,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.8019323671,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.4318181818,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.8413793103,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,0.6972477064,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | GABAPENTIN,,,,,,,,0.5213675214,,,,,,0.4985337243,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | GABAPENTIN | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8848920863,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | GABAPENTIN | SERTRALINE HCL,,,,,,,,,,,,,,0.8090614887,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | HYDRALAZINE HCL,,,,,,,,,,,,,,0.416,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.4644549763,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.8214285714,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6422018349,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.7,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.435,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4262536873,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.8623853211,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8669817691,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.5400943396,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.9176470588,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8394793926,,
  1 ,"Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,0.4692307692,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | METFORMIN HCL,,,,,,,,,,,,,,0.5145631068,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,,,,0.481865285,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.864628821,,
  2 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | PAROXETINE HCL,,,,,,,,,,,0.4230769231,0.7366071429,,,,
  2 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,0.5679012346,,,0.8103599649,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7399103139,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,0.5620437956,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | SIMVASTATIN,,,,,,,,,,,,,,0.4624505929,,
  1 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.4909090909,,
  2 ,Age: 65-79 | Gender: Female | ATORVASTATIN CALCIUM | VENLAFAXINE HCL,,,,,,,,,,,0.5078125,,,,,0.75
  1 ,Age: 65-79 | Gender: Female | BENIGN HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE (dxo:ICD9:40210),,,0.4142857143,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113),,,,,,,,0.5886524823,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113) | FLUOXETINE HCL,,,,,,,,0.75,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BLEPHARITIS, UNSPECIFIED (dxo:ICD9:37300)",,,0.3879310345,,,,,,,,,,,,,
  3 ,"Age: 65-79 | Gender: Female | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",,,0.4599156118,,,0.2101910828,,,,,,,,,0.02054794521,
  1 ,"Age: 65-79 | Gender: Female | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851) | CITALOPRAM HYDROBROMIDE",,,0.6666666667,,,,,,,,,,,,,
  14 ,Age: 65-79 | Gender: Female | BUPROPION HCL,0.01639344262,0.05379231413,0.4134419552,0.6283185841,,0.3310961969,0.1797366915,0.4213528932,0.1353383459,0.05940594059,0.4597620714,0.3762214984,,0.4248900063,0.02164502165,0.4504792332
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.05521472393,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | Last AD: Same & No Remiss",,0.01670644391,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.004237288136,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.0414507772,,,,,,,,,,,,,,
  8 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,0.05521885522,0.6078016329,,,0.3263888889,0.2585034014,0.3432835821,,,0.572039072,,,0.4325842697,,0.59
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,,,,,,,,,0.4301075269,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,,,,,,,,,,0.44,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,,,,,,,,,,0.4411764706,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.03189066059,0.7180094787,,,,,,,,0.6533907427,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.03378378378,0.7530864198,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6007067138,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.6,,,,,,,,0.6211031175,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,0,,,,,,,,,0.4213836478,,,,0.01904761905,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.06175771971,0.7191780822,,,,,,,,0.6302083333,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.05555555556,0.7326388889,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,0.02739726027,,,,,,,,,0.5034482759,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.6037735849,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5369458128,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5442708333,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,,,,,,,,,0.728314239,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.786407767,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6204620462,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.675,,,,,,,,0.6195652174,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,,,,,,,,,0.431372549,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.312,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5945945946,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5033112583,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,,,,,,,,,0.512605042,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,,,,,,,,,,0.4803149606,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | SIMVASTATIN,,,,,,,,,,,0.7904761905,,,,,
  4 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.01694915254,0.5099601594,,,,,,,,0.4568661972,,,,0.03076923077,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,,,,,,,,,,0.4678899083,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | CLONAZEPAM,,,,,,,,,,,0.2844036697,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.062,,,,,,,,,0.2941176471,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.0308988764,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DESVENLAFAXINE SUCCINATE,,,,,,,,,,,0.4383116883,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.06748466258,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000) | Last AD: Same & No Remiss",,0.01492537313,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DOXEPIN HCL,,,,,,,,,,,0.416856492,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL,,0.05227655987,,,,0.5085043988,,,,,0.4577114428,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,,,,,0.4285714286,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | FLUOXETINE HCL,,,,,,,,,,,0.4606741573,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | LAMOTRIGINE,,,,,,,,,,,0.126984127,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.04719764012,,,,0.582278481,,,,,0.5279069767,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04761904762,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4462365591,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3474576271,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6203703704,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & Remiss,,0.05696202532,,,,0.7119341564,,,,,0.6396396396,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.3896103896,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3555555556,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3826714801,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6415584416,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6150442478,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.6333333333,,,,,0.5390625,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4311926606,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3614457831,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3516483516,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4260869565,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5327868852,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.4382716049,,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.4102564103,,,,,0.3327171904,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.464,,,,,
  4 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE,,0.05555555556,,,,,0.3708832335,,,,0.3932038835,,,0.4102564103,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,,,,,0.3488372093,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.04697986577,,,,,0.4082446809,,,,0.4464534075,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.05,,,,,0.3821989529,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,0.3191489362,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.4337016575,,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3605442177,,,,0.04587155963,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.1030927835,,,,,0.6388888889,,,,0.6448598131,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,0.6492890995,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,0,,,,,0.1900826446,,,,0.2590361446,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2380952381,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3623853211,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3670886076,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,,,,,0.6557863501,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5625,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.4854771784,,,,0.4918918919,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4545454545,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,,,,,0.3296089385,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4210526316,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1851851852,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1937984496,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,,,,,0.5095541401,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,,,,,0.3362831858,,,,,
  4 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,0.009433962264,,,,,0.3066666667,,,,0.3146387833,,,,0.03571428571,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,,,,,0.392,,,,,
  7 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL,,0.05337620579,0.4201680672,,,0.3284671533,0.2236024845,0.5555555556,,,0.5630885122,,,0.4251207729,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1981132075,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04242424242,,,,,,0.7103448276,,,0.6980854197,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.04347826087,,,,,,0.6700767263,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,,,,,,0.627027027,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.7041800643,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4671052632,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.07612456747,,,,,,0.6804733728,,,0.6802721088,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,0.07619047619,,,,,,0.6741214058,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.4946808511,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5798816568,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5658682635,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.7343096234,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.566539924,,,,,
  3 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.3185840708,,,,,,0.6165803109,,,0.5230769231,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3613445378,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6709183673,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3211009174,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5701754386,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5838926174,,,,,
  4 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,0.05140186916,,,,,,0.3861788618,,,0.4357592093,,,,0.03731343284,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4,,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | GABAPENTIN,,0.08018867925,,,,,,,,,0.2815533981,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | GABAPENTIN | Last AD: Same & No Remiss,,0.05035971223,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),,0.1267605634,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002) | Last AD: Same & No Remiss,,0.01785714286,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.03076923077,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | LAMOTRIGINE,,,,,,,,,,,0.1206896552,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.2765957447,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.246031746,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.1056338028,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | ROPINIROLE HCL,,,,,,,,,,,0.1709401709,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1102831595,,,,,
  8 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss,,,0.4148148148,,,0.297979798,0.1342857143,0.4397590361,,,0.3103130755,,,0.4098360656,0.01445086705,0.3898305085
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.04191616766,,,,,,,,,0.3636363636,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.5562913907,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6373626374,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,0.02857142857,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.725,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.04918032787,,,,,,,,,,,,0.7182835821,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.0157480315,,,,,,,,,,,,,0.01824817518,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.2462686567,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,0.5935828877,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6187845304,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4132231405,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1066997519,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,0.5546875,,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.015625,,,,,,,,,0.6083550914,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03990024938,,,,,,,,,0.6933497537,,,0.6432748538,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4293785311,,,,0.02586206897,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.03669724771,,,,,,,,,0.1109530583,,,,0.02370990237,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.02985074627,,,,,,,,,0.5185185185,,,,,0.7
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss,,0.1044083527,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6730769231,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7259259259,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,0.075,,,,,,,,,,,,0.7622739018,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | PAROXETINE HCL,,0.02013422819,,,,,,,,,,0.722513089,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,0.06613756614,,,,,,,,,0.6737967914,,,0.7628361858,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.1376146789,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,0.07096774194,,,,,,,,,,,,,,0.700729927
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss,,0.0215372456,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.08,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.007530120482,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,0.02008032129,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.5346534653,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5320197044,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1124260355,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.01869158879,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.0251572327,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.3868613139,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5821917808,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL,,0.03100775194,,,,,,,,,0.5265306122,,,0.4454545455,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.513368984,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,0.02479338843,,,,,,,,,0.1760722348,,,,0.008695652174,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5588235294,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4368932039,,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss,,0.6267942584,,,,,,,,,0.6929703653,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.7483443709,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7751937984,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.754985755,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6984615385,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.5924170616,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.57,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5148514851,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.5517241379,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,0.6711409396,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6090225564,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6399082569,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.7687366167,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5481481481,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5871559633,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5757575758,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.6764705882,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.5119617225,,,,,,,,,0.747706422,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.8303571429,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.6821705426,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.49,,,,,,,,,0.66437684,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6343283582,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6260869565,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6444805195,,,,,
  4 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.2518277823,,,,0.43,0.3716814159,,,,0.5381054131,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.528,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4807692308,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+",,,,,,,,,,,0.4571428571,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.5066225166,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.5652173913,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.5803108808,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.4140625,,,,,
  3 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,0.2871287129,,,,,,,,,0.6033519553,,,0.7131782946,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,0.2608695652,,,,,,,,,0.4717090069,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.4245283019,,,,,
  2 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.5601851852,,,,,0.6396396396
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,0.06306306306,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | MIRTAZAPINE,,0.06302521008,,,,,,,0.2631578947,,0.3741534989,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.303030303,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3133462282,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.4135802469,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2760736196,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.3435582822,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.03770197487,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL,,0,,,,,,,,0.1428571429,0.3855606759,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.224137931,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL",,,,,,,,,,,,0.54375,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | PAROXETINE HCL",,,,,,,,,,,,0.7352941176,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7188049209,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.3179791976,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.465,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4558823529,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4040114613,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.4461077844,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3543788187,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.435483871,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3452991453,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3212851406,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.5465838509,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.08333333333,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.3482142857,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | OMEPRAZOLE,,,,,,,,,,,0.2330827068,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.06167400881,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | PAROXETINE HCL,,0.03810775296,,,,,,,,,0.5395555556,0.5965362412,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4944134078,0.5841584158,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,0.05726872247,,,,,,,,,0.497438286,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4803625378,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.424,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.46875,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3992146597,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1437908497,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.1129032258,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.1403508772,,,,,
  1 ,"Age: 65-79 | Gender: Female | BUPROPION HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.3153153153,,,,,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.4690265487,,0.5205479452,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.1058495822,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.08173076923,,,,,
  3 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL,,0.05056179775,,,,,,,,,0.4854304636,,0.3986013986,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5055555556,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.376114082,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5,,,,,
  7 ,Age: 65-79 | Gender: Female | BUPROPION HCL | SERTRALINE HCL,,0.04835589942,0.4269005848,,,0.3521126761,0.2019704433,0.4634146341,,,0.5943432778,,,0.6048141377,,
  4 ,Age: 65-79 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,0.04605263158,,,,,,,,,0.4519230769,,,0.4959016393,0.03496503497,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4711538462,,,,,
  1 ,Age: 65-79 | Gender: Female | BUPROPION HCL | SIMVASTATIN,,,,,,,,,,,0.2680412371,,,,,
  5 ,Age: 65-79 | Gender: Female | BUPROPION HCL | TRAZODONE HCL,,0.05139565795,,,,0.2540983607,0.06542056075,,,,0.3625626121,,,,0.02242152466,
  2 ,Age: 65-79 | Gender: Female | BUPROPION HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3742757822,,,,,0.3764705882
  4 ,Age: 65-79 | Gender: Female | BUPROPION HCL | VENLAFAXINE HCL,,0.04651162791,,,,,,,,,0.4655462185,,,0.4180327869,,0.5761217949
  2 ,Age: 65-79 | Gender: Female | BUSPIRONE HCL,,,,,,,0.09765625,,,,,,,0.3398058252,,
  1 ,Age: 65-79 | Gender: Female | BUSPIRONE HCL | ESCITALOPRAM OXALATE,,,,,,,0.4621212121,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CARBIDOPA/LEVODOPA | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.4433497537,,,,,
  1 ,Age: 65-79 | Gender: Female | CARBIDOPA/LEVODOPA | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5744680851,,,,,
  1 ,Age: 65-79 | Gender: Female | CARBIDOPA/LEVODOPA | PARALYSIS AGITANS (dxo:ICD9:3320) | SERTRALINE HCL,,,,,,,,,,,0.5196078431,,,,,
  1 ,Age: 65-79 | Gender: Female | CELECOXIB,,,0.471291866,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CELECOXIB | CITALOPRAM HYDROBROMIDE,,,0.8036363636,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CELECOXIB | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.8217821782,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CETIRIZINE HCL,,,0.5048543689,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,0.1530612245,,,,,,,0.505952381,,
  1 ,"Age: 65-79 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650) | SERTRALINE HCL",,,,,,,,,,,,,,0.7520661157,,
  1 ,"Age: 65-79 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.02398989899,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.02461538462,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",,0,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071),,,0.3454545455,,,,,,,,,,,,,
  15 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE,0.02551020408,0.03791174643,0.6474247571,,0.1770334928,0.3940990516,0.2868916797,0.5072164948,0.1076779026,0.06666666667,0.4172581248,0.3970432946,0.1660079051,0.5161498708,0.01032565528,0.537428023
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | CLONAZEPAM,,,0.7777777778,,,,,,,,0.5023255814,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.7430167598,,,,,,,,0.4620253165,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & No Remiss",,,0.3391304348,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & Remiss",,,0.8394495413,,,,,,,,,,,,,
  4 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,0.7050847458,,,,,,,,0.4204545455,,,,0.006896551724,0.6836734694
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.025,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,,0.3529411765,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss",,,0.8439716312,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SIMVASTATIN",,,0.7714285714,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01459854015,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.7093023256,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | Last AD: Same & No Remiss,,,0.2877697842,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | Last AD: Same & Remiss,,,0.8223684211,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DOXEPIN HCL,,,0.6321428571,,0.4277108434,,,,,,0.5223367698,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,0.6498161765,,,0.5306122449,,,,,0.4491017964,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss,,,0.7464788732,,,0.5346534653,,,,,0.5022026432,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.7281553398,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6730769231,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.6698113208,,,,,,,,0.4672897196,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Diff & Remiss,,,0.7014925373,,,0.5898876404,,,,,0.5526315789,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5165562914,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.63,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | Num Previous Episodes: 2+,,,0.6587301587,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.534351145,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | TRAZODONE HCL,,,0.4854368932,,,0.4350649351,,,,,0.470212766,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889),,,0.7720930233,,,,,,,,,,,,,
  5 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,,0.745272525,,,,0.3621621622,0.4563106796,,,0.3368669022,,,0.4956896552,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,0.7512437811,,,,0.356979405,,,,0.3394833948,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,0.75,,,,0.3680781759,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.6103896104,,,,0.3419354839,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.6172839506,,,,,,,,0.3513513514,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,0.86,,,,0.4653061224,,,,0.4285714286,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3",,,,,,,0.504,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,0.5628415301,,,,0.141025641,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4054054054,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,0.8494623656,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,,,,,0.3388429752,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.6285714286,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.2100840336,,,,0.4373259053,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM,,,0.7507739938,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM | Last AD: Same & No Remiss,,,0.425,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM | Last AD: Same & Remiss,,,0.7644230769,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.7061728395,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & No Remiss",,,0.3913043478,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & Remiss",,,0.7527472527,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | PRAVASTATIN SODIUM",,,0.6893203883,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SIMVASTATIN",,,0.7926829268,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | EZETIMIBE/SIMVASTATIN,,,0.7835820896,,,,,,,,,,,,,
  4 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,,0.6511299435,,,,,0.6590909091,,,0.4105263158,,,0.5086206897,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.465,,,,,
  4 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN,,,0.8056265985,,,0.4052287582,0.3703703704,,,,0.5069444444,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | Last AD: Same & No Remiss,,,0.4074074074,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | Last AD: Same & Remiss,,,0.825,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | GABAPENTIN | SIMVASTATIN,,,0.7540983607,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.5877862595,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.7630057803,,,,,,,,,,,,0.006289308176,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0.02,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01941747573,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.024,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.02631578947,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1529680365,,,,,,,,0.1694915254,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1181818182,,,,,
  11 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,0.0078125,0.01866666667,,,,0.3180212014,0.1833333333,0.3486590038,0.1124031008,,0.3380634391,0.3131868132,,0.4076433121,0.01129943503,0.3454545455
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,0.6780821918,,,,,,0.213836478,,0.5518394649,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,,0.6764705882,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.5950413223,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+,,,0.592,,,,,,,,0.5230769231,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.5,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6019417476,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.5856873823,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6793478261,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.6666666667,,,,,,,,,,,,0.02,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3625,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5869947276,,,,,,,,0.5669064748,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6916666667,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6805555556,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SERTRALINE HCL,,,0.7615384615,,,,,,,,0.4522613065,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | SIMVASTATIN,,,,,,,,,,,0.3564356436,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,0.6680911681,,,,,,,,0.6126914661,,,,0.0111662531,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,0.801980198,,,,,,,,0.5281690141,,,,,0.7731092437
  9 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.07142857143,,,,0.4607508532,0.310880829,0.6411764706,0.246835443,,0.4854045038,,,0.5823170732,0.03597122302,0.5555555556
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | MIRTAZAPINE,,,0.6625,,,,,,0.3050847458,,0.5514018692,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL",,,0.641221374,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.6394557823,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.7485380117,,,,,,,,,,,,0.01612903226,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,0.6319444444,,,,,,,,0.7450980392,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.6647398844,,,,,,,,0.5424836601,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,0.6266666667,,,,,,,,0.7117117117,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL,,,0.6347826087,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | ROPINIROLE HCL,,,0.6038961039,,,,,,,,0.6525423729,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | SERTRALINE HCL,,,0.6428571429,,,,,,,,0.5586206897,,,0.7578125,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | SIMVASTATIN,,,,,,,,,,,0.4615384615,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | TRAZODONE HCL,,,0.719047619,,,,,,,,0.5953757225,,,,0.02707275804,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7450980392
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3724237099,,,,,,,,0.33,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.4095238095,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.4822695035,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.3803748622,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SIMVASTATIN,,,0.37,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4311111111,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.4019138756,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6818181818,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.34,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SERTRALINE HCL,,,0.396039604,,,,,,,,,,,0.4074074074,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SIMVASTATIN,,,0.4015748031,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,0.3255813953,,,,,,,,0.408045977,,,,0.01639344262,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.822295475,,,,,,,,0.4864864865,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.850877193,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.7283950617,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.6034482759,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,0.6555555556,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,0.9109414758,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.8318584071,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6932515337,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,0.9108910891,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.8095238095,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.8697916667,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6557377049,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PRAVASTATIN SODIUM,,,0.8015267176,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6932270916,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5263157895,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SIMVASTATIN,,,0.8507936508,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,0.8317757009,,,,,,,,0.7002096436,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LEVOTHYROXINE SODIUM,,,0.7976190476,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.7701149425,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE | Last AD: Same & No Remiss,,,0.350877193,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE | Last AD: Same & Remiss,,,0.861003861,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE | SIMVASTATIN,,,0.8013245033,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOSS OF WEIGHT (dxo:ICD9:78321),,,0.6954314721,,,,,,0.08133971292,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOSS OF WEIGHT (dxo:ICD9:78321) | Last AD: Same & No Remiss,,,0.3596491228,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOVASTATIN,,,0.7904290429,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOVASTATIN | Last AD: Same & No Remiss,,,0.4058823529,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOVASTATIN | Last AD: Same & Remiss,,,0.8403361345,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,0.7723004695,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.7315789474,,,,,,,,0.4850746269,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.7394957983,,,,,,,,0.5197505198,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,0.6536312849,,,,,,,,0.6068965517,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,0.5628318584,,,,,,0.2185886403,,0.4696174044,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | Num Previous Episodes: 2+,,,0.5714285714,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | TRAZODONE HCL,,,0.5,,,,,,,,0.3977777778,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | MONTELUKAST SODIUM,,,0.7314814815,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,0.6082725061,,,,,,,0.1215686275,0.5398773006,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4565217391,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6801801802,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | SERTRALINE HCL,,,0.5480769231,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5825242718,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+,,,0.9033816425,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+ | TRAZODONE HCL,,,0.6170212766,,,,,,,,0.7320261438,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.7906976744,,,,,,,,0.533557047,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SIMVASTATIN,,,0.7967479675,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | OMEPRAZOLE,,,,,,,,,,,0.4485714286,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | OMEPRAZOLE | SIMVASTATIN,,,,,,,,,,,0.519379845,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER DISORDERS OF BONE AND CARTILAGE (dxo:ICD9:73399),,,0.7433628319,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319),,,0.7830687831,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,,0.7322404372,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | OXYBUTYNIN CHLORIDE,,,,,,,,,,,0.5319148936,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PALPITATIONS (dxo:ICD9:7851),,,0.7387387387,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PARALYSIS AGITANS (dxo:ICD9:3320),,,0.6359649123,,,,,,,,0.4268774704,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL,,,,,,,,,,,0.5480769231,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,,0.5922077922,,,,,,,,0.3467741935,0.5627376426,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3818181818,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PEN NEEDLE, DIABETIC",,,0.7535545024,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.3946188341,,,,,,,,0.2025862069,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,0.2697368421,,,,,,,,0.2352941176,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,0.5859106529,,,,,,,,0.611752361,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6837944664,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.5839416058,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.5550239234,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAVASTATIN SODIUM,,,0.7375690608,,,,,,,,0.4705882353,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PREGABALIN,,,0.7046979866,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,0.6272189349,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.6358024691,,,,,,,,0.3262032086,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1551724138,,,,,
  2 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.4963235294,,,,,,,,0.2275132275,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2561983471,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,0.7891566265,,,,,,,,0.5162790698,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,0.6834532374,,,,,,,,0.6686217009,,0.4548611111,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.610619469,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,0.2140350877,,,,,,,,0.1762452107,,,,,
  2 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | RISPERIDONE | TRAZODONE HCL,,,0.15,,,,,,,,0.1282051282,,,,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,0.5749506903,,,,,,,,0.6114996115,,0.3914209115,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5537634409,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROSUVASTATIN CALCIUM,,,0.737704918,,,,,,,,,,,,,
  7 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,,0.5778894472,,,0.3839285714,0.1801242236,0.3309352518,,,0.4318936877,0.4,,0.6135721018,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | TRAZODONE HCL,,,0.4180327869,,,,,,,,0.4685534591,,,0.5611510791,,
  3 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | SIMVASTATIN,,,0.7844202899,,,,,,,,0.4875886525,,,0.6736842105,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.731092437,,,,,
  1 ,"Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | SODIUM, POTASSIUM,MAG SULFATES",,,0.7372262774,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAMADOL HCL/ACETAMINOPHEN,,,0.6697247706,,,,,,,,,,,,,
  8 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,0.03225806452,0.5733701423,,,0.2287581699,0.1586206897,0.3853211009,,,0.532717475,,,0.4010152284,0.01419446416,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4422442244,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED INFLAMMATORY AND TOXIC NEUROPATHY (dxo:ICD9:3579),,,0.81,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4602272727,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.7636363636,,,,,,,,,,,,,
  4 ,Age: 65-79 | Gender: Female | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,,0.6272965879,,,,,,,,0.4371941272,,,0.5288461538,,0.7409638554
  6 ,Age: 65-79 | Gender: Female | CLONAZEPAM,,,0.4777070064,,,,0.1428571429,,0.1354166667,,0.28125,,,0.4663212435,0.01351351351,
  1 ,Age: 65-79 | Gender: Female | CLONAZEPAM | DULOXETINE HCL,,,,,,,,,,,0.4822335025,,,,,
  1 ,Age: 65-79 | Gender: Female | CLONAZEPAM | ESCITALOPRAM OXALATE,,,,,,,,,,,0.3769633508,,,,,
  1 ,Age: 65-79 | Gender: Female | CLONAZEPAM | FLUOXETINE HCL,,,,,,,,,,,0.5394736842,,,,,
  1 ,Age: 65-79 | Gender: Female | CLONAZEPAM | PAROXETINE HCL,,,,,,,,,,,0.3768115942,,,,,
  2 ,Age: 65-79 | Gender: Female | CLONAZEPAM | SERTRALINE HCL,,,,,,,,,,,0.496124031,,,0.7642276423,,
  1 ,Age: 65-79 | Gender: Female | CLONAZEPAM | TRAZODONE HCL,,,,,,,,,,,0.3247863248,,,,,
  1 ,Age: 65-79 | Gender: Female | CLONAZEPAM | VENLAFAXINE HCL,,,,,,,,,,,0.5670731707,,,,,
  1 ,Age: 65-79 | Gender: Female | CLONIDINE HCL,,,,,,,,,,,,,,,0.02112676056,
  1 ,"Age: 65-79 | Gender: Female | CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)",,,,,,,,0.4220779221,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280) | FLUOXETINE HCL",,,,,,,,0.7692307692,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)",,,,,0.1470588235,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | CYCLOBENZAPRINE HCL,,,,,,,,,,,,,,,0,
  4 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.519630485,,,,,,,,0.3169014085,0.4807692308,,0.5612648221,,
  2 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.816,,,0.4958677686,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.8258064516,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.8461538462,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.7395626243,,,,
  2 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,0.5325443787,,,0.8082901554,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL | SIMVASTATIN",,,,,,,,,,,,,,0.8214285714,,
  15 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.02595419847,0.03855421687,0.5685131195,0.632183908,0.1984732824,0.4181818182,0.1304347826,0.6283018868,,0.08928571429,0.3744493392,0.4820846906,0.2340425532,0.5467836257,0.007867132867,0.5161290323
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DESVENLAFAXINE SUCCINATE",,,,0.7983193277,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | DULOXETINE HCL",,,,,,0.5658536585,,,,,,,,,,0.625
  2 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,0.2901234568,,,,,,,,,0.5703125
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01666666667,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.103626943,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.5337837838,,,,,,,,,,,,,0.6030534351
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7212121212
  3 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.7678321678,,,0.4957264957,,,,,0.5980392157
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & No Remiss",,,,,,,,0.4408602151,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | Last AD: Same & Remiss",,,,,,,,0.8616352201,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | SIMVASTATIN",,,,,,,,0.8152173913,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.03571428571,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | HEADACHE (dxo:ICD9:7840)",0.01333333333,,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.005063291139,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.02285714286,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.007142857143,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6666666667
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.009523809524,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | NORTRIPTYLINE HCL",,,,,,,,,,0.09090909091,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2903225806,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01686746988,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4644194757
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.8797814208,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.8859649123,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.8136363636
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.756302521
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | MUSCLE WEAKNESS (GENERALIZED) (dxo:ICD9:72887) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.756302521
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | NORTRIPTYLINE HCL",,,,,,,,,,0.2083333333,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",,0.04166666667,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",0.04132231405,,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.7480620155,,,,
  4 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,0.4605263158,,,0.8006872852,0.0245398773,0.6121212121
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.01612903226,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAMADOL HCL",,,,,,,,,,,,,,,0.009174311927,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,,,,,,,,,,,,,,0.008310249307,
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.690647482
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.703125
  2 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,0.427184466,,,,,0.741580756
  1 ,"Age: 65-79 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.009174311927,
  6 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.4218316374,,,,0.1125592417,0.390438247,0.1109785203,,0.3571428571,0.332361516,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ESCITALOPRAM OXALATE,,,,,,,0.321656051,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1336898396,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | FLUOXETINE HCL,,,,,,,,0.7454545455,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1355932203,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.1014492754,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | MIRTAZAPINE,,,,,,,,,0.2081632653,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | OMEPRAZOLE,,,,,,,0.05940594059,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | PAROXETINE HCL,,,,,,,,,,,,0.5836575875,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,0.06194690265,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | SIMVASTATIN,,,0.4261363636,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.1021505376,,,,,,,
  4 ,Age: 65-79 | Gender: Female | DESVENLAFAXINE SUCCINATE,,,,0.5681435782,,,0.1694915254,,,,0.3723849372,,,,,0.7262569832
  1 ,Age: 65-79 | Gender: Female | DESVENLAFAXINE SUCCINATE | Last AD: Same & No Remiss,,,,0.4503816794,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DESVENLAFAXINE SUCCINATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,0.553030303,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DESVENLAFAXINE SUCCINATE | MIRTAZAPINE,,,,,,,,,,,0.3474576271,,,,,
  2 ,Age: 65-79 | Gender: Female | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,0.6350364964,,,,,,,0.4416666667,,,,,
  1 ,"Age: 65-79 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED (dxo:ICD9:25001)",0.03246753247,,,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.03971119134,,,,,,,,,,,0.2391304348,,,
  1 ,Age: 65-79 | Gender: Female | DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE (dxo:ICD9:5533),,,0.5273972603,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DONEPEZIL HCL,,,,,,,,0.4736842105,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DONEPEZIL HCL | FLUOXETINE HCL,,,,,,,,0.6824324324,,,,,,,,
  5 ,Age: 65-79 | Gender: Female | DOXEPIN HCL,,,0.3821138211,,0.4350649351,,0.1327433628,,,,0.4357306809,,,0.4180327869,,
  2 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | DULOXETINE HCL,,,,,,0.6244725738,,,,,0.4444444444,,,,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,0.6339285714,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE,,,,,0.493902439,,0.284,,,,0.3955223881,,,,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.2592592593,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DOXEPIN HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.2660550459,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | FLUOXETINE HCL,,,,,0.3777777778,,,0.6865079365,,,0.4666666667,,,,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.3412698413,,,,,
  1 ,"Age: 65-79 | Gender: Female | DOXEPIN HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.780141844,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | Last AD: Same & No Remiss,,,,,0.1953642384,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | Last AD: Same & Remiss,,,,,0.7264957265,,,,,,0.5960912052,,,,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6173913043,,,,,
  1 ,"Age: 65-79 | Gender: Female | DOXEPIN HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.626984127,,,,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | MIRTAZAPINE,,,,,,,,,,,0.3939393939,,,,,
  1 ,"Age: 65-79 | Gender: Female | DOXEPIN HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7712418301,,
  3 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | PAROXETINE HCL,,,,,0.4587155963,,,,,,0.5581395349,0.6244343891,,,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4970760234,,,,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | ROPINIROLE HCL,,,,,,,,,,,0.5322580645,,,,,
  3 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | SERTRALINE HCL,,,,,0.3537735849,,,,,,0.5,,,0.7048346056,,
  1 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.4100486224,,,,,
  2 ,Age: 65-79 | Gender: Female | DOXEPIN HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3985239852,,,,,0.6906077348
  15 ,Age: 65-79 | Gender: Female | DULOXETINE HCL,0.009661835749,0.03557312253,0.5055865922,,0.1652173913,0.5074270557,0.1910377358,0.5410958904,0.122605364,0.05128205128,0.4166300527,0.4130434783,0.1120689655,0.5375722543,0.0406504065,0.5637065637
  4 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,0.5331325301,0.3550135501,,,,0.3655913978,,,0.495049505,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,0.5462555066,0.3894389439,,,,0.3744075829,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.3268292683,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,0.4761904762,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3984375,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,,,,,0.2803738318,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.3816091954,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL,,,,,,0.5620437956,,0.6977547496,,,0.4123867069,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,,,,,0.679389313,,,,,0.4934210526,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.7482517483,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,0.6481481481,,0.8108108108,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5752212389,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.7517241379,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5039164491,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN,,,,,,0.6491677337,,,,,0.4644351464,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.5,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss,,,,,,0.3018867925,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3495934959,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss,,,,,,0.7639484979,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.7475728155,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN | TRAMADOL HCL,,,,,,0.6460176991,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN | TRAZODONE HCL,,,,,,0.4954954955,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6719242902,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.006369426752,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.1499118166,,,,,0.130952381,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,0.1900826446,,,,,0.1060606061,,,,,
  9 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss,0,0.01796407186,0.447761194,,,,0.1009463722,0.5070422535,,,0.3257790368,,,0.4435797665,0.007518796992,0.4350649351
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,0.4285714286,,,0.2583333333,,0.4919786096,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,0.4803921569,,,,,0.5625,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.6475409836,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7777777778,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.009302325581,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.5043478261,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,0.4233576642,,,,,0.5146067416,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.4351851852,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6633663366,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,0.4577464789,,,,,0.615942029,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,0.5612244898,,,,,0.5161290323,,,0.7459016393,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.5060240964,,,,,0.5533049041,,,,0.01519756839,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5236051502,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,0.6516129032,,,,,0.5161290323,,,,,0.7651006711
  4 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss,,,0.6285714286,,,0.6425120773,0.2524271845,,,,0.5044378698,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | MIRTAZAPINE,,,,,,0.5961538462,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7966101695,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.0234375,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,0.69,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | ROPINIROLE HCL,,,,,,0.4918032787,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,0.6024096386,,,,,0.4258064516,,,0.8,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,0.6690647482,,,,,0.5634517766,,,,0.06188925081,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.7166666667,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5631067961,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.2916666667,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.2788461538,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.36,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,0.3121693122,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4137931034,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5193370166,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,0.350877193,,,,,0.4,,,,0,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3319587629,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,0.7426160338,,,,,0.6,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6574074074,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.6178343949,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.625,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | PREGABALIN,,,,,,0.7307692308,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6253968254,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.6086956522,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6176470588,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6018518519,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.7725118483,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,0.7104722793,,,,,0.7222222222,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.4640522876,,,,,
  2 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5334394904,,,,,0.4876190476,,,,,
  2 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,0.4801444043,,,,,0.4912718204,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | MELOXICAM,,,,,,0.5950413223,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.4165651644,,,0.2188841202,,0.3846153846,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2679738562,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.3027522936,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,0.3353658537,,,,,0.374717833,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | NORTRIPTYLINE HCL,,,,,,0.5352697095,,,,0.1222222222,0.4689655172,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3740458015,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7818696884,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4553571429,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3028571429,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,0.6724137931,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.4827586207,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | OMEPRAZOLE,,,,,,,,,,,0.4266666667,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.6666666667,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | OXYBUTYNIN CHLORIDE,,,,,,,,,,,0.53,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.6138613861,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.4125874126,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PAROXETINE HCL,,,,,,0.5504885993,,,,,0.4127516779,0.6681318681,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5592105263,,,,,
  2 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,0.3388429752,,,,,0.2075471698,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,0.436036036,,,,,0.5866141732,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6586345382,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4962962963,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4913793103,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PREGABALIN,,,,,,0.7142857143,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6935483871,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.3047619048,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1571428571,,,,,
  1 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.2700729927,,,,,
  2 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,0.2987551867,,,,,0.261682243,,,,,
  2 ,"Age: 65-79 | Gender: Female | DULOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,0.3070866142,,,,,0.277027027,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4428571429,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6013071895,,0.5170731707,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5436241611,,,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | RISPERIDONE,,,,,,0.2160493827,,,,,0.1979695431,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1678321678,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL,,,,,,0.4275510204,,,,,0.578683834,,0.3788546256,,,
  2 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,0.4196428571,,,,,0.4517958412,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | ROSUVASTATIN CALCIUM,,,,,,0.6810344828,,,,,,,,,,
  4 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | SERTRALINE HCL,,,,,,0.5466847091,0.21875,,,,0.4604072398,,,0.6990131579,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,0.4033613445,,,,,0.4776422764,,,0.515625,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | SIMVASTATIN,,,,,,,,,,,0.5288461538,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | TRAMADOL HCL,,,,,,0.6585365854,,,,,,,,,,
  4 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.4666849465,0.125,,,,0.4753432605,,,,0.03389830508,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4897959184,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4832402235,,,,,
  1 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.6462303231,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,0.6180257511,,,,,0.4237037037,,,,,0.7418032787
  1 ,Age: 65-79 | Gender: Female | DYSTHYMIC DISORDER (dxo:ICD9:3004),,,,,,,,,,,,,,,0.008064516129,
  1 ,Age: 65-79 | Gender: Female | ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869),,,,,,,0.1438356164,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889),,,0.4491525424,,,,,,,,,,,,,
  15 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE,0.02268431002,0.02099236641,0.6312464101,,0.09941520468,0.4117154812,0.3177217102,0.4689042448,0.1200941915,0.0487804878,0.2945093605,0.3951612903,0.175257732,0.4708365311,0.01606086221,0.508650519
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | ESOMEPRAZOLE MAGNESIUM,,,0.6060606061,,,,0.3316582915,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | ESOMEPRAZOLE MAGNESIUM | Last AD: Same & No Remiss,,,,,,,0.15,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | FAMOTIDINE,,,,,,,0.3045977011,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | FAMOTIDINE | Last AD: Same & No Remiss,,,,,,,0.1034482759,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | FENOFIBRATE NANOCRYSTALLIZED,,,,,,,0.4068965517,,,,,,,,,
  4 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,0.2659732541,0.6402877698,,,0.3083900227,,,0.4181818182,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,0.2932330827,,,,0.28,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.27,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4193548387,,,,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN,,,,,,0.4411764706,0.3875,,,,0.3095238095,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,0.158974359,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & Remiss,,,,,,,0.7467532468,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.4661654135,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,0.2462686567,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss",,,,,,,0.1428571429,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss",,,,,,,,,,,,,,,0.01724137931,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.01515151515,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01621621622,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE,,,,,,,0.1308411215,,,,0.06993006993,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.07751937984,,,,,
  11 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,0.01388888889,0.01301518438,0.5512820513,,,0.3310185185,,0.4340277778,0.09652509653,,0.1858349578,0.3240223464,,0.41325811,0.008928571429,0.4170040486
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,0.2783505155,,0.246835443,,0.336,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,0.2911877395,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+,,,,,,,,,,,0.3333333333,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,,0.2966101695,,,,0.396039604,,,,,
  2 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.2047058824,,,,,,,,0.008547008547,
  2 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,0.3352601156,,,,,,,0.6592178771,,
  2 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.2718446602,,,,,,,,0.01123595506,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | VENLAFAXINE HCL",,,,,,,0.4285714286,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.178807947,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2973421927,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,0.2692307692,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.56,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,0.305785124,,,,0.2681564246,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | SIMVASTATIN,,,0.572815534,,,,,,,,0.1333333333,,,,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.2768987342,,,,0.3410507569,,,,0.0181200453,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,0.4201183432,,,,0.3361344538,,,,,0.6422018349
  7 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,0.0873015873,0.681372549,,,0.4821428571,,,0.3106796117,,0.4829659319,,,0.6057692308,0.06896551724,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | MIRTAZAPINE,,,,,,,,,0.4112149533,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.6403508772,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | ROPINIROLE HCL,,,,,,,0.3727272727,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,0.3679245283,,,,0.5438596491,,,,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,0.6202531646,,,,0.642384106,,,,0.08695652174,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1164383562,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.2060606061,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.3076923077,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2617449664,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.1038961039,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.1522678186,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3303167421,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1608040201,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OLMESARTAN MEDOXOMIL,,,,,,,0.1090909091,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OMEPRAZOLE,,,,,,,0.06563706564,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.07006369427,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1183431953,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | RANITIDINE HCL,,,,,,,0.07042253521,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | RISEDRONATE SODIUM,,,,,,,0.08620689655,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.1018518519,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,0.1232876712,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SIMVASTATIN,,,,,,,0.1136363636,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,0.1360946746,,,,0.289048474,,,,0.02189781022,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | VALSARTAN,,,,,,,0.0625,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.7463087248,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.6707317073,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,0.947761194,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,0.9391891892,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.7573529412,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | OMEPRAZOLE,,,,,,,0.7884615385,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6973180077,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.7,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.8415841584,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | SIMVASTATIN,,,,,,,0.8487394958,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6536312849,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.1161290323,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.1367521368,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | LOVASTATIN,,,,,,,0.3044982699,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | LOVASTATIN | Last AD: Same & No Remiss,,,,,,,0.05940594059,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.626349892,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,,,,0.4198473282,,,,,
  2 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.4039133473,,,,0.4413965087,,,,,
  2 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,0.4273127753,,,,0.4421487603,,,,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.2745490982,,0.2206047032,,0.3148301574,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.1274509804,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,0.2937062937,,,,0.2429906542,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.4464285714,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.3246753247,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | NORTRIPTYLINE HCL,,,,,,,0.3423076923,,,0.1674418605,0.347826087,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6807511737,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | Num Previous Episodes: 2+,,,0.5871559633,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.4101910828,,,,0.4207650273,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | OLMESARTAN MEDOXOMIL,,,,,,,0.2857142857,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | OMEPRAZOLE,,,,,,,0.3648915187,,,,0.3825136612,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | OXYBUTYNIN CHLORIDE,,,,,,,0.4102564103,,,,0.3675213675,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.316017316,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,0.328125,,,,0.356223176,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5625,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL,,,,,,,,,,,0.5490196078,,,,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PAROXETINE HCL,,,,,,,0.2763636364,,,,0.264,0.5389105058,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4380952381,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1090047393,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.2079207921,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,0.2992327366,,,,0.5271903323,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5359477124,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.467032967,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PRAVASTATIN SODIUM,,,,,,,0.3783783784,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PREGABALIN,,,,,,,0.3173076923,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,,,,,0.2928571429,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,0.2631578947,,,,0.2067039106,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1527777778,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.168,,,,,
  2 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,0.1778846154,,,,0.1674641148,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2923076923,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | RAMIPRIL,,,,,,,0.3076923077,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | RANITIDINE HCL,,,,,,,0.3451327434,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4335664336,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5695652174,,0.4636363636,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | RISEDRONATE SODIUM,,,,,,,0.3303571429,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,0.0873015873,,,,0.09049773756,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.05298013245,,,,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,0.2893481717,,,,0.52,,0.4243421053,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4744525547,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,0.2580645161,,,,,,,,,
  7 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,0.4745762712,,,,0.2628458498,0.4761904762,0.1029411765,,0.328440367,0.396039604,,0.5945151812,,
  3 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,0.1851851852,,,,0.3859649123,,,0.5454545455,,
  4 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | SIMVASTATIN,,,0.7884615385,,,,0.3483146067,,,,0.390070922,,,0.5963302752,,
  5 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,0.4434782609,,,,0.3114901257,,,,0.362082777,,,0.4031007752,0.02035456336,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4615384615,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491),,,,,,,0.3076923077,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.4817518248,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | VALSARTAN,,,,,,,0.3216080402,,,,,,,,,
  4 ,Age: 65-79 | Gender: Female | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,0.3615221987,,,,0.3670634921,,,0.4090909091,,0.6872852234
  3 ,Age: 65-79 | Gender: Female | ESOMEPRAZOLE MAGNESIUM,,,0.4268060837,,,,0.1032608696,0.4792626728,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | ESOMEPRAZOLE MAGNESIUM | FLUOXETINE HCL,,,,,,,,0.7549019608,,,,,,,,
  6 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.4595300261,,0.18,0.3175675676,,,,,,0.4369747899,,0.5130434783,,0.4589041096
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.8571428571
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LEVOTHYROXINE SODIUM",,,0.3644067797,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LISINOPRIL",,,0.4583333333,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | LOVASTATIN",,,0.5225225225,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | PALPITATIONS (dxo:ICD9:7851)",,,0.297029703,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | PRAVASTATIN SODIUM",,,0.4171122995,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | ROSUVASTATIN CALCIUM",,,0.5247524752,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SIMVASTATIN",,,0.4752252252,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7364864865
  2 ,Age: 65-79 | Gender: Female | ESTRADIOL,,,,,,,,0.4480519481,,,,,,0.4951456311,,
  1 ,Age: 65-79 | Gender: Female | ESTRADIOL | FLUOXETINE HCL,,,,,,,,0.7901234568,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET",,,0.5398230088,,,,,,,,,,,0.5342465753,,
  1 ,"Age: 65-79 | Gender: Female | ESTROGEN,CON/M-PROGEST ACET | SERTRALINE HCL",,,,,,,,,,,,,,0.712,,
  2 ,"Age: 65-79 | Gender: Female | ESTROGENS, CONJUGATED",,,,,,,,0.5259259259,,,,,,0.5194174757,,
  1 ,"Age: 65-79 | Gender: Female | ESTROGENS, CONJUGATED | FLUOXETINE HCL",,,,,,,,0.7578125,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | ESTROGENS, CONJUGATED | SERTRALINE HCL",,,,,,,,,,,,,,0.7189542484,,
  1 ,Age: 65-79 | Gender: Female | ESZOPICLONE,,,0.48125,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | EZETIMIBE,,,,,,,0.1515151515,,,,,,,,,
  4 ,Age: 65-79 | Gender: Female | EZETIMIBE/SIMVASTATIN,,,0.4897959184,,,,0.08585858586,0.5153846154,,,,,,0.55,,
  1 ,Age: 65-79 | Gender: Female | EZETIMIBE/SIMVASTATIN | FLUOXETINE HCL,,,,,,,,0.8102189781,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | EZETIMIBE/SIMVASTATIN | SERTRALINE HCL,,,,,,,,,,,,,,0.7795275591,,
  2 ,Age: 65-79 | Gender: Female | FAMOTIDINE,,,,,,0.2075471698,0.1017811705,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FENOFIBRATE,,,,,,,,,,,,,,0.5303643725,,
  1 ,Age: 65-79 | Gender: Female | FENOFIBRATE | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8991596639,,
  1 ,Age: 65-79 | Gender: Female | FENOFIBRATE | SERTRALINE HCL,,,,,,,,,,,,,,0.8540772532,,
  1 ,Age: 65-79 | Gender: Female | FENOFIBRATE NANOCRYSTALLIZED,,,,,,,0.1293103448,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881),,,,,,,,,,,,,,0.5110294118,,
  1 ,Age: 65-79 | Gender: Female | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881) | SERTRALINE HCL,,,,,,,,,,,,,,0.7572254335,,
  1 ,"Age: 65-79 | Gender: Female | FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)",,,,,,,,,,,,0.3106796117,,,,
  15 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL,0.0250965251,0.04709345107,0.5208860759,,0.1379310345,0.4293606946,0.2078328982,0.6596601809,0.1567164179,0.09236947791,0.4175777965,0.4412903226,0.124260355,0.5079812207,0.009080590238,0.5457705678
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.8040904198,,,0.5107526882,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,,0.4047619048,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | Last AD: Same & Remiss,,,,,,,,0.8313253012,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | GABAPENTIN | SIMVASTATIN,,,,,,,,0.7916666667,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,,,,,,0.5,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.7613882863,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.008771929825,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss",,,,,,,,0.3785714286,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss",,,,,,,,0.7431693989,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.2114427861,,,0.08280254777,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1171875,,,,,
  8 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.01421800948,0.4517766497,,,0.3072289157,0.110701107,,,,0.3561847988,,,0.5220883534,0,0.4285714286
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.5231788079,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,,0.6666666667,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.6092896175,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6981132075,,
  2 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6489795918,,,,,,,0.01886792453,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3663366337,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5902777778,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.5327102804,,,,,
  3 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,0.6686746988,,,0.6496539792,,,,0.01858108108,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4955752212,,,,,
  9 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.08152173913,0.6025641026,,,0.4782608696,0.3085714286,,0.3142857143,,0.4794007491,,,0.5823529412,0.04700854701,0.606557377
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.6607142857,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6849015317,,,,,,,0.03097345133,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4778761062,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,0.6055045872,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,0.6795366795,,,0.6103448276,,,,0.04376012966,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3937823834,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,0.4220183486,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.4023972603,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.5761589404,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.2549019608,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | SIMVASTATIN,,,,,,,,0.437037037,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,0.4695652174,,,0.4945054945,,,,0.01503759398,
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.8235947567,,,0.547008547,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.8415841584,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,0.7902097902,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.6476190476,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+,,,,,,,,0.5666666667,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,,,,,,0.9033816425,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.7535211268,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,,,,,,0.9090909091,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,,,,0.78,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.7086956522,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.7,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | SIMVASTATIN,,,,,,,,0.8543307087,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.7114178168,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,0.8175675676,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | LEVOTHYROXINE SODIUM,,,,,,,,0.7843137255,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | LOVASTATIN,,,,,,,,0.8712871287,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,0.7893518519,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,,,,,,0.813559322,,,0.5,,,,,
  2 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.6726296959,,,0.5154929577,,,,,
  2 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,0.5862068966,,,0.5658914729,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,0.7887931034,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.6304347826,0.2363315697,,0.462745098,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,,0.6666666667,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.3906810036,,,,,
  3 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,0.6825938567,,0.1322751323,0.6089385475,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7142857143,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6490514905,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Num Previous Remissions: 2+,,,,,,,,0.8968253968,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | Num Previous Remissions: 2+ | TRAZODONE HCL,,,,,,,,0.609929078,,,0.7380952381,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.5208333333,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | OMEPRAZOLE,,,,,,,,,,,0.4266666667,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | OXYBUTYNIN CHLORIDE,,,,,,,,,,,0.496,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | PALPITATIONS (dxo:ICD9:7851),,,,,,,,0.746031746,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.4173228346,,,,,
  3 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | PAROXETINE HCL,,,,,,,,0.631147541,,,0.3473053892,0.6039387309,,,,
  2 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,0.4402985075,,,0.145631068,,,,,
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,0.5025125628,,,0.5740740741,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.7049180328,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4793814433,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | PREGABALIN,,,,,,,,0.8475609756,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.2307692308,,,,,
  2 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,0.4956521739,,,0.2235294118,,,,,
  1 ,"Age: 65-79 | Gender: Female | FLUOXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.2824427481,,,,,
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,0.7577639752,,,0.5294117647,,,,,
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6735751295,,0.384180791,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | RISPERIDONE,,,,,,,,,,,0.1388888889,,,,,
  3 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,0.5594512195,,,0.576184379,,0.4529147982,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4590747331,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | ROSUVASTATIN CALCIUM,,,,,,,,0.8257575758,,,,,,,,
  5 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL,,,0.4285714286,,,,0.2366412214,0.5981161695,,,0.4451038576,,,0.5917431193,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4325842697,,,,,
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.7822706065,,,0.5044247788,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | SIMVASTATIN | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,0.7524752475,,,,,,,,
  6 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | TRAZODONE HCL,,0.06611570248,,,,,0.1515151515,0.5754608295,,,0.5564516129,,,0.32,0.02998001332,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4566210046,,,,,
  2 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5483870968,,0.8044692737,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,0.7325842697,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359),,,,,,,,0.7168141593,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,0.6295399516,,,0.4433399602,,,,,0.6586826347
  9 ,Age: 65-79 | Gender: Female | GABAPENTIN,,0.01465201465,0.4574829932,,,0.2858701582,0.1015523933,0.4622395833,,0.03832752613,0.2708333333,0.4517133956,,0.4735830932,,
  1 ,"Age: 65-79 | Gender: Female | GABAPENTIN | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.431372549,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.376,,,,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4522292994,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.8,,,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8095238095,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8173076923,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.2108433735,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | OMEPRAZOLE,,,,,,,0.08035714286,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | GABAPENTIN | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.3025210084,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | GABAPENTIN | PAROXETINE HCL,,,,,,,,,,,0.3933333333,0.7264957265,,,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | PREGABALIN,,,,,,0.3205741627,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | GABAPENTIN | SERTRALINE HCL,,,,,,0.4496644295,,,,,0.5438596491,,,0.8191933241,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8181818182,,
  3 ,Age: 65-79 | Gender: Female | GABAPENTIN | SIMVASTATIN,,,0.4827586207,,,,,0.4568965517,,,,,,0.4572368421,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | TRAMADOL HCL,,,,,,0.2873134328,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | TRAZODONE HCL,,,,,,,,,,,0.3575418994,,,,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),,,,,,0.323943662,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | UNSPECIFIED INFLAMMATORY AND TOXIC NEUROPATHY (dxo:ICD9:3579),,,,,,0.2277227723,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.2987249545,,,,,,,,0.4220183486,,
  1 ,Age: 65-79 | Gender: Female | GABAPENTIN | VENLAFAXINE HCL,,,,,,,,,,,0.4094488189,,,,,
  1 ,Age: 65-79 | Gender: Female | GEMFIBROZIL,,,0.4921465969,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002),0.02919708029,0.04278074866,,,,,0.156626506,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723),,,,,,,0.1271186441,,,,,0.3692307692,,,,
  1 ,Age: 65-79 | Gender: Female | GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723) | PAROXETINE HCL,,,,,,,,,,,,0.7289719626,,,,
  2 ,Age: 65-79 | Gender: Female | HEADACHE (dxo:ICD9:7840),0.01155115512,,,,,,,,,0.03276353276,,,,,,
  1 ,Age: 65-79 | Gender: Female | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.04242424242,,,,,,
  1 ,Age: 65-79 | Gender: Female | HEADACHE (dxo:ICD9:7840) | NORTRIPTYLINE HCL,,,,,,,,,,0.1647727273,,,,,,
  1 ,Age: 65-79 | Gender: Female | HEADACHE (dxo:ICD9:7840) | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | HEADACHE (dxo:ICD9:7840) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.009615384615,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | HEMATURIA (dxo:ICD9:5997),,,0.4426229508,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | HERPES ZOSTER WITHOUT MENTION OF COMPLICATION (dxo:ICD9:0539),0,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364),,,,,,,,,,,,,,,0.004651162791,
  2 ,Age: 65-79 | Gender: Female | HYDRALAZINE HCL,,,0.371040724,,,,,,,,,,,0.4190283401,,
  1 ,Age: 65-79 | Gender: Female | HYDRALAZINE HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8039215686,,
  1 ,Age: 65-79 | Gender: Female | HYDRALAZINE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.7692307692,,
  1 ,Age: 65-79 | Gender: Female | HYDRALAZINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.4473684211,,
  6 ,Age: 65-79 | Gender: Female | HYDROCODONE/ACETAMINOPHEN,0.01724137931,,,,,0.3072916667,0.08,,,,,,0.25,0.4893617021,0.01083032491,
  1 ,Age: 65-79 | Gender: Female | HYDROXYCHLOROQUINE SULFATE,,,,,,,,,,,,,,0.5139664804,,
  1 ,Age: 65-79 | Gender: Female | HYDROXYCHLOROQUINE SULFATE | SERTRALINE HCL,,,,,,,,,,,,,,0.7936507937,,
  1 ,Age: 65-79 | Gender: Female | HYDROXYZINE HCL,,,,,0.1805555556,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | IBUPROFEN,,,,,,,,,,,,,,0.4823529412,0.005988023952,
  1 ,Age: 65-79 | Gender: Female | IMIPRAMINE HCL,,,,,,,,,,,0.2199630314,,,,,
  1 ,Age: 65-79 | Gender: Female | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.07901907357,,,,,
  2 ,"Age: 65-79 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805)",,,,,,,,,,,0.1504424779,,,,,0.2192982456
  1 ,"Age: 65-79 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES  (px:CPT4:90805) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4262295082
  7 ,"Age: 65-79 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.2361111111,,,0.2598425197,0.07954545455,0.2941176471,,,,0.2403846154,,0.201320132,,0.3146067416
  1 ,"Age: 65-79 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.3423423423,,
  3 ,"Age: 65-79 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",,,0.2298136646,,,,0.1016949153,,,,,,,0.224852071,,
  1 ,"Age: 65-79 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | SERTRALINE HCL",,,,,,,,,,,,,,0.4807692308,,
  1 ,"Age: 65-79 | Gender: Female | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4601769912
  7 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",0.009708737864,,0.3975609756,,0.2169811321,,,0.4524180967,0.09119496855,,,,,0.4576271186,0.01125082727,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | MIRTAZAPINE",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,,,,,0.009009009009,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.009950248756,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,0.3669724771,,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.01639344262,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | MIRTAZAPINE",,,,,,,,,0.1268656716,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.3170731707,,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.005154639175,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.008771929825,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & Remiss | SERTRALINE HCL",,,,,,,,,,,,,,0.830449827,,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",,,,,,,,,,,,,,,0.008620689655,
  2 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.7677902622,0.03496503497,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL | SIMVASTATIN",,,,,,,,,,,,,,0.8176470588,,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,,0.01503759398,
  2 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SIMVASTATIN",,,0.4952380952,,,,,,,,,,,0.4512195122,,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TEMAZEPAM",,,,,,,,,,,,,,,0.02040816327,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAMADOL HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.009280742459,
  1 ,"Age: 65-79 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.008051529791,
  1 ,Age: 65-79 | Gender: Female | IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641),,,,,,,,,,0.02857142857,,,,,,
  2 ,Age: 65-79 | Gender: Female | LACTULOSE,,,0.3471502591,,,,0.09392265193,,,,,,,,,
  7 ,Age: 65-79 | Gender: Female | LAMOTRIGINE,,,0.1438596491,,,0.1317567568,0.07692307692,0.1845493562,,,0.1111713666,,,0.1456953642,,0.2017167382
  1 ,"Age: 65-79 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.3516949153,,,,,
  1 ,"Age: 65-79 | Gender: Female | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.3461538462,,,,,
  1 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.1333333333,,,,,
  1 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.07906976744,,,,,
  1 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.1354166667,,,,,
  1 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | ROPINIROLE HCL,,,,,,,,,,,0.1357142857,,,,,
  1 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.1978021978,,,,,
  1 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,,,,0.2205882353,,
  1 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.118245391,,,,,
  1 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.08121827411,,,,,
  2 ,Age: 65-79 | Gender: Female | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,0.1241134752,,,,,0.1571969697
  1 ,Age: 65-79 | Gender: Female | LANSOPRAZOLE,,,,,,,,,0.1517857143,,,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss,,,,,,,,,,,,,,,0.003571428571,
  5 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE,,,0.3503184713,,,,0.1034482759,,,,0.288326301,,,0.3274336283,0.003424657534,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5568862275,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6635514019,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.5185185185,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2236024845,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,,,0.496350365,,,,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.2516556291,,0.5723905724,,,,,
  3 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1924290221,,0.2615384615,,,,0.006779661017,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.5806451613,,,,,0.5714285714
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.2746781116,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6923076923,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.652173913,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.5526315789,,,,
  2 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6137724551,0,
  2 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6215277778,,,0.01342281879,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | ROPINIROLE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.652892562,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | SIMVASTATIN | TRAZODONE HCL",,,,,,,,,,,,,,0.7904761905,,
  2 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6726283048,0.005988023952,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.7089552239,,
  2 ,"Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.01923076923,0.8347826087
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5316091954,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.3668639053,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5786240786,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3115384615,,,,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6617210682,,,,,0.5517241379
  8 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL,,0.01986754967,0.2732240437,,,0.2920353982,0.1028938907,0.3565217391,,,0.3011583012,,,0.4354243542,0.01333333333,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5904486252,,,,0.01550387597,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.38,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.7463768116,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | ROPINIROLE HCL,,,,,,,,,,,0.4134078212,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6910994764,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.006849315068,
  11 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL,0.02189781022,0.01891891892,0.4118942731,,,0.3153153153,0.100286533,0.3829787234,0.1145833333,,0.3476151981,0.2990654206,,,0.008503401361,0.4036697248
  3 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6245975531,,,0.6654275093,0.01199563795,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4579439252,,,,,0.6538461538
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.3612903226,,,,,
  11 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL,0.009852216749,0.02051282051,0.3406862745,,,0.2577319588,0.08477842004,0.3917050691,0.1144781145,,0.336940482,0.3141025641,,0.361003861,0.01243455497,
  3 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6605374823,,,,0.02549575071,0.6452702703
  7 ,Age: 65-79 | Gender: Female | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,0.0234375,0.4453781513,,,0.3025210084,0.09580838323,,,,0.3791208791,,,0.4397163121,0.01675977654,
  5 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss,,0.09090909091,,,,0.5591836735,,,0.2807881773,,,,,,0.05440613027,0.6473988439
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,,,,,0.4336283186,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,,,,,0.375,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.6115702479,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.3465045593,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE,,,,,,,,,0.3854351687,,0.4924623116,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.731884058,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.2946428571,,,,,0.7044025157,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.8252427184,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6428571429,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5879396985,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.619047619,,
  2 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6842105263,,,0.009803921569,
  2 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6753246753,0.01369863014,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,0.008196721311,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6923076923,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5405405405,,,,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6583333333,,,0.6092715232,,
  6 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL,,,0.5321100917,,,0.4112149533,0.2913385827,,,,0.4585365854,,,0.6095890411,0.1007194245,
  3 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5744680851,0.6730769231,,,0.0365448505,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.5867768595,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6206896552,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6305220884,,,,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.5873015873,,,0.5986842105,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.01904761905,
  10 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL,,0.04089219331,0.5106382979,,,0.4618055556,0.2118644068,0.5763888889,0.2188841202,,0.4915611814,0.5,,,0.04788732394,0.7085714286
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.544,,,,,
  3 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.618556701,,,0.6761133603,0.03170409511,
  1 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.04915953061,
  3 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6064257028,,,,0.05291005291,0.6827794562
  4 ,Age: 65-79 | Gender: Female | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,0.6052631579,,,,,0.4800796813,,,,0.08396946565,0.8103448276
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss,,,,,,,,,,,0.09795321637,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.4672897196,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.3741007194
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1156515035,,,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,0.04545454545,,,,,,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.1607142857,,0.3870967742,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5135135135,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2606060606,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.09090909091,,,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.0500481232,,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.3755656109,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3962264151,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4522613065,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.4822335025,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4642857143,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,,,,,0.002309468822,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.45,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4245614035
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5046728972,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.3259557344,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.2924528302,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4401544402,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742) | TRAZODONE HCL,,,,,,,,,,,,,,,0.02083333333,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.2702702703,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4128787879,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5167785235,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.6639344262,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.4315068493,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PREGABALIN | SERTRALINE HCL,,,,,,,,,,,,,,0.5294117647,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.2893401015,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.2346938776,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,,,0.2181588903,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.4403669725,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  2 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.4174757282,,,0.4124748491,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.4380403458,,
  3 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.428057554,,,0.4255319149,0.005617977528,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | TRAMADOL HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.00701754386,
  2 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2027027027,,,,0.008172605427,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.009803921569,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4219409283,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.4048543689
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss,,,,,,,,,,,0.5973348783,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.7448979592,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,,,,0.8450704225,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6683168317,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.7303370787,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.664,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.7155963303,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.807106599,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.687037037,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.7452830189,,,,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SERTRALINE HCL",,,,,,,,,,,,,,0.7894736842,,
  1 ,"Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.8129496403
  2 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,0.6453488372,,0.622833843,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.5648148148,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.562962963,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,,,0.6142857143,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.6948051948,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.5733788396,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.6606060606,,,,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.744966443,0.6600877193,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6305732484,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5514018692,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.6355140187,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.9084507042,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.9362416107,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.947826087,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.7570093458,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.6160714286,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.6534296029,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.7705882353,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.9084745763,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.9346405229,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.7388059701,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | PAROXETINE HCL,,,,,,,,,,,,0.8796296296,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.8530612245,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5905511811,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.8148667602,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6330935252,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | PRAVASTATIN SODIUM,,,,,,,,,,,,0.8440366972,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.821875,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.7098445596,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6592734226,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.7127071823,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.5769230769,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.6426735219,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.5595238095,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6797752809,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8804347826,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | PREGABALIN | SERTRALINE HCL,,,,,,,,,,,,,,0.8372093023,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.7155172414,,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6718246293,,0.7013888889,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6851851852,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.536,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5734908136,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6534653465,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8636363636,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.5140186916,,,0.8391304348,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8567395907,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.7532314924,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.8483146067,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6857638889,,,,,
  1 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.7032810271,,,,,
  2 ,Age: 65-79 | Gender: Female | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.64,,,,,0.8181257707
  1 ,Age: 65-79 | Gender: Female | LEVOFLOXACIN,,,,,,,0.07299270073,,,,,,,,,
  5 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM,,,0.4533333333,,,,0.1,0.5238095238,,,0.2443181818,,,0.4653893696,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.372,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.86,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8850574713,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | PRAVASTATIN SODIUM,,,,,,,,,,,,,,0.4607329843,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8660714286,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | ROSUVASTATIN CALCIUM,,,,,,,,,,,,,,0.5606060606,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8181818182,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7963671128,,
  1 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8564920273,,
  2 ,Age: 65-79 | Gender: Female | LEVOTHYROXINE SODIUM | SIMVASTATIN,,,0.4414414414,,,,,,,,,,,0.4774590164,,
  1 ,Age: 65-79 | Gender: Female | LISINOPRIL,,,0.4037267081,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.4351939451,,,,0.1073170732,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | LISINOPRIL/HYDROCHLOROTHIAZIDE | SIMVASTATIN,,,0.4524886878,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | LORAZEPAM,,0.05298013245,0.3771929825,,,,,,,,,,,0.423580786,,
  1 ,Age: 65-79 | Gender: Female | LORAZEPAM | SERTRALINE HCL,,,,,,,,,,,,,,0.7431192661,,
  5 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321),,,0.3518248175,,,,,0.4318181818,0.1088769004,,,0.3036437247,,0.4418604651,,
  1 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1175115207,,,,,,,
  1 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.2173913043,,,,,,,
  1 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.186440678,,,,,,,
  1 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.2112676056,,,,,,,
  1 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | PAROXETINE HCL,,,,,,,,,,,,0.6124031008,,,,
  2 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | SERTRALINE HCL,,,,,,,,,0.1397379913,,,,,0.6742424242,,
  1 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | TRAZODONE HCL,,,,,,,,,0.1351351351,,,,,,,
  1 ,Age: 65-79 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.1029411765,,,,,,,
  3 ,Age: 65-79 | Gender: Female | LOVASTATIN,0.01694915254,,0.4275132275,,,,0.1160572337,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.4951140065,,,,,,,,,0.6866197183,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.8263598326,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.8114285714,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MIRTAZAPINE",,,,,,,,,,,0.6766917293,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.7024793388,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | ROPINIROLE HCL",,,,,,,,,,,0.715,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.6860730594,,,,,
  10 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.496194825,0.6629213483,,,0.6705426357,0.5598455598,0.6774193548,0.5251798561,,0.6807994023,,,0.652360515,0.4060606061,0.6987179487
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6431924883,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6235294118,,,,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE",,,,,,,,,0.5306122449,,0.662835249,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.6608695652,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.7138643068,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | ROPINIROLE HCL",,,,,,,,,,,0.6759493671,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.6294117647,,,,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,0.6666666667,,,0.8164983165,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6614785992,,,,0.3979238754,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,0.6824324324,,,,,0.7614678899
  3 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",,,0.5555555556,,,,,,,,0.2916666667,,,0.4569892473,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,0.5283018868,,,0.7908496732,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | VENLAFAXINE HCL",,,,,,,,,,,0.4174757282,,,,,
  14 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",0.2196261682,0.2591380251,0.5529411765,0.5319148936,,0.4571428571,0.3525641026,0.5690866511,0.3328488372,0.3115942029,0.5075757576,0.5079365079,,0.5849056604,0.1895093063,0.5328836425
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.3771251932,,0.536380597,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.3818181818,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | SERTRALINE HCL",,,,,,,,,,,0.5769230769,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.5,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | VENLAFAXINE HCL",,,,,,,,,,,0.462962963,,,,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | NORTRIPTYLINE HCL",,,,,,,,,,0.3333333333,0.544600939,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.44,,,,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,,,,,,,,,,0.4819277108,0.6714513557,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6545454545,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.5875831486,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL | TRAZODONE HCL",,,,,,,,,,,0.5183486239,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | RISPERIDONE",,,,,,,,,,,0.3185840708,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.5606936416,,,,,
  1 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.493902439,,,,,
  4 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,0.3816793893,,0.3017241379,,0.4760820046,,,0.7978142077,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.5137254902,,,0.619047619,,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.518572825,,,,0.1936056838,
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.5454545455,,,,,0.6237623762
  2 ,"Age: 65-79 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.5278350515,,,,,0.6493987049
  4 ,"Age: 65-79 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,0.01886792453,,,,,,0.502994012,,,,,,0.4803418803,,0.4416749751
  1 ,"Age: 65-79 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SERTRALINE HCL",,,,,,,,,,,,,,0.8448844884,,
  1 ,"Age: 65-79 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | SIMVASTATIN",,,,,,,,,,,,,,0.5083333333,,
  1 ,"Age: 65-79 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6258992806
  1 ,"Age: 65-79 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7395411606
  1 ,Age: 65-79 | Gender: Female | MASTODYNIA (dxo:ICD9:61171),,,,,,,,,,,,,,0.4187192118,,
  1 ,Age: 65-79 | Gender: Female | MASTODYNIA (dxo:ICD9:61171) | SERTRALINE HCL,,,,,,,,,,,,,,0.7722772277,,
  2 ,Age: 65-79 | Gender: Female | MECLIZINE HCL,,,0.4037267081,,,,,,,,,,,0.3951367781,,
  1 ,Age: 65-79 | Gender: Female | MECLIZINE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.7846153846,,
  1 ,Age: 65-79 | Gender: Female | MELOXICAM,,,,,,0.296460177,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | METAXALONE,,,0.452173913,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | METFORMIN HCL,,,,,,,,,0.1111111111,,,0.3515151515,,0.4586466165,,
  1 ,Age: 65-79 | Gender: Female | METFORMIN HCL | PAROXETINE HCL,,,,,,,,,,,,0.7988505747,,,,
  12 ,Age: 65-79 | Gender: Female | MIRTAZAPINE,0.01538461538,0.01875,0.3403908795,,,0.279491833,0.1379897785,0.2745098039,0.2473789516,,0.39622488,0.2698412698,,0.3559928444,0.015625,0.3623188406
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.4326241135,,,,,
  1 ,"Age: 65-79 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6637931034,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.309375,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.35,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.304,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3653846154,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3155216285,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2415730337,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.3082706767,,,,,
  3 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,0.2092050209,,0.4426229508,0.5567928731,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3522012579,,,,,
  1 ,"Age: 65-79 | Gender: Female | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,0.1339285714,,,,,
  1 ,"Age: 65-79 | Gender: Female | MIRTAZAPINE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.1404958678,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5178571429,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4954954955,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,,,,,,,,,0.1968503937,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.1612318841,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1598746082,,,,,
  2 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,0.2427184466,,0.4401913876,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4133333333,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,0.3490566038,,,,,,,
  4 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL,,,,,,,0.18,,0.2279693487,,0.4723214286,,,0.6134316134,,
  2 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4273504274,,,0.5555555556,,
  3 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1906976744,,0.3485893417,,,,0.032,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3412322275,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,0.36,,,,,,,
  1 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.2662337662,,,,,,,
  3 ,Age: 65-79 | Gender: Female | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,0.2140077821,,0.3977272727,,,,,0.6403940887
  1 ,Age: 65-79 | Gender: Female | MITRAL VALVE DISORDERS (dxo:ICD9:4240),,,,,,,0.1436781609,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | MONTELUKAST SODIUM,,,0.4539007092,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.126394052,,0.1503759398,,,,,,,
  1 ,Age: 65-79 | Gender: Female | MOXIFLOXACIN HCL,,,,,,,0.1240875912,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | MUSCLE WEAKNESS (GENERALIZED) (dxo:ICD9:72887),,,,,,,,,,,,,,,,0.472
  1 ,Age: 65-79 | Gender: Female | MUSCLE WEAKNESS (GENERALIZED) (dxo:ICD9:72887) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.752293578
  3 ,Age: 65-79 | Gender: Female | MYOPIA (dxo:ICD9:3671),,0.0737704918,0.3953488372,,,,,,,,,,,0.5446428571,,
  5 ,Age: 65-79 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02059357965,,,,,0.1044546851,,0.1157407407,,,,,0.4219858156,0.005464480874,
  1 ,Age: 65-79 | Gender: Female | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.01092896175,,,,,,,,,,,,,,
  9 ,Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL,0.01612903226,,0.3870967742,,,0.3115577889,0.1111111111,,0.11,0.1603568845,0.4799128751,,,0.4421052632,,0.4
  1 ,"Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7160493827,,
  1 ,Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3488372093,,,,,
  3 ,Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL | PAROXETINE HCL,,,,,,,,,,0.1304347826,0.4889867841,0.7019607843,,,,
  1 ,Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5823754789,,,,,
  1 ,Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5596590909,,,,,
  3 ,Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,0.1609195402,0.5965665236,,,0.666,,
  2 ,Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,0.1897810219,0.4180569185,,,,,
  3 ,Age: 65-79 | Gender: Female | NORTRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,0.1415929204,0.5669781931,,,,,0.6720430108
  1 ,"Age: 65-79 | Gender: Female | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.5498489426,,,,
  1 ,"Age: 65-79 | Gender: Female | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.6265822785,,,,
  1 ,"Age: 65-79 | Gender: Female | Num Previous Antidep: 2,3 | ROPINIROLE HCL | SERTRALINE HCL",,,,,,,,,,,,,,0.6666666667,,
  1 ,"Age: 65-79 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6719653179,,
  1 ,"Age: 65-79 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL | VENLAFAXINE HCL",,,,,,,,,,,,,,0.701986755,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+,,,,,,,,,,,0.2943469786,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | PAROXETINE HCL,,,,,,,,,,,,0.41,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.4074074074,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.495049505,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4593495935,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4070351759,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | ROPINIROLE HCL,,,,,,,,,,,0.3512658228,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.419804742,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4166666667,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3387779794,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Antidep: 4+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.2990654206,,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.5545722714,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.9,,,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.9302694136,,
  2 ,Age: 65-79 | Gender: Female | Num Previous Remissions: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.7012195122,,,0.625,,
  1 ,Age: 65-79 | Gender: Female | Num Previous Remissions: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.547008547
  1 ,Age: 65-79 | Gender: Female | Num Previous Remissions: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.8662420382
  2 ,"Age: 65-79 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.03383458647,,,,,,,0.102189781,,,,,,,
  1 ,Age: 65-79 | Gender: Female | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2592592593,,,,,
  8 ,Age: 65-79 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),0.01923076923,,0.5060240964,,,,0.1363220494,,0.09701492537,,0.376,0.4805825243,,0.530884808,0.01379310345,
  2 ,Age: 65-79 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | PAROXETINE HCL,,,,,,,,,,,0.4556962025,0.7740740741,,,,
  2 ,Age: 65-79 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,0.5192982456,,,0.8230769231,,
  1 ,Age: 65-79 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.85625,,
  2 ,Age: 65-79 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SIMVASTATIN,,,0.5339805825,,,,,,,,,,,0.51875,,
  1 ,Age: 65-79 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | TRAZODONE HCL,,,,,,,,,,,0.3302752294,,,,,
  1 ,Age: 65-79 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | VENLAFAXINE HCL,,,,,,,,,,,0.5256410256,,,,,
  1 ,Age: 65-79 | Gender: Female | OLMESARTAN MEDOXOMIL,,,,,,,0.09785932722,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | OMEPRAZOLE,,,,,,,0.09433962264,,,,0.2782369146,,,,,
  1 ,Age: 65-79 | Gender: Female | OMEPRAZOLE | PAROXETINE HCL,,,,,,,,,,,0.3779069767,,,,,
  1 ,Age: 65-79 | Gender: Female | OMEPRAZOLE | SERTRALINE HCL,,,,,,,,,,,0.4703947368,,,,,
  1 ,Age: 65-79 | Gender: Female | OMEPRAZOLE | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.4545454545,,,,,
  2 ,Age: 65-79 | Gender: Female | OMEPRAZOLE | SIMVASTATIN,,,,,,,0.08878504673,,,,0.380952381,,,,,
  1 ,Age: 65-79 | Gender: Female | OMEPRAZOLE | TRAZODONE HCL,,,,,,,,,,,0.3435582822,,,,,
  1 ,Age: 65-79 | Gender: Female | OMEPRAZOLE | VENLAFAXINE HCL,,,,,,,,,,,0.4912280702,,,,,
  2 ,Age: 65-79 | Gender: Female | OTHER DISORDERS OF BONE AND CARTILAGE (dxo:ICD9:73399),,,0.4824561404,,,,,,0.1059602649,,,,,,,
  2 ,Age: 65-79 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,0.4166666667,,0.3175853018,,,
  1 ,Age: 65-79 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.608,,,
  2 ,Age: 65-79 | Gender: Female | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,0.4351851852,,0.5183150183,,,
  3 ,Age: 65-79 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.02714932127,,,,0.3484486874,,,,,,,,,0.01,
  1 ,Age: 65-79 | Gender: Female | OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319),,,0.3784860558,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | OTHER PERSISTENT MENTAL DISORDERS DUE TO CONDITIONS CLASSIFIED ELSEWHERE (dxo:ICD9:2948),,,0.4293785311,,,,,,0.09248554913,,,,,,,
  2 ,Age: 65-79 | Gender: Female | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.0162601626,0.3489583333,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.01296596434,,,,,,,,,,,,,0.5255255255,,
  1 ,Age: 65-79 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.006779661017,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612) | SERTRALINE HCL,,,,,,,,,,,,,,0.7952755906,,
  1 ,Age: 65-79 | Gender: Female | OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283),,,0.52,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Female | OXYBUTYNIN CHLORIDE,,,,,,,0.1318181818,,,,0.2666666667,,,0.4807692308,,
  1 ,Age: 65-79 | Gender: Female | OXYBUTYNIN CHLORIDE | PAROXETINE HCL,,,,,,,,,,,0.4519230769,,,,,
  1 ,Age: 65-79 | Gender: Female | OXYBUTYNIN CHLORIDE | SERTRALINE HCL,,,,,,,,,,,0.530726257,,,,,
  1 ,Age: 65-79 | Gender: Female | OXYBUTYNIN CHLORIDE | TRAZODONE HCL,,,,,,,,,,,0.3168316832,,,,,
  2 ,Age: 65-79 | Gender: Female | OXYCODONE HCL,0.005154639175,,,,,,0.1146496815,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",,,,,,0.36328125,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949) | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",,,,,,0.3401360544,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",,,,,,0.3366336634,,,,,,,,,,
  7 ,Age: 65-79 | Gender: Female | PALPITATIONS (dxo:ICD9:7851),,,0.3633802817,,,0.3181818182,0.08023774146,0.469273743,,,0.2316384181,0.3597122302,,0.3956043956,,
  1 ,Age: 65-79 | Gender: Female | PALPITATIONS (dxo:ICD9:7851) | PAROXETINE HCL,,,,,,,,,,,,0.6926605505,,,,
  1 ,Age: 65-79 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001),,,,,,,,,,,,0.3454545455,,,,
  1 ,Age: 65-79 | Gender: Female | PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001) | PAROXETINE HCL,,,,,,,,,,,,0.6862745098,,,,
  6 ,Age: 65-79 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320),,,0.3214285714,,,,0.09459459459,,,,0.4457593688,,0.4542253521,0.4169278997,0.008333333333,
  1 ,Age: 65-79 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | PAROXETINE HCL,,,,,,,,,,,0.4888888889,,,,,
  1 ,Age: 65-79 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5278450363,,,,,
  1 ,Age: 65-79 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.5737704918,,,,,
  2 ,Age: 65-79 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL,,,,,,,,,,,0.5487804878,,0.5990990991,,,
  1 ,Age: 65-79 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6168224299,,,,,
  2 ,Age: 65-79 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | SERTRALINE HCL,,,,,,,,,,,0.5091575092,,,0.6816143498,,
  1 ,Age: 65-79 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | VENLAFAXINE HCL,,,,,,,,,,,0.5384615385,,,,,
  14 ,Age: 65-79 | Gender: Female | PAROXETINE HCL,0.02801120448,0.04157549234,0.4899211218,,,0.4019715225,0.1740121581,0.4704,0.1456521739,0.03289473684,0.3859191656,0.6228051392,0.1768292683,0.5104895105,0.02995391705,0.5186046512
  1 ,"Age: 65-79 | Gender: Female | PAROXETINE HCL | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,,,,,,,,,,0.3851351351,,,,
  2 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6029776675,0.5218658892,,,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6296296296,,,,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | PRAVASTATIN SODIUM,,,,,,,,,,,,0.7605177994,,,,
  1 ,"Age: 65-79 | Gender: Female | PAROXETINE HCL | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,0.46,,,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.4403669725,,,,,
  2 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5244755245,,0.4697986577,,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | RISEDRONATE SODIUM,,,,,,,,,,,,0.6279069767,,,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | RISPERIDONE,,,,,,,,,,,,0.225,,,,
  3 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.6291913215,0.5948827292,0.4236311239,,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5592105263,,,,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,0.7358490566,,,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),,,,,,,,,,,,0.7055555556,,,,
  3 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,0.3967611336,0.5798319328,,0.5647558386,,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.534351145,,,,,
  2 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | SIMVASTATIN,,,,,,,,,,,0.3769470405,0.7115384615,,,,
  3 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5394366197,0.5562390158,,,0.02190332326,
  1 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5391304348,,,,,
  3 ,Age: 65-79 | Gender: Female | PAROXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4110169492,0.6268656716,,,,0.5238095238
  1 ,"Age: 65-79 | Gender: Female | PEN NEEDLE, DIABETIC",,,0.3966244726,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742),,,,,,,,,,,,,,0.4765100671,0.01079136691,
  7 ,"Age: 65-79 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2630208333,,,0.1891891892,,,0.03896103896,,0.183908046,,,0.2602040816,0.02755905512,0.2183406114
  2 ,"Age: 65-79 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,0.1657754011,,,0.4773662551,,
  2 ,"Age: 65-79 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.2195121951,,,0.3461538462,,
  2 ,"Age: 65-79 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL",,,,,,,,,,,0.156462585,,,,0.05882352941,
  2 ,"Age: 65-79 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.3119266055,,,,,0.2920353982
  2 ,"Age: 65-79 | Gender: Female | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,0.2352941176,,,,,0.3388157895
  1 ,Age: 65-79 | Gender: Female | POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572),0.006493506494,,,,,,,,,,,,,,,
  10 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL,,0.02631578947,0.3045977011,,,0.2094017094,0.1005586592,0.3916666667,0.1226415094,,0.545154434,,,0.3737864078,0.01142857143,0.3486238532
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5831775701,,,,,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5392156863,,,,,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.6811023622,,,,,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | TRAZODONE HCL,,,,,,,,,,,0.654676259,,,,,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | VENLAFAXINE HCL,,,,,,,,,,,0.6902654867,,,,,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.5133574007,,,,,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6347826087,,,,,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4326465927,,,,,
  2 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.6431767338,,,0.5850556439,,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5603864734,,,,,
  2 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4799037304,,,,0.003389830508,
  1 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4918918919,,,,,
  2 ,Age: 65-79 | Gender: Female | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5559322034,,,,,0.4606060606
  5 ,Age: 65-79 | Gender: Female | PRAVASTATIN SODIUM,,,0.4200426439,,,,0.08561643836,,,,0.2327586207,0.38671875,,0.4553140097,,
  1 ,Age: 65-79 | Gender: Female | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8238434164,,
  5 ,Age: 65-79 | Gender: Female | PREGABALIN,,,0.4129554656,,,0.3640776699,0.1124260355,0.5433526012,,,,,,0.4795321637,,
  1 ,Age: 65-79 | Gender: Female | PREGABALIN | SERTRALINE HCL,,,,,,,,,,,,,,0.7857142857,,
  1 ,Age: 65-79 | Gender: Female | PREGABALIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3411764706,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Female | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,0.3891050584,,,,0.1065989848,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511),,,,,,,,,0.1194029851,,,,,0.5283018868,,
  1 ,Age: 65-79 | Gender: Female | PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511) | SERTRALINE HCL,,,,,,,,,,,,,,0.7456140351,,
  1 ,Age: 65-79 | Gender: Female | PROCHLORPERAZINE MALEATE,,,,,,,,,0.1224489796,,,,,,,
  3 ,Age: 65-79 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.275862069,,,,0.08955223881,,,,,,,0.4016620499,,
  3 ,"Age: 65-79 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2232142857,,,,0.07947019868,,,,,,,0.2628865979,,
  1 ,"Age: 65-79 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.5454545455,,
  1 ,Age: 65-79 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SERTRALINE HCL,,,,,,,,,,,,,,0.6887755102,,
  2 ,Age: 65-79 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792),,,0.2549019608,,,,,,,,,,,0.4682539683,,
  9 ,Age: 65-79 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.3039215686,,,0.2429378531,0.09796672828,0.3431372549,0.08532423208,,0.2205882353,0.2279411765,,0.3608490566,,0.3787878788
  2 ,Age: 65-79 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | SERTRALINE HCL,,,,,,,,,,,0.2795698925,,,0.6096256684,,
  1 ,Age: 65-79 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801) | TRAZODONE HCL,,,,,,,,,,,0.168,,,,,
  2 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",,,,,,,,,,,0.1920903955,,,,0.05660377358,
  2 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | SERTRALINE HCL",,,,,,,,,,,0.2133333333,,,0.5384615385,,
  1 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL",,,,,,,,,,,0.162962963,,,,,
  1 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.25,,,,,
  2 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833) | VENLAFAXINE HCL",,,,,,,,,,,0.1376146789,,,,,0.3720930233
  8 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.2341137124,,,0.1728813559,0.07915057915,0.1978021978,,,0.1751412429,,,0.2158590308,0.006097560976,0.2427184466
  2 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.2452830189,,,0.4955223881,,
  2 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.3271604938,,,0.3555555556,,
  1 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL",,,,,,,,,,,0.1871345029,,,,,
  2 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | TRAZODONE HCL | VENLAFAXINE HCL",,,,,,,,,,,0.3980582524,,,,,0.3305785124
  2 ,"Age: 65-79 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,0.2307692308,,,,,0.4033898305
  2 ,Age: 65-79 | Gender: Female | RAMIPRIL,,,,,,,0.09589041096,,,,,,,0.4845814978,,
  1 ,Age: 65-79 | Gender: Female | RAMIPRIL | SERTRALINE HCL,,,,,,,,,,,,,,0.8214285714,,
  2 ,Age: 65-79 | Gender: Female | RANITIDINE HCL,,,,,,0.2072072072,0.08070866142,,,,,,,,,
  5 ,Age: 65-79 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,0.427184466,,,,0.1388888889,,,,0.4663212435,,0.2437238494,0.5252525253,,
  2 ,Age: 65-79 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.517571885,,0.5036166365,,,
  3 ,Age: 65-79 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.7166212534,,0.4641909814,0.7043010753,,
  1 ,Age: 65-79 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5460526316,,,,,
  2 ,Age: 65-79 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4143646409,,0.502994012,,,
  2 ,Age: 65-79 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.7048192771,,0.4285714286,,,
  2 ,Age: 65-79 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | SERTRALINE HCL,,,,,,,,,,,0.5138888889,,,0.756097561,,
  1 ,Age: 65-79 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | TRAZODONE HCL,,,,,,,,,,,0.4358974359,,,,,
  1 ,Age: 65-79 | Gender: Female | RHEUMATOID ARTHRITIS (dxo:ICD9:7140),,,,,,0.2357723577,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | RISEDRONATE SODIUM,,,,,,,0.1088709677,,,,,0.2866242038,,,,
  7 ,Age: 65-79 | Gender: Female | RISPERIDONE,,,0.1788856305,,,0.1695906433,0.07172995781,,0.08333333333,,0.145272867,,,0.1824324324,,0.2582417582
  1 ,Age: 65-79 | Gender: Female | RISPERIDONE | ROPINIROLE HCL,,,,,,,,,,,0.2105263158,,,,,
  2 ,Age: 65-79 | Gender: Female | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.1561181435,,,0.1877934272,,
  2 ,Age: 65-79 | Gender: Female | RISPERIDONE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1489361702,,,0.1988636364,,
  1 ,Age: 65-79 | Gender: Female | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1324921136,,,,,
  2 ,Age: 65-79 | Gender: Female | RISPERIDONE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.1288343558,,,,,0.2038834951
  2 ,Age: 65-79 | Gender: Female | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,0.1569506726,,,,,0.2184615385
  12 ,Age: 65-79 | Gender: Female | ROPINIROLE HCL,0.03225806452,0.02197802198,0.3404255319,,,0.2278820375,0.127388535,0.3389830508,0.1237623762,,0.5154676843,,0.4425207756,0.33,0.02469135802,0.3065693431
  3 ,Age: 65-79 | Gender: Female | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.647385103,,0.3875598086,0.590729783,,
  1 ,Age: 65-79 | Gender: Female | ROPINIROLE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.496350365,,,,,
  3 ,Age: 65-79 | Gender: Female | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4475661058,,0.5080213904,,0.009174311927,
  1 ,Age: 65-79 | Gender: Female | ROPINIROLE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.44140625,,,,,
  3 ,Age: 65-79 | Gender: Female | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5621436716,,0.4060150376,,,0.5492662474
  5 ,Age: 65-79 | Gender: Female | ROSUVASTATIN CALCIUM,,,0.4752851711,,,0.3140495868,,0.5436893204,,,,,,0.5081967213,0,
  1 ,Age: 65-79 | Gender: Female | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8333333333,,
  3 ,Age: 65-79 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,0.04464285714,,,,,,,,,,0.3961038961,,,0.01126760563,
  1 ,"Age: 65-79 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",,,,,,,,,,,,,,,0.01503759398,
  1 ,Age: 65-79 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL,,,,,,,,,,,,,,,0.01226993865,
  1 ,Age: 65-79 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,,,,,,,0.01282051282,
  5 ,Age: 65-79 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231),0.01224489796,,,,,0.362962963,0.1244870041,,0.1037974684,,,0.3901639344,,,,
  1 ,Age: 65-79 | Gender: Female | ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231) | SIMVASTATIN,,,,,,,0.1034482759,,,,,,,,,
  16 ,Age: 65-79 | Gender: Female | SERTRALINE HCL,0.02986857826,0.03256936068,0.4539059608,0.6086956522,0.156,0.3958333333,0.173346056,0.4501891551,0.1308627678,0.04815864023,0.4420747489,0.3930921053,0.1753846154,0.6828550897,0.01551389787,0.5610200364
  2 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.5045372051,,,0.8086096568,,
  2 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.7777777778,,,0.6017699115,,
  1 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | SIMVASTATIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.8108108108,,
  1 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | TOPIRAMATE,,,,,,,,,,,,,,0.8322147651,,
  8 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | TRAZODONE HCL,,0.01724137931,0.4109589041,,,0.25,0.149122807,0.3577235772,,,0.5674122717,,,0.5967329266,0.02083333333,
  1 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4868421053,,,,,
  2 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5172413793,,,,,,,,0.7620320856,,
  1 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,,,,,,,,,,,,0.7857142857,,
  1 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,,,,,,0.698630137,,
  1 ,"Age: 65-79 | Gender: Female | SERTRALINE HCL | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.7295081967,,
  3 ,Age: 65-79 | Gender: Female | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.466819222,,,0.6299112801,,0.6284916201
  6 ,Age: 65-79 | Gender: Female | SIMVASTATIN,,,0.4593120805,,,,0.099543379,0.536101083,,,0.2945454545,0.3812154696,,0.4788235294,,
  1 ,Age: 65-79 | Gender: Female | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.3505976096,,,,,
  1 ,Age: 65-79 | Gender: Female | SIMVASTATIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,,,,,,,,,0.4365079365,,
  1 ,Age: 65-79 | Gender: Female | SIMVASTATIN | VENLAFAXINE HCL,,,,,,,,,,,0.5067264574,,,,,
  1 ,"Age: 65-79 | Gender: Female | SODIUM, POTASSIUM,MAG SULFATES",,,0.5393258427,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Female | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",,,,,,,,,,,,,,,0.01592356688,
  1 ,Age: 65-79 | Gender: Female | SPECIAL SCREENING FOR OTHER SPECIFIED CONDITIONS (dxo:ICD9:V8289),,,0.4433962264,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272),,,,,,,,,,,,,,,,0.4362244898
  1 ,Age: 65-79 | Gender: Female | SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.6887417219
  1 ,Age: 65-79 | Gender: Female | TEMAZEPAM,,,,,,,,,,,,,,,0.007722007722,
  1 ,Age: 65-79 | Gender: Female | TOPIRAMATE,,,,,,,,,,,,,,0.5602409639,,
  4 ,Age: 65-79 | Gender: Female | TRAMADOL HCL,,,,,,0.2723279649,0.1308016878,,,,,,0.2180094787,,0.01149425287,
  1 ,Age: 65-79 | Gender: Female | TRAMADOL HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.01773049645,
  1 ,Age: 65-79 | Gender: Female | TRAMADOL HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.3333333333,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | TRAMADOL HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0,
  2 ,Age: 65-79 | Gender: Female | TRAMADOL HCL/ACETAMINOPHEN,,,0.4139344262,,,0.3173076923,,,,,,,,,,
  14 ,Age: 65-79 | Gender: Female | TRAZODONE HCL,0.02004454343,0.03821656051,0.3421633554,,,0.2418918919,0.1189979123,0.3574938575,0.1290849673,0.04326923077,0.4392921384,0.3092269327,0.2,0.3579931973,0.02056743042,0.3293413174
  3 ,Age: 65-79 | Gender: Female | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5074557316,,,,0.02786377709,0.5702097405
  1 ,Age: 65-79 | Gender: Female | TRAZODONE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.01834862385,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491),,,,,,,0.1121076233,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,0.4819277108,,,,,,,,,,,0.4630541872,,
  2 ,Age: 65-79 | Gender: Female | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,0.112033195,,,,,,0.009345794393,
  4 ,Age: 65-79 | Gender: Female | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),0.01162790698,,,,,0.2834224599,,,,0.05882352941,,,,0.4153846154,,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED INFLAMMATORY AND TOXIC NEUROPATHY (dxo:ICD9:3579),,,0.4205607477,,,,,,,,,,,,,
  8 ,Age: 65-79 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),0.01680672269,,0.4153225806,,,0.3284169125,0.08849557522,0.5052631579,,,,0.34,,0.4589285714,0,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291) | VENLAFAXINE HCL,,,,,,0.6571428571,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,0.4939271255,0.1182943604,,,,,,,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED PERIPHERAL VASCULAR DISEASE (dxo:ICD9:4439),,,,,,,0.09793814433,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED PRURITIC DISORDER (dxo:ICD9:6989),,,,,0.17,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED PSYCHOSIS (dxi:ICD9:2989),,,,,,,,,,,,,,,0,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.00956937799,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259),,,,,,,,,,,,,,0.408,,
  2 ,Age: 65-79 | Gender: Female | UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515),,,0.3833333333,,,,,0.4117647059,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359),,,,,,,,0.4096385542,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED URTICARIA (dxo:ICD9:7089),,,,,0.2233009709,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Female | UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610),,,0.3981191223,,,,,,,,,,,0.4156378601,,
  4 ,Age: 65-79 | Gender: Female | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,0.07246376812,,,,0.2403846154,0.4928057554,,0.3582089552
  1 ,Age: 65-79 | Gender: Female | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689) | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.785467128
  1 ,"Age: 65-79 | Gender: Female | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.4520547945,,
  1 ,Age: 65-79 | Gender: Female | VALSARTAN,,,,,,,0.1004901961,,,,,,,,,
  1 ,Age: 65-79 | Gender: Female | VALSARTAN/HYDROCHLOROTHIAZIDE,,,,,,,0.05833333333,,,,,,,,,
  15 ,Age: 65-79 | Gender: Female | VENLAFAXINE HCL,0.03053435115,0.05378151261,0.5419103314,,0.1666666667,0.5022970904,0.2004357298,0.5262135922,0.1273712737,0.03669724771,0.4128744423,0.4487951807,0.1419753086,0.5155737705,0.02044293015,0.6156418354
  1 ,Age: 65-79 | Gender: Female | VILAZODONE HCL,,,,,,,,,,,0.640625,,,,,
  2 ,Age: 65-79 | Gender: Female | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,0.4711538462,0.004287245445,
  16 ,Age: 65-79 | Gender: Male,0.03590551181,0.06713811769,0.5566496064,0.4973544974,0.2686890574,0.4034687109,0.2244993422,0.5729525608,0.1977289113,0.1089275688,0.4354581713,0.5286304604,0.4045660567,0.5810285363,0.02631675943,0.5403739907
  2 ,Age: 65-79 | Gender: Male | ALLOPURINOL,,,,,,,,0.5568862275,,,,,,0.530726257,,
  1 ,Age: 65-79 | Gender: Male | ALPRAZOLAM,,,,,,,,,,,,,,0.4516129032,,
  2 ,Age: 65-79 | Gender: Male | ALZHEIMER'S DISEASE (dxo:ICD9:3310),,,,,,,,0.4677419355,,,,0.3942307692,,,,
  10 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL,0.05572682001,0,0.462962963,,,0.2985074627,0.1256038647,0.4711538462,,0.09649122807,0.4517374517,,,0.4429824561,0.03225806452,
  3 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL,0.08609271523,0.04608294931,,,,,,,,,0.3263433814,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Last AD: Diff & No Remiss,,0.02631578947,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.4181818182,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | BUPROPION HCL | TRAZODONE HCL,,,,,,,,,,,0.2085561497,,,,,
  3 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE,0.07729468599,,0.5891238671,,,,,,,,0.546875,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,,,,,,,,,,0.5964912281,,,,,
  1 ,"Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.06557377049,,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",0.01,,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL,0.08196721311,,,,,0.5283687943,,,,,0.4153846154,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,0.4854368932,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE,0.05673758865,,,,,,0.355450237,,,,0.344,,,,,
  3 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | FLUOXETINE HCL,0.04242424242,,,,,,,0.6452991453,,,0.6049382716,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | HEADACHE (dxo:ICD9:7840) | Last AD: Same & No Remiss,0,,,,,,,,,,,,,,,
  4 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss,,,,,,0.31,,,,,0.3206896552,,,0.4803921569,0.007194244604,
  1 ,"Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6416666667,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.6304347826,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.02542372881,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.01909307876,,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6704545455,,,,,
  1 ,"Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.6056338028,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3745173745,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.4150943396,,,,,
  1 ,"Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.641221374,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3411764706,,,,,
  3 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | PAROXETINE HCL,0.06422018349,,,,,,,,,,0.518134715,0.6183574879,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5458333333,,,,,
  1 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5314861461,,,,,
  3 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | SERTRALINE HCL,0.01694915254,,,,,,,,,,0.5196850394,,,0.6433566434,,
  2 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | TRAZODONE HCL,0.1118421053,,,,,,,,,,0.335347432,,,,,
  2 ,Age: 65-79 | Gender: Male | AMITRIPTYLINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5318181818,,,,,0.6842105263
  2 ,Age: 65-79 | Gender: Male | AMLODIPINE BESYLATE,0.01041666667,,,,,,,,,,,,,,0.01081081081,
  1 ,Age: 65-79 | Gender: Male | ANOREXIA (dxo:ICD9:7830),,,,,,,,,0.1217391304,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ANOREXIA (dxo:ICD9:7830) | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.1428571429,,,,,,,
  4 ,"Age: 65-79 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,0.02985074627,,,,,0.1469957082,,,,,0.4064748201,,,0.01612903226,
  1 ,"Age: 65-79 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL",,0.08527131783,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | BUPROPION HCL | Last AD: Same & No Remiss",,0.05769230769,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,,,,,,0.3127035831,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.1164658635,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.2816901408,,,,
  1 ,"Age: 65-79 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & Remiss | PAROXETINE HCL",,,,,,,,,,,,0.8104575163,,,,
  1 ,"Age: 65-79 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL",,,,,,,,,,,,0.6994219653,,,,
  1 ,Age: 65-79 | Gender: Male | ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400),,,,,,,,,,,,,,,0.02,
  2 ,"Age: 65-79 | Gender: Male | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)",,,0.4652406417,,,,,0.4919354839,,,,,,,,
  6 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM,,,0.4615384615,,,,0.1442307692,0.5573566085,,,0.3154761905,0.4716981132,,0.5283806344,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE,,,0.7982646421,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.86875,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.4444444444,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL,,,,,,,,0.8047337278,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.4907407407,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.8530612245,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | GABAPENTIN,,,,,,,,,,,,,,0.4888888889,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | GABAPENTIN | SERTRALINE HCL,,,,,,,,,,,,,,0.8125,,
  1 ,"Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,0.5,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.473880597,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8498293515,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,,,,0.6157407407,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.843373494,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8298784846,,
  1 ,Age: 65-79 | Gender: Male | ATORVASTATIN CALCIUM | SIMVASTATIN,,,,,,,,,,,,,,0.5070422535,,
  1 ,Age: 65-79 | Gender: Male | BENIGN NEOPLASM OF COLON (dxo:ICD9:2113),,,,,,,,0.6306306306,,,,,,,,
  11 ,Age: 65-79 | Gender: Male | BUPROPION HCL,,0.06460344672,0.4315789474,,,0.3827655311,0.1609353508,0.4189473684,0.1598360656,,0.4348799045,0.3807692308,,0.4376693767,0.02173913043,0.4346793349
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.06228373702,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | Last AD: Same & No Remiss",,0.01158301158,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.01526717557,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.06201550388,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,0.04287901991,0.5735294118,,,,,,,,0.5518367347,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.02926829268,0.664516129,,,,,,,,0.64,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+",,,0.5428571429,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,0.5315315315,,,,,,,,0.6171428571,,,,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.05612244898,0.7080291971,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4392523364,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,,,,,,,,,0.7466063348,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+,,,0.5128205128,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,,,,,,,,,0.4152542373,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,0.07881773399,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss",,0.04054054054,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | DESVENLAFAXINE SUCCINATE,,,,,,,,,,,0.3619047619,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.1018518519,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | DOXEPIN HCL,,,,,,,,,,,0.3708609272,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | DULOXETINE HCL,,0.05172413793,,,,0.5100671141,,,,,0.4370946822,,,,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Diff & No Remiss,,0.04615384615,,,,,,,,,0.5460992908,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6363636364,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3419354839,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE,,0.0406504065,,,,,0.3367243133,,,,0.3766478343,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.03378378378,,,,,0.3555555556,,,,0.4290322581,,,,,
  2 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,0.0396039604,,,,,0.3571428571,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.3959731544,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,,,,,0.2450331126,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,,,,,0.6320754717,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.284457478,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL,,0.08205128205,,,,,,0.5247058824,,,0.5067264574,,,,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.04511278195,,,,,,,,,0.6315789474,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,,0.6611570248,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+,,,,,,,,,,,0.625,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Diff & Remiss,,0.1467889908,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.7080291971,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | Num Previous Antidep: 2,3",,,,,,,,0.6611570248,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3905723906,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784),,0.1007194245,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | Last AD: Same & No Remiss,,0.0223880597,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | LAMOTRIGINE,,,,,,,,,,,0.1120448179,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1030927835,,,,,
  5 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss,,,0.5284552846,,,,0.1144578313,,,,0.2593250444,,,0.4423076923,0.006802721088,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | MIRTAZAPINE,,0.03007518797,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.7407407407,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7487437186,,
  2 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,0.03401360544,,,,,,,,,,,,,0.02127659574,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.6956521739,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1103448276,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.6,,,,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.03888888889,,,,,,,,,0.6890243902,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.03947368421,,,,,,,,,0.1061093248,,,,0.02941176471,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.6470588235,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss,,0.1184834123,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7401574803,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Diff & Remiss | SERTRALINE HCL,,0.02976190476,,,,,,,,,,,,0.7388059701,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss,,0.02925925926,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.01477832512,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4324324324,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2075471698,,,,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss,,0.6439393939,,,,,,,,,0.6884576098,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.75,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7058823529,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.6229508197,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6279069767,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6075949367,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,0.75,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5825471698,,,,,
  2 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.504950495,,,,,,,,,0.75,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.7463768116,,,,,
  2 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.4797687861,,,,,,,,,0.6933962264,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6169154229,,,,,
  2 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.2517985612,,,,,,,,,0.5307212823,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.4511278195,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | Num Previous Antidep: 4+ | TRAZODONE HCL",,,,,,,,,,,0.4645669291,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4676007005,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | MIRTAZAPINE,,0.03092783505,,,,,,,0.2629482072,,0.3543078412,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+,,,,,,,,,,,0.2820512821,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.316017316,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2887323944,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.05487804878,,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.4210526316,,,,,
  1 ,"Age: 65-79 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.7579908676,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.3270676692,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3039215686,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2745098039,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.297810219,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | PAROXETINE HCL,,0.06389776358,,,,,,,,,0.564231738,0.6117424242,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3481481481,,,,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,0.1111111111,,,,,,,,,0.484375,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.4454545455,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.3432835821,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | RISPERIDONE,,,,,,,,,,,0.1989247312,,,,,
  2 ,Age: 65-79 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL,,0.005617977528,,,,,,,,,0.4686623012,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.2968299712,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | SERTRALINE HCL,,0.0353460972,,,,,,,,,0.5905974535,,,0.5854456255,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3908045977,,,,,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | SILDENAFIL CITRATE,,0.1,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | TRAZODONE HCL,,0.07552870091,,,,,,,,,0.319213045,,,,0.02716468591,
  1 ,Age: 65-79 | Gender: Male | BUPROPION HCL | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3263598326,,,,,
  3 ,Age: 65-79 | Gender: Male | BUPROPION HCL | VENLAFAXINE HCL,,0.09465020576,,,,,,,,,0.4812593703,,,,,0.5527522936
  1 ,Age: 65-79 | Gender: Male | CARBIDOPA/LEVODOPA | Last AD: Same & Remiss | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6822429907,,,,,
  2 ,Age: 65-79 | Gender: Male | CARBIDOPA/LEVODOPA | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.5346820809,,0.5740740741,,,
  1 ,Age: 65-79 | Gender: Male | CARBIDOPA/LEVODOPA | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6966292135,,,,,
  1 ,Age: 65-79 | Gender: Male | CARBIDOPA/LEVODOPA | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL,,,,,,,,,,,0.6695652174,,,,,
  1 ,Age: 65-79 | Gender: Male | CELECOXIB,,,0.5,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Male | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,0.1384615385,,,,,,,0.5730994152,,
  1 ,"Age: 65-79 | Gender: Male | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0.02389078498,,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496) | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",,0.0201793722,,,,,,,,,,,,,,
  13 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE,0.03664921466,0.03346203346,0.6540367076,,,0.4375,0.2850877193,0.5019455253,0.1177829099,,0.4416952474,0.453038674,0.2566371681,0.5517826825,0.01901140684,0.5947242206
  1 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.8324324324,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.7170731707,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,0.6258992806,,,0.5,,,,,0.4,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4918032787,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,,0.7557755776,,,,0.3650793651,,,,0.3665594855,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.3706293706,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3",,,,,,,0.4230769231,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.3965517241,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM,,,0.6815642458,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.7413793103,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,,0.6960784314,,,,,0.6492537313,,,0.4306569343,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | GABAPENTIN,,,0.7338709677,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | LAMOTRIGINE,,,0.1658291457,,,,,,,,,,,,,
  9 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,0.01357466063,,,,0.396039604,0.2162162162,0.4351851852,0.1428571429,,0.3737373737,,,0.4746543779,0.01639344262,0.45
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.5609756098,,,,,
  1 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.5112359551,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.6267605634,,,,,,,,,,,,0,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5079365079,,,,,,,,0.59566787,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,0.6428571429,,,,,,,,0.643129771,,,,0.005865102639,
  4 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,0.0390625,,,,,0.2923076923,,,,0.519379845,,,0.690647482,,
  2 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.7457627119,,,,,,,,,,,,0,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | TRAZODONE HCL,,,0.7137096774,,,,,,,,,,,,0.01746724891,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.4155783582,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.458781362,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.4083333333,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SIMVASTATIN,,,0.4492753623,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3899082569,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.8247595148,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+,,,0.9109589041,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | Num Previous Remissions: 2+,,,0.9121621622,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.8534201954,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6899224806,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6829268293,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SIMVASTATIN,,,0.8452380952,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.7207207207,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.7527472527,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | LOVASTATIN,,,0.7080745342,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,0.7605633803,,,,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.7447698745,,,,,,,,0.5928571429,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,0.5433789954,,,,,,0.2616033755,,0.4632107023,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.3679245283,,,,,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,0.6576576577,,,,,,,,0.514084507,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.5120772947,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | Num Previous Remissions: 2+,,,0.9072847682,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.8121387283,,,,,,,,0.5815217391,,,,,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | PARALYSIS AGITANS (dxo:ICD9:3320),,,0.6912751678,,,,,,,,0.4585152838,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,,0.5955882353,,,,,,,,0.3663366337,0.546961326,,,,
  1 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.4247787611,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,0.5251141553,,,,,,,,0.5833333333,,,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | PRAVASTATIN SODIUM,,,0.8181818182,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.48,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6454545455,,0.4660194175,,,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,0.1866666667,,,,,,,,0.09448818898,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,0.6042780749,,,,,,,,0.6265822785,,0.4827586207,,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4888888889,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,,0.6457765668,,,,,,,,0.4672489083,,,0.63,,
  1 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4049586777,,,,,
  2 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | SIMVASTATIN,,,0.8071895425,,,,,,,,0.5389221557,,,,,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,0.5528700906,,,,,,,,0.520287622,,,,0.008591065292,
  3 ,Age: 65-79 | Gender: Male | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,,0.6266666667,,,,,,,,0.3863636364,,,,,0.753968254
  3 ,Age: 65-79 | Gender: Male | CLONAZEPAM,,,,,,,,,0.1548387097,,0.4137931034,,,,0.01219512195,
  1 ,"Age: 65-79 | Gender: Male | CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)",,,,,,,,0.4757281553,,,,,,,,
  4 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.4961538462,,,,,,,,0.2871287129,0.4952380952,,0.5274725275,,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.7434210526,,,,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.7722772277,,
  11 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0.0293040293,0.04255319149,0.527027027,,,0.3630136986,0.181184669,0.5622119816,,,0.4257425743,0.5,,0.6148148148,0.01497005988,0.4839319471
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | ESCITALOPRAM OXALATE",,,,,,,0.3813559322,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | FLUOXETINE HCL",,,,,,,,0.7463414634,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.02380952381,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.01886792453,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.009478672986,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.5142857143
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & Remiss | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.8052631579
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.7253521127,,,,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 65-79 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7467811159
  5 ,Age: 65-79 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.485042735,,,,0.1305263158,0.5092592593,0.1211538462,,,0.4277108434,,,,
  1 ,Age: 65-79 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ESCITALOPRAM OXALATE,,,,,,,0.3402777778,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.1261261261,,,,,,,
  1 ,Age: 65-79 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | MIRTAZAPINE,,,,,,,,,0.2476190476,,,,,,,
  1 ,Age: 65-79 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | PAROXETINE HCL,,,,,,,,,,,,0.7064220183,,,,
  2 ,Age: 65-79 | Gender: Male | DESVENLAFAXINE SUCCINATE,,,,0.5123558484,,,,,,,0.3456221198,,,,,
  1 ,Age: 65-79 | Gender: Male | DESVENLAFAXINE SUCCINATE | TRAZODONE HCL,,,,,,,,,,,0.4285714286,,,,,
  2 ,"Age: 65-79 | Gender: Male | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",,0.008695652174,,,,,,,,,,,0.3300970874,,,
  2 ,Age: 65-79 | Gender: Male | DOXEPIN HCL,,,,,0.4204435873,,,,,,0.480964467,,,,,
  1 ,Age: 65-79 | Gender: Male | DOXEPIN HCL | Last AD: Same & No Remiss,,,,,0.2388663968,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | DOXEPIN HCL | MIRTAZAPINE,,,,,,,,,,,0.35,,,,,
  2 ,Age: 65-79 | Gender: Male | DOXEPIN HCL | SERTRALINE HCL,,,,,,,,,,,0.5688073394,,,0.7102803738,,
  1 ,Age: 65-79 | Gender: Male | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.4429824561,,,,,
  11 ,Age: 65-79 | Gender: Male | DULOXETINE HCL,0.03448275862,0.05357142857,0.4746268657,,,0.491125016,0.2088772846,0.5542857143,0.1732673267,,0.3995416348,,,0.5361111111,0.05084745763,0.5542168675
  2 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,0.3953488372,,,,0.3913043478,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.41,,,,,
  3 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | FLUOXETINE HCL,,,,,,0.5299145299,,0.6714285714,,,0.3988095238,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | GABAPENTIN,,,,,,0.6237288136,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss,,,,,,0.2896551724,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | LAMOTRIGINE,,,,,,0.1442307692,,,,,,,,,,
  4 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,0.1570247934,,,,0.3527131783,,,0.4636363636,0,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.4745762712,,,,,
  3 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.4647302905,,,,,0.5269709544,,,,0.01224489796,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.4846938776,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.01652892562,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.2777307367,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.3513513514,,,,,
  2 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,0.7504332756,,,,,0.6842105263,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6431924883,,,,,
  1 ,"Age: 65-79 | Gender: Male | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,0.6666666667,,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Male | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5347593583,,,,,0.44375,,,,,
  3 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.4055944056,,,0.2393617021,,0.4376470588,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.3401360544,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | NORTRIPTYLINE HCL,,,,,,,,,,,0.421875,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | PAROXETINE HCL,,,,,,,,,,,,0.6805555556,,,,
  2 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,0.3714285714,,,,,0.5153846154,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | PREGABALIN,,,,,,0.637037037,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | ROPINIROLE HCL,,,,,,0.4549019608,,,,,0.5156695157,,,,,
  3 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | SERTRALINE HCL,,,,,,0.567839196,,,,,0.4460966543,,,0.6834319527,,
  3 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.4606060606,,,,,0.451183432,,,,0.02919708029,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.656,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | DULOXETINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.3788819876,,,,,
  1 ,Age: 65-79 | Gender: Male | ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889),,,0.4112149533,,,,,,,,,,,,,
  12 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE,0.02,0.04255319149,0.6642494561,,,0.4807197943,0.320591161,0.5028089888,0.122244489,,0.3094362745,0.4113924051,,0.5162882527,0.01670146138,0.5710723192
  3 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,0.3045685279,0.6315789474,,,0.3274336283,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | GABAPENTIN,,,,,,,0.3556701031,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,0.1743119266,,,,,,,,,
  9 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,0.02290076336,0.6170212766,,,0.339869281,,0.4356435644,0.1274509804,,0.2363636364,,,0.4944649446,0.01276595745,0.5147058824
  2 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,0.2341772152,,,,0.35,,,,,
  1 ,"Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,0.2173913043,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.2269503546,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.2550143266,,,,,,,,0.03333333333,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2585365854,,,,,
  3 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.2543859649,,,,0.2731958763,,,,0.01412429379,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,,,,,0.4906542056,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,0.7058823529,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1184417216,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.1630434783,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1622807018,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | SIMVASTATIN,,,,,,,0.1016949153,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2554112554,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.7703703704,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.7894736842,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6857142857,,,,,
  1 ,"Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.6119402985,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.3798767967,,,,0.3951612903,,,,,
  3 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.2829268293,,0.2459893048,,0.3122743682,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2752808989,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,,,,,,0.325203252,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.4149377593,,,,0.380952381,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | OMEPRAZOLE,,,,,,,0.4589041096,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,0.3365384615,,,,0.3886010363,,,,,
  1 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5420560748,,,,,
  2 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | PAROXETINE HCL,,,,,,,,,,,0.4117647059,0.5736842105,,,,
  2 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,0.2941176471,,,,0.596,,,,,
  1 ,"Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,0.2212389381,,,,,
  3 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,0.2328244275,,,,0.5436893204,,0.4351145038,,,
  3 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,0.28125,,,,0.3333333333,,,0.5864022663,,
  2 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | SIMVASTATIN,,,,,,,0.3766816143,,,,0.358490566,,,,,
  3 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.2840283242,,,,0.3069090909,,,,0.0136286201,
  3 ,Age: 65-79 | Gender: Male | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,0.3875968992,,,,0.3389830508,,,,,0.7087378641
  2 ,Age: 65-79 | Gender: Male | ESOMEPRAZOLE MAGNESIUM,,,0.4364089776,,,,0.1360946746,,,,,,,,,
  3 ,"Age: 65-79 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.4978070175,,,0.3238095238,,,,,,,,,,0.5
  1 ,"Age: 65-79 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SIMVASTATIN",,,0.5661157025,,,,,,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7548076923
  2 ,Age: 65-79 | Gender: Male | EZETIMIBE/SIMVASTATIN,,,0.5760869565,,,,0.1111111111,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FAMOTIDINE,,,,,,,0.1095890411,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FENOFIBRATE,,,,,,,,,,,,,,0.5440414508,,
  1 ,Age: 65-79 | Gender: Male | FENOFIBRATE | SERTRALINE HCL,,,,,,,,,,,,,,0.8767123288,,
  1 ,Age: 65-79 | Gender: Male | FENOFIBRATE NANOCRYSTALLIZED,,,,,,,0.1632653061,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881),,,,,,,,,,,,,,0.5201793722,,
  12 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL,0.008474576271,0.02841918295,0.5256916996,,,0.3873873874,0.1939799331,0.6560312699,0.1504178273,,0.4245014245,0.5059760956,,0.5265251989,0.0261627907,0.5283687943
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.7509881423,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | FLUOXETINE HCL | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,0.786259542,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | LAMOTRIGINE,,,,,,,,0.1746031746,,,,,,,,
  5 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss,,0.02586206897,,,,,0.1142857143,,,,0.3914590747,,,0.4504504505,0.02752293578,
  1 ,"Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,,0.5229357798,,,,,,,,
  1 ,"Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6116071429,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.6257668712,,,,,
  2 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.6455331412,,,,0.0197044335,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.5350553506,,,,,
  1 ,"Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6571428571,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,0.6623376623,,,,,,,0.03333333333,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.4243394716,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,,0.4765100671,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | SIMVASTATIN,,,,,,,,0.4666666667,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4247787611,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.8409602401,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | SIMVASTATIN,,,,,,,,0.9020618557,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6872037915,,,,,
  1 ,"Age: 65-79 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,0.7476635514,,,,,,,,
  2 ,"Age: 65-79 | Gender: Male | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.6891025641,,,0.5471698113,,,,,
  3 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.5945945946,0.2566037736,,0.4813664596,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.376146789,,,,,
  1 ,"Age: 65-79 | Gender: Male | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.6150442478,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,,,,,0.5238095238,,,,,
  1 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | PAROXETINE HCL,,,,,,,,,,,,0.6974789916,,,,
  2 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,0.6466165414,,,0.5543478261,,,,,
  2 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,0.577092511,,,0.6666666667,,,,,
  3 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | SERTRALINE HCL,,,,,,,,0.5846153846,,,0.3888888889,,,0.6713286713,,
  2 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.81724846,,,0.5882352941,,,,,
  3 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.5409047161,,,0.5363565285,,,,0.03921568627,
  2 ,Age: 65-79 | Gender: Male | FLUOXETINE HCL | VENLAFAXINE HCL,,,,,,,,0.6486486486,,,0.4736842105,,,,,
  9 ,Age: 65-79 | Gender: Male | GABAPENTIN,,0.04195804196,0.4657534247,,,0.3047530289,0.1293375394,0.4948453608,,0.07926829268,0.3,0.3970588235,,0.4828431373,,
  1 ,Age: 65-79 | Gender: Male | GABAPENTIN | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.1391304348,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | GABAPENTIN | PREGABALIN,,,,,,0.417218543,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | GABAPENTIN | SERTRALINE HCL,,,,,,,,,,,,,,0.7663043478,,
  1 ,Age: 65-79 | Gender: Male | GABAPENTIN | SIMVASTATIN,,,,,,,,,,,,,,0.4748201439,,
  1 ,Age: 65-79 | Gender: Male | GABAPENTIN | TRAMADOL HCL,,,,,,0.2627737226,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | GABAPENTIN | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),,,,,,0.3430232558,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.2569444444,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | GEMFIBROZIL,,,0.5309734513,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | HEADACHE (dxo:ICD9:7840),0.009756097561,,,,,,,,,0.02727272727,,,,,,
  1 ,Age: 65-79 | Gender: Male | HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364),,,,,,,,,,,,,,,0,
  2 ,Age: 65-79 | Gender: Male | HYDRALAZINE HCL,,,0.4173913043,,,,,,,,,,,0.4483775811,,
  1 ,Age: 65-79 | Gender: Male | HYDRALAZINE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.685483871,,
  5 ,Age: 65-79 | Gender: Male | HYDROCODONE/ACETAMINOPHEN,0.01526717557,,,,,0.3168316832,0.1451612903,,,,,,0.3119266055,,0.005494505495,
  1 ,Age: 65-79 | Gender: Male | HYDROXYZINE HCL,,,,,0.196969697,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | HYPERTROPHY (BENIGN) OF PROSTATE WITH URINARY OBSTRUCTION AND OTHER LOWER URINARY TRACT SYMPTOMS [LUTS] (dxo:ICD9:60001),,,,,,,,,,,,0.4111111111,,,,
  1 ,Age: 65-79 | Gender: Male | IMIPRAMINE HCL,,,,,,,,,,,0.1782178218,,,,,
  1 ,Age: 65-79 | Gender: Male | IMIPRAMINE HCL | Last AD: Same & No Remiss,,,,,,,,,,,0.09045226131,,,,,
  2 ,Age: 65-79 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784),,0,,,,,,,,,,,,0.4924242424,,
  1 ,Age: 65-79 | Gender: Male | IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784) | SERTRALINE HCL,,,,,,,,,,,,,,0.7692307692,,
  3 ,"Age: 65-79 | Gender: Male | INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES  (px:CPT4:90806)",,,0.253164557,,,,0.08139534884,,,,,,,0.255952381,,
  5 ,"Age: 65-79 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,0.5222929936,,,,,0.4929078014,0.1345454545,,,,,0.4724770642,0.01380897583,
  1 ,"Age: 65-79 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.008871989861,
  1 ,"Age: 65-79 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.7535211268,,
  1 ,"Age: 65-79 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TEMAZEPAM",,,,,,,,,,,,,,,0.006993006993,
  1 ,"Age: 65-79 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.02105263158,
  1 ,"Age: 65-79 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.01347708895,
  2 ,Age: 65-79 | Gender: Male | LACTULOSE,,,0.4205607477,,,,0.1395348837,,,,,,,,,
  5 ,Age: 65-79 | Gender: Male | LAMOTRIGINE,,,0.1888111888,,,0.1370967742,,,,,0.1256476684,,,0.2027972028,,0.1386138614
  1 ,"Age: 65-79 | Gender: Male | LAMOTRIGINE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.3142857143,,,,,
  1 ,Age: 65-79 | Gender: Male | LAMOTRIGINE | MIRTAZAPINE,,,,,,,,,,,0.174863388,,,,,
  1 ,Age: 65-79 | Gender: Male | LAMOTRIGINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.145631068,,,,,
  1 ,Age: 65-79 | Gender: Male | LAMOTRIGINE | SERTRALINE HCL,,,,,,,,,,,,,,0.1940298507,,
  1 ,Age: 65-79 | Gender: Male | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1457943925,,,,,
  1 ,Age: 65-79 | Gender: Male | LAMOTRIGINE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.1534391534
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss,,,,,,,,,,,,,,,0.006611570248,
  4 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,0.09166666667,,,,0.2985781991,,,0.381294964,0.01069518717,
  1 ,"Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.568,,,,,
  3 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.25,,0.2662337662,,,,0.01149425287,
  1 ,"Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5865384615,,
  2 ,"Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6593137255,0.008547008547,
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6396396396,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5656934307,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.75,,,,,
  2 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.3155555556,,,0.4054054054,,
  2 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6480686695,,,,0.0078125,
  9 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL,,0.02293577982,0.4494382022,,,0.325203252,0.1365313653,0.3706896552,0.1097560976,,0.4079173838,,,,0.007220216606,0.3805309735
  2 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6086956522,,,,0.01,
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.3529411765,,,,,
  9 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.03539823009,0.3591160221,,,0.2824427481,0.09375,0.3431372549,0.1428571429,,0.3131046614,,,0.4179104478,0.01428571429,
  3 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.7089201878,,,,0.02307692308,0.6557377049
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.4,,,,,
  3 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss,,0.1071428571,,,,,,,0.2437810945,,,,,,0.0487804878,
  1 ,"Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,,,,,0.3009708738,
  2 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | MIRTAZAPINE,,,,,,,,,0.5271565495,,0.5897435897,,,,,
  2 ,"Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.718061674,0.02912621359,
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.4583333333,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0.01769911504,
  6 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL,,0.09090909091,,,,0.38,0.2700729927,,0.2830188679,,0.5171790235,,,,0.03125,
  3 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6173913043,,,0.716,0.02536231884,
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.04010695187,
  2 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,,0.07936507937,0.6448598131
  1 ,Age: 65-79 | Gender: Male | Last AD: Diff & Remiss | VENLAFAXINE HCL,,,,,,,,,,,0.5481927711,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss,,,,,,,,,,,0.1076115486,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1483433735,,,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.06994818653,,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.375,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4958677686,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,,,,,0.01423487544,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3653846154
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5169491525,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.3529886914,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.298245614,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,,,0.2567567568,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700) | TRAZODONE HCL,,,,,,,,,,,,,,,0.01941747573,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.4366914935,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.4941176471,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4266666667,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.01196381675,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3979057592
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss,,,,,,,,,,,0.6357615894,,,,,
  1 ,"Age: 65-79 | Gender: Male | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.7134502924,,,,,
  2 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,0.6632996633,,0.6281755196,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.5754385965,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | NORTRIPTYLINE HCL,,,,,,,,,,,0.6336633663,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.9417475728,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.9393939394,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.9423076923,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.9396551724,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,,,,0.9183673469,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SERTRALINE HCL,,,,,,,,,,,,,,0.8306451613,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6228571429,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.8192968111,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6640625,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6897810219,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.6147540984,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.7393939394,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.6683168317,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.6393762183,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.6262135922,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8320051004,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.85428051,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6947791165,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6806181584,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.6926829268,,,,,
  1 ,Age: 65-79 | Gender: Male | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.8188854489
  1 ,Age: 65-79 | Gender: Male | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.6071428571,,
  1 ,Age: 65-79 | Gender: Male | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8095238095,,
  2 ,Age: 65-79 | Gender: Male | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.5073170732,,,,0.1442307692,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | LORAZEPAM,,,,,,,,,,,,,,0.5196078431,,
  4 ,Age: 65-79 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321),,,0.3988095238,,,,,,0.1393162393,,,0.3095238095,,0.429245283,,
  1 ,Age: 65-79 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321) | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1588785047,,,,,,,
  1 ,Age: 65-79 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.2580645161,,,,,,,
  2 ,Age: 65-79 | Gender: Male | LOVASTATIN,,,0.5067024129,,,,0.1779141104,,,,,,,,,
  2 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,0.5555555556,,,,,,,,,0.7046035806,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.8181818182,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.722972973,,,,,
  3 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,0.5033557047,,,,,,,,,0.6837560712,,,,0.4238095238,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE",,,,,,,,,,,0.69,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.6875,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | ROPINIROLE HCL",,,,,,,,,,,0.7583333333,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,,,,0.797979798,,
  2 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6393442623,,,,0.3846153846,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.7479674797
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632) | SERTRALINE HCL",,,,,,,,,,,,,,0.816,,
  10 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.2676886792,0.5925925926,,,0.4262820513,0.3483709273,0.5755813953,0.3192771084,,0.510794897,,,0.5362318841,0.2069857697,0.5466101695
  2 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.3872053872,,0.5324947589,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.4736842105,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,,,,,,,,,,,0.6993464052,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PRAMIPEXOLE DI-HCL",,,,,,,,,,,0.5966386555,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.5343137255,,,,,
  1 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL | TRAZODONE HCL",,,,,,,,,,,0.4311926606,,,,,
  2 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,0.5745856354,,,0.7632398754,,
  2 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.5134719015,,,,0.2022727273,
  2 ,"Age: 65-79 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.46,,,,,0.6304347826
  2 ,Age: 65-79 | Gender: Male | METFORMIN HCL,,,,,,,,,0.08771929825,,,0.5405405405,,,,
  9 ,Age: 65-79 | Gender: Male | MIRTAZAPINE,,,0.3869731801,,,0.3181818182,0.1096345515,0.4166666667,0.2910852077,,0.4004688063,,,0.3601398601,0,0.4310344828
  1 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.325,,,,,
  1 ,"Age: 65-79 | Gender: Male | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5950413223,,
  1 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3141993958,,,,,
  1 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.4237288136,,,,,
  2 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,,,0.4945054945,0.6242038217,,,,
  1 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5169230769,,,,,
  1 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.1302521008,,,,,
  1 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1161290323,,,,,
  2 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,0.25,,0.4819944598,,,,,
  3 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.2276029056,,0.4875,,,0.5592885375,,
  1 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3858267717,,,,,
  2 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.282674772,,0.3392612859,,,,,
  1 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.298013245,,,,,
  3 ,Age: 65-79 | Gender: Male | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,0.268907563,,0.375257732,,,,,0.6231884058
  1 ,Age: 65-79 | Gender: Male | MORBID OBESITY (dxo:ICD9:27801),,,,,,,0.1578947368,,,,,,,,,
  5 ,Age: 65-79 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051),,0.02118644068,,,,,0.1125827815,,0.1260504202,,,,,0.4024390244,0.01025641026,
  1 ,Age: 65-79 | Gender: Male | NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051) | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,0.01324503311,,,,,,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | NORTRIPTYLINE HCL,,,,,,,,,,0.1645663454,0.4328621908,,,,,
  2 ,Age: 65-79 | Gender: Male | NORTRIPTYLINE HCL | SERTRALINE HCL,,,,,,,,,,,0.5643564356,,,0.6554621849,,
  1 ,Age: 65-79 | Gender: Male | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3639344262,,,,,
  1 ,"Age: 65-79 | Gender: Male | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.5740740741,,,,
  1 ,"Age: 65-79 | Gender: Male | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.6568848758,,
  1 ,Age: 65-79 | Gender: Male | Num Previous Antidep: 4+,,,,,,,,,,,0.3333333333,,,,,
  1 ,Age: 65-79 | Gender: Male | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4259259259,,,,,
  1 ,Age: 65-79 | Gender: Male | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3721973094,,,,,
  1 ,Age: 65-79 | Gender: Male | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3301158301,,,,,
  1 ,Age: 65-79 | Gender: Male | Num Previous Episodes: 2+ | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,,0.5727272727,,,,
  1 ,Age: 65-79 | Gender: Male | Num Previous Remissions: 2+ | PAROXETINE HCL,,,,,,,,,,,,0.9345794393,,,,
  1 ,Age: 65-79 | Gender: Male | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.9382716049,,
  2 ,"Age: 65-79 | Gender: Male | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,0.009009009009,,,,,,,0.09677419355,,,,,,,
  1 ,Age: 65-79 | Gender: Male | OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003),,,,,,,,,,,0.2711864407,,,,,
  9 ,Age: 65-79 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),0,,0.5574092247,,,,0.1568627451,,0.2071005917,,0.3944099379,0.4836956522,0.3278688525,0.5613682093,0.005235602094,
  1 ,Age: 65-79 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | PAROXETINE HCL,,,,,,,,,,,,0.8055555556,,,,
  2 ,Age: 65-79 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL,,,,,,,,,,,0.5485714286,,,0.8496240602,,
  1 ,Age: 65-79 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7966101695,,
  2 ,Age: 65-79 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723) | SIMVASTATIN,,,0.4916666667,,,,,,,,,,,0.6123595506,,
  1 ,Age: 65-79 | Gender: Male | OLMESARTAN MEDOXOMIL,,,,,,,0.1654135338,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | OMEPRAZOLE,,,,,,,0.1255605381,,,,0.2585034014,,,,,
  1 ,Age: 65-79 | Gender: Male | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399),,,,,,,,,,,,,0.3975903614,,,
  1 ,Age: 65-79 | Gender: Male | OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399) | ROPINIROLE HCL,,,,,,,,,,,,,0.4795081967,,,
  3 ,Age: 65-79 | Gender: Male | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,0.01777777778,,,,0.2686567164,,,,,,,,,0,
  1 ,Age: 65-79 | Gender: Male | OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319),,,0.3965517241,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | OTHER PERSISTENT MENTAL DISORDERS DUE TO CONDITIONS CLASSIFIED ELSEWHERE (dxo:ICD9:2948),,,0.5,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698),,,0.448,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572),,,,,,,0.132231405,,,,,0.4416666667,,0.5320512821,,
  1 ,Age: 65-79 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | PAROXETINE HCL,,,,,,,,,,,,0.7722772277,,,,
  1 ,Age: 65-79 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SERTRALINE HCL,,,,,,,,,,,,,,0.8532818533,,
  1 ,Age: 65-79 | Gender: Male | OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572) | SIMVASTATIN,,,,,,,,,,,,,,0.5660377358,,
  2 ,Age: 65-79 | Gender: Male | OXYCODONE HCL,0.0157480315,,,,,,0.1532258065,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | PALPITATIONS (dxo:ICD9:7851),,,0.3831775701,,,,0.08898305085,,,,,0.3534482759,,,,
  7 ,Age: 65-79 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320),,,0.4253968254,,,,0.115727003,,,,0.5099150142,0.4059405941,0.496350365,0.4702970297,0.0127388535,
  1 ,Age: 65-79 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | PAROXETINE HCL,,,,,,,,,,,0.4454545455,,,,,
  1 ,Age: 65-79 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6004366812,,,,,
  1 ,Age: 65-79 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.4820143885,,,,,
  2 ,Age: 65-79 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL,,,,,,,,,,,0.5528455285,,0.6474358974,,,
  1 ,Age: 65-79 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6090909091,,,,,
  2 ,Age: 65-79 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | SERTRALINE HCL,,,,,,,,,,,0.4810126582,,,0.7533039648,,
  1 ,Age: 65-79 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | TRAZODONE HCL,,,,,,,,,,,0.3693693694,,,,,
  12 ,Age: 65-79 | Gender: Male | PAROXETINE HCL,0.02777777778,0.04802259887,0.5117493473,,,0.4266666667,0.2286324786,0.4471544715,0.1295336788,,0.4104432301,0.6305073791,,0.5010224949,0.03115264798,0.6078431373
  2 ,Age: 65-79 | Gender: Male | PAROXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5302013423,0.5426356589,,,,
  1 ,Age: 65-79 | Gender: Male | PAROXETINE HCL | PRAVASTATIN SODIUM,,,,,,,,,,,,0.7361111111,,,,
  3 ,Age: 65-79 | Gender: Male | PAROXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5980392157,0.5492227979,0.4311926606,,,
  2 ,Age: 65-79 | Gender: Male | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,,0.5355191257,,0.6153846154,,
  1 ,Age: 65-79 | Gender: Male | PAROXETINE HCL | SIMVASTATIN,,,,,,,,,,,0.380952381,,,,,
  3 ,Age: 65-79 | Gender: Male | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5584415584,0.5726495726,,,0.016563147,
  1 ,"Age: 65-79 | Gender: Male | PEN NEEDLE, DIABETIC",,,0.4758064516,,,,,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742),,,,,,,,,,,,,,,0.02189781022,
  5 ,"Age: 65-79 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",,,0.2574257426,,,,,,,,0.1344537815,,,0.2333333333,0.05844155844,0.2755905512
  1 ,"Age: 65-79 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | SERTRALINE HCL",,,,,,,,,,,,,,0.4188034188,,
  1 ,"Age: 65-79 | Gender: Male | PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.4121621622
  1 ,Age: 65-79 | Gender: Male | POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572),0.01801801802,,,,,,,,,,,,,,,
  3 ,Age: 65-79 | Gender: Male | PRAMIPEXOLE DI-HCL,,,,,,,0.09900990099,,,,0.5479980704,,,0.3534482759,,
  1 ,Age: 65-79 | Gender: Male | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6136363636,,,,,
  1 ,Age: 65-79 | Gender: Male | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.522875817,,,,,
  1 ,Age: 65-79 | Gender: Male | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4362745098,,,,,
  2 ,Age: 65-79 | Gender: Male | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.5643564356,,,0.6079027356,,
  2 ,Age: 65-79 | Gender: Male | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4661921708,,,,0.01379310345,
  2 ,Age: 65-79 | Gender: Male | PRAMIPEXOLE DI-HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5434782609,,,,,0.5555555556
  4 ,Age: 65-79 | Gender: Male | PRAVASTATIN SODIUM,,,0.5428571429,,,,0.09701492537,,,,,0.4318181818,,0.5153374233,,
  1 ,Age: 65-79 | Gender: Male | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8393782383,,
  3 ,Age: 65-79 | Gender: Male | PREGABALIN,,,0.5538461538,,,0.382566586,,,,,,,,0.5611814346,,
  1 ,Age: 65-79 | Gender: Male | PREGABALIN | SERTRALINE HCL,,,,,,,,,,,,,,0.8120300752,,
  2 ,"Age: 65-79 | Gender: Male | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,0.4029850746,,,,0.103626943,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511),,,,,,,,,0.1176470588,,,,,0.4086956522,,
  1 ,Age: 65-79 | Gender: Male | PROCHLORPERAZINE MALEATE,,,,,,,,,0.1171875,,,,,,,
  3 ,Age: 65-79 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.3203125,,,,0.08724832215,,,,,,,0.3579766537,,
  1 ,"Age: 65-79 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,0.2991452991,,
  6 ,Age: 65-79 | Gender: Male | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.3759398496,,,0.2407407407,0.1049562682,,0.09493670886,,0.2435897436,,,0.358662614,,
  7 ,"Age: 65-79 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.288,,,0.1417910448,0.1068376068,,,,0.21,,,0.2450592885,0.008333333333,0.2093023256
  1 ,"Age: 65-79 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,,,,0.4722222222,,
  1 ,"Age: 65-79 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.35
  2 ,Age: 65-79 | Gender: Male | RAMIPRIL,,,,,,,0.1658291457,,,,,,,0.5398230088,,
  1 ,Age: 65-79 | Gender: Male | RANITIDINE HCL,,,,,,,0.1374407583,,,,,,,,,
  2 ,Age: 65-79 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.5054347826,,0.2939632546,,,
  2 ,Age: 65-79 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.5494071146,,0.5555555556,,,
  2 ,Age: 65-79 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6293103448,,0.5363636364,,,
  5 ,Age: 65-79 | Gender: Male | RISPERIDONE,,,0.188172043,,,,0.06349206349,,0.125,,0.1438016529,,,0.2137931034,,
  2 ,Age: 65-79 | Gender: Male | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.1810344828,,,0.2110091743,,
  1 ,Age: 65-79 | Gender: Male | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1818181818,,,,,
  1 ,Age: 65-79 | Gender: Male | RISPERIDONE | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3114754098
  8 ,Age: 65-79 | Gender: Male | ROPINIROLE HCL,,,0.389261745,,,0.28125,0.1076923077,,0.1775700935,,0.5136605416,,0.4810372771,0.3724137931,0.01973684211,
  3 ,Age: 65-79 | Gender: Male | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6405529954,,0.4050632911,0.5668316832,,
  1 ,Age: 65-79 | Gender: Male | ROPINIROLE HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5135135135,,,,,
  2 ,Age: 65-79 | Gender: Male | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4266600595,,,,0.008695652174,
  3 ,Age: 65-79 | Gender: Male | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5875486381,,0.4513274336,,,0.568627451
  3 ,Age: 65-79 | Gender: Male | ROSUVASTATIN CALCIUM,,,0.525,,,,,,,,,,,0.5459940653,0.01418439716,
  1 ,Age: 65-79 | Gender: Male | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.8481675393,,
  1 ,Age: 65-79 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,,0.01670644391,
  15 ,Age: 65-79 | Gender: Male | SERTRALINE HCL,0.01581027668,0.04495747266,0.4466950959,,0.1810344828,0.378559464,0.1901408451,0.455858748,0.148427673,0.07438016529,0.4410828025,0.3798283262,0.2213114754,0.6786190411,0.01355421687,0.5271966527
  1 ,Age: 65-79 | Gender: Male | SERTRALINE HCL | SILDENAFIL CITRATE,,,,,,,,,,,,,,0.7756410256,,
  2 ,Age: 65-79 | Gender: Male | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.4673913043,,,0.7913961039,,
  1 ,Age: 65-79 | Gender: Male | SERTRALINE HCL | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,,,,,,,,,,,,0.8712871287,,
  3 ,Age: 65-79 | Gender: Male | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5456120092,,,0.5889807163,0.01756440281,
  3 ,Age: 65-79 | Gender: Male | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5354330709,,,0.6842105263,,0.6589147287
  3 ,Age: 65-79 | Gender: Male | SILDENAFIL CITRATE,,0.04794520548,0.4619565217,,,,,,,,,,,0.5171232877,,
  6 ,Age: 65-79 | Gender: Male | SIMVASTATIN,,,0.5376088678,,,,0.1443123939,0.5525876461,,,0.3385093168,0.4247787611,,0.533916849,,
  1 ,Age: 65-79 | Gender: Male | SIMVASTATIN | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,,,,,,,,,,,,0.6,,
  1 ,Age: 65-79 | Gender: Male | SIMVASTATIN | TRAZODONE HCL,,,,,,,,,,,0.4077669903,,,,,
  3 ,Age: 65-79 | Gender: Male | SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644),,,0.4925373134,,,,,,0.1739130435,,,,,0.5362318841,,
  1 ,"Age: 65-79 | Gender: Male | SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",,,,,,,,,,,,,,,0.006578947368,
  2 ,Age: 65-79 | Gender: Male | TAMSULOSIN HCL,,,,,,,,,0.1538461538,,,0.4154929577,,,,
  1 ,Age: 65-79 | Gender: Male | TEMAZEPAM,,,,,,,,,,,,,,,0.01069518717,
  2 ,Age: 65-79 | Gender: Male | TRAMADOL HCL,,,,,,0.3558718861,,,,,,,,,0.01079913607,
  12 ,Age: 65-79 | Gender: Male | TRAZODONE HCL,0.01463414634,0.04347826087,0.3394160584,,,0.2661596958,0.1254071661,0.3096590909,0.1432160804,,0.4104195063,0.2694300518,,0.3983870968,0.01932528113,0.3659305994
  3 ,Age: 65-79 | Gender: Male | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4940334129,,,,0.0328358209,0.5306603774
  1 ,Age: 65-79 | Gender: Male | UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491),,,,,,,0.1483679525,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,,,,,,,,,,,,0.4368932039,,
  2 ,Age: 65-79 | Gender: Male | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,0.1532258065,,,,,,0.01777777778,
  4 ,Age: 65-79 | Gender: Male | UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569),0,,,,,0.3805970149,,,,0.06796116505,,,,0.4607843137,,
  2 ,Age: 65-79 | Gender: Male | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.2822580645,,,,,,,,0.4278606965,,
  1 ,Age: 65-79 | Gender: Male | UNSPECIFIED PERIPHERAL VASCULAR DISEASE (dxo:ICD9:4439),,,,,,,0.1346153846,,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050),,,,,,,,,,,,,,,0.0157480315,
  1 ,Age: 65-79 | Gender: Male | UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359),,,,,,,,0.4666666667,,,,,,,,
  1 ,Age: 65-79 | Gender: Male | VALSARTAN,,,,,,,0.1075268817,,,,,,,,,
  11 ,Age: 65-79 | Gender: Male | VENLAFAXINE HCL,,0.06274509804,0.516025641,,,0.4938271605,0.2239747634,0.5066666667,0.1575342466,,0.4059240718,0.4509803922,,0.5259067358,0.03827751196,0.6102777778
  1 ,Age: 65-79 | Gender: Male | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.004893964111,
  16 ,Age: 80-89 | Gender: Female,0.02184124002,0.06116584565,0.442839815,0.5467980296,0.2601067887,0.3267411866,0.1662853754,0.4891436129,0.130985622,0.06310679612,0.4023461212,0.4753609901,0.3349325337,0.4902145792,0.01903935185,0.4857095655
  1 ,Age: 80-89 | Gender: Female | ALPRAZOLAM,,,,,,,,,,,,,,0.2611464968,,
  4 ,Age: 80-89 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310),,,,,,0.2213740458,,0.3546099291,0.07236842105,,,0.3613445378,,,,
  1 ,Age: 80-89 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | CITALOPRAM HYDROBROMIDE,,,,,,,,,,,0.4252336449,,,,,
  1 ,Age: 80-89 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,,,,,,,0.0775862069,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | ESCITALOPRAM OXALATE,,,,,,,,,,,0.2953020134,,,,,
  1 ,Age: 80-89 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | FLUOXETINE HCL,,,,,,,,0.6044776119,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | MIRTAZAPINE,,,,,,,,,,,0.313559322,,,,,
  1 ,Age: 80-89 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | PAROXETINE HCL,,,,,,,,,,,,0.615942029,,,,
  1 ,Age: 80-89 | Gender: Female | ALZHEIMER'S DISEASE (dxo:ICD9:3310) | SERTRALINE HCL,,,,,,,,,,,0.461928934,,,,,
  6 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL,0.03002610966,,0.2148760331,,,0.2598425197,0.1132075472,,,,0.393675527,,,0.3259668508,,
  1 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | BUPROPION HCL,,,,,,,,,,,0.3372781065,,,,,
  3 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | CITALOPRAM HYDROBROMIDE,0.05072463768,,0.5642023346,,,,,,,,0.5131086142,,,,,
  2 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | DULOXETINE HCL,,,,,,0.5096153846,,,,,0.4966442953,,,,,
  2 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | ESCITALOPRAM OXALATE,,,,,,,0.2535211268,,,,0.243902439,,,,,
  1 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.2275449102,,,,,
  1 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.009118541033,,,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | Last AD: Same & Remiss,,,,,,,,,,,0.7333333333,,,,,
  1 ,"Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.4916666667,,,,,
  1 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | MIRTAZAPINE,,,,,,,,,,,0.3854961832,,,,,
  1 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6193548387,,,,,
  1 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.5024630542,,,,,
  3 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | SERTRALINE HCL,0.03048780488,,,,,,,,,,0.5622119816,,,0.6150793651,,
  2 ,Age: 80-89 | Gender: Female | AMITRIPTYLINE HCL | TRAZODONE HCL,0.0625,,,,,,,,,,0.3376865672,,,,,
  1 ,Age: 80-89 | Gender: Female | AMLODIPINE BESYLATE,,,,,,,,,,,,,,,0.008474576271,
  1 ,Age: 80-89 | Gender: Female | ANOREXIA (dxo:ICD9:7830),,,,,,,,,0.07294117647,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ANOREXIA (dxo:ICD9:7830) | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,,,,,,,0.05454545455,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ANOREXIA (dxo:ICD9:7830) | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.1149825784,,,,,,,
  3 ,"Age: 80-89 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,,,,,,0.0687960688,,,,,0.2242990654,,,0.006666666667,
  1 ,"Age: 80-89 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",,,,,,,0.04132231405,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE",,,,,,,0.3201438849,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss",,,,,,,0.07423580786,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | Last AD: Same & No Remiss | PAROXETINE HCL",,,,,,,,,,,,0.3137254902,,,,
  1 ,"Age: 80-89 | Gender: Female | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000) | PAROXETINE HCL",,,,,,,,,,,,0.6548042705,,,,
  1 ,Age: 80-89 | Gender: Female | ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400),,,,,,,,,,,,,,,0.01298701299,
  2 ,"Age: 80-89 | Gender: Female | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)",,,0.265625,,,,,,,,,,,0.3588516746,,
  1 ,"Age: 80-89 | Gender: Female | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020) | CITALOPRAM HYDROBROMIDE",,,0.5517241379,,,,,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020) | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",,,0.2534246575,,,,,,,,,,,,,
  3 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM,,,0.3392857143,,,,,0.3593073593,,,,,,0.3453536755,,
  1 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM | CITALOPRAM HYDROBROMIDE,,,0.6775700935,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM | FLUOXETINE HCL,,,,,,,,0.6732026144,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM | GABAPENTIN,,,,,,,,,,,,,,0.4,,
  1 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3348214286,,
  1 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8344594595,,
  1 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.2989130435,,
  1 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.5982905983,,
  1 ,Age: 80-89 | Gender: Female | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7044025157,,
  1 ,"Age: 80-89 | Gender: Female | BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",,,0.2561983471,,,,,,,,,,,,,
  9 ,Age: 80-89 | Gender: Female | BUPROPION HCL,,0.04353448276,0.3507853403,,,0.2195121951,0.1352657005,0.3435114504,0.1119402985,,0.4142055162,,,0.4600760456,,0.3619047619
  3 ,Age: 80-89 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,0.03260869565,0.5544041451,,,,,,,,0.5142118863,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,,,,,,,,,,0.5980392157,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,,,,,,,,,0.4230769231,,,,,
  2 ,Age: 80-89 | Gender: Female | BUPROPION HCL | DULOXETINE HCL,,,,,,0.4829545455,,,,,0.4280155642,,,,,
  3 ,Age: 80-89 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE,,0.008064516129,,,,,0.3449131514,,,,0.3230337079,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.39,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,,,,,0.2857142857,,,,,
  3 ,Age: 80-89 | Gender: Female | BUPROPION HCL | FLUOXETINE HCL,,0.08396946565,,,,,,0.5196850394,,,0.4972972973,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.2619047619,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,0.009090909091,,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | Last AD: Same & No Remiss,,0.02935010482,,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss,,,,,,,,,,,0.6480836237,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.496350365,,,,,
  1 ,"Age: 80-89 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.7033898305,,,,,
  2 ,"Age: 80-89 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.1923076923,,,,,,,,,0.4460784314,,,,,
  1 ,"Age: 80-89 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,,,0.3762376238,,,,,
  1 ,"Age: 80-89 | Gender: Female | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.461928934,,,,,
  3 ,Age: 80-89 | Gender: Female | BUPROPION HCL | MIRTAZAPINE,,0.04464285714,,,,,,,0.2463768116,,0.3795731707,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.2867647059,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.1853932584,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+,,,,,,,,,,,0.2796610169,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3280632411,,,,,
  2 ,Age: 80-89 | Gender: Female | BUPROPION HCL | PAROXETINE HCL,,,,,,,,,,,0.5882352941,0.6276595745,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5504587156,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL,,,,,,,,,,,0.4595469256,,,,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.3953488372,,,,,
  3 ,Age: 80-89 | Gender: Female | BUPROPION HCL | SERTRALINE HCL,,0.02298850575,,,,,,,,,0.5592592593,,,0.5647058824,,
  1 ,Age: 80-89 | Gender: Female | BUPROPION HCL | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.431372549,,,,,
  3 ,Age: 80-89 | Gender: Female | BUPROPION HCL | TRAZODONE HCL,,0.03875968992,,,,,,,,,0.3224834237,,,,0,
  2 ,Age: 80-89 | Gender: Female | BUPROPION HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4972972973,,,,,0.664
  1 ,"Age: 80-89 | Gender: Female | CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",,,,,,,,,,,,,,0.3300970874,,
  1 ,"Age: 80-89 | Gender: Female | CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",,0,,,,,,,,,,,,,,
  11 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE,,0.048,0.5560261554,,,0.3242009132,0.2334581773,0.3890784983,0.08962868118,,0.3833287634,0.3772727273,,0.4606164384,0.01333333333,0.4242424242
  1 ,"Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.6748971193,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.5884476534,,,,,,,,,,,,,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL,,,0.6034482759,,,0.4342857143,,,,,0.445,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | DULOXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5096153846,,,,,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,,0.6422764228,,,,0.2626262626,,,,0.3675889328,,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,0.2356687898,,,,0.3225806452,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | ESOMEPRAZOLE MAGNESIUM,,,0.6985294118,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | FLUOXETINE HCL,,,0.5039370079,,,,,,,,,,,,,
  5 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,,,,,,0.1377245509,,0.09356725146,,0.2871690428,,,0.3452380952,0.004672897196,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,0.4779411765,,,,,,0.1842105263,,0.4269230769,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+,,,,,,,,,,,0.4672897196,,,,,
  1 ,"Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,0.4790419162,,,,,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,0.5165562914,,,,,,,,,,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.4833333333,,,,,,,,0.4782608696,,,,,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,0.5095238095,,,,,,,,0.488372093,,,,0.008438818565,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,,,,,,0.1862745098,,,,0.4494047619,,,0.5428571429,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | MIRTAZAPINE,,,0.6803278689,,,,,,0.2926829268,,,,,,,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss | TRAZODONE HCL,,,0.6683937824,,,,,,,,0.5952380952,,,,0.05147058824,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.2731760834,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.2475247525,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.4085365854,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,0.3668122271,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | SIMVASTATIN,,,0.2857142857,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.358490566,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.8058823529,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,,,0.5533980583,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | SIMVASTATIN,,,0.8692810458,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6176470588,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.7037037037,,,,,,,,,,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOSS OF WEIGHT (dxo:ICD9:78321),,,0.6347826087,,,,,,0.1095890411,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.1328125,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | LOVASTATIN,,,0.704,,,,,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,0.6333333333,,,,,,,,,,,,,
  2 ,"Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,0.7276785714,,,,,,,,0.4754901961,,,,,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,0.4934210526,,,,,,0.1517128874,,0.4051383399,,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | TRAZODONE HCL,,,0.3557692308,,,,,,,,0.3712121212,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | NORTRIPTYLINE HCL,,,,,,,,,,,0.5092592593,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,0.4855769231,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.7517241379,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | OMEPRAZOLE,,,,,,,,,,,0.4339622642,,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | PARALYSIS AGITANS (dxo:ICD9:3320),,,0.6857142857,,,,,,,,0.3805970149,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | PAROXETINE HCL,,,,,,,,,,,,0.6194690265,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRAMIPEXOLE DI-HCL,,,0.5384615385,,,,,,,,0.6225680934,,,,,
  2 ,"Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,0.5925925926,,,,,,,,0.4789473684,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.6339285714,,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | RISPERIDONE,,,0.2743362832,,,,,,,,0.1584699454,,,,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1262135922,,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,0.5105633803,,,,,,,,0.583106267,,,,,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,,0.5424657534,,,,,,,,0.3726415094,,,0.6022988506,,
  1 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3796296296,,,,,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | SIMVASTATIN,,,0.6771428571,,,,,,,,0.5147058824,,,,,
  3 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,0.4757630162,,,,,,,,0.4523663184,,,,0.009456264775,
  2 ,Age: 80-89 | Gender: Female | CITALOPRAM HYDROBROMIDE | VENLAFAXINE HCL,,,0.5869565217,,,,,,,,0.3787878788,,,,,
  1 ,Age: 80-89 | Gender: Female | CLONAZEPAM,,,,,,,,,0.1238938053,,,,,,,
  2 ,"Age: 80-89 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",,,0.3607594937,,,,,,,,,,,0.5044247788,,
  1 ,"Age: 80-89 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | PAROXETINE HCL",,,,,,,,,,,,0.7808219178,,,,
  1 ,"Age: 80-89 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311) | SERTRALINE HCL",,,,,,,,,,,,,,0.744966443,,
  4 ,"Age: 80-89 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",0,,,,,,0.05825242718,,,,,,,,0.005424954792,0.3450292398
  1 ,"Age: 80-89 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,,,,,,,0.01075268817,
  1 ,"Age: 80-89 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,"Age: 80-89 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | TRAZODONE HCL",,,,,,,,,,,,,,,0.01324503311,
  1 ,"Age: 80-89 | Gender: Female | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311) | VENLAFAXINE HCL",,,,,,,,,,,,,,,,0.6840148699
  5 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.2974504249,,,,0.09548611111,0.3603603604,0.07778510218,,,0.2372881356,,,,
  1 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | ESCITALOPRAM OXALATE,,,,,,,0.2102564103,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1393939394,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.07174887892,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.0762195122,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | MIRTAZAPINE,,,,,,,,,0.1658536585,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | SIMVASTATIN,,,0.2867647059,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,0.06586826347,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.0820668693,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DESVENLAFAXINE SUCCINATE,,,,0.6351351351,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DONEPEZIL HCL,,,,,,,,0.3636363636,,,,,,,,
  2 ,Age: 80-89 | Gender: Female | DOXEPIN HCL,,,,,0.4228675136,,,,,,0.4632206759,,,,,
  1 ,Age: 80-89 | Gender: Female | DOXEPIN HCL | Last AD: Same & No Remiss,,,,,0.09649122807,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DOXEPIN HCL | MIRTAZAPINE,,,,,,,,,,,0.362745098,,,,,
  1 ,Age: 80-89 | Gender: Female | DOXEPIN HCL | TRAZODONE HCL,,,,,,,,,,,0.368852459,,,,,
  6 ,Age: 80-89 | Gender: Female | DULOXETINE HCL,,,0.4126984127,,,0.4399203764,0.1620689655,,0.07490636704,,0.3795656466,,,0.4315068493,,
  2 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | ESCITALOPRAM OXALATE,,,,,,,0.2912087912,,,,0.3276836158,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | GABAPENTIN,,,,,,0.4901960784,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | GABAPENTIN | Last AD: Same & No Remiss,,,,,,0.1913043478,,,,,,,,,,
  2 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.2612612613,,,,0,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.3545454545,,,,,
  3 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,0.3761904762,,,,,0.4019607843,,,,0.007518796992,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.4833333333,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.2032828283,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | Last AD: Same & No Remiss | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.2115384615,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss,,,,,,0.755351682,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5804195804,,,,,
  1 ,"Age: 80-89 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,0.6831683168,,,,,,,,,,
  2 ,"Age: 80-89 | Gender: Female | DULOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,0.5014326648,,,,,0.4444444444,,,,,
  3 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.364764268,,,0.1991150442,,0.3817097416,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.3449781659,,,,,
  1 ,"Age: 80-89 | Gender: Female | DULOXETINE HCL | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.72,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5810055866,,,,,
  2 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL,,,,,,0.4235294118,,,,,0.6409266409,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5428571429,,,,,
  3 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | SERTRALINE HCL,,,,,,0.4742268041,,,,,0.5024390244,,,0.6276923077,,
  2 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.4187935035,,,,,0.429760666,,,,,
  1 ,Age: 80-89 | Gender: Female | DULOXETINE HCL | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.5912408759,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889),,,0.3263888889,,,,,,,,,,,,,
  11 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE,,0.05555555556,0.5289256198,,,0.2943548387,0.2486320438,0.3978494624,0.09752925878,,0.2408579466,0.324742268,,0.4012539185,0.01851851852,0.4464285714
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | FLUOXETINE HCL,,,,,,,0.2406015038,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN,,,,,,,0.2991452991,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | GABAPENTIN | Last AD: Same & No Remiss,,,,,,,0.1138211382,,,,,,,,,
  6 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,0.4611872146,,,0.2547169811,,,0.1061452514,,0.1517027864,,,0.3544776119,0.009049773756,
  3 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,0.148409894,,0.1363636364,,0.2770562771,,,,,
  1 ,"Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3",,,,,,,0.1313131313,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+,,,,,,,,,,,0.2772277228,,,,,
  1 ,"Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | TRAZODONE HCL",,,,,,,0.1485714286,,,,,,,,,
  2 ,"Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.1609498681,,,,,,,,0.008771929825,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.2056074766,,,,,
  3 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.1566731141,,,,0.2135678392,,,,0.007272727273,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Diff & Remiss,,,,,,,,,,,0.3714285714,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.09389671362,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.1953125,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.174863388,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | Num Previous Episodes: 2+,,,,,,,0.1352941176,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,,,,,0.04807692308,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.2283105023,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.7315175097,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.5871559633,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.05607476636,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.1603773585,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,0.64,,,,,,,,,
  2 ,"Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.2994454713,,,,0.273255814,,,,,
  3 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.2175792507,,0.1710914454,,0.2894736842,,,,,
  2 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,0.1465517241,,,,0.2303523035,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,,,,,0.380952381,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | OMEPRAZOLE,,,,,,,0.2818791946,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.2941176471,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | PAROXETINE HCL,,,,,,,,,,,,0.5,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6571428571,,,,,
  2 ,"Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,,,,,0.3106382979,,,,0.2168674699,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | RISPERIDONE,,,,,,,,,,,0.1543624161,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1287128713,,,,,
  2 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | ROPINIROLE HCL,,,,,,,0.1987951807,,,,0.5454545455,,,,,
  3 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,0.1566951567,,,,0.2976744186,,,0.5176151762,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3921568627,,,,,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | SIMVASTATIN,,,,,,,0.1923076923,,,,,,,,,
  3 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.2031484258,,,,0.2714636141,,,,0.01310043668,
  1 ,Age: 80-89 | Gender: Female | ESCITALOPRAM OXALATE | VENLAFAXINE HCL,,,,,,,,,,,0.3818181818,,,,,
  1 ,Age: 80-89 | Gender: Female | ESOMEPRAZOLE MAGNESIUM,,,0.325,,,,,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.3653136531,,,,,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011) | SIMVASTATIN",,,0.3185840708,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | FAMOTIDINE,,,,,,,0.03076923077,,,,,,,,,
  11 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL,,0.03870967742,0.4,,,0.262195122,0.1411764706,0.6063504987,0.1095890411,,0.3876723439,0.4196428571,,0.4380952381,0.02631578947,0.495412844
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | GABAPENTIN,,,,,,,,0.7272727273,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss,,,,,,,,,,,0.2845528455,,,,,
  1 ,"Age: 80-89 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.5609756098,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.5780346821,,,,,
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | Last AD: Diff & Remiss,,,,,,,,,,,0.4690265487,,,,,
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3517964072,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.831300813,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | FLUOXETINE HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,0.6585365854,,,,,,,,
  3 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,0.5525114155,0.2213114754,,0.462006079,,,,,
  1 ,"Age: 80-89 | Gender: Female | FLUOXETINE HCL | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,0.564516129,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6,,,,,
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.6974789916,,,,,
  2 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | SERTRALINE HCL,,,,,,,,0.523364486,,,,,,0.5329341317,,
  1 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | SIMVASTATIN,,,,,,,,0.754601227,,,,,,,,
  3 ,Age: 80-89 | Gender: Female | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.5810810811,,,0.5233160622,,,,0.02604166667,
  5 ,Age: 80-89 | Gender: Female | GABAPENTIN,,,0.3,,,0.1775862069,0.06603773585,0.3469387755,,,,,,0.373549884,,
  1 ,Age: 80-89 | Gender: Female | GABAPENTIN | SERTRALINE HCL,,,,,,,,,,,,,,0.7174887892,,
  1 ,Age: 80-89 | Gender: Female | GABAPENTIN | SIMVASTATIN,,,,,,,,,,,,,,0.4838709677,,
  1 ,Age: 80-89 | Gender: Female | GABAPENTIN | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.1450381679,,,,,,,,,,
  2 ,Age: 80-89 | Gender: Female | HEADACHE (dxo:ICD9:7840),0.0125,,,,,,,,,0.02380952381,,,,,,
  1 ,Age: 80-89 | Gender: Female | HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364),,,,,,,,,,,,,,,0.006211180124,
  2 ,Age: 80-89 | Gender: Female | HYDRALAZINE HCL,,,0.2761904762,,,,,,,,,,,0.3103448276,,
  1 ,Age: 80-89 | Gender: Female | HYDRALAZINE HCL | SERTRALINE HCL,,,,,,,,,,,,,,0.7008547009,,
  1 ,Age: 80-89 | Gender: Female | HYDROCODONE/ACETAMINOPHEN,,,,,,,,,,,,,,,0,
  1 ,Age: 80-89 | Gender: Female | IMIPRAMINE HCL,,,,,,,,,,,0.1132075472,,,,,
  3 ,"Age: 80-89 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,0.1313559322,,,,,0.3607954545,0.004811547715,
  1 ,"Age: 80-89 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.005940594059,
  1 ,"Age: 80-89 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | SERTRALINE HCL",,,,,,,,,,,,,,0.7028985507,,
  1 ,"Age: 80-89 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0.006622516556,
  1 ,"Age: 80-89 | Gender: Female | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | ZOLPIDEM TARTRATE",,,,,,,,,,,,,,,0.00495049505,
  1 ,Age: 80-89 | Gender: Female | LAMOTRIGINE,,,,,,,,,,,0.07239819005,,,,,
  1 ,Age: 80-89 | Gender: Female | LAMOTRIGINE | TRAZODONE HCL,,,,,,,,,,,0.1428571429,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss,,,,,,,,,,,,,,,0.01041666667,
  5 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE,,,0.2456140351,,,,0.04395604396,,,,0.2250755287,,,0.3301886792,0.01276595745,
  1 ,"Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL",,,,,,,,,,,,,,0.5488721805,,
  1 ,"Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5789473684,,
  1 ,"Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,,,,,,,,,0.008403361345,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,0.4504504505,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,0.1386138614,,,,,
  2 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.1756756757,,0.4961832061,,,,,
  3 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1517241379,,0.1867007673,,,,0.007299270073,
  1 ,"Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.523364486,,
  1 ,"Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5969827586,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5316455696,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL,,,,,,,,,,,0.2461538462,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4720496894,,,,,
  5 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL,,,0.2804232804,,,,0.04982206406,,0.06167400881,,0.3352826511,,,,0.004716981132,
  2 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5633187773,,,,0.01355932203,
  6 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL,,,0.3,,,,0.04242424242,,0.06299212598,,0.2281368821,,,0.3088235294,0.01153846154,
  2 ,Age: 80-89 | Gender: Female | Last AD: Diff & No Remiss | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.5089285714,,,,,0.5725806452
  2 ,Age: 80-89 | Gender: Female | Last AD: Diff & Remiss,,,,,,,,,0.1764705882,,,,,,0.0406779661,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE,,,,,,,,,0.380952381,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.6934306569,,
  2 ,Age: 80-89 | Gender: Female | Last AD: Diff & Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.2075471698,,,,,0.6993464052,,
  1 ,"Age: 80-89 | Gender: Female | Last AD: Diff & Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.7644230769,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & Remiss | PAROXETINE HCL,,,,,,,,,,,0.4392523364,,,,,
  4 ,Age: 80-89 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,0.2095238095,,0.1886792453,,0.5251798561,,,,0.03773584906,
  3 ,Age: 80-89 | Gender: Female | Last AD: Diff & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6176470588,,,0.7672413793,0.02604166667,
  1 ,Age: 80-89 | Gender: Female | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.0447761194,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss,,,,,,,,,,,0.1287128713,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.07883211679,,,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.2890625,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4030612245,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2075471698,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | MIRTAZAPINE | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.06993006993,,,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | NORTRIPTYLINE HCL,,,,,,,,,,0.01777777778,,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.4151785714,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | Num Previous Episodes: 2+ | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.2833607908,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.1666666667,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,,,0.1848739496,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.3514957265,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.3348623853,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4019607843,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | TRAMADOL HCL | TRAZODONE HCL,,,,,,,,,,,,,,,0,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.006789524733,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & No Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.3703703704
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss,,,,,,,,,,,0.5440613027,,,,,
  1 ,"Age: 80-89 | Gender: Female | Last AD: Same & Remiss | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.6893203883,,,,,
  2 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,0.5610687023,,0.6398390342,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,,,0.6435643564,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,,,0.6984126984,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5576923077,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.5472636816,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | Num Previous Episodes: 2+ | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.935483871,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.936,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.8452579035,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6577946768,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.525974026,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.7129909366,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.6348314607,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8216094541,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.873015873,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.6344086022,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6324786325,,,,,
  1 ,Age: 80-89 | Gender: Female | Last AD: Same & Remiss | VENLAFAXINE HCL,,,,,,,,,,,,,,,,0.7966101695
  1 ,Age: 80-89 | Gender: Female | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.3582966226,,
  1 ,Age: 80-89 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7052980132,,
  1 ,Age: 80-89 | Gender: Female | LEVOTHYROXINE SODIUM | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7317073171,,
  1 ,Age: 80-89 | Gender: Female | LEVOTHYROXINE SODIUM | SIMVASTATIN,,,,,,,,,,,,,,0.4470046083,,
  1 ,Age: 80-89 | Gender: Female | LISINOPRIL/HYDROCHLOROTHIAZIDE,,,0.32,,,,,,,,,,,,,
  3 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321),,,0.2534246575,,,,,,0.07896160087,,,,,0.3734439834,,
  1 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.09545454545,,,,,,,
  1 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.1642599278,,,,,,,
  1 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.1151079137,,,,,,,
  1 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1479289941,,,,,,,
  1 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | SERTRALINE HCL,,,,,,,,,0.0875,,,,,,,
  1 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | TRAZODONE HCL,,,,,,,,,0.06779661017,,,,,,,
  1 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,0.02941176471,,,,,,,
  1 ,Age: 80-89 | Gender: Female | LOSS OF WEIGHT (dxo:ICD9:78321) | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.08333333333,,,,,,,
  2 ,Age: 80-89 | Gender: Female | LOVASTATIN,,,0.3356164384,,,,0.07659574468,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.6873508353,,,,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636) | TRAZODONE HCL",,,,,,,,,,,0.6554621849,,,,,
  2 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.6537313433,,,,0.3865546218,
  2 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | MIRTAZAPINE",,,,,,,,,0.4409448819,,0.6320754717,,,,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | SERTRALINE HCL",,,,,,,,,,,,,,0.7178217822,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635) | TRAZODONE HCL",,,,,,,,,,,0.6381578947,,,,,
  9 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.2107279693,0.4436090226,,,0.3455497382,0.2405405405,,0.2084168337,,0.434864105,,,0.4772727273,0.1232323232,0.5267857143
  2 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.298791019,,0.4416107383,,,,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | SERTRALINE HCL",,,,,,,,,0.3465346535,,,,,,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE | TRAZODONE HCL",,,,,,,,,,,0.384083045,,,,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | PAROXETINE HCL",,,,,,,,,,,,0.5944444444,,,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | ROPINIROLE HCL",,,,,,,,,,,0.5535714286,,,,,
  2 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,0.5,,,0.7438271605,,
  1 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,0.4859813084,,,,,
  2 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.450888681,,,,0.1412639405,
  2 ,"Age: 80-89 | Gender: Female | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | VENLAFAXINE HCL",,,,,,,,,,,0.4827586207,,,,,0.6147540984
  2 ,"Age: 80-89 | Gender: Female | MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",,,,,,,,,,,,,,0.3241758242,,0.3247863248
  1 ,Age: 80-89 | Gender: Female | MECLIZINE HCL,,,,,,,,,,,,,,0.2941176471,,
  1 ,Age: 80-89 | Gender: Female | METFORMIN HCL,,,,,,,,,0.1057692308,,,,,,,
  7 ,Age: 80-89 | Gender: Female | MIRTAZAPINE,,,0.2473404255,,,0.1653846154,0.08409090909,,0.1866873065,,0.3610426663,,,0.337398374,0.005649717514,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | NORTRIPTYLINE HCL,,,,,,,,,,,0.32,,,,,
  1 ,"Age: 80-89 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 2,3 | SERTRALINE HCL",,,,,,,,,,,,,,0.5806451613,,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3288135593,,,,,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.2831858407,,,,,
  3 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | PAROXETINE HCL,,,,,,,,,0.2127659574,,0.406779661,0.5514403292,,,,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5859872611,,,,,
  1 ,"Age: 80-89 | Gender: Female | MIRTAZAPINE | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,,,,,,,,,0.2796610169,,,,,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | RISPERIDONE,,,,,,,,,,,0.171641791,,,,,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1215686275,,,,,
  2 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,0.2049180328,,0.5214953271,,,,,
  3 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.1683731513,,0.4440677966,,,0.5741106719,,
  2 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4032258065,,,0.5,,
  3 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1561712846,,0.3259237875,,,,0,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4124293785,,,,,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,0.2038834951,,,,,,,
  1 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.2464788732,,,,,,,
  3 ,Age: 80-89 | Gender: Female | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,0.1870503597,,0.3959276018,,,,,0.5842105263
  2 ,Age: 80-89 | Gender: Female | NORTRIPTYLINE HCL,,,,,,,,,,0.09665427509,0.364,,,,,
  1 ,Age: 80-89 | Gender: Female | NORTRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3374233129,,,,,
  1 ,"Age: 80-89 | Gender: Female | Num Previous Antidep: 2,3 | PAROXETINE HCL | TRAZODONE HCL",,,,,,,,,,,,0.5247524752,,,,
  1 ,"Age: 80-89 | Gender: Female | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5987903226,,
  1 ,Age: 80-89 | Gender: Female | Num Previous Antidep: 4+,,,,,,,,,,,0.35,,,,,
  1 ,Age: 80-89 | Gender: Female | Num Previous Antidep: 4+ | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.4587155963,,,,,
  1 ,Age: 80-89 | Gender: Female | Num Previous Antidep: 4+ | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4649681529,,,,,
  1 ,Age: 80-89 | Gender: Female | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3253588517,,,,,
  1 ,Age: 80-89 | Gender: Female | Num Previous Remissions: 2+ | SERTRALINE HCL,,,,,,,,,,,,,,0.9172932331,,
  1 ,"Age: 80-89 | Gender: Female | OBESITY, UNSPECIFIED (dxo:ICD9:27800)",,,,,,,,,0.1297709924,,,,,,,
  3 ,Age: 80-89 | Gender: Female | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.4071856287,,,,0.09090909091,,,,,,,0.3095238095,,
  1 ,Age: 80-89 | Gender: Female | OLMESARTAN MEDOXOMIL,,,,,,,0.09482758621,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | OMEPRAZOLE,,,,,,,0.07988980716,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | OTHER DISORDERS OF BONE AND CARTILAGE (dxo:ICD9:73399),,,,,,,,,0.07185628743,,,,,,,
  2 ,Age: 80-89 | Gender: Female | OTHER MALAISE AND FATIGUE (dxo:ICD9:78079),,,,,,0.1959459459,,,,,,,,,0.006944444444,
  1 ,Age: 80-89 | Gender: Female | OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319),,,0.347107438,,,,,,,,,,,,,
  2 ,Age: 80-89 | Gender: Female | OTHER PERSISTENT MENTAL DISORDERS DUE TO CONDITIONS CLASSIFIED ELSEWHERE (dxo:ICD9:2948),,,0.3925233645,,,,,,0.144,,,,,,,
  1 ,Age: 80-89 | Gender: Female | OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612),0.008333333333,,,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | OXYBUTYNIN CHLORIDE,,,,,,,0.09259259259,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | PALPITATIONS (dxo:ICD9:7851),,,,,,,0.03592814371,,,,,,,,,
  4 ,Age: 80-89 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320),,,0.3493150685,,,,0.07462686567,,,,0.4829931973,,,0.3948717949,,
  1 ,Age: 80-89 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5523809524,,,,,
  2 ,Age: 80-89 | Gender: Female | PARALYSIS AGITANS (dxo:ICD9:3320) | SERTRALINE HCL,,,,,,,,,,,0.4196428571,,,0.6944444444,,
  10 ,Age: 80-89 | Gender: Female | PAROXETINE HCL,,0.01694915254,0.4135338346,,,0.347826087,0.159375,0.375,0.1244635193,,0.3666666667,0.5948601663,,0.387283237,0.01401869159,
  1 ,Age: 80-89 | Gender: Female | PAROXETINE HCL | ROPINIROLE HCL,,,,,,,,,,,0.701754386,,,,,
  2 ,Age: 80-89 | Gender: Female | PAROXETINE HCL | SERTRALINE HCL,,,,,,,,,,,,0.5068493151,,0.5620437956,,
  3 ,Age: 80-89 | Gender: Female | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4439655172,0.5265082267,,,0.02745098039,
  1 ,Age: 80-89 | Gender: Female | PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742),,,,,,,,,,,,,,,0.009523809524,
  1 ,Age: 80-89 | Gender: Female | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5786285961,,,,,
  1 ,Age: 80-89 | Gender: Female | PRAMIPEXOLE DI-HCL | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,0.6355140187,,,,,
  1 ,Age: 80-89 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.5607638889,,,,,
  1 ,Age: 80-89 | Gender: Female | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.5939849624,,,,,
  2 ,Age: 80-89 | Gender: Female | PRAMIPEXOLE DI-HCL | SERTRALINE HCL,,,,,,,,,,,0.5854700855,,,0.5705521472,,
  1 ,Age: 80-89 | Gender: Female | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.5011185682,,,,,
  2 ,Age: 80-89 | Gender: Female | PRAVASTATIN SODIUM,,,0.2542372881,,,,,,,,,,,0.4253246753,,
  1 ,Age: 80-89 | Gender: Female | PRAVASTATIN SODIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.76,,
  2 ,Age: 80-89 | Gender: Female | PREGABALIN,,,,,,0.1923076923,,,,,,,,0.3985507246,,
  3 ,"Age: 80-89 | Gender: Female | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,0.3011235955,,,,0.07724719101,,,,0.216,,,,,
  1 ,"Age: 80-89 | Gender: Female | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010) | SERTRALINE HCL",,,,,,,,,,,0.4675324675,,,,,
  2 ,Age: 80-89 | Gender: Female | PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511),,,,,,,,,0.04411764706,,,,,0.3612903226,,
  3 ,Age: 80-89 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,0.1985294118,,,,0.08695652174,,,,,,,0.3038869258,,
  1 ,"Age: 80-89 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,0.2352941176,,
  1 ,Age: 80-89 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791) | SERTRALINE HCL,,,,,,,,,,,,,,0.6363636364,,
  2 ,Age: 80-89 | Gender: Female | PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792),,,0.3157894737,,,,,,,,,,,0.4114583333,,
  4 ,Age: 80-89 | Gender: Female | PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801),,,0.252688172,,,,0.07,,0.04,,,,,0.3170731707,,
  1 ,"Age: 80-89 | Gender: Female | PSYCHOTHERAPY, 30 MINUTES WITH PATIENT (px:CPT4:90832)",,,,,,,,,0.03529411765,,,,,,,
  3 ,"Age: 80-89 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,0.1268656716,,,,0.04568527919,,,,,,,0.2356020942,,
  1 ,"Age: 80-89 | Gender: Female | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834) | SERTRALINE HCL",,,,,,,,,,,0.1818181818,,,,,
  1 ,Age: 80-89 | Gender: Female | RANITIDINE HCL,,,,,,,0.0652173913,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,,,0.2283464567,,,
  2 ,Age: 80-89 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,0.4083969466,,0.5040871935,,,
  2 ,Age: 80-89 | Gender: Female | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6936936937,,0.3846153846,,,
  5 ,Age: 80-89 | Gender: Female | RISPERIDONE,,,0.1630434783,,,,0.048,,0.01570680628,,0.1559370529,,,0.2085561497,,
  2 ,Age: 80-89 | Gender: Female | RISPERIDONE | SERTRALINE HCL,,,,,,,,,,,0.1835443038,,,0.2066115702,,
  2 ,Age: 80-89 | Gender: Female | RISPERIDONE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.1176470588,,,0.2338709677,,
  1 ,Age: 80-89 | Gender: Female | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1368015414,,,,,
  4 ,Age: 80-89 | Gender: Female | ROPINIROLE HCL,,,,,,,,,0.05769230769,,0.5344628417,,0.4401664932,0.2475247525,,
  3 ,Age: 80-89 | Gender: Female | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6398713826,,0.4375,0.5589353612,,
  2 ,Age: 80-89 | Gender: Female | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.467791411,,,,0,
  1 ,Age: 80-89 | Gender: Female | ROPINIROLE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.624,,,,,
  1 ,Age: 80-89 | Gender: Female | ROSUVASTATIN CALCIUM,,,,,,,,,,,,,,0.3440366972,,
  1 ,Age: 80-89 | Gender: Female | ROSUVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7238095238,,
  1 ,Age: 80-89 | Gender: Female | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,,0.01136363636,
  12 ,Age: 80-89 | Gender: Female | SERTRALINE HCL,0.0157480315,0.04761904762,0.3317013464,,,0.2826086957,0.1257253385,0.3551912568,0.1089108911,,0.4251587542,0.3059210526,,0.6159116863,0.01140684411,0.3723849372
  2 ,Age: 80-89 | Gender: Female | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,0.4388489209,,,0.7331701346,,
  3 ,Age: 80-89 | Gender: Female | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.4965800274,,,0.5581395349,0.01621621622,
  1 ,Age: 80-89 | Gender: Female | SERTRALINE HCL | VENLAFAXINE HCL,,,,,,,,,,,,,,0.632183908,,
  5 ,Age: 80-89 | Gender: Female | SIMVASTATIN,,,0.3264984227,,,,0.04501607717,0.4126213592,,,0.2137931034,,,0.4269304403,,
  1 ,Age: 80-89 | Gender: Female | TEMAZEPAM,,,,,,,,,,,,,,,0.007874015748,
  2 ,Age: 80-89 | Gender: Female | TRAMADOL HCL,,,,,,0.1725663717,,,,,,,,,0.01836734694,
  10 ,Age: 80-89 | Gender: Female | TRAZODONE HCL,,0.04464285714,0.2928571429,,,0.2124183007,0.07600950119,0.2266666667,0.05335968379,,0.3725424858,,,0.3031914894,0.01560486757,0.2553191489
  3 ,Age: 80-89 | Gender: Female | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4613050076,,,,0.05844155844,0.5373443983
  1 ,Age: 80-89 | Gender: Female | UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491),,,,,,,0.03980099502,,,,,,,,,
  1 ,Age: 80-89 | Gender: Female | UNSPECIFIED CONSTIPATION (dxo:ICD9:56400),,,,,,,,,,,,,,0.3759398496,,
  2 ,Age: 80-89 | Gender: Female | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,0.08278867102,,,,,,0,
  1 ,Age: 80-89 | Gender: Female | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019) | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.1111111111,,,,,,,
  2 ,Age: 80-89 | Gender: Female | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.1698564593,,,,,,,,0.3435582822,,
  1 ,Age: 80-89 | Gender: Female | UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300),,,,,,,,,0.09752747253,,,,,,,
  2 ,Age: 80-89 | Gender: Female | UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689),,,,,,,,,0.07975460123,,,,,0.40625,,
  1 ,"Age: 80-89 | Gender: Female | URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",,,,,,,,,,,,,,0.3043478261,,
  1 ,Age: 80-89 | Gender: Female | VALSARTAN,,,,,,,0.02941176471,,,,,,,,,
  7 ,Age: 80-89 | Gender: Female | VENLAFAXINE HCL,,,0.3931034483,,,,0.1605839416,,0.072,,0.3955719557,,,0.39453125,0.02702702703,0.5916292975
  1 ,Age: 80-89 | Gender: Female | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0.01090909091,
  16 ,Age: 80-89 | Gender: Male,0.02093397746,0.05571847507,0.465679677,0.5407407407,0.2550091075,0.3226809955,0.1726860992,0.4873153053,0.1524376021,0.07056798623,0.4189134079,0.4661218931,0.3845060412,0.5145301781,0.01517389553,0.5233918129
  2 ,Age: 80-89 | Gender: Male | AMITRIPTYLINE HCL,0.03183520599,,,,,,,,,,0.4031007752,,,,,
  1 ,Age: 80-89 | Gender: Male | AMITRIPTYLINE HCL | Last AD: Same & No Remiss,0.005882352941,,,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Male | AMITRIPTYLINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3308823529,,,,,
  1 ,Age: 80-89 | Gender: Male | AMLODIPINE BESYLATE,,,,,,,,,,,,,,,0,
  1 ,Age: 80-89 | Gender: Male | ANOREXIA (dxo:ICD9:7830),,,,,,,,,0.100591716,,,,,,,
  1 ,Age: 80-89 | Gender: Male | ANOREXIA (dxo:ICD9:7830) | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.1140350877,,,,,,,
  1 ,"Age: 80-89 | Gender: Male | ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",,,,,,,0.0612244898,,,,,,,,,
  1 ,Age: 80-89 | Gender: Male | ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400),,,,,,,,,,,,,,,0.008620689655,
  1 ,"Age: 80-89 | Gender: Male | ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)",,,0.3274336283,,,,,,,,,,,,,
  3 ,Age: 80-89 | Gender: Male | ATORVASTATIN CALCIUM,,,0.3434343434,,,,,0.4285714286,,,,,,0.4441687345,,
  1 ,Age: 80-89 | Gender: Male | ATORVASTATIN CALCIUM | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8173076923,,
  1 ,Age: 80-89 | Gender: Male | ATORVASTATIN CALCIUM | SERTRALINE HCL,,,,,,,,,,,,,,0.7532894737,,
  3 ,Age: 80-89 | Gender: Male | BUPROPION HCL,,0.04,,,,,,,,,0.422832981,,,0.4298245614,,
  2 ,Age: 80-89 | Gender: Male | BUPROPION HCL | CITALOPRAM HYDROBROMIDE,,,0.5319148936,,,,,,,,0.5593220339,,,,,
  2 ,Age: 80-89 | Gender: Male | BUPROPION HCL | ESCITALOPRAM OXALATE,,,,,,,0.3196721311,,,,0.3529411765,,,,,
  1 ,Age: 80-89 | Gender: Male | BUPROPION HCL | Last AD: Same & No Remiss,,0.04186046512,,,,,,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Male | BUPROPION HCL | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,,,,,0.5357142857,,,,,
  1 ,Age: 80-89 | Gender: Male | BUPROPION HCL | MIRTAZAPINE,,,,,,,,,,,0.3946188341,,,,,
  1 ,Age: 80-89 | Gender: Male | BUPROPION HCL | ROPINIROLE HCL,,,,,,,,,,,0.5294117647,,,,,
  2 ,Age: 80-89 | Gender: Male | BUPROPION HCL | SERTRALINE HCL,,,,,,,,,,,0.5555555556,,,0.612244898,,
  2 ,Age: 80-89 | Gender: Male | BUPROPION HCL | TRAZODONE HCL,,0.04724409449,,,,,,,,,0.3115577889,,,,,
  9 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE,,0.01801801802,0.581498829,,,0.3023255814,0.2113207547,0.496,0.09917355372,,0.4176182708,,,0.5438596491,0.006211180124,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | ESCITALOPRAM OXALATE,,,,,,,0.2566371681,,,,,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss,,,,,,,,,,,0.3663366337,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,,,0.4840764331,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Diff & Remiss,,,,,,,,,,,0.512,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & No Remiss,,,0.3054607509,,,,,,,,,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | Last AD: Same & Remiss,,,0.8104166667,,,,,,,,,,,,,
  3 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE,,,0.5546558704,,,,,,0.1301369863,,0.4514106583,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.35,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | PARALYSIS AGITANS (dxo:ICD9:3320),,,,,,,,,,,0.4513274336,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | ROPINIROLE HCL,,,,,,,,,,,0.5272727273,,,,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | SERTRALINE HCL,,,,,,,,,,,,,,0.6460176991,,
  1 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | SIMVASTATIN,,,0.6934306569,,,,,,,,,,,,,
  3 ,Age: 80-89 | Gender: Male | CITALOPRAM HYDROBROMIDE | TRAZODONE HCL,,,0.4915572233,,,,,,,,0.501953125,,,,0.007299270073,
  1 ,"Age: 80-89 | Gender: Male | DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",,,,,,,,,,,,,,,0.008163265306,
  3 ,Age: 80-89 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101),,,0.3824561404,,,,0.09157509158,,0.1055662188,,,,,,,
  1 ,Age: 80-89 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | LOSS OF WEIGHT (dxo:ICD9:78321),,,,,,,,,0.1180555556,,,,,,,
  1 ,Age: 80-89 | Gender: Male | DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101) | MIRTAZAPINE,,,,,,,,,0.1818181818,,,,,,,
  2 ,Age: 80-89 | Gender: Male | DOXEPIN HCL,,,,,0.4173913043,,,,,,0.3540372671,,,,,
  3 ,Age: 80-89 | Gender: Male | DULOXETINE HCL,,,,,,0.4397506925,,,,,0.4413919414,,,0.4230769231,,
  1 ,Age: 80-89 | Gender: Male | DULOXETINE HCL | Last AD: Same & No Remiss,,,,,,0.2592592593,,,,,,,,,,
  2 ,Age: 80-89 | Gender: Male | DULOXETINE HCL | MIRTAZAPINE,,,,,,0.4761904762,,,,,0.2698412698,,,,,
  2 ,Age: 80-89 | Gender: Male | DULOXETINE HCL | TRAZODONE HCL,,,,,,0.4202898551,,,,,0.3705357143,,,,,
  6 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE,,,0.5473684211,,,,0.2695547533,,0.1450980392,,0.2654867257,,,0.4892307692,0.01142857143,
  2 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss,,,,,,,,,,,0.1380952381,,,0.3898305085,,
  1 ,"Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | TRAZODONE HCL",,,,,,,0.2028985507,,,,,,,,,
  2 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,0.2277777778,,,,0.237704918,,,,,
  1 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & No Remiss,,,,,,,0.1060820368,,,,,,,,,
  1 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | Last AD: Same & Remiss,,,,,,,0.6772486772,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,,,,,,0.3313253012,,,,,,,,,
  3 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | MIRTAZAPINE,,,,,,,0.2554347826,,0.1931818182,,0.3617021277,,,,,
  1 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.2,,,,,
  1 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | SERTRALINE HCL,,,,,,,,,,,,,,0.5350877193,,
  3 ,Age: 80-89 | Gender: Male | ESCITALOPRAM OXALATE | TRAZODONE HCL,,,,,,,0.2219626168,,,,0.2702702703,,,,0.02666666667,
  1 ,"Age: 80-89 | Gender: Male | ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",,,0.4019607843,,,,,,,,,,,,,
  5 ,Age: 80-89 | Gender: Male | FLUOXETINE HCL,,,,,,,0.2,0.6093445814,0.0962962963,,0.4125874126,,,0.4632768362,,
  1 ,Age: 80-89 | Gender: Male | FLUOXETINE HCL | Last AD: Same & No Remiss,,,,,,,,0.3640776699,,,,,,,,
  1 ,Age: 80-89 | Gender: Male | FLUOXETINE HCL | Last AD: Same & Remiss,,,,,,,,0.8164556962,,,,,,,,
  1 ,Age: 80-89 | Gender: Male | FLUOXETINE HCL | MIRTAZAPINE,,,,,,,,,,,0.5148514851,,,,,
  2 ,Age: 80-89 | Gender: Male | FLUOXETINE HCL | TRAZODONE HCL,,,,,,,,0.5922330097,,,0.5279187817,,,,,
  3 ,Age: 80-89 | Gender: Male | GABAPENTIN,,,,,,0.2039215686,0.1272727273,,,,,,,0.4494382022,,
  1 ,Age: 80-89 | Gender: Male | HYDRALAZINE HCL,,,,,,,,,,,,,,0.4471544715,,
  3 ,"Age: 80-89 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",,,,,,,,,0.1145038168,,,,,0.3870967742,0.01453957997,
  1 ,"Age: 80-89 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | Last AD: Same & No Remiss | TRAZODONE HCL",,,,,,,,,,,,,,,0.007751937984,
  1 ,"Age: 80-89 | Gender: Male | INSOMNIA, UNSPECIFIED (dxo:ICD9:78052) | TRAZODONE HCL",,,,,,,,,,,,,,,0,
  1 ,Age: 80-89 | Gender: Male | Last AD: Diff & No Remiss,,,,,,,,,,,,,,,0.01104972376,
  2 ,Age: 80-89 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE,,,,,,,,,,,0.2431372549,,,,0,
  2 ,Age: 80-89 | Gender: Male | Last AD: Diff & No Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1454545455,,0.2058823529,,,,,
  1 ,"Age: 80-89 | Gender: Male | Last AD: Diff & No Remiss | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5632911392,,
  2 ,Age: 80-89 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL,,,,,,,,,,,0.2938596491,,,,0.009523809524,
  2 ,Age: 80-89 | Gender: Male | Last AD: Diff & No Remiss | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5722543353,,,,0.009009009009,
  3 ,Age: 80-89 | Gender: Male | Last AD: Diff & No Remiss | TRAZODONE HCL,,,,,,,,,0.04310344828,,0.2493297587,,,,0.005882352941,
  1 ,Age: 80-89 | Gender: Male | Last AD: Diff & Remiss,,,,,,,,,,,,,,,0.05882352941,
  1 ,Age: 80-89 | Gender: Male | Last AD: Diff & Remiss | SERTRALINE HCL,,,,,,,,,,,0.5088757396,,,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Diff & Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.05042016807,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.1033973412,,,,,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & No Remiss | PAROXETINE HCL,,,,,,,,,,,,0.2696629213,,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & No Remiss | ROPINIROLE HCL,,,,,,,,,,,,,0.3235294118,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & No Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.374260355,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & No Remiss | TRAZODONE HCL,,,,,,,,,,,,,,,0.00920598389,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss,,,,,,,,,,,0.534351145,,,,,
  2 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss | MIRTAZAPINE,,,,,,,,,0.592,,0.6442307692,,,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,,,0.5537190083,,,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss | PAROXETINE HCL,,,,,,,,,,,,0.8538011696,,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.7008196721,,,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss | ROPINIROLE HCL,,,,,,,,,,,0.5652173913,,,,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL,,,,,,,,,,,,,,0.8306332842,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.8287671233,,
  1 ,Age: 80-89 | Gender: Male | Last AD: Same & Remiss | TRAZODONE HCL,,,,,,,,,,,0.6878612717,,,,,
  1 ,Age: 80-89 | Gender: Male | LEVOTHYROXINE SODIUM,,,,,,,,,,,,,,0.3722627737,,
  2 ,Age: 80-89 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321),,,0.3605442177,,,,,,0.1030150754,,,,,,,
  1 ,Age: 80-89 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321) | Last AD: Same & No Remiss | MIRTAZAPINE,,,,,,,,,0.134751773,,,,,,,
  1 ,Age: 80-89 | Gender: Male | LOSS OF WEIGHT (dxo:ICD9:78321) | MIRTAZAPINE,,,,,,,,,0.2325581395,,,,,,,
  2 ,Age: 80-89 | Gender: Male | LOVASTATIN,,,0.4,,,,0.1100917431,,,,,,,,,
  1 ,"Age: 80-89 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",,,,,,,,,,,0.671641791,,,,,
  1 ,"Age: 80-89 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",,,,,,,,,,,0.6263345196,,,,,
  5 ,"Age: 80-89 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",,0.2389380531,,,,,0.1901408451,,0.1937172775,,0.4502446982,,,,0.07692307692,
  2 ,"Age: 80-89 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | MIRTAZAPINE",,,,,,,,,0.3554216867,,0.4801980198,,,,,
  1 ,"Age: 80-89 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | SERTRALINE HCL",,,,,,,,,,,,,,0.8118811881,,
  1 ,"Age: 80-89 | Gender: Male | MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630) | TRAZODONE HCL",,,,,,,,,,,0.4574132492,,,,,
  5 ,Age: 80-89 | Gender: Male | MIRTAZAPINE,,,0.3553719008,,,,0.1071428571,,0.2249745504,,0.4036885246,,,0.3619047619,,
  1 ,Age: 80-89 | Gender: Male | MIRTAZAPINE | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.5603448276,,,,,
  1 ,Age: 80-89 | Gender: Male | MIRTAZAPINE | ROPINIROLE HCL,,,,,,,,,,,0.4634146341,,,,,
  3 ,Age: 80-89 | Gender: Male | MIRTAZAPINE | SERTRALINE HCL,,,,,,,,,0.178030303,,0.5063291139,,,0.6178861789,,
  1 ,Age: 80-89 | Gender: Male | MIRTAZAPINE | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.3664122137,,,,,
  2 ,Age: 80-89 | Gender: Male | MIRTAZAPINE | TRAZODONE HCL,,,,,,,,,0.1739130435,,0.321536906,,,,,
  1 ,Age: 80-89 | Gender: Male | MIRTAZAPINE | VENLAFAXINE HCL,,,,,,,,,,,0.4833333333,,,,,
  2 ,Age: 80-89 | Gender: Male | NORTRIPTYLINE HCL,,,,,,,,,,0.1187214612,0.3333333333,,,,,
  1 ,"Age: 80-89 | Gender: Male | Num Previous Antidep: 2,3 | SERTRALINE HCL | TRAZODONE HCL",,,,,,,,,,,,,,0.5568862275,,
  1 ,Age: 80-89 | Gender: Male | Num Previous Antidep: 4+ | TRAZODONE HCL,,,,,,,,,,,0.3818181818,,,,,
  3 ,Age: 80-89 | Gender: Male | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723),,,0.414507772,,,,0.06912442396,,,,,,,0.503875969,,
  1 ,Age: 80-89 | Gender: Male | OMEPRAZOLE,,,,,,,0.1161290323,,,,,,,,,
  5 ,Age: 80-89 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320),,,0.3333333333,,,,0.07518796992,,,,0.4736842105,,,0.4339622642,0,
  2 ,Age: 80-89 | Gender: Male | PARALYSIS AGITANS (dxo:ICD9:3320) | SERTRALINE HCL,,,,,,,,,,,0.5344827586,,,0.691588785,,
  3 ,Age: 80-89 | Gender: Male | PAROXETINE HCL,,,,,,,,,,,0.396039604,0.6112637363,,0.4571428571,,
  2 ,Age: 80-89 | Gender: Male | PAROXETINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5319148936,0.6068965517,,,,
  1 ,Age: 80-89 | Gender: Male | PRAMIPEXOLE DI-HCL,,,,,,,,,,,0.6040723982,,,,,
  1 ,Age: 80-89 | Gender: Male | PRAMIPEXOLE DI-HCL | ROPINIROLE HCL,,,,,,,,,,,0.5628415301,,,,,
  1 ,Age: 80-89 | Gender: Male | PRAMIPEXOLE DI-HCL | TRAZODONE HCL,,,,,,,,,,,0.5464788732,,,,,
  1 ,Age: 80-89 | Gender: Male | PRAVASTATIN SODIUM,,,,,,,,,,,,,,0.4285714286,,
  2 ,"Age: 80-89 | Gender: Male | PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",,,0.3006134969,,,,0.1064516129,,,,,,,,,
  1 ,Age: 80-89 | Gender: Male | PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511),,,,,,,,,0.1111111111,,,,,,,
  1 ,Age: 80-89 | Gender: Male | PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791),,,,,,,,,,,,,,0.3065693431,,
  1 ,"Age: 80-89 | Gender: Male | PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",,,,,,,,,,,,,,0.23,,
  1 ,Age: 80-89 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394),,,,,,,,,,,,,0.2403846154,,,
  1 ,Age: 80-89 | Gender: Male | RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394) | ROPINIROLE HCL,,,,,,,,,,,,,0.5423728814,,,
  1 ,Age: 80-89 | Gender: Male | RISPERIDONE,,,,,,,,,,,0.1885245902,,,,,
  1 ,Age: 80-89 | Gender: Male | RISPERIDONE | TRAZODONE HCL,,,,,,,,,,,0.1299435028,,,,,
  2 ,Age: 80-89 | Gender: Male | ROPINIROLE HCL,,,,,,,,,,,0.4938547486,,0.4912516824,,,
  2 ,Age: 80-89 | Gender: Male | ROPINIROLE HCL | SERTRALINE HCL,,,,,,,,,,,0.6446280992,,,0.619047619,,
  1 ,Age: 80-89 | Gender: Male | ROPINIROLE HCL | TRAZODONE HCL,,,,,,,,,,,0.4038461538,,,,,
  1 ,Age: 80-89 | Gender: Male | ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700),,,,,,,,,,,,,,,0.01162790698,
  10 ,Age: 80-89 | Gender: Male | SERTRALINE HCL,,0.05084745763,0.4103585657,,,0.3865546218,0.1467576792,0.4551724138,0.09798994975,,0.4313253012,0.3448275862,,0.6335877863,0.02057613169,
  1 ,Age: 80-89 | Gender: Male | SERTRALINE HCL | SIMVASTATIN,,,,,,,,,,,,,,0.7785234899,,
  3 ,Age: 80-89 | Gender: Male | SERTRALINE HCL | TRAZODONE HCL,,,,,,,,,,,0.5284872299,,,0.5486725664,0.01,
  4 ,Age: 80-89 | Gender: Male | SIMVASTATIN,,,0.4143646409,,,,0.1348314607,0.4416666667,,,,,,0.4682814302,,
  1 ,Age: 80-89 | Gender: Male | TAMSULOSIN HCL,,,,,,,,,0.1115384615,,,,,,,
  1 ,Age: 80-89 | Gender: Male | TRAMADOL HCL,,,,,,,,,,,,,,,0,
  6 ,Age: 80-89 | Gender: Male | TRAZODONE HCL,,,0.3216374269,,,,0.07975460123,,0.1198156682,,0.3845238095,,,0.2923728814,0.0137342242,
  2 ,Age: 80-89 | Gender: Male | TRAZODONE HCL | VENLAFAXINE HCL,,,,,,,,,,,0.4293478261,,,,,0.624
  1 ,Age: 80-89 | Gender: Male | UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491),,,,,,,0.06349206349,,,,,,,,,
  2 ,Age: 80-89 | Gender: Male | UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019),,,,,,,,,0.1638418079,,,,,,0,
  1 ,Age: 80-89 | Gender: Male | UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291),,,,,,0.2352941176,,,,,,,,,,
  2 ,Age: 80-89 | Gender: Male | VENLAFAXINE HCL,,,,,,,,,,,0.4195979899,,,,,0.6362735382
  1 ,Age: 80-89 | Gender: Male | ZOLPIDEM TARTRATE,,,,,,,,,,,,,,,0,